<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC1142204/results/search/disease/results.xml">
   <result pre="has increased considerably, especially for chronic conditions such as cancer," exact="rheumatoid arthritis" post="and cystic fibrosis in which pain may be a"/>
   <result pre="increased considerably, especially for chronic conditions such as cancer, rheumatoid" exact="arthritis" post="and cystic fibrosis in which pain may be a"/>
   <result pre="especially for chronic conditions such as cancer, rheumatoid arthritis and" exact="cystic fibrosis" post="in which pain may be a significant problem. Despite"/>
   <result pre="use among pediatric patients with chronic conditions such as cancer," exact="rheumatoid arthritis" post="and cystic fibrosis range from 30 to 70% ("/>
   <result pre="among pediatric patients with chronic conditions such as cancer, rheumatoid" exact="arthritis" post="and cystic fibrosis range from 30 to 70% ("/>
   <result pre="patients with chronic conditions such as cancer, rheumatoid arthritis and" exact="cystic fibrosis" post="range from 30 to 70% ( 6, 7). For"/>
   <result pre="children referred to an acupuncturist for chronic pain problems (e.g." exact="migraine" post="headaches, endometriosis and reflex sympathetic dystrophy), 67% reported that"/>
   <result pre="to an acupuncturist for chronic pain problems (e.g. migraine headaches," exact="endometriosis" post="and reflex sympathetic dystrophy), 67% reported that acupuncture was"/>
   <result pre="were referred for a variety of problems including myofacial and" exact="migraine" post="headaches (46%), abdominal pain (21%), fibromyalgia (11%) and complex"/>
   <result pre="problems including myofacial and migraine headaches (46%), abdominal pain (21%)," exact="fibromyalgia" post="(11%) and complex regional pain syndrome, type I, of"/>
   <result pre="and migraine headaches (46%), abdominal pain (21%), fibromyalgia (11%) and" exact="complex regional pain syndrome," post="type I, of an extremity (11%). Treatment comprised six"/>
   <result pre="by Pintov and colleagues, 22 patients aged 7–15 years with" exact="migraine" post="headaches received either true acupuncture or placebo acupuncture (superficial"/>
   <result pre="of the endogenous opioid antinociceptive system has been proposed in" exact="migraine" post="( 20, 21), blood samples were taken to examine"/>
   <result pre="showed that the true acupuncture group had clear reductions in" exact="migraine" post="frequency and severity. In addition, panopioid activity in plasma"/>
   <result pre="receiving medication were excluded from the study, even though many" exact="migraine" post="patients are on regular, prophylactic and/or as needed medications."/>
   <result pre="Thus, the study sample may not be representative of pediatric" exact="migraine" post="patients. Also, no information on refusal rates was reported,"/>
   <result pre="on pain in children, with the majority focused on pediatric" exact="migraine" post="and a few on tension headache. The most frequently"/>
   <result pre="Hermann and Blanchard ( 22) maintain that TBF for pediatric" exact="migraine" post="may be considered ‘possibly efficacious’ according to the APA"/>
   <result pre="the limited available data on the natural course of pediatric" exact="migraine" post="suggest that alternative, non-specific factors (e.g. growing out of"/>
   <result pre="study reported moderate pain relief in eight children with juvenile" exact="arthritis" post="who were treated with a package containing progressive muscle"/>
   <result pre="in one case-controlled study on AT ( 34), children with" exact="leukemia" post="(aged 2–14 years) administered an AT package were compared"/>
   <result pre="naturopathic herbal extract (NHE) on ear pain associated with acute" exact="otitis media" post="(AOM) ( 43, 44). In the first study, 103"/>
   <result pre="and related symptoms in 50 children (ages 8–12 years) with" exact="irritable bowel syndrome" post="( 48). By the end of the 2 week"/>
   <result pre="focused on the management of acute procedural pain, particularly in" exact="cancer" post="patients. In their recent, comprehensive review, Wild and Espie"/>
   <result pre="as the two most painful and distressing procedures associated with" exact="cancer" post="treatment ( 55). Following guidelines published by the Canadian"/>
   <result pre="manual-based clinical hypnosis intervention in alleviating pain in 80 pediatric" exact="cancer" post="patients (6–16 years of age) undergoing regular LP. Patients"/>
   <result pre="( 75) compared propranolol, placebo and self-hypnosis in 28 pediatric" exact="migraine" post="patients (aged 6–12 years). The results indicated that self-hypnosis"/>
   <result pre="relaxation/self-hypnosis/guided imagery as well established and efficacious for recurrent pediatric" exact="migraine" post="and tension headaches. However, it is unclear whether their"/>
   <result pre="children ( 76). In this study, 20 children with juvenile" exact="rheumatoid arthritis" post="(JRA) aged 5–14 years received either a daily 15"/>
   <result pre="( 76). In this study, 20 children with juvenile rheumatoid" exact="arthritis" post="(JRA) aged 5–14 years received either a daily 15"/>
   <result pre="RC Canda ER Doershuk CF Use of nonmedical treatment by" exact="cystic fibrosis" post="patients J Adolesc Health 1992 13 612 5 1420216"/>
   <result pre="J Acupuncture and the opioid system: implications in management of" exact="migraine" post="Pediatr Neurol 1997 17 129 33 9367292 20 Baldi"/>
   <result pre="MG Cappelli G Brocchi A et al. Intermittent hypoendorphinaemia in" exact="migraine" post="attack Cephalalgia 1982 2 77 81 6290072 21 Leone"/>
   <result pre="G Beta-endorphin concentrations in the peripheral blood mononuclear cells of" exact="migraine" post="and tension-type headache patients Cephalalgia 1992 12 154 7"/>
   <result pre="controlled study of minimal-contact thermal biofeedback treatment in children with" exact="migraine" post="J Pediatr Psychol 2002 27 109 19 11821495 24"/>
   <result pre="19 11821495 24 Hernandez-Latorre MA Roig M Natural history of" exact="migraine" post="in childhood Cephalalgia 2000 20 573 9 11075841 25"/>
   <result pre="of a psychological treatment package for treating pain in juvenile" exact="rheumatoid arthritis" post="Arthritis Care Res 1992 5 101 10 1390962 31"/>
   <result pre="a psychological treatment package for treating pain in juvenile rheumatoid" exact="arthritis" post="Arthritis Care Res 1992 5 101 10 1390962 31"/>
   <result pre="Di Cataldo A Art therapy as support for children with" exact="leukemia" post="during painful procedures Med Pediatr Oncol 2001 36 474"/>
   <result pre="extracts in the management of ear pain associated with acute" exact="otitis media" post="Arch Pediatr Adolesc Med 2001 155 796 9 11434846"/>
   <result pre="45 Rosenfeld RM What to expect from medical treatment of" exact="otitis media" post="Pediatr Infect Dis J 1995 14 731 7 quiz"/>
   <result pre="14 731 7 quiz 738 8559620 46 Lehnert T Acute" exact="otitis media" post="in children. Role of antibiotic therapy Can Fam Physician"/>
   <result pre="GJ Enteric-coated, pH-dependent peppermint oil capsules for the treatment of" exact="irritable bowel syndrome" post="in children J Pediatr 2001 138 125 8 11148527"/>
   <result pre="Jacobs J Springer DA Crothers D Homeopathic treatment of acute" exact="otitis media" post="in children: a preliminary randomized placebo-controlled trial Pediatr Infect"/>
   <result pre="treatment of distress, pain, and anxiety for young children with" exact="cancer" post="J Dev Behav Pediatr 1988 9 374 81 3220958"/>
   <result pre="hypnosis versus cognitive behavioral training for pain management with pediatric" exact="cancer" post="patients undergoing bone marrow aspirations Int J Clin Exp"/>
   <result pre="The efficacy and efficiency of a self-administered treatment for adolescent" exact="migraine" post="Pain 1992 49 321 4 1408297 71 Larsson B"/>
   <result pre="of self-hypnosis and propranolol in the treatment of juvenile classic" exact="migraine" post="Pediatrics 1987 79 593 7 3822681 76 Field T"/>
   <result pre="syndrome: massage therapy effects on depression and somatic symptoms in" exact="chronic fatigue syndrome" post="J Chronic Fatigue Syndr 1997 3 43 51 Figures"/>
   <result pre="CAM modality Condition Designation Acupuncture Chronic pain (various) Promising Pediatric" exact="migraine" post="Possibly efficacious Biofeedback     Thermal Pediatric migraine Possibly efficacious a"/>
   <result pre="pain (various) Promising Pediatric migraine Possibly efficacious Biofeedback     Thermal Pediatric" exact="migraine" post="Possibly efficacious a     biofeedback Tension headaches Promising     EMG-biofeedback Tension"/>
   <result pre="Possibly efficacious Recurrent pediatric headache Efficacious b Massage therapy Juvenile" exact="rheumatoid arthritis" post="Promising Procedural pain in pediatric burn injuries Promising AOM"/>
   <result pre="efficacious Recurrent pediatric headache Efficacious b Massage therapy Juvenile rheumatoid" exact="arthritis" post="Promising Procedural pain in pediatric burn injuries Promising AOM"/>
   <result pre="Promising Procedural pain in pediatric burn injuries Promising AOM acute" exact="otitis media;" post="Designation = designation according to criteria for empirically supported"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC2957635/results/search/disease/results.xml">
   <result pre="small to medium effect on verbal communication in children with" exact="autism" post="and related pervasive developmental disorders [ 17]. Although these"/>
   <result pre="music on cognitive functioning and social behavior in children with" exact="autism" post="[ 35, 36]. Buday et al. showed that children"/>
   <result pre="[ 45– 47]; two trials focused primarily on children with" exact="cancer" post="[ 45, 46]. A comparison of the effects of"/>
   <result pre="parent experiences of chest physiotherapy in infants and toddlers with" exact="cystic fibrosis." post="This moderate quality trial found treatment music resulted in"/>
   <result pre="and symptomatic pain treatment on the frequency and severity of" exact="migraine" post="headaches. Relative to the placebo, both interventions reduced migraine"/>
   <result pre="of migraine headaches. Relative to the placebo, both interventions reduced" exact="migraine" post="frequency over an extended period. Music therapy, however, had"/>
   <result pre="impact compared to the pharmacological approach, with significant reductions in" exact="migraine" post="frequency posttreatment and on follow-up [ 49]. 3.4. Qualitative"/>
   <result pre="a positive effect on parental reports of children's experience of" exact="cystic fibrosis" post="chest treatments (PEDro score = 5) [ 48]. However"/>
   <result pre="with a moderate PEDro score of 6, significant reductions in" exact="migraine" post="frequency were reported via a self-report diary following music"/>
   <result pre="significant effects were reported for both studies involving children with" exact="autism" post="[ 35, 36], one of two studies involving children"/>
   <result pre="35]. Clinical symptoms were also improved with significant reductions in" exact="migraine" post="frequency [ 49] and motor impulsivity [ 39]. As"/>
   <result pre="symptomatology, such as maladaptive behaviors [ 39, 40, 42] and" exact="migraine" post="frequency [ 49]. Current understanding of the potential benefits"/>
   <result pre="ZY Wang JZ Meta-analysis of assisted music therapy for chronic" exact="schizophrenia" post="Acta Academiae Medicinae Sinicae 2002 24 6 564 567"/>
   <result pre="C Heldal TO Dahle T Wigram T Music therapy for" exact="schizophrenia" post="or schizophrenia-like illnesses Cochrane Database of Systematic Reviews (Online)"/>
   <result pre="JS Bruinsma MS Scholten RJ Music therapy for people with" exact="dementia" post="Cochrane Database of Systematic Reviews (Online) 2004 3 Article"/>
   <result pre="with music on sign and speech imitation by children with" exact="autism" post="Journal of Music Therapy 1995 32 189 202 36"/>
   <result pre="of the active music engagement (AME) intervention on children with" exact="cancer" post="Psycho-Oncology 2008 17 7 699 708 18033724 47 Froehlich"/>
   <result pre="an adjunct to chest physiotherapy in infants and toddlers with" exact="cystic fibrosis" post="Pediatric Pulmonology 2000 29 5 371 381 10790249 49"/>
   <result pre="comprehensive measure of methodological quality than the Jadad scale in" exact="stroke" post="rehabilitation literature Journal of Clinical Epidemiology 2005 58 7"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC3330267/results/search/disease/results.xml">
   <result pre="of progressive cognitive decline, typically at the stage of AD" exact="dementia" post="(Sperling et al., 2011). The National Institute on Aging-Alzheimer’s"/>
   <result pre="thus considers that AD can be used to refer to" exact="dementia" post="stages, as well as to MCI and pre-MCI phases."/>
   <result pre="pathology (AD-P) are at increased risk of progression to AD" exact="dementia" post="(AD-D). However, the ability of the biomarkers of AD-P"/>
   <result pre="critical role in AD development, but several other mechanisms of" exact="neurodegeneration" post="have been proposed, including pro-inflammatory responses (Wyss-Coray, 2007), mitochondrial"/>
   <result pre="correlation between cerebral amyloid plaque burden and the severity of" exact="dementia" post="(Terry et al., 1991; Nagy et al., 1996; Ingelsson,"/>
   <result pre="Contrarily to what was observed for amyloid plaques, severity of" exact="dementia" post="has been strongly correlated with NFT density (in studies"/>
   <result pre="as with soluble oligomeric Aβ (Arendt, 2009). Tau deposition and" exact="neurodegeneration" post="occur in stereotyped fashion, progressing over six stages: stages"/>
   <result pre="stages V–VI, there is severe neocortical destruction and fully developed" exact="dementia" post="(Braak and Braak, 1995; Perl, 2010). Recent investigation involving"/>
   <result pre="early onset AD; (2) individuals with a family history of" exact="dementia" post="with one or more cases of early onset AD;"/>
   <result pre="brain areas (Ruitenberg et al., 2005) and suggesting that peripheral" exact="atherosclerosis" post="biomarkers can be early indicators of a subclinical phase"/>
   <result pre="severity to AD (Knopman, 2006). Similarly to hypertension, overweight and" exact="obesity" post="initiated at adulthood seem to increase the susceptibility for"/>
   <result pre="glucose tolerance have also been associated with increased odds of" exact="dementia" post="(Biessels et al., 2006; Qiu et al., 2007). The"/>
   <result pre="et al., 2007). The direct effect of glucose-mediated toxicity and" exact="hyperinsulinemia" post="on amyloid metabolism and AD neurodegenerative processes has been"/>
   <result pre="et al., 2009). Additional risk factors have been suggested, including" exact="migraine" post="(Tyas et al., 2001), high intake of saturated fat"/>
   <result pre="(Bots et al., 1998), peripheral inflammation (Engelhart et al., 2004)," exact="atrial fibrillation" post="(Duron and Hanon, 2010) and head injury (Guo et"/>
   <result pre="the levels of mental, social and physical activity and the" exact="dementia" post="risk (Wang et al., 2002; Rovio et al., 2005)."/>
   <result pre="Stern, 2006). Epidemiology AD is the most common cause of" exact="dementia" post="(Fratiglioni et al., 2000; Lobo et al., 2000). By"/>
   <result pre="North America and Western Europe exhibited the highest prevalence of" exact="dementia" post="(6.4 and 5.4%, respectively), followed by those from Latin"/>
   <result pre="Western Pacific (4.0%) and Eastern Europe (3.8–3.9%). The annual regional" exact="dementia" post="incidence rates (per 1.000 individuals) were estimated to be"/>
   <result pre="It has been calculated that the number of people with" exact="dementia" post="may rise to 81.1 million by 2040 (Ferri et"/>
   <result pre="AD pathology is more likely to be clinically expressed as" exact="dementia" post="in women than in men (Barnes et al., 2005)."/>
   <result pre="population (Arrighi et al., 2010). Diagnosis The clinical diagnosis of" exact="dementia" post="caused by AD can approach an accuracy rate of"/>
   <result pre="followed up comprehensively over time. Outside of specialized centers, AD" exact="dementia" post="is correctly diagnosed only in about 50% of affected"/>
   <result pre="was cognitive and functional decline (a requisite incorporating MCI and" exact="dementia" post="criteria) or not. There may not always be a"/>
   <result pre="AD (MCI-AD; Albert et al., 2011) and the diagnosis of" exact="dementia" post="due to AD (AD dementia; McKhann et al., 2011),"/>
   <result pre="dementia, (2) possible AD dementia, (3) probable or possible AD" exact="dementia" post="with evidence of the AD pathophysiological process. The first"/>
   <result pre="be used for research purposes only. The authors underline that" exact="dementia" post="from all causes implies the presence of cognitive decline"/>
   <result pre="disorder. According to McKhann et al. ( 2011), probable AD" exact="dementia" post="is diagnosed when the patient meets criteria for dementia"/>
   <result pre="AD dementia is diagnosed when the patient meets criteria for" exact="dementia" post="and, in addition, there is clear-cut history of worsening"/>
   <result pre="The NIA-AA workgroup recommends that the diagnosis of probable AD" exact="dementia" post="should not be applied when there is evidence of"/>
   <result pre="core features of Dementia with Lewy bodies (DLB; other than" exact="dementia" post="itself), prominent features of fronto-temporal lobar degeneration (FTLD), evidence"/>
   <result pre="According to the same workgroup, a diagnosis of possible AD" exact="dementia" post="is made when there is an atypical course, that"/>
   <result pre="may increase the certainty that the basis of the clinical" exact="dementia" post="syndrome is the AD pathophysiological process. However, the authors"/>
   <result pre="visuo-spatial areas of the occipital and parietal cortices. Primary progressive" exact="aphasia" post="(PPA) affects almost exclusively language related structures. The PCA"/>
   <result pre="early appearance (before the age of 60) of alexia with" exact="agraphia" post="(the most frequent symptoms, which occur without significant derangement"/>
   <result pre="stream of visual perception – the where stream), manifested by" exact="agraphia" post="and apraxia, and others show occipital dysfunction (involving the"/>
   <result pre="the what stream), expressed by symptoms of visual agnosia, prosopagnosia," exact="achromatopsia" post="and alexia. A third PCA group has been suggested,"/>
   <result pre="third PCA group has been suggested, consisting of patients with" exact="cortical blindness," post="caused by degeneration of the occipital primary visual cortex"/>
   <result pre="were also difficult to differentiate from CBD cases. Primary progressive" exact="aphasia" post="was first described by Mesulam as a syndrome consisting"/>
   <result pre="PPA cases than was first considered. The syndrome of primary" exact="aphasia" post="was classically divided into two distinct patterns: non-fluent aphasia"/>
   <result pre="primary aphasia was classically divided into two distinct patterns: non-fluent" exact="aphasia" post="and semantic dementia. Recently, a third pattern was proposed,"/>
   <result pre="(CBS) cases, about 40% of the patients with the non-fluent" exact="aphasia" post="syndrome and a small percentage with behavioral FTLD and"/>
   <result pre="syndrome and a small percentage with behavioral FTLD and semantic" exact="dementia" post="syndromes had AD pathology (Alladi et al., 2007). This"/>
   <result pre="of AD, symptoms characteristic of FTLD (particularly the progressive non-fluent" exact="aphasia" post="type) or CBS should not rule out this diagnosis."/>
   <result pre="visuo-spatial abilities (Hort et al., 2010). As the differentiation of" exact="dementia" post="from MCI rests on the determination of whether or"/>
   <result pre="because marked hippocampal atrophy has also been shown in fronto-temporal" exact="dementia" post="(Galton et al., 2001), dementia with Lewy bodies (DLB;"/>
   <result pre="also been shown in fronto-temporal dementia (Galton et al., 2001)," exact="dementia" post="with Lewy bodies (DLB; Barber et al., 2000), Parkinson’s"/>
   <result pre="Lewy bodies (DLB; Barber et al., 2000), Parkinson’s disease with" exact="dementia" post="(Tam et al., 2005), vascular dementia (Barber et al.,"/>
   <result pre="al., 2000), Parkinson’s disease with dementia (Tam et al., 2005)," exact="vascular dementia" post="(Barber et al., 2000) and hippocampal sclerosis (Barkhof et"/>
   <result pre="2000), Parkinson’s disease with dementia (Tam et al., 2005), vascular" exact="dementia" post="(Barber et al., 2000) and hippocampal sclerosis (Barkhof et"/>
   <result pre="FDG PET imaging in individuals with difficult-to-characterize memory loss or" exact="dementia" post="who eventually received pathologic confirmation of diagnosis. The sensitivity,"/>
   <result pre="CSF AD profile could identify patients with potential AD type" exact="dementia" post="among patients with MCI at sensitivities in the range"/>
   <result pre="In a large cross-sectional study involving patients with AD, fronto-temporal" exact="dementia" post="(FTD) and DLB, CSF concentrations of p-tau-181 discriminated between"/>
   <result pre="CSF in cases that had clinically ambiguous diagnoses, using autopsy-confirmed" exact="dementia" post="diagnosis as gold standard. AD and non-AD patients showed"/>
   <result pre="of CBD individuals, and in almost 30% of FTLD and" exact="vascular dementia" post="patients. Individuals with psychiatric diseases and with subjective memory"/>
   <result pre="CBD individuals, and in almost 30% of FTLD and vascular" exact="dementia" post="patients. Individuals with psychiatric diseases and with subjective memory"/>
   <result pre="on many aspects of the management of this form of" exact="dementia" post="with some degree of certainty (Hort et al., 2010;"/>
   <result pre="progression. The measures currently advocated to manage this form of" exact="dementia" post="involve adapting the patient’s environment and treating the patient"/>
   <result pre="parkinsonism, chest infections, ankle edema, and an increased risk of" exact="stroke" post="and death. As already stated, minimal effective doses should"/>
   <result pre="be administered earlier in the course of AD, before significant" exact="neurodegeneration" post="has occurred. Hopefully, biomarkers will allow diagnosis before a"/>
   <result pre="neurodegeneration has occurred. Hopefully, biomarkers will allow diagnosis before a" exact="dementia" post="syndrome is installed and permit testing drugs at a"/>
   <result pre="A. O’Brien J. T. ( 2000). MRI volumetric study of" exact="dementia" post="with Lewy bodies: a comparison with AD and vascular"/>
   <result pre="of dementia with Lewy bodies: a comparison with AD and" exact="vascular dementia" post=". Neurology 54, 1304– 1309 10746602 Barkhof F. Polvikoski"/>
   <result pre="dementia with Lewy bodies: a comparison with AD and vascular" exact="dementia" post=". Neurology 54, 1304– 1309 10746602 Barkhof F. Polvikoski"/>
   <result pre="Brunner E. Brayne C. Scheltens P. ( 2006). Risk of" exact="dementia" post="in diabetes mellitus: a systematic review. Lancet Neurol. 5,"/>
   <result pre="19370562 Birks J. Harvey R. J. ( 2006). Donepezil for" exact="dementia" post="due to Alzheimer’s disease. Cochrane Database Syst. Rev. 1,"/>
   <result pre="Roth M. ( 1968). The association between quantitative measures of" exact="dementia" post="and of senile change in the cerebral grey matter"/>
   <result pre="markers and risk of dementia: the Dutch vascular factors in" exact="dementia" post="study . Haemostasis 28, 216– 222 10420069 Braak H."/>
   <result pre="Medial temporal lobe atrophy on MRI differentiates Alzheimer’s disease from" exact="dementia" post="with Lewy bodies and vascular cognitive impairment: a prospective"/>
   <result pre="R. Minoshima S. ( 2007). FDG-PET improves accuracy in distinguishing" exact="frontotemporal dementia" post="and Alzheimer’s disease . Brain 130( Pt 10), 2616–"/>
   <result pre="Minoshima S. ( 2007). FDG-PET improves accuracy in distinguishing frontotemporal" exact="dementia" post="and Alzheimer’s disease . Brain 130( Pt 10), 2616–"/>
   <result pre="Martinez-Lage J. Soininen H. Hofman A. ( 2000). Incidence of" exact="dementia" post="and major subtypes in Europe: a collaborative study of"/>
   <result pre="2001). Temporal lobe rating scale: application to Alzheimer’s disease and" exact="frontotemporal dementia" post=". J. Neurol. Neurosurg. Psychiatr. 70, 165– 173 10.1136/jnnp.70.2.165"/>
   <result pre="Temporal lobe rating scale: application to Alzheimer’s disease and frontotemporal" exact="dementia" post=". J. Neurol. Neurosurg. Psychiatr. 70, 165– 173 10.1136/jnnp.70.2.165"/>
   <result pre="Crystal H. Bang S. Dresner R. ( 1988). Screening for" exact="dementia" post="by memory testing. Neurology 38, 900– 903 3368071 Guo"/>
   <result pre="10.1148/radiol.10091402 20720076 Kawas C. Corrada M. ( 2006). Alzheimer’s and" exact="dementia" post="in the oldest-old: a century of challenges. Curr. Alzheimer"/>
   <result pre="and vascular risk factors at midlife and the risk of" exact="dementia" post="and Alzheimer disease . Arch. Neurol. 62, 1556– 1560"/>
   <result pre="B. Stevens J. C. ( 2001). Practice parameter: diagnosis of" exact="dementia" post="(an evidence-based review). Neurology 56, 1143– 1153 11342678 Kukull"/>
   <result pre="and Work Groups ( 1999). Rates and risk factors for" exact="dementia" post="and Alzheimer’s disease: results from EURODEM pooled analyses ."/>
   <result pre="( 2010). Added diagnostic value of CSF biomarkers in differential" exact="dementia" post="diagnosis. Neurobiol. Aging 31, 1867– 1876 10.1016/j.neurobiolaging.2008.10.017 19150153 Leung"/>
   <result pre="Martinez-Lage J. Soininen H. Hofman A. ( 2000). Prevalence of" exact="dementia" post="and major subtypes in Europe: a collaborative study of"/>
   <result pre="Weintraub S. Phelps C. H. ( 2011). The diagnosis of" exact="dementia" post="due to Alzheimer’s disease: recommendations from the National Institute"/>
   <result pre="R. L. Kuhl D. E. ( 2001). Alzheimer’s disease versus" exact="dementia" post="with Lewy bodies: cerebral metabolic distinction with autopsy confirmation"/>
   <result pre="J. Fratiglioni L. ( 2006). Heart failure and risk of" exact="dementia" post="and Alzheimer disease: a population-based cohort study . Arch."/>
   <result pre="( 2004). A diagnostic dilemma: is &quot;Alzheimer’s dementia&quot; Alzheimer’s disease," exact="vascular dementia," post="or both? Lancet Neurol. 3, 141 10.1016/S1474-4422(04)00674-X 14980525 Roselli"/>
   <result pre="2005). Leisure-time physical activity at midlife and the risk of" exact="dementia" post="and Alzheimer’s disease . Lancet Neurol. 4, 705– 711"/>
   <result pre="Flier W. M. ( 2012). Cerebrospinal fluid markers for differential" exact="dementia" post="diagnosis in a large memory clinic cohort . Neurology"/>
   <result pre="fluid biomarkers and rate of cognitive decline in very mild" exact="dementia" post="of the Alzheimer type . Arch. Neurol. 66, 638–"/>
   <result pre="Parkinson’s disease with dementia: a comparison with Alzheimer’s disease and" exact="dementia" post="with Lewy bodies . Neurology 64, 861– 865 10.1212/01.WNL.0000153070.82309.D4"/>
   <result pre="Jack C. R. Jr. ( 2011). Antemortem differential diagnosis of" exact="dementia" post="pathology using structural MRI: differential-STAND. Neuroimage 55, 522– 531"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC3484252/results/search/disease/results.xml">
   <result pre="2]. Approximately 5–15 % of the adolescent population suffers from" exact="migraine" post="and further 15–25 % from tension-type headache [ 3–"/>
   <result pre="investigated the adolescent’s perception of triggers for their headache, especially" exact="migraine" post="[ 9– 12]; stress, lack of sleep and environmental"/>
   <result pre="headache was reported by 49 % of the participants. Co-existing" exact="migraine" post="plus tension-type headache were found in 20 % subjects."/>
   <result pre="(0.5 %), sexual activity (0.4 %), physical inactivity (0.3 %)," exact="allergy" post="(0.2 %), problems with braces (0.2 %), driving in"/>
   <result pre="[ 9] or Thailand [ 10] and pediatric or adolescent" exact="migraine" post="patients from a hospital samples in India [ 11]"/>
   <result pre="a population-based study [ 23], 58 % of adults with" exact="migraine" post="and 49 % of adults with tension-type headache reported"/>
   <result pre="G Holmen TL Stovner LJ Sand T The prevalence of" exact="migraine" post="and tension-type headaches among adolescents in Norway. The Nord-Trøndelag"/>
   <result pre="Blaschek A Heinen F et al. Associations between stress and" exact="migraine" post="and tension-type headache: results from a school-based study in"/>
   <result pre="Straube A et al. Self-reported muscle pain in adolescents with" exact="migraine" post="and tension-type headache Cephalalgia 2012 32 3 241 249"/>
   <result pre="EL Ranke AH Honkoop PC Precipitating and aggravating factors of" exact="migraine" post="versus tension-type headache Headache 2001 41 6 554 558"/>
   <result pre="11437890 22. Ierusalimschy R Moreira Filho PF Precipitating factors of" exact="migraine" post="attacks in patients with migraine without aura Arq Neuropsiquiatr"/>
   <result pre="Filho PF Precipitating factors of migraine attacks in patients with" exact="migraine" post="without aura Arq Neuropsiquiatr 2002 60 3-A 609 613"/>
   <result pre="25. Kelman L The triggers or precipitants of the acute" exact="migraine" post="attack Cephalalgia 2007 27 5 394 402 10.1111/j.1468-2982.2007.01303.x 17403039"/>
   <result pre="RK Kalita J Misra UK A study of triggers of" exact="migraine" post="in India Pain Med 2010 11 1 44 47"/>
   <result pre="V Guerrero-Peral ÁL García M et al. Precipitating factors of" exact="migraine" post="attacks in patients attended in neurology services. The factor"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC3865373/results/search/disease/results.xml">
   <result pre="diabetes training, therapy center; neuropediatrics with a special focus on" exact="epilepsy" post="with digital electroencephalogram (EEG), EEG monitoring, video EEG; developmental"/>
   <result pre="catheters, pumps, neurolytic blocks. Respiratory medicine, including whole body plethysmography," exact="sleep apnea" post="investigations, flexible video-bronchoscopy, thoracoscopy, endobronchial ultrasound, filling of pneumonectomy"/>
   <result pre="invasive surgery including natural orifice transluminal endoscopic surgery, vascular surgery," exact="colorectal cancer" post="center, outpatient and inpatient operations. Gynecology and obstetrics (approximately"/>
   <result pre="surgery including natural orifice transluminal endoscopic surgery, vascular surgery, colorectal" exact="cancer" post="center, outpatient and inpatient operations. Gynecology and obstetrics (approximately"/>
   <result pre="superficial bladder cancer—was superior. Mistletoe in Cancer. Mistletoe treatment for" exact="cancer" post="originated within anthroposophic medicine. It is one of the"/>
   <result pre="medicine. It is one of the most commonly prescribed complementary" exact="cancer" post="therapies in Central Europe 44 , 45 and has"/>
   <result pre="51 – 53 They also have an effect on multidrug-resistant" exact="cancer" post="cells 54 and enhance the cytotoxicity of anticancer drugs."/>
   <result pre="in vivo. 46 , 47 Clinical studies on mistletoe in" exact="cancer" post="describe rather consistently positive effects on quality of life:"/>
   <result pre="been concluded; it investigated mistletoe therapy in patients with advanced" exact="pancreatic cancer" post="who were not eligible for chemotherapy. The first interim"/>
   <result pre="concluded; it investigated mistletoe therapy in patients with advanced pancreatic" exact="cancer" post="who were not eligible for chemotherapy. The first interim"/>
   <result pre="following local and high-dose applications of mistletoe extracts, eg, in" exact="liver cancer," post="64 pancreatic cancer, 65 Merkel cell carcinoma, 66 breast"/>
   <result pre="high-dose applications of mistletoe extracts, eg, in liver cancer, 64" exact="pancreatic cancer," post="65 Merkel cell carcinoma, 66 breast cancer, 66 primary"/>
   <result pre="liver cancer, 64 pancreatic cancer, 65 Merkel cell carcinoma, 66" exact="breast cancer," post="66 primary cutaneous B-cell lymphoma, 67 cutaneous squamous cell"/>
   <result pre="(anxiety disorders, asthma, attention deficit/hyperactivity disorder, depression, low back pain," exact="migraine" post="77 – 83 ), and the effects were retained"/>
   <result pre="randomization. 40 A complex project on anthroposophic healthcare in advanced" exact="cancer" post="funded by the Swiss National Science Foundation demonstrated the"/>
   <result pre="89 A system comparison of anthroposophic and conventional healthcare in" exact="cancer" post="patients was performed at the University of Uppsala in"/>
   <result pre="effectiveness study, comparing anthroposophic with conventional healthcare for patients with" exact="rheumatoid arthritis." post="The study was funded by the German Federal Ministry"/>
   <result pre="yet been published. Another study investigated chronic facial pain (mostly" exact="trigeminal neuralgia," post="present for more than 10 years in half of"/>
   <result pre="93 A retrospective study showed a favorable cure rate of" exact="anorexia nervosa" post="following inpatient anthroposophic therapy. 94 Clinical Studies on Single"/>
   <result pre="monotherapies or fixed combination therapies, for instance mistletoe treatment in" exact="cancer" post="(see above) and in hepatitis, 95 – 97 betulin-based"/>
   <result pre="above) and in hepatitis, 95 – 97 betulin-based oleogel in" exact="actinic keratosis," post="98 , 99 rhythmic embrocation (with Solum oil) in"/>
   <result pre="105 mistletoe combined with Articulatio coxae or genus D30 in" exact="osteoarthritis" post="of the hip and knee, 106 Gelsemium comp. in"/>
   <result pre="108 one on postoperative wound care, 109 and one on" exact="actinic keratosis," post="99 showed positive results. Four recent new randomized controlled"/>
   <result pre="medications are commonly described: local reactions from topical application, systemic" exact="hypersensitivity" post="including very rare cases of anaphylactic reactions, and aggravation"/>
   <result pre="G Kiene H From reductionism to holism: systems-oriented approaches in" exact="cancer" post="research. Global Adv Health Med. 2012; 1( 5): 68–"/>
   <result pre=", et al. Use of complementary and alterna-tive medicine in" exact="cancer" post="patients: a European survey. Ann Oncol. 2005; 16( 4):"/>
   <result pre="I, II and III on sensitive and multidrug resistant human" exact="colon cancer" post="cell lines in vitro . Toxicology. 2002; 171( 2-3):"/>
   <result pre="II and III on sensitive and multidrug resistant human colon" exact="cancer" post="cell lines in vitro . Toxicology. 2002; 171( 2-3):"/>
   <result pre="of Viscum album agglutinin-1 and anticancer agents against human A549" exact="lung cancer" post="cells . Anticancer Res. 2001; 21( 4A): 2687– 91"/>
   <result pre="Viscum album agglutinin-1 and anticancer agents against human A549 lung" exact="cancer" post="cells . Anticancer Res. 2001; 21( 4A): 2687– 91"/>
   <result pre="album L (European mistletoe) extracts on quality of life in" exact="cancer" post="patients: a systematic review of controlled clinical studies ."/>
   <result pre="3): 109– 19 12730032 61. Kienle GS Kiene H Complementary" exact="cancer" post="therapy: a systematic review of prospective clinical trials on"/>
   <result pre="Phase II study of viscum fraxini-2 in patients with advanced" exact="hepatocellular carcinoma." post="Br J Cancer. 2004; 90( 1): 65– 9 14710208"/>
   <result pre="M , et al. Durable regression of primary cutaneous B-cell" exact="lymphoma" post="following fever-inducing mistletoe treatment—two case reports . Global Adv"/>
   <result pre="Hamre HJ Glockmann A Kienle GS Kiene H Combined bias" exact="suppression" post="in single-arm therapy studies. J Eval Clin Pract. 2008;"/>
   <result pre="P Braun SB Ziegler R , et al. Palliative inpatient" exact="cancer" post="treatment in an anthroposophic hospital: I. Treatment patterns and"/>
   <result pre="Berger Braun S Bertschy M , et al. Palliative inpatient" exact="cancer" post="treatment in an anthroposophic hospital: II. Quality of life"/>
   <result pre="a research project on anthroposophical medicine in patients with advanced" exact="cancer" post=". Schweiz Med Wochenschr. 2000; 130( 34): 1173– 84"/>
   <result pre="and beliefs towards disease and treatment in patients with advanced" exact="cancer" post="using anthroposophical medicine . Onkologie 2000; 23: 558– 563"/>
   <result pre="E Evaluation of quality of life/life satisfaction in women with" exact="breast cancer" post="in complementary and conventional care . Acta Oncol. 2004;"/>
   <result pre="Evaluation of quality of life/life satisfaction in women with breast" exact="cancer" post="in complementary and conventional care . Acta Oncol. 2004;"/>
   <result pre="A five-year follow-up of quality of life in women with" exact="breast cancer" post="in anthroposophic and conventional care . Evid Based Complement"/>
   <result pre="five-year follow-up of quality of life in women with breast" exact="cancer" post="in anthroposophic and conventional care . Evid Based Complement"/>
   <result pre="of a mistletoe preparation with defined lectin content on chronic" exact="hepatitis" post="C: an individually controlled cohort study . Eur J"/>
   <result pre="Tusenius KJ Spoek JM Kramers CW Iscador Qu for chronic" exact="hepatitis" post="C: an exploratory study. Complement Ther Med. 2001; 9("/>
   <result pre="the effects of treatment with two mistletoe preparations on chronic" exact="hepatitis" post="C . Arzneimittelforschung. 2005; 55( 12): 749– 53 16430029"/>
   <result pre="Tüchelmann T Heusser P Therapeutic eurythmy—movement therapy for children with" exact="attention deficit hyperactivity disorder" post="(ADHD): a pilot study . Complement Ther Nurs Midwifery."/>
   <result pre="R Effectiveness of subcutaneous in-jections of a cartilage preparation in" exact="osteoarthritis" post="of the knee—a randomized, placebo controlled phase II study"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC3892961/results/search/disease/results.xml">
   <result pre="hysterical crying, panic attacks, and episodes of depression. Manifestations of" exact="polyneuropathy" post="included numbness, paresthesias, increased sweating, temperature sensitivity, and arterial"/>
   <result pre="factors include stroke, 6 intake of morning medication, 6 or" exact="cannabis abuse." post="8 Severity of CVS in adults ranges from mild"/>
   <result pre="phenotypic feature in seven of eleven patients with mitochondrial encephalomyopathy," exact="lactic acidosis," post="and stroke-like episodes (MELAS) first described in the literature."/>
   <result pre="causative. 29– 32 Some CVS patients may also present with" exact="lactic acidosis." post="10, 33 CVS has been regarded a manifestation of"/>
   <result pre="acidosis. 10, 33 CVS has been regarded a manifestation of" exact="migraine" post="by some authors 34 since it evolves to migraine"/>
   <result pre="of migraine by some authors 34 since it evolves to" exact="migraine" post="in one third of the cases. 32, 35 Further"/>
   <result pre="FAOD multiple acyl-coenzyme A dehydrogenase deficiency, manifesting with anion gap" exact="metabolic acidosis," post="nonketotic hypoglycemia, collapse, multiorgan failure, and death. 18 Generally,"/>
   <result pre="deficiency, short-chain 3-hydroxy acyl-CoA dehydrogenase deficiency, gastrointestinal reflux, and chronic" exact="cannabis abuse." post="4 These diagnoses need to be excluded before diagnosing"/>
   <result pre="this topic. 45– 50 His medical history is noteworthy for" exact="dyslexia" post="and amusia, and at school-age in Shrewsbury he developed"/>
   <result pre="due to esophagitis, gastroesophageal reflux, Barrett’s esophagus, or a perforating" exact="peptic ulcer." post="47 Family history The youngest sister of CD’s mother"/>
   <result pre="(Todd’s paresis), and episodes of blindness. She died with progressive" exact="dementia" post="at the age of 8 years ( Figure 1)."/>
   <result pre="was most likely a result of hyperemesis gravidarum. She experienced" exact="motion sickness" post="and complained about not looking young. 41 After graduation,"/>
   <result pre="of chronic abuse, hyperemesis may evolve, which is why chronic" exact="cannabis abuse" post="should be included in the differential diagnoses of CVS."/>
   <result pre="the fact that low levels of endocannabinoids are associated with" exact="motion sickness." post="79 Arguments against CVS in CD are that he"/>
   <result pre="sweating, temperature sensitivity, dysautonomia), vestibular manifestations, cardiac manifestations (palpitations, probably" exact="atrial fibrillation," post="chest pain), gastrointestinal manifestations (CVS, dental problems, abnormal seasickness,"/>
   <result pre="associated with convulsive seizures. An argument against the presence of" exact="epilepsy" post="is that convulsions, tongue bites, or secessus were never"/>
   <result pre="individual phenotypes. Assuming that his disease was hereditary, infections, intoxications," exact="autoimmune disease," post="or allergies could not have been causative. Second, none"/>
   <result pre="Ni YH Weng WC Lee WT Cyclic vomiting syndrome and" exact="migraine" post="in children J Formos Med Assoc 2011 110 6"/>
   <result pre="Buffington CA Rackley R Zhang D Chelimsky T Co-morbidities of" exact="interstitial cystitis" post="Front Neurosci 2012 6 114 22907988 16 Abu-Arafeh I"/>
   <result pre="CA Rackley R Zhang D Chelimsky T Co-morbidities of interstitial" exact="cystitis" post="Front Neurosci 2012 6 114 22907988 16 Abu-Arafeh I"/>
   <result pre="T Two common mitochondrial DNA polymorphisms are highly associated with" exact="migraine" post="headache and cyclic vomiting syndrome Cephalalgia 2009 29 7"/>
   <result pre="(CVS) biologically different conditions? Relationship of adult-onset CVS with the" exact="migraine" post="and pediatric CVS-associated common mtDNA polymorphisms 16519T and 3010A"/>
   <result pre="DiMauro S De Vivo DC Rowland LP Mitochondrial myopathy, encephalopathy," exact="lactic acidosis," post="and strokelike episodes: a distinctive clinical syndrome Ann Neurol"/>
   <result pre="481 488 6093682 25 Nalini A Gayathri N Mitochondrial neurogastrointestinal" exact="encephalopathy" post="in an Indian family with possible manifesting carriers of"/>
   <result pre="15794318 36 Stickler GB Relationship between cyclic vomiting syndrome and" exact="migraine" post="Clin Pediatr (Phila) 2005 44 6 505 508 16015397"/>
   <result pre="M Li BU Maternal inheritance in cyclic vomiting syndrome with" exact="neuromuscular disease" post="Am J Med Genet A 2003 120A 4 474"/>
   <result pre="P Olden KW Cyclic vomiting and compulsive bathing with chronic" exact="cannabis abuse" post="Clin Gastroenterol Hepatol 2008 6 6 710 712 18456571"/>
   <result pre="133 95 Barloon TJ Noyes R Jr Charles Darwin and" exact="panic disorder" post="JAMA 1997 277 2 138 141 8990339 96 Bernstein"/>
   <result pre="117 122 106 Smith F Charles Darwin’s health problems: the" exact="allergy" post="hypothesis J Hist Biol 1992 25 2 285 306"/>
   <result pre="death after a week or so would be consistent with" exact="acute pancreatitis" post="and peritonitis. Sarah (Sally) Wedgwood, wife of Josiah (Josiah"/>
   <result pre="after a week or so would be consistent with acute" exact="pancreatitis" post="and peritonitis. Sarah (Sally) Wedgwood, wife of Josiah (Josiah"/>
   <result pre="active when young, but she developed chronic illness with severe" exact="arthritis" post="and &quot;rheumatism.&quot; Some of her symptoms are those of"/>
   <result pre="&quot;everyone seems young but me.&quot; She had a history of" exact="motion sickness," post="and died with sudden, severe abdominal illness and probable"/>
   <result pre="Richard died in infancy with an &quot;acute abdominal complaint&quot; suggesting" exact="acute pancreatitis." post="Josiah II, developed parkinson’s disease in later life. Tom,"/>
   <result pre="sine prole (died without issue); k, killed; MELAS, mitochondrial encephalomyopathy," exact="lactic acidosis," post="and stroke-like episodes. Table 1 Benchmark data of Charles"/>
   <result pre="47, 94  Bereavement syndrome 47  Panic disorder 95  Anxiety disorder," exact="agoraphobia" post="51, 96  Neurasthenia 97  Nervous indigestion 98  Somatization disorder"/>
   <result pre="homosexual attraction to Fitzroy R 51  Malingering (shamming) 51 Central" exact="nervous system disease" post=" Narcolepsy 99 Ocular disease  Chronic eye strain 100 Otologic"/>
   <result pre=" Crohn’s disease 101  Peptic ulcer 101  Biliary tract disease, chronic" exact="cholecystitis" post="48, 101  Chronic appendicitis 48  Duodenal ulcer 48  Diaphragmatic"/>
   <result pre="ulcer 101  Biliary tract disease, chronic cholecystitis 48, 101  Chronic" exact="appendicitis" post="48  Duodenal ulcer 48  Diaphragmatic hernia 102 Metabolic disease"/>
   <result pre="cholecystitis 48, 101  Chronic appendicitis 48  Duodenal ulcer 48  Diaphragmatic" exact="hernia" post="102 Metabolic disease  Mitochondrial disorder 51  Intermittent porphyria 103"/>
   <result pre="48  Diaphragmatic hernia 102 Metabolic disease  Mitochondrial disorder 51  Intermittent" exact="porphyria" post="103  Metabolic disease 104  Gout 70  Hyperinsulinism 71 Infection"/>
   <result pre="48  Brucellosis 105  Chilean fever 48  Typhoid fever 47  Smoldering" exact="hepatitis" post="48  Borreliosis 51  Malaria 51  Pyorrhoea with septicemia 48"/>
   <result pre="preservative chemicals 51 Allergy  Multiple allergies 47  Allergy 106  Pigeon" exact="allergy" post="48 Autoimmune  Systemic lupus erythematosus 51 Blood  Pyroluria 51"/>
   <result pre=" Multiple allergies 47  Allergy 106  Pigeon allergy 48 Autoimmune  Systemic" exact="lupus erythematosus" post="51 Blood  Pyroluria 51 Others  Lactose intolerance 107"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC3978558/results/search/disease/results.xml">
   <result pre="to understand the current body of knowledge pertaining to pediatric" exact="cancer" post="pain management. A user-centered approach to development was used"/>
   <result pre="established the current state of research related to nonpharmacological pediatric" exact="cancer" post="pain management. The 2-day consensus conference established which clinically"/>
   <result pre="approach to develop a pain management algorithm for adolescents with" exact="cancer" post="and the system requirements of an associated app. The"/>
   <result pre="feasibility, and effectiveness testing of the app for adolescents with" exact="cancer" post="pain. adolescent pain neoplasms cellular phone algorithms Introduction The"/>
   <result pre="with cancer. It is estimated that 49%-62% of adolescents with" exact="cancer" post="will experience pain related to the disease and/or associated"/>
   <result pre="affects an adolescent’s quality of life [ 3- 5], impedes" exact="cancer" post="recovery [ 6], results in adolescent and family distress"/>
   <result pre="associated with long-term morbidity [ 11, 12]. Pain related to" exact="cancer" post="also represents a significant cost burden to the health"/>
   <result pre="[ 13], with pain being the most common reason for" exact="cancer" post="patients to utilize emergency health services [ 14- 16]."/>
   <result pre="advancements and health care system changes have allowed adolescents with" exact="cancer" post="to spend increasing amounts of time in the outpatient"/>
   <result pre="time in the outpatient setting over the course of their" exact="cancer" post="care [ 17, 18]. While this is a welcome"/>
   <result pre="adolescents and families, it means that a significant amount of" exact="cancer" post="symptoms (including pain) are experienced in an environment where"/>
   <result pre="may be limited (eg, at home). Despite the impact of" exact="cancer" post="on adolescent health quality and cost, very limited research"/>
   <result pre="that this app will enable adolescents to better manage their" exact="cancer" post="pain in real-time and in their natural settings. This"/>
   <result pre="to build upon the PainSquad app by providing adolescents with" exact="cancer" post="real-time pain management advice based on their PainSquad pain"/>
   <result pre="have been targeted by apps include diabetes, alcoholism, cancer, and" exact="post-traumatic stress disorder" post="[ 19- 24]. A consistent focus of researchers to"/>
   <result pre="patients with conditions including arthritis, depression, anxiety, alcoholism, diabetes, and" exact="migraine" post="[ 26- 33]. These programs have positive effects across"/>
   <result pre="by a patient’s data. The effectiveness of algorithm-informed and e-based" exact="cancer" post="symptom monitoring and management has also been demonstrated. Research"/>
   <result pre="also been demonstrated. Research in the area in adults with" exact="cancer" post="has demonstrated &amp;gt;30% decreases in symptom occurrence when care"/>
   <result pre="care algorithm and catalogue of system requirements for the adolescent" exact="cancer" post="pain management app. Methods Phase 1: Multidisciplinary Consensus Conference"/>
   <result pre="to understand the current body of knowledge pertaining to pediatric" exact="cancer" post="pain management. Results of this review, along with the"/>
   <result pre="pain) was also included. The pain consumer did not have" exact="cancer" post="but was asked to participate because of their extensive"/>
   <result pre="pediatric oncology and pain health care providers and adolescents with" exact="cancer" post="to vet and refine the algorithm and requirements. A"/>
   <result pre="who were English speaking, 12-18 years of age, diagnosed with" exact="cancer" post="at least 3 months before testing, actively undergoing cancer"/>
   <result pre="with cancer at least 3 months before testing, actively undergoing" exact="cancer" post="treatment, and having experienced pain of any intensity in"/>
   <result pre="3 (30) Male 7 (70) Diagnosis Lymphoma 4 (40) Acute" exact="myeloid leukemia" post="3 (30) Ewing’s sarcoma 1 (10) Osteosarcoma 1 (10)"/>
   <result pre="(30) Male 7 (70) Diagnosis Lymphoma 4 (40) Acute myeloid" exact="leukemia" post="3 (30) Ewing’s sarcoma 1 (10) Osteosarcoma 1 (10)"/>
   <result pre="Diagnosis Lymphoma 4 (40) Acute myeloid leukemia 3 (30) Ewing’s" exact="sarcoma" post="1 (10) Osteosarcoma 1 (10) Wilm’s tumor 1 (10)"/>
   <result pre="(N=9). Process Audio-recorded individual interviews were conducted with adolescents with" exact="cancer" post="and health care professionals. Interviews were conducted with each"/>
   <result pre="and thought that it would be beneficial to adolescents with" exact="cancer" post="pain. Specific beneficial aspects of the system from the"/>
   <result pre="the moment it occurs and to intervene when adolescents experience" exact="cancer" post="pain in their home environments. The benefits of the"/>
   <result pre="and mobile-based interventions to manage symptoms of diseases such as" exact="cancer" post="have the potential capacity to provide patients with cost-effective,"/>
   <result pre="elements of an electronic symptom assessment questionnaire for children with" exact="cancer" post="[ 64]. The authors of this study were able"/>
   <result pre="structure, and efficacy of pain self-management programs for adults with" exact="cancer" post="[ 65]. In this review, those studies with the"/>
   <result pre="families in the consensus conference. The inclusion of adolescents with" exact="cancer" post="and their parents would have provided valuable insight into"/>
   <result pre="the clinical practices and workflow of this center. Adolescents with" exact="cancer" post="who are from multiple centers will be enrolled in"/>
   <result pre="B Portenoy RK The measurement of symptoms in children with" exact="cancer" post="J Pain Symptom Manage 2000 5 19 5 363"/>
   <result pre="Varni JW Burwinkle TM Katz ER The PedsQL in pediatric" exact="cancer" post="pain: a prospective longitudinal analysis of pain and emotional"/>
   <result pre="R Dzolganovski B Almeida R Klassen A Identification of paediatric" exact="cancer" post="patients with poor quality of life Br J Cancer"/>
   <result pre="Nausea, pain, fatigue, and multiple symptoms in hospitalized children with" exact="cancer" post="Oncol Nurs Forum 2011 9 38 5 E382 93"/>
   <result pre="Parents' perceptions of their child's symptom burden during and after" exact="cancer" post="treatment J Pain Symptom Manage 2013 9 46 3"/>
   <result pre="Matchar DB A clinical decision and economic analysis model of" exact="cancer" post="pain management Am J Manag Care 2003 10 9"/>
   <result pre="Barbera L Taylor C Dudgeon D Why do patients with" exact="cancer" post="visit the emergency department near the end of life?"/>
   <result pre="Kuo KL Saokaew S Stenehjem DD The pharmacoeconomics of breakthrough" exact="cancer" post="pain J Pain Palliat Care Pharmacother 2013 6 27"/>
   <result pre="analgesic use and pain expression in parents of children with" exact="cancer" post="J Pediatr Hematol Oncol 2012 5 34 4 257"/>
   <result pre="of a multidimensional iPhone pain assessment application for adolescents with" exact="cancer" post="J Med Internet Res 2013 15 3 e51 10.2196/jmir.2350"/>
   <result pre="Lorig KR Ritter PL Laurent DD Plant K The internet-based" exact="arthritis" post="self-management program: a one-year randomized trial for patients with"/>
   <result pre="arthritis self-management program: a one-year randomized trial for patients with" exact="arthritis" post="or fibromyalgia Arthritis Rheum 2008 7 15 59 7"/>
   <result pre="program: a one-year randomized trial for patients with arthritis or" exact="fibromyalgia" post="Arthritis Rheum 2008 7 15 59 7 1009 17"/>
   <result pre="validity of a multidimensional electronic pain diary for adolescents with" exact="arthritis" post="Pain 2008 6 136 3 281 92 10.1016/j.pain.2007.07.002 17723279"/>
   <result pre="Scharfenberger JA Pfeifer MP Development of a telehealth intervention for" exact="head and neck cancer" post="patients Telemed J E Health 2009 1 15 1"/>
   <result pre="MP Development of a telehealth intervention for head and neck" exact="cancer" post="patients Telemed J E Health 2009 1 15 1"/>
   <result pre="A Zemel L Algorithm development for corticosteroid management in systemic" exact="juvenile idiopathic arthritis" post="trial using consensus methodology Pediatr Rheumatol Online J 2012"/>
   <result pre="L Algorithm development for corticosteroid management in systemic juvenile idiopathic" exact="arthritis" post="trial using consensus methodology Pediatr Rheumatol Online J 2012"/>
   <result pre="Luca NJ Jibb LA Assessment and management of pain in" exact="juvenile idiopathic arthritis" post="Pain Res Manag 2012 17 6 391 6 23248812"/>
   <result pre="Jibb LA Assessment and management of pain in juvenile idiopathic" exact="arthritis" post="Pain Res Manag 2012 17 6 391 6 23248812"/>
   <result pre="structure, and efficacy of interventions to improve patients' self-management of" exact="cancer" post="pain J Pain Symptom Manage 2012 8 44 2"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC3996073/results/search/disease/results.xml">
   <result pre="24580721 doi: 10.1186/1129-2377-15-12 : Research Article Headstrong intervention for pediatric" exact="migraine" post="headache: a randomized clinical trial Rapoff Michael A 1"/>
   <result pre="life. Methods Participants were 35 children ages 7–12 years with" exact="migraine" post="recruited from one university medical center and two children’s"/>
   <result pre="has been estimated to be as high as 58.4%, with" exact="migraine" post="occurring in up to 10% of young children ["/>
   <result pre="is regarded as the optimal standard of care for pediatric" exact="migraine" post="[ 6, 7]. Traditional biobehavioral interventions include relaxation, biofeedback,"/>
   <result pre="have been developed and tested with children and adolescents with" exact="migraine" post="[ 12- 14] and other recurrent or persistent pain"/>
   <result pre="pediatric headache [ 18, 19]. We hypothesized that children with" exact="migraine" post="headaches who received the Headstrong program would demonstrate greater"/>
   <result pre="following inclusion criteria: (a) 7–12 years of age; (b) having" exact="migraine" post="occurring on the average at least once per week"/>
   <result pre="symptom-free periods; and (c) having a board-certified neurologist's diagnosis of" exact="migraine" post="with or without aura, using International Classification of Headache"/>
   <result pre="30] and it can reliably document the effects of pediatric" exact="migraine" post="on QOL [ 3, 31]. The Total Scale Score"/>
   <result pre="71%, fathers 68%), and the children diagnosed most frequently with" exact="migraine" post="headache (94%) and treated with prescribed ibuprofen (57%) and/or"/>
   <result pre="of these findings is also limited for the broader pediatric" exact="migraine" post="population because of our exclusion of children with headaches"/>
   <result pre="Razak S Sivaraman B Graham C Prevalence of headache and" exact="migraine" post="in children and adolescents: a systematic review of population-based"/>
   <result pre="study of a minimal-contact thermal biofeedback treatment in children with" exact="migraine" post="J Pediatr Psychol 2002 15 109 119 10.1093/jpepsy/27.2.109 11821495"/>
   <result pre="Weert E Bouma J Promoting physical activity in children with" exact="juvenile idiopathic arthritis" post="through an internet-based program: Results of a pilot randomized"/>
   <result pre="Bouma J Promoting physical activity in children with juvenile idiopathic" exact="arthritis" post="through an internet-based program: Results of a pilot randomized"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC4080372/results/search/disease/results.xml">
   <result pre="McCormick, a medical student, operated for the removal of a" exact="cancer" post="of the lower lip on Mr. James Ewings of"/>
   <result pre="wanted her to sit at his knee and let him" exact="stroke" post="her golden curls, like a perfect Victorian daughter. She"/>
   <result pre="cottages varied wildly. Before leaving home, my father gave us" exact="typhoid fever" post="shots. In my earliest memories there was a cramped"/>
   <result pre="adult life, I have wondered if Skip had a mild" exact="learning disability" post="as he frequently had to be tutored; on the"/>
   <result pre="back to Vienna. Bernie died in 1987, very suddenly of" exact="heart disease;" post="his mother actually outlived him by a year or"/>
   <result pre="a year or so. My mother died in 1947 of" exact="breast cancer" post="that had been in remission. &quot;I started school at"/>
   <result pre="year or so. My mother died in 1947 of breast" exact="cancer" post="that had been in remission. &quot;I started school at"/>
   <result pre="to work with him. He worked and published until his" exact="diabetic retinopathy" post="and atherosclerosis got bad enough that he could no"/>
   <result pre="work with him. He worked and published until his diabetic" exact="retinopathy" post="and atherosclerosis got bad enough that he could no"/>
   <result pre="him. He worked and published until his diabetic retinopathy and" exact="atherosclerosis" post="got bad enough that he could no longer work."/>
   <result pre="York Hospital. I took a position working with previously undiagnosed" exact="tuberculosis" post="patients with far advanced disease with lung cavitation. This"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC4197753/results/search/disease/results.xml">
   <result pre="pain conditions including general pain, headache, migraine, back pain, fibromyalgia," exact="arthritis" post="and degenerative disc disease. The primary app functions included"/>
   <result pre="including general pain, headache, migraine, back pain, fibromyalgia, arthritis and" exact="degenerative disc disease." post="The primary app functions included self-management components such as"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC4244172/results/search/disease/results.xml">
   <result pre="http://www.uk.sagepub.com/aboutus/openaccess.htm). Caregivers, employment, and healthcare utilization P001 Caregiver’s burden in" exact="multiple sclerosis" post="is higher in Mexican population R Llorens-Arenas 1, L"/>
   <result pre="are no studies addressing the issue in Mexican caregivers of" exact="multiple sclerosis" post="patients. Objectives: To describe the prevalence and predicting factors"/>
   <result pre="describe the prevalence and predicting factors of caregiver burden in" exact="multiple sclerosis" post="within a Mexican population. Methods: 99 Caregiver-patient pairs were"/>
   <result pre="even 5 years before diagnosis. P003 Knowledge and attitude towards" exact="multiple sclerosis" post="in Turkey S Canbaz Kabay 1,2, H Ozışık Karaman"/>
   <result pre="Turkey, in an eastern city Kütahya. Methods: The Survey of" exact="multiple sclerosis" post="patients, their relatives and control group on the Knowledge,"/>
   <result pre="of working capability in a Swiss cohort of patients with" exact="multiple sclerosis" post="O Findling 1, M Baltisberger 1, CP Kamm 1,"/>
   <result pre="München, Neurology, München, Germany Background: Diagnosis and disability associated with" exact="multiple sclerosis" post="(MS) have far reaching implications on the patient’s private"/>
   <result pre="education-related inequalities are warranted. P005 Profile of social participation of" exact="multiple sclerosis" post="adults in Québec city N Lacroix 1,2, N Boucher"/>
   <result pre="physical and psychological consequences of chronic degenerative diseases such as" exact="multiple sclerosis" post="(MS). Only a few studies have focused on the"/>
   <result pre="roles. P006 Determinants of stigma experienced by patients suffering from" exact="multiple sclerosis." post="A Hellenic population study M Anagnostouli 1, S Katsavos"/>
   <result pre="and Society, Division of Nursing, Huddinge, Sweden Background: People with" exact="multiple sclerosis" post="(PwMS) use a large amount of health care services"/>
   <result pre="University Hospital, Neurology, Rennes, France Background: Introducing oral treatment for" exact="multiple sclerosis" post="(MS) relapses should improve its accessibility, patients quality of"/>
   <result pre="mg twice daily, for improvement in walking in patients with" exact="multiple sclerosis" post="(MS). Objectives: To describe patient characteristics and to evaluate"/>
   <result pre="prior claims for stroke, Parkinson’s disease, brain neoplasm/abscess, tendonitis, or" exact="cerebral palsy." post="Demographics and comorbidities were assessed at baseline. Patients were"/>
   <result pre="approved in over 30 countries for the treatment of relapsing-remitting" exact="multiple sclerosis" post="(RRMS). In the phase 3 CARE-MS II study, alemtuzumab"/>
   <result pre="is approved in over 30 countries for treatment of relapsing-remitting" exact="multiple sclerosis" post="(RRMS). Alemtuzumab demonstrated superior efficacy over subcutaneous interferon beta-1a"/>
   <result pre="Swedish social redistribution systems. P015 Prevalence of complications in hospitalized" exact="multiple sclerosis" post="patients among different age groups: national perspective AA Patel"/>
   <result pre="Lansing, MI, United States Background: Multiple Sclerosis (MS) is a" exact="neurological disorder" post="without any clinical findings that are unique to MS."/>
   <result pre="is national representative of 1,393,298 (weighted) patients. Overall prevalence of" exact="optic neuritis" post="(1.6%), urinary tract infection (UTI)(25.2%), unspecified hypertension (HTN)(30.2%), aspiration"/>
   <result pre="of 1,393,298 (weighted) patients. Overall prevalence of optic neuritis (1.6%)," exact="urinary tract infection" post="(UTI)(25.2%), unspecified hypertension (HTN)(30.2%), aspiration pneumonia(3.6%), depressive disorder (14.1%),"/>
   <result pre="infection (UTI)(25.2%), unspecified hypertension (HTN)(30.2%), aspiration pneumonia(3.6%), depressive disorder (14.1%)," exact="neurogenic bladder" post="(10.6%), septicemia(10.1%), epilepsy(3.6%). After age groups stratification prevalence of"/>
   <result pre="bladder (10.6%), septicemia(10.1%), epilepsy(3.6%). After age groups stratification prevalence of" exact="optic neuritis" post="was highest (11.5%) in 0-18 age group and was"/>
   <result pre="with increasing age (p&amp;lt; 0.001). Prevalence of UTI, HTN and" exact="aspiration pneumonia" post="were increasing with age being highest (35.2%, 43.3% and"/>
   <result pre="increasing age (p&amp;lt; 0.001). Prevalence of UTI, HTN and aspiration" exact="pneumonia" post="were increasing with age being highest (35.2%, 43.3% and"/>
   <result pre="50-59 and then declining with age (p&amp;lt; 0.001). Prevalence of" exact="neurogenic bladder" post="and septicemia were increasing with age being highest (13.4%"/>
   <result pre="then decreased in age group &amp;gt;70 (p&amp;lt; 0.001). Prevalence of" exact="epilepsy" post="was also increasing with age being highest (4.1%) in"/>
   <result pre="patients is highly variable in different age groups. Prevalence of" exact="optic neuritis" post="and epilepsy were more in younger patients of MS"/>
   <result pre="variable in different age groups. Prevalence of optic neuritis and" exact="epilepsy" post="were more in younger patients of MS while other"/>
   <result pre="more in younger patients of MS while other complications like" exact="neurogenic bladder," post="UTIs, aspiration pneumonia, septicemia and depressive disorder were higher"/>
   <result pre="patients of MS while other complications like neurogenic bladder, UTIs," exact="aspiration pneumonia," post="septicemia and depressive disorder were higher in old age"/>
   <result pre="and atrophy are associated with employment status in patients with" exact="multiple sclerosis" post="S Tauhid 1, R Chu 1, R Sasane 2,"/>
   <result pre="ability to perform occupational functions is a common difficulty for" exact="multiple sclerosis" post="(MS) patients. This impaired level of performance can frequently"/>
   <result pre="hypointensity is most relevant. P017 Treatment patterns and cost in" exact="multiple sclerosis" post="- a cross-sectional study from Slovakia V Donath 1,"/>
   <result pre="2013), as well as estimate the long term cost of" exact="multiple sclerosis" post="to patients in Norway. Methods: Information on disease related"/>
   <result pre="patients with MS. P020 Updates from the Sonya Slifka longitudinal" exact="multiple sclerosis" post="study and the comprehensive analysis of the direct and"/>
   <result pre="among a generally representative sample of almost 2,200 individuals with" exact="multiple sclerosis" post="(MS) in the United States (US). A second cohort"/>
   <result pre="efficient healthcare resources allocation. P022 The economic cost of a" exact="multiple sclerosis" post="relapse K O’Connell 1, SB Kelly 1, E Fogarty"/>
   <result pre="of MS patients regardless of disease severity. P024 People with" exact="multiple sclerosis" post="unmet perceived needs point toward a personalised intervention M"/>
   <result pre="Medicine and Public Health, Siena, Italy Background: The effects of" exact="multiple sclerosis" post="(MS) are wide-ranging, having an impact on physical, psychological,"/>
   <result pre="Idiopathic Inflammatory Demyelinating Central Nervous System Disorders (IIDCDs) such as" exact="neuromyelitis optica" post="(NMO) and multiple sclerosis (MS) causes higher prevalence of"/>
   <result pre="Nervous System Disorders (IIDCDs) such as neuromyelitis optica (NMO) and" exact="multiple sclerosis" post="(MS) causes higher prevalence of the diseases over the"/>
   <result pre="and emergency room visits in the US among patients with" exact="multiple sclerosis" post="A Farr 1, S Curkendall 2, E Yu 3,"/>
   <result pre="3Genentech, San Francisco, CA, United States Background: Among patients with" exact="multiple sclerosis" post="(MS), few studies have examined the association between persistence"/>
   <result pre="the prevalence and characteristics of medicare patients using treatments for" exact="multiple sclerosis" post="and related symptoms in the USA S Chahin 1,"/>
   <result pre="is a non-interventional study in 1705 patients with relapsing remitting" exact="multiple sclerosis" post="(RRMS). PEARL collected pharmacoeconomic and clinical data for 24"/>
   <result pre="on healthcare resource utilization and medical costs for patients with" exact="multiple sclerosis" post="S Yermakov 1, M Davis 1, M Calnan 1,"/>
   <result pre="disease modifying therapy (DMT) is suboptimal in many patients with" exact="multiple sclerosis" post="(MS). Prior studies have shown MS patients with high"/>
   <result pre="explore the appropriateness of current and emerging treatments for relapsing-remitting" exact="multiple sclerosis" post="HJ Stoevelaar 1, F Barkhof 2, T Berger 3,"/>
   <result pre="Dresden, Germany Background: The therapeutic arsenal for patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS) is rapidly expanding. Over the last few years,"/>
   <result pre="the study of quality of life (QoL) in patients with" exact="multiple sclerosis" post="(MS). However the study of QoL and well-being in"/>
   <result pre="tests to monitor disease activity among patients with relapsing remitting" exact="multiple sclerosis" post="in the United States and Europe P O’Meara 1,"/>
   <result pre="a validation tool for fine-grained measures of motor dysfunction in" exact="multiple sclerosis" post="J Burggraaff 1, M D’Souza 2, J Dorn 3,"/>
   <result pre="For a more reliable and sensitive assessment of disability in" exact="multiple sclerosis" post="(MS) we are developing the ASSESS-MS system, which relies"/>
   <result pre="Scale (EDSS) is the most widely used disability-rating scale in" exact="multiple sclerosis" post="(MS), but has been criticized for its low reliability."/>
   <result pre="Infrared depth sensor based automated classification of motor dysfunction in" exact="multiple sclerosis" post="- a proof-of-concept study M D’Souza 1, J Burggraaf"/>
   <result pre="is the most frequently used scale to rate disability in" exact="multiple sclerosis" post="(MS) and an important outcome measure in clinical trials"/>
   <result pre="The squares test as a measure of hand function in" exact="multiple sclerosis" post="J Gielen 1, J Laton 1, J Van Schependom"/>
   <result pre="upper extremity function using the manual dexterity component of the" exact="multiple sclerosis" post="performance test: validation of novel metrics F Bethoux 1,"/>
   <result pre="of upper extremity (UE) function is a frequent consequence of" exact="multiple sclerosis" post="(MS). The MS Performance Test (MSPT) is an Ipad"/>
   <result pre="across subgroups with alemtuzumab versus interferon beta-1a in treatment-naive relapsing-remitting" exact="multiple sclerosis" post="X Montalban 1, DL Arnold 2,3, E Fisher 4,"/>
   <result pre="CARE-MS I (NCT00530348) trial in treatment-naive patients with active relapsing-remitting" exact="multiple sclerosis" post="(RRMS), alemtuzumab proved superior to subcutaneous interferon beta-1a (SC"/>
   <result pre="across various subgroups. P040 MRI outcomes in patients with early" exact="multiple sclerosis" post="treated with teriflunomide: subgroup analyses from the TOPIC phase"/>
   <result pre="Background: Teriflunomide is a once-daily oral immunomodulator approved for relapsing-remitting" exact="multiple sclerosis" post="(MS). TOPIC (NCT00622700) is a phase 3 study that"/>
   <result pre="improve recovery following relapses: data from the 2-year ADVANCE relapsing-remitting" exact="multiple sclerosis" post="study BC Kieseier 1, TF Scott 2,3, SD Newsome"/>
   <result pre="in risk of sustained disability progression (SDP) observed in relapsing-remitting" exact="multiple sclerosis" post="(RRMS) patients treated with subcutaneous peginterferon beta-1a (PEG-IFN; 125"/>
   <result pre="Background: Alemtuzumab is approved in over 30 countries for relapsing-remitting" exact="multiple sclerosis" post="(RRMS). The phase 3 CARE-MS II study in patients"/>
   <result pre="other therapies. P044 Alemtuzumab improves quality of life in relapsing-remitting" exact="multiple sclerosis" post="patients who relapsed on prior therapy: 3-year follow-up of"/>
   <result pre="approved in over 30 countries for the treatment of relapsing-remitting" exact="multiple sclerosis" post="(RRMS). In CARE-MS II (NCT00548405), alemtuzumab had superior efficacy"/>
   <result pre="Background: Teriflunomide is a once-daily oral immunomodulator approved for relapsing-remitting" exact="multiple sclerosis" post="(MS). The TEMSO (NCT00134563) and TOWER (NCT00751881) phase 3"/>
   <result pre="Background: Analysis of brain volume (BV) in patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS) in fingolimod clinical trials revealed relationships between variables"/>
   <result pre="a dose-ranging study of subcutaneous ofatumumab in subjects with relapsing-remitting" exact="multiple sclerosis" post="PS Sorenson 1, ST Kavanagh 2, DJ Austin 3,"/>
   <result pre="demonstrated the benefits of anti-CD20 monoclonal antibody treatments in relapsing-remitting" exact="multiple sclerosis" post="(RRMS). This study investigated the safety and efficacy of"/>
   <result pre="activity. Objectives: To assess subject safety, persistence of MRI lesion" exact="suppression" post="and B-cell repletion over the course of a 24-week"/>
   <result pre="SAE reported by more than one subject; no cases of" exact="progressive multifocal leukoencephalopathy" post="or opportunistic infections were observed. Assessment of efficacy data"/>
   <result pre="observed. Assessment of efficacy data showed that the MRI lesion" exact="suppression" post="seen during the 24-week treatment phase persisted through week"/>
   <result pre="P049 Safety, tolerability and efficacy of Boswellic acids in relapsing-remitting" exact="multiple sclerosis" post="- the SABA proof-of-concept trial KH Stürner 1, J-P"/>
   <result pre="to exhibit anti-inflammatory activities. Clinical trials with frankincense extracts in" exact="rheumatoid arthritis" post="showed very good tolerability and good efficacy in restraining"/>
   <result pre="exhibit anti-inflammatory activities. Clinical trials with frankincense extracts in rheumatoid" exact="arthritis" post="showed very good tolerability and good efficacy in restraining"/>
   <result pre="(S1P)-1,5 modulator, being developed for the treatment of secondary progressive" exact="multiple sclerosis" post="(MS). The therapeutic effects include prevention of circulating effector"/>
   <result pre="HYP 150mg once-monthly compared with placebo in patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS). Objectives: To determine the impact of DAC HYP"/>
   <result pre="Delayed-release dimethyl fumarate (DMF) demonstrated efficacy and safety in relapsing-remitting" exact="multiple sclerosis" post="in Phase 3 studies. Gastrointestinal (GI) events were common"/>
   <result pre="GI events. The incidences of flatulence (38.6% vs 50.6%) and" exact="diarrhea" post="(36.4% vs 48.2%) were lower in the bismuth subsalicylate"/>
   <result pre="1.8; LS mean difference [95% CI]: 0.7 [0.1, 1.3]) and" exact="diarrhea" post="(1.0 vs 1.6; LS mean difference [95% CI]: 0.6"/>
   <result pre="for flatulence (severe, 1.1% vs 5.9%; extreme, 0% vs 0%)," exact="diarrhea" post="(severe, 1.1% vs 9.4%; extreme, 0% vs 0%), upper"/>
   <result pre="on fatigue and quality of life measures in relapsing remitting" exact="multiple sclerosis" post="(MS) patients. Methods: We conducted a randomized-controlled, rater-blinded, 1-year"/>
   <result pre="oral L-carnitine versus placebo for the treatment of fatigue in" exact="multiple sclerosis" post="J-C Ouallet 1, D Laplaud 2, S Wiertlewski 2,"/>
   <result pre="supplementation. P057 Delayed-release dimethyl fumarate and disability assessed by the" exact="multiple sclerosis" post="functional composite: integrated analysis of DEFINE and CONFIRM G"/>
   <result pre="measures and an acceptable safety profile in patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS) in the Phase 3 DEFINE and CONFIRM studies."/>
   <result pre="oral immunomodulator approved for the treatment of patients with relapsing-remitting" exact="multiple sclerosis" post="(MS). The teriflunomide clinical development program includes four monotherapy"/>
   <result pre="fumarate (DMF) demonstrated efficacy and safety in patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS) in the 2-year, Phase 3 DEFINE and CONFIRM"/>
   <result pre="Background: Teriflunomide is a once-daily oral immunomodulator approved for relapsing-remitting" exact="multiple sclerosis" post="(MS). Teriflunomide is known to decrease the proliferation of"/>
   <result pre="7 mg), and one (0.1%; placebo) patients discontinued due to" exact="neutropenia" post="or neutrophil count decrease as per the protocol requirement."/>
   <result pre="P062 Clinical efficacy of laquinimod 0.6mg once-daily in worsening relapsing-remitting" exact="multiple sclerosis" post="defined by baseline EDSS over 3 TL Vollmer 1,"/>
   <result pre="Neuro-Oncologie et Neuro-Inflammation, Lyon, France Background: Women are affected by" exact="multiple sclerosis" post="(MS) mainly in their childbearing years and the risk"/>
   <result pre="CONFIRM studies across a broad range of patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS). ENDORSE is an ongoing, 5-year, dose-blind extension study"/>
   <result pre="DMF on annualized relapse rate (ARR) in patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS) from DEFINE and CONFIRM who had received prior"/>
   <result pre="delayed-release dimethyl fumarate (DMF) was demonstrated in patients with relapsing−remitting" exact="multiple sclerosis" post="(RRMS) in the Phase 3 DEFINE and CONFIRM studies."/>
   <result pre="Year 1 of the Phase 3 ADVANCE study in relapsing-remitting" exact="multiple sclerosis" post="(RRMS), with a safety profile reflecting that of established"/>
   <result pre="LAQ had a more pronounced effect on indices of underlying" exact="neurodegeneration" post="(CDP, brain tissue loss) than on markers of acute"/>
   <result pre="effect on disability reduction is explained by mechanisms other than" exact="suppression" post="of acute inflammation. LAQ appears to have a different"/>
   <result pre="action of laquinimod and the onset of its activity in" exact="multiple sclerosis" post="(MS) patients are currently unknown. When 0.6mg of laquinimod"/>
   <result pre="erythropoietin on clinical disability and MRI in patients with progressive" exact="multiple sclerosis" post="KI Schreiber 1, M Magyari 1, FT Sellebjerg 1,"/>
   <result pre="weeks over placebo at 1 year in patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS; n=1512). Objectives: To explore the influence of treatment"/>
   <result pre="3 CARE-MS II trial (NCT00548405) in patients with active relapsing-remitting" exact="multiple sclerosis" post="(RRMS) who relapsed on prior therapy, alemtuzumab was superior"/>
   <result pre="Delayed-release dimethyl fumarate (DMF) demonstrated efficacy and safety in relapsing-remitting" exact="multiple sclerosis" post="in placebo-controlled clinical trials, including a Phase 2b trial"/>
   <result pre="a once-daily oral immunomodulator approved for the treatment of relapsing-remitting" exact="multiple sclerosis" post="(MS). Phase 3 studies of teriflunomide in patients with"/>
   <result pre="is a once-daily oral immunomodulator for the treatment of relapsing-remitting" exact="multiple sclerosis" post="(MS). In phase 2 and 3 studies, teriflunomide had"/>
   <result pre="randomized, double-blind, placebo-controlled phase IIa study of alpha B-crystallin in" exact="multiple sclerosis" post="JM van Noort 1, M Bsibsi 1, PJ Nacken"/>
   <result pre="1, EH Venneker 1 1Delta Crystallon, Leiden, Netherlands Background: During" exact="multiple sclerosis" post="(MS), widespread accumulation occurs of the small heat shock"/>
   <result pre="we identified a dose of HspB5 that led to significant" exact="suppression" post="of HspB5-specific memory T cell responses. Objectives: In this"/>
   <result pre="was the first oral therapy approved for treatment of relapsing-remitting" exact="multiple sclerosis" post="(RRMS). Between EMA approval and fingolimod availability on the"/>
   <result pre="systemic infections, history or presence of malignancy, uncontrolled diabetes or" exact="diabetic retinopathy," post="macular edema (ME), severe cardiovascular (CV) disease. Safety and"/>
   <result pre="history or presence of malignancy, uncontrolled diabetes or diabetic retinopathy," exact="macular edema" post="(ME), severe cardiovascular (CV) disease. Safety and tolerability of"/>
   <result pre="in 35.4% of patients, the most frequent being headache (4.1%)," exact="influenza" post="(2.1%), lymphopenia (1.8%), asthenia (1.8%) and pyrexia (1.8%). 18/906"/>
   <result pre="patients had a self-limiting CV AE (including 2 cases of" exact="atrioventricular block" post="- AVB- second degree Mobitz type I) with onset"/>
   <result pre="type I, 1 case of pneumonia, 1 case of acute" exact="respiratory failure," post="1 case of transaminase increase and 1 case of"/>
   <result pre="vitamin D deficiency to both susceptibility to, and severity of," exact="multiple sclerosis." post="We report the dose- response results in a sub-group"/>
   <result pre="efficacy over placebo at 1 year in patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS; n=1512). 1332 (88%) participants completed Year 1 of"/>
   <result pre="the previous pivotal multicenter trials. P087 Vitamin D levels in" exact="multiple sclerosis" post="in correlation to age, sex, EDSS and dosage of"/>
   <result pre="1 1Marianne Strauss Klinik, Berg, Germany Background: Vitamin D in" exact="multiple sclerosis" post="(MS) is still controversial discussed regarding the impact of"/>
   <result pre="reduces disease activity in treatment-naive patients with highly active relapsing-remitting" exact="multiple sclerosis" post="S Krieger 1, C Lubetzki 2, J Palmer 3,"/>
   <result pre="(65.7 vs 42.6%), thyroid events (13.3 vs 9.8%), and immune" exact="thrombocytopenia" post="(ITP; 1.9 vs 0%). Two alemtuzumab patients had grade"/>
   <result pre="Background: Alemtuzumab is approved in over 30 countries for relapsing-remitting" exact="multiple sclerosis" post="(RRMS). The phase 3 CARE-MS I study in treatment-naive"/>
   <result pre="and remained in the study. P091 Attitudes of people with" exact="multiple sclerosis" post="towards clinical research S Jordan 1, K O’Connell 1,"/>
   <result pre="against the MSRV envelope protein, pharmacodynamic responses in patients with" exact="multiple sclerosis" post="F Curtin 1 1GeNeuro, Plan les Ouates, Switzerland Background:"/>
   <result pre="and autoimmune cascade via Toll-Like receptor 4. MSRV-Env expressed in" exact="multiple sclerosis" post="(MS) plaques has an inhibitory effect on oligodendrocyte precursor"/>
   <result pre="of the Multiple Sclerosis associated Retrovirus (MSRV) Env protein in" exact="multiple sclerosis" post="(MS) patients. Methods: We report the results of Phase"/>
   <result pre="from invariant NKT (iNKT) cells, would suppress the development of" exact="autoimmune disease" post="models, including experimental autoimmune encephalomyelitis (EAE) (Miyamoto et al."/>
   <result pre="suppress the development of autoimmune disease models, including experimental autoimmune" exact="encephalomyelitis" post="(EAE) (Miyamoto et al. Nature 2001). Objectives: Here we"/>
   <result pre="gene expressions of whole blood with DNA microarray. Results: Mild" exact="leukopenia" post="occurred in two subjects, but recovered without any treatments."/>
   <result pre="to start an early phase 2 study for patients with" exact="multiple sclerosis" post="(MS). At April 2012, we have finished administration of"/>
   <result pre="The placebo-controlled portion of prior trials in patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS) was 1 year in duration. Objectives: To evaluate"/>
   <result pre="patients who had experienced a first clinical episode suggestive of" exact="multiple sclerosis" post="(MS). Teriflunomide 14 mg reduced the risk of relapse"/>
   <result pre="measures and an acceptable safety profile in patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS) in the Phase 3 DEFINE and CONFIRM studies."/>
   <result pre="a once-daily oral immunomodulator approved for the treatment of relapsing-remitting" exact="multiple sclerosis." post="In phase 2 and 3 studies, teriflunomide has shown"/>
   <result pre="to evaluate an integrated approach for optimized patient management in" exact="multiple sclerosis" post="patients treated with natalizumab H-P Hartung 1, T Ziemssen"/>
   <result pre="referral system on outcome of natalizumab (Tysabri ®) treated relapsing-remitting" exact="multiple sclerosis" post="(RRMS) patients, an open-label real-world study is being conducted"/>
   <result pre="Pharmaceuticals Corporation, East Hanover, NJ, United States Background: In relapsing-remitting" exact="multiple sclerosis" post="(RRMS), the presence of gadolinium-enhancing (Gd+) T1 lesions on"/>
   <result pre="Free Status? http://www.clevelandclinicmeded.com/online/webcasts/ms-vgr/treating-to-target-in-MS/. P103 Alemtuzumab improves MRI outcomes in relapsing-remitting" exact="multiple sclerosis" post="patients who relapsed on prior therapy: three-year follow-up of"/>
   <result pre="is approved in over 30 countries for treatment of relapsing-remitting" exact="multiple sclerosis" post="(RRMS). In the CARE-MS II trial in active RRMS"/>
   <result pre="P105 A double-blind, randomized, versus-placebo study of palmitoylethanolamide in relapsing-remitting" exact="multiple sclerosis" post="N Orefice 1, M Calabrese 2, A Carotenuto 3,"/>
   <result pre="been reported to reduce inflammatory markers in animal models of" exact="multiple sclerosis" post="(MS). Objectives: To evaluate the potential antiinflammatory effects of"/>
   <result pre="High Yield Process (HYP) demonstrated benefits in treatment of relapsing-remitting" exact="multiple sclerosis" post="(RRMS) in a large Phase 2b trial (SELECT). Objectives:"/>
   <result pre="(S1PR) modulator, is approved for the treatment of relapsing remitting" exact="multiple sclerosis" post="(RRMS) and more than 91,500 patients have been treated"/>
   <result pre="daily clinical routine. P108 Efficacy of delayed-release dimethyl fumarate in" exact="multiple sclerosis" post="patients with moderate disability: an integrated analysis of the"/>
   <result pre="measures and an acceptable safety profile in patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS) in the Phase 3 DEFINE and CONFIRM studies."/>
   <result pre="to have a direct effect on the CNS-based pathology in" exact="multiple sclerosis" post="by acting on S1P1 and/or S1P5 receptor expressing cells"/>
   <result pre="and lesion count reduction. Methods: Data from 296 relapsing remitting" exact="multiple sclerosis" post="patients from the placebo-controlled phase II study was analyzed."/>
   <result pre="fumarate (DMF) demonstrated efficacy and safety in patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS) in the 2-year, Phase 3 DEFINE and CONFIRM"/>
   <result pre="is in clinical development for the treatment of secondary progressive" exact="multiple sclerosis" post="(SPMS). MIS416 is a microparticulate formulation of bacterial ligands"/>
   <result pre="magnetic resonance imaging (MRI) and clinical outcomes in patients with" exact="multiple sclerosis" post="(MS) has been demonstrated in two large phase 3,"/>
   <result pre="function P114 Independent component analysis of cognitive performance in primary-progressive" exact="multiple sclerosis" post="M Petracca 1,2, H Bender 2, C Farrell 2,"/>
   <result pre="and cognitive impairment: comparison between relapsing remitting and secondary progressive" exact="multiple sclerosis" post="F Tona 1, E Sbardella 1,2, N Petsas 1,2,"/>
   <result pre="Strasbourg, Neurologie, Strasbourg, France Background: Affective disorders are frequent in" exact="multiple sclerosis" post="(MS), but their specificity remains controversial and the underlying"/>
   <result pre="intrinsic resting-state functional connectivity modulation induced by mental effort in" exact="multiple sclerosis" post="patients with fatigue C Zecca 1, E Pravatà 1,2,3,"/>
   <result pre="Background: Fatigue is a common and debilitating symptom related to" exact="multiple sclerosis" post="(MS). Fatigue may follow physical or mental efforts, resulting"/>
   <result pre="of thalamo-cortical projections. P118 Brief computerized cognitive testing in pediatric-onset" exact="multiple sclerosis" post="(MS) LE Charvet 1,2, MW Porter 1,2, B Harel"/>
   <result pre="first sign of neurocognitive impairment in children and teens with" exact="multiple sclerosis" post="(MS). Prompt identification of pediatric MS patients with impaired"/>
   <result pre="are a major determinant of impaired neuropsychological performance (NP) in" exact="multiple sclerosis" post="(MS). Previous data suggested that focal juxta- and leuko-cortical"/>
   <result pre="a history of major medical, neurologic or psychiatric illnesses, active" exact="substance abuse," post="current psychoactive medication usage (chronic sedatives/hypnotics and narcotic analgesics),"/>
   <result pre="Assessment for Multiple Sclerosis and the brief repeatable battery in" exact="multiple sclerosis" post="patients E Portaccio 1, B Goretti 1, C Niccolai"/>
   <result pre="and magnetic resonance imaging (MRI) has been investigated extensively in" exact="multiple sclerosis" post="(MS), MRI correlates of CI in CIS patients are"/>
   <result pre="impairment has been estimated to affect 45-65% of patients with" exact="multiple sclerosis" post="(MS), with deficits in executive function among the most"/>
   <result pre="3Azienda Ospedaliera Universitaria Integrata, Neurology Unit, Verona, Italy Background: Benign" exact="multiple sclerosis" post="(BMS) definition is generally based on a minimum disease"/>
   <result pre="domains P134 SDMT performance predicts real-world functioning in adults with" exact="multiple sclerosis" post="(MS) LE Charvet 1,2, M Kasschau 1,2, W Scherl"/>
   <result pre="an expanded version of a system developed for use in" exact="dementia" post="populations and previously validated for use in an MS"/>
   <result pre="and psychoaffective disturbances may present already in children affected by" exact="multiple sclerosis" post="(MS). The most vulnerable areas include attention, visual-perceptual abilities,"/>
   <result pre="in 25% of patients, may represent the first attack of" exact="multiple sclerosis" post="(MS). Although cognitive impairment (CI) has been well described"/>
   <result pre="variability is associated with white matter microstructure in persons with" exact="multiple sclerosis" post="MA Wojtowicz 1, EL Mazerolle 2, A Omisade 1,"/>
   <result pre="attention and information processing speed are common in persons with" exact="multiple sclerosis" post="(MS) and may contribute to impairments of other cognitive"/>
   <result pre="cerebellum in cognitive test performance in children and adolescents with" exact="multiple sclerosis" post="K Weier 1, C Till 2,3, V Fonov 1,"/>
   <result pre="Children’s Hospital of Philadelphia, Philadelphia, PA, United States Background: Pediatric-onset" exact="multiple sclerosis" post="(MS) is often accompanied by cognitive impairment. Severity of"/>
   <result pre="cognitive fatigue is a function of time on task in" exact="multiple sclerosis" post="J Sandry 1,2, H Genova 1,2, J DeLuca 1,2,3,"/>
   <result pre="task. P142 Response inhibition on a Go/No-go task in pediatric-onset" exact="multiple sclerosis" post="patients: an fMRI study M Lysenko 1, N Akbar"/>
   <result pre="to withhold a response, is typically preserved in patients with" exact="multiple sclerosis" post="(MS), despite impairment in other executive functions. The role"/>
   <result pre="and cognitive reserve as moderators of cognitive decline in pediatric-onset" exact="multiple sclerosis" post="patients C Till 1,2, B Hosseini 1, D Flora"/>
   <result pre="information across the corpus callosum is slowed in patients with" exact="multiple sclerosis" post="compared to healthy controls J Bacon 1,2, T Bacon"/>
   <result pre="is a frequent and early locus of disease activity in" exact="multiple sclerosis" post="(MS) . We predicted that, relative to controls, MS"/>
   <result pre="particularly relevant to study the early mechanisms of CI in" exact="multiple sclerosis" post="(MS). Diffusion tensor imaging (DTI) allows to study white"/>
   <result pre="is a sensitive measure of information processing speed deficits in" exact="multiple sclerosis" post="(MS) and has been demonstrated to be more palatable"/>
   <result pre="drive in the individual patient. P148 Inhibitory control in early" exact="multiple sclerosis" post="L Crivelli 1, MF Farez 1, RF Allegri 1,"/>
   <result pre="States Background: Cognitive dysfunction is a frequently occurring symptom of" exact="multiple sclerosis" post="(MS) and it has become an increasingly important focus"/>
   <result pre="future thinking and their relation to cerebral structure in early" exact="multiple sclerosis" post="patients GO Nygaard 1,2, KB Walhovd 3, AM Fjell"/>
   <result pre="Background: Self-reported episodic memory may be affected in relapsing remitting" exact="multiple sclerosis" post="(RRMS), but it is not clear whether it is"/>
   <result pre="France Background: Assessment of cognitive impairment (CI) in persons with" exact="multiple sclerosis" post="(PwMS) requires large neuropsychological (NP) batteries covering different domains:"/>
   <result pre="Incipient cognitive dysfunction revealed by dual-task posturography in patients with" exact="multiple sclerosis" post="L Prosperini 1, L De Giglio 1, L Castelli"/>
   <result pre="independently associated with postural instability and falls in patients with" exact="multiple sclerosis" post="(MS). However, whether a dual-task paradigm may even reveal"/>
   <result pre="processing speed test is associated with verbal memory abilities in" exact="multiple sclerosis" post="C Mavis 1,2, B Roberg 1, S O’Bryan 1,"/>
   <result pre="and auditory verbal memory are frequently impaired in people with" exact="multiple sclerosis" post="(MS). Whereas information processing speed can be quickly assessed,"/>
   <result pre="NS, Canada Background: Cognitive impairments are common among persons with" exact="multiple sclerosis" post="(MS) as are subjective cognitive complaints. The association between"/>
   <result pre="of information processing speed. P156 Cognitive impairment, oxidative stress and" exact="neurodegeneration" post="in multiple sclerosis AJ Hughes 1, I-Y Choi 2,"/>
   <result pre="processing speed. P156 Cognitive impairment, oxidative stress and neurodegeneration in" exact="multiple sclerosis" post="AJ Hughes 1, I-Y Choi 2, P Lee 3,"/>
   <result pre="Kansas City, KS, United States Background: Accumulating evidence points to" exact="neurodegeneration" post="as the primary force driving cognitive impairment in multiple"/>
   <result pre="to neurodegeneration as the primary force driving cognitive impairment in" exact="multiple sclerosis" post="(MS). In addition to examining traditional structural markers of"/>
   <result pre="sclerosis (MS). In addition to examining traditional structural markers of" exact="neurodegeneration" post="(e.g., atrophy), recent work in our laboratory has assessed"/>
   <result pre="and modestly correlated with GSH. Results provide further evidence for" exact="neurodegeneration" post="as the most likely process underlying cognitive impairment in"/>
   <result pre="of Wechsler Memory Scale-fourth edition (WMS-IV) in memory evaluation in" exact="multiple sclerosis" post="patients CT Spedo 1,2, MP Foss 1, DA Pereira"/>
   <result pre="To investigate the memory functioning and its processes in relapsing-remitting" exact="multiple sclerosis" post="patients (MS-RR) and to compare it with healthy controls"/>
   <result pre="in MS-RR. P158 Cognitive impairment and corpus callosum atrophy in" exact="multiple sclerosis" post="MY Pérez Martín 1, M González Platas 1, A"/>
   <result pre="Spain Background: Cognitive impairment affects 43-75% of the patients with" exact="multiple sclerosis" post="patients (MS). Several studies have shown that neuropsychological impairment"/>
   <result pre="P159 Do disease modifying treatments affect cognitive performance in early" exact="multiple sclerosis?" post="MC Graves 1, K Ribbons 2, R Lea 3,"/>
   <result pre="7University of Newcastle, Newcastle, Australia Background: Cognition is impaired in" exact="multiple sclerosis" post="(MS) even in early disease. Objectives: The aim of"/>
   <result pre="is known to be a common and debilitating consequence of" exact="multiple sclerosis" post="(MS), affecting approximately 43-60% of MS with a significant"/>
   <result pre="into adequate rehabilitation protocols. P162 Cognitive impairment in patients with" exact="neuromyelitis optica" post="spectrum disorder: a preliminary report S-H Kim 1, J-W"/>
   <result pre="studies have recently reported that about half of patients with" exact="neuromyelitis optica" post="spectrum disorder (NMOSD) have cognitive impairment. However, the patterns"/>
   <result pre="for Multiple Sclerosis during treatment of relapses in patients with" exact="multiple sclerosis" post="O Oztürk 1, B Piri Cinar 2, S Ozakbas"/>
   <result pre="Turkey Background: As would be expected a substantial number of" exact="multiple sclerosis" post="(MS) patients are compromised neuropsychologically. The Expanded Disability Status"/>
   <result pre="executive control components of working memory equally affected in pediatric-onset" exact="multiple sclerosis" post="patients? C Till 1,2, M Sadeghi 1, M Lysenko"/>
   <result pre="Working memory (WM) dysfunction is common amongst patients with pediatric-onset" exact="multiple sclerosis" post="(MS). WM consists of two key cognitive functions, storage"/>
   <result pre="Modalities Test: demographic effects on identification of impairment in Dutch" exact="multiple sclerosis" post="patients J Burggraaff 1, D Knol 2, B Uitdehaag"/>
   <result pre="volume is related to decreased information processing speed in relapse-remitting" exact="multiple sclerosis" post="patients T Uher 1, J Blahova-Dusankova 1, M Tyblova"/>
   <result pre="important predictor of relapse activity and sustained disability progression in" exact="multiple sclerosis" post="(MS) patients. However, there are only few large studies"/>
   <result pre="contribution of cortical lesions to cognitive impairment in patients with" exact="multiple sclerosis" post="O Geisseler 1, T Pflugshaupt 1,2, L Bezzola 3,"/>
   <result pre="that grey matter lesions occur frequently and early in all" exact="multiple sclerosis" post="phenotypes. However, the impact on cognitive and clinical impairment"/>
   <result pre="on cognitive tests. P171 Reaction time distributions in early-phase relapsing-remitting" exact="multiple sclerosis" post="differ from controls GT Howell 1, J-A LeFevre 1,2,"/>
   <result pre="of mean RT differences on the CTIP between patients with" exact="multiple sclerosis" post="(MS) and matched controls, potentially due to the MS"/>
   <result pre="Predictivity of executive functions deficit on episodic memory disorder in" exact="multiple sclerosis" post="R Barthelemy 1,2, B Lenne 1,3, D Leuse 1,"/>
   <result pre="risk behaviors P174 Does smoking influence MRI disease activity in" exact="multiple sclerosis?" post="SAS Kvistad 1, K-M Myhr 1, T Holmøy 2,"/>
   <result pre="an effect on the disease course. P176 Obesity interacts with" exact="infectious mononucleosis" post="in risk of multiple sclerosis L Alfredsson 1, AK"/>
   <result pre="course. P176 Obesity interacts with infectious mononucleosis in risk of" exact="multiple sclerosis" post="L Alfredsson 1, AK Hedström 1, IL Bomfim 2,"/>
   <result pre="Environmental risk factors influencing MS risk include a history of" exact="infectious mononucleosis" post="(IM) and adolescent obesity. Obesity results in a state"/>
   <result pre="Objectives: We aimed to investigate the possible interaction between adolescent" exact="obesity" post="and past IM with regard to MS risk. Methods:"/>
   <result pre="of HLA status, a substantial interaction was observed between adolescent" exact="obesity" post="and past IM with regard to MS risk. The"/>
   <result pre="MS was 14.7 (95% CI 5.9-36.6) among subjects with adolescent" exact="obesity" post="and past IM after the age of 10, compared"/>
   <result pre="between adolescent BMI and past IM. Measures taken against adolescent" exact="obesity" post="may thus be a preventive strategy against MS. P177"/>
   <result pre="inflammatory bowel disease (IBD) but presumably can induce or unmask" exact="multiple sclerosis" post="(MS) and MS-like idiopathic inflammatory-demyelinating disease of the central"/>
   <result pre="anti-TNFα exposure was estimated for IBD, Crohn’s disease (CD) and" exact="ulcerative colitis" post="(UC) groups separately (Wilcoxon rank sum and Fischer exact"/>
   <result pre="exposure was estimated for IBD, Crohn’s disease (CD) and ulcerative" exact="colitis" post="(UC) groups separately (Wilcoxon rank sum and Fischer exact"/>
   <result pre="in 2000 (0.2%). P178 Prescription drug use among patients with" exact="multiple sclerosis" post="LW Svenson 1,2,3, DP Schopflocher 1,3,4, SA Warren 5"/>
   <result pre="2.9). MS patients were less likely to receive drugs for" exact="cardiovascular disease" post="(OR = 0.8, 95% CI: 0.76, 0.84), anti-parasitic (OR"/>
   <result pre="treatment of common MS co-morbidities. P179 Comorbidities in patients with" exact="multiple sclerosis" post="compared with the general population: retrospective analysis of the"/>
   <result pre="Background: Limited data are available regarding comorbidities in patients with" exact="multiple sclerosis" post="(MS). Results from a retrospective study using the US"/>
   <result pre="more common in the MS vs non-MS cohort. ERs for" exact="breast cancer" post="were similar in both cohorts (1.1, 1.0-1.2). These ERRs"/>
   <result pre="common in the MS vs non-MS cohort. ERs for breast" exact="cancer" post="were similar in both cohorts (1.1, 1.0-1.2). These ERRs"/>
   <result pre="vs DOD database. Conclusions: ERs of comorbidities, such as ischaemic" exact="stroke" post="and opportunistic infections, were higher in patients with MS"/>
   <result pre="sleep disruption. The more common sleep disorders include insomnia, sleepness," exact="sleep apnea," post="restless legs syndrome (RLS) or narcolepsy. Frequently, these disturbances"/>
   <result pre="The more common sleep disorders include insomnia, sleepness, sleep apnea," exact="restless legs syndrome" post="(RLS) or narcolepsy. Frequently, these disturbances have a major"/>
   <result pre="patients seen in the DD consultation and the relationship of" exact="sleep disorder" post="and QoL and fatigue. Methods: 240 patients were included;"/>
   <result pre="included; mean age 43±11 years, 187 women. 163 patients with" exact="multiple sclerosis" post="(MS): 144 relapsing-remitting (RR), 14 secondary progressive (SP) and"/>
   <result pre="Moderate/severe insomnia 12.5%, OSA 5.8%, RLS 9.6% (confirmed three cases)," exact="narcolepsy" post="0, fatigue (&amp;gt;4) 24.6%. Physical QoL 66.6±19.6, Mental QoL"/>
   <result pre="seems to be growing evidence of an association between adolescent" exact="obesity" post="and increased risk of multiple sclerosis (MS), it has"/>
   <result pre="of an association between adolescent obesity and increased risk of" exact="multiple sclerosis" post="(MS), it has yet to be determined if weight"/>
   <result pre="potentially influence lifestyle and dietary habits. P182 Alcohol-use disorders and" exact="multiple sclerosis" post="risk: a national record-linkage study J Pakpoor 1, R"/>
   <result pre="of people with a record for alcohol use (10156 people)," exact="alcohol abuse" post="(255827 people) and alcohol dependence (281305 people) were constructed"/>
   <result pre="for alcohol use (10156 people), alcohol abuse (255827 people) and" exact="alcohol dependence" post="(281305 people) were constructed by identifying the first recorded"/>
   <result pre="a significantly increased risk of MS following alcohol use (p=0.003)," exact="alcohol abuse" post="(p&amp;lt; 0.0001) and alcohol dependence (p=0.001). Considering the possibility"/>
   <result pre="MS following alcohol use (p=0.003), alcohol abuse (p&amp;lt; 0.0001) and" exact="alcohol dependence" post="(p=0.001). Considering the possibility of reverse causality we found"/>
   <result pre="risk of MS within one year of first admission for" exact="alcohol abuse" post="only (p&amp;lt; 0.0001), but not for alcohol use or"/>
   <result pre="follow-up studies are required to ascertain the relationship. P183 The" exact="metabolic syndrome" post="in disabled multiple sclerosis patients: prevalence and characteristics M"/>
   <result pre="to ascertain the relationship. P183 The metabolic syndrome in disabled" exact="multiple sclerosis" post="patients: prevalence and characteristics M Livne 1,2, O Pinhas-Hamiel"/>
   <result pre="the association of metabolic commodities and disability in patients with" exact="multiple sclerosis" post="(MS). Objectives: To examine the prevalence of the metabolic"/>
   <result pre="multiple sclerosis (MS). Objectives: To examine the prevalence of the" exact="metabolic syndrome" post="(MetS) and characterize its components in MS patients with"/>
   <result pre="of any three of the following five components 1) central" exact="obesity" post="as measured by WC (males &amp;gt;102 cm, females &amp;gt;88"/>
   <result pre="for males and &amp;lt; 50 mg/dl for females, or treated" exact="dyslipidemia" post="4) blood pressure &amp;gt;135/85 or treated hypertension, and 5)"/>
   <result pre="MetS was 36.9% with no gender difference. 55.9% had central" exact="obesity" post="by WC, 28 % had treated hypertension, and 45.8%"/>
   <result pre="and 45.8% had elevated blood pressure, 11% had type 2" exact="diabetes mellitus" post="and 36.4% had hyperglycemia, 31.4% had treated dyslipidemia and"/>
   <result pre="2 diabetes mellitus and 36.4% had hyperglycemia, 31.4% had treated" exact="dyslipidemia" post="and 28.8% had elevated TG level, 31.4 had low"/>
   <result pre="related effect. P184 Burden of comorbidities in patients with incident" exact="multiple sclerosis" post="prior to and following diagnosis: a nationwide population study"/>
   <result pre="Taoyuan, Taiwan, Republic of China Background: Comorbidities in individuals with" exact="multiple sclerosis" post="(MS) may delay diagnosis and the accumulation of comorbidities"/>
   <result pre="P185 Smoking, systemic inflammation and T-cell reactivity in patients with" exact="multiple sclerosis" post="and healthy controls C Ammitzboell 1, LS Börnsen 1,"/>
   <result pre="neuroinflammation, axonal damage and disease progression in patients with progressive" exact="multiple sclerosis" post="(MS). Smoking is one of the environmental factors associated"/>
   <result pre="from HCs. P186 Tobacco influence in the clinical progression of" exact="multiple sclerosis" post="S Batista 1, Z Argyropoulou 2, I Correia 1,"/>
   <result pre="effect in the disease evolution. P187 Prevalence and predictors of" exact="substance abuse" post="in multiple sclerosis N Brennecke 1, AL Boster 2,3,"/>
   <result pre="disease evolution. P187 Prevalence and predictors of substance abuse in" exact="multiple sclerosis" post="N Brennecke 1, AL Boster 2,3, AM Wehr 4,"/>
   <result pre="Department of Biostatistics, Columbus, OH, United States Background: Patients with" exact="multiple sclerosis" post="(MS) have been shown to be more likely to"/>
   <result pre="population, creating interest in the prevelance and risk factors for" exact="substance abuse" post="among this patient population. Objectives: To assess the prevalence"/>
   <result pre="among this patient population. Objectives: To assess the prevalence of" exact="substance abuse" post="among MS patients in a large, academic MS clinic"/>
   <result pre="large, academic MS clinic and to identify predictors associated with" exact="substance abuse." post="Methods: MS patients presenting for routine clinic visits at"/>
   <result pre="model using backward selection was performed to identify predictors of" exact="substance abuse." post="Results: A total of 255 MS patients were included"/>
   <result pre="total of 29 patients (12%) were identified to have current" exact="substance abuse," post="208 (88%) did not currently abuse substances and 18"/>
   <result pre="status was found to be a significant predictor of current" exact="substance abuse." post="For unemployed patients with MS, the odds of current"/>
   <result pre="abuse. For unemployed patients with MS, the odds of current" exact="substance abuse" post="was 4.67 times that of an employed patient with"/>
   <result pre="MS patient population. Unemployment significantly increased the risk of current" exact="substance abuse." post="Race, age, sex, MS disease course, disability and marital"/>
   <result pre="course, disability and marital status were not significant predictors of" exact="substance abuse." post="Larger studies are needed to confirm the results obtained"/>
   <result pre="needed to confirm the results obtained from this study. Since" exact="substance abuse" post="may adversely affect MS patient health and ability to"/>
   <result pre="to remain adherent to MS disease modifying therapy, screening for" exact="substance abuse" post="should be considered by MS specialists, especially among patients"/>
   <result pre="Hospital of Philadelphia, Philadelphia, PA, United States Background: Overweight and" exact="obesity" post="in childhood and early adolescence has been associated with"/>
   <result pre="United States Background: Neurological reserve may slow disease progression in" exact="multiple sclerosis" post="(MS), and is associated with not engaging in destructive"/>
   <result pre="interventions are discussed. P190 Concomitant diseases and MRI outcomes in" exact="multiple sclerosis" post="R Zivadinov 1,2, B Raj 1, M Ramanathan 2,"/>
   <result pre="United States Background: While concomitant diseases occur in association with" exact="multiple sclerosis" post="(MS), no studies utilized sensitive magnetic resonance imaging (MRI)"/>
   <result pre="on each disease and category. The Th1 mediated disease included:" exact="systemic lupus erythematosus," post="rheumatoid arthritis, Crohn’s disease, diabetes mellitus type 1, manic"/>
   <result pre="each disease and category. The Th1 mediated disease included: systemic" exact="lupus erythematosus," post="rheumatoid arthritis, Crohn’s disease, diabetes mellitus type 1, manic"/>
   <result pre="and category. The Th1 mediated disease included: systemic lupus erythematosus," exact="rheumatoid arthritis," post="Crohn’s disease, diabetes mellitus type 1, manic depressive illness,"/>
   <result pre="mediated disease included: systemic lupus erythematosus, rheumatoid arthritis, Crohn’s disease," exact="diabetes mellitus" post="type 1, manic depressive illness, psoriasis, allergies, thyroiditis and"/>
   <result pre="disease, diabetes mellitus type 1, manic depressive illness, psoriasis, allergies," exact="thyroiditis" post="and myasthenia gravis. The Th2 mediated diseases included asthma"/>
   <result pre="mellitus type 1, manic depressive illness, psoriasis, allergies, thyroiditis and" exact="myasthenia gravis." post="The Th2 mediated diseases included asthma and ulcerative colitis,"/>
   <result pre="allergies, thyroiditis and myasthenia gravis. The Th2 mediated diseases included" exact="asthma" post="and ulcerative colitis, while non-Th-mediated disease included cancer, diabetes"/>
   <result pre="and myasthenia gravis. The Th2 mediated diseases included asthma and" exact="ulcerative colitis," post="while non-Th-mediated disease included cancer, diabetes mellitus type 2,"/>
   <result pre="included asthma and ulcerative colitis, while non-Th-mediated disease included cancer," exact="diabetes mellitus" post="type 2, epilepsy, irritable bowel syndrome migraine and chronic"/>
   <result pre="while non-Th-mediated disease included cancer, diabetes mellitus type 2, epilepsy," exact="irritable bowel syndrome" post="migraine and chronic obstructive pulmonary disease. The MRI outcomes"/>
   <result pre="included cancer, diabetes mellitus type 2, epilepsy, irritable bowel syndrome" exact="migraine" post="and chronic obstructive pulmonary disease. The MRI outcomes included"/>
   <result pre="diabetes mellitus type 2, epilepsy, irritable bowel syndrome migraine and" exact="chronic obstructive pulmonary disease." post="The MRI outcomes included lesion, atrophy magnetization transfer ratio"/>
   <result pre="Th1 and Th2 effects. P191 Multiple sclerosis in patients with" exact="common variable immunodeficiency" post="disease: co-incidence or consequence? K Pandey 1,2, I Kister"/>
   <result pre="despite deficiency in functional antibodies, autoimmune diseases such as cytopenias," exact="autoimmune hepatitis" post="or inflmmatory bowel disease, affect about 20% of CVID"/>
   <result pre="deficiency in functional antibodies, autoimmune diseases such as cytopenias, autoimmune" exact="hepatitis" post="or inflmmatory bowel disease, affect about 20% of CVID"/>
   <result pre="first clinical manifestation of immune deficiency . To our knowledge," exact="multiple sclerosis" post="(MS) has not been reported as an autoimmune condition"/>
   <result pre="Ramat Gan, Israel, 4Medistat, Tel-Aviv, Israel Background: We hypothesized that" exact="multiple sclerosis" post="(MS) patients with significant disability will be heavier than"/>
   <result pre="Overweight was defined as 25kg/m 2&amp;lt; BMI&amp;lt; 30kg/m 2 and" exact="obesity" post="was defined as BMI≥30kg/m 2. Comparison was performed with"/>
   <result pre="comorbid psychiatric disorders in worsening the quality of life in" exact="multiple sclerosis" post="patients L Lorefice 1, G Trincas 2, MF Moro"/>
   <result pre="determinant in reducing QoL, in particular in MS patients without" exact="mood disorder" post="(p&amp;lt; 0.0001). No association was found for other clinical"/>
   <result pre="the management of MS. P194 Subclinical coronary artery disease in" exact="multiple sclerosis" post="patients E Andreadou 1, S Gerakoulis 1, V Haina"/>
   <result pre="Hospital, Athens, Greece Background: The incidence and prevalence of ischemic" exact="heart disease" post="in the MS population has been reported to be"/>
   <result pre="Genetic risk factors are associated with cerebrospinal fluid measures in" exact="multiple sclerosis" post="A Goris 1, I Pauwels 1, MW Gustavsen 2,3,"/>
   <result pre="Department of Molecular Biology, Oslo, Norway Background: Immunological hallmarks of" exact="multiple sclerosis" post="(MS) are production of antibodies expressed as oligoclonal bands"/>
   <result pre="IGHC region as major determinants. P196 CSF isoelectric focusing differentiates" exact="multiple sclerosis" post="from other CNS autoimmune disorders E Bernitsas 1, F"/>
   <result pre="studies have examined the utility of CSF IEF in distinguishing" exact="multiple sclerosis" post="from other CAID. Objectives: To examine the presence of"/>
   <result pre="other CAID were included in the study. Other CAID included" exact="vasculitis" post="(n=6), Sjogren’s (n=7), sarcoidosis (n=30), lupus (n=6), and anti-phospholipid"/>
   <result pre="in the study. Other CAID included vasculitis (n=6), Sjogren’s (n=7)," exact="sarcoidosis" post="(n=30), lupus (n=6), and anti-phospholipid antibody syndrome (n=4), all"/>
   <result pre="patients presenting with a clinically isolated syndrome (CIS) suggestive of" exact="multiple sclerosis" post="(MS) do not fulfil the MRI criteria for dissemination"/>
   <result pre="2010 criteria. P198 Comprehensive Immunophenotyping of CSF cells in relapsing-remitting" exact="multiple sclerosis" post="patients with daclizumb therapy Y-C Lin 1, P Winokur"/>
   <result pre="chain of IL-2 receptor (IL-2Ra; CD25) stabilizes clinical symptoms of" exact="multiple sclerosis" post="(MS), the debilitating neuro-inflammatory disorder. By using 12 color"/>
   <result pre="who tolerate this treatment long-term. P199 Intrathecal B-cell response in" exact="multiple sclerosis" post="brain recognizes auto-antigens DL Walker 1, CE Estrem 1,"/>
   <result pre="response may act as antigen-presenting cells that mediate demyelination or" exact="neurodegeneration" post="in MS. P200 Increased intrathecal inflammation in progressive multiple"/>
   <result pre="or neurodegeneration in MS. P200 Increased intrathecal inflammation in progressive" exact="multiple sclerosis" post="M Komori 1, A Blake 1, Y-C Lin 1,"/>
   <result pre="Background: Lack of therapeutic efficacy of immunomodulatory therapies in progressive" exact="multiple sclerosis" post="(MS) has been interpreted as evidence that neurodegeneration rather"/>
   <result pre="progressive multiple sclerosis (MS) has been interpreted as evidence that" exact="neurodegeneration" post="rather than immunopathology drives central nervous system (CNS) tissue"/>
   <result pre="prognostic marker in MS. P202 Intrathecal IgG from patients with" exact="multiple sclerosis" post="target patient-specific phage peptides T Pointon 1, S Manton"/>
   <result pre="at onset 31.2±7.7 years. The most frequent presenting syndrome was" exact="optic neuritis" post="(31.9%) followed by transverse myelitis (28.6%). LS-OCMB were present"/>
   <result pre="frequent presenting syndrome was optic neuritis (31.9%) followed by transverse" exact="myelitis" post="(28.6%). LS-OCMB were present in 17.6% patients, and all"/>
   <result pre="Subclinical intrathecal inflammation is risk for disease reactivation in early" exact="multiple sclerosis" post="S Rossi 1,2, V Studer 1,2, C Motta 1,2,"/>
   <result pre="Italy Background: Pathogenic events leading to brain structural damage in" exact="multiple sclerosis" post="(MS) start early, independently of clinical signs. An earlier"/>
   <result pre="presence of oligoclonal bands (OCBs) in cerebrospinal fluid (CSF) of" exact="multiple sclerosis" post="(MS) is now well established to support the clinical"/>
   <result pre="them were diagnosed clinically isolated syndrome (CIS), 49% relapsing remitting" exact="multiple sclerosis" post="(RRMS) according to Poser criteria, 11.8% secondary progressive MS"/>
   <result pre="was diagnosed other inflammatory neurological diseases (OIND) (9.8%) (1pt with" exact="chronic inflammatory demyelinating polyneuropathy," post="1pt with neuromyelitis optica, 1pt with paraneoplastic syndrome, 2pts"/>
   <result pre="(OIND) (9.8%) (1pt with chronic inflammatory demyelinating polyneuropathy, 1pt with" exact="neuromyelitis optica," post="1pt with paraneoplastic syndrome, 2pts with acute disseminated encephalomyelitis)."/>
   <result pre="the pivotal studies were not intended to aggressive forms of" exact="multiple sclerosis" post="(MS). Objectives: To investigate whether the presence of LS-OCMB"/>
   <result pre="times to failure to first-line therapies. P207 miR-142-3p expression in" exact="multiple sclerosis" post="cerebrospinal fluid is related to better cognitive performance L"/>
   <result pre="Neuritis (CRION/RION). Sometimes the initial diagnosis can be difficult because" exact="optic neuritis" post="and/or myelitis are clinical syndromes shared to all these"/>
   <result pre="the initial diagnosis can be difficult because optic neuritis and/or" exact="myelitis" post="are clinical syndromes shared to all these medical conditions."/>
   <result pre="and more time than traditional LP. P210 Oligoclonal bands predict" exact="multiple sclerosis" post="in children with isolated optic neuritis: a retrospective multicenter"/>
   <result pre="13University of Würzburg, Department of Neuropediatrics, Würzburg, Germany Background: Isolated" exact="optic neuritis" post="(ON) in childhood may remain a singular event or"/>
   <result pre="remain a singular event or indicate the clinical beginning of" exact="multiple sclerosis" post="(MS). Higher age and pathological cranial MRI at presentation"/>
   <result pre="risk factors, including cerebrospinal fluid findings, in children with isolated" exact="optic neuritis" post="as a first demyelinating event. Methods: Only children with"/>
   <result pre="nervous system but also in the CSF of patients with" exact="multiple sclerosis" post="(MS). In MS intrathecal IgM synthesis seems to correlated"/>
   <result pre="Lipid-specific oligoclonal IgM bands and cognition in early stages of" exact="multiple sclerosis" post="J Gich 1,2, R Menéndez 2, E Quintana 2,"/>
   <result pre="of sialylated IgG antibody in the CSF of patients with" exact="multiple sclerosis" post="T Curley 1, T Pointon 1, H Collins 1,"/>
   <result pre="Background: A characteristic feature of the CNS inflammatory response in" exact="multiple sclerosis" post="(MS) is the intrathecal synthesis of IgG and the"/>
   <result pre="sialylation in the CSF and paired serum of patients with" exact="multiple sclerosis." post="Methods: Purified IgG antibody in CSF and paired serum"/>
   <result pre="disease pathogenesis. P215 Cerebrospinal fluid markers of the course of" exact="multiple sclerosis" post="I Smagina 1, S Elchaninova 1 1Altai State Medical"/>
   <result pre="for a phenome-wide examination of the comorbidity burden associated with" exact="multiple sclerosis" post="disease outcome M Goodman 1, B Healy 2, T"/>
   <result pre="Background: Comorbid conditions can impact disease outcome and course in" exact="multiple sclerosis" post="(MS). Objectives: To perform a phenome-wide association study (PheWAS)"/>
   <result pre="OR=3.7, p=2.3e-7), venous embolism and thrombosis (n=61, OR=4.5, p=2.6e-6), and" exact="respiratory failure" post="(n=31, OR=10.5, p=9.0e-6). Finally, we found intriguing associations with"/>
   <result pre="OR=2.2, p=0.0028), as well as inverse associations with benign skin" exact="neoplasm" post="(n=248, OR=0.52, p=0.00018) and breast lump or mass (n=142,"/>
   <result pre="severe MS disability. P218 Establishment of a global registry for" exact="multiple sclerosis" post="patients on extended dose natalizumab schedules J Herbert 1,"/>
   <result pre="sclerosis (MS). However, its use is limited by susceptibility to" exact="progressive multifocal leukoencephalopathy" post="(PML) in patients with serological evidence of exposure to"/>
   <result pre="is a Web-based, global observational registry for an ‘orphan’ disorder:" exact="neuromyelitis optica" post="I Kister 1, T Bacon 1, R Alroughani 2,"/>
   <result pre="orphan diseases. P220 Argentinean registry of patients with relapsing remitting" exact="multiple sclerosis" post="treated with fingolimod (REAL): design and results of interim"/>
   <result pre="(Gilenya) is approved in Argentina for the treatment of relapsing" exact="multiple sclerosis" post="(MS) since April 2011. Despite the fact that many"/>
   <result pre="treatment was needed. One serious adverse event was reported (severe" exact="pneumonia" post="followed by death not related to fingolimod according to"/>
   <result pre="Background: Natalizumab (NTZ) is a disease modulatory treatment for relapsing-remitting" exact="multiple sclerosis" post="(RRMS) with high efficacy. However, post-marketing surveillance is important"/>
   <result pre="but included 7 non-fatal cases and 1 fatal case of" exact="progressive multifocal leukoencephalopathy" post="(PML, 0.3%), with the latest case reported 2012-10-31. The"/>
   <result pre="is an important concern. Diagnosis and differential diagnosis P222 Transverse" exact="myelitis" post="in neuro-Behcet’s disease HS Lee 1, HY Shin 1,"/>
   <result pre="University of Korea, Neurology, Seoul, Korea, Republic of Background: Transverse" exact="myelitis" post="(TM) can appear as the first manifestation in conditions"/>
   <result pre="can appear as the first manifestation in conditions such as" exact="multiple sclerosis" post="(MS) and neuromyelitis optica (NMO). However a number of"/>
   <result pre="first manifestation in conditions such as multiple sclerosis (MS) and" exact="neuromyelitis optica" post="(NMO). However a number of disorders including Behcet’s disease"/>
   <result pre="was longer than three vertebral bodies, i.e. longitudinal extensive transverse" exact="myelitis" post="(LETM). Conclusions: TM can be developed in patients with"/>
   <result pre="in patients with LETM. P223 Methionyl-tRNA formyltransferase (MTFMT) deficiency mimicking" exact="neuromyelitis optica" post="JA Pena 1,2, F Scaglia 3, TE Lotze 1,2"/>
   <result pre="TX, United States Background: Neuromyelitis optica (NMO) is typified by" exact="optic neuritis" post="and transverse myelitis, often with longitudinally extensive cord lesions."/>
   <result pre="extensive cord lesions. Brain MRI findings are otherwise atypical for" exact="multiple sclerosis." post="Rarely, mitochondrial diseases can present with features of an"/>
   <result pre="of an acquired demyelinating syndrome, such as NMO, to include" exact="optic neuropathy" post="and longitudinally extensive transverse myelitis. Objectives: We describe an"/>
   <result pre="an acquired demyelinating syndrome, such as NMO, to include optic" exact="neuropathy" post="and longitudinally extensive transverse myelitis. Objectives: We describe an"/>
   <result pre="to combined oxidative phosphorylation deficiency. Methods: Case of MTFMT mimicking" exact="neuromyelitis optica." post="Results: A 19 year old male presented with relapsing"/>
   <result pre="with relapsing longitudinally extensive transverse myelitis, brainstem demyelination, and progressive" exact="optic neuropathy." post="NMO was initially considered due to gadolinium enhancement of"/>
   <result pre="features suggestive of NMO to include a relapsing clinical course," exact="optic neuropathy," post="myelopathy associated with long cord lesions, and atypical brain"/>
   <result pre="syndrome detected by spectral domain optical coherence tomography differentiates from" exact="multiple sclerosis" post="M Ringelstein 1, P Albrecht 1, I Kleffner 2,"/>
   <result pre="of encephalopathy, sensorineural hearing deficits, and visual disturbances due to" exact="branch retinal artery occlusion" post="(BRAO) detectable by fluorescein angiography (FA). Differentiation from Multiple"/>
   <result pre="from MS. P225 Brain lesion location at onset helps differentiate" exact="neuromyelitis optica" post="and multiple sclerosis NH Kim 1, DE Kim 1,"/>
   <result pre="Brain lesion location at onset helps differentiate neuromyelitis optica and" exact="multiple sclerosis" post="NH Kim 1, DE Kim 1, SH Woo 1,"/>
   <result pre="by antibodies to aquaporin-4 water channel. Making diagnosis of antibody-negative" exact="neuromyelitis optica" post="spectrum disorder (NMOSD) is difficult because the more prevalent"/>
   <result pre="optica spectrum disorder (NMOSD) is difficult because the more prevalent" exact="multiple sclerosis" post="(MS) can present similarly. It is important to distinguish"/>
   <result pre="identify those at risk of conversion to MS. P227 Aggressive" exact="multiple sclerosis" post="S Menon 1,2,3, SA Morrow 1,2,3, M Kremenchutzky 1,2,3"/>
   <result pre="are difficult to predict at onset. Objectives: To study aggressive" exact="multiple sclerosis" post="(AMS) in a natural history MS cohort. Methods: Population"/>
   <result pre="Background: Baló’s concentric sclerosis (Baló) is a rare variant of" exact="multiple sclerosis" post="(MS) characterized by its particular multi-layered or onion-shaped lesions,"/>
   <result pre="plaques and in additional typical MS lesions. P229 Aquaporin-4 antibody-seropositive" exact="myelitis" post="initially biopsied due to suspected spinal cord tumors: diagnostic"/>
   <result pre="P230 Artificial intelligence techniques in the diagnosis of clinically definite" exact="multiple sclerosis" post="G Dalla Costa 1, L Moiola 1, L Leocani"/>
   <result pre="early identification of patients at risk of developing clinically definite" exact="multiple sclerosis" post="(CDMS) represents the main purpose of diagnostic criteria and"/>
   <result pre="clinical and paraclinical data. P231 MRI study of Leber’s hereditary" exact="optic neuropathy" post="and MS suggests common lesion pathology and an 83%"/>
   <result pre="and paraclinical data. P231 MRI study of Leber’s hereditary optic" exact="neuropathy" post="and MS suggests common lesion pathology and an 83%"/>
   <result pre="is the observation that the rare mitochondrial disease Leber’s hereditary" exact="optic neuropathy" post="(LHON) and an MS-like illness (LHON-MS) coexist more frequently"/>
   <result pre="the observation that the rare mitochondrial disease Leber’s hereditary optic" exact="neuropathy" post="(LHON) and an MS-like illness (LHON-MS) coexist more frequently"/>
   <result pre="et al., J Neurol, 2000. 247(7): p. 535-43. P232 Diagnosing" exact="multiple sclerosis" post="with a gait measuring system, an analysis of the"/>
   <result pre="other diagnoses were already possible, the most frequent diagnoses were" exact="migraine" post="(in 15 cases), vascular encephalopathy including PTO (in 13"/>
   <result pre="the most frequent diagnoses were migraine (in 15 cases), vascular" exact="encephalopathy" post="including PTO (in 13 cases), recurrent optic neuritis (in"/>
   <result pre="15 cases), vascular encephalopathy including PTO (in 13 cases), recurrent" exact="optic neuritis" post="(in 2 cases), systemic erythematous lupus (in 2 cases),"/>
   <result pre="cases), dizziness (in 2 cases), neuroBechet’s disease (in 2 cases)," exact="neuromyelitis optica" post="(in 2 cases). Conclusions: Our preliminary analysis confirm that"/>
   <result pre="patients presenting with symptoms suggestive of MS. Migraine and vascular" exact="encephalopathy" post="are by far the most frequent alternative diagnosis, while,"/>
   <result pre="with MS. P234 The thalamus and basal ganglia lesions in" exact="multiple sclerosis" post="and primary angiitis of the central nervous system in"/>
   <result pre="be helpful in making a differential diagnosis. P235 Patients with" exact="multiple sclerosis" post="criteria subsequently displayed Behçet disease signs L Ait Aissa"/>
   <result pre="P237 Magnetic resonance spectroscopy in cases of clinical conflict between" exact="multiple sclerosis," post="vasculitis and multiple lacunar infarcts of the brain SS"/>
   <result pre="resonance spectroscopy in cases of clinical conflict between multiple sclerosis," exact="vasculitis" post="and multiple lacunar infarcts of the brain SS Salama"/>
   <result pre="investigation of the normal-appearing white matter (NAWM) in patients with" exact="multiple sclerosis" post="(MS). Metabolic changes in NAWM are of special interest"/>
   <result pre="isolated syndromes (CIS) suggesting a conflicting clinical diagnosis of MS," exact="vasculitis" post="or multiple lacunar infarcts Objectives: The purpose of this"/>
   <result pre="use of high-field 1H-MR spectroscopy to help differentiate between MS," exact="vasculitis" post="and multiple lacunar infarcts. Methods: With use of a"/>
   <result pre="( posing a conflict in their diagnosis between MS and" exact="vasculitis" post="or MS and multiple lacunar infarcts) divided into three"/>
   <result pre="the suspected clinical diagnosis, suspected MS group sMS(n =16), suspected" exact="vasculitis" post="group sVasc (n=10) and suspected lacunar infarcts group sMLI"/>
   <result pre="± 0.17, P &amp;lt; 0.001) but not in the suspected" exact="vasculitis" post="and suspected multiple lacunar infarcts groups. Mean mIns /Cr"/>
   <result pre="CIS suggestive of MS but not in patients with suspected" exact="vasculitis" post="or multiple lacunar infarcts. P238 HTLV-1-associated myelopathy/tropical spastic paraparesis:"/>
   <result pre="HTLV-1-associated myelopathy/tropical spastic paraparesis: a differential diagnosis in primary progressive" exact="multiple sclerosis" post="FJ Carod Artal 1, H Mourao Mesquita 2 1Raigmore"/>
   <result pre="and thoracic spine cord (21.4%). Conclusions: TSP/HAM is a progressive" exact="neurological disorder" post="that may mimic clinically and radiologically multiple sclerosis in"/>
   <result pre="a progressive neurological disorder that may mimic clinically and radiologically" exact="multiple sclerosis" post="in endemic areas. Some patients may initially present with"/>
   <result pre="may be helpful to differentiate HAM/TSP patients from primary progressive" exact="multiple sclerosis." post="P239 Microscopic polyangiitis presenting with long extended tranverse myelitis"/>
   <result pre="multiple sclerosis. P239 Microscopic polyangiitis presenting with long extended tranverse" exact="myelitis" post="(LETMS) HÖ Köse 1, V Akdemir 2, Y Celik"/>
   <result pre="cytoplasmic antibody (MPO-ANCA). MPA often presented with rapidly progressive necrotizing" exact="glomerulonephritis" post="or alveolar hemorrhage. Neurological findings are observed in 20"/>
   <result pre="observed in 20 -50% of cases consisting of cranial and" exact="peripheral neuropathy," post="and central nervous system involvement including chronic hypertrophic pachymeningitis,"/>
   <result pre="gland involvement, intracerebral hemorrhage, multiple ischemic infarcts, subarachnoid hemorrhage and" exact="vasculitis" post="during the disease and rarely as initial symptom. Objectives:"/>
   <result pre="Microscopic polyangiitis (MPA) as initial manifestation of longitudinally extensive transverse" exact="myelitis" post="(LETM). Methods: A case report demonstrating unique LETM presentation"/>
   <result pre="chronic spastic paraparesis a clinical picture of longitudinally extensive transverse" exact="myelitis" post="(LETM). MPA should be considered as a differential diagnosis"/>
   <result pre="abscesses. Clinical and radiologic features are different than in typical" exact="multiple sclerosis" post="(MS), leading to difficulty in diagnosis and treatment. Objectives:"/>
   <result pre="P242 Glial and neuronal markers in CSF predict progression in" exact="multiple sclerosis" post="MA Mañé Martinez 1,2, B Olsson 3, L Bau"/>
   <result pre="gene and protein expression levels and microRNA (miRNA) profiles in" exact="multiple sclerosis" post="(MS) patients as biomarkers for disease status and response"/>
   <result pre="prognostic markers. P244 Interferon inducible transcriptional profile in secondary progressive" exact="multiple sclerosis" post="patients M Gurevich 1, G Miron 1, E Hanael"/>
   <result pre="the recommended immunomodulatory treatment for the treatment of secondary progressive" exact="multiple sclerosis" post="(SPMS) patients. Interferon inducible transcriptional signatures have been well"/>
   <result pre="P246 Gray matter related proteins in cerebrospinal fluid differentiate between" exact="multiple sclerosis" post="and other acquired demyelinating syndromes in childhood V Singh"/>
   <result pre="1Erasmus MC, Rotterdam, Netherlands Background: A few percent of all" exact="multiple sclerosis" post="(MS) patients experience a first attack in childhood. In"/>
   <result pre="monophasic ADS. P247 Global metabolomics identifies a metabolic profile of" exact="multiple sclerosis" post="P Bhargava 1, B Poore 2, C Nguyen 2,"/>
   <result pre="P248 CSF biomarkers of inflammation and neuronal damage in acute" exact="optic neuritis" post="predict later development of MS and long-term disability S"/>
   <result pre="(CSF) levels of inflammatory biomarkers have been suggested to predict" exact="multiple sclerosis" post="(MS) development after clinically isolated syndromes, but there is"/>
   <result pre="MS (CDMS) and long-term disability. Methods: 86 patients with acute" exact="optic neuritis" post="(ON) as a first demyelinating event seen in our"/>
   <result pre="were examined by the corresponding author incl. an EDSS and" exact="multiple sclerosis" post="functional composit (MSFC) evaluation. 18.6 % were interviewed by"/>
   <result pre="regression was used for time to CDMS, multivariate regression for" exact="multiple sclerosis" post="severity score (MSSS) and Spearman correlation and linear regression"/>
   <result pre="proteome profile of the urine is different in patients with" exact="neuromyelitis optica" post="compared to multiple sclerosis and healthy subjects HH Nielsen"/>
   <result pre="urine is different in patients with neuromyelitis optica compared to" exact="multiple sclerosis" post="and healthy subjects HH Nielsen 1, LP Kristensen 2,"/>
   <result pre="The demyelinating diseases comprise a broad spectrum of diseases like" exact="multiple sclerosis" post="(MS) neuromyelitis optica (NMO) and the NMO spectrum disorders"/>
   <result pre="comprise a broad spectrum of diseases like multiple sclerosis (MS)" exact="neuromyelitis optica" post="(NMO) and the NMO spectrum disorders (NMO-SD). Despite clear"/>
   <result pre="to a panel of biomarkers in newly diagnosed patients with" exact="multiple sclerosis" post="M Stilund 1,2, MC Gjelstrup 2, T Petersen 1,"/>
   <result pre="for the clinic and provides a useful tool for diagnosing" exact="multiple sclerosis" post="patterns. Studies of the recombinant antibodies produced from these"/>
   <result pre="being observed. P253 Peripheral blood cells from patients with benign" exact="multiple sclerosis" post="are characterized by a TNF gene expression signature NM"/>
   <result pre="P254 Cerebrospinal fluid proteome analysis reveals differentially abundant proteins in" exact="multiple sclerosis" post="J Füvesi 1, R Danielsson 2, K Bencsik 1,"/>
   <result pre="marker for ongoing axonal damage, for example in patients with" exact="multiple sclerosis." post="In order to interpret values of NFL in a"/>
   <result pre="of NFL in the healthy is required. Another biomarker for" exact="neurodegeneration" post="is the investigation of brain atrophy using magnetic resonance"/>
   <result pre="are associated with neurodegeneration, for example in the case of" exact="multiple sclerosis," post="where both are associated with increased disease activity. A"/>
   <result pre="age related neurodegeneration. P256 UP-regulation of Nod-like receptor signaling in" exact="multiple sclerosis" post="F La Rosa 1, F Piancone 1, I Marventano"/>
   <result pre="Basel, Department of Biomedicine, Basel, Switzerland Background: The patho-physiology of" exact="multiple sclerosis" post="disease onset and progression remains undetermined. Understanding this is"/>
   <result pre="proteomics studies for the detection of pathologically relevant proteins for" exact="multiple sclerosis" post="(MS). Because the course of the disease after clinically"/>
   <result pre="of biomarkers for diagnosis and therapeutic monitoring of patients with" exact="multiple sclerosis" post="(MS) has proven difficult due to the varied clinical"/>
   <result pre="in human cerebrospinal fluid (CSF) associated with disease progression in" exact="multiple sclerosis" post="(MS) and allow stratification of the two progressive disease"/>
   <result pre="from controls with no disease (n=15), patients with primary progressive" exact="multiple sclerosis" post="(PPMS; n=15), and patients with secondary progressive multiple sclerosis"/>
   <result pre="progressive multiple sclerosis (PPMS; n=15), and patients with secondary progressive" exact="multiple sclerosis" post="(SPMS; n=15) were analyzed on the GC/MS and LC/MS/MS"/>
   <result pre="as potential predictors of clinically isolated syndrome (CIS) converted to" exact="multiple sclerosis" post="(MS). Among the multitude of biomarkers which have been"/>
   <result pre="P261 Urine levels of 8-Isoprostane in relapsing-remitting and secondary progressive" exact="multiple sclerosis" post="P Kivisäkk 1, Y Hyvert 2, K Melo 1,"/>
   <result pre="8-Isoprostane are increased in cerebrospinal fluid (CSF) from patients with" exact="multiple sclerosis" post="(MS), with maximum levels in patients with secondary progressive"/>
   <result pre="urine levels as a marker of oxidative stress associated with" exact="neurodegeneration" post="during the progressive phase of MS. P262 Potential biomarkers"/>
   <result pre="for potential to lead to remyelination and functional recovery in" exact="multiple sclerosis" post="(MS). Systemic intravenous (IV) doses of BIIB033 up to"/>
   <result pre="nerve fiber layer thickness and disability in different phases of" exact="multiple sclerosis" post="C Uzunköprü 1, N Yuceyar 1, D Taskiran 2,"/>
   <result pre="candidate to be a reliable biomarker of axonal degeneration in" exact="multiple sclerosis" post="(MS).The measurement of retinal nerve fiber layer (RNFL) has"/>
   <result pre="higher levels of both biomarkers than RRMS(p&amp;lt; 0,05) Irrespective of" exact="optic neuritis" post="history, all MS patients exhibited significantly lower RNFL thickness"/>
   <result pre="MS. P264 Correlation of mRNA expression in the blood with" exact="multiple sclerosis" post="disease activity on MRI JW Lindsey 1, EY Lu"/>
   <result pre="Background: Exacerbations or relapses are a typical clinical feature of" exact="multiple sclerosis" post="(MS). Some relapses follow infections, but most occur without"/>
   <result pre="MS activity will differ widely between individuals. P265 Identification of" exact="multiple sclerosis" post="cerebrospinal fluid biomarkers using nuclear magnetic resonance spectroscopy MA"/>
   <result pre="small molecular weight present in cerebrospinal fluid (CSF). Diagnosis of" exact="multiple sclerosis" post="(MS) and clinically isolated syndrome (CIS) is based on"/>
   <result pre="sequencing of microRNA in the CD4+ T-cells of secondary progressive" exact="multiple sclerosis" post="individuals KA Sanders 1,2, RA Lea 2, SE Agland"/>
   <result pre="Genetics, Newcastle, Australia Background: The role of microRNAs (miRNA) in" exact="multiple sclerosis" post="extends beyond their use as biomarkers for diagnosis and"/>
   <result pre="mechanisms in MS progression. P267 MicroRNA-572 expression in serum of" exact="multiple sclerosis" post="patients with different patterns of disease progression S Agostini"/>
   <result pre="Foundation, Lab Molecular Medicine, Milano, Italy Background: Clinical progression of" exact="multiple sclerosis" post="(MS) is correlated to accumulation of impairment due to"/>
   <result pre="biomarker for remyelination. P268 Uric acid levels are reduced in" exact="multiple sclerosis" post="M Moccia 1, R Lanzillo 1, R Palladino 2,3,"/>
   <result pre="by means of gene expression profiling in patients with progressive" exact="multiple sclerosis" post="R Nurtdinov 1, C Tur 1, S Malhotra 1,"/>
   <result pre="in patients with clinically isolated syndromes (CIS) who convert to" exact="multiple sclerosis" post="(MS) in comparison to those who remain as CIS."/>
   <result pre="Sendai, Japan Background: Neuromyelitis optica (NMO) is characterized by severe" exact="optic neuritis" post="and transverse myelitis. The extensive loss of AQP4 and"/>
   <result pre="astrocytic destructive damages. CSF-GFAP level itself in the relapse of" exact="optic neuritis" post="in NMOsd is relatively low prevalence than cerebral lesion"/>
   <result pre="low levels of phosphatidylcholines and sphingomyelins in cerebrospinal fluid of" exact="multiple sclerosis" post="patients D Pieragostino 1,2, M D’Alessandro 1,2, M Di"/>
   <result pre="the molecular mechanisms underlying the disease. P274 Metabolomic profile of" exact="multiple sclerosis" post="patients E Cocco 1, L Lorefice 1, F Murgia"/>
   <result pre="of cerebrospinal fluid reveals a distinctive biochemical alteration associated with" exact="multiple sclerosis" post="M di Ioia 1, D Pieragostino 1, M D’Alessandro"/>
   <result pre="of superoxide anion, antioxidative enzyme activity and oxidative damage in" exact="multiple sclerosis" post="patients during relapse D Obradovic 1, M Jovanovic 1,"/>
   <result pre="one of possible mechanisms of central nervous system damage in" exact="multiple sclerosis" post="(MS). Objectives: It was our aim to investigate free"/>
   <result pre="highlighted the involvement of LCN2 in the murine experimental auto-immune" exact="encephalomyelitis" post="(EAE) model of multiple sclerosis (MS), by showing that"/>
   <result pre="LCN2 in the murine experimental auto-immune encephalomyelitis (EAE) model of" exact="multiple sclerosis" post="(MS), by showing that its expression in the brain"/>
   <result pre="levels at diagnosis were associated with clinical severity in a" exact="multiple sclerosis" post="cohort followed in our clinic. Methods: Normal 0 21"/>
   <result pre="predict a faster disease progression. P279 Expression of miRNAs in" exact="multiple sclerosis" post="cerebrospinal fluid and their relation to MR activity E"/>
   <result pre="effectiveness of natalizumab (NAT) versus fingolimod (FTY) in active relapsing-remitting" exact="multiple sclerosis" post="(RR-MS). Objectives: Aim of our study was to compare"/>
   <result pre="The influence of immunomodulatory treatment on the clinical course of" exact="multiple sclerosis" post="A Kavaliunas 1, L Stawiarz 1, A Glaser 1,"/>
   <result pre="One of the major questions concerning the clinical progression of" exact="multiple sclerosis" post="(MS), still insufficiently elaborated or confirmed, is if it"/>
   <result pre="(GA) has provided a safe and effective treatment option for" exact="multiple sclerosis" post="patients. Decades of study have yielded considerable insight into"/>
   <result pre="investigation is warranted in order to ensure the safety of" exact="multiple sclerosis" post="patients. P283 Rituximab following natalizumab withdrawal in relapsing remitting"/>
   <result pre="sclerosis patients. P283 Rituximab following natalizumab withdrawal in relapsing remitting" exact="multiple sclerosis" post="BE Beaber 1, G Mallari 1, D Le 1,"/>
   <result pre="CA, United States Background: Withdrawal from natalizumab treatment in relapsing-remitting" exact="multiple sclerosis" post="(RRMS) often leads to an increase in disease activity"/>
   <result pre="fingolimod versus interferon beta/glatiramer acetate as second-line therapy in active" exact="multiple sclerosis" post="A He 1, T Spelman 1, V Jokubaitis 2,"/>
   <result pre="fingolimod versus IFN/GA as second-line therapy after on-treatment relapse in" exact="multiple sclerosis." post="Methods: Data was extracted from MSBase, an international observational"/>
   <result pre="sclerosis. Methods: Data was extracted from MSBase, an international observational" exact="multiple sclerosis" post="registry. Patients previously treated with IFN/GA for a minimum"/>
   <result pre="therapy (IFNβ) and long-term disability outcomes in patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS). Methods: A prospective and longitudinal 12-year follow-up study"/>
   <result pre="with active disease. P286 Rituximab in the treatment of secondary-progressive" exact="multiple sclerosis" post="C Perrone 1, I Berriosmorales 1, B Beretich 2,"/>
   <result pre="While mitoxantrone is the only FDA-approved drug to treat secondary-progressive" exact="multiple sclerosis" post="(SPMS), its use is limited by high toxicity. A"/>
   <result pre="is limited by susceptibility of NTZ-treated patients to a serious" exact="viral disease" post="of the central nervous system (CNS) - Progressive Multifocal"/>
   <result pre="efficacy of switch to natalizumab or fingolimod in active relapsing-remitting" exact="multiple sclerosis" post="T Kalincik 1,2, D Horakova 3, T Spelman 2,"/>
   <result pre="outcomes between escalation to natalizumab or fingolimod due to active" exact="multiple sclerosis" post="(MS) on injectable immunomodulatory agents. Methods: Using MSBase, an"/>
   <result pre="Background: Persistence with disease-modifying therapies (DMTs) improves clinical outcomes in" exact="multiple sclerosis" post="(MS). No studies have compared persistence among patients receiving"/>
   <result pre="of brain volume loss in the definition of disease-activity-free in" exact="multiple sclerosis" post="using fingolimod phase 3 data N De Stefano 1,"/>
   <result pre="healthy individuals (HIs) is 0.1-0.3%, whereas in patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS), mean annual BVL is accelerated (0.5-1.35%). However, BVL"/>
   <result pre="trial. P292 A six-year clinical follow-up study of patients with" exact="multiple sclerosis" post="who started natalizumab L Prosperini 1, P Annovazzi 2,"/>
   <result pre="treatment to prevent relapses and accumulation of disability due to" exact="multiple sclerosis" post="(MS), as shown in both pivotal trials and real-life"/>
   <result pre="efficacy of Natalizumab and Fingolimod in the treatment of relapsing-remitting" exact="multiple sclerosis" post="(MS) has been proven in randomized trials. However, such"/>
   <result pre="P294 Comparison of dropout rates of disease modifying therapies in" exact="multiple sclerosis" post="M Kurtuncu 1, S Yildiz Celik 1, A Coban"/>
   <result pre="There is an obvious need for head-to-head treatment studies in" exact="multiple sclerosis" post="(MS). The lack of drug comparison trials may at"/>
   <result pre="RI, United States Background: A robust, up-to-date treatment algorithm for" exact="multiple sclerosis" post="(MS) based on class I evidence has not been"/>
   <result pre="Background: Interferon Beta-1a (IFNB-1a) is routinely prescribed to persons with" exact="multiple sclerosis" post="(PwMS). Clinicians have an option for choosing the needle"/>
   <result pre="needle for IFNB-1a injection. Methods: Twenty patients with relapsing remitting" exact="multiple sclerosis" post="using IFNB-1a with a 25G needle as part of"/>
   <result pre="25G needle when injecting IFNB-1a. P297 Influence of treatments on" exact="multiple sclerosis" post="disability: a cohort study E Cocco 1, C Sardu"/>
   <result pre="efficacy of treosulfan in 21 patients with active secondary progressive" exact="multiple sclerosis" post="after treatment with mitoxantrone A Deiß 1, S Bräuninger"/>
   <result pre="Münster, Germany Background: Immunotherapy of patients with active secondary progressive" exact="multiple sclerosis" post="(SPMS), after having reached the maximal cumulative dose of"/>
   <result pre="a therapeutic challenge. Treosulfan, a well-tolerated alkylating agent approved for" exact="ovarian cancer," post="was previously found to be effective and safe in"/>
   <result pre="adverse events, including urosepsis followed by deep vein thrombosis and" exact="pulmonary embolism" post="in one patient, as well as severe pneumonia requiring"/>
   <result pre="and pulmonary embolism in one patient, as well as severe" exact="pneumonia" post="requiring assisted ventilation in the other. Both patients fully"/>
   <result pre="adverse events leading to dose or interval alterations included leukocytopenia," exact="thrombocytopenia" post="and infections. No haematologic malignancy was observed (mean follow-up"/>
   <result pre="Comparative tolerability and efficacy of dimethyl fumarate and fingolimod in" exact="multiple sclerosis" post="S Cohn 1, R Bermel 2, C Hara 2,"/>
   <result pre="two commonly used oral disease modifying therapies (DMT) for relapsing" exact="multiple sclerosis" post="(MS). Phase 3 clinical trials established the efficacy and"/>
   <result pre="adverse events of high-dose intravenous methylprednisolone for relapse treatment in" exact="multiple sclerosis" post="(FEEL study) I Stavrakaki 1, ELJ Hoogervorst 2, P"/>
   <result pre="for 3-5 days is the mainstay of relapse treatment in" exact="multiple sclerosis" post="(MS). Despite IVMP being generally considered as well tolerated"/>
   <result pre="P303 Safety and efficacy of dimethyl fumarate in patients with" exact="multiple sclerosis" post="- real world experience C Chaves 1, R Ganguly"/>
   <result pre="disease modifying agent (DMA) recently approved to treat relapsing remitting" exact="multiple sclerosis" post="(RRMS). Its safety and efficacy were demonstrated in two"/>
   <result pre="among propensity score matched patients receiving disease modifying therapy for" exact="multiple sclerosis" post="BH Johnson 1, MM Bonafede 1, C Watson 2"/>
   <result pre="Cambridge, MA, United States Background: A recent study conducted using" exact="multiple sclerosis" post="(MS) registry data mainly from Europe found that natalizumab"/>
   <result pre="5Heinrich-Heine University, Department of Neurology, Düsseldorf, Germany Background: Patients with" exact="multiple sclerosis" post="(MS) frequently discontinue treatment with therapy, although beneficial effects"/>
   <result pre="vs. 43.5), mass (11.8 vs. 21.9), pruritus (7.8 vs. 13.0)," exact="urticaria" post="(5.4 vs. 12.3), and swelling (5.3 vs. 19.4). The"/>
   <result pre="Disease modifying therapies (DMTs) are the mainstay treatment in relapsing-remitting" exact="multiple sclerosis" post="(RRMS). Certain DMTs, such as dimethyl fumarate (DMF), interferon"/>
   <result pre="fumarate in a multicenter, open-label study of patients with relapsing" exact="multiple sclerosis" post="EJ Fox 1, A Vasquez 2, W Grainger 3,"/>
   <result pre="Delayed-release dimethyl fumarate (DMF) demonstrated efficacy and safety in relapsing-remitting" exact="multiple sclerosis" post="(MS) in Phase 3 studies. Gastrointestinal (GI) events were"/>
   <result pre="GI events. P310 A novel MIF inhibitor as therapy for" exact="multiple sclerosis" post="and stroke AA Vandenbark 1,2, R Meza-Romero 1, G"/>
   <result pre="A novel MIF inhibitor as therapy for multiple sclerosis and" exact="stroke" post="AA Vandenbark 1,2, R Meza-Romero 1, G Benedek 1,2,"/>
   <result pre="regulator of CD74 that could block MIF effects and treat" exact="multiple sclerosis" post="(MS) and other CNS diseases. Objectives: Identify the CD74-binding"/>
   <result pre="Determine efficacy of DR-α1 constructs for treatment of experimental autoimmune" exact="encephalomyelitis" post="(EAE) and experimental stroke. Methods: DRa1-peptide constructs were produced,"/>
   <result pre="may have the potential to treat subjects with MS and" exact="stroke" post="without need for HLA screening. P311 Strategies to reduce"/>
   <result pre="the United States for the treatment of relapsing forms of" exact="multiple sclerosis" post="(MS). In the Phase 3 DEFINE and CONFIRM studies,"/>
   <result pre="as an add-on therapy is effective in long-term treatment of" exact="multiple sclerosis" post="S Ozakbas 1, B Piri Cinar 2, D Oz"/>
   <result pre="and combination of interferon beta (IFNB) and pulsed methylprednisolone in" exact="multiple sclerosis" post="(MS), but more evidence are needed to establish clinical"/>
   <result pre="interferon beta 1a and glatiramer asetate in patients with relapsing-remitting" exact="multiple sclerosis" post="leads to a significant reduction in relapse rate and"/>
   <result pre="demographics and disease-modifying therapy use in relapsing-remitting and secondary progressive" exact="multiple sclerosis" post="in the United States HJ Gross 1, C Watson"/>
   <result pre="Inc., Cambridge, MA, United States Background: Some patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS) subsequently develop secondary progressive multiple sclerosis (SPMS). While"/>
   <result pre="patients with relapsing-remitting multiple sclerosis (RRMS) subsequently develop secondary progressive" exact="multiple sclerosis" post="(SPMS). While the number of effective treatment options indicated"/>
   <result pre="number of effective treatment options indicated for relapsing forms of" exact="multiple sclerosis" post="(MS) in the United States (US) has increased over"/>
   <result pre="mainly used as second line therapies for patients with relapsing-remitting" exact="multiple sclerosis" post="and insufficient response on first line therapies. No formal"/>
   <result pre="P315 Clinical experience with rituximab in the treatment of refractory" exact="multiple sclerosis" post="F Gascón 1, A Navarré 1, C Alcalá 2,"/>
   <result pre="Background: Rituximab (RTX) is an anti-CD20 monoclonal antibody approved for" exact="rheumatoid arthritis" post="and non-Hodgkin lymphoma that lyses B-cells. Off-label RTX has"/>
   <result pre="Rituximab (RTX) is an anti-CD20 monoclonal antibody approved for rheumatoid" exact="arthritis" post="and non-Hodgkin lymphoma that lyses B-cells. Off-label RTX has"/>
   <result pre="an anti-CD20 monoclonal antibody approved for rheumatoid arthritis and non-Hodgkin" exact="lymphoma" post="that lyses B-cells. Off-label RTX has been used in"/>
   <result pre="autoimmune neurological diseases where B lymphocytes are involved, such as" exact="neuromyelitis optica," post="myasthenia gravis and multiple sclerosis (MS). RTX use in"/>
   <result pre="diseases where B lymphocytes are involved, such as neuromyelitis optica," exact="myasthenia gravis" post="and multiple sclerosis (MS). RTX use in MS has"/>
   <result pre="lymphocytes are involved, such as neuromyelitis optica, myasthenia gravis and" exact="multiple sclerosis" post="(MS). RTX use in MS has been reported to"/>
   <result pre="(21.2%) and 5 mild infections (15.2%). One patient experienced moderate" exact="neutropenia" post="which required RTX withdrawal. Conclusions: In our series RTX"/>
   <result pre="safety and efficacy of fingolimod in clinical practice, experience of" exact="multiple sclerosis" post="health network in Alsace region C Berthe 1, J-C"/>
   <result pre="the first oral therapy for patient with very active relapsing-remitting" exact="multiple sclerosis." post="Objectives: This study gives the first results about Fingolimod"/>
   <result pre="any adverse events (60.0%) including 3 serious adverse events of" exact="macular edema." post="In term of efficiency, FREEDOMS study announced a reduction"/>
   <result pre="and MRI disease activity in young adult patients with relapsing" exact="multiple sclerosis" post="T Chitnis 1, G Karlsson 2, DA Häring 2,"/>
   <result pre="MRI activity have been reported to be higher in younger" exact="multiple sclerosis" post="(MS) patients. To date, no controlled study has been"/>
   <result pre="network meta-analysis of peginterferon beta-1a and injectable therapies for relapsing-remitting" exact="multiple sclerosis" post="K Tolley 1, M Hutchinson 2, A Pachner 3,"/>
   <result pre="or every 4 weeks [Q4W]) has been studied in relapsing-remitting" exact="multiple sclerosis" post="(RRMS) patients in the 2-year Phase 3 ADVANCE trial"/>
   <result pre="beta treatment response with magnetic resonance spectroscopy in relapsing remitiıng" exact="multiple sclerosis" post="MF Yetkin 1, M Mirza 1, H Dönmez 2"/>
   <result pre="black hole and cerebral atrophy burden in Hispanic population with" exact="multiple sclerosis?" post="AR Chinea 1, YG Hernandez 1, ER Estades 1"/>
   <result pre="reported. P321 Challenges experienced by neurologists in the individualization of" exact="multiple sclerosis" post="treatment: findings from an international study SM Hayes 1,"/>
   <result pre="University Hospital, Colchester, United Kingdom Background: The unpredictable nature of" exact="multiple sclerosis" post="(MS) creates several challenges for healthcare providers in the"/>
   <result pre="levels. P322 Fingolimod (Gilenya) confers cognitive stability in active relapsing-remitting" exact="multiple sclerosis" post="patients Y Barak 1,2, D Magalashvili 3, T Paz"/>
   <result pre="efficacy in reducing relapses and delaying disability progression in relapsing-remitting" exact="multiple sclerosis" post="(RRMS) RRMS patients acting as a superagonist to sphingosine-1-phosphate"/>
   <result pre="de Lemos, Spain Background: Fingolimod is a treatment for relapsing-remitting" exact="multiple sclerosis" post="(RRMS). The clinical trials that led to the approval"/>
   <result pre="at another one (x5 normal value). Another side effects were:" exact="macular edema" post="(n=1), self-limited leukopenia (n=7); arterial hypertension (n=2); self-limited liver"/>
   <result pre="normal value). Another side effects were: macular edema (n=1), self-limited" exact="leukopenia" post="(n=7); arterial hypertension (n=2); self-limited liver enzyme elevation (n=2)"/>
   <result pre="patients improved or stabilized). P324 Efficacy of second-line treatments in" exact="multiple sclerosis" post="patients: a multicenter experience in clinical practice R Totaro"/>
   <result pre="second-line treatments (natalizumab and fingolimod) in a cohort of relapsing-remitting" exact="multiple sclerosis" post="(MS) patients completing a treatment period of 12 months"/>
   <result pre="immunomodulatory over immunosuppressive drugs. P326 Spanish Registry of patients with" exact="multiple sclerosis" post="treated with fingolimod (GILENYA Registry): safety and effectiveness after"/>
   <result pre="the follow up period, being only 1 of them serious," exact="second-degree atrioventricular block" post="(0.4%). 1 year after starting treatment with fingolimod, 80.0%"/>
   <result pre="follow up period, being only 1 of them serious, second-degree" exact="atrioventricular block" post="(0.4%). 1 year after starting treatment with fingolimod, 80.0%"/>
   <result pre="follow-up is required. P327 Neurocognitive changes in patients with relapsing-remitting" exact="multiple sclerosis" post="treated with natalizumab N Doehler 1, S Mueller 1,"/>
   <result pre="Pharmacy, Barcelona, Spain Background: Natalizumab is an effective treatment for" exact="multiple sclerosis" post="(MS) patients when administered in 300 mg every 4"/>
   <result pre="300 mg every 4 weeks. However, the incidence of treatment-associated" exact="progressive multifocal leukoencephalopathy" post="(PML) caused by JC virus, compromises this efficacious treatment."/>
   <result pre="treatment. Epidemiology P330 In utero 25-hydroxyvitamin D and risk of" exact="multiple sclerosis" post="among offspring in the Finnish Maternity Cohort K Munger"/>
   <result pre="vitamin D nutrition is associated with a reduced risk of" exact="multiple sclerosis" post="(MS), but whether vitamin D exposure in utero is"/>
   <result pre="cod liver oil use as a vitamin D source and" exact="multiple sclerosis" post="risk in Norway: the EnvIMS study M Cortese 1,2,3,"/>
   <result pre="D level has been associated with an increased risk of" exact="multiple sclerosis." post="It is still unclear whether this suggested effect is"/>
   <result pre="estimates were adjusted for possible confounders such as sun exposure," exact="infectious mononucleosis" post="and smoking. Results: An inverse association was observed for"/>
   <result pre="development of MS. P332 Potential impact of air pollutants on" exact="multiple sclerosis" post="incidence in Tehran, Iran: role of vitamin D P"/>
   <result pre="MS. P333 Temporal effects on the presentation and evolution of" exact="multiple sclerosis" post="KE Harding 1, MD Willis 1, S Loveless 1,"/>
   <result pre="Cardiff, United Kingdom Background: There is evidence that presentation of" exact="multiple sclerosis" post="(MS) is changing, with increasing sex ratios reported in"/>
   <result pre="of mechanisms underlying pathogenesis in MS. P334 The association of" exact="multiple sclerosis" post="prevalence and the soil heavy metal in Isfahan, Iran:"/>
   <result pre="Republic of Background: The steep rising in the number of" exact="multiple sclerosis" post="(MS) patients in Isfahan province, makes this province a"/>
   <result pre="MS risks. P336 Neonatal vitamin D status and risk of" exact="multiple sclerosis" post="P Ueda 1, F Rafatnia 2, M Bäärnhielm 3,"/>
   <result pre="at birth may be associated with risk of adult onset" exact="multiple sclerosis" post="but this link has not been studied directly. Objectives:"/>
   <result pre="relation between 25-hydroxyvitamin D concentration at birth and risk of" exact="multiple sclerosis." post="Methods: This was a population-based case-control study in Sweden"/>
   <result pre="population-based case-control study in Sweden including 459 incident cases of" exact="multiple sclerosis" post="and 663 controls, randomly drawn from a national population"/>
   <result pre="mass spectroscopy method. Using logistic regression, odds ratios for developing" exact="multiple sclerosis" post="were compared between quintiles of neonatal 25-hydroxyvitamin D. Results:"/>
   <result pre="no association between neonatal 25-hydroxyvitamin D quintile and risk of" exact="multiple sclerosis." post="The crude odds ratios for the quintiles, in increasing"/>
   <result pre="index at 20 years of age) as well as ancestry," exact="multiple sclerosis" post="heredity, and socioeconomic group, did not considerably affect the"/>
   <result pre="D status at birth is not associated with risk of" exact="multiple sclerosis" post="at a broad population level, this study provides no"/>
   <result pre="Background: A recent Norwegian study shows an increasing prevalence of" exact="multiple sclerosis" post="(MS) in Norway. The nationwide crude prevalence on 1"/>
   <result pre="play a role. P338 High incidence and increasing prevalence of" exact="multiple sclerosis" post="in British Columbia, Canada: findings from over two decades"/>
   <result pre="validated case definition to estimate the incidence and prevalence of" exact="multiple sclerosis" post="(MS) in BC over a 15 and 20 year"/>
   <result pre="expectancy of women. P339 35 years of mortality due to" exact="multiple sclerosis" post="in Canada, 1975-2009: no decrease in mortality rates despite"/>
   <result pre="Alberta, Edmonton, AB, Canada Background: In the past persons with" exact="multiple sclerosis" post="(MS) died at notably younger ages than the general"/>
   <result pre="Canada Background: Previous studies into seasonal variation of relapses in" exact="multiple sclerosis" post="have had conflicting results. Small relapse numbers, differing diagnostic"/>
   <result pre="with increasing latitudes associated with shorter gaps. P341 Risk of" exact="multiple sclerosis" post="related to month of birth changes over time EG"/>
   <result pre="the changing face of MS hypothesis. P343 The incidence of" exact="multiple sclerosis" post="in New Zealand, 2013: a population- based study S"/>
   <result pre="of Neurology, Christchurch, New Zealand Background: Worldwide, the incidence of" exact="multiple sclerosis" post="(MS) appears to be increasing. Currently there are no"/>
   <result pre="reported prevalence gradient with latitude. P344 Genes and environment in" exact="multiple sclerosis" post="(GEMS) study: enabling the prospective study of individuals at"/>
   <result pre="study: enabling the prospective study of individuals at risk of" exact="multiple sclerosis" post="Z Xia 1,2, L Chibnik 1, A von Korff"/>
   <result pre="currently no reliable tool to guide individualized risk assessment for" exact="multiple sclerosis" post="(MS). Objectives: To test the efficacy of an algorithm"/>
   <result pre="environmental risk score (GERS) that includes 63 genetic variants, sex," exact="infectious mononucleosis" post="(IM), and smoking. We tested the efficacy of GERS"/>
   <result pre="transition from health to disease. P345 Prevalence and incidence of" exact="multiple sclerosis" post="estimated in European Register for Multiple Sclerosis (EUReMS): study"/>
   <result pre="Drulovic, W. Brola, for providing data. P346 Vitamin D in" exact="multiple sclerosis;" post="clinical and immunological implications J Hejgaard Laursen 1, H"/>
   <result pre="Center, Copenhagen, Denmark Background: Vitamin D insufficiency is common among" exact="multiple sclerosis" post="(MS) patients, and hypovitaminosis D has been associated with"/>
   <result pre="of wGRS on familial aggregation and clinical phenotypes in Italian" exact="multiple sclerosis" post="patients F Esposito 1,2, C Guaschino 1,2, L Ferrè"/>
   <result pre="in the past decades as potential risk factors for developing" exact="multiple sclerosis" post="(MS). Pediatric MS offers a unique opportunity to study"/>
   <result pre="of pediatric MS. P349 Increasing prevalence and stable incidence of" exact="multiple sclerosis" post="in Western Norway, 1953-2013 N Grytten 1, JH Aarseth"/>
   <result pre="Hordaland County, Western Norway is a high risk area for" exact="multiple sclerosis" post="(MS). Follow-up studies have suggested a rising prevalence although"/>
   <result pre="has many implications for healthcare services. P351 Sodium intake in" exact="multiple sclerosis" post="patients MF Farez 1, MP Fiol 1, MI Gaitán"/>
   <result pre="in spot urine samples from a cohort of 70 relapsing-remitting" exact="multiple sclerosis" post="patients using Tanaka’s equation. The effect of sodium intake"/>
   <result pre="D status modify the response to vitamin D supplementation in" exact="multiple sclerosis" post="patients and healthy controls P Bhargava 1, SU Steele"/>
   <result pre="Background: While vitamin D insufficiency is a risk factor for" exact="multiple sclerosis" post="(MS), it is common in the general population. Since"/>
   <result pre="may be required based on these variables. P353 Epidemiology of" exact="multiple sclerosis" post="in the Republic of Moldova: an incidence and prevalence"/>
   <result pre="(EUReMS), EAHC Second Health programme 2008-13. P354 Increasing incidence of" exact="multiple sclerosis" post="among women in Buenos Aires: a 21-year health maintenance"/>
   <result pre="Argentina, 2Hospital Italiano, Buenos Aires, Argentina Background: Epidemiological studies in" exact="multiple sclerosis" post="(MS) suggest a trend of increasing disease prevalence and"/>
   <result pre="populations and mainly a disproportional increase in the incidence of" exact="multiple sclerosis" post="in women. The reasons for this are unclear and"/>
   <result pre="Institute, Milan, Italy Background: Multiple sclerosis (MS) is a demyelinating" exact="autoimmune disease" post="influenced by a combination of genetic and environmental factors."/>
   <result pre="of MS-associated variants. P356 The use of valproic acid and" exact="multiple sclerosis" post="NM Nielsen 1, H Svanström 1, E Stenager 2,3,4,"/>
   <result pre="deacetylase (HDAC) might have a beneficial effect on experimental allergic" exact="encephalomyelitis" post="(a murine model of multiple sclerosis). Valproic acid (VPA),"/>
   <result pre="antibody titers against Epstein-Barr virus and human herpesvirus 6 in" exact="multiple sclerosis" post="patients: a one-year follow-up study I Ortega-Madueño 1, L"/>
   <result pre="years, altered levels of vitamin D have been associated with" exact="multiple sclerosis" post="(MS). Objectives: To evaluate the possible association between the"/>
   <result pre="studies will be needed to confirm these results. P358 Early-onset" exact="multiple sclerosis" post="in Isfahan, Iran: a report of the demographic and"/>
   <result pre="of differential diagnosis of MS during childhood. P359 Using patient-derived" exact="multiple sclerosis" post="severity score to demonstrate differences in MS severity across"/>
   <result pre="course was observed in AA men. P360 Disease progression in" exact="multiple sclerosis" post="after age 65 E Leray 1,2, M Genevray 3,"/>
   <result pre="Infectious Diseases Department, Paris, France Background: Age at onset of" exact="multiple sclerosis" post="(MS) is known to be associated with both disease"/>
   <result pre="65. P361 Age at disease onset in familial and sporadic" exact="multiple sclerosis" post="in Argentina JI Rojas 1, L Patrucco 1, J"/>
   <result pre="neurological diseases in which genetic inheritance has a role. In" exact="multiple sclerosis" post="(MS), some population studies found an anticipation of age"/>
   <result pre="anticipation of age at onset in younger generations of familial" exact="multiple sclerosis" post="(FMS) vs. sporadic MS (SMS) in Argentina. Methods: this"/>
   <result pre="D deficiency has been associated with several autoimmune conditions including" exact="multiple sclerosis" post="(MS), and occurs more frequently in regions of high"/>
   <result pre="D in Scotland. P363 Prevalence, demographics and clinical characteristics of" exact="multiple sclerosis" post="in the city of Tlemcen, Algeria Z Barka Bedrane"/>
   <result pre="studies have indicated that Algeria is a low-risk zone for" exact="multiple sclerosis" post="(MS). Objectives: Our objective were to determine the prevalence,"/>
   <result pre="P364 Large scale epidemiological survey of disability progression in Japanese" exact="multiple sclerosis" post="patients I Nakashima 1, N Harada 2, F Nakaya"/>
   <result pre="on the disability status and progression in Japanese patients with" exact="multiple sclerosis" post="(MS) has not been well established. Kumar et al."/>
   <result pre="treatment may slow the progression of MS. P365 Highly active" exact="multiple sclerosis" post="and Epstein-Barr virus reactivation MM Paz Soldan 1, EP"/>
   <result pre="Clinic, Neurology, Rochester, MN, United States Background: Risk of developing" exact="multiple sclerosis" post="(MS) has been associated with an expanding number of"/>
   <result pre="reports. P366 Residential distance from main roads, air pollution, and" exact="multiple sclerosis" post="disability in Southern California L Amezcua 1, V Chat"/>
   <result pre="United States Background: CNS inflammation and axonal degeneration contribute to" exact="multiple sclerosis" post="(MS)-related disability. Air pollution has been reported to be"/>
   <result pre="VA, United States Background: Identification of modifiable risk factors for" exact="multiple sclerosis" post="is ongoing. Exposure to some of these risk factors"/>
   <result pre="regardless of age of onset. In regression models, race and" exact="obesity" post="were independent predictors of vitamin D status. The prevalence"/>
   <result pre="were independent predictors of vitamin D status. The prevalence of" exact="obesity" post="was significantly higher in the childhood-onset cohort (CO=58.5%; Y-AO=31%;"/>
   <result pre="to vitamin D status in demyelinating disease. Both race and" exact="obesity" post="are independent factors impacting vitamin D insufficiency/deficiency, regardless of"/>
   <result pre="and may have a role in the development of childhood-onset" exact="multiple sclerosis." post="P368 Vitamin D level and its clinical correlation in"/>
   <result pre="of vitamin D was one of the risk factor for" exact="multiple sclerosis" post="(MS). Moreover, some reported found that replacement vitamin D"/>
   <result pre="other demyelinating diseases such as Clinical Isolated Syndrome (CIS) or" exact="neuromyelitis optica" post="(NMO)/NMO spectrum disorders (NMOSDs). Objectives: To evaluate vitamin D"/>
   <result pre="with degree of disability in patients with fully ambulatory relapsing-remitting" exact="multiple sclerosis" post="E Thouvenot 1,2, M Orsini 3, J-P Daures 3,"/>
   <result pre="Background: Vitamin D deficiency is a recognized risk factor for" exact="multiple sclerosis" post="(MS) and is associated with increased disease activity. It"/>
   <result pre="University of Copenhagen, Neurology, Glostrup, Denmark Background: The aetiology of" exact="multiple sclerosis" post="(MS) is complex, both genetic traits and environmental factors"/>
   <result pre="(EDSS=6). The most common symptom was numbness (58%) followed by" exact="optic neuritis" post="(16%). Patients treated with a DMT were only half"/>
   <result pre="benign in most patients. P373 Specific clinical phenotypes of relapsing" exact="multiple sclerosis" post="based on disease activity EJ Gettings 1, CT Hackett"/>
   <result pre="patterns. Objectives: To identify and characterize clinical phenotypes of relapsing" exact="multiple sclerosis" post="(MS) in a longitudinally designed retrospective study. We aimed"/>
   <result pre="Sclerosis (MS) is classically considered as a T lymphocyte- mediated" exact="autoimmune disease." post="However, the efficacy of therapies targeting B cells and"/>
   <result pre="made use of a genetically determined model of experimental autoimmune" exact="encephalomyelitis" post="in transgenic mice harboring MOG specific T and B"/>
   <result pre="autoimmunity. P376 Serpine1 is a negative regulator of experimental autoimmune" exact="encephalomyelitis" post="M Rangachari 1, N Boivin 1, A Chen 2,"/>
   <result pre="expression, has been linked genetically to the increased incidence of" exact="multiple sclerosis" post="(MS). These findings suggest that Serpine1 can repress central"/>
   <result pre="Caen, France Background: Today MR diagnosis and therapeutic assessment of" exact="multiple sclerosis" post="(MS) is only based on quantification of contrast-enhancing lesions"/>
   <result pre="and prevents disease progression in a humanized mouse model of" exact="multiple sclerosis" post="D Graham 1, S Huang 1, J-K Choi 2,"/>
   <result pre="myelin basic protein (MBP), selected based on immunodominant epitopes in" exact="multiple sclerosis" post="(MS) patients with human leukocyte antigen (HLA) haplotypes DRB1*1501"/>
   <result pre="a new therapeutic under investigation in clinical trials. Experimental autoimmune" exact="encephalomyelitis" post="(EAE) induced in humanized mice engineered to express the"/>
   <result pre="Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune" exact="encephalomyelitis" post="R Kim 1, N Itoh 1, A Hoffman 1,"/>
   <result pre="function in vivo during disease in the most widely used" exact="multiple sclerosis" post="model, experimental autoimmune encephalomyelitis (EAE), is not known ."/>
   <result pre="in the most widely used multiple sclerosis model, experimental autoimmune" exact="encephalomyelitis" post="(EAE), is not known . Objectives: Determine the role"/>
   <result pre="short chain fatty acids on the course of experimental autoimmune" exact="encephalomyelitis" post="A Haghikia 1, A Duscha 1, J Berg 1,"/>
   <result pre="Background: Despite new insights into the genetics and epigenetics of" exact="multiple sclerosis" post="(MS) its etiology, in particular the role that the"/>
   <result pre="particular propionic acid (PA) on the course of experimental autoimmune" exact="encephalomyelitis" post="(EAE). Methods: MOG-immunized C57/Bl6-mice were either treated with PA"/>
   <result pre="properties that is being developed for the treatment of relapsing-remitting" exact="multiple sclerosis" post="(RRMS) and other inflammatory and neurodegenerative diseases. In two"/>
   <result pre="progression. P382 Oxysterols regulate T lymphocytes trafficking during experimental autoimmune" exact="encephalomyelitis" post="F Chalmin 1, V Rochemont 1, C Lippens 1,"/>
   <result pre="oxysterols and of Ch25h in the pathogenesis of experimental autoimmune" exact="encephalomyelitis" post="(EAE), an animal model of multiple sclerosis and to"/>
   <result pre="pathogenesis of experimental autoimmune encephalomyelitis (EAE), an animal model of" exact="multiple sclerosis" post="and to investigate the underlying mechanisms. Methods: EAE model"/>
   <result pre="disease severity and cognitive impairment especially in later stages of" exact="multiple sclerosis" post="(MS), they can be hardly detected by conventional MRI."/>
   <result pre="potent activator of the Nurr1 signaling pathway, on experimental autoimmune" exact="encephalomyelitis" post="in mouse F Montarolo 1, C Raffaele 2, S"/>
   <result pre="Discovery Chemistry, Basel, Switzerland Background: Multiple sclerosis (MS) is an" exact="autoimmune disease" post="affecting central nervous system, in which Th1/Th17 cells are"/>
   <result pre="1-phosphate (S1P), a lysophospholipid, was shown to be relevant to" exact="multiple sclerosis" post="(MS) therapeutics through oral fingolimod (FTY720), an S1P analog"/>
   <result pre="of Neurology, Sendai, Japan Background: Neuromyelitis optica (NMO) is an" exact="autoimmune disease" post="associated with NMO-IgG, which targets aquaporin 4 (AQP4) mainly"/>
   <result pre="P387 Laquinimod prevents NMOIg-induced disease exacerbation in a model of" exact="neuromyelitis optica" post="AT Argaw 1,2,3, L Asp 1,2,3, J Zhang 1,2,3,"/>
   <result pre="the immunomodulator laquinimod, currently in a Phase 3 trial for" exact="multiple sclerosis," post="restricts NMOIg CNS entry and exacerbation of neuropathology and"/>
   <result pre="of an anti-mouse CD52 antibody (anti-muCD52) in an experimental autoimmune" exact="encephalomyelitis" post="(EAE) mouse model has allowed for further characterization of"/>
   <result pre="effects of anti-muCD52 treatment in an EAE mouse model of" exact="multiple sclerosis" post="(MS) to provide a better understanding of the mechanism"/>
   <result pre="an important correlate to clinical disability and disease duration in" exact="multiple sclerosis" post="(MS). Gray matter atrophy in the cerebral cortex has"/>
   <result pre="cerebral cortex has been shown by MRI in experimental autoimmune" exact="encephalomyelitis" post="(EAE), the most widely used model of MS. The"/>
   <result pre="administered after disease onset. P390 Chondroitin 6-O-sulfate ameliorates experimental autoimmune" exact="encephalomyelitis" post="K Miyamoto 1, R Ueno 1, K Kadomatsu 2,"/>
   <result pre="6-O-sulfate transferase 1-deficient (C6st1 −/−) mice were induced experimental autoimmune" exact="encephalomyelitis" post="(EAE) . C6ST1 is the enzyme that transfers sulfate"/>
   <result pre="be a novel therapeutic strategy for neuroimmunological diseases such as" exact="multiple sclerosis." post="P391 Adaptive angioplasticity promotes recovery in experimental autoimmune encephalomyelitis"/>
   <result pre="multiple sclerosis. P391 Adaptive angioplasticity promotes recovery in experimental autoimmune" exact="encephalomyelitis" post="N Esen 1, P Dore-Duffy 1 1Wayne State University,"/>
   <result pre="conditioning). We hypothesize that adaptive angioplasticity will ameliorate experimental autoimmune" exact="encephalomyelitis" post="(EAE) in mice through a Hypoxia Inducible Factor-1alpha (HIF-1a)/HIF-2a-dependent"/>
   <result pre="effect of adaptive angioplasty in a neurodegenerative disease model of" exact="multiple sclerosis" post="(MS). Methods: C57BL/6 mice were immunized with MOG35-55 peptide."/>
   <result pre="(MRI) correlates strongly with disease duration and clinical disability in" exact="multiple sclerosis" post="(MS). However, the mechanisms underlying gray matter atrophy remain"/>
   <result pre="cerebral cortex has been shown by MRI in experimental autoimmune" exact="encephalomyelitis" post="(EAE), the most widely used model of MS. Objectives:"/>
   <result pre="GA treatment on mitochondrial dynamics and biogenesis in experimental allergic" exact="encephalomyelitis" post="(EAE), an animal model for MS. Methods: EAE was"/>
   <result pre="of GA but also provide a good target to prevent" exact="neurodegeneration" post="in EAE and MS. P394 Superior efficacy of glucocorticoid"/>
   <result pre="MS. P394 Superior efficacy of glucocorticoid treatment of experimental autoimmune" exact="encephalomyelitis" post="in macrophage migration inhibitory factor deficient mice N Ji"/>
   <result pre="effects. GCs are the standard treatment for acute attacks of" exact="multiple sclerosis" post="(MS), however, they eventually lose efficacy and overall do"/>
   <result pre="a role in resistance to GC treatment using experimental autoimmune" exact="encephalomyelitis" post="(EAE), a common animal model of MS. Methods: We"/>
   <result pre="both the brains of Wt and MIF-/- mice; however, the" exact="suppression" post="lasted longer in MIF-/- mice once the treatment was"/>
   <result pre="reduces disease severity in a mouse model of experimental autoimmune" exact="encephalomyelitis" post="S-K Kim 1, J Kassis 1, O Attucks 1,"/>
   <result pre="mice confers cytoprotection against spinal cord injury and experimental autoimmune" exact="encephalomyelitis" post="(EAE). We therefore designed potent and specific inhibitors of"/>
   <result pre="of critical importance in a range of experimental conditions including" exact="obesity" post="and autoimmunity. The functional properties of GALT derived regulatory"/>
   <result pre="including CCL22 and CXCL13. In separate experiments, e xperimental autoimmune" exact="encephalomyelitis" post="(EAE) was induced in SJL/J mice with proteolipid protein"/>
   <result pre="and mechanisms of antigen-specific tolerogenic dendritic cells in experimental autoimmune" exact="encephalomyelitis" post="MJ Mansilla 1, S Fabregas 1, J Navarro 1,"/>
   <result pre="attenuation of pathogenic T cells in autoimmune diseases such as" exact="multiple sclerosis" post="(MS). Objectives: To compare the therapeutic effect of antigen-specific"/>
   <result pre="unloaded TolDCs in the animal model of MS, experimental autoimmune" exact="encephalomyelitis" post="(EAE). Methods: Bone marrow (BM) cells from C57BL/6 mice"/>
   <result pre="axon circuit alterations in a chronic demyelinating mouse model of" exact="multiple sclerosis" post="N Harris 1, A Khalaj 2, R Mofrad-Babapour 2,"/>
   <result pre="Riverside, CA, United States Background: Unlike autoimmune demyelinating pathology in" exact="multiple sclerosis" post="(MS) and experimental autoimmune encephalomyelitis (EAE) mice, cuprizone (CPZ)"/>
   <result pre="autoimmune demyelinating pathology in multiple sclerosis (MS) and experimental autoimmune" exact="encephalomyelitis" post="(EAE) mice, cuprizone (CPZ) diet-induced demyelination and normal diet-induced"/>
   <result pre="reveal optic nerve involvement in a relapsing remitting model of" exact="multiple sclerosis" post="R Santangelo 1, V Castoldi 1, L Camaleonti 1,"/>
   <result pre="Spectroscopic determination of chelating properties and uptake in the cuprizone" exact="multiple sclerosis" post="model AA Taraboletti 1, JA Caporoso 1, H Huang"/>
   <result pre="study pathways involved in white matter damage that occurs in" exact="multiple sclerosis" post="(MS). Administration of cuprizone to mice results in reproducible"/>
   <result pre="Brain Research Institute, Zurich, Switzerland Background: The targeted experimental autoimmune" exact="encephalomyelitis" post="(EAE) model in rats is a variant of EAE,"/>
   <result pre="of an experimental MS. P404 Clinical outcome of experimental autoimmune" exact="encephalomyelitis" post="in semaphorin 7A-deficient mice A Gutiérrez-Franco 1, H Eixarch"/>
   <result pre="(CNS) injury. Its role in the pathogenesis of experimental autoimmune" exact="encephalomyelitis" post="(EAE) is controversial. Objectives: We aimed to study the"/>
   <result pre="our current protocol: 50µg of MOG 35-55, 300µg of Mycobacterium" exact="tuberculosis" post="(McT) and 150ng of pertussis toxin (Pt) per mouse."/>
   <result pre="MOG 35-55, 300µg of Mycobacterium tuberculosis (McT) and 150ng of" exact="pertussis" post="toxin (Pt) per mouse. Additionally, different doses of antigen"/>
   <result pre="for EAE outcome. P405 Gender-specific neuregulin1 modulation of experimental autoimmune" exact="encephalomyelitis" post="F Song 1, H Deol 1, J Liu 1,"/>
   <result pre="Background: The mechanisms that modulate disease severity and progression in" exact="multiple sclerosis" post="(MS) are poorly understood and MS is more common"/>
   <result pre="NRG1 antagonist (HBD-S-H4) on myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune" exact="encephalomyelitis" post="(EAE). Methods: HBD-S-H4 is a novel humanized fusion protein"/>
   <result pre="protect against optic nerve degeneration in an experimental model of" exact="multiple sclerosis" post="C Cordova 1, B Gutierrez 2, R Martin 3,"/>
   <result pre="Optic neuritis (ON) is a frequent and early symptom of" exact="multiple sclerosis" post="(MS). ON is a condition involving inflammation, oxidative stress,"/>
   <result pre="visual loss. Currently, ON has no effective treatment. Experimental autoimmune" exact="encephalomyelitis" post="(EAE) is the animal model used to study MS"/>
   <result pre="injury. Therefore OA may be a therapeutic strategy for suppressing" exact="neurodegeneration" post="in optic neuritis. P407 Relative protection of H. pylori"/>
   <result pre="OA may be a therapeutic strategy for suppressing neurodegeneration in" exact="optic neuritis." post="P407 Relative protection of H. pylori sonicate administration against"/>
   <result pre="of epidemiological correlation between Helicobacter Pylori ( Hp) infection and" exact="multiple sclerosis" post="(MS). However, experimental evidence on the field is lacking."/>
   <result pre="compared to the PBS-treated group, upon induction of experimental autoimmune" exact="encephalomyelitis" post="(EAE), through immunization with MOG 35-55 peptide (mean EAE"/>
   <result pre="is sufficient to drive neuro-inflammation in an animal model of" exact="multiple sclerosis" post="CR Parker 1, AS Archambault 1, J Sim 2,"/>
   <result pre="cells are increasingly regarded as integral to the pathogenesis of" exact="multiple sclerosis" post="(MS). The mechanisms by which B cells participate in"/>
   <result pre="support disease in the animal model of MS, experimental autoimmune" exact="encephalomyelitis" post="(EAE). However, due to the indirect clinical evidence for"/>
   <result pre="APC function during the initiation and propagation of experimental autoimmune" exact="encephalomyelitis" post="(EAE). In particular, we aimed to examine the role"/>
   <result pre="cells (BMCs) transduced with MOG 40-55 peptide into experimental autoimmune" exact="encephalomyelitis" post="(EAE) mice improved the disease. We also reported that"/>
   <result pre="by neuronal cells under physiological conditions, has been implicated in" exact="cerebellar ataxia" post="and schizophrenia. Although its relative TGM2 has been found"/>
   <result pre="differentiation and inflammation, the involvement of TGM6 in EAE and" exact="multiple sclerosis" post="is still unknown. Objectives: To investigate TGM6 in murine"/>
   <result pre="induced in C57BL6 mice by MOG 35-55/CFA immunization followed by" exact="pertussis" post="toxin injections (at 0 and 48h post immunization). Animals"/>
   <result pre="loci for anti-EBNA-1 IgG titres are associated with risk of" exact="multiple sclerosis" post="Y Zhou 1, G Zhu 2, DR Nyholt 2,"/>
   <result pre="infection with EBV is associated with an increased risk of" exact="multiple sclerosis" post="(MS). Objectives: To identify genetic susceptibility loci for EBV"/>
   <result pre="NcoI polymorphism is associated with inflammatory and metabolic markers in" exact="multiple sclerosis" post="patients AP Kallaur 1, SR Oliveira 1, PRVP Rodrigues"/>
   <result pre="a pro-inflammatory cytokine that might induce the inflammatory process in" exact="multiple sclerosis" post="(MS) patients and results in high disability levels and"/>
   <result pre="incidence and severity. P414 Impact of genetic risk loci in" exact="multiple sclerosis" post="on expression of proximal genes T James 1, M"/>
   <result pre="Medicine, Stockholm, Sweden Background: The major genetic susceptibility factors for" exact="multiple sclerosis" post="(MS) are different alleles in the HLA-DRB1 and HLA-A"/>
   <result pre="Department of Neurology, Bochum, Germany Background: The genetic basis of" exact="multiple sclerosis" post="(MS) as a multifactorial disease was underscored by the"/>
   <result pre="variation study identified T-cell receptor as a susceptibility gene for" exact="multiple sclerosis" post="and neuromyelitis optica S Sato 1, K Yamamoto 2,"/>
   <result pre="T-cell receptor as a susceptibility gene for multiple sclerosis and" exact="neuromyelitis optica" post="S Sato 1, K Yamamoto 2, T Matsushita 1,"/>
   <result pre="in several diseases, the effect of CNVs on susceptibility to" exact="multiple sclerosis" post="(MS) and neuromyelitis optica (NMO) is unknown. Objectives: To"/>
   <result pre="effect of CNVs on susceptibility to multiple sclerosis (MS) and" exact="neuromyelitis optica" post="(NMO) is unknown. Objectives: To identify CNVs associated with"/>
   <result pre="patients with MS and NMO. P417 Genetic interaction analysis of" exact="multiple sclerosis" post="risk loci M Lindén 1, I Lima Bomfim 1,"/>
   <result pre="Environmental Medicine, Stockholm, Sweden Background: The sibling recurrence risk for" exact="multiple sclerosis" post="(MS) is estimated to be 7.1. The major genetic"/>
   <result pre="Groningen, Netherlands Background: In the recent IMSGC collaborative study 110" exact="multiple sclerosis" post="(MS) risk loci have been established which, next to"/>
   <result pre="These results support the previous studies. P419 Susceptibility variants for" exact="multiple sclerosis" post="in the Japanese population T Matsushita 1, S Sato"/>
   <result pre="people of Japanese and European descent. P420 Genetic predictors of" exact="multiple sclerosis" post="G Disanto 1, R Dobson 2, J Pakpoor 3,"/>
   <result pre="investigate the genetic and environmental architecture of immune variation in" exact="multiple sclerosis" post="PA Winn 1, M Cimpean 1, A Robbins 1,"/>
   <result pre="Multiple genetic as well as environmental factors influence susceptibility to" exact="multiple sclerosis" post="(MS). These genetic risk factors are common in the"/>
   <result pre="their receptors modulate IFN-γ and TNF-α associations with relapse in" exact="multiple sclerosis" post="Y Zhou 1, BV Taylor 1, N Stewart 1,"/>
   <result pre="mononuclear cells (PBMC) production of cytokines have been found in" exact="multiple sclerosis" post="(MS) compared to healthy controls. We have previously found"/>
   <result pre="and plasma concentration of IL-18 and IL-36 in relapsing remitting" exact="multiple sclerosis" post="patients F Khosravian 1, M Azadi 1, F Alsahebfosoul"/>
   <result pre="that cytokines play an important role in the pathogenesis of" exact="multiple sclerosis" post="(MS). Here we will focus on two of the"/>
   <result pre="control group. Methods: 105 Iranian patients that clinically definite as" exact="multiple sclerosis" post="(RRM) and 113 healthy controls were enrolled. IL-18 gene"/>
   <result pre="All selected patients were clinically diagnosed as having relapsing remitting" exact="multiple sclerosis" post="(RRMS) .The plasma levels of the cytokines IL-36 and"/>
   <result pre="imaging findings in healthy, genetically characterized, asymptomatic first-degree relatives of" exact="multiple sclerosis" post="patients SU Steele 1, AC Bakshi 1, Z Xia"/>
   <result pre="lesions precede the onset of clinical signs and symptoms in" exact="multiple sclerosis" post="(MS). Identification of a subset of first-degree relatives at"/>
   <result pre="of neurological disability. P426 Target resequencing of regions associated with" exact="multiple sclerosis" post="in the Italian population N Barizzone 1, S Anand"/>
   <result pre="P427 Human Aquaporin 4 gene polymorphisms in Chinese patients with" exact="neuromyelitis optica" post="spectrum disorders W Qiu 1, Y Chang 1, R"/>
   <result pre="(AQP4) and anti-AQP4 autoantibodies（NMO-IgG） are involved in the pathogenesis of" exact="neuromyelitis optica" post="(NMO) and neuromyelitis optica spectrum disorders (NMOSD). Conflicting results"/>
   <result pre="are involved in the pathogenesis of neuromyelitis optica (NMO) and" exact="neuromyelitis optica" post="spectrum disorders (NMOSD). Conflicting results have been reported regarding"/>
   <result pre="Interestingly, DDX39B (BAT1) has also been associated with Myasthenia Gravis," exact="rheumatoid arthritis" post="and systemic lupus. Analyses of naïve CD4+ T cells"/>
   <result pre="DDX39B (BAT1) has also been associated with Myasthenia Gravis, rheumatoid" exact="arthritis" post="and systemic lupus. Analyses of naïve CD4+ T cells"/>
   <result pre="gene variability influences recovery and residual disability after relapses in" exact="multiple sclerosis" post="M Vercellino 1, C Fenoglio 2, C Chiavazza 1,"/>
   <result pre="gray matter (GM) atrophy are related to clinical disability in" exact="multiple sclerosis" post="(MS), but their respective contribution is still debated. Objectives:"/>
   <result pre="debated. Objectives: To investigate WM and GM damage in benign" exact="multiple sclerosis" post="(BMS). Methods: A prospective study included relapsing-remitting MS patients"/>
   <result pre="cord gray matter atrophy with disability and disease type in" exact="multiple sclerosis" post="R Schlaeger 1,2, ND Papinutto 1, C Bevan 1,"/>
   <result pre="and Biomedical Imaging, San Francisco, CA, United States Background: In" exact="multiple sclerosis" post="(MS) cerebral gray matter (GM) atrophy correlates more strongly"/>
   <result pre="is of great interest in many neurodegenerative diseases, such as" exact="multiple sclerosis" post="and Alzheimer’s disease. It is further established that age-related"/>
   <result pre="diffuse structural pathology in the motor network in subjects with" exact="multiple sclerosis" post="(MS). To explore the impact of NE changes on"/>
   <result pre="(WM) injury are the pathological substrate of clinical progression in" exact="multiple sclerosis" post="(MS). The interdependence between these two processes, however, is"/>
   <result pre="Texture of deep gray matter areas relates to disability in" exact="multiple sclerosis" post="L Gaetano 1, S Magon 1, M Chakravarty 2,3,"/>
   <result pre="of Neurology, Basel, Switzerland Background: Brain volume loss (BVL) in" exact="multiple sclerosis" post="(MS) occurs at rates that exceed those reported in"/>
   <result pre="catch up regarding overall brain volume loss. P440 Iron in" exact="multiple sclerosis" post="lesions can be detected by larger volumes on quantitative"/>
   <result pre="Haven, NY, United States Background: A key feature of inflamed" exact="multiple sclerosis" post="lesions is the presence of activated microglia/macrophages (m/M), some"/>
   <result pre="Grey matter abnormalities in mesial temporal lobe characterize patients with" exact="multiple sclerosis" post="and epilepsy M Calabrese 1, NS Orefice 2, M"/>
   <result pre="in mesial temporal lobe characterize patients with multiple sclerosis and" exact="epilepsy" post="M Calabrese 1, NS Orefice 2, M Castellaro 3,"/>
   <result pre="cross-sectional and longitudinal studies we observed that MS patients with" exact="epilepsy" post="had a significant increase in number and volume of"/>
   <result pre="15 patients, 9 reported symptoms that could be ascribed to" exact="temporal lobe epilepsy" post="(such as deja vu, jamais vu or auditory, gustatory"/>
   <result pre="9 reported symptoms that could be ascribed to temporal lobe" exact="epilepsy" post="(such as deja vu, jamais vu or auditory, gustatory"/>
   <result pre="This would be in line with the high frequency of" exact="temporal lobe epilepsy" post="observed in our patients. P442 OASIS and SuBLIME software"/>
   <result pre="be in line with the high frequency of temporal lobe" exact="epilepsy" post="observed in our patients. P442 OASIS and SuBLIME software"/>
   <result pre="can be used to detect lesions in the brains of" exact="multiple sclerosis" post="(MS) patients and is essential for evaluating disease-modifying therapies"/>
   <result pre="long-term demyelination in normal appearing white matter from relapsing remitting" exact="multiple sclerosis" post="IM Vavasour 1, SC Huijskens 2, SM Meyers 2,"/>
   <result pre="generally accumulate over time in the brains of people with" exact="multiple sclerosis" post="(MS), but there is also evidence for on-going pathological"/>
   <result pre="longitudinal studies. P444 Extended cortical lesion determining acute relapses in" exact="multiple sclerosis" post="M Puthenparampil 1, D Poggiali 1, P Perini 1,"/>
   <result pre="SNPSRR, Padova, Italy Background: Cortical lesions can be observed at" exact="multiple sclerosis" post="onset, increase in number and volume over the course"/>
   <result pre="phase-sensitive inversion recovery (PSIR) magnetic resonance imaging sequences. Results: Five" exact="multiple sclerosis" post="patients had acute &quot;cortical relapses&quot; characterized by Wernicke’s aphasia,"/>
   <result pre="sclerosis patients had acute &quot;cortical relapses&quot; characterized by Wernicke’s aphasia," exact="agraphia" post="with acalculia not associated to motor deficit or linguistic"/>
   <result pre="acute onset of left lower limb paroxysmal hypertonia, temporal lobe" exact="status epilepticus" post="with psychotic symptoms mimicking encephalitis. DIR and PSIR disclosed"/>
   <result pre="scanning can be used to image pathological determinants of progressive" exact="multiple sclerosis" post="L Airas 1, E Rissanen 2, M Gardberg 1,"/>
   <result pre="Finland, 2Turku PET Centre, Turku, Finland Background: In secondary progressive" exact="multiple sclerosis" post="(SPMS),there is diffuse smoldering inflammation compartmentalized within the central"/>
   <result pre="progressive MS. P446 In vivo characterization of axonal damage in" exact="multiple sclerosis" post="using high-gradient diffusion magnetic resonance imaging SY Huang 1,2,"/>
   <result pre="Axonal damage is considered the pathologic substrate of disability in" exact="multiple sclerosis" post="(MS). However, in vivo imaging biomarkers specific for axonal"/>
   <result pre="NAWM. P447 Bi-directional trans-synaptic degeneration in the visual pathway in" exact="multiple sclerosis" post="LJ Balk 1, MD Steenwijk 1, P Tewarie 1,"/>
   <result pre="the different components and for comparing patients with and without" exact="optic neuritis" post="and HC. Results: In patients with MS, an episode"/>
   <result pre="and HC. Results: In patients with MS, an episode of" exact="optic neuritis" post="(MSON) was significantly associated with decreased integrity of the"/>
   <result pre="negatively associated with pRNFL and GCC thickness in patients without" exact="optic neuritis" post="(MSNON). The pRNFL and GCC showed associations with integrity"/>
   <result pre="mechanism. P449 Improved white matter integrity with natalizumab treatment in" exact="multiple sclerosis" post="OT Wiebenga 1,2, MM Schoonheim 2, HE Hulst 2,"/>
   <result pre="atrophy and pathology in connected white matter tracts in long-standing" exact="multiple sclerosis" post="MD Steenwijk 1, M Daams 1,2, PJW Pouwels 3,"/>
   <result pre="Amsterdam, Netherlands Background: Gray matter (GM) atrophy is common in" exact="multiple sclerosis" post="(MS), but the relationship with white matter (WM) pathology"/>
   <result pre="predicted by degree of white matter insult, slows cognition in" exact="multiple sclerosis" post="NA Hubbard 1, MP Turner 1, DM Robinson 2,"/>
   <result pre="within the temporoparietal junction is linked to impaired attention in" exact="multiple sclerosis" post="SM Tobyne 1, D Boratyn 1, J Sherman 1,2,"/>
   <result pre="effortful deployment of attention, a commonly observed cognitive deficit in" exact="multiple sclerosis" post="(MS). Imaging biomarkers of LFC and DFC network integrity"/>
   <result pre="in cerebral deep grey matter is a consistent finding in" exact="multiple sclerosis" post="(MS) while respective results have been controversial in patients"/>
   <result pre="volumetry identifies clinically meaningful atrophy in early relapsing forms of" exact="multiple sclerosis" post="R Opfer 1, A Tewes 1, L Spies 1,"/>
   <result pre="Background: Brain atrophy occurs early and in different subtypes of" exact="multiple sclerosis" post="(MS). Neuro-axonal damage in MS is thought to be"/>
   <result pre="cord area between spinal cord measurements using different coils in" exact="multiple sclerosis" post="patients with 3.0T MRI F-X Aymerich 1, D Pareto"/>
   <result pre="Thalamus structure and function determines severity of cognitive impairment in" exact="multiple sclerosis" post="MM Schoonheim 1, HE Hulst 1, RB Brandt 2,"/>
   <result pre="Center, Neurology, Amsterdam, Netherlands Background: Cognitive impairment is prominent in" exact="multiple sclerosis" post="(MS) and is strongly influenced by thalamic damage. Objectives:"/>
   <result pre="the thalamus explain different severities of cognitive impairment in early" exact="multiple sclerosis." post="Methods: A homogeneous cohort of 157 early MS patients"/>
   <result pre="and function are highly informative regarding overall cognitive performance in" exact="multiple sclerosis." post="Increased thalamic functional connectivity only became apparent in more"/>
   <result pre="tract integrity changes are associated with cognition and disinhibition in" exact="multiple sclerosis" post="HE Hulst 1, RHB Benedict 2, MD Steenwijk 3,"/>
   <result pre="NY, United States Background: Thalamic pathology is frequently found in" exact="multiple sclerosis" post="(MS). These thalamic abnormalities are highly correlated with conversion"/>
   <result pre="MS. P463 Multimodal quantitative magnetic resonance imaging of thalamus in" exact="multiple sclerosis" post="and neuromyelitis optica J Wang 1, Y Liu 2,3,"/>
   <result pre="quantitative magnetic resonance imaging of thalamus in multiple sclerosis and" exact="neuromyelitis optica" post="J Wang 1, Y Liu 2,3, Y Duan 2,"/>
   <result pre="Background: Memory deficits develop in 40-65% of the patients with" exact="multiple sclerosis" post="(MS) and generally lead to problems in daily life"/>
   <result pre="Spain Background: Grey matter pathology is known to occur in" exact="multiple sclerosis" post="(MS) patients early during the disease course. It has"/>
   <result pre="of white matter changes in pediatric monophasic demyelinating disorders and" exact="multiple sclerosis" post="G Longoni 1,2, P Momayyezsiahkal 2, RA Brown 2,"/>
   <result pre="United States Background: In contrast to the multifocal nature of" exact="multiple sclerosis" post="(MS), monophasic acquired demyelinating syndromes (mADS) during childhood may"/>
   <result pre="between pediatric MS and the main mADS presentations (acute disseminated" exact="encephalomyelitis" post="(ADEM), monofocal mADS (mADS m), polyfocal mADS (mADS p),"/>
   <result pre="Background: Chronic black holes (CBHs) indicate irreversible axonal loss in" exact="multiple sclerosis" post="(MS). Objectives: To assess the evolution of gadolinium-enhancing (Gd+)"/>
   <result pre="Ultra-high field MRI of intra- and extra-cellular sodium concentration in" exact="multiple sclerosis" post="M Petracca 1,2, R Teodorescu 1, L Fleysher 3,"/>
   <result pre="Hospitals (UCLH) Biomedical Research Centre, London, United Kingdom Background: In" exact="multiple sclerosis" post="(MS), combined clinical and MRI studies have shown that"/>
   <result pre="the evolution of gadolinium-enhancing (Gd+) lesions into CBHs in relapsing-remitting" exact="multiple sclerosis" post="(RRMS) and secondary progressive multiple sclerosis (SPMS). Methods: The"/>
   <result pre="into CBHs in relapsing-remitting multiple sclerosis (RRMS) and secondary progressive" exact="multiple sclerosis" post="(SPMS). Methods: The PRISMS (RRMS; baseline Expanded Disability Status"/>
   <result pre="P474 Unraveling the neuroimaging markers of motor dysfunction in long-standing" exact="multiple sclerosis" post="M Daams 1,2, MD Steenwijk 1, MP Wattjes 1,"/>
   <result pre="Neurology, Amsterdam, Netherlands Background: Motor dysfunction is well described in" exact="multiple sclerosis" post="(MS) but its pathological substrate is not fully understood."/>
   <result pre="of cortical thickness and cortical lesions with clinical symptoms in" exact="multiple sclerosis" post="K Reuter 1, O Geisseler 1, T Pflugshaupt 1,2,"/>
   <result pre="Institut, Zurich, Switzerland Background: Inflammatory lesions and brain atrophy in" exact="multiple sclerosis" post="(MS) impact the central nervous system white matter as"/>
   <result pre="Bethesda, MD, United States Background: The pathological characteristics of chronic" exact="multiple sclerosis" post="(MS) lesions have been studied extensively. At autopsy, particularly"/>
   <result pre="connectivity of cortical lesions to deep white matter lesions in" exact="multiple sclerosis" post="J-M Tillema 1, S Weigand 2, J Port 3,"/>
   <result pre="a marker and predictor of cognitive function and disability in" exact="multiple sclerosis" post="(MS). Methods: In this longitudinal study, 45 MS patients"/>
   <result pre="P482 Functional and structural connectivity abnormalities underlying clinical disability in" exact="multiple sclerosis" post="E Sbardella 1,2, N Filippi 3, F Tona 1,"/>
   <result pre="matter lesion central veins: an interscanner comparison of patients with" exact="multiple sclerosis" post="and ischemic lesions at 3-Tesla MRI A Samaraweera 1,"/>
   <result pre="3T scanner used. P485 Inflammation does not cause chronic global" exact="neurodegeneration" post="in NMO? A longitudinal multimodel quantitative MRI study comparing"/>
   <result pre="central nervous system lesions are a common feature of both" exact="neuromyelitis optica" post="(NMO) and MS. However accrual of disability in MS"/>
   <result pre="to assess if there is any evidence of progressive, non-lesional" exact="neurodegeneration" post="outside of relapses in NMO as occurs in MS."/>
   <result pre="in MS. If not, this would question the theory that" exact="neurodegeneration" post="occurs as a chronic sequelae to prior inflammatory and"/>
   <result pre="assess whether seropositive NMO is associated with imaging markers of" exact="neurodegeneration" post="over one year. Methods: 18 patients with aquaporin-4 antibody"/>
   <result pre="modalities corroborate to support a lack of non-lesional and progressive" exact="neurodegeneration" post="in NMO, in contrast to MS. The results highlight"/>
   <result pre="of therapies and intervention or track dynamics of disease in" exact="multiple sclerosis" post="(MS). However, to date limited longitudinal data of RS-fMRI"/>
   <result pre="future studies. P487 Functional MRI encoding task for faces in" exact="multiple sclerosis" post="L Vacchi 1, MA Rocca 1,2, GC Riccitelli 1,"/>
   <result pre="associated to poor cognitive outcome. P488 Brain atrophy quantification in" exact="multiple sclerosis" post="S Jain 1, D Smeets 1, DM Sima 1,"/>
   <result pre="the brain has become a standard radiological tool for examining" exact="multiple sclerosis" post="patients. Apart from the presence and location of lesions,"/>
   <result pre="again only with the WM, GM and CSF classes. 20" exact="multiple sclerosis" post="patients participated in a study at VU University Medical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC4244175/results/search/disease/results.xml">
   <result pre="P492 Corpus callosal myelin water fraction and transcallosal inhibition in" exact="multiple sclerosis" post="IM Vavasour 1, EY Zhao 2, MR Borich 3,"/>
   <result pre="fraction (MWF), a marker for central nervous system demyelination in" exact="multiple sclerosis" post="(MS). Transcallosal inhibition (TCI), elicited by transcranial magnetic stimulation"/>
   <result pre="musculature. Single pulses were delivered ipsilaterally to elicit a transient" exact="suppression" post="in the electromyographic activity of the forearm during a"/>
   <result pre="(50% max). The onset latency, duration and depth of this" exact="suppression" post="were used to quantify levels of TCI. Results: TCI"/>
   <result pre="tract pathology, such as traumatic spinal cord injury (SCI) and" exact="neuromyelitis optica" post="(NMO) with extensive spinal cord lesions, gave conflicting results."/>
   <result pre="(SCI and NMO), inflammatory tumour-like lesions (TLL) and relapsing remitting" exact="multiple sclerosis" post="(RRMS) with or without spinal cord lesions. Methods: Fifteen"/>
   <result pre="in RRMS. P494 Characteristic of orbit magnetic resonance imaging in" exact="neuromyelitis optica" post="and multiple sclerosis patients presenting with optic neuritis Y-M"/>
   <result pre="Characteristic of orbit magnetic resonance imaging in neuromyelitis optica and" exact="multiple sclerosis" post="patients presenting with optic neuritis Y-M Lim 1, KM"/>
   <result pre="imaging in neuromyelitis optica and multiple sclerosis patients presenting with" exact="optic neuritis" post="Y-M Lim 1, KM An 1, J Lee 1,"/>
   <result pre="Police Hospital, Neurology, Seoul, Korea, Republic of Background: Patients with" exact="neuromyelitis optica" post="(NMO) and multiple sclerosis (MS) both can present with"/>
   <result pre="Korea, Republic of Background: Patients with neuromyelitis optica (NMO) and" exact="multiple sclerosis" post="(MS) both can present with optic neuritis (ON). There"/>
   <result pre="optica (NMO) and multiple sclerosis (MS) both can present with" exact="optic neuritis" post="(ON). There have been several reports on neuroimaging findings"/>
   <result pre="NMO/NMOSD from MS. P495 High field spinal cord imaging in" exact="multiple sclerosis" post="at 7 Tesla S Pawate 1, A Dula 2,"/>
   <result pre="Amsterdam, Netherlands Background: Both spinal cord and brain atrophy in" exact="neuromyelitis optica" post="(NMO) was reported. However how is the relationship between"/>
   <result pre="with other MRI measurements and clinical disability, compared with well-matched" exact="multiple sclerosis" post="(MS) patients and healthy controls (HC). Methods: We recruited"/>
   <result pre="shift imaging as a sensitive measure of longitudinal changes in" exact="multiple sclerosis" post="lesions V Wiggermann 1,2, E Hernandez-Torres 2,3, IM Vavasour"/>
   <result pre="decrease in frequency at long-term follow up. P500 Distinction between" exact="neuromyelitis optica" post="and multiple sclerosis using multi-voxel pattern classification MA Sahraian"/>
   <result pre="at long-term follow up. P500 Distinction between neuromyelitis optica and" exact="multiple sclerosis" post="using multi-voxel pattern classification MA Sahraian 4, V Wottschel"/>
   <result pre="(NMO) is often the alternative diagnosis in patients misdiagnosed with" exact="multiple sclerosis" post="(MS), because patients with both diseases share some similarities."/>
   <result pre="magnetic resonance imaging (MRI) criteria to support the diagnosis of" exact="multiple sclerosis" post="(MS) are based on dissemination in time (DIT) and"/>
   <result pre="P502 A longitudinal study of spinal cord atrophy in progressive" exact="multiple sclerosis" post="D Plantone 1, H Kearney 1, MC Yiannakas 1,2,"/>
   <result pre="Spinal cord atrophy is strongly associated with physical disability in" exact="multiple sclerosis" post="(MS) and has previously been used as a secondary"/>
   <result pre="Clinical Translational Research Center, Buffalo, NY, United States Background: Although" exact="multiple sclerosis" post="(MS) was originally considered to be a disease affecting"/>
   <result pre="of GM pathology. P504 Microstructural white matter damage in fatigued" exact="multiple sclerosis" post="patients: a DTI-TBSS study A d’Ambrosio 1,2, G Caiazzo"/>
   <result pre="Neurology, St. Louis, MO, United States Background: For many years," exact="multiple sclerosis" post="(MS) has been considered as a &quot;white matter (WM)&quot;"/>
   <result pre="in clinical use. P506 Functional neuroimaging of inattentional blindness in" exact="multiple sclerosis" post="J Ellis 1, K Romero 1, M Theaudin 1,"/>
   <result pre="University, Tel Aviv, Israel Background: Diffusion-tensor imaging (DTI) studies in" exact="multiple sclerosis" post="(MS) reveal white matter (WM) injury with disease progression."/>
   <result pre="time. Objectives: To evaluate microstructural white matter damage in relapsing-remitting" exact="multiple sclerosis" post="(RRMS) as measured by brain DTI in patients with"/>
   <result pre="WM microstructure. P508 Regional cortical thickness in African Americans with" exact="multiple sclerosis" post="M Alkawaz 1, E Monohan 1, JS Perumal 1,"/>
   <result pre="P509 Can we really differentiate spinal cord ischemia from the" exact="myelitis" post="of neuromyelitis optica with MRI in the acute setting?"/>
   <result pre="we really differentiate spinal cord ischemia from the myelitis of" exact="neuromyelitis optica" post="with MRI in the acute setting? E Johnson 1,"/>
   <result pre="United States Background: Both spinal cord infarct and the acute" exact="myelitis" post="associated with Neuromyelitis Optica (NMO) have similar clinical presentations"/>
   <result pre="identify useful distinguishing imaging features for differentiating SCI from NMO" exact="myelitis" post="during an acute clinical presentation. Methods: We used a"/>
   <result pre="in all subjects. Results: The age at presentation for acute" exact="myelitis" post="did not differ between groups (mean 51 yrs, P&amp;gt;0.05),"/>
   <result pre="well as other brain metabolite concentrations, in patients with relapsing" exact="multiple sclerosis" post="(RMS) compared to healthy controls. Methods: 26 RMS subjects"/>
   <result pre="which until recently was considered to be a subtype of" exact="multiple sclerosis" post="(MS). NMO is characterized by episodes of inflammation and"/>
   <result pre="of inflammation and damage to astrocytes that can result in" exact="optic neuritis" post="and myelitis. Unlike MS, the immune attacks in NMO"/>
   <result pre="Resting state fMRI probed as predictor of fatigue symptoms in" exact="multiple sclerosis" post="PG Sämann 1, M Knop 2, S Nischwitz 2,"/>
   <result pre="brain. Objectives: To propose a new approach (SLF) to fill" exact="multiple sclerosis" post="(MS) lesions in T1-w images that overcomes some of"/>
   <result pre="perfusion weighted imaging - a marker of inflammatory activity in" exact="multiple sclerosis?" post="P Sowa 1,2, GO Nygaard 2,3, A Bjørnerud 4,5,"/>
   <result pre="P517 Cellular and microstructural changes due to iron deposition in" exact="multiple sclerosis" post="lesions Y Ge 1, H Sheng 1, S Chawla"/>
   <result pre="tool in detecting iron deposition in many neurological diseases including" exact="multiple sclerosis" post="(MS). Although several studies reported increased iron deposition in"/>
   <result pre="and warrant further investigation. P518 Imaging of brain perfusion in" exact="multiple sclerosis" post="and neurodegenerative disorders: association with endothelial factors. An interim"/>
   <result pre="episodic inflammation in focal lesions resulting in demyelination of axons," exact="neurodegeneration" post="and axonal loss. Conventional magnetic resonance (MR) outcomes correlate"/>
   <result pre="frequency shift imaging demonstrates that iron accumulation is rare in" exact="multiple sclerosis" post="lesions V Wiggermann 1,2, LE Lee 3, E Hernandez-Torres"/>
   <result pre="BC, Canada Background: One of the main radiological signs of" exact="multiple sclerosis" post="(MS) is the appearance of focal lesions due to"/>
   <result pre="MS lesions. P521 Characteristics of patients with MRI-only conversion to" exact="multiple sclerosis" post="after a clinically isolated syndrome WJ Brownlee 1, JK"/>
   <result pre="of these patients satisfy McDonald criteria for a diagnosis of" exact="multiple sclerosis" post="(MS) with MRI, but not clinical evidence of dissemination"/>
   <result pre="impairment in the long term. P522 Discriminative radiological features of" exact="multiple sclerosis" post="and neuromyelitis optica in Chinese patients S Cheng 1,"/>
   <result pre="long term. P522 Discriminative radiological features of multiple sclerosis and" exact="neuromyelitis optica" post="in Chinese patients S Cheng 1, R Li 1,"/>
   <result pre="Hospital, Hong Kong, Hong Kong Background: Multiple sclerosis (MS) and" exact="neuromyelitis optica" post="(NMO) are recognized to be clinically distinct entities which"/>
   <result pre="network (DMN) represent a potential biomarker for clinical disability in" exact="multiple sclerosis" post="(MS). Cortical areas part of the DMN are also"/>
   <result pre="Department, Barcelona, Spain Background: Some of the available treatments for" exact="multiple sclerosis" post="(MS) have demonstrated to improve the curve of brain"/>
   <result pre="brain tissue. Many studies have documented increased T1 associated with" exact="multiple sclerosis" post="(MS) disease progression in normal appearing white and gray"/>
   <result pre="other neurodegenerative diseases. P527 1-H MRSI in patients with relapsing" exact="multiple sclerosis" post="at 7 Tesla Y Li 1, BAC Cree 2,"/>
   <result pre="spectroscopic imaging has the potential to provide mechanistic insights in" exact="multiple sclerosis" post="(MS). With improved detection of myo-Inositol (mI), glutamate (Glu),"/>
   <result pre="lesion evolution. P528 Utilization of routine magnetic resonance imaging in" exact="multiple sclerosis" post="patient management S Cohan 1, C Chen 1, L"/>
   <result pre="MRI in therapeutic decision-making in clinically stable patients with relapsing" exact="multiple sclerosis" post="(RMS), treated with first-line DMT. Methods: A retrospective chart"/>
   <result pre="era of diminishing healthcare resources. P529 Basal ganglia iron in" exact="multiple sclerosis" post="patients measured with 7T quantitative susceptibility mapping (QSM) correlates"/>
   <result pre="Center, Radiology, Seattle, WA, United States Background: Brain atrophy in" exact="multiple sclerosis" post="(MS) occurs at a faster rate than the normal"/>
   <result pre="an association between depression and hippocampal atrophy in patients with" exact="multiple sclerosis" post="(MS). Objectives: Aim of this study was to investigate"/>
   <result pre="(DTI) and magnetization transfer imaging (MTI) are increasingly utilized in" exact="multiple sclerosis" post="(MS) clinical trials. The relationship between these MRI measures"/>
   <result pre="a mouse model of inflammatory cerebral demyelination. Methods: Experimental autoimmune" exact="encephalomyelitis" post="(EAE) was induced in C57BL/6 mice (n=12) using MOG"/>
   <result pre="use of imaging biomarkers in MS clinical development. P534 Automatic" exact="multiple sclerosis" post="brain lesion localisation and volumetry S Jain 1, D"/>
   <result pre="(MRI) are important criteria for diagnosis, follow-up and prognosis of" exact="multiple sclerosis." post="Quantitative values such as lesion volumetry are expected to"/>
   <result pre="prior knowledge that lesions appear hyperintense on FLAIR images. 20" exact="multiple sclerosis" post="patients participated in a study at VU University Medical"/>
   <result pre="Disruption of brain functional reorganization leads to disability progression in" exact="multiple sclerosis" post="A Faivre 1, E Robinet 1, C Rousseau 1,"/>
   <result pre="have demonstrated consistent reorganization of brain networks in patients with" exact="multiple sclerosis" post="(MS), with complex relationships with disability. Objectives: We aimed"/>
   <result pre="PSIR images improve detection and classification of cortical lesions in" exact="multiple sclerosis" post="and clinically isolated syndromes A Favaretto 1, D Poggiali"/>
   <result pre="Cortical gray matter lesions (CL) constitute a relevant aspect of" exact="multiple sclerosis" post="(MS) pathology. Studies based on double inversion recovery (DIR)"/>
   <result pre="Compensatory remapping of fMRI functional connectivity during resting state in" exact="multiple sclerosis" post="S-J Lin 1, A Liu 2, ZJ Wang 2,"/>
   <result pre="Altered functional connectivity appears to be a robust feature in" exact="multiple sclerosis" post="(MS). Compensatory mechanisms, whereby functional connectivity between brain regions"/>
   <result pre="robust alterations in fMRI connectivity patterns in patients with relapsing" exact="multiple sclerosis" post="(RMS) compared to age and gender matched healthy controls."/>
   <result pre="pathways. P539 Permeability of the blood-brain barrier predicts conversion from" exact="optic neuritis" post="to multiple sclerosis SP Cramer 1,2, HJ Simonsen 1,"/>
   <result pre="of the blood-brain barrier predicts conversion from optic neuritis to" exact="multiple sclerosis" post="SP Cramer 1,2, HJ Simonsen 1, JL Frederiksen 2,"/>
   <result pre="(BBB) in normal appearing white matter (NAWM) in patients with" exact="multiple sclerosis" post="(Cramer et al. 2013). 50% of patients with Optic"/>
   <result pre="conspicuity between two contrast-enhanced T1-weighted sequences in the detection of" exact="multiple sclerosis" post="lesions with 3.0T MRI F-X Aymerich 1, C Auger"/>
   <result pre="spin-echo (SE) is the sequence of choice to detect enhancing" exact="multiple sclerosis" post="(MS) lesions with 3.0T MRI. Objectives: The aim of"/>
   <result pre="inter-hemispheric functional connectivity is related to clinical measures of disabilityin" exact="multiple sclerosis" post="DA Boratyn 1, SA Tobyne 1, EC Klawiter 2,3"/>
   <result pre="in somatomotor and visual cortices in healthy controls (HC). In" exact="multiple sclerosis" post="(MS), studies have largely examined inter-hemispheric connectivity of a"/>
   <result pre="Central and peripheral alterations in glucose uptake in patients with" exact="multiple sclerosis" post="during treadmill walking JH Kindred 1, JR Hebert 2,"/>
   <result pre="Department of Statistics, Coventry, United Kingdom Background: The assessment of" exact="multiple sclerosis" post="(MS) is largely based on clinical scores and only"/>
   <result pre="are influenced by the degree of cervical spine involvement in" exact="multiple sclerosis" post="LH Hua 1, SL Donlon 2, MJ Sobhanian 3,"/>
   <result pre="as a marker for disease progression in patients with relapsing-remitting" exact="multiple sclerosis" post="using magnetic resonance spectroscopic imaging V Fleischer 1, R"/>
   <result pre="Germany Background: Magnetic resonance spectroscopic imaging (MRSI) in patients with" exact="multiple sclerosis" post="(MS) offers the possibility to detect metabolic alterations in"/>
   <result pre="with the progressive neurological disability. The relation between inflammation and" exact="neurodegeneration" post="is currently intensively debated and, at later stages of"/>
   <result pre="States Background: Vitamin D deficiency is a risk factor for" exact="multiple sclerosis" post="(MS). Low vitamin D levels are associated with increased"/>
   <result pre="D might play a role in grey matter atrophy and" exact="neurodegeneration" post="in MS. The lack of correlations in the RRMS"/>
   <result pre="examined evolution of iron deposition on susceptibility-weighted imaging (SWI) in" exact="multiple sclerosis" post="(MS) patients. Objectives: To explore whether treatment with glatiramer"/>
   <result pre="patients. P552 Cortical and subcortical volume dynamics in active relapsing-remitting" exact="multiple sclerosis" post="patients treated with in Fingolimod (Gilenya) A Achiron 1,2,"/>
   <result pre="Neuroradiology, Ramat Gan, Israel Background: Morphometric brain changes in relapsing-remitting" exact="multiple sclerosis" post="(RRMS) include alterations in the volume of subcortical regions,"/>
   <result pre="one year of treatment. P553 Perfusion and diffusion changes in" exact="multiple sclerosis" post="lesions and correlation with brain atrophy and clinical disability"/>
   <result pre="Detroit, MI, United States Background: Although the pathogenesis of the" exact="multiple sclerosis" post="(MS) is not yet fully understood, it has been"/>
   <result pre="connectivity is related to atrophy of the corpus callosum in" exact="multiple sclerosis" post="S Tobyne 1, D Boratyn 1, EC Klawiter 1"/>
   <result pre="(CC) is a hallmark feature of white matter pathology in" exact="multiple sclerosis" post="(MS). Degeneration of the CC is hypothesized to impair"/>
   <result pre="RRMS. P555 Imaging myelin pathology in the gray matter in" exact="multiple sclerosis" post="Y Wang 1, C Wu 1, J Zhu 1,"/>
   <result pre="Reserve University, Cleveland, OH, United States Background: Clinical disability in" exact="multiple sclerosis" post="(MS) is often associated with distinct myelin pathology in"/>
   <result pre="P556 Sex differences in brain glucose uptake in patients with" exact="multiple sclerosis" post="during walking JR Hebert 1, JH Kindred 2, M"/>
   <result pre="CD8+ T cells and CD19+ B cells isolated from relapsing/remitting" exact="multiple sclerosis" post="patients MC Graves 1, M Benton 2, R Lea"/>
   <result pre="lymphocytes has not been assessed. The development and progression of" exact="multiple sclerosis" post="result in part from the balance between effector and"/>
   <result pre="differentiation and is instrumental in prevention of autoimmune diseases and" exact="multiple sclerosis." post="We further demonstrated that 25-OHC prevented T R1 cell"/>
   <result pre="for Neurologic Diseases, Boston, MA, United States Background: Experimental autoimmune" exact="encephalomyelitis" post="(EAE) induced by myelin protein peptides serves as the"/>
   <result pre="cells. P563 Identification of a key role for complement in" exact="neurodegeneration" post="in multiple sclerosis I Huitinga 1, I Michailidou 2,"/>
   <result pre="Identification of a key role for complement in neurodegeneration in" exact="multiple sclerosis" post="I Huitinga 1, I Michailidou 2, M van Strien"/>
   <result pre="and axons is a main cause of clinical disability in" exact="multiple sclerosis" post="(MS) but the mechanisms responsible for neurodegeneration are largely"/>
   <result pre="disability in multiple sclerosis (MS) but the mechanisms responsible for" exact="neurodegeneration" post="are largely unknown. A number of studies suggest that"/>
   <result pre="recent identification of the association between complement genetic variants and" exact="neurodegeneration" post="in classical neurodegenerative diseases, led to our hypothesis that"/>
   <result pre="complement components and regulators in post-mortem brainstem tissue from progressive" exact="multiple sclerosis" post="donors, in relation to neuropathological changes, and compared the"/>
   <result pre="neurons, subsequent clinical disability and neuropathology in the experimental autoimmune" exact="encephalomyelitis" post="(EAE) model of MS. In addition, pharmacological inhibition of"/>
   <result pre="in MS grey matter and plays a key role in" exact="neurodegeneration" post="in models and man. P564 Intrathecal Epstein-Barr virus specific"/>
   <result pre="man. P564 Intrathecal Epstein-Barr virus specific CD8 T-cell responses in" exact="multiple sclerosis" post="patients are directed to lytic viral antigens GP van"/>
   <result pre="interferon-beta and inhibits IL-12 expression: a novel immunomodulatory mechanism in" exact="multiple sclerosis" post="LL Aung 1, V Bhise 1, S Dhib-Jalbut 1,"/>
   <result pre="of human Th17 subsets in healthy subjects and patients with" exact="multiple sclerosis" post="D Hu 1, N Pochet 1, R Cialic 1,"/>
   <result pre="Multiple Sclerosis (MS) is a chronic central nervous system (CNS)" exact="autoimmune disease" post="in which proinflammatory Th17 cells are increased. Recent studies"/>
   <result pre="the pathogenicity of the cells. P567 The immunological architecture of" exact="multiple sclerosis" post="and treatment J Dooley 1,2, I Pauwels 3, D"/>
   <result pre="importance of the adaptive immune system in the development of" exact="multiple sclerosis." post="However in-depth analysis of the role of the adaptive"/>
   <result pre="the adaptive immune system in the development and resolution of" exact="autoimmune disease" post="in human patients has proven to be difficult due"/>
   <result pre="have applied a systems immunology approach to the study of" exact="multiple sclerosis" post="(MS) and for comparison another autoimmune disorder, autoimmune thyroid"/>
   <result pre="multiple sclerosis (MS) and for comparison another autoimmune disorder, autoimmune" exact="thyroid disease" post="(AITD), to identify unique immunological signatures of disease and"/>
   <result pre="of 38 variables covering the adaptive immune system in 219" exact="autoimmune disease" post="patient samples (MS: N=164, AITD: N=55) and 36 healthy"/>
   <result pre="well as promoted CNS T cell immune modulation in the" exact="multiple sclerosis" post="(MS) model, experimental autoimmune encephalomyelitis (EAE) (Benkhoucha M. et"/>
   <result pre="immune modulation in the multiple sclerosis (MS) model, experimental autoimmune" exact="encephalomyelitis" post="(EAE) (Benkhoucha M. et al., PNAS, 2010). We showed"/>
   <result pre="Our results identify GILZ as a critical factor for effective" exact="suppression" post="of T-cell-mediated CNS inflammation by HGF via the induction"/>
   <result pre="of Pathology, Shanghai, China Background: Multiple sclerosis (MS) is an" exact="autoimmune disease" post="of the CNS characterized by a CD4+ Th1 lymphocyte-mediated"/>
   <result pre="by myelin oligodendrocyte glycoprotein (MOG 35-55) to induce experimental autoimmune" exact="encephalomyelitis" post="(EAE) and then given CGS21680 by i.p. daily. Neurological"/>
   <result pre="Autoreactive CD4 +T cells are important in the pathogenesis of" exact="multiple sclerosis" post="(MS). CD4 +T cells can be classified into six"/>
   <result pre="of early response to toll-like receptor 7 agonist stimulation in" exact="multiple sclerosis" post="patients MP Mycko 1, H Cwiklinska 1, M Cichalewska"/>
   <result pre="autoimmune demyelination. Methods: We studied function of pDCs in relapsing-remitting" exact="multiple sclerosis" post="(RRMS; n=32) patients and controls (n= 33) by analysis"/>
   <result pre="mechanisms of MS. P574 Neuroprotective effects of calcitriol in autoimmune" exact="optic neuritis" post="K-W Sühs 1, K Pars 1, SK Williams 2,"/>
   <result pre="form of vitamin D 3, in a rat model of" exact="optic neuritis," post="using myelin oligodendrocyte glycoprotein (MOG) induced experimental autoimmune encephalomyelitis"/>
   <result pre="optic neuritis, using myelin oligodendrocyte glycoprotein (MOG) induced experimental autoimmune" exact="encephalomyelitis" post="(EAE). Methods: RGCs were retrogradly labelled by stereotactical fluorogold"/>
   <result pre="P576 Immune cells in the diffusely abnormal white matter of" exact="multiple sclerosis" post="C Laule 1,2,3, V Pavlova 2, E Leung 2,"/>
   <result pre="useful for demonstrating areas of damage which can occur in" exact="multiple sclerosis" post="(MS) brain. Diffusely-abnormal white matter (DAWM) exhibits a signal"/>
   <result pre="P577 Interleukin-1β activates the apoptotic protein p53 to cause excitotoxic" exact="neurodegeneration" post="and disease progression in multiple sclerosis S Rossi 1,2,"/>
   <result pre="protein p53 to cause excitotoxic neurodegeneration and disease progression in" exact="multiple sclerosis" post="S Rossi 1,2, V Studer 1,2, C Motta 1,2,"/>
   <result pre="apoptotic pathways. Apoptosis and excitotoxcicity are proposed as determinants of" exact="neurodegeneration" post="in many neurological diseases and could be the link"/>
   <result pre="neurological diseases and could be the link between neuroinflammation and" exact="neurodegeneration" post="in multiple sclerosis (MS). Objectives: To investigate the role"/>
   <result pre="and could be the link between neuroinflammation and neurodegeneration in" exact="multiple sclerosis" post="(MS). Objectives: To investigate the role of the apoptotic"/>
   <result pre="damage was modulated by p53 genotype. Conclusions: Inflammatory synaptopathy and" exact="neurodegeneration" post="caused by IL-1β in RRMS patients involve the apoptotic"/>
   <result pre="to intrathecal antibodies in the cerebrospinal fluid of patients with" exact="multiple sclerosis" post="H Collins 1, D Gunaydin 1, K Tamanito 1,"/>
   <result pre="response are unknown. The risk of MS is increased after" exact="infectious mononucleosis," post="and MS patients have higher serum titers of EBV"/>
   <result pre="1 1Université de Montréal, CRCHUM, Montréal, QC, Canada Background: In" exact="multiple sclerosis" post="(MS), CD4 + T helper (TH) cells are of"/>
   <result pre="ephrin/Eph system in MS and its animal model, experimental autoimmune" exact="encephalomyelitis" post="(EAE), specifically in the pathogenicity and migration potential of"/>
   <result pre="Münster, Germany Background: CD8+ T cells are frequently found in" exact="multiple sclerosis" post="lesions, however their precise influence on disease pathology is"/>
   <result pre="T cells in C57/Bl6 mice and induced active experimental autoimmune" exact="encephalomyelitis" post="(EAE) by immunization with MOG 33-55 after a reconstitution"/>
   <result pre="leading to a selective enrichment of OT-1 in experimental autoimmune" exact="encephalomyelitis" post="lesions. However, the myelin-recognition of CD8+ T cells in"/>
   <result pre="a clinically significant manner. P583 Mucosal associated invariant T-cells from" exact="multiple sclerosis" post="patients are effector cells with increased activation and homing"/>
   <result pre="allow further characterization in MS lesions. P584 Metabolic syndrome and" exact="multiple sclerosis." post="Metformin and thioazolinediones activate different immunomodulatory pathways J Correale"/>
   <result pre="thioazolinediones on immune regulation in obese MS patients who developed" exact="metabolic syndrome" post="Methods: Twenty obese patients with diagnosis of relapsing remitting"/>
   <result pre="patients with diagnosis of relapsing remitting MS, who also developed" exact="metabolic syndrome," post="were studied. Fourteen patients received metformin and 6 patients"/>
   <result pre="P585 Amino acid catabolism is altered in immune cells from" exact="multiple sclerosis" post="patients J Correale 1, MF Farez 1 1Institute for"/>
   <result pre="preventing autoimmunity, whereas increased AA catalytic activity may reinforce immune" exact="suppression" post="promoting pathogen persistence and chronic infection. Objectives: To evaluate"/>
   <result pre="in the therapeutic effect of glatiramer acetate in experimental autoimmune" exact="encephalomyelitis" post="R Aharoni 1, T Feferman 1, DD Bar Lev"/>
   <result pre="Glatiramer acetate (GA), a therapeutic agent for the treatment of" exact="multiple sclerosis" post="(MS), induces a broad immunomodulatory effect on various subsets"/>
   <result pre="the therapeutic activity of GA in the animal model of" exact="multiple sclerosis" post="- experimental autoimmune encephalomyelitis (EAE). Methods: Tregs were identified"/>
   <result pre="in the animal model of multiple sclerosis - experimental autoimmune" exact="encephalomyelitis" post="(EAE). Methods: Tregs were identified immunohistochemically in the CNS"/>
   <result pre="was tested in Foxp3GFPLuciDTR-4 transgenic mice, in which Tregs express" exact="diphtheria" post="toxin (DT) receptor, thus facilitating their selective depletion by"/>
   <result pre="in leukocytes in active lesions in MS and experimental autoimmune" exact="encephalomyelitis" post="(EAE) (Brain 136:1760, 2013). Furthermore, anti-EMMPRIN antibodies reduced the"/>
   <result pre="the animal model of Multiple Sclerosis (MS), i.e. experimental autoimmune" exact="encephalomyelitis" post="(EAE). Methods: We evaluated the effects of genetic ablation"/>
   <result pre="Tc17 and mucosal-associated invariant T cells in treated and untreated" exact="multiple sclerosis" post="patients L Negrotto 1, E Cantó 1, M Tintoré"/>
   <result pre="Spain Background: Th17 cells are important in the immunopathogenesis of" exact="multiple sclerosis" post="(MS). However, IL-17 production is not limited to CD4+"/>
   <result pre="of these therapies in MS. P590 Altered glycosylation patterns during" exact="multiple sclerosis" post="generate neo-autoantigens D Lefranc 1, B Oxombre 1, M"/>
   <result pre="of myeloid dendritic cells in peripheral blood of patients with" exact="multiple sclerosis" post="B Wildemann 1, A Schwarz 1, M Korporal-Kuhnke 1,"/>
   <result pre="the impaired development of regulatory T cells in patients with" exact="multiple sclerosis." post="P593 c-Myc activity in T-cells is critical for autoimmune"/>
   <result pre="copper. P595 Principal component analysis allows to cluster patients with" exact="multiple sclerosis" post="on the basis of different subsets of CD8+ and"/>
   <result pre="vary during autoimmune diseases. Increased serum concentration of IL-18 in" exact="multiple sclerosis" post="(MS) was previously shown. Objectives: to evaluate the level"/>
   <result pre="role of endogenous interferon-beta in the pathogenesis of relapsing remitting" exact="multiple sclerosis" post="X Zhang 1, Y Tao 1, S Markovic-Plese 1"/>
   <result pre="role of endogenous IFNb in the pathogenesis of relapsing remitting" exact="multiple sclerosis" post="(RRMS). Objectives: To investigate the role of endogenous IFNb"/>
   <result pre="(CNS) in the animal model of MS, i.e. experimental autoimmune" exact="encephalomyelitis" post="(EAE). Objectives: As the influence of NaCl on macrophages"/>
   <result pre="P599 Suppression of IL-10 production by calcitriol in patients with" exact="multiple sclerosis" post="M Niino 1, T Fukazawa 2, Y Miyazaki 3,"/>
   <result pre="Medical Center, Department of Neurology, Sapporo, Japan Background: Risk for" exact="multiple sclerosis" post="(MS) was found to decrease significantly with increasing serum"/>
   <result pre="Disability Status Scale (EDSS) scores, which means that stronger calcitriol-dependent" exact="suppression" post="of IL-10 was associated with higher EDSS score. Conclusions:"/>
   <result pre="brand Copaxone® (glatiramer acetate injection) in an animal model of" exact="multiple sclerosis" post="C Honan 1, TC Ganguly 1, I Fier 1,"/>
   <result pre="a generic version of Copaxone® for the treatment of relapsing-remitting" exact="multiple sclerosis" post="(RRMS) and is under FDA review. Equivalence between M356"/>
   <result pre="and Copaxone® by using several variants of the experimental autoimmune" exact="encephalomyelitis" post="(EAE) model, a longstanding and widely-used model of MS."/>
   <result pre="of Th1 cells, Th2 cells or macrophage/monocytes (M/M1). Experimental allergic" exact="encephalomyelitis" post="(EAE) was induced in mice by immunization with myelin-oligodendrocyte"/>
   <result pre="and spinal cords of mice with EAE, a model of" exact="multiple sclerosis" post="(MS). In glial cultures, FAT10 message was upregulated 600-fold"/>
   <result pre="treatment on lymphocyte subpopulations and S1P-dependent migration in patients with" exact="multiple sclerosis" post="T Hottenrott 1, H Sic 2, H Eibel 2,"/>
   <result pre="in all types of immune response including autoimmune diseases like" exact="multiple sclerosis" post="(MS). Lymphocyte egress from lymphoid tissue into the blood"/>
   <result pre="and fingolimod (FTY) are two efficacious treatment options in relapsing-remitting" exact="multiple sclerosis" post="(MS). NZB blocks alpha-4-associated extravasation whereas the main effector"/>
   <result pre="candidates involved in immunomodulatory processes in therapy and pathomechanism of" exact="multiple sclerosis" post="MJ Knop 1, S Nischwitz 2, H Faber 1,"/>
   <result pre="the expression of Th17-related genes on circulating CD4+ T-cells after" exact="multiple sclerosis" post="relapse C de Andres 1,2, MI Garcia 2, A"/>
   <result pre="T cell population in the Central Nervous System (CNS) in" exact="multiple sclerosis" post="(MS) lesions. However, no Th17 biomarkers have been consistently"/>
   <result pre="P606 Using social media for large-scale recruitment in a prospective" exact="multiple sclerosis" post="(MS) inception cohort: the genes and environment in MS"/>
   <result pre="global analysis of the use of social media to discuss" exact="multiple sclerosis" post="J Pakpoor 1, S Nyein 2, G Disanto 3,"/>
   <result pre="sites than any other type of site. Individuals affected by" exact="multiple sclerosis" post="(MS) and MS related organisations use social media to"/>
   <result pre="episodes or accumulate clinically silent MRI lesions, raising concern for" exact="multiple sclerosis" post="(MS) or neuromyelitis optica (NMO). As treatments differ, it"/>
   <result pre="silent MRI lesions, raising concern for multiple sclerosis (MS) or" exact="neuromyelitis optica" post="(NMO). As treatments differ, it is critical to distinguish"/>
   <result pre="implementing a blog, as a tool for better interaction between" exact="multiple sclerosis" post="patients and their doctors JD Steinberg 1, MC Curbelo"/>
   <result pre="and reviews. Surveys: physical/work or therapy access, sleep diseases, nutrition/dietary," exact="sexual dysfunction." post="The blog is fully in Spanish with Google translator."/>
   <result pre="modified by Candida kefyr reduces the susceptibility to experimental autoimmune" exact="encephalomyelitis" post="K Takata 1, T Tomita 2, T Koda 1,"/>
   <result pre="to examine the effects of dietary yeast on experimental autoimmune" exact="encephalomyelitis" post="(EAE). Methods: We chose 11 kinds of yeast which"/>
   <result pre="and immune- mediated CNS demyelination has shed light on human" exact="multiple sclerosis" post="etiology and clinical utilization of microbiota products. We have"/>
   <result pre="gut symbiont strain Bacteroides fragilis, protects against murine experimental autoimmune" exact="encephalomyelitis" post="(EAE) via TLR2 both prophylactically and therapeutically. TLR2 signaling"/>
   <result pre="both prophylactically and therapeutically. TLR2 signaling is critical for PSA-mediated" exact="suppression" post="of CNS inflammation and anatomically localized expansion of CD39"/>
   <result pre="P616 Gut microbiome is linked to immune cell phenotype in" exact="multiple sclerosis" post="R Gandhi 1, FV Glehn 1, MA Mazzola 1,"/>
   <result pre="derived from the gut microbiome in the treatment of human" exact="multiple sclerosis" post="(MS). P618 The MS Microbiome Consortium (MSMC): an academic"/>
   <result pre="with development or severity of Crohn’s disease, type I diabetes," exact="obesity" post="and autism. Objectives: To develop a multi-Center academic consortium"/>
   <result pre="P620 Expression profiles of inflammation associated microRNAs in astrocytes from" exact="multiple sclerosis" post="lesions VTS Rao 1, SC Fuh 1, CS Moore"/>
   <result pre="of new treatment paradigms to repair myelin in patients with" exact="multiple sclerosis" post="(MS). Agents which can promote oligodendrocyte precursor cell (OPC)"/>
   <result pre="of KIR4.1 in glia cells affects binding of autoantibodies in" exact="multiple sclerosis" post="R Srivastava 1, SR Kalluri 1, Y Schäfer 1,"/>
   <result pre="(KIR4.1) specific serum antibodies were reported in a sub-population of" exact="multiple sclerosis" post="(MS) patients. KIR4.1 is a glycosylated channel protein expressed"/>
   <result pre="Oligodendrocyte injury and inflammatory demyelination are important pathological abnormalities of" exact="multiple sclerosis" post="(MS) as well as in its animal model, the"/>
   <result pre="as well as in its animal model, the experimental autoimmune" exact="encephalomyelitis" post="(EAE). Emerging evidence over the last decade suggests that"/>
   <result pre="methylation sensitive PCR. Further, in-vitro studies have shown that human" exact="oligodendroglioma" post="(HOG) cells treated with cytokines caused cell death. We"/>
   <result pre="States Background: Excessive extracellular matrix (ECM) deposition in active demyelinating" exact="multiple sclerosis" post="(MS) lesions may impede axonal regeneration and can modify"/>
   <result pre="Molecular Science, Melbourne, Australia Background: Evidence from the experimental autoimmune" exact="encephalomyelitis" post="(EAE) model reveals a nonimmunological effect of the sphingosine-1"/>
   <result pre="treatment for various autoimmune conditions, treatment trials of IVIG for" exact="multiple sclerosis," post="using varying doses of IVIG, yielded controversial results. Objectives:"/>
   <result pre="entities. P632 Plasmablasts as AQP4-Ab producers in the pathogenesis of" exact="neuromyelitis optica" post="N Chihara 1,2,3, T Aranami 1,4, S Oki 1,"/>
   <result pre="of the central nervous system characterized by recurrent attacks of" exact="optic neuritis" post="and myelitis. Although the probable autoantigen aquaporin-4 (AQP4) is"/>
   <result pre="blood of healthy subjects or patients with NMO who received" exact="influenza" post="vaccination. The frequency of plasmablasts in a portion of"/>
   <result pre="in a portion of patients with NMO who received H1N1" exact="influenza" post="vaccination were elevated from the baseline for more than"/>
   <result pre="to target PBs and their migration. P633 Neuropsychiatric features of" exact="neuromyelitis optica" post="P Moore 1, A Methley 1, C Pollard 1,"/>
   <result pre="-1.5SD). 31.3% of participants met diagnostic criteria for a current" exact="anxiety disorder" post="and 16.7% for current depression. Lifetime prevalence of depression"/>
   <result pre="including age, disease duration, EDSS, or presence of depression or" exact="anxiety disorder." post="Conclusions: Evidence of at least mild impairment in cognitive"/>
   <result pre="therapy. P635 HLA class 11 alleles and environmental associations with" exact="neuromyelitis optica" post="in Indian population L Pandit 1, C Malli 1,"/>
   <result pre="is unclear whether there are genetic and environmental associations with" exact="neuromyelitis optica" post="(NMO) particularly in Indian population. Objectives: To determine HLA"/>
   <result pre="They included NMO diagnosed by Wingerchuck 2006 criteria (61), recurrent" exact="myelitis" post="with long cord lesions (11), recurrent optic neuritis (20)"/>
   <result pre="criteria (61), recurrent myelitis with long cord lesions (11), recurrent" exact="optic neuritis" post="(20) and sero positive recurrent tumefactive demyelination (1). DRB1&amp;amp;"/>
   <result pre="CD56 high NK cells and activated Treg-cells in patient with" exact="neuromyelitis optica" post="after treatment with anti-IL-6R antibody tocilizumab T Matsuoka 1,"/>
   <result pre="Medicine, Immunology, Tokyo, Japan Background: Neuromyelitis optica (NMO) is an" exact="autoimmune disease" post="of the central nervous system, accompanying elevation of pathogenic"/>
   <result pre="Evaluation of treatment response to plasmapheresis in acute exacerbations of" exact="neuromyelitis optica" post="GES Linhares 1, SLA Pereira 1, FMH Jorge 1,"/>
   <result pre="Paulo, Neurology, São Paulo, Brazil Background: Neuromyelitis optica is an" exact="autoimmune disease" post="of the central nervous system that presents predominantly with"/>
   <result pre="disease of the central nervous system that presents predominantly with" exact="optic neuritis" post="(ON) and myelitis. The association of the IgG class"/>
   <result pre="cord atrophy and 3rd. ventricle widening to clinical disability in" exact="neuromyelitis optica" post="R Schneider 1, B Bellenberg 2, F Weiler 3,"/>
   <result pre="Bremen, Germany Background: Neuromyelitis optica (NMO) can present similarly to" exact="multiple sclerosis" post="(MS) and involvement of the cervical cord is common"/>
   <result pre="the pathologic processes in NMO patients. P639 Neuromyelitis optica and" exact="neuromyelitis optica" post="spectrum disorder patients in Turkish cohort: demographic, clinical, laboratory"/>
   <result pre="as follows: Classical NMO, Single or recurrent attacks of transverse" exact="myelitis" post="with longitudinally extending spinal cord lesions (LETM), Recurrent optic"/>
   <result pre="transverse myelitis with longitudinally extending spinal cord lesions (LETM), Recurrent" exact="optic neuritis" post="(ON) with normal brain MRI or cranial MRI lesions"/>
   <result pre="normal brain MRI or cranial MRI lesions not compatible with" exact="multiple sclerosis" post="(MS), Optico-spinal MS (OSMS), ON or TM accompanying systemic"/>
   <result pre="the LETM group with respect to classical NMO and recurrent" exact="optic neuritis" post="(0.70±1.73 vs 0.17±0.34 and 0.08±0.12). The mean EDSS and"/>
   <result pre="the more severe disability in NMO/NMOSD patients presenting with transverse" exact="myelitis" post="and late onset subgroups. P640 Therapy of neuromyelitis optica"/>
   <result pre="with transverse myelitis and late onset subgroups. P640 Therapy of" exact="neuromyelitis optica" post="exacerbations: a retrospective evaluation of 840 episodes with 1168"/>
   <result pre="(NMOSD) typically take a relapsing disease course. In comparison to" exact="multiple sclerosis," post="exacerbations are often more severe, respond less to therapy"/>
   <result pre="rate was 1.06 (95% CI 0.96-1.12). 150 patients had ≥1" exact="optic neuritis" post="(ON) and 179 patients had ≥1 myelitis (MY). Episodes"/>
   <result pre="had ≥1 optic neuritis (ON) and 179 patients had ≥1" exact="myelitis" post="(MY). Episodes of isolated MY (59%) were more frequent"/>
   <result pre="Clinical and radiological profiles of anterior visual pathway involvement in" exact="neuromyelitis optica" post="I Kawachi 1, A Yokoseki 1, E Saji 1,"/>
   <result pre="pathway is a frequent site of injury, as shown by" exact="optic neuritis" post="(ON) during the course of neuromyelitis optica (NMO); however,"/>
   <result pre="as shown by optic neuritis (ON) during the course of" exact="neuromyelitis optica" post="(NMO); however, the details of pathomechanism in ON of"/>
   <result pre="that in NMOsd spinal cords. P642 Factor H autoantibodies in" exact="neuromyelitis optica" post="B Uzonyi 1, M Jozsi 1, Z Illes 2,3"/>
   <result pre="P643 Retrospective review of optimal treatment for acute relapses in" exact="neuromyelitis optica" post="H Abboud 1, M Mealy 2, S Sasidharan 2,"/>
   <result pre="Medical Center, Neurology, Baltimore, MD, United States Background: Patients with" exact="neuromyelitis optica" post="(NMO) are known to suffer from severe relapses that"/>
   <result pre="IVMP + PLEX in the treatment of acute relapses in" exact="neuromyelitis optica" post="(NMO). Methods: We conducted a retrospective review of 85"/>
   <result pre="with confirmed acute relapses of transverse myelitis, brainstem lesions and/or" exact="optic neuritis" post="treated with either high dose IVMP alone versus high"/>
   <result pre="is insufficient. P644 Pathological study of tumefactive brain lesions in" exact="neuromyelitis optica" post="Y Chang 1, W Qiu 1, B Zhang 1,"/>
   <result pre="may benefit the tumefactive brain lesion patients. P645 Is late-onset" exact="neuromyelitis optica" post="spectrum disorder associated with a worse outcome? H-J Cho"/>
   <result pre="aquaporin-4 (AQP4-ab) has been able to broaden this disease category;" exact="neuromyelitis optica" post="spectrum disorders (NMOSD). Recent studies suggested that the age"/>
   <result pre="needed. P646 Presence of HLA DR10 in Mexican patients with" exact="neuromyelitis optica" post="(Devic’s disease) J Flores 1, V Rivas 1, Y"/>
   <result pre="are attended for other diagnoses no including MS or another" exact="autoimmune disease." post="The samples in the laboratory following standardized procedures. The"/>
   <result pre="allele has been described in other autoimmune diseases such as" exact="rheumatoid arthritis" post="and it seems to be protective for MS in"/>
   <result pre="has been described in other autoimmune diseases such as rheumatoid" exact="arthritis" post="and it seems to be protective for MS in"/>
   <result pre="DRB1*15. P647 The plasma antiaquaporin antibodies and the outcome of" exact="myelitis" post="in neuromyelitis optica and neuromyelitis optica spectrum disorders: any"/>
   <result pre="The plasma antiaquaporin antibodies and the outcome of myelitis in" exact="neuromyelitis optica" post="and neuromyelitis optica spectrum disorders: any relationship? E Idiman"/>
   <result pre="antibodies and the outcome of myelitis in neuromyelitis optica and" exact="neuromyelitis optica" post="spectrum disorders: any relationship? E Idiman 1, F Idiman"/>
   <result pre="3Dokuz Eylul University, Oncology, Izmir, Turkey Background: Some patients with" exact="neuromyelitis optica" post="(NMO) and NMO spectrum disorders (NMOSD) have similar clinical"/>
   <result pre="AQP4 antibody has a relationship with the prognosis of transverse" exact="myelitis" post="in terms of motor disability. Methods: Sera of 34"/>
   <result pre="patients with NMO (n=27) and NMOSD with isolated or recurrent" exact="myelitis" post="(n=7) were all investigated for the presence of AQP4"/>
   <result pre="antibody-positive patients show significantly older disease onset. The outcome of" exact="myelitis" post="in terms of motor disability was similar in both"/>
   <result pre="anti-AQP4 antibody-positive and negative patients. P648 Autoantibodies in patients with" exact="neuromyelitis optica" post="WLCJ Pereira 1, AP Kallaur 1, SR Oliveira 1,"/>
   <result pre="2 years, p=0.0240). Although patients presented others autoimmune diseases (systemic" exact="lupus erythematosus," post="systemic sclerosis, juvenile rheumatoid arthritis, hypothyroidism, hyperthyroidism and Raynaud’s"/>
   <result pre="presented others autoimmune diseases (systemic lupus erythematosus, systemic sclerosis, juvenile" exact="rheumatoid arthritis," post="hypothyroidism, hyperthyroidism and Raynaud’s phenomenon), no statistically significant differences"/>
   <result pre="diseases (systemic lupus erythematosus, systemic sclerosis, juvenile rheumatoid arthritis, hypothyroidism," exact="hyperthyroidism" post="and Raynaud’s phenomenon), no statistically significant differences were found"/>
   <result pre="Cheshire, CT, United States Background: Due to the rarity of" exact="neuromyelitis optica" post="(NMO) the prognosis on and off treatment is unclear."/>
   <result pre="and 13 mixed race /other. Only 3.6% had both transverse" exact="myelitis" post="(TM) and optic neuritis at onset. The median time"/>
   <result pre="race /other. Only 3.6% had both transverse myelitis (TM) and" exact="optic neuritis" post="at onset. The median time from onset to diagnosis"/>
   <result pre="age and attack type. P650 Magnetic resonance imaging features of" exact="optic neuritis" post="distinguishing neuromyelitis optica from multiple sclerosis HY Shin 1,"/>
   <result pre="type. P650 Magnetic resonance imaging features of optic neuritis distinguishing" exact="neuromyelitis optica" post="from multiple sclerosis HY Shin 1, NY Shin 2,"/>
   <result pre="resonance imaging features of optic neuritis distinguishing neuromyelitis optica from" exact="multiple sclerosis" post="HY Shin 1, NY Shin 2, M Park 2,"/>
   <result pre="Background: Optic neuritis (ON) may be the initial manifestations of" exact="multiple sclerosis" post="(MS) and neuromyelitis optic (NMO). Differential diagnosis between these"/>
   <result pre="ON. P651 Involvement of cerebral cortex in anti-aquaporin-4 antibody seropositive" exact="neuromyelitis optica" post="spectrum disorder patients SY Kim 1, W Kim 1,"/>
   <result pre="characteristic locations and configurations are helpful in the diagnosis of" exact="neuromyelitis optica" post="spectrum disorder (NMOSD). It was previously reported that cortical"/>
   <result pre="not found in patients with NMO, which was contrast to" exact="multiple sclerosis" post="(MS). Objectives: We aimed to determine whether involvement of"/>
   <result pre="symptom. 43.5% were not affected by Myelitis. 50% had Cervical" exact="myelitis" post="and 6.5% both cervical and thoracic myelitis. 23.9% had"/>
   <result pre="sensitivity of these laboratory tests. P653 An unusual case of" exact="neurofibromatosis" post="type 1, high titer antinuclear autoantibodies and neuromyelitis optica"/>
   <result pre="case of neurofibromatosis type 1, high titer antinuclear autoantibodies and" exact="neuromyelitis optica" post="Y Jin 1, D Segal 1, M Hillen 1"/>
   <result pre="been described. There are 5 case reports of NF1 with" exact="systemic lupus erythematosus" post="(SLE) and 6 case reports of NF1 with multiple"/>
   <result pre="described. There are 5 case reports of NF1 with systemic" exact="lupus erythematosus" post="(SLE) and 6 case reports of NF1 with multiple"/>
   <result pre="lupus erythematosus (SLE) and 6 case reports of NF1 with" exact="multiple sclerosis" post="in the medical literature up-to-date. Neuromyelitis optica (NMO) spectrum"/>
   <result pre="normal brain, abnormal T2 hyperintensity from T2-T6, as seen in" exact="myelitis" post="and L3-L5 root lesions which were proven to be"/>
   <result pre="gait improved after intravenous corticosteroid treatment. A diagnosis of autoimmune" exact="myelitis" post="was made. Patient was treated with oral steroids and"/>
   <result pre="or are coincidental needs further study. P654 Neuromyelitis optica and" exact="neuromyelitis optica" post="spectrum disorders: the evaluation of 86 patients followed by"/>
   <result pre="spectrum disorders (NMOSD) are relatively rare disorders when compared to" exact="multiple sclerosis" post="(MS). Objectives: We aimed to evaluate clinical characteristics and"/>
   <result pre="at our MS unit; 24 had NMO, 42 had recurrent" exact="optic neuritis" post="(RON); and 20 had longitudinally extensive transverse myelitis (LETM)."/>
   <result pre="recurrent optic neuritis (RON); and 20 had longitudinally extensive transverse" exact="myelitis" post="(LETM). The mean age of the patients was 40.1±14.1"/>
   <result pre="diseases may have neurological side-effects. Among them, few cases of" exact="optic neuritis" post="(ON) have been reported whatever anti-TNFa category. Objectives: The"/>
   <result pre="imaging in acute optic neuritis: a new potential biomarker for" exact="multiple sclerosis" post="RC Sergott 1, ML Moster 2, E Affel 3"/>
   <result pre="investigate the potential role for MLCI in patients with acute" exact="optic neuritis." post="Methods: We investigated 15 patients with acute optic neuritis"/>
   <result pre="acute optic neuritis. Methods: We investigated 15 patients with acute" exact="optic neuritis" post="at the time of their presentation and 3 months"/>
   <result pre="3 months after their initial visual symptoms. The event of" exact="optic neuritis" post="was the first clinical demyelinating event in 8 patients"/>
   <result pre="with RRMS. Results: In 10 of 15 patients with acute" exact="optic neuritis," post="MCLI demonstrated hyper-reflective zones encircling the fovea and macular"/>
   <result pre="monochromatic fundus photography. P657 White matter damage is associated with" exact="optic neuritis" post="related retinal nerve fiber and ganglion cell loss in"/>
   <result pre="neuritis related retinal nerve fiber and ganglion cell loss in" exact="neuromyelitis optica" post="spectrum disorders F Pache 1,2, H Zimmermann 1, S"/>
   <result pre="Neuromyelitis optica (NMO) is an autoimmune CNS disease characterized by" exact="optic neuritis" post="(ON) and myelitis. Attacks can be devastating, especially damage"/>
   <result pre="devastating, especially damage by ON is more severe than in" exact="multiple sclerosis." post="Previous studies reported retinal nerve fiber layer thinning in"/>
   <result pre="biomarker of disease and repair in a mouse model of" exact="multiple sclerosis" post="P Kim 1, A Khalaj 2, M Syed 2,"/>
   <result pre="is integral to developing treatments for neurodegenerative diseases such as" exact="multiple sclerosis" post="(MS). Optic neuritis (ON) is a common acute manifestation"/>
   <result pre="a common acute manifestation of MS onset; similarly, experimental autoimmune" exact="encephalomyelitis" post="(EAE) mice, a rodent model of MS, exhibit ON."/>
   <result pre="Retrograde axonal and neuronal degeneration of the retina in acute" exact="optic neuritis" post="EH Martínez-Lapiscina 1, I Gabilondo 1, E Fraga-Pumar 1,"/>
   <result pre="detailed description of the diffusion of retinal damage in acute" exact="optic neuritis" post="(ON) and its correlation with visual disability is relevant"/>
   <result pre="participants and 45% of non-fatigued participants had a history of" exact="optic neuritis" post="(ON). Ninety five percent and 5% of participants in"/>
   <result pre="Retinal structural injury is worse in African-Americans than Caucasians with" exact="multiple sclerosis" post="J Chorostecki 1, F Bao 1, G Bao 1,"/>
   <result pre="and macular atrophy than CAU-MS. In patients without history of" exact="optic neuritis," post="our results extend previous observations of greater irreversible tissue"/>
   <result pre="100 Hue testing is tightly associated with retinal thinning in" exact="multiple sclerosis" post="EE Longbrake 1, S Lancia 1, N Tutlam 1,"/>
   <result pre="States Background: Color vision abnormalities are common among patients with" exact="multiple sclerosis." post="This has been established using several screening tests including"/>
   <result pre="relationship between the FM-100 and other visual outcome measures in" exact="multiple sclerosis" post="(MS) patients who had previously suffered optic neuritis (ON)."/>
   <result pre="measures in multiple sclerosis (MS) patients who had previously suffered" exact="optic neuritis" post="(ON). Methods: Forty six MS patients with stable ON"/>
   <result pre="P663 Retinal ganglion cell layer thinning and vision outcome in" exact="optic neuritis" post="over six months MJ Kupersmith 1, J-K Wang 2,"/>
   <result pre="at presentation and thinning occurs within one month of acute" exact="optic neuritis" post="(ON), long before retinal nerve fiber layer (RNFL) thinning"/>
   <result pre="months were moderately correlated (r=0.48, p =0.02). Conclusions: For acute" exact="optic neuritis," post="the largest proportion of GCL loss has already occurred"/>
   <result pre="to demonstrate early loss; and as an outcome measure of" exact="optic neuritis," post="it shows residual injury better than the RNFL or"/>
   <result pre="motility: a potential method of quantifying progressive cerebral dysfunction in" exact="multiple sclerosis" post="and clinically isolated syndrome M Clough 1, L Mitchell"/>
   <result pre="and SD-OCT between RRMS and PPMS patients with and without" exact="optic neuritis" post="AM Flowers 1, MK Adam 2, RC Sergott 2,3"/>
   <result pre="Ophthalmology and Neurology, Philadelphia, PA, United States Background: Relapsing remitting" exact="multiple sclerosis" post="(RRMS) and primary progressive multiple sclerosis (PPMS) are characterized"/>
   <result pre="States Background: Relapsing remitting multiple sclerosis (RRMS) and primary progressive" exact="multiple sclerosis" post="(PPMS) are characterized by distinct clinical presentations, genetic profiles,"/>
   <result pre="neuroimaging findings. RRMS patients frequently experience visual loss caused by" exact="optic neuritis" post="(ON). In contrast, PPMS patients develop ON much less"/>
   <result pre="5Hospital Clínic de Barcelona, Barcelona, Spain Background: Chronic relapsing inflammatory" exact="optic neuropathy" post="(CRION), recently described, is characterized by subacute inflammatory optic"/>
   <result pre="Clínic de Barcelona, Barcelona, Spain Background: Chronic relapsing inflammatory optic" exact="neuropathy" post="(CRION), recently described, is characterized by subacute inflammatory optic"/>
   <result pre="optic neuropathy (CRION), recently described, is characterized by subacute inflammatory" exact="optic neuropathy," post="bilateral often with prominent pain, and a clinical course"/>
   <result pre="that there not be a evidence of additional neurological deficit," exact="sarcoidosis" post="or systemic autoimmune disease. Objectives: To perform a clinical"/>
   <result pre="be a evidence of additional neurological deficit, sarcoidosis or systemic" exact="autoimmune disease." post="Objectives: To perform a clinical description of CRION by"/>
   <result pre="of CRION by analyzing a serie of patients with recurrent" exact="optic neuritis" post="(ON). Methods: A transversal study was carried out on"/>
   <result pre="62.5%, MRI that were not normal not meet criteria for" exact="multiple sclerosis." post="ANA positivity was found only in one patient, ACE"/>
   <result pre="is to assess the neuroprotective efficacy of amiloride in acute" exact="optic neuritis." post="Objectives: To evaluate structural and electrophysiological correlates of the"/>
   <result pre="system with clinical visual outcomes in the setting of acute" exact="optic neuritis," post="within a phase II neuroprotection trial. Methods: Patients were"/>
   <result pre="trial. Methods: Patients were recruited with a first episode of" exact="optic neuritis," post="and baseline assessments of vision, retinal nerve fibre layer"/>
   <result pre="PERG is more consistently recorded than the PVEP in acute" exact="optic neuritis." post="Inclusion of PERG increases electrophysiological data capture at baseline"/>
   <result pre="electrophysiological data capture at baseline assessment in clinical trials of" exact="optic neuritis," post="and may provide useful structure-function information. SLP derived RNFL"/>
   <result pre="confounded by swelling than OCT in the acute phase of" exact="optic neuritis," post="appears to have a significant correlation with vision in"/>
   <result pre="data. P670 Sector-specific macular volume compromise in relapsing &amp;amp; remitting" exact="multiple sclerosis" post="as measured by optical coherence tomography AS Fjeldstad 1,"/>
   <result pre="volume in Relapsing-Remitting MS (RR-MS) patients with or without prior" exact="optic neuritis" post="(ON), and compare the results to healthy controls. Methods:"/>
   <result pre="ON. In addition, ON findings are consistent with a uniform" exact="neurodegeneration" post="in the perimacular retina. Future OCT studies may focus"/>
   <result pre="well as the individual sector volumes as sensitive measures of" exact="neurodegeneration" post="in MS and ON. P671 The utility of optical"/>
   <result pre="United States Background: Acute monocular visual loss is common in" exact="multiple sclerosis" post="(MS). Differential diagnoses include optic neuritis (ON), arteritic or"/>
   <result pre="loss is common in multiple sclerosis (MS). Differential diagnoses include" exact="optic neuritis" post="(ON), arteritic or non-arteritic ischemic optic neuropathy (AION/NAION), and"/>
   <result pre="Differential diagnoses include optic neuritis (ON), arteritic or non-arteritic ischemic" exact="optic neuropathy" post="(AION/NAION), and central or branch retinal artery occlusion (CRAO/BRAO)."/>
   <result pre="diagnoses include optic neuritis (ON), arteritic or non-arteritic ischemic optic" exact="neuropathy" post="(AION/NAION), and central or branch retinal artery occlusion (CRAO/BRAO)."/>
   <result pre="arteritic or non-arteritic ischemic optic neuropathy (AION/NAION), and central or" exact="branch retinal artery occlusion" post="(CRAO/BRAO). Distinguishing ON from BRAO may be challenging because"/>
   <result pre="because acute retinal whitening can be subtle and transient and" exact="optic atrophy" post="may develop chronically from retrograde axonal degeneration. Objectives: We"/>
   <result pre="Objectives: We present two patients referred to our center for" exact="optic neuropathy" post="where spectral-domain optical coherence tomography (SD-OCT) provided vital clues"/>
   <result pre="We present two patients referred to our center for optic" exact="neuropathy" post="where spectral-domain optical coherence tomography (SD-OCT) provided vital clues"/>
   <result pre="in his left eye was referred with a diagnosis of" exact="optic neuritis." post="Examination revealed reduced visual acuity, color impairment, a paracentral"/>
   <result pre="a diagnosis of NAION and history of a thoracic dissecting" exact="aortic aneurysm" post="2 years prior was referred for evaluation of optic"/>
   <result pre="NAION. Conclusions: OCT imaging of macular layers can help distinguish" exact="optic neuropathy," post="a common finding in MS, from a primary retinal"/>
   <result pre="nervous system (CNS). The clinical presentation is characterized by uveitis," exact="aseptic meningitis," post="hearing loss and sometimes vitiligo and poliosis. It has"/>
   <result pre="is characterized by uveitis, aseptic meningitis, hearing loss and sometimes" exact="vitiligo" post="and poliosis. It has no specific markers and white"/>
   <result pre="early diagnosis of VKHD is underlined by the fact that" exact="uveitis" post="can exert a catastrophic effect on the visual function,"/>
   <result pre="affect the visual pathway and the central nervous system like" exact="multiple sclerosis" post="(MS) or Cogan disease should be ruled out. In"/>
   <result pre="Cogan disease should be ruled out. In any patient with" exact="aseptic meningitis," post="white matter lesions and hearing loss or vertigo, VKHD"/>
   <result pre="two and three way receiver operating characterization (ROC) analyses for" exact="optic neuritis" post="transfer function characterization SH Choudhury 1, B Goodyear 1,"/>
   <result pre="Background: Optic neuritis (ON) represents a single-lesion model to explore" exact="multiple sclerosis" post="(MS). Functional magnetic resonance imaging transfer function (fMRI-TF) measures"/>
   <result pre="can track ON recovery. P674 25-hydroxyvitamin D levels in acute" exact="optic neuritis." post="Relation to paraclinical findings, demographic characteristics and risk of"/>
   <result pre="Denmark Background: The importance of vitamin D in development of" exact="multiple sclerosis" post="(MS) is becoming increasingly accepted. Optic neuritis is a"/>
   <result pre="D (25HVITD) levels in patients in the acute phase of" exact="optic neuritis" post="(ON) with comparisons to a general MS population and"/>
   <result pre="nerve head volume as a marker for neuronal damage after" exact="optic neuritis" post="in multiple sclerosis and neuromyelitis optica HG Zimmermann 1,"/>
   <result pre="as a marker for neuronal damage after optic neuritis in" exact="multiple sclerosis" post="and neuromyelitis optica HG Zimmermann 1, EM Kadas 1,"/>
   <result pre="for neuronal damage after optic neuritis in multiple sclerosis and" exact="neuromyelitis optica" post="HG Zimmermann 1, EM Kadas 1, F Pache 1,"/>
   <result pre="Multiple Sclerosis Research Center, Berlin, Germany Background: Optic neuritis in" exact="multiple sclerosis" post="(MS) and neuromyelitis optica (NMO) leads to thinning of"/>
   <result pre="Berlin, Germany Background: Optic neuritis in multiple sclerosis (MS) and" exact="neuromyelitis optica" post="(NMO) leads to thinning of the retinal nerve fiber"/>
   <result pre="compare ONH volume and RNFL thickness as markers for optic" exact="neurodegeneration" post="in eyes with a history of optic neuritis in"/>
   <result pre="markers for optic neurodegeneration in eyes with a history of" exact="optic neuritis" post="in NMO and relapsing-remitting MS (RRMS). Methods: Seventy-one patients"/>
   <result pre="relapsing-remitting MS (RRMS). Methods: Seventy-one patients with a history of" exact="optic neuritis" post="(49 RRMS and 22 NMO) and 39 healthy controls"/>
   <result pre="was significantly reduced in patients’ eyes with a history of" exact="optic neuritis" post="in comparison to patients’ eyes without in MS (B=0.295,"/>
   <result pre="evoked potentials (VEPs) in assessing visual involvement in patients with" exact="multiple sclerosis" post="(MS). Methods: Cross-sectional study of 121 consecutive subjects with"/>
   <result pre="MS. Of 242 eyes, 166 had no previous history of" exact="optic neuritis" post="(ON), 22 had a single recent ON episode (&amp;lt;"/>
   <result pre="a higher sensitivity of VEPs in the subacute phases of" exact="optic neuritis" post="and in asymptomatic eyes. This discrepancy fades off after"/>
   <result pre="verified through longitudinal studies. P677 Optical coherence tomography after first" exact="optic neuritis" post="for the differentiation between neuromyelitis optica and multiple sclerosis"/>
   <result pre="coherence tomography after first optic neuritis for the differentiation between" exact="neuromyelitis optica" post="and multiple sclerosis NH Kim 1, YJ Shin 2,"/>
   <result pre="first optic neuritis for the differentiation between neuromyelitis optica and" exact="multiple sclerosis" post="NH Kim 1, YJ Shin 2, KS Jeong 3,"/>
   <result pre="(OCT) has been suggested to be useful in discrimination between" exact="neuromyelitis optica" post="(NMO) and multiple sclerosis (MS). However, multiple episodes of"/>
   <result pre="to be useful in discrimination between neuromyelitis optica (NMO) and" exact="multiple sclerosis" post="(MS). However, multiple episodes of optic neuritis (ON) result"/>
   <result pre="optica (NMO) and multiple sclerosis (MS). However, multiple episodes of" exact="optic neuritis" post="(ON) result in cumulative severe reduction of RNFLT, making"/>
   <result pre="enrolled a total of 96 eyes from 48 patients with" exact="multiple sclerosis" post="(48 IFNβ-1b-treated and 48 untreated eyes) and 24 eyes"/>
   <result pre="balance of TNF signalling in cortical grey matter in progressive" exact="multiple sclerosis" post="R Magliozzi 1,2, P Durrenberger 3, O Howell 4,"/>
   <result pre="(GM) pathology is the best correlate of clinical progression in" exact="multiple sclerosis" post="(MS). Recent studies of cortical pathology in secondary progressive"/>
   <result pre="Astrocytes upregulate interleukin-17 receptor expression in white matter lesions in" exact="multiple sclerosis" post="J Raffel 1, R Nicholas 1, F Roncaroli 1,"/>
   <result pre="attracted attention for its putative role in disease pathogenesis in" exact="multiple sclerosis" post="(MS). In humans, post-mortem tissue studies in MS have"/>
   <result pre="and transporter transcripts in normal appearing grey matter of chronic" exact="multiple sclerosis" post="patients R Klaver 1, P Nijland 2, GJ Schenk"/>
   <result pre="Although grey matter (GM) pathology correlates with the progression of" exact="multiple sclerosis" post="(MS), the question remains how does GM pathology arise?"/>
   <result pre="the data on protein level. P684 Podoplanin is expressed in" exact="multiple sclerosis" post="meninges and perivascular infiltrates and regulates T-cell proliferation and"/>
   <result pre="lymphatic system and in the biology of immune cells. In" exact="multiple sclerosis" post="(MS), formation of ectopic meningeal lymphoid follicles is associated"/>
   <result pre="formation of ectopic meningeal lymphoid follicles is associated with accelerated" exact="neurodegeneration" post="and disability progression. Recent work in EAE mice suggests"/>
   <result pre="findings suggest a critical but unknown role for PDPN in" exact="multiple sclerosis." post="Objectives: To characterize expression of PDPN and its ligands"/>
   <result pre="patients. P685 Epigenetic changes control memory function following demyelination in" exact="multiple sclerosis" post="A Chomyk 1, S Deckhard 1, RJ Fox 2,"/>
   <result pre="brains were donated for research purposes (two patients affected by" exact="multiple sclerosis" post="and one by anti-NMDA-r encephalitis): two were sectioned using"/>
   <result pre="changes observed in disease. P688 S100B levels are increased in" exact="multiple sclerosis" post="and modulates demyelination, glial reactivity and inflammation A Barateiro"/>
   <result pre="identified in cerebrospinal fluid (CSF) and post-mortem brain tissue of" exact="multiple sclerosis" post="(MS) patients and correlated with glia reactivity upon demyelination."/>
   <result pre="of retroviral sequences in brain tissue from patients with progressive" exact="multiple sclerosis" post="JD Kriesel 1, PJ Bhetariya 1, BK Chan 1,2,"/>
   <result pre="of total RNA extracted from 12 primary progressive MS, 2" exact="neuromyelitis optica," post="and 14 normal control frozen brain specimens was performed"/>
   <result pre="Differential oxidative stress and cytokine profile between progressive and relapsing-remitting" exact="multiple sclerosis" post="patients AP Kallaur 1, SR Oliveira 2, LJV Schiavão"/>
   <result pre="Although inflammation is the driving force for brain injury in" exact="multiple sclerosis" post="(MS), studies suggest that oxidative stress may also modulate"/>
   <result pre="disease. P691 Neuropathological study of glucose and monocarboxylate transporters in" exact="multiple sclerosis" post="K Masaki 1, SO Suzuki 2, M Watanabe 1,"/>
   <result pre="loss of astrocytic and oligodendrocytic Cxs in active lesions of" exact="multiple sclerosis" post="(MS), neuromyelitis optica (NMO) and Baló’s disease (BD), suggesting"/>
   <result pre="and oligodendrocytic Cxs in active lesions of multiple sclerosis (MS)," exact="neuromyelitis optica" post="(NMO) and Baló’s disease (BD), suggesting early disruption of"/>
   <result pre="Marburg’s type and 20 with other neurological diseases. Results: In" exact="myasthenia gravis" post="case, GLUT1 and MCT1 were abundantly expressed in the"/>
   <result pre="Is inflammation atherogenic in neurological diseases? A case-control study with" exact="migraine" post="and multiple sclerosis patients V González Quintanilla 1, M"/>
   <result pre="atherogenic in neurological diseases? A case-control study with migraine and" exact="multiple sclerosis" post="patients V González Quintanilla 1, M Toriello 1, S"/>
   <result pre="Objectives: To determine the endothelial damage in patients suffering from" exact="multiple sclerosis" post="(MS) and migraine measuring the carotid intima-media thickness (IMT)"/>
   <result pre="endothelial damage in patients suffering from multiple sclerosis (MS) and" exact="migraine" post="measuring the carotid intima-media thickness (IMT) and the endothelial-dependant"/>
   <result pre="and the endothelial-dependant flow-mediated vasodilation (EDV), as subclinical biomarkers of" exact="atherosclerosis" post="and predictors of cardiovascular events. Methods: Subjects were recruited"/>
   <result pre="for MS diagnosis, and ICH-2004 and 2006 criteria for chronic" exact="migraine" post="(CM). A control group were also recruited. Ultrasonografic images"/>
   <result pre="and Pearson regression test. Results: We recruited 22 controls, 59" exact="migraine" post="patients (25 CM), 33 MS patients. IMT was thicker"/>
   <result pre="and FISS PI11/1232 grants. P693 CHI3L1 and SPP1 distribution in" exact="multiple sclerosis" post="lesions I Ahmad 1, S Wergeland 1, L Bø"/>
   <result pre="a secreted glycoprotein that is up-regulated in inflammatory conditions, including" exact="multiple sclerosis" post="(MS). The function of CHI3L1 expression has not been"/>
   <result pre="a similar cellular distribution. P694 Endothelial function in patients with" exact="multiple sclerosis" post="NN Spirina 1, NN Spirin 1, AN Boyko 2,"/>
   <result pre="Federation Background: One of the first theories of pathogenesis of" exact="multiple sclerosis" post="(MS) was a vascular theory. A key step in"/>
   <result pre="(DMT) of MS, a comparative analysis of endothelial function in" exact="multiple sclerosis" post="patients and healthy volunteers. Methods: 33 patients (20 female,"/>
   <result pre="therapeutic interventions in MS. Neurophysiology P695 Visual evoked potentials in" exact="neuromyelitis optica" post="and its spectrum disorders P Albrecht 1, M Ringelstein"/>
   <result pre="Germany Background: Optic neuritis (ON) is a key feature of" exact="neuromyelitis optica" post="(NMO) and its spectrum disorders (NMOSD). It is responsible"/>
   <result pre="the function of the visual pathway. After ON in classical" exact="multiple sclerosis" post="(MS) VEPs typically show prolonged P100 latencies and often"/>
   <result pre="Melsbroek, Melsbroek, Belgium Background: Cognitive impairment affects half of the" exact="multiple sclerosis" post="(MS) population, is difficult to detect and requires extensive"/>
   <result pre="Visual and auditory evoked potentials as related to fatigue in" exact="multiple sclerosis" post="A Pokryszko-Dragan 1, M Bilinska 1, E Gruszka 1,"/>
   <result pre="of Wroclaw, Wroclaw, Poland Background: The origin of fatigue in" exact="multiple sclerosis" post="remains unclear. Disturbed neural conduction within the brain due"/>
   <result pre="evaluate visual and brainstem auditory evoked potentials (VEP, BAEP) in" exact="multiple sclerosis" post="(MS) patients with regards to fatigue and disease-related variables."/>
   <result pre="Modulation of action tremor by repetitive transcranial magnetic stimulation in" exact="multiple sclerosis" post="patients M Gangitano 1, P Ragonese 1, J Battaglini"/>
   <result pre="P699 Heart rate variability analysis in recently diagnosed patients with" exact="multiple sclerosis" post="D Ozbek 1, A Cincin 2, P Kahraman Koytak"/>
   <result pre="score: a promising tool for evaluation of brainstem involvement in" exact="multiple sclerosis" post="I Adamec 1, T Gabelic 1, M Krbot Skoric"/>
   <result pre="involvement. Objectives: Concerning the great importance of brainstem involvement in" exact="multiple sclerosis" post="(MS), the aim of this study was to explore"/>
   <result pre="Toplice, Croatia Background: Signs of autonomic nervous system involvement in" exact="multiple sclerosis" post="(MS) occur in 50-86% of cases. However, frequency of"/>
   <result pre="biomarker used to track visual system function in MS and" exact="optic neuritis" post="patients. Understanding how VEP measures relate to underlying pathology"/>
   <result pre="optic coherence tomography in monitoring involvement of visual pathways in" exact="multiple sclerosis" post="L Leocani 1, S Guerrieri 1, G Di Maggio"/>
   <result pre="in subsequent recording sessions. To apply the procedure to relapsing" exact="multiple sclerosis" post="(MS) patients to measure acute changes of CMCF to"/>
   <result pre="duration and different QRS axis were found in relapsing remitting" exact="multiple sclerosis" post="patients during remission D Obradovic 1, D Spreng 1,"/>
   <result pre="Belgrade, Serbia Background: Autonomic nervous system dysfunction is present in" exact="multiple sclerosis" post="(MS) patients, which may influence the electrocardiography (ECG) pattern."/>
   <result pre="QT interval, QTc interval, QRS axis and the frequency of" exact="right bundle branch block" post="(RBBB) was compared between 101 patients with relapsing-remitting MS"/>
   <result pre="MS. P709 NMDA receptor blockade is neuroprotective in experimental autoimmune" exact="optic neuritis" post="K-W Sühs 1, R Fairless 2, SK Williams 2,"/>
   <result pre="receptor blockers memantine and MK-801, in a rat model of" exact="optic neuritis," post="inducing Experimental autoimmune encephalomyelitis (EAE) by myelin oligodendrocyte glycoprotein"/>
   <result pre="in a rat model of optic neuritis, inducing Experimental autoimmune" exact="encephalomyelitis" post="(EAE) by myelin oligodendrocyte glycoprotein immunization. Methods: Female BN"/>
   <result pre="a gain of function estradiol analog for inducing remyelination in" exact="multiple sclerosis" post="patients SH Nye 1, S Medicetty 2, BD Trapp"/>
   <result pre="clinical trials, yet they impact only the neuroprotective aspects of" exact="multiple sclerosis" post="(MS), rather than the elusive remyelination activity needed to"/>
   <result pre="partly independent of its effect on focal damage in relapsing-remitting" exact="multiple sclerosis" post="patients N De Stefano 1, L Kappos 2, EW"/>
   <result pre="tissue damage coexist in the brain of patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS) and may occur independently. Diffuse damage underlies complex"/>
   <result pre="MS. P712 Anti- SEMA4D antibody ameliorates pathogenic processes related to" exact="multiple sclerosis" post="AS Jonason 1, E Klimatcheva 1, T Fisher 1,"/>
   <result pre="and neuronal degeneration. Antibody neutralization of SEMA4D could, therefore, ameliorate" exact="multiple sclerosis" post="through multiple mechanisms. Objectives: Blocking SEMA4D could promote differentiation"/>
   <result pre="survival and differentiation. In vivo, anti-SEMA4D significantly attenuates experimental autoimmune" exact="encephalomyelitis" post="in multiple rodent models by preserving BBB integrity and"/>
   <result pre="antibody-mediated neutralization of SEMA4D represents a viable therapeutic strategy for" exact="multiple sclerosis." post="To this end, a randomized, placebo-controlled, double blind, single"/>
   <result pre="Neurology, Detroit, MI, United States Background: Patients with relapsing remitting" exact="multiple sclerosis" post="(RRMS) are commonly treated with high doses of intravenous"/>
   <result pre="agonist, in preclinical development for neuroprotective and regenerative therapy of" exact="multiple sclerosis" post="P Fagergren 1, S Tiwari-Woodruff 2, M Osterlund 1"/>
   <result pre="(ER) beta agonists, avoiding the ERalfa mediated increased risk of" exact="cancer" post="and thrombosis, represent a novel neuroregenerative therapy of Multiple"/>
   <result pre="disease symptoms in a rat model of relapsing-remitting experimental autoimmune" exact="encephalomyelitis" post="(RR-EAE), and an in vitro neuroprotection assay. Methods: RR-EAE"/>
   <result pre="MS. P716 The role of vitamin D and gender in" exact="optic neuritis" post="recovery J Burton 1, J Trufyn 2, C Tung"/>
   <result pre="pathway markers. Vitamin D insufficiency is a risk factor for" exact="multiple sclerosis" post="while vitamin D ameliorates inflammation. Assessment of vitamin D"/>
   <result pre="vitamin D ameliorates inflammation. Assessment of vitamin D status in" exact="optic neuritis" post="may support a neuroprotective role as well. Objectives: We"/>
   <result pre="is associated with better OCT outcomes and axonal preservation/recovery after" exact="optic neuritis." post="Outcomes include RNFL thickness, ganglion cell layer (GCL) thickness"/>
   <result pre="cohort study, a total target of 50 patients with acute" exact="optic neuritis" post="undergo OCT to assess RNFL GCL, macular volume (MV)"/>
   <result pre="respectively) versus women. Conclusions: Not surprisingly, vitamin D insufficiency at" exact="optic neuritis" post="onset is associated with greater baseline edema. At 6"/>
   <result pre="confer neuroprotection and/or improved recovery of the optic nerve after" exact="optic neuritis." post="P717 Tissue plasminogen activator (tPA) influences recovery after white"/>
   <result pre="First, we have shown that the outcome of experimental autoimmune" exact="encephalomyelitis" post="(a classical model of MS) is worse in tPA"/>
   <result pre="progression, brain atrophy and relapse rate in patients with relapsing-remitting" exact="multiple sclerosis" post="(MS). LAQ reduces demyelination and axonal damage in mice"/>
   <result pre="aimed at (i) analysing GPR17 expression in the experimental autoimmune" exact="encephalomyelitis" post="(EAE) MS rodent model, and (ii) assessing the functional"/>
   <result pre="is the natural repair mechanism of CNS demyelinated lesions in" exact="multiple sclerosis" post="(MS), but it is often incomplete or even fails."/>
   <result pre="Cleveland, OH, United States Background: A primary pathological feature of" exact="multiple sclerosis" post="is the loss of myelin-producing oligodendrocytes (OL) and myelin"/>
   <result pre="for successful remyelination and repair in demyelinating diseases such as" exact="multiple sclerosis" post="(MS). Understanding the time course of the oligodendrocyte progenitor"/>
   <result pre="degeneration are considered the major cause of neurological disability in" exact="multiple sclerosis" post="(MS). Vitamin D has been shown to modulate relapse"/>
   <result pre="Medical Center Mainz, Neurology, Mainz, Germany Background: Chronic disability in" exact="multiple sclerosis" post="(MS) is due to neuronal degeneration, which is not"/>
   <result pre="specialised cells in the brain responsible for myelinating neurons. In" exact="multiple sclerosis" post="(MS), myelin becomes damaged, and over time, repair of"/>
   <result pre="Neuroprotective effects of hesperidin in a C57BL/6 mouse model of" exact="multiple sclerosis" post="O Ciftci 1, C Ozcan 2, O Kamisli 2,"/>
   <result pre="Health, Directorate of Health Services, Ankara, Turkey Background: Experimental allergic" exact="encephalomyelitis" post="(EAE) is a T cell-mediated inflammatory demyelinating autoimmune disease"/>
   <result pre="Experimental allergic encephalomyelitis (EAE) is a T cell-mediated inflammatory demyelinating" exact="autoimmune disease" post="that serves as an animal model for multiple sclerosis"/>
   <result pre="demyelinating autoimmune disease that serves as an animal model for" exact="multiple sclerosis" post="(MS). Destruction of myelin sheaths and oligodendrocytes as well"/>
   <result pre="(MS). Destruction of myelin sheaths and oligodendrocytes as well as" exact="neurodegeneration" post="in MS are associated with massive oxidative stress and"/>
   <result pre="anti-inflammatory compounds such as flavonoids may protects nervous system against" exact="autoimmune disease" post="such as MS. Hesperidin (HP) is a bioflavonoid found"/>
   <result pre="and HP+EAE. After induction of EAE with (MOG 35-55) and" exact="pertussis" post="toxin, the mice treated with HP at the doses"/>
   <result pre="Zentrum, Klinik und Poliklinik fur Neurologie, Dresden, Germany Background: Acute" exact="optic neuritis" post="(AON) is characterized by inflammatory demyelinating and axonal injury"/>
   <result pre="of AON. P732 Production of differential screening-selected gene aberrative in" exact="neuroblastoma" post="(DAN) in the CNS may support neurogenesis/ oligodendrogenesis in"/>
   <result pre="School, Tel Aviv, Israel Background: The inadequate tissue repair of" exact="multiple sclerosis" post="(MS) lesions is assumed to be, in part, due"/>
   <result pre="oligodendrogenesis and neurogenesis. BMP-2,4,5 are upregulated in immune cells of" exact="multiple sclerosis" post="patients, while their antagonists, noggin and follistatin, are down"/>
   <result pre="down regulated in these cells. Differential screening-selected gene aberrative in" exact="neuroblastoma" post="(DAN) is a member of the DAN family of"/>
   <result pre="secreted glycoproteins that are putative BMP antagonists. Its role in" exact="multiple sclerosis" post="has not yet been studied. Objectives: To study the"/>
   <result pre="P733 Predictors of fear of sexual rejection in individuals with" exact="multiple sclerosis" post="S Flood 1, H Quinn 1, E Mendelowitz 1,"/>
   <result pre="Sciences, Winnipeg, MB, Canada Background: Multiple Sclerosis (MS) is an" exact="autoimmune disease" post="of the central nervous system that is often associated"/>
   <result pre="sexual rejection. P734 Development of the neurological coping index for" exact="multiple sclerosis" post="(NCI-MS) CA Young 1,2, A Tennant 3, Trajectories of"/>
   <result pre="P735 Psychiatric diagnoses, medication and risk for disability pension in" exact="multiple sclerosis" post="patients; a population-based register study P Brenner 1, J"/>
   <result pre="Clinical Neuroscience, Stockholm, Sweden Background: Psychiatric comorbidity is common among" exact="multiple sclerosis" post="(MS) patients. The majority of MS patients of working"/>
   <result pre="as well as in a societal perspective. P736 Depression and" exact="multiple sclerosis" post="in the CombiRx study L Stone 1, SS Cofield"/>
   <result pre="TX, United States Background: Depression is common in persons with" exact="multiple sclerosis" post="(MS). Severity can change overtime and be related to"/>
   <result pre="traits are associated with the quality of patient-provider relationships in" exact="multiple sclerosis" post="C Ray 1, S O’Bryan 1, C Mavis 1,"/>
   <result pre="use as a means of coping. Methods: Seventy-seven individuals with" exact="multiple sclerosis" post="(MS) were administered the NEO Five Factor Inventory, the"/>
   <result pre="interventions. P739 Depression correlate with disability and clinical course in" exact="multiple sclerosis" post="patients: an Italian multicenters study C Solaro 1, Neuropathic"/>
   <result pre="people with MS. P740 Does anxiety moderate the relationship between" exact="bowel dysfunction" post="and illness intrusiveness in multiple sclerosis? AS Castiglione 1,"/>
   <result pre="moderate the relationship between bowel dysfunction and illness intrusiveness in" exact="multiple sclerosis?" post="AS Castiglione 1, ES Gromisch 2, V Zemon 2,"/>
   <result pre="York, NY, United States Background: Patients with MS often experience" exact="bowel dysfunction," post="with fecal incontinence and constipation the two most prevalent"/>
   <result pre="with MS often experience bowel dysfunction, with fecal incontinence and" exact="constipation" post="the two most prevalent symptoms. Patients may experience bowel"/>
   <result pre="by the Beck Depression Inventory-II (BDI-II), moderating the relationship between" exact="bowel dysfunction" post="and illness intrusiveness. Objectives: To examine the relationship between"/>
   <result pre="illness intrusiveness. Objectives: To examine the relationship between anxiety and" exact="bowel dysfunction," post="and how that relationship contributes to perceived illness intrusiveness."/>
   <result pre="the Incapacity Status Scale (ISS). Moderation analyses were run with" exact="bowel dysfunction" post="as the predictor, anxiety as measured by the Hospital"/>
   <result pre="score was 7.93 ± 3.75 (range: 0-20). The interaction between" exact="bowel dysfunction" post="and anxiety was significant, F (3, 204) = 19.34,"/>
   <result pre="intrusiveness individually. Anxiety also acted as a significant moderator between" exact="bowel dysfunction" post="and illness intrusiveness. This finding highlights the need to"/>
   <result pre="measure of worry across a broad range of disability in" exact="multiple sclerosis" post="I Pomeroy 1,2, A Tennant 3, CA Young 1,2,"/>
   <result pre="is a construct that is distinct from a multidimensional generalised" exact="anxiety disorder." post="Although generalised anxiety disorder is known to be common"/>
   <result pre="is distinct from a multidimensional generalised anxiety disorder. Although generalised" exact="anxiety disorder" post="is known to be common in multiple sclerosis (MS),"/>
   <result pre="Although generalised anxiety disorder is known to be common in" exact="multiple sclerosis" post="(MS), chronic worry has not been extensively studied in"/>
   <result pre="burden and satisfaction with treatment in caregivers and patients with" exact="multiple sclerosis." post="MS-feeling study J Meca-Lallana 1, M Mendibe 2 1Hospital"/>
   <result pre="Cruces, Cruces, Spain Background: In chronic illnesses such as relapsing-remitting" exact="multiple sclerosis" post="(RRMS), caregiver burden is associated with the disease control"/>
   <result pre="prospective Study aims to describe outcomes after first episode of" exact="acute disseminated encephalomyelitis" post="(ADEM); transverse myelitis (TM); optic neuritis (ON); other clinically"/>
   <result pre="aims to describe outcomes after first episode of acute disseminated" exact="encephalomyelitis" post="(ADEM); transverse myelitis (TM); optic neuritis (ON); other clinically"/>
   <result pre="outcomes after first episode of acute disseminated encephalomyelitis (ADEM); transverse" exact="myelitis" post="(TM); optic neuritis (ON); other clinically isolated syndrome (CIS);"/>
   <result pre="first episode of acute disseminated encephalomyelitis (ADEM); transverse myelitis (TM);" exact="optic neuritis" post="(ON); other clinically isolated syndrome (CIS); neuromyelitis optica (NMO)."/>
   <result pre="myelitis (TM); optic neuritis (ON); other clinically isolated syndrome (CIS);" exact="neuromyelitis optica" post="(NMO). Objectives: To test the hypothesis that children with"/>
   <result pre="more common among the youngest. P745 Cognitive impairment in pediatric" exact="multiple sclerosis" post="patients is not related to cortical lesions MA Rocca"/>
   <result pre="a relationship between educational attainment and employment in adults with" exact="multiple sclerosis" post="(MS), with the underlying hypothesis that progressive MS pathology"/>
   <result pre="subsequent employment. P747 Vitamin D status as a predictor of" exact="multiple sclerosis" post="outcome in children with acute demyelinating syndromes: a prospective"/>
   <result pre="Background: Vitamin D may be a protective etiologic factor for" exact="multiple sclerosis" post="(MS). Acute demyelinating syndromes (ADS) of the CNS represent"/>
   <result pre="possibly reduce risk of MS. P748 Puberty onset and pediatric" exact="multiple sclerosis" post="course S Lulu 1, J Graves 1, E Waubant"/>
   <result pre="new insights in important factors regulating disease processes. P749 Recurrent" exact="optic neuritis" post="in children L Benson 1, G Heidary 1, J"/>
   <result pre="States, 9Boston Children’s Hospital, Boston, MA, United States Background: Recurrent" exact="optic neuritis" post="(ON) occurs in children without MS or NMO, yet"/>
   <result pre="and treatment of the disease. P750 Behavioral ratings in pediatric" exact="multiple sclerosis" post="(MS) MW Porter 1,2, LE Charvet 1,2, D Serafin"/>
   <result pre="Stony Brook, Stony Brook, NY, United States Background: Acute disseminated" exact="encephalomyelitis" post="(ADEM) is an inflammatory demyelinating disease of the CNS"/>
   <result pre="by EDSS. P752 Assessing long-term functional outcomes in children with" exact="acute disseminated encephalomyelitis" post="CS Beatty 1, AS Drake 1, D Ramasamy 1,"/>
   <result pre="P752 Assessing long-term functional outcomes in children with acute disseminated" exact="encephalomyelitis" post="CS Beatty 1, AS Drake 1, D Ramasamy 1,"/>
   <result pre="warranted. P753 A case-control study for risk factors of pediatric" exact="multiple sclerosis" post="in Iran: highlighting the role of puberty M Fereidan-Esfahani"/>
   <result pre="of Background: Although several studies have assessed risk factors for" exact="multiple sclerosis" post="(MS) in adult, there is a lack of data"/>
   <result pre="of MS in who had the positive medical history of" exact="rubella" post="before puberty (OR= 5.206, 95% CI: 1.540-17.601). Finally, mode"/>
   <result pre="P754 Sex related differences in T2 lesion load in pediatric" exact="multiple sclerosis" post="patients HM Hummel 1, P Huppke 1, T Friede"/>
   <result pre="Statistics, Göttingen, Germany Background: A preponderance of females affected by" exact="multiple sclerosis" post="is well reviewed. Several studies have shown an equal"/>
   <result pre="been performed exploring possible differences in the MRI presentation of" exact="multiple sclerosis" post="in boys and girls. Objectives: To study sex-and age"/>
   <result pre="Objectives: To study sex-and age related differences in pediatric relapsing-remitting" exact="multiple sclerosis" post="before and after puberty. Methods: Single center retrospective study"/>
   <result pre="six month after disease manifestation in 178 children with definite" exact="multiple sclerosis" post="recruited by the Center for Multiple Sclerosis in Childhood"/>
   <result pre="in brain volume in a cohort of pediatric patients with" exact="multiple sclerosis" post="(MS), clinical isolated syndromes (CIS), acute disseminated encephalomyelitis (ADEM),"/>
   <result pre="pediatric patients with multiple sclerosis (MS), clinical isolated syndromes (CIS)," exact="acute disseminated encephalomyelitis" post="(ADEM), and other neurological disorders (OND). Methods: In this"/>
   <result pre="with multiple sclerosis (MS), clinical isolated syndromes (CIS), acute disseminated" exact="encephalomyelitis" post="(ADEM), and other neurological disorders (OND). Methods: In this"/>
   <result pre="OND group included 10 headache, 6 seizure and 3 CNS" exact="vasculitis" post="patients. MRI was performed at baseline, with 2 and"/>
   <result pre="been recently FDA approved for the treatment of adults with" exact="multiple sclerosis" post="(MS). Objectives: To evaluate safety, tolerability and preliminary efficacy"/>
   <result pre="(n=1), GI symptoms (nausea, vomiting, abdominal pain) (n= 7), and" exact="rash" post="(n=2). Three patients discontinued (D/C) the oral DMTs; 1"/>
   <result pre="is one of the most common symptoms in children with" exact="multiple sclerosis" post="(MS) and after acute disseminated encephalomeyelitis (ADEM). In children,"/>
   <result pre="intracranial volume) is linked to level of disability on the" exact="multiple sclerosis" post="functional composite JF Sumowski 1, CS Riley 2, G"/>
   <result pre="Background: Physical disability is prevalent but variable across patients with" exact="multiple sclerosis" post="(MS), even among patients with comparable disease burden. This"/>
   <result pre="Philadelphia, Philadelphia, PA, United States Background: MRI features of pediatric-onset" exact="multiple sclerosis" post="(MS) are well understood, and recent work has focused"/>
   <result pre="less well studied. Early predictors of outcome in children with" exact="multiple sclerosis" post="have implications for clinical care and for identifying eligible"/>
   <result pre="treatment decisions. P762 Possible prognostic factors for visual function after" exact="optic neuritis" post="GH Dale 1, K Bacher Svendsen 1, T Bek"/>
   <result pre="T Petersen 1 1Aarhus University Hospital, Aarhus, Denmark Background: Acute" exact="optic neuritis" post="(ON) may lead to permanent visual impairment, but suitable"/>
   <result pre="prognostic marker for BCVA 6 months after an episode of" exact="optic neuritis." post="Contrast sensitivity and the overall classification of RNFLT, does"/>
   <result pre="Unit, Genoa, Italy Background: Early identification of patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS) who are at risk of disease progression may"/>
   <result pre="Biostatistics Unit, Genoa, Italy Background: Timely identification of patients with" exact="multiple sclerosis" post="(MS) who are at risk of poor outcomes facilitates"/>
   <result pre="resonance imaging (MRI) has improved the diagnosis and monitoring of" exact="multiple sclerosis" post="(MS). Parameters usually studied are weakly correlated with physical"/>
   <result pre="test and 9HPT. P768 A clinical prediction model for definite" exact="multiple sclerosis" post="in patients with clinically isolated syndrome TF Runia 1,"/>
   <result pre="Clinically isolated syndrome (CIS) is often the first manifestation of" exact="multiple sclerosis" post="(MS). However, not all patients with CIS will go"/>
   <result pre="not all patients with CIS will go on to develop" exact="multiple sclerosis" post="(MS). The uncertainty about whether or not a CIS"/>
   <result pre="early start of immunomodulatory treatment. P769 Predicting clinical course in" exact="multiple sclerosis" post="using machine learning T Chitnis 1, Y Zhao 2,"/>
   <result pre="To explore the utility of machine-learning techniques to reliably predict" exact="multiple sclerosis" post="disease progression status at up to five years of"/>
   <result pre="the most relevant surrogate markers for conversion to clinically definite" exact="multiple sclerosis" post="(CDMS) and development of sustained disability progression (SDP). Investigation"/>
   <result pre="also associated with SDP. P771 Predictors of disability accrual in" exact="multiple sclerosis" post="patients on first-line therapy T Spelman 1, V Jokubaitis"/>
   <result pre="principal objective when managing the clinical care of people with" exact="multiple sclerosis" post="(MS) is to prevent the irreversible accumulation of neurological"/>
   <result pre="expanded disability status scale (EDSS) change in patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS) treated with any interferon-beta (IFNβ) preparation or glatiramer"/>
   <result pre="and QOL P772 Psychosocial factors affecting quality of life in" exact="multiple sclerosis" post="- a review of the current evidence base CA"/>
   <result pre="predict the perceived health-related quality of life in persons with" exact="multiple sclerosis" post="IR Zarbo 1,2, S Demontis 3, G Carpentras 3,"/>
   <result pre="Canada, 7University of Manitoba, Winnipeg, MB, Canada Background: Persons with" exact="multiple sclerosis" post="(MS) report lower health-related quality of life (HRQoL) than"/>
   <result pre="undergone extensive psychometric testing but their performance in persons with" exact="multiple sclerosis" post="(MS) with a range of cognitive impairment has not"/>
   <result pre="Denmark Background: Ambulatory impairment is common in patients with secondary-progressive" exact="multiple sclerosis" post="(SPMS). In the ASCEND study of patients with SPMS,"/>
   <result pre="6MWT distance. P778 Longitudinal course of depression and fatigue in" exact="multiple sclerosis" post="EE Greeke 1, AS Chua 1, BC Healy 1,"/>
   <result pre="Background: Depression and fatigue are commonly reported in patients with" exact="multiple sclerosis" post="(MS). Although there are numerous studies looking at the"/>
   <result pre="of patient-reported symptoms and impairment in relapsing-remitting and secondary progressive" exact="multiple sclerosis" post="HJ Gross 1, C Watson 2 1Kantar Health, Princeton,"/>
   <result pre="(88.6% vs 69.9%; P=0.001); muscle spasms (74.3% vs 54.1%; P=0.001);" exact="sexual dysfunction" post="(33.3% vs 22.7%; P=0.023); stiffness (56.2% vs 34.9%; P&amp;lt;"/>
   <result pre="(56.2% vs 34.9%; P&amp;lt; 0.001); tremor (25.7% vs 15.3%; P=0.011);" exact="constipation" post="(51.4% vs 28.2%; P&amp;lt; 0.001); and urinary incontinence or"/>
   <result pre="Idec Inc. P780 Cognition and fatigue in patients with relapsing" exact="multiple sclerosis" post="treated by subcutaneous interferon beta-1a: an observational study SKORE"/>
   <result pre="r.o., Prague, Czech Republic Background: Cognitive impairment often occurs in" exact="multiple sclerosis" post="(MS) patients, even in the early stages of the"/>
   <result pre="of Liverpool, Liverpool, United Kingdom Background: 70-80% of patients with" exact="multiple sclerosis" post="(MS) will experience some lower urinary tract symptoms (LUTS)"/>
   <result pre="P784 Psychometric testing of the early mobility impairment questionnaire for" exact="multiple sclerosis" post="T Ziemssen 1, A Mathias 2, C Coon 2,"/>
   <result pre="University, MS, United States Background: Nearly all subjects (93%) with" exact="multiple sclerosis" post="(MS) experience some degree of mobility impairment—over half (58%)"/>
   <result pre="2004;42(9):851-859 P786 Psychometric properties of the French version of the" exact="multiple sclerosis" post="knowledge questionnaire Y Bourhis 1, S Chrétin 1, S"/>
   <result pre="France, 3Hôpital Central, Nancy, France Background: Improving patient information about" exact="multiple sclerosis" post="(MS) requires reliable assessment of patient knowledge. The Multiple"/>
   <result pre="investigated. P787 Rasch analysis of the Leeds Spasticity Scale in" exact="multiple sclerosis" post="RJ Mills 1, K Milinis 2,3, A Tennant 4,"/>
   <result pre="longer form measures. P788 Dalfampridine improves spasticity and fatigue in" exact="multiple sclerosis" post="M-A Guyot 1, C Donzé 1, H Khenioui 1,"/>
   <result pre="Lomme, France Background: Fatigue and spasticity are common symptoms in" exact="multiple sclerosis" post="(MS) with significant impairment of quality of life. Objectives:"/>
   <result pre="P789 Evaluation of the health related quality of life in" exact="neuromyelitis optica" post="spectrum disorder S-Y Huh 1, HJ Kim 2, J"/>
   <result pre="of care provided to patients with chronic disease such as" exact="neuromyelitis optica" post="spectrum disorder (NMOSD). However, there have been limited studies"/>
   <result pre="interim analysis of quality of life in patients with relapsing-remitting" exact="multiple sclerosis" post="treated with delayed-release dimethyl fumarate SP Sarda 6, M"/>
   <result pre="a 24-months, non-interventional study in 1705 patients with relapsing remitting" exact="multiple sclerosis" post="(RRMS). Of 1705 patients, 1214 patients used injectable interferon"/>
   <result pre="been reported, but the prevalence of specific symptoms in relapsing-remitting" exact="multiple sclerosis" post="(RRMS), how they are related to one another, and"/>
   <result pre="and their impact on quality of life in patients with" exact="multiple sclerosis" post="N Oztekin 1, MF Oztekin 2, E Eruyar 1,"/>
   <result pre="acetate (GA) and interferon-beta (IFN-β) are disease-modifying therapies (DMTs) for" exact="multiple sclerosis" post="that are administered through subcutaneous (SC) or intramuscular (IM)"/>
   <result pre="QoL. Methods: It is a longutudinal study among patients with" exact="multiple sclerosis" post="who had been treated with their first DMT for"/>
   <result pre="times a week (p&amp;lt; 0.05). The other side effects were" exact="anemia" post="and leucopenia (60 %), 40% in patients using GA"/>
   <result pre="the FSMC. P796 Development of the neurological hope index for" exact="multiple sclerosis" post="(NHI-MS) CA Young 1,2, A Tennant 3, Trajectories of"/>
   <result pre="of the WHO Disability Assessment Schedule 2.0 for use in" exact="multiple sclerosis" post="CJ Gibbons 1, R Mills 2, A Tennant 3,"/>
   <result pre="study evaluated the suitability of this measure for use in" exact="multiple sclerosis" post="(MS) by applying scale data to the Rasch model,"/>
   <result pre="(AEs) associated with interferon beta treatments (IFN) in patients with" exact="multiple sclerosis" post="(MS) and may have a negative effect on patients’"/>
   <result pre="4University of Manitoba, Winnipeg, MB, Canada Background: Persons living with" exact="multiple sclerosis" post="(MS) frequently experience bladder dysfunction which can vary in"/>
   <result pre="and sexual problems in 2010. P801 New sleep scales for" exact="multiple sclerosis" post="RJ Mills 1, A Tennant 2, CA Young 3,"/>
   <result pre="There is an intimate relationship between fatigue and sleep in" exact="multiple sclerosis" post="(MS). During the construction of the Neurological Fatigue Index"/>
   <result pre="approved in over 30 countries for the treatment of relapsing-remitting" exact="multiple sclerosis" post="(RRMS). In the 2-year phase 3 CARE-MS II study,"/>
   <result pre="relapses and quality of life in patients with relapsing remitting" exact="multiple sclerosis" post="L Grau-Lopez 1, M Tintoré 2, L Ramió-Torrentà 3,"/>
   <result pre="relapses in quality of life of patients with relapsing remitting" exact="multiple sclerosis." post="Methods: Forty-nine MS patients with a relapse included in"/>
   <result pre="2Biogen Idec Inc., Cambridge, MA, United States Background: Patients with" exact="multiple sclerosis" post="(MS) often report diminished health-related quality of life (HRQoL)."/>
   <result pre="the general US population. P806 Italian validation of the 12-item" exact="multiple sclerosis" post="walking scale (MSWS-12) E Trabucco 1, M Cella 1,"/>
   <result pre="been commonly reported in the lower limbs of people with" exact="multiple sclerosis" post="(MS). CMI is typically documented based on performing a"/>
   <result pre="disability status. P808 Corticospinal reserve predicts walking improvement in progressive" exact="multiple sclerosis" post="patients undergoing neurorehabilitation and deep rTMS with H-coil A"/>
   <result pre="Background: Walking impairment affect up to 85% of subjects with" exact="multiple sclerosis" post="- MS - with a major impact on their"/>
   <result pre="P809 Efficacy of mental imagery to improve autobiographical memory in" exact="multiple sclerosis" post="patients: a double approach in neuropsychology and neuroimaging A"/>
   <result pre="We previously showed autobiographical memory (AM) impairment in non-depressed relapsing-remitting" exact="multiple sclerosis" post="(RR-MS) patients, very likely caused by a retrieval-strategy deficit."/>
   <result pre="Republic Background: Gait abnormalities are a common feature of the" exact="multiple sclerosis" post="(MS) patients. Even MS patients with minimal clinical disability"/>
   <result pre="validity of the narrow path walking test for people with" exact="multiple sclerosis" post="U Rosenblum 1,2, I Melzer 2, A Achiron 1,3"/>
   <result pre="scores. P812 Visual delay adaptation to reduce intention tremor in" exact="multiple sclerosis" post="M Heenan 1, R Scheidt 1,2,3, S Beardsley 1,4,5"/>
   <result pre="tremor is a disabling symptom affecting ~15% of those with" exact="multiple sclerosis" post="(MS). Our previous work has shown that tremor may"/>
   <result pre="A novel characterization of gait pattern alterations in individuals with" exact="multiple sclerosis" post="based on quantitative movement analysis M Pau 1, G"/>
   <result pre="P815 Factors affecting physical activity in minimally impaired people with" exact="multiple sclerosis" post="T Kahraman 1, S Savci 1, E Coskuner Poyraz"/>
   <result pre="known benefits of physical activity, evidence shows that people with" exact="multiple sclerosis" post="(pwMS) are relatively inactive. There are several studies about"/>
   <result pre="Sclerosis Center, Sheba Medical Center, Tel-Hashomer, Israel Background: People with" exact="multiple sclerosis" post="(MS) identify mobility limitations as one of the greatest"/>
   <result pre="level of concern. P819 Brain activity during motor imagery in" exact="multiple sclerosis" post="G Brichetto 1, A Tacchino 1, R Teodorescu 2,"/>
   <result pre="Neuropsychological and neurophysiological assessment of a cognitive rehabilitation program for" exact="multiple sclerosis" post="patients M Vazquez-Marrufo 1, A Galvao-Carmona 1, M Borges"/>
   <result pre="Sclerosis Unit, Seville, Spain Background: Cognitive impairment is common in" exact="multiple sclerosis" post="patients. One of the main challenges nowadays is to"/>
   <result pre="of applying a cognitive rehabilitation program to a sample of" exact="multiple sclerosis" post="patients. Methods: Thirty-three subjects were assigned to three groups"/>
   <result pre="of gait during a long distance walk in persons with" exact="multiple sclerosis" post="JM Wagner 1, V Levasseur 2, G Adusumilli 2,"/>
   <result pre="Gonda Brain Research Center, Ramat Gan, Israel Background: Persons with" exact="multiple sclerosis" post="(pwMS) have difficulties walking long distances yet the specific"/>
   <result pre="Kansas City, KS, United States Background: Up to 65% of" exact="multiple sclerosis" post="(MS) patients experience cognitive deficits associated in the disease,"/>
   <result pre="The relationship between core stability and balance in patients with" exact="multiple sclerosis" post="G Yazici 1, A Guclu-Gunduz 1, C Ozkul 1,"/>
   <result pre="United States Background: The chronic, progressive, and variable nature of" exact="multiple sclerosis" post="(MS) underscores the importance of establishing strong relationships between"/>
   <result pre="medicine: enabling evidence-based and individualized treatment decisions for patients with" exact="multiple sclerosis" post="V Viglietta 1, K Raghupathi 1, W Gabel 1,"/>
   <result pre="to a rapid expansion in available treatments for patients with" exact="multiple sclerosis" post="(MS) in recent years. However, benefit-risk profiles are not"/>
   <result pre="treatment decision making will be presented. P826 Do patients with" exact="multiple sclerosis" post="understand quantitative health information? A comparison of patients with"/>
   <result pre="Background: Natalizumab (NAT) is a highly effective therapy in relapsing" exact="multiple sclerosis" post="(MS), yet bears the risk of a progressive multifocal"/>
   <result pre="relapsing multiple sclerosis (MS), yet bears the risk of a" exact="progressive multifocal leukoencephalopathy" post="as a rare but severe side effect. To make"/>
   <result pre="of data from an adult day program for people with" exact="multiple sclerosis" post="D Burke 1, S Minden 1, M Serotkin 2,"/>
   <result pre="adherence and persistence. P829 Aerobic fitness and hippocampal volume in" exact="multiple sclerosis" post="RW Motl 1, B Sutton 1, E Hubbard 1,"/>
   <result pre="States Background: The hippocampus is important for memory functions in" exact="multiple sclerosis" post="(MS). Importantly, there is significant atrophy of this structure"/>
   <result pre="Background: Falls are a significant health concern for individuals with" exact="multiple sclerosis" post="(IwMS) and have been associated with physical injury, fear"/>
   <result pre="among non-ambulatory IwMS. P832 Low-cost portable posturography for patients with" exact="multiple sclerosis" post="using Wii balance board L Prosperini 1, L Stocchi"/>
   <result pre="objective and specific outcome measures for balance of patients with" exact="multiple sclerosis" post="(MS). Despite this, the lack of standardisation, heterogeneity of"/>
   <result pre="of fascial mobilization on dynamic walking parameters in patients with" exact="multiple sclerosis" post="H Keklicek 1, Y Salci 1, A Fil 1,"/>
   <result pre="Vitamin D serum levels and balance are not related in" exact="multiple sclerosis" post="G Coghe 1, M Pau 2, E Cocco 1,"/>
   <result pre="and efficacy of working memory training for individuals with pediatric-onset" exact="multiple sclerosis" post="B Kuni 1, A Sye 2, EA Yeh 2,3,4,"/>
   <result pre="a relationship between cognitive and motor performance in persons with" exact="multiple sclerosis" post="(MS), generally using as experimental setting the dual task"/>
   <result pre="and pregnancy P838 Glatiramer acetate and pregnancy in women with" exact="multiple sclerosis" post="- results from the German multiple sclerosis and pregnancy"/>
   <result pre="in women with multiple sclerosis - results from the German" exact="multiple sclerosis" post="and pregnancy registry S Herbstritt 1,2, M Rockhoff 1,"/>
   <result pre="Pharmacy, Toronto, ON, Canada Background: MS is the most common" exact="autoimmune disease" post="of the central nervous system, which mainly affects young"/>
   <result pre="of glatiramer acetate (GLAT) exposure during pregnancy of patients with" exact="multiple sclerosis" post="(MS). Methods: We compared the outcome of pregnancies of"/>
   <result pre="were born with malformations of non-genetic origin: 2 with an" exact="atrial septal defect," post="1 with dysmelia of tibia and fibula of the"/>
   <result pre="of childbearing age make up a large proportion of the" exact="multiple sclerosis" post="population, it is important to evaluate effects of delayed-release"/>
   <result pre="Clinical studies of delayed-release DMF included 2,665 MS patients, 320" exact="psoriasis" post="patients, 101 rheumatoid arthritis patients, and 338 healthy volunteers;"/>
   <result pre="delayed-release DMF included 2,665 MS patients, 320 psoriasis patients, 101" exact="rheumatoid arthritis" post="patients, and 338 healthy volunteers; subjects were required to"/>
   <result pre="DMF included 2,665 MS patients, 320 psoriasis patients, 101 rheumatoid" exact="arthritis" post="patients, and 338 healthy volunteers; subjects were required to"/>
   <result pre="MA, United States Background: Almost half of women living with" exact="multiple sclerosis" post="(MS) are post-menopausal. While puberty and pregnancy represent key"/>
   <result pre="to explore a potential role for HRT. P841 Risk of" exact="neuromyelitis optica" post="spectrum disorder relapse associated with pregnancy on Japanese patients"/>
   <result pre="describing the influence of pregnancy on the clinical course of" exact="neuromyelitis optica" post="spectrum disorder (NMOSD). Previously reports reviewed the annualized relapse"/>
   <result pre="Alemtuzumab, approved in over 30 countries for treatment of relapsing-remitting" exact="multiple sclerosis" post="(RRMS), showed superior efficacy over subcutaneous interferon beta-1a (SC"/>
   <result pre="and disease activity after exposure to natalizumab in patients with" exact="multiple sclerosis" post="E Portaccio 1, B Hakiki 1, L Pastò 1,"/>
   <result pre="and disease activity after in utero exposure to natalizuamb in" exact="multiple sclerosis" post="(MS) patients. Objectives: To assess the impact of natalizumab"/>
   <result pre="during and after pregnancy are ongoing. P844 Pregnancy issues in" exact="multiple sclerosis" post="patients: preliminary results from a multicenter retrospective cohort study"/>
   <result pre="and to higher rates of elective abortion rather than to" exact="infertility" post="issues. P845 Sex life of women with multiple sclerosis:"/>
   <result pre="tremor, muscle weakness, sensorial disorders, depression, cognitive problems, bladder and" exact="bowel dysfunction" post="and sexual dysfunction are commonly seen in multiple sclerosis"/>
   <result pre="sensorial disorders, depression, cognitive problems, bladder and bowel dysfunction and" exact="sexual dysfunction" post="are commonly seen in multiple sclerosis (MS) and these"/>
   <result pre="and bowel dysfunction and sexual dysfunction are commonly seen in" exact="multiple sclerosis" post="(MS) and these conditions significantly affect the quality of"/>
   <result pre="Background: Teriflunomide is a once-daily oral immunomodulator approved for relapsing-remitting" exact="multiple sclerosis" post="(MS). Evidence from animal studies suggests a potential risk"/>
   <result pre="pregnancies in the post-marketing setting. P847 Exclusive breastfeeding and postpartum" exact="multiple sclerosis" post="relapses K Hellwig 1, M Rockhoff 1, S Herbstritt"/>
   <result pre="Department Kaiser Permanente, Pasadena, CA, United States Background: Women with" exact="multiple sclerosis" post="(MS) experience an elevated relapse risk after birth. The"/>
   <result pre="postpartum relapses. P848 Ovarian reserve and sex hormone levels in" exact="multiple sclerosis" post="patients M Sepulveda 1, E Hernández 1, M Hervàs"/>
   <result pre="causes associated with impairment of the fertility in women with" exact="multiple sclerosis" post="(MS). However, the ovarian reserve, a measure of the"/>
   <result pre="with gonadotoxic treatments and/or had a history of any known" exact="endocrine disease" post="or infertility (e.g., polycystic ovary syndrome). MS patients were"/>
   <result pre="and/or had a history of any known endocrine disease or" exact="infertility" post="(e.g., polycystic ovary syndrome). MS patients were free from"/>
   <result pre="the prime of their sexual lives. Objectives: In everyday practice" exact="sexual dysfunction" post="is underestimated because clinicians mostly concentrate on the classical"/>
   <result pre="We included in our study 97 patients with relapse remitting" exact="multiple sclerosis" post="from our MS register, 22 men and 75 women"/>
   <result pre="men and 75 women with established diagnosis of relapse remitting" exact="multiple sclerosis" post="according to McDonald criteria. Patients completed the questionnaires (Sexual"/>
   <result pre="without aid, self sufficient patients) we found positive correlation between" exact="sexual dysfunction" post="and depression showing that even in such patients quality"/>
   <result pre="order to improve their quality of life. P850 Prevalence of" exact="sexual dysfunction" post="in multiple sclerosis RAP da Silva 1, LP Stievano"/>
   <result pre="their quality of life. P850 Prevalence of sexual dysfunction in" exact="multiple sclerosis" post="RAP da Silva 1, LP Stievano 1, GS do"/>
   <result pre="social, family and emotional relationships. It was observed that the" exact="sexual dysfunction" post="(SD) affects 82 to 91% of men and 59"/>
   <result pre="life interfere with sexual health of these patients. Objectives: Assess" exact="sexual dysfunction" post="by The Multiple Sclerosis Intimicy and Sexuality Questionnaire-19 (MSISQ-19),"/>
   <result pre="group and 134 patients with MS. Results: The incidence of" exact="sexual dysfunction" post="in our study was 72% in women and 54%"/>
   <result pre="be used as a tool for assessing the impact of" exact="sexual dysfunction" post="in patients with MS.Most research suggests that MS has"/>
   <result pre="important to consider, however, that despite the high prevalence of" exact="sexual dysfunction" post="in MS, we should not neglect other conditions that"/>
   <result pre="States Background: Reproductive hormones impact the onset and course of" exact="multiple sclerosis" post="(MS). Recent interest in reproductive health in MS, as"/>
   <result pre="time. The rates of women limiting their pregnancy due to" exact="infertility" post="and lack of desire to have children remained stable,"/>
   <result pre="practices and disease course. P852 The role of breastfeeding in" exact="multiple sclerosis" post="patients S Perez-Sanchez 1, S Eichau-Madueño 1, M Rus-Hidalgo"/>
   <result pre="type of feeding. Methods: We observed all pregnancies in relapsing-remitting" exact="multiple sclerosis" post="(RRMS) women at Virgen Macarena University Hospital from 2004"/>
   <result pre="P853 Examining the effectiveness of pregnancy counseling in women with" exact="multiple sclerosis" post="of childbearing potential LH Travis 1, K Clarke 1,"/>
   <result pre="in September. P854 Sexual dysfunctions in female patients with relapsing-remitting" exact="multiple sclerosis" post="K Zebenholzer 1, R Prohazka 1, S Salhofer-Polanyi 1,"/>
   <result pre="the 42 MS patients 35.7 % had any form of" exact="sexual dysfunction," post="with primary sexual dysfunction being the most common form"/>
   <result pre="35.7 % had any form of sexual dysfunction, with primary" exact="sexual dysfunction" post="being the most common form (40 %), and 33.3"/>
   <result pre="most common form (40 %), and 33.3 % having tertiary" exact="sexual dysfunction." post="Of the 31 headache patients 22.6 % had any"/>
   <result pre="the 31 headache patients 22.6 % had any form of" exact="sexual dysfunction," post="with primary and tertiary sexual dysfunctions being the most"/>
   <result pre="more often had a combination of primary, secondary and tertiary" exact="sexual dysfunction." post="Depression and the psychological and physical scale of the"/>
   <result pre="psychological and physical scale of the SF-36 correlated significantly with" exact="sexual dysfunction" post="in both groups. Conclusions: A considerable number of females"/>
   <result pre="P856 Progestin content of oral contraceptives and the risk of" exact="multiple sclerosis" post="AM Langer-Gould 1, K Hellwig 2, LH Chen 1,"/>
   <result pre="first patient is 49 year old woman with relapsing remitting" exact="multiple sclerosis" post="(RRMS) on NZB for 3 years and 6months who"/>
   <result pre="opportunistic brain infection caused by the John Cunningham virus (JCV)," exact="progressive multifocal leukoencephalopathy" post="(PML) occurs in immunecompromised states, including treatment of multiple"/>
   <result pre="multifocal leukoencephalopathy (PML) occurs in immunecompromised states, including treatment of" exact="multiple sclerosis" post="(MS) with natalizumab. We treated fifteen patients with MS,"/>
   <result pre="To present an all-surviving cohort of 15 patients with natalizumab-associated" exact="progressive multifocal leukoencephalopathy" post="(PML) in whom management strategies evolved to a core"/>
   <result pre="1University Hospital of Padova, Padova, Italy Background: Natalizumab-treated relapsing remitting" exact="multiple sclerosis" post="(RRMS) patients may face a high risk of progressive"/>
   <result pre="multiple sclerosis (RRMS) patients may face a high risk of" exact="progressive multifocal leukoencephalopathy" post="(PML). Actually, in RRMS patients treated for more then"/>
   <result pre="SAEs, 14 Herpes Zoster events, 2 malignancies (excluding non melanoma" exact="skin cancer," post="NMSC) and 5 NMSC were recorded on fingolimod, compared"/>
   <result pre="P861 Longitudinal serum JCV indexes in MS patients with natalizumab-associated" exact="progressive multifocal leukoencephalopathy" post="A Vennegoor 1, JA van Rossum 1, M Wattjes"/>
   <result pre="serum antibodies is a risk factor for the development of" exact="progressive multifocal leukoencephalopathy" post="(PML) in multiple sclerosis (MS) patients treated with natalizumab."/>
   <result pre="factor for the development of progressive multifocal leukoencephalopathy (PML) in" exact="multiple sclerosis" post="(MS) patients treated with natalizumab. We hypothesize that higher"/>
   <result pre="with clear recommendations on immunization against varicella. P863 Treatment of" exact="multiple sclerosis" post="patients after 24 Natalizumab doses: a prospective observational study:"/>
   <result pre="Italy Background: Natalizumab is the most effective drug for relapsing-remitting" exact="multiple sclerosis" post="(RR-MS) but could rarely be associated with progressive multifocal"/>
   <result pre="relapsing-remitting multiple sclerosis (RR-MS) but could rarely be associated with" exact="progressive multifocal leukoencephalopathy" post="(PML), whose risk increases after 24 natalizumab administrations. Objectives:"/>
   <result pre="after NTZ discontinuation. P865 Anti-JC virus antibodies in a Portuguese" exact="multiple sclerosis" post="cohort I Correia 1, IB Marques 1, S Batista"/>
   <result pre="used off-label in various autoimmune disorders including MS, NMO, and" exact="myasthenia gravis." post="Early stage clinical trials and several case series have"/>
   <result pre="States Background: Alemtuzumab is approved in &amp;gt;30 countries for relapsing-remitting" exact="multiple sclerosis" post="(RRMS). In 3 clinical trials, alemtuzumab demonstrated superior efficacy"/>
   <result pre="times weekly. Standardized incidence ratios (SIRs) were calculated to quantify" exact="cancer" post="risk in alemtuzumab-treated patients compared with a retrospective MS"/>
   <result pre="of autoimmune thyroid disorders. The other most common malignancies were" exact="breast cancer" post="(SIR 0.85; 95% CI 0.35-2.04), malignant melanoma (SIR 0.88;"/>
   <result pre="autoimmune thyroid disorders. The other most common malignancies were breast" exact="cancer" post="(SIR 0.85; 95% CI 0.35-2.04), malignant melanoma (SIR 0.88;"/>
   <result pre="of anti-JCV-antibodies serves as an established risk predictor for natalizumab-associated" exact="progressive multifocal leukoencephalopathy" post="(PML). More recently, the level of antibodies (index) as"/>
   <result pre="in the limelight as serious adverse event of some new" exact="multiple sclerosis" post="(MS) drugs such as Natalizumab, Fingolimod, and Dimethyl Fumarate."/>
   <result pre="(WM) disease, since several &quot;cortical&quot; signs as seizures, behavioural disturbances," exact="aphasia" post="and cortical blindness have been described. The involvement of"/>
   <result pre="since several &quot;cortical&quot; signs as seizures, behavioural disturbances, aphasia and" exact="cortical blindness" post="have been described. The involvement of GM has been"/>
   <result pre="1 with HIV-related leukoencephalopathy, 3 MS subjects, 2 patients with" exact="metachromatic leukodystrophy" post="and 5 healthy controls were recruited in the study."/>
   <result pre="with HIV-related leukoencephalopathy, 3 MS subjects, 2 patients with metachromatic" exact="leukodystrophy" post="and 5 healthy controls were recruited in the study."/>
   <result pre="to the pial surface, were observed. In HIV-related leukoencephalopathy and" exact="metachromatic leukodystrophy" post="lesions were limited to the WM and never entered"/>
   <result pre="the pial surface, were observed. In HIV-related leukoencephalopathy and metachromatic" exact="leukodystrophy" post="lesions were limited to the WM and never entered"/>
   <result pre="P872 Application of serum natalizumab levels during plasma exchange in" exact="multiple sclerosis" post="patients with progressive multifocal leukoencephalopathy A Vennegoor 1, T"/>
   <result pre="natalizumab levels during plasma exchange in multiple sclerosis patients with" exact="progressive multifocal leukoencephalopathy" post="A Vennegoor 1, T Rispens 2, BW van Oosten"/>
   <result pre="PLEX may optimize the current treatment strategy. Methods: In four" exact="multiple sclerosis" post="(MS) patients who developed natalizumab-associated PML we measured serum"/>
   <result pre="first oral therapy approved for the treatment of relapsing remitting" exact="multiple sclerosis" post="(RRMS). Its therapeutic effect in MS is exerted through"/>
   <result pre="Results: A 49-yrs woman with history of mild, non-treatment requiring" exact="asthma" post="during adolescence was diagnosed with RRMS in 1999. She"/>
   <result pre="not contribute to reduced bone mineral density in patients with" exact="multiple sclerosis" post="A Olsson 1, D Oturai 1, PS Sorensen 1,"/>
   <result pre="in MS patients. Results: Osteopenia was present in 38% and" exact="osteoporosis" post="in 7% of the study population. The mean Z-score"/>
   <result pre="appears not to be the primary underlying cause of secondary" exact="osteoporosis" post="in MS patients. The principal factors associated with reduced"/>
   <result pre="Two-years clinical and radiological activity during fingolimod post-natalizumab in relapsing-remitting" exact="multiple sclerosis." post="Single-center experience R Hernández-Clares 1,2, E Carreón-Guarnizo 1,2, E"/>
   <result pre="(NTZ) was the treatment of choice in patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS) who had not responded after a course of"/>
   <result pre="aggressive onset of disease. In some patients, the risk of" exact="progressive multifocal leukoencephalopathy" post="(PML) causes NTZ withdrawal despite its efficacy. Fingolimod was"/>
   <result pre="While natalizumab therapy is highly efficacious for the treatment of" exact="multiple sclerosis" post="(MS), it does carry significant risk for progressive multifocal"/>
   <result pre="of multiple sclerosis (MS), it does carry significant risk for" exact="progressive multifocal leukoencephalopathy" post="(PML) in patients who have an immunosuppressant history, &amp;gt;=24"/>
   <result pre="(JCV) seropositivity is a risk factor for the development of" exact="progressive multifocal leukoencephalopathy" post="(PML) during natalizumab treatment in multiple sclerosis (MS) patients."/>
   <result pre="development of progressive multifocal leukoencephalopathy (PML) during natalizumab treatment in" exact="multiple sclerosis" post="(MS) patients. It has been suggested that patients who"/>
   <result pre="of NAT. P880 Management of infusion-associated reactions in alemtuzumab-treated relapsing-remitting" exact="multiple sclerosis" post="patients L Mayer 1, L Casady 2, G Clayton"/>
   <result pre="is approved in over 30 countries for treatment of relapsing-remitting" exact="multiple sclerosis" post="(RRMS). Alemtuzumab demonstrated superior efficacy over subcutaneous interferon beta-1a"/>
   <result pre="JCV antibody index and adhesion molecule expression levels in natalizumab-treated" exact="multiple sclerosis" post="patients - a cross-sectional study P Wipfler 1, A"/>
   <result pre="of anti-JC virus (JCV) antibodies is a risk factor for" exact="progressive multifocal leukoencephalopathy" post="(PML) development in natalizumab (NTZ)-treated multiple sclerosis (MS) patients."/>
   <result pre="factor for progressive multifocal leukoencephalopathy (PML) development in natalizumab (NTZ)-treated" exact="multiple sclerosis" post="(MS) patients. According to recent studies JCV reactivation occurs"/>
   <result pre="JC V serostatus. P882 Anti JC virus antibodies in pediatric" exact="multiple sclerosis" post="P Huppke 1, H Hummel 1, D Ellenberger 2,"/>
   <result pre="shown to be a very effective treatment in severe pediatric" exact="multiple sclerosis." post="So far no cases of progressive multifocal leukoencephalopathy have"/>
   <result pre="in severe pediatric multiple sclerosis. So far no cases of" exact="progressive multifocal leukoencephalopathy" post="have been reported in multiple sclerosis patients in this"/>
   <result pre="no cases of progressive multifocal leukoencephalopathy have been reported in" exact="multiple sclerosis" post="patients in this age group. Prevalence for anti JC"/>
   <result pre="antibody status on the clinical course in a large pediatric" exact="multiple sclerosis" post="cohort. Methods: Anti-JC virus antibodies were analyzed in serum"/>
   <result pre="course, NTZ is unfortunately associated with a risk of developing" exact="progressive multifocal leukoencephalopathy" post="(PML) that led to restriction use depending of PML"/>
   <result pre="allowed physicians to refine his decision. P884 Disease reactivation in" exact="multiple sclerosis" post="pregnant women who stopped natalizumab during the first gestational"/>
   <result pre="patients. Neurological irAES have been reported as single cases of" exact="aseptic meningitis," post="Guillain-Barré syndrome, facial palsy, myasthenia gravis, and Tolosa-Hunt syndrome."/>
   <result pre="as single cases of aseptic meningitis, Guillain-Barré syndrome, facial palsy," exact="myasthenia gravis," post="and Tolosa-Hunt syndrome. Objectives: This is the first case"/>
   <result pre="and Tolosa-Hunt syndrome. Objectives: This is the first case of" exact="multiple sclerosis" post="as irAE after IPI treatment. Methods: A 30-year-old patient"/>
   <result pre="Results: Brain biopsy ruled out cerebral metastases, but detected a" exact="multiple sclerosis" post="lesion with histopathological pattern I according to Lucchinetti et"/>
   <result pre="pattern I according to Lucchinetti et al. One month later" exact="optic neuritis" post="occurred as a first clinical manifestation and the diagnosis"/>
   <result pre="Background: John Cunningham virus (JCV) is known to cause rare" exact="progressive multifocal leukoencephalopathy" post="(PML) in natalizumab-treated MS-patients. Measuring of Anti-JCV Antibodies by"/>
   <result pre="patients (107 female, 36 male) at the outpatient clinic for" exact="multiple sclerosis" post="in Innsbruck, Austria have been tested for Anti-JCV Antibodies."/>
   <result pre="the test could be increased. P887 Is there an increased" exact="cancer" post="risk in people with relapsing multiple sclerosis taking cladribine?"/>
   <result pre="Is there an increased cancer risk in people with relapsing" exact="multiple sclerosis" post="taking cladribine? J Pakpoor 1, G Disanto 2, DR"/>
   <result pre="trial (CLARITY) of oral cladribine (Movectro) in people with relapsing" exact="multiple sclerosis" post="(pwRMS) reported significant efficacy. However, concerns over the safety"/>
   <result pre="by American and European regulatory bodies. Specifically, a suspected increased" exact="cancer" post="risk was key for the rejection of cladribine for"/>
   <result pre="Medicines Agency (EMA) in 2011. The small number of observed" exact="cancer" post="during CLARITY may be insufficient to definitively assess cancer"/>
   <result pre="observed cancer during CLARITY may be insufficient to definitively assess" exact="cancer" post="risk. Objectives: We compared the cancer risk of cladribine"/>
   <result pre="insufficient to definitively assess cancer risk. Objectives: We compared the" exact="cancer" post="risk of cladribine in CLARITY with other disease-modifying therapies"/>
   <result pre="pwRMS were included. Fisher’s exact test was used to compare" exact="cancer" post="rates. Results: Twelve phase III trials reported cancer rates"/>
   <result pre="to compare cancer rates. Results: Twelve phase III trials reported" exact="cancer" post="rates and were therefore included in this meta-analysis. Study"/>
   <result pre="interferon-beta 1a (IFN beta-1a)) were initially used for analysis. The" exact="cancer" post="rate in the CLARITY treatment group (1.13%) was not"/>
   <result pre="those with an IFN beta-1a comparator arm (1.05%, p=0.0951). No" exact="cancer" post="was detected in pwRMS assigned to placebo in CLARITY"/>
   <result pre="in pwRMS assigned to placebo in CLARITY whilst the combined" exact="cancer" post="rate of all other placebo groups was 1.19% (p=0.0159)."/>
   <result pre="rate of all other placebo groups was 1.19% (p=0.0159). The" exact="cancer" post="rate of zero in the CLARITY placebo group is"/>
   <result pre="demyelination (ORACLE), p=0.0012. In contrast, no difference was detected between" exact="cancer" post="rates in the treatment groups of CLARITY and ORACLE"/>
   <result pre="in CLARITY and ORACLE does not increase the risk of" exact="cancer" post="in pwRMS. The impression that it would appears driven"/>
   <result pre="impression that it would appears driven by an unusually low" exact="cancer" post="rate in the placebo group of CLARITY. Long term"/>
   <result pre="group of CLARITY. Long term follow-up will help determine the" exact="cancer" post="risk of all DMTs. Given its efficacy, tolerability and"/>
   <result pre="related to stem cells immune regulatory function in experimental autoimmune" exact="encephalomyelitis" post="(EAE) M Swiderek-Matysiak 1, M Fortak-Michalska 1, M Mycko"/>
   <result pre="with different immune regulatory potential assessed in animal model of" exact="multiple sclerosis," post="EAE. Methods: MicroRNA expression profile from freshly isolated BMSC"/>
   <result pre="stem cells used in a phase I clinical trial in" exact="multiple sclerosis" post="SM Planchon 1, I Warshawsky 2, JS Reese 3,4,"/>
   <result pre="I study of autologous mesenchymal stem cell (MSC) transplantation in" exact="multiple sclerosis" post="(MS), human MSCs were culture-expanded ex-vivo and infused IV."/>
   <result pre="increased probe coverage of genes relevant to stem cell and" exact="cancer" post="biology. Results: Some deletions and amplifications were detected in"/>
   <result pre="those that aim to improve the remyelination process in progressive" exact="multiple sclerosis," post="could be complimentary in targeting astrocytes, microglia, and infiltrated"/>
   <result pre="trial of autologous culture-expanded mesenchymal stem cell transplantation for relapsing" exact="multiple sclerosis" post="A Bar-Or 1, M-N Boivin 1, A Rozenberg 1,"/>
   <result pre="autologous MSCs administered intravenously in patients with relapsing forms of" exact="multiple sclerosis" post="(MS). Methods: In a single-arm open-label Phase I trial"/>
   <result pre="neural stem cells after therapeutic intrathecal transplantation in experimental autoimmune" exact="encephalomyelitis" post="A Merlini 1, D De Feo 1, F Ruffini"/>
   <result pre="neural stem/precursor cells (NPCs) ameliorates disease severity in experimental autoimmune" exact="encephalomyelitis" post="(EAE), the animal model of multiple sclerosis. Understanding the"/>
   <result pre="severity in experimental autoimmune encephalomyelitis (EAE), the animal model of" exact="multiple sclerosis." post="Understanding the kinetics of NPC behavior in vivo might"/>
   <result pre="experience in autologous hematopoietic stem cell transplantation in refractory aggressive" exact="multiple sclerosis" post="C Alcalá 1, F Pérez-Miralles 1, I Boscá 1,"/>
   <result pre="clinical experience of a series of refractory patients with aggressive" exact="multiple sclerosis" post="subject in which a BMT was performed at some"/>
   <result pre="BMT, 2 of them serious; 3 patients developed neoplasms (1" exact="carcinoma in situ" post="of the cervix, 2 breast cancers), with median time"/>
   <result pre="vitro and in the animal model of MS, experimental autoimmune" exact="encephalomyelitis" post="(EAE). Methods: Eight MS patients were selected with no"/>
   <result pre="outcome. P898 Autologous hematopoietic stem cell transplant in patients with" exact="neuromyelitis optica" post="J Burton 1, J Storek 2, P Duggan 2,"/>
   <result pre="and baseline EDSS 4.0. Transplant complications included transient asymptomatic febrile" exact="neutropenia" post="and volume overload. Her ARR 36 months post-transplant is"/>
   <result pre="P899 Generation and characterization of neuralized mesenchymal stem cells from" exact="multiple sclerosis" post="patients I Kassis 1, P Petrou 1, D Karussis"/>
   <result pre="Objectives: To generate and characterize neuralized mesenchymal stem cells from" exact="multiple sclerosis" post="patients. Methods: MSC were isolated from the BM of"/>
   <result pre="(NeuroCult™ NS-A).The immunomdualtory effects of MSC-NPs were tested with lymphocytes" exact="suppression" post="assay in vitro. Results: We were able to generate"/>
   <result pre="(GFAP marker) and oligodendrocytes (CNPase marker). Morevover, MSC-NPs induced dose-dependent" exact="suppression" post="of lymphocytes. Conclusions: The generation of MSC-NPs (which hold"/>
   <result pre="for neuroregeneration and remyelination in future autologous cell-therapy treatments for" exact="multiple sclerosis." post="P900 Anti-neural precursor cell (NPCs) - immune response in"/>
   <result pre="Anti-neural precursor cell (NPCs) - immune response in experimental autoimmune" exact="encephalomyelitis" post="(EAE) E Kesidou 1, O Touloumi 1, R Lagoudaki"/>
   <result pre="therapeutic safety in a recently completed Phase I trial in" exact="multiple sclerosis." post="As in our trial, standard ex-vivo culture techniques utilize"/>
   <result pre="use. P902 Assessment of bone marrow-derived cell therapy in progressive" exact="multiple sclerosis" post="(ACTiMuS) CM Rice 1, DI Marks 2, Y Ben-Shlomo"/>
   <result pre="immunological monitoring of autologous IL-10 modified dendritic cells transplantation in" exact="multiple sclerosis" post="G Bisaga 1, V Chirsky 1, M Odinak 1,"/>
   <result pre="Multiple sclerosis (MS) is postulated to be a T cell-mediated" exact="autoimmune disease" post="with altered antigen presentation. Dendritic cells (DCs) are the"/>
   <result pre="Symptom management P904 Cingulum bundle alterations underlie subjective fatigue in" exact="multiple sclerosis" post="M Pardini 1,2,3, L Bonzano 1,2, M Bergamino 1,2,"/>
   <result pre="Long-term, sustained safety and efficacy of repeat onabotulinumtoxinA treatment in" exact="multiple sclerosis" post="patients with neurogenic detrusor overactivity J Panicker 1, P"/>
   <result pre="300U were comparable. Most common AEs (onabotA 200U) were uncomplicated" exact="urinary tract infection" post="(58.3, 47.4, 47.6, 40.2, and 34.4%; cycles 1-5, respectively)"/>
   <result pre="fampridine enhances physical activity during everyday life in patients with" exact="multiple sclerosis" post="(FAMPKIN) D Weller 1, T Sutter 1, B Zörner"/>
   <result pre="effects on walking ability in a subset of patients with" exact="multiple sclerosis" post="(MS). Not only walking speed (Goodman and colleagues), but"/>
   <result pre="of fampridine-induced modifications of the gait pattern in patients with" exact="multiple sclerosis" post="L Lörincz 1, B Zörner 1, D Weller 1,"/>
   <result pre="1University Hospital Zurich, Department of Neurology, Zurich, Switzerland Background: Although" exact="multiple sclerosis" post="(MS) often leads to an impairment of ambulatory function,"/>
   <result pre="features of patients presenting with seizures at the time of" exact="multiple sclerosis" post="diagnosis: a 12-year retrospective case-control study A Jammoul 1,"/>
   <result pre="NJ, United States Background: Elevated body temperature in people with" exact="multiple sclerosis" post="(MS) relative to healthy individuals was recently reported for"/>
   <result pre="effects of prolonged-release fampridine on walking function in patients with" exact="multiple sclerosis" post="(FAMPKIN) B Zörner 1, K Reuter 1, L Filli"/>
   <result pre="(4-aminopyridine) on gait velocity in a subset of patients with" exact="multiple sclerosis" post="(MS). Fampridine blocks voltage-gated potassium channels leading to enhanced"/>
   <result pre="Restless legs syndrome, sleep quality and depression in relapsing remitting" exact="multiple sclerosis" post="and correlations with cervical spinal cord damage O Kilinc"/>
   <result pre="Faculty, Istanbul, Turkey Background: There is a growing interest in" exact="restless legs syndrome" post="(RLS) and sleep disorders in multiple sclerosis (MS). Spinal"/>
   <result pre="interest in restless legs syndrome (RLS) and sleep disorders in" exact="multiple sclerosis" post="(MS). Spinal cord (SC) damage represents a significant risk"/>
   <result pre="prevalence of RLS and depression in patients with relapsing remitting" exact="multiple sclerosis" post="(RRMS). Methods: A total of 93 RRMS patients (67"/>
   <result pre="in MS is required. P914 Reassessment of Lhermitte’s sign in" exact="multiple sclerosis" post="Y Beckmann 1, S Özakbaş 2, NG Bülbül 1,"/>
   <result pre="Background: The reliability and diagnostic value of Lhermitte’s sign in" exact="multiple sclerosis" post="(MS) has not been fully established. Objectives: The purpose"/>
   <result pre="with neuroradiologic and neurophysiologic abnormalities. P915 Restless leg syndrome and" exact="multiple sclerosis" post="M Terzi 1, D Yazıcı 1, M Onar 1"/>
   <result pre="+ group (p&amp;lt; 0.05). For clinical involvement, the presence of" exact="optic neuritis," post="tetraparesis, paresthesia and tremor was significantly higher in MS-RLS"/>
   <result pre="of sleep and measures of fatigue, depression and cognition in" exact="multiple sclerosis" post="RA Sater 1, M Gudesblatt 2, K Kresa-Reahl 3,"/>
   <result pre="States, 4Hope Neurology, Knoxville, TN, United States Background: People with" exact="multiple sclerosis" post="(MS) report more difficulty with poor sleep, fatigue, sleepiness,"/>
   <result pre="sleep efficiency (SE), periodic limb movements of sleep (PLMS), and" exact="obstructive sleep apnea" post="(OSA) in MS patients. The inter-relationship between symptoms and"/>
   <result pre="efficiency (SE), periodic limb movements of sleep (PLMS), and obstructive" exact="sleep apnea" post="(OSA) in MS patients. The inter-relationship between symptoms and"/>
   <result pre="for intractable chronic pain and spasticity in conditions such as" exact="multiple sclerosis" post="(MS). Objectives: To describe nabilone use in the UK"/>
   <result pre="of fampridine (4-aminopyridine) on the manual functions of patients with" exact="multiple sclerosis" post="Z Savin 1, I Lejbkowicz 1,2, L Glass-Marmor 1,2,"/>
   <result pre="Obersteiner-Redlich zone of the trigeminal nerve in an exacerbation of" exact="multiple sclerosis" post="(MS) D Anbarasan 1, J Herbert 2, J Howard"/>
   <result pre="sample size. P921 Changes in functional impairment in persons with" exact="multiple sclerosis" post="treated with dalfampridine AC Lo 1,2,3, JA Ruiz 1,"/>
   <result pre="impact functional performance and quality of life in persons with" exact="multiple sclerosis" post="(pwMS). Although dalfampridine extended release (D-ER) has been available"/>
   <result pre="of pwMS. P922 Walking ability and balance in patients with" exact="multiple sclerosis" post="treated with prolonged-release fampridine: randomized, double-blind MOBILE study R"/>
   <result pre="United States Background: Walking impairment is a common disability in" exact="multiple sclerosis" post="(MS) and negatively impacts patients’ quality of life (QoL)."/>
   <result pre="stable dose. One patient died during the follow up from" exact="aspiration pneumonia" post="due to MS related generalized paralysis. One patient opted"/>
   <result pre="dose. One patient died during the follow up from aspiration" exact="pneumonia" post="due to MS related generalized paralysis. One patient opted"/>
   <result pre="and is associated with reduced quality of life (QoL) in" exact="multiple sclerosis" post="(MS). Prolonged-release (PR) fampridine tablet (dalfampridine extended release in"/>
   <result pre="in France. P925 Special challenges of neuro palliative care in" exact="multiple sclerosis" post="patients J Koehler 1, G Lindena 2, B Basedow-Rajwich"/>
   <result pre="Palliative care is a special challenge in the treatment of" exact="multiple sclerosis" post="patients and an unmet need at present. In contrast"/>
   <result pre="previous studies of our neuropalliative care (NPC) treated patients with" exact="multiple sclerosis" post="(MS) in our center (MSK) we could demonstrate strong"/>
   <result pre="handwriting recordings. Samples were shuffled and rated by a blinded" exact="movement disorder" post="expert. Dystonic features (including dystonic posturing, mirror movements, geste"/>
   <result pre="the importance of recognizing dystonia as part of the complex" exact="movement disorder" post="that represents MS tremor. The presence of dystonia points"/>
   <result pre="P927 Efficiency sulbutiamine for treatment of fatigue in patients with" exact="multiple sclerosis" post="Y Khyzhniak 1,2, T Kobus 2, O Mialovytska 2"/>
   <result pre="Increase the effectiveness of diagnosis and treatment of fatigue in" exact="multiple sclerosis." post="Methods: Twenty-two patients (8 male and 14 female), aged"/>
   <result pre="analysis revealed that the severity of fatigue in patients with" exact="multiple sclerosis" post="increases significantly with age. There was no significant relation"/>
   <result pre="control trial of a brief multidisciplinary consultation intervention for treating" exact="sexual dysfunction" post="in multiple sclerosis LC Schairer 1, H Quinn 1,"/>
   <result pre="a brief multidisciplinary consultation intervention for treating sexual dysfunction in" exact="multiple sclerosis" post="LC Schairer 1, H Quinn 1, S Flood 1,"/>
   <result pre="Center, Teaneck, NJ, United States Background: Sexual dysfunction (SD) in" exact="multiple sclerosis" post="(MS) patients is a common but often overlooked symptom."/>
   <result pre="intervention utilizing a consultation model for adults with MS and" exact="sexual dysfunction." post="Further, to test the hypothesis that the intervention group"/>
   <result pre="of voltage-gated potassium channels, on walking speed in patients with" exact="multiple sclerosis" post="(MS) was demonstrated previously in two Phase III trials."/>
   <result pre="the 6-minute walk test (6mWT) assessing endurance, and the 12-item" exact="multiple sclerosis" post="walking scale (12MSWS) assessing the patients’ perspective. Results: Gait"/>
   <result pre="United States Background: Higher body temperature in persons with relapsing-remitting" exact="multiple sclerosis" post="(RRMS) relative to secondary progressive MS (SPMS) was recently"/>
   <result pre="a patient with residual cognitive sequelae after post-malaria acute demyelinating" exact="encephalomyelitis" post="(ADEM) LY Cheng 1, TI de Silva 2, ST"/>
   <result pre="report a case of severe ADEM two months after a" exact="malaria" post="infection, resulting in significant cognitive sequelae. We review the"/>
   <result pre="old man, who was diagnosed and treated for P. falciparum" exact="malaria" post="infection two months previously, presented with ataxia and confusion."/>
   <result pre="matter with Gadolinium enhancement. A diagnosis of post-infective acute demyelinating" exact="encephalomyelitis" post="(ADEM) was made and he was treated with intravenous"/>
   <result pre="Union (EU) for the improvement of walking in patients with" exact="multiple sclerosis" post="(MS). Objectives: In this study, we provide a descriptive"/>
   <result pre="Background: Spasticity is a frequent disabling symptom in patients with" exact="multiple sclerosis" post="(MS). Intrathecal baclofen (ITB) delivered by programmable pump devices"/>
   <result pre="T et al. Long-term effects of dalfampridine in patients with" exact="multiple sclerosis." post="J Neurol Sci 2014; 337:18-24. P935 PR-Fampridine improves walking"/>
   <result pre="on its impact on overall quality of life (QOL) in" exact="multiple sclerosis" post="(MS) is limited. Furthermore, qualitative studies indicate that spasticity"/>
   <result pre="influence overall QOL. P937 Radiosurgical thalamotomy for treatment of severe" exact="multiple sclerosis" post="associated tremor and its impact on quality of life"/>
   <result pre="Clinic, Mexico, Mexico, 3INNNMVS, Radiosurgery, Mexico, Mexico Background: Patients with" exact="multiple sclerosis" post="(MS) frequently suffer from disabling tremor. Pharmacological treatment has"/>
   <result pre="stimulation and thalamotomy diminish tremor in patients with parkinsonian or" exact="essential tremor." post="These represent a novel option, but the procedures can"/>
   <result pre="MS-induced tremor. Methods: We studied 4 patients with secondary progressive" exact="multiple sclerosis." post="All of them presented important tremor that significantly affected"/>
   <result pre="P938 Impact of bladder symptoms on quality of life in" exact="multiple sclerosis" post="K Abdel-Aziz 1, C Young 2, AJ Thompson 1,3,"/>
   <result pre="Kingdom Background: Neurogenic bladder dysfunction is a common feature of" exact="multiple sclerosis" post="(MS) but the effect of bladder dysfunction on quality"/>
   <result pre="treatment with prolonged-release fampridine on cognitive functioning in patients with" exact="multiple sclerosis" post="SD Broicher 1, O Geisseler 1, N Germann 1,"/>
   <result pre="prevent the long-term decline of cognitive functions in subjects with" exact="multiple sclerosis" post="(MS). In FAMPKIN, the original study of the EXTENSION"/>
   <result pre="formulation improves subjective spasticity and pain in patients with progressive" exact="multiple sclerosis" post="G van Amerongen 1, T Beumer 2, J Killestein"/>
   <result pre="using a diary. P943 Heterogeneous etiology of fatigue syndrome in" exact="multiple sclerosis" post="patients A Podlecka-Piętowska 1, S Szuwarska 1, M Nojszewska"/>
   <result pre="is one of the most common and disabling symptoms in" exact="multiple sclerosis" post="(MS). It can profoundly disrupt the occupational and social"/>
   <result pre="detrusor overactivity (NDO) is common in patients who suffer from" exact="multiple sclerosis" post="(ME). We assessed the efficacy, safety and effects on"/>
   <result pre="life of abobotulinumtoxinA (ABX-A) in patients with NDO resulting from" exact="multiple sclerosis." post="Objectives: Assess the efficacy, safety and effects on quality"/>
   <result pre="life of abobotulinumtoxinA (ABX-A) in patients with NDO resulting from" exact="multiple sclerosis." post="Methods: Twelve patients with MS underwent their first ABX-A"/>
   <result pre="A injections for refractory neurogenic detrusor overactivity in patients with" exact="multiple sclerosis" post="have a consistente effect on bladder control, resulting in"/>
   <result pre="in sustained improvement in quality of life. P945 Incidence of" exact="hypogonadism" post="and fatigue in male multiple sclerosis patients JJ Marriott"/>
   <result pre="of life. P945 Incidence of hypogonadism and fatigue in male" exact="multiple sclerosis" post="patients JJ Marriott 1, N Hall 1, N Reider"/>
   <result pre="or any other demographic or clinical features of MS. If" exact="hypogonadism" post="is common in MS this might reflect an unappreciated"/>
   <result pre="a neuroendocrine manifestation of MS itself. P946 Urinary dysfunction in" exact="multiple sclerosis;" post="frequency, characteristics and management in standard care L Wdowiak"/>
   <result pre="or nociceptive pain. Once considered rare, central pain syndromes in" exact="multiple sclerosis" post="(MS) are now recognized as highly prevalent and clinically"/>
   <result pre="including dysesthetic limb pain, L’hermitte’s sign, painful tonic spasms, and" exact="trigeminal neuralgia." post="It is widely acknowledged that pain has a significant"/>
   <result pre="pain in the MS population. P948 Increased arrhythmic incidence in" exact="multiple sclerosis" post="is associated with the location of the demyelinating plaques"/>
   <result pre="patients (20,37%) had abnormal holter with 8 (7,4%) patients having" exact="atrioventricular block" post="and 14 (12,96%) had CVA. Premature ventricular beats were"/>
   <result pre="implicated in the pathogenesis of numerous autoimmune diseases, including relapsing-remitting" exact="multiple sclerosis" post="(RRMS). Daclizumab HYP (DAC HYP) is a humanized monoclonal"/>
   <result pre="P952 Fingolimod promotes regulatory phenotype and function in B-cells of" exact="multiple sclerosis" post="patients B Grützke 1, S Hucke 1, CC Gross"/>
   <result pre="Düsseldorf, Germany Background: Fingolimod is a recently approved treatment for" exact="multiple sclerosis," post="a chronic inflammatory disease of the CNS, aimed at"/>
   <result pre="The influence of Fingolimod treatment on B cell subsets of" exact="multiple sclerosis" post="patients and its potential clinical relevance have not been"/>
   <result pre="of B cells derived from peripheral blood mononuclear cells from" exact="multiple sclerosis" post="patients under Fingolimod treatment in comparison to untreated multiple"/>
   <result pre="multiple sclerosis patients under Fingolimod treatment in comparison to untreated" exact="multiple sclerosis" post="patients and healthy controls, by flow cytometry and ELISA."/>
   <result pre="+ CD5 +) was significantly increased when compared to treatment-naïve" exact="multiple sclerosis" post="patients and to healthy controls, and significantly more regulatory"/>
   <result pre="of Fingolimod in correction of impaired B cell functions in" exact="multiple sclerosis" post="by enhancing regulatory B cells. P953 Vitamin D3 administration"/>
   <result pre="randomized, placebo and active-controlled, multi-center trial in patients with relapsing-remitting" exact="multiple sclerosis" post="(RRMS), the number of gadolinium-enhancing (Gd+) lesions and annualized"/>
   <result pre="immunomodulator, is currently under investigation for the treatment of relapsing-remitting" exact="multiple sclerosis" post="(MS). In previous clinical trials laquinimod considerably reduced the"/>
   <result pre="Republic Background: Alemtuzumab, a highly effective treatment in relapsing remitting" exact="multiple sclerosis" post="(RRMS), is associated with a long-standing lymphopenia, particularly of"/>
   <result pre="selectively affect antigen-presenting cells ex vivo and in vitro in" exact="multiple sclerosis" post="K Thomas 1, U Hainke 1, T Sehr 1,"/>
   <result pre="of innate immunity and suggested to be directly involved in" exact="multiple sclerosis" post="(MS) pathogenesis. The most frequent proinflammatory human blood DC"/>
   <result pre="subjects dosed with XP23829, a novel fumaric acid ester for" exact="multiple sclerosis" post="L Steinman 1, RJ Fox 2, D Lissin 3,"/>
   <result pre="Background: Teriflunomide is a once-daily oral immunomodulator approved for relapsing-remitting" exact="multiple sclerosis" post="(MS). It inhibits dihydroorotate dehydrogenase, the key mitochondrial enzyme"/>
   <result pre="various teriflunomide concentrations; teriflunomide impact in a rat experimental autoimmune" exact="encephalomyelitis" post="(EAE) model (disease severity, central nervous system [CNS] immune"/>
   <result pre="adenovirus. Teriflunomide-treated patients with MS mounted effective memory responses to" exact="influenza" post="vaccine (TERIVA, NCT01403376), and teriflunomide-dosed healthy subjects made seroprotective"/>
   <result pre="NCT01403376), and teriflunomide-dosed healthy subjects made seroprotective antibody responses to" exact="rabies" post="vaccine (neoantigen), albeit at lower titers than those given"/>
   <result pre="immunity in patients with MS. P960 Enhanced axonal metabolism in" exact="multiple sclerosis" post="patients treated with natalizumab OT Wiebenga 1,2, AM Klauser"/>
   <result pre="Background: The anti-inflammatory effect of natalizumab, second-line therapy for relapsing-remitting" exact="multiple sclerosis" post="(RRMS) in most countries, leads to a dramatic reduction"/>
   <result pre="levels of IL-2Rβγ and are expanded in DAC HYP-treated relapsing-remitting" exact="multiple sclerosis" post="(RRMS) patients. It is hypothesized that the increased numbers"/>
   <result pre="system and is in Phase 3 clinical trials for relapsing-remitting" exact="multiple sclerosis." post="Laquinimod crosses the blood-brain barrier and enters the CNS,"/>
   <result pre="receptor (TCR) repertoire in peripheral venous blood of patients with" exact="multiple sclerosis" post="(MS). Methods: The TCR repertoire of CD4+ and CD8+"/>
   <result pre="NY, United States Background: The primary innate immune cells in" exact="multiple sclerosis" post="(MS) consist of infiltrating macrophages/monocytes and resident microglia for"/>
   <result pre="treatment alters transcripts of susceptibility genes in peripheral blood of" exact="multiple sclerosis" post="patients H Faber 1, S Nischwitz 1, M Knop"/>
   <result pre="To date, more than 100 genetic risk loci associated with" exact="multiple sclerosis" post="(MS) have been detected in two recent genome-wide association"/>
   <result pre="emerging drug therapies in immune disorders and neurodegenerative diseases. In" exact="multiple sclerosis" post="(MS), miRNAs are abnormally expressed in cells comprising the"/>
   <result pre="P968 Effect of natalizumab treatment on circulating CD4+CD62L+ T-cells in" exact="multiple sclerosis" post="patients M Spadaro 1, F Marnetto 1, M Caldano"/>
   <result pre="of CD62L on CD4 + T-cells and the development of" exact="progressive multifocal leukoencephalopathy" post="(PML) in Natalizumab(NTZ)-treated Multiple Sclerosis (MS) patients. Objectives: To"/>
   <result pre="expression of T-cell subsets in the blood of patients with" exact="multiple sclerosis" post="B Fitzner 1,2, M Hecker 1,2, D Koczan 2,"/>
   <result pre="is an oral disease-modifying agent approved for the treatment of" exact="multiple sclerosis" post="(MS). It is a sphingosine-1-phosphate receptor modulator that prevents"/>
   <result pre="the Central Nervous System and reduces inflammatory immune reaction in" exact="multiple sclerosis" post="(MS). Therapy with Natalizumab is highly effective in relapsing"/>
   <result pre="Background: B cells are implicated in the immune pathogenesis of" exact="multiple sclerosis" post="(MS) by secreting antibodies and cytokines as well as"/>
   <result pre="Treg and iNKT cells after treatment with Fingolimod in relapsing-remitting" exact="multiple sclerosis" post="patients D Ferraro 1, AM Simone 1, F Vitetta"/>
   <result pre="of IFNβ1a. P975 Natalizumab increases HLA-G expression in PDCs of" exact="multiple sclerosis" post="patients AC Dionete 1, AS Moraes 1, M Domingues"/>
   <result pre="Campinas, Brazil Background: Multiple sclerosis (MS) is the most common" exact="autoimmune disease" post="of the central nervous system (CNS). MS symptoms are"/>
   <result pre="cell subsets in the blood of patients with relapsing remitting" exact="multiple sclerosis" post="K Thomas 1, J Blankeburg 1, J Eisele 1,"/>
   <result pre="evaluate effects of alemtuzumab on different immune cell subtypes in" exact="multiple sclerosis" post="patients. Methods: Peripheral blood mononuclear cells from 12 relapsing-remitting"/>
   <result pre="sclerosis patients. Methods: Peripheral blood mononuclear cells from 12 relapsing-remitting" exact="multiple sclerosis" post="patients were drawn before and after alemtuzumab infusion including"/>
   <result pre="-5 agonist in clinical development for the treatment of relapsing-remitting" exact="multiple sclerosis." post="In vitro studies have shown that ceralifimod is slowly"/>
   <result pre="CD20, a B-cell surface antigen, used for treatment of non-Hodgkin’s" exact="lymphoma" post="and several autoimmune diseases, including demyelinating diseases of the"/>
   <result pre="mg (FTY) is an established oral drug for relapsing-remitting (RR)" exact="multiple sclerosis" post="(MS). FTY inhibits lymphocytes egress from lymph nodes, interrupting"/>
   <result pre="of FTY treatment efficacy. P980 A two-years follow-up study of" exact="multiple sclerosis" post="patients treated with interferon-beta: predictive value of NAbs at"/>
   <result pre="Background: Interferon beta (IFN-beta) is a first-line treatment of relapsing-remitting" exact="multiple sclerosis" post="(MS); although the clinical efficacy of this therapy has"/>
   <result pre="effect (CPE) assay using the encephalomyocarditis murine virus on human" exact="lung carcinoma" post="cell line (A549). The titres were calculated according to"/>
   <result pre="TRU. P981 Stress induced angioplasticity is protective in experimental autoimmune" exact="encephalomyelitis" post="V Katyshev 1, N Esen 1, S Katysheva 1,"/>
   <result pre="underlie the pathophysiology of a number of neurodegenerative diseases including" exact="multiple sclerosis" post="(MS). We hypothesize that treatment strategies that restore vascular"/>
   <result pre="clinical outcome in myelin oligodendrocyte glycoprotein (MOG) peptide-induced experimental autoimmune" exact="encephalomyelitis" post="(EAE). Objectives: Identify new molecular targets that promote repair"/>
   <result pre="new molecular targets that promote repair in neurodegenerative diseases including" exact="multiple sclerosis." post="EAE with stress induced angioplasticity is the key model"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC4654741/results/search/disease/results.xml">
   <result pre="(e.g., the WHO reported prevalence rates of depression (5.7 %)," exact="post-traumatic stress disorder" post="(PTSD) (1.5 %) and migraine (13.9 %) correspond to"/>
   <result pre="depression (5.7 %), post-traumatic stress disorder (PTSD) (1.5 %) and" exact="migraine" post="(13.9 %) correspond to the rate of positive answers"/>
   <result pre="the traumatic event in dreams or flashback (1.5 %) and" exact="migraine" post="(14.1 %)). Table 3 Summary of core mental and"/>
   <result pre="Registry thus far have predominantly focused on mental disorders, and" exact="schizophrenia" post="in particular. For instance, school records have shown an"/>
   <result pre="lower behavioral ratings with an earlier age of onset of" exact="schizophrenia" post="[ 9]. Data of the Israeli Army Draft Board"/>
   <result pre="Israeli Army Draft Board also indicated associations between IQ and" exact="obesity" post="in adolescence [ 30], and an advanced paternal age"/>
   <result pre="in adolescence [ 30], and an advanced paternal age and" exact="autism" post="[ 31]. Strengths and weaknesses As indicated above, the"/>
   <result pre="PB Moilanen K et al. Early developmental milestones in adult" exact="schizophrenia" post="and other psychoses. A 31-year follow-up of the Northern"/>
   <result pre="van Os J Kenis G Rutten BP The environment and" exact="schizophrenia" post="Nature 2010 468 7321 203 212 10.1038/nature09563 21068828 4."/>
   <result pre="Levine SZ Reichenberg A Rabinowitz J Real-world premorbid functioning in" exact="schizophrenia" post="and affective disorders during the early teenage years: a"/>
   <result pre="intellectual performance in schizophrenia: premorbid intellectual decline and risk for" exact="schizophrenia" post="Arch Gen Psychiatry 2005 62 12 1297 1304 10.1001/archpsyc.62.12.1297"/>
   <result pre="Z Davidson M Cognitive and behavioural functioning in men with" exact="schizophrenia" post="both before and shortly after first admission to hospital."/>
   <result pre="S et al. Advancing paternal age and the risk of" exact="schizophrenia" post="Arch Gen Psychiatry 2001 58 4 361 367 10.1001/archpsyc.58.4.361"/>
   <result pre="al. Cancer risk among parents and siblings of patients with" exact="schizophrenia" post="Br J Psychiatry 2007 190 156 161 10.1192/bjp.bp.106.024943 17267933"/>
   <result pre="et al. Social and cognitive functioning, urbanicity and risk for" exact="schizophrenia" post="Br J Psychiatr 2007 191 320 324 10.1192/bjp.bp.106.031328 20."/>
   <result pre="C Auyeung B Baron-Cohen S Toward brief &quot;Red Flags&quot; for" exact="autism" post="screening: the short autism spectrum quotient and the short"/>
   <result pre="S Toward brief &quot;Red Flags&quot; for autism screening: the short" exact="autism" post="spectrum quotient and the short quantitative checklist for Autism"/>
   <result pre="et al. Social and cognitive functioning, urbanicity and risk for" exact="schizophrenia" post="Br J Psychiatry 2007 191 320 324 10.1192/bjp.bp.106.031328 17906242"/>
   <result pre="premorbid intellectual, language, and behavioral functioning in patients with schizophrenia," exact="schizoaffective disorder," post="and nonpsychotic bipolar disorder Am J Psychiatry 2002 159"/>
   <result pre="behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic" exact="bipolar disorder" post="Am J Psychiatry 2002 159 12 2027 2035 10.1176/appi.ajp.159.12.2027"/>
   <result pre="E, Portuguese S, Davidson M, Weiser M (2014) IQ and" exact="obesity" post="in adolescence: a population-based, cross-sectional study. Pediatr Obes 9(6):419–26"/>
   <result pre="Knobler HY Davidson M Susser E Advancing paternal age and" exact="autism" post="Arch Gen Psychiatry 2006 63 9 1026 1032 10.1001/archpsyc.63.9.1026"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC4702057/results/search/disease/results.xml">
   <result pre="nasal steroids can be performed for prophylaxis, especially with simultaneous" exact="allergic rhinitis." post="However, the effectiveness is not proven. Reliable alternative medicamentous"/>
   <result pre="is effective as accompanying therapy in all types of CRS," exact="allergic rhinitis," post="acute rhinosinusitis, and for prophylaxis of frequent upper airway"/>
   <result pre="requiring systemic application of cortisone every 2 years, CRSsNP and" exact="asthma" post="every 12 months, and CRSwNP, asthma, and analgesic intolerance"/>
   <result pre="[ 72], [ 73], [ 74]. Also the development of" exact="cataract" post="increases with higher radiation exposure of CT diagnostics of"/>
   <result pre="aeruginosa and other gram-negative germs was found in patients with" exact="diabetes mellitus" post="in the context of endoscopic sinus surgery for chronic"/>
   <result pre="after &amp;gt;36 months. Treatment results in cases of therapy refractory" exact="maxillary sinusitis" post="after previous surgery by means of medial maxillectomy (with"/>
   <result pre="&amp;gt;36 months. Treatment results in cases of therapy refractory maxillary" exact="sinusitis" post="after previous surgery by means of medial maxillectomy (with"/>
   <result pre="211], [ 279], [ 281] (e.g. in cases of recurrent" exact="acute maxillary sinusitis," post="dental maxillary sinusitis), and to enlarge other ostia in"/>
   <result pre="[ 279], [ 281] (e.g. in cases of recurrent acute" exact="maxillary sinusitis," post="dental maxillary sinusitis), and to enlarge other ostia in"/>
   <result pre="of the maxillary sinus [ 294], [ 295]. Therapy refractory" exact="maxillary sinusitis" post="or dysfunctional maxillary sinusitis [ 210] obviously include the"/>
   <result pre="the maxillary sinus [ 294], [ 295]. Therapy refractory maxillary" exact="sinusitis" post="or dysfunctional maxillary sinusitis [ 210] obviously include the"/>
   <result pre="[ 294], [ 295]. Therapy refractory maxillary sinusitis or dysfunctional" exact="maxillary sinusitis" post="[ 210] obviously include the fact that the mucociliary"/>
   <result pre="294], [ 295]. Therapy refractory maxillary sinusitis or dysfunctional maxillary" exact="sinusitis" post="[ 210] obviously include the fact that the mucociliary"/>
   <result pre="middle meatus [ 228], [ 315]. In cases of dental" exact="maxillary sinusitis," post="the results were independent from the access via the"/>
   <result pre="sinus and the adjacent nasal septum in therapy resistant chronic" exact="sphenoid sinusitis" post="[ 248], [ 348]. In cases of straight septum"/>
   <result pre="and the adjacent nasal septum in therapy resistant chronic sphenoid" exact="sinusitis" post="[ 248], [ 348]. In cases of straight septum"/>
   <result pre="the reason is actually unclear. Impairing factors are allergic fungal" exact="sinusitis" post="[ 241] or eosinophilic rhinosinusitis [ 401], surgery of"/>
   <result pre="[ 442], [ 443], [ 444]. Preferential development of postoperative" exact="frontal sinusitis" post="(75% vs. 45% in a retrospective case control study,"/>
   <result pre="442], [ 443], [ 444]. Preferential development of postoperative frontal" exact="sinusitis" post="(75% vs. 45% in a retrospective case control study,"/>
   <result pre="intravenous antibiotic therapy [ 568]. This concerns also isolated acute" exact="sinusitis" post="of single paranasal sinuses, Impending or definitive complications (orbital,"/>
   <result pre="in those cases the indication for surgery becomes urgent, Acute" exact="sphenoid sinusitis" post="with accompanying impaired vision requires intravenous antibiotic therapy and"/>
   <result pre="those cases the indication for surgery becomes urgent, Acute sphenoid" exact="sinusitis" post="with accompanying impaired vision requires intravenous antibiotic therapy and"/>
   <result pre="of the systems and increased availability can be expected. Recurrent" exact="orbital cellulitis" post="may serve as a clinical hint for an anatomical"/>
   <result pre="the systems and increased availability can be expected. Recurrent orbital" exact="cellulitis" post="may serve as a clinical hint for an anatomical"/>
   <result pre="tumor is characterized by a frontal subperiostal abscess with concomitant" exact="osteomyelitis" post="in (acute) frontal sinusitis [ 589]. It is still"/>
   <result pre="by a frontal subperiostal abscess with concomitant osteomyelitis in (acute)" exact="frontal sinusitis" post="[ 589]. It is still not clear if it"/>
   <result pre="a frontal subperiostal abscess with concomitant osteomyelitis in (acute) frontal" exact="sinusitis" post="[ 589]. It is still not clear if it"/>
   <result pre="It is still not clear if it is a true" exact="osteomyelitis" post="or only a small inflammatory perforation. Beside the intravenous"/>
   <result pre="frequently those complications are subdural empyema (33%), cranial abscess (27%)," exact="meningitis" post="(24%), epidural abscess (21%), cerebritis, or cavernous sinus thrombosis"/>
   <result pre="cranial abscess (27%), meningitis (24%), epidural abscess (21%), cerebritis, or" exact="cavernous sinus thrombosis" post="[ 607]. Even today, a mortality of 0–19% or"/>
   <result pre="This aspect has been analyzed and reported most frequently for" exact="meningitis" post="[ 611], but in general it is applicable for"/>
   <result pre="form of intracranial infection. Meningitis caused by pneumococci or Hemophilus" exact="influenza" post="or recurrent bacterial meningitis is often based on a"/>
   <result pre="infection. Meningitis caused by pneumococci or Hemophilus influenza or recurrent" exact="bacterial meningitis" post="is often based on a defect of the skull"/>
   <result pre="Meningitis caused by pneumococci or Hemophilus influenza or recurrent bacterial" exact="meningitis" post="is often based on a defect of the skull"/>
   <result pre="dura defect, or CSF leak requires duraplasty! In case of" exact="cavernous sinus thrombosis," post="a combined therapy of endonasal (sphenoid) sinus surgery, intravenous"/>
   <result pre="surgery. Those upper airway infections are mostly associated with concomitant" exact="sinusitis" post="of which the symptoms are not in the focus."/>
   <result pre="An indication of sinus surgery is given when the concomitant" exact="sinusitis" post="causes relevant symptoms dominating the disease and thus leading"/>
   <result pre="narrow ethmoid, the presence of infraorbital cells [ 203], or" exact="allergic rhinitis" post="[ 620] favor the development of RARS. The aim"/>
   <result pre="ethmoid, the presence of infraorbital cells [ 203], or allergic" exact="rhinitis" post="[ 620] favor the development of RARS. The aim"/>
   <result pre="frontal sinus involvement. 4.4 Choanal atresia Endonasal endoscopic surgery of" exact="choanal atresia" post="is established as successful therapy. Even in preterm infants"/>
   <result pre="very experienced in endonasal surgery. Even in cases of bilateral" exact="choanal atresia," post="a routinely performed emergency intervention &quot;at night&quot; or &quot;at"/>
   <result pre="is neither necessary nor reasonable. There are reports about bilateral" exact="choanal atresia" post="in children and also in adults [ 636], ["/>
   <result pre="of the posterior nasal area on the side of the" exact="choanal atresia" post="is significantly reduced in comparison to the healthy side."/>
   <result pre="rates amount to 7–42% for unilateral and 8–65% for bilateral" exact="choanal atresia" post="[ 635], [ 648], [ 649], [ 650], ["/>
   <result pre="was achieved with exclusive puncture, dilatation and stenting of bilateral" exact="choanal atresia" post="[ 656]. The positive effect may at least partly"/>
   <result pre="a very young age, which is automatically associated with bilateral" exact="choanal atresia" post="and narrow anatomical conditions and possibly also with additional"/>
   <result pre="to the antrochoanal polyp [ 686], [ 687]. 4.4.2 Dentogenic" exact="maxillary sinusitis" post="Reasons for dentogenic maxillary sinusitis are often preapical and"/>
   <result pre="the antrochoanal polyp [ 686], [ 687]. 4.4.2 Dentogenic maxillary" exact="sinusitis" post="Reasons for dentogenic maxillary sinusitis are often preapical and"/>
   <result pre="686], [ 687]. 4.4.2 Dentogenic maxillary sinusitis Reasons for dentogenic" exact="maxillary sinusitis" post="are often preapical and periodontal abscesses based on caries"/>
   <result pre="[ 687]. 4.4.2 Dentogenic maxillary sinusitis Reasons for dentogenic maxillary" exact="sinusitis" post="are often preapical and periodontal abscesses based on caries"/>
   <result pre="followed by the premolars [ 688]. The incidence of dentogenic" exact="sinusitis" post="seems to increase during the last years [ 689]."/>
   <result pre="488], [ 701], [ 702]. The average risk to develop" exact="meningitis" post="in case of an accident-related lesion of the dura"/>
   <result pre="704]. In summary, there is a high risk to acquire" exact="meningitis" post="after untreated rhino-basal lesions of the dura. Apparently it"/>
   <result pre="intracranial hypertension [ 704], [ 707]. Even episodes of late" exact="meningitis" post="are possible in cases of spontaneously ceasing liquorrhea, intervals"/>
   <result pre="low morbidity in comparison to the incidence and morbidity/mortality of" exact="meningitis" post="or other intracranial infection, conservative therapy (confinement to bed,"/>
   <result pre="duraplasty, it is currently recommended to immediately vaccine patients with" exact="meningitis" post="in cases of suspected or proven lesion of the"/>
   <result pre="and nasal dryness (34%), numbness of the palate (13%), acute" exact="sinusitis" post="(3%) reduced lacrimation (3%), or septal perforation (3%) ["/>
   <result pre="and therapy of a &quot;sinogenic focus&quot; is asked. Hereby, acute" exact="sinusitis" post="is in the focus. As chronic rhinosinusitis is usually"/>
   <result pre="in the focus. As chronic rhinosinusitis is usually no primary" exact="bacterial disease," post="the idea of focus in immunocompetent patients with chronic"/>
   <result pre="rule out any sinogenic focus [ 801]. Psoriasis with its" exact="acropustulosis" post="subtype of pustulosis palmaris et plantaris is understood as"/>
   <result pre="vulgaris, Nr. 013-001). Reliable data on possible (causal) relations between" exact="psoriasis" post="and rhinosinusitis do not exist. A single cohort study"/>
   <result pre="cohort study from Taiwan could show an increased risk of" exact="psoriasis" post="in patients with CRSsNP [ 802]. Triggering of psoriasis"/>
   <result pre="of psoriasis in patients with CRSsNP [ 802]. Triggering of" exact="psoriasis" post="exacerbations by acute infections is possible (Guideline on Therapy"/>
   <result pre="about surgical procedure if patients report about recurrent or regular" exact="psoriasis" post="exacerbations induced by acute rhinosinusitis. It may be a"/>
   <result pre="the affected maxillary sinus leading to subsequent exacerbations of the" exact="psoriasis" post="disease. In cases of chronic urticaria, possible associations with"/>
   <result pre="relevance of foci for people scheduled for heart surgery, acute" exact="sinusitis" post="should be looked for. Chronic rhinosinusitis does not seem"/>
   <result pre="would require intervention for example before heart surgery. In contrast," exact="uveitis" post="may develop based on acute sinusitis. In summary, according"/>
   <result pre="to artifical respiraton in intensive care units frequently develop nosocomial" exact="sinusitis" post="[ 803], [ 804], [ 805], [ 806]. It"/>
   <result pre="however, is a good predictor for the presence of acute" exact="sinusitis" post="[ 811]. Positive radiological findings in intensive care patients"/>
   <result pre="patients with fever do not necessarily mean that a suspected" exact="sinusitis" post="is the reason for fever [ 812]. Negative endoscopy"/>
   <result pre="According to the present literature, conservative treatment of a diagnosed" exact="sinusitis" post="before transplantation seems to be an appropriate way. Also,"/>
   <result pre="appropriate way. Also, evidence is low for patients suffering from" exact="cystic fibrosis," post="whether sinus surgery helps avoiding the re-colonization and infection"/>
   <result pre="the re-colonization and infection of the lungs in patients with" exact="cystic fibrosis" post="and lung transplantation and positively influences the survival rate."/>
   <result pre="smears before starting antibiotic therapy. Accompanying important diseases such as" exact="allergic rhinitis," post="gastro-esophageal reflux or immunodeficiency should be treated accordingly with"/>
   <result pre="often biofilms in their adenoids than for example children with" exact="sleep apnea" post="[ 850]. The success rate of exclusive adenoidectomy amounts"/>
   <result pre="for children as for adults. Antrochoanal polyps, mucoceles, or fungal" exact="sinusitis" post="[ 857] generally call for surgical therapy [ 842]."/>
   <result pre="the child’s face [ 448], [ 866]. 4.4.9 Cystic fibrosis," exact="primary ciliary dyskinesia" post="Endonasal endoscopic sinus surgery in cases of cystic fibrosis"/>
   <result pre="primary ciliary dyskinesia Endonasal endoscopic sinus surgery in cases of" exact="cystic fibrosis" post="leads to significant improvement of sinonasal complaints and endoscopic"/>
   <result pre="869], [ 870]. The long-term recurrence rate of polyposis in" exact="cystic fibrosis" post="amounts to 42–100% [ 842], [ 871], [ 872]."/>
   <result pre="results after intensive local therapy [ 814]. In cases of" exact="primary ciliary dyskinesia" post="that often leads to chronic rhinosinusitis and to nasal"/>
   <result pre="a final therapeutic option in cases of therapy-resistant non-allergic and" exact="allergic rhinitis" post="with the leading symptom of severely increased nasal secretion"/>
   <result pre="final therapeutic option in cases of therapy-resistant non-allergic and allergic" exact="rhinitis" post="with the leading symptom of severely increased nasal secretion"/>
   <result pre="be considered as safe surgery for therapy-refractory allergic and non-allergic" exact="rhinitis" post="performed by an experienced sinus surgeon. As the majority"/>
   <result pre="eyeball regresses by 1–2 mm after surgery [ 925], the" exact="enophthalmos" post="by 2 mm (0.5–4 mm [ 901]). Thus it"/>
   <result pre="midfacial region and trace it back to a mostly chronic" exact="sinusitis" post="by own decision making or by medical consultations. Up"/>
   <result pre="More recent publications confirm an increased comorbidity of headaches or" exact="migraine" post="and CRS [ 930], [ 931]. Different theories (immunologic"/>
   <result pre="of the cases a neurological origin of those headaches, mostly" exact="migraine" post="or tension headache [ 929], [ 937]. 80% of"/>
   <result pre="triptans [ 937], [ 938], [ 939]. Patients suffering from" exact="migraine" post="report in up to &amp;gt;50% nasal symptoms like nasal"/>
   <result pre="the paranasal sinuses and who do not respond to neurological" exact="migraine" post="therapy, may be offered surgery. The benefit and the"/>
   <result pre="946]. Endonasal endoscopic DCR as immediate therapy in case of" exact="acute dacryocystitis" post="with empyema of the lacrimal sac avoids the risk"/>
   <result pre="Endonasal endoscopic DCR as immediate therapy in case of acute" exact="dacryocystitis" post="with empyema of the lacrimal sac avoids the risk"/>
   <result pre="of aggressive growth (hyperkeratosis, squamous cell metaplasia, high mitotic index," exact="carcinoma in situ," post="multicenter growth). The local control is performed primarily by"/>
   <result pre="papyracea), [ 1064], [ 1066], [ 1100], [ 1101], intraoperative" exact="cardiac arrest" post="[ 1102]. Numerous case series, retro- and prospective studies"/>
   <result pre="and the ethmoid infundibulum in cases of circumscribed therapy-refractory chronic" exact="sinusitis" post="of the maxillary sinus and sometimes the anterior ethmoid"/>
   <result pre="patients [ 1110], frontal sinus mucoceles [ 1105], [ 1111]," exact="acute frontal sinusitis" post="[ 1112], Pott’s puffy tumor [ 1113], sinogenic headaches"/>
   <result pre="[ 1110], frontal sinus mucoceles [ 1105], [ 1111], acute" exact="frontal sinusitis" post="[ 1112], Pott’s puffy tumor [ 1113], sinogenic headaches"/>
   <result pre="1110], frontal sinus mucoceles [ 1105], [ 1111], acute frontal" exact="sinusitis" post="[ 1112], Pott’s puffy tumor [ 1113], sinogenic headaches"/>
   <result pre="1112], Pott’s puffy tumor [ 1113], sinogenic headaches [ 1082]," exact="frontal sinusitis," post="treated with retrograde balloon dilatatio via minigrapanation [ 1114]."/>
   <result pre="can be indicated in case of isolated recurrent acute or" exact="chronic frontal sinusitis." post="In some cases, also hybrid interventions in combination with"/>
   <result pre="be indicated in case of isolated recurrent acute or chronic" exact="frontal sinusitis." post="In some cases, also hybrid interventions in combination with"/>
   <result pre="headache was caused in the majority of the cases by" exact="migraine" post="and other neurological types of headaches and that an"/>
   <result pre="non-randomized study [ 1243]. Endonasal endoscopic sinus surgery improves bronchial" exact="asthma" post="(in 76% of the patients with 85% less asthma"/>
   <result pre="bronchial asthma (in 76% of the patients with 85% less" exact="asthma" post="attacks), reduces the number of inpatient treatments (by 64%),"/>
   <result pre="achieved, the endoscopic sinus surgery generally does not significantly influence" exact="obstructive sleep apnea" post="[ 1245]. General sleep quality and sexual activity are"/>
   <result pre="the endoscopic sinus surgery generally does not significantly influence obstructive" exact="sleep apnea" post="[ 1245]. General sleep quality and sexual activity are"/>
   <result pre="according to an extensive US database analysis [ 1274]. Bronchial" exact="asthma" post="[ 24], [ 323], [ 1227], [ 1265], ["/>
   <result pre="years and 89% within 10 years [ 1265]). Allergic fungal" exact="sinusitis" post="[ 241], [ 1281]. Evidence of staphylococcus infection with"/>
   <result pre="contraindication for endoscopic sinus surgery [ 1300]. The influence of" exact="allergic rhinitis" post="on the surgical outcome is currently not clearly defined."/>
   <result pre="for endoscopic sinus surgery [ 1300]. The influence of allergic" exact="rhinitis" post="on the surgical outcome is currently not clearly defined."/>
   <result pre="defined. It is recommended to preoperatively optimize therapy of the" exact="allergy" post="in order to improve the postoperative result [ 1218],"/>
   <result pre="to improve the postoperative result [ 1218], [ 1303]. Tissue" exact="eosinophilia" post="and histological parameters: An increased tissue eosinophilia correlates with"/>
   <result pre="[ 1303]. Tissue eosinophilia and histological parameters: An increased tissue" exact="eosinophilia" post="correlates with a poorer surgical result and increases the"/>
   <result pre="by all studies [ 1308]. In patients with lower-grade tissue" exact="eosinophilia" post="and reduced subepithelial edema, the postoperative improvement is two"/>
   <result pre="on frontal sinus surgery) and anterior ethmoidectomy in cases of" exact="chronic frontal sinusitis," post="a success was found in 88.5% of a heterogeneous"/>
   <result pre="frontal sinus surgery) and anterior ethmoidectomy in cases of chronic" exact="frontal sinusitis," post="a success was found in 88.5% of a heterogeneous"/>
   <result pre="are currently no recommendations [ 1340]. In special cases of" exact="cystic fibrosis," post="postoperative Tobramycin rinsing can reduce the incidence of revision"/>
   <result pre="recommendation is given against postoperative vasoconstrictive nasal drops to avoid" exact="rhinitis" post="medicamentosa [ 1329]. 7.6 Systemic therapy In cases of"/>
   <result pre="Shiffman RN Smith TL Witsell DL Clinical practice guideline: adult" exact="sinusitis" post="Otolaryngol Head Neck Surg 9 2007 137 3 Suppl"/>
   <result pre="SB Ben David G Thomas KE Parental knowledge of potential" exact="cancer" post="risks from exposure to computed tomography Pediatrics 8 2013"/>
   <result pre="JL Mezzarobba M Aubert B Laurier D Bernier MO Predicted" exact="cancer" post="risks induced by computed tomography examinations during childhood, by"/>
   <result pre="tomography in pediatrics and the associated radiation exposure and estimated" exact="cancer" post="risk JAMA Pediatr 8 2013 167 8 700 707"/>
   <result pre="KP Bhargavan M Lewis R Mettler F Land C Projected" exact="cancer" post="risks from computed tomographic scans performed in the United"/>
   <result pre="MC Chang SJ Chen HW Leu HB The risk of" exact="cataract" post="associated with repeated head and neck CT studies: a"/>
   <result pre="5 483 486 11700446 89 Gwaltney JM Jr Acute community-acquired" exact="sinusitis" post="Clin Infect Dis 12 1996 23 6 1209 1223"/>
   <result pre="Saitoglu L Pharyngeal packing is a predisposing factor for postoperative" exact="aphthous stomatitis" post="in nasal surgery Otolaryngol Head Neck Surg 5 2010"/>
   <result pre="L Pharyngeal packing is a predisposing factor for postoperative aphthous" exact="stomatitis" post="in nasal surgery Otolaryngol Head Neck Surg 5 2010"/>
   <result pre="L Howland TJ Cohen NA Palmer JN The effect of" exact="diabetes mellitus" post="on chronic rhinosinusitis and sinus surgery outcome Int Forum"/>
   <result pre="188 Stammberger H Endoscopic surgery for mycotic and chronic recurring" exact="sinusitis" post="Ann Otol Rhinol Laryngol Suppl Sep-Oct 1985 119 1"/>
   <result pre="194 Catalano P Roffman E Outcome in patients with chronic" exact="sinusitis" post="after the minimally invasive sinus technique Am J Rhinol"/>
   <result pre="McFadden EA Kany RJ Fink JN Toohill RJ Surgery for" exact="sinusitis" post="and aspirin triad Laryngoscope 10 1990 100 10 Pt"/>
   <result pre="after failed endoscopic middle meatus antrostomy in patients with chronic" exact="sinusitis" post="Laryngoscope 12 2003 113 12 2148 2150 10.1097/00005537-200312000-00018 Available"/>
   <result pre="BA Parker RO Schlosser RJ Modified endoscopic medial maxillectomy for" exact="chronic maxillary sinusitis" post="Am J Rhinol May-Jun 2006 20 3 317 319"/>
   <result pre="Parker RO Schlosser RJ Modified endoscopic medial maxillectomy for chronic" exact="maxillary sinusitis" post="Am J Rhinol May-Jun 2006 20 3 317 319"/>
   <result pre="RO Schlosser RJ Modified endoscopic medial maxillectomy for chronic maxillary" exact="sinusitis" post="Am J Rhinol May-Jun 2006 20 3 317 319"/>
   <result pre="Gullung JL Schlosser RJ Modified endoscopic medial maxillectomy for recalcitrant" exact="chronic maxillary sinusitis" post="Int Forum Allergy Rhinol Nov-Dec 2011 1 6 493"/>
   <result pre="JL Schlosser RJ Modified endoscopic medial maxillectomy for recalcitrant chronic" exact="maxillary sinusitis" post="Int Forum Allergy Rhinol Nov-Dec 2011 1 6 493"/>
   <result pre="Schlosser RJ Modified endoscopic medial maxillectomy for recalcitrant chronic maxillary" exact="sinusitis" post="Int Forum Allergy Rhinol Nov-Dec 2011 1 6 493"/>
   <result pre="DY Hwang PH Results of endoscopic maxillary mega-antrostomy in recalcitrant" exact="maxillary sinusitis" post="Am J Rhinol Nov-Dec 2008 22 6 658 662"/>
   <result pre="Hwang PH Results of endoscopic maxillary mega-antrostomy in recalcitrant maxillary" exact="sinusitis" post="Am J Rhinol Nov-Dec 2008 22 6 658 662"/>
   <result pre="Small and large middle meatus antrostomies in the treatment of" exact="chronic maxillary sinusitis" post="Otolaryngol Head Neck Surg 10 2004 131 4 542"/>
   <result pre="and large middle meatus antrostomies in the treatment of chronic" exact="maxillary sinusitis" post="Otolaryngol Head Neck Surg 10 2004 131 4 542"/>
   <result pre="large middle meatus antrostomies in the treatment of chronic maxillary" exact="sinusitis" post="Otolaryngol Head Neck Surg 10 2004 131 4 542"/>
   <result pre="Canine fossa puncture for severe maxillary disease in unilateral chronic" exact="sinusitis" post="with nasal polyp Laryngoscope 12 2013 123 12 E79"/>
   <result pre="Dinu C The canine fossa puncture technique in chronic odontogenic" exact="maxillary sinusitis" post="Am J Rhinol Allergy Sep-Oct 2011 25 5 358"/>
   <result pre="C The canine fossa puncture technique in chronic odontogenic maxillary" exact="sinusitis" post="Am J Rhinol Allergy Sep-Oct 2011 25 5 358"/>
   <result pre="JA Five 'nontraditional' techniques for use in patients with recalcitrant" exact="sinusitis" post="Curr Opin Otolaryngol Head Neck Surg 2 2013 21"/>
   <result pre="http://dx.doi.org/10.1002/lary.24393 24752614 345 Metson R Gliklich RE Endoscopic treatment of" exact="sphenoid sinusitis" post="Otolaryngol Head Neck Surg 6 1996 114 6 736"/>
   <result pre="24752614 345 Metson R Gliklich RE Endoscopic treatment of sphenoid" exact="sinusitis" post="Otolaryngol Head Neck Surg 6 1996 114 6 736"/>
   <result pre="The modified endoscopic Lothrop procedure in the treatment of complicated" exact="chronic frontal sinusitis" post="Clin Otolaryngol Allied Sci 6 2003 28 3 215"/>
   <result pre="modified endoscopic Lothrop procedure in the treatment of complicated chronic" exact="frontal sinusitis" post="Clin Otolaryngol Allied Sci 6 2003 28 3 215"/>
   <result pre="endoscopic Lothrop procedure in the treatment of complicated chronic frontal" exact="sinusitis" post="Clin Otolaryngol Allied Sci 6 2003 28 3 215"/>
   <result pre="Gross CW The role of mini-trephination in the management of" exact="frontal sinusitis" post="Am J Rhinol Jul-Aug 1999 13 4 289 293"/>
   <result pre="CW The role of mini-trephination in the management of frontal" exact="sinusitis" post="Am J Rhinol Jul-Aug 1999 13 4 289 293"/>
   <result pre="Wachter B The endoscopic modified Lothrop procedure for salvage of" exact="chronic frontal sinusitis" post="after osteoplastic flap failure Otolaryngol Head Neck Surg 12"/>
   <result pre="B The endoscopic modified Lothrop procedure for salvage of chronic" exact="frontal sinusitis" post="after osteoplastic flap failure Otolaryngol Head Neck Surg 12"/>
   <result pre="The endoscopic modified Lothrop procedure for salvage of chronic frontal" exact="sinusitis" post="after osteoplastic flap failure Otolaryngol Head Neck Surg 12"/>
   <result pre="382 389 1408223 435 Fortune DS Duncavage JA Incidence of" exact="frontal sinusitis" post="following partial middle turbinectomy Ann Otol Rhinol Laryngol 6"/>
   <result pre="389 1408223 435 Fortune DS Duncavage JA Incidence of frontal" exact="sinusitis" post="following partial middle turbinectomy Ann Otol Rhinol Laryngol 6"/>
   <result pre="endoscopic sinus surgery (FESS) on facial growth in children with" exact="cystic fibrosis." post="Comparison of 10 cephalometric parameters of the midface for"/>
   <result pre="J Nayak JV Hwang PH Outpatient endoscopic sinus surgery in" exact="cystic fibrosis" post="patients: predictive factors for admission Int Forum Allergy Rhinol"/>
   <result pre="akuter therapieresistenter Sinusitis Endonasal endoscopic ethmoidectomy in acute therapy refractory" exact="sinusitis" post="Laryngorhinootologie 5 1996 75 5 286 289 10.1055/s-2007-997580 Available"/>
   <result pre="L Ben-Shosan Y Kronenberg J The clinical behavior of isolated" exact="sphenoid sinusitis" post="Otolaryngol Head Neck Surg 4 2007 136 4 610"/>
   <result pre="Ben-Shosan Y Kronenberg J The clinical behavior of isolated sphenoid" exact="sinusitis" post="Otolaryngol Head Neck Surg 4 2007 136 4 610"/>
   <result pre="Scaramuzza C Marseglia A Leone M Ciprandi G Acute isolated" exact="sphenoid sinusitis" post="in children Int J Pediatr Otorhinolaryngol 12 2006 70"/>
   <result pre="C Marseglia A Leone M Ciprandi G Acute isolated sphenoid" exact="sinusitis" post="in children Int J Pediatr Otorhinolaryngol 12 2006 70"/>
   <result pre="DJ Stevens ER The pathogenesis of orbital complications in acute" exact="sinusitis" post="Laryngoscope 9 1970 80 9 1414 1428 10.1288/00005537-197009000-00007 Available"/>
   <result pre="516 8140703 581 Bedwell J Bauman NM Management of pediatric" exact="orbital cellulitis" post="and abscess Curr Opin Otolaryngol Head Neck Surg 12"/>
   <result pre="8140703 581 Bedwell J Bauman NM Management of pediatric orbital" exact="cellulitis" post="and abscess Curr Opin Otolaryngol Head Neck Surg 12"/>
   <result pre="M Bose S Zalzal GH Choi S Management of pediatric" exact="orbital cellulitis" post="in patients with radiographic findings of subperiosteal abscess Otolaryngol"/>
   <result pre="Bose S Zalzal GH Choi S Management of pediatric orbital" exact="cellulitis" post="in patients with radiographic findings of subperiosteal abscess Otolaryngol"/>
   <result pre="ZF Medical treatment of pediatric subperiosteal orbital abscess secondary to" exact="sinusitis" post="J AAPOS 12 1998 2 6 351 355 10.1016/S1091-8531(98)90033-7"/>
   <result pre="and surgical management of subperiosteal orbital abscess secondary to acute" exact="sinusitis" post="in children Int J Pediatr Otorhinolaryngol 11 2006 70"/>
   <result pre="Gallagher RM Gross CW Phillips CD Suppurative intracranial complications of" exact="sinusitis" post="Laryngoscope 11 1998 108 11 Pt 1 1635 1642"/>
   <result pre="Hoxworth JM Glastonbury CM Orbital and intracranial complications of acute" exact="sinusitis" post="Neuroimaging Clin N Am 11 2010 20 4 511"/>
   <result pre="Karkos PD Karagama Y Karkanevatos A Srinivasan V Recurrent periorbital" exact="cellulitis" post="in a child: A random event or an underlying"/>
   <result pre="Santa Maria PL Pott's puffy tumour and intracranial complications of" exact="frontal sinusitis" post="in pregnancy J Laryngol Otol 1 2013 127 Suppl"/>
   <result pre="Maria PL Pott's puffy tumour and intracranial complications of frontal" exact="sinusitis" post="in pregnancy J Laryngol Otol 1 2013 127 Suppl"/>
   <result pre="Wang HS Kuo MF Huang SC Diagnostic approach to recurrent" exact="bacterial meningitis" post="in children Chang Gung Med J 7 2005 28"/>
   <result pre="HS Kuo MF Huang SC Diagnostic approach to recurrent bacterial" exact="meningitis" post="in children Chang Gung Med J 7 2005 28"/>
   <result pre="ML Lin KL Kao PF Chen JF Recurrence of pneumococcal" exact="meningitis" post="due to primary spontaneous cerebrospinal fluid fistulas Chang Gung"/>
   <result pre="8208564 626 Gliklich RE Metson R Economic implications of chronic" exact="sinusitis" post="Otolaryngol Head Neck Surg 3 1998 118 3 Pt"/>
   <result pre="AN Andriolo RB Cruz OL Pignatari SN Surgery for congenital" exact="choanal atresia" post="Cochrane Database Syst Rev 2012 2 CD008993 10.1002/14651858.CD008993.pub2 Available"/>
   <result pre="http://dx.doi.org/10.1016/j.otc.2009.01.001 19328897 636 Panda NK Simhadri S Ghosh S Bilateral" exact="choanal atresia" post="in an adult: is it compatible with life? J"/>
   <result pre="Tatar EÇ Ozdek A Akcan F Korkmaz H Bilateral congenital" exact="choanal atresia" post="encountered in late adulthood J Laryngol Otol 9 2012"/>
   <result pre="Cadd B Talwar R Bajaj Y Conservative management of bilateral" exact="choanal atresia?" post="Bilateral choanal atresia diagnosed in a 5-year-old girl BMJ"/>
   <result pre="R Bajaj Y Conservative management of bilateral choanal atresia? Bilateral" exact="choanal atresia" post="diagnosed in a 5-year-old girl BMJ Case Rep 2014"/>
   <result pre="Available from: http://dx.doi.org/10.1136/bcr-2014-204455 639 Yasar H Ozkul MH Bilateral congenital" exact="choanal atresia" post="in a 51-year-old woman Am J Rhinol Nov-Dec 2007"/>
   <result pre="Cedin AC Fujita R Cruz OL Endoscopic transeptal surgery for" exact="choanal atresia" post="with a stentless folded-over-flap technique Otolaryngol Head Neck Surg"/>
   <result pre="HH Transnasal mucosal flap rotation technique for repair of posterior" exact="choanal atresia" post="Otolaryngol Head Neck Surg 6 2001 124 6 674"/>
   <result pre="Swinging door flap technique for endoscopic transeptal repair of bilateral" exact="choanal atresia" post="Eur Arch Otorhinolaryngol 11 2008 265 11 1341 1347"/>
   <result pre="Choanalatresien ohne Verwendung von Platzhaltern Combined transseptal-transnasal surgery of unilateral" exact="choanal atresia" post="without using stents Laryngorhinootologie 12 1999 78 12 697"/>
   <result pre="SS Filho LL Chiu AG Palmer JN Endoscopic repair of" exact="choanal atresia" post="Atlas of endoscopic sinus and skull base surgery 2013"/>
   <result pre="El-Ahl MA El-Anwar MW Stentless endoscopic transnasal repair of bilateral" exact="choanal atresia" post="starting with resection of vomer Int J Pediatr Otorhinolaryngol"/>
   <result pre="Santamaria VE Lippert BM Mann WJ Forty-one cases of congenital" exact="choanal atresia" post="over 26 years--retrospective analysis of outcome and technique Rhinology"/>
   <result pre="T Predictive factors for success after transnasal endoscopic treatment of" exact="choanal atresia" post="Arch Otolaryngol Head Neck Surg 1 2008 134 1"/>
   <result pre="10.1007/s00405-012-1982-y Available from: http://dx.doi.org/10.1007/s00405-012-1982-y 22392520 653 Pirsig W Surgery of" exact="choanal atresia" post="in infants and children: historical notes and updated review"/>
   <result pre="CS Daniel SJ James AL Forte V Management of bilateral" exact="choanal atresia" post="in the neonate: an institutional review Int J Pediatr"/>
   <result pre="Goettmann D Strohm M Strecker EP Treatment of a recurrent" exact="choanal atresia" post="by balloon dilatation Cardiovasc Intervent Radiol Nov-Dec 2000 23"/>
   <result pre="N Zalzal GH Preciado DA Balloon dilation for management of" exact="choanal atresia" post="and stenosis Int J Pediatr Otorhinolaryngol 12 2011 75"/>
   <result pre="M Hoffmann TK Rotter N Transnasal endoscopic treatment of bilateral" exact="choanal atresia" post="in newborns using balloon dilatation: own results and review"/>
   <result pre="Al-Omari B Hone S Russell J Transnasal endoscopic repair of" exact="choanal atresia" post="in a tertiary care centre: a review of outcomes"/>
   <result pre="C Guarisco JL The efficacy of mitomycin and stenting in" exact="choanal atresia" post="repair: a 20 year experience Int J Pediatr Otorhinolaryngol"/>
   <result pre="24367937 663 Bedwell JR Choi SS Are stents necessary after" exact="choanal atresia" post="repair? Laryngoscope 11 2012 122 11 2365 2366 10.1002/lary.23381"/>
   <result pre="http://dx.doi.org/10.1007/s00405-012-1956-0 22441680 665 Zuckerman JD Zapata S Sobol SE Single-stage" exact="choanal atresia" post="repair in the neonate Arch Otolaryngol Head Neck Surg"/>
   <result pre="from: http://dx.doi.org/10.1001/archotol.134.10.1090 18936357 666 De Freitas RP Berkowitz RG Bilateral" exact="choanal atresia" post="repair in neonates - a single surgeon experience Int"/>
   <result pre="A Yilmaz B Sengul E Topcu I Patients with congenital" exact="choanal atresia" post="treated by transnasal endoscopic surgery J Craniofac Surg 5"/>
   <result pre="Martínez-Rodriguez N Martínez-González JM Meta-analysis of the etiology of odontogenic" exact="maxillary sinusitis" post="Med Oral Patol Oral Cir Bucal 1 2010 15"/>
   <result pre="N Martínez-González JM Meta-analysis of the etiology of odontogenic maxillary" exact="sinusitis" post="Med Oral Patol Oral Cir Bucal 1 2010 15"/>
   <result pre="NS Evidence of an increase in the incidence of odontogenic" exact="sinusitis" post="over the last decade in the UK J Laryngol"/>
   <result pre="BF 4th Ferguson BJ Frequency of a dental source for" exact="acute maxillary sinusitis" post="Laryngoscope 3 2009 119 3 580 584 10.1002/lary.20095 Available"/>
   <result pre="4th Ferguson BJ Frequency of a dental source for acute" exact="maxillary sinusitis" post="Laryngoscope 3 2009 119 3 580 584 10.1002/lary.20095 Available"/>
   <result pre="Ferguson BJ Frequency of a dental source for acute maxillary" exact="sinusitis" post="Laryngoscope 3 2009 119 3 580 584 10.1002/lary.20095 Available"/>
   <result pre="Ferguson BJ Odontogenic sinusitis: an ancient but under-appreciated cause of" exact="maxillary sinusitis" post="Curr Opin Otolaryngol Head Neck Surg 2 2012 20"/>
   <result pre="BJ Odontogenic sinusitis: an ancient but under-appreciated cause of maxillary" exact="sinusitis" post="Curr Opin Otolaryngol Head Neck Surg 2 2012 20"/>
   <result pre="Tudela-Cabello K Crovetto-de la Torre MA Frequency of the odontogenic" exact="maxillary sinusitis" post="extended to the anterior ethmoid sinus and response to"/>
   <result pre="K Crovetto-de la Torre MA Frequency of the odontogenic maxillary" exact="sinusitis" post="extended to the anterior ethmoid sinus and response to"/>
   <result pre="Zerman N Polini F Politi M Endoscopic surgical treatment of" exact="chronic maxillary sinusitis" post="of dental origin J Oral Maxillofac Surg 2 2007"/>
   <result pre="N Polini F Politi M Endoscopic surgical treatment of chronic" exact="maxillary sinusitis" post="of dental origin J Oral Maxillofac Surg 2 2007"/>
   <result pre="Polini F Politi M Endoscopic surgical treatment of chronic maxillary" exact="sinusitis" post="of dental origin J Oral Maxillofac Surg 2 2007"/>
   <result pre="J Koudounarakis E Alexopoulos K Kotsani A Kyrmizakis DE Maxillary" exact="sinusitis" post="of dental origin due to oroantral fistula, treated by"/>
   <result pre="21493214 704 Daudia A Biswas D Jones NS Risk of" exact="meningitis" post="with cerebrospinal fluid rhinorrhea Ann Otol Rhinol Laryngol 12"/>
   <result pre="http://dx.doi.org/10.3109/02688699008993796 2076209 706 Bernal-Sprekelsen M Bleda-Vázquez C Carrau RL Ascending" exact="meningitis" post="secondary to traumatic cerebrospinal fluid leaks Am J Rhinol"/>
   <result pre="Esmaeeli B Prophylactic administration of ceftriaxone for the prevention of" exact="meningitis" post="after traumatic pneumocephalus: results of a clinical trial J"/>
   <result pre="802 Keller JJ Wu CS Lin HC Increased risk of" exact="psoriasis" post="following chronic rhinosinusitis without nasal polyps: a population-based matched-cohort"/>
   <result pre="M Vardakas KZ Gkegkes ID Kapaskelis A Falagas ME Ventilator-associated" exact="sinusitis" post="in adults: systematic review and meta-analysis Respir Med 8"/>
   <result pre="RG Steere EL Nunnally FK Beckford N Mayhall CG Nosocomial" exact="sinusitis" post="in patients in the medical intensive care unit: a"/>
   <result pre="Stein M Caplan ES Nosocomial sinusitis: a unique subset of" exact="sinusitis" post="Curr Opin Infect Dis 4 2005 18 2 147"/>
   <result pre="Nipshagen MD de Bree R Girbes AR Polderman KH Hospital-acquired" exact="sinusitis" post="is a common cause of fever of unknown origin"/>
   <result pre="TD Marsault C Risk factors and clinical relevance of nosocomial" exact="maxillary sinusitis" post="in the critically ill Am J Respir Crit Care"/>
   <result pre="Marsault C Risk factors and clinical relevance of nosocomial maxillary" exact="sinusitis" post="in the critically ill Am J Respir Crit Care"/>
   <result pre="cultures vs computed tomographic scans in the diagnosis of bacterial" exact="sinusitis" post="in intensive care units J Crit Care 6 2012"/>
   <result pre="9339797 812 Skoulas IG Helidonis E Kountakis SE Evaluation of" exact="sinusitis" post="in the intensive care unit patient Otolaryngol Head Neck"/>
   <result pre="PH Effects of sinus surgery on lung transplantation outcomes in" exact="cystic fibrosis" post="Am J Rhinol Mar-Apr 2008 22 2 192 196"/>
   <result pre="Boehler A Impact of sinus surgery on pseudomonal airway colonization," exact="bronchiolitis" post="obliterans syndrome and survival in cystic fibrosis lung transplant"/>
   <result pre="on pseudomonal airway colonization, bronchiolitis obliterans syndrome and survival in" exact="cystic fibrosis" post="lung transplant recipients Respiration 2013 86 1 25 31"/>
   <result pre="mucociliary transport change after endoscopic sinus surgery in children with" exact="chronic maxillary sinusitis" post="Int J Pediatr Otorhinolaryngol 8 2006 70 8 1361"/>
   <result pre="transport change after endoscopic sinus surgery in children with chronic" exact="maxillary sinusitis" post="Int J Pediatr Otorhinolaryngol 8 2006 70 8 1361"/>
   <result pre="change after endoscopic sinus surgery in children with chronic maxillary" exact="sinusitis" post="Int J Pediatr Otorhinolaryngol 8 2006 70 8 1361"/>
   <result pre="of the adenoid core and middle meatus in children with" exact="sinusitis" post="J Laryngol Otol 3 2011 125 3 279 281"/>
   <result pre="L Simsek M Akcali C Kucukcan A Chronic rhinosinusitis and" exact="adenoid hypertrophy" post="in children Am J Otolaryngol Jan-Feb 2004 25 1"/>
   <result pre="from: http://dx.doi.org/10.1016/j.ijporl.2005.04.010 15996759 860 Ramadan HH Surgical management of chronic" exact="sinusitis" post="in children Laryngoscope 12 2004 114 12 2103 2109"/>
   <result pre="822 10.1002/alr.21190 Available from: http://dx.doi.org/10.1002/alr.21190 23839953 868 Aanæs K Bacterial" exact="sinusitis" post="can be a focus for initial lung colonisation and"/>
   <result pre="initial lung colonisation and chronic lung infection in patients with" exact="cystic fibrosis" post="J Cyst Fibros 9 2013 12 Suppl 2 S1"/>
   <result pre="pulmonary function and microbial pathogens in a pediatric population with" exact="cystic fibrosis" post="Arch Otolaryngol Head Neck Surg 6 2011 137 6"/>
   <result pre="JG Koitschev A Pathogenesis and management of nasal polyposis in" exact="cystic fibrosis" post="Curr Allergy Asthma Rep 4 2012 12 2 163"/>
   <result pre="and likelihood of revision endoscopic sinus surgery in patients with" exact="cystic fibrosis" post="Arch Otolaryngol Head Neck Surg 10 2010 136 10"/>
   <result pre="after paranasal sinus surgery in children and young adults with" exact="cystic fibrosis" post="Laryngoscope 3 2007 117 3 475 479 10.1097/MLG.0b013e31802d6e4f Available"/>
   <result pre="JM Mackay IS Endoscopic sinus surgery in the treatment of" exact="cystic fibrosis" post="with nasal polyposis Laryngoscope 12 1996 106 12 Pt"/>
   <result pre="Woodworth BA Extensive surgical and comprehensive postoperative medical management for" exact="cystic fibrosis" post="chronic rhinosinusitis Am J Rhinol Allergy Jan-Feb 2012 26"/>
   <result pre="Jaberoo MC Pulido MA Saleh HA Modified Lothrop procedure in" exact="cystic fibrosis" post="patients: does it have a role? J Laryngol Otol"/>
   <result pre="ND What is the optimal management of chronic rhinosinusitis in" exact="cystic fibrosis?" post="Curr Opin Otolaryngol Head Neck Surg 2 2014 22"/>
   <result pre="from: http://dx.doi.org/10.1002/lary.24503 24338982 880 Moss RB King VV Management of" exact="sinusitis" post="in cystic fibrosis by endoscopic surgery and serial antimicrobial"/>
   <result pre="24338982 880 Moss RB King VV Management of sinusitis in" exact="cystic fibrosis" post="by endoscopic surgery and serial antimicrobial lavage. Reduction in"/>
   <result pre="C collab: National PCD Service, UK Diagnosis and management of" exact="primary ciliary dyskinesia" post="Arch Dis Child 9 2014 99 9 850 856"/>
   <result pre="24771309 883 Campbell R Managing upper respiratory tract complications of" exact="primary ciliary dyskinesia" post="in children Curr Opin Allergy Clin Immunol 2 2012"/>
   <result pre="vidian neurectomy in the management of moderate to severe persistent" exact="allergic rhinitis" post="Arch Otolaryngol Head Neck Surg 5 2012 138 5"/>
   <result pre="neurectomy in the management of moderate to severe persistent allergic" exact="rhinitis" post="Arch Otolaryngol Head Neck Surg 5 2012 138 5"/>
   <result pre="safety of endoscopic vidian neurectomy for the treatment of intractable" exact="rhinitis" post="Clin Exp Otorhinolaryngol 12 2010 3 4 212 216"/>
   <result pre="Therapeutic effectiveness of endoscopic vidian neurectomy for the treatment of" exact="vasomotor rhinitis" post="Acta Otolaryngol 3 2014 134 3 260 267 10.3109/00016489.2013.831478"/>
   <result pre="effectiveness of endoscopic vidian neurectomy for the treatment of vasomotor" exact="rhinitis" post="Acta Otolaryngol 3 2014 134 3 260 267 10.3109/00016489.2013.831478"/>
   <result pre="Rose GE Lund VJ Clinical features and treatment of late" exact="enophthalmos" post="after orbital decompression: a condition suggesting cause for idiopathic"/>
   <result pre="CP Sinus problems as a cause of headache refractoriness and" exact="migraine" post="chronification Curr Pain Headache Rep 8 2009 13 4"/>
   <result pre="936 Jones NS The prevalence of facial pain and purulent" exact="sinusitis" post="Curr Opin Otolaryngol Head Neck Surg 2 2009 17"/>
   <result pre="http://dx.doi.org/10.1016/j.otc.2013.10.006 24680492 943 Jones NS Midfacial segment pain: implications for" exact="rhinitis" post="and rhinosinusitis Clin Allergy Immunol 2007 19 323 333"/>
   <result pre="DR Bewley AF Case-control analysis of survival outcomes in sinonasal" exact="acinic cell carcinoma" post="Int Forum Allergy Rhinol 6 2014 4 6 507"/>
   <result pre="SC Balloon dilation of the frontal recess in patients with" exact="chronic frontal sinusitis" post="and advanced sinus disease: an initial report Ann Otol"/>
   <result pre="Balloon dilation of the frontal recess in patients with chronic" exact="frontal sinusitis" post="and advanced sinus disease: an initial report Ann Otol"/>
   <result pre="dilation of the frontal recess in patients with chronic frontal" exact="sinusitis" post="and advanced sinus disease: an initial report Ann Otol"/>
   <result pre="Jr Balloon dilation of the frontal recess in patients with" exact="chronic frontal sinusitis" post="and advanced sinus disease: an initial report Ann Otol"/>
   <result pre="Balloon dilation of the frontal recess in patients with chronic" exact="frontal sinusitis" post="and advanced sinus disease: an initial report Ann Otol"/>
   <result pre="dilation of the frontal recess in patients with chronic frontal" exact="sinusitis" post="and advanced sinus disease: an initial report Ann Otol"/>
   <result pre="1112 Hopkins C Noon E Roberts D Balloon sinuplasty in" exact="acute frontal sinusitis" post="Rhinology 12 2009 47 4 375 378 10.4193/Rhin08.057 Available"/>
   <result pre="Hopkins C Noon E Roberts D Balloon sinuplasty in acute" exact="frontal sinusitis" post="Rhinology 12 2009 47 4 375 378 10.4193/Rhin08.057 Available"/>
   <result pre="C Noon E Roberts D Balloon sinuplasty in acute frontal" exact="sinusitis" post="Rhinology 12 2009 47 4 375 378 10.4193/Rhin08.057 Available"/>
   <result pre="irrigator – a safe and effective advance in treating pediatric" exact="sinusitis" post="Int J Pediatr Otorhinolaryngol 4 2011 75 4 461"/>
   <result pre="instruments and mechanical debriders for surgery of patients with chronic" exact="sinusitis" post="Am J Rhinol Jul-Aug 2003 17 4 197 202"/>
   <result pre="W Olfactory function after functional endoscopic sinus surgery for chronic" exact="sinusitis" post="Rhinology 3 1998 36 1 15 19 9569436 1237"/>
   <result pre="Nguyen SA Schlosser RJ A systematic review and meta-analysis of" exact="asthma" post="outcomes following endoscopic sinus surgery for chronic rhinosinusitis Int"/>
   <result pre="Comparative outcomes of endoscopic sinus surgery in patients with chronic" exact="sinusitis" post="and nasal polyps Eur Arch Otorhinolaryngol 9 2007 264"/>
   <result pre="Cauwenberge P Bachert C Gevaert P The importance of local" exact="eosinophilia" post="in the surgical outcome of chronic rhinosinusitis: a 3-year"/>
   <result pre="Sobol SE Outcome analysis of endoscopic sinus surgery for chronic" exact="sinusitis" post="in patients having Samter's triad J Otolaryngol 2 2000"/>
   <result pre="of endoscopic sinus surgery in patients with nasal polyps and" exact="asthma" post="Laryngoscope 10 2003 113 10 1703 1706 10.1097/00005537-200310000-00008 Available"/>
   <result pre="Chung YJ Kim MG Clinical characteristics of chronic rhinosinusitis with" exact="asthma" post="Auris Nasus Larynx 12 2006 33 4 403 408"/>
   <result pre="from: http://dx.doi.org/10.1016/j.anl.2006.05.002 16930901 1279 Kountakis SE Bradley DT Effect of" exact="asthma" post="on sinus computed tomography grade and symptom scores in"/>
   <result pre="SB Bent JP 3rd Kuhn FA Prognosis for allergic fungal" exact="sinusitis" post="Otolaryngol Head Neck Surg 7 1997 117 1 35"/>
   <result pre="is associated with an unfavorable evolution after surgery for chronic" exact="sinusitis" post="and nasal polyposis Otolaryngol Head Neck Surg 6 2006"/>
   <result pre="G Timmermans M Toskala E Zhang N Bousquet J Uncontrolled" exact="allergic rhinitis" post="and chronic rhinosinusitis: where do we stand today? Allergy"/>
   <result pre="Timmermans M Toskala E Zhang N Bousquet J Uncontrolled allergic" exact="rhinitis" post="and chronic rhinosinusitis: where do we stand today? Allergy"/>
   <result pre="ZM Sauer D Mace J Smith TL Impact of mucosal" exact="eosinophilia" post="and nasal polyposis on quality-of-life outcomes after sinus surgery"/>
   <result pre="Pilot study of budesonide inhalant suspension irrigations for chronic eosinophilic" exact="sinusitis" post="J Allergy Clin Immunol 12 2009 124 6 1352"/>
   <result pre="BN Is there evidence to link acid reflux with chronic" exact="sinusitis" post="or any nasal symptoms? A review of the evidence"/>
   <result pre="Cable HR Middle meatal antrostomy: long-term patency and results in" exact="chronic maxillary sinusitis." post="A prospective study Clin Otolaryngol Allied Sci 4 1993"/>
   <result pre="HR Middle meatal antrostomy: long-term patency and results in chronic" exact="maxillary sinusitis." post="A prospective study Clin Otolaryngol Allied Sci 4 1993"/>
   <result pre="http://dx.doi.org/10.1007/s001060050045 9005231 1321 Wigand ME Hosemann W Endoscopic surgery for" exact="frontal sinusitis" post="and its complications Am J Rhinol 1991 5 85–9"/>
   <result pre="9005231 1321 Wigand ME Hosemann W Endoscopic surgery for frontal" exact="sinusitis" post="and its complications Am J Rhinol 1991 5 85–9"/>
   <result pre="management of chronic rhinosinusitis with polyposis: lack of significant adrenal" exact="suppression" post="J Otolaryngol Head Neck Surg 12 2008 37 6"/>
   <result pre="nasal pack on mucosal healing in a sheep model of" exact="sinusitis" post="Am J Rhinol Nov-Dec 2005 19 6 572 576"/>
   <result pre="meatus after functional endoscopic sinus surgery in children with chronic" exact="sinusitis" post="Int J Pediatr Otorhinolaryngol 10 2008 72 10 1535"/>
   <result pre="scan (b) Figure 10 Female patient with condition after pneumococci" exact="meningitis" post="and bony defect of the posterior wall of the"/>
   <result pre="b) MRI (CISS sequence). Figure 11 Female patient with pneumococci" exact="meningitis" post="and acute sphenoid sinusitis and intact skull base in"/>
   <result pre="sequence). Figure 11 Female patient with pneumococci meningitis and acute" exact="sphenoid sinusitis" post="and intact skull base in thin layer CT scan."/>
   <result pre="Figure 11 Female patient with pneumococci meningitis and acute sphenoid" exact="sinusitis" post="and intact skull base in thin layer CT scan."/>
   <result pre="the sphenoid sinus/anterior wall of the pituitary. Figure 12 Chronic" exact="maxillary sinusitis" post="of the right side. The causative preapical abscess was"/>
   <result pre="sphenoid sinus/anterior wall of the pituitary. Figure 12 Chronic maxillary" exact="sinusitis" post="of the right side. The causative preapical abscess was"/>
   <result pre="of the maxillary sinus by exophytic tumor mass with typical" exact="hyperostosis" post="at the small-sized origin at the base of the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC4782684/results/search/disease/results.xml">
   <result pre="0.03  Withdrawal from illicit substances—no known patient(s) 181 0.02  Other" exact="substance abuse" post="750 0.09   Subtotal 5,783 0.72 Administrative  Expert witness"/>
   <result pre="response to an event rather than an event prediction. This" exact="aids" post="in situational awareness and resilience during and after a"/>
   <result pre="in significant residual disability or disfigurement (e.g., repeated seizures or" exact="status epilepticus," post="respiratory compromise requiring intubation, ventricular tachycardia with hypotension, cardiac"/>
   <result pre="significant past medical history presented to a community hospital with" exact="shortness" post="of breath preceded by fatigue. She developed status epilepticus"/>
   <result pre="hospital with shortness of breath preceded by fatigue. She developed" exact="status epilepticus" post="unresponsive to midazolam and required endotracheal intubation. She was"/>
   <result pre="for persistent hyperammonemia and initiated a workup for late presenting" exact="inborn error of metabolism." post="Patient was given cobalamin, thiamine, biotin, levocarnitine, and riboflavin."/>
   <result pre="levocarnitine, and riboflavin. Toxicology service was then consulted for unresolving" exact="metabolic acidosis" post="despite resuscitation and bicarbonate infusion. Patient was given fomepizole."/>
   <result pre="He was given dopamine, 6 vials of antivenin (Fab fragment)," exact="tetanus" post="toxoid, epinephrine, methylprednisolone, and diphenhydramine. He was transferred to"/>
   <result pre="access to cyanide salts. Initial labs were notable for profound" exact="metabolic acidosis" post="with markedly elevated lactate. ECG showed nonspecific intra ventricular"/>
   <result pre="(∼10 mcg/mL, reporting limit 0.3 mcg/mL). Cause of death: hypoxic" exact="encephalopathy" post="and possible subarachnoid hemorrhage complicating acute cyanide toxicity. The"/>
   <result pre="CxR showed bibasilar infiltrates; he received prophylactic antibiotics for presumed" exact="aspiration pneumonia." post="Respiratory status improved, and he was weaned from ventilator"/>
   <result pre="on maximal IV propofol and midazolam when he had a" exact="pulmonary embolism" post="and was suspected despite prophylactic heparin administration. Prior to"/>
   <result pre="hemorrhagic gastritis, marked cerebral edema, cerebellar tonsillar herniation and infarct," exact="cerebral venous sinus thrombosis." post="Postmortem specimens of heart blood were negative for amphetamines,"/>
   <result pre="cold and became tachycardic and dyspneic. Past Medical History: Hematuria," exact="prostate cancer." post="Physical Exam: BP 132/82, HR 114, RR 18, T"/>
   <result pre="Hct 28, platelets 222, INR 2.2-2.8. Clinical Course: CxR showed" exact="pulmonary embolism." post="He was twice successfully resuscitated following cardiac arrest. He"/>
   <result pre="CxR showed pulmonary embolism. He was twice successfully resuscitated following" exact="cardiac arrest." post="He intubated and sedated in the ICU, completed first"/>
   <result pre="endotracheally intubated; 3 h after exposure, the patient experienced a" exact="cardiac arrest" post="and could not be resuscitated. Autopsy Findings: Mild hyperemia"/>
   <result pre="blood was reported as &amp;gt; 60%. Autopsy Findings: Autopsy demonstrated" exact="pulmonary edema" post="and congestion. Petechiae were distributed over head and neck."/>
   <result pre="He developed a T 38.7°C. The patient had a second" exact="cardiac arrest" post="at Hour 21 and could not be resuscitated. Autopsy"/>
   <result pre="the presence of any gases. Past Medical History: hypertension and" exact="atrial fibrillation." post="Autopsy Findings: The ME initially assumed the patient and"/>
   <result pre="patient and her husband died of overdoses. An autopsy showed" exact="pulmonary edema" post="and mild cardiomegaly. Toxicology revealed a COHb of &amp;gt;"/>
   <result pre="wife had been recently hospitalized and intubated secondary to lead" exact="encephalopathy" post="thought to be caused by drinking homemade moonshine. She"/>
   <result pre="this moonshine. Physical Exam: In the ED, he was in" exact="status epilepticus," post="intubated, sedated. He was afebrile, BP 127/98, HR 80."/>
   <result pre="Ca disodium EDTA. Despite maximal therapy, the patient remained in" exact="status epilepticus," post="and was treated with phenytoin, levetiracetam, propofol, midazolam, and"/>
   <result pre="Approximately 3 h after ED arrival, the patient had a" exact="cardiac arrest." post="He was resuscitated and given additional calcium. He was"/>
   <result pre="was aggressively treated with IV calcium, and suffered a terminal" exact="cardiac arrest" post="∼7 h after ingestion. Autopsy Findings: Not performed. Case"/>
   <result pre="cooling measures which were initiated. The patient suffered an asystolic" exact="cardiac arrest," post="ACLS was initiated, but resuscitation was unsuccessful. During the"/>
   <result pre="hospital personal were required to manage him. He had a" exact="cardiac arrest" post="soon after arrival at the tertiary care hospital from"/>
   <result pre="witnessed seizure and EMS was summoned. Patient had a VT" exact="cardiac arrest" post="enroute to hospital. He received 20 min of CPR"/>
   <result pre="neurological activity despite being weaned from all sedation. Bronchoscopy showed" exact="aspiration pneumonia." post="The patient developed progressive hypotension and tachycardia requiring vasopressors,"/>
   <result pre="Hypertension, hypercholesterolemia, and anxiety, no history of smoking tobacco or" exact="lung disease." post="Physical Exam: Upon initial presentation to the ED, he"/>
   <result pre="Medications included atorvastatin, clobetasol, lisinopril, magnesium, and metoprolol. History of" exact="alcohol abuse," post="a prior suicide attempt, a daughter committed suicide &quot;years"/>
   <result pre="propofol. His BP dropped 102/65, HR 75 (paced), secretions and" exact="diarrhea" post="increased. He became more active without muscle fasciculations but"/>
   <result pre="and 7-OH mitragynine only. Cause of death was severe hypoxic" exact="encephalopathy" post="complicating apparent mitragynine toxicity. The packet of the suspect"/>
   <result pre="to the ED. Past Medical History: Depression, GERD, chronic pain," exact="atrial fibrillation," post="pacemaker, hypertension, and hyperglycemia. Patient did not have a"/>
   <result pre="was pronounced dead at the scene Autopsy Findings: Autopsy showed" exact="pulmonary edema." post="Iliac blood free buprenorphine was 2.5 ng/mL, and free"/>
   <result pre="found in her purse. Past Medical History: Anxiety, depression, possible" exact="substance abuse," post="and gastric bypass surgery previous year. Medications: sucralfate, misoprostol,"/>
   <result pre="for hemodialysis. His ABGs showed a mixed respiratory alkalosis with" exact="metabolic acidosis." post="Sodium bicarbonate was given. He was admitted to the"/>
   <result pre="was admitted to the ICU and experienced nausea, vomiting, and" exact="diarrhea" post="for 2–3 h. He became confused, agitated, and combative."/>
   <result pre="no evidence of an acute self-harm intent. He developed profuse" exact="diarrhea" post="(7–8 stools/day) and weakness, and was brought back to"/>
   <result pre="Gout, end-stage renal disease on hemodialysis, hypertension, hypokalemia, leukopenia, thrombocytopenia," exact="peptic ulcer" post="disease, myocardial infarction, congestive heart failure, anemia, syncope, cardiogenic"/>
   <result pre="hemodialysis, hypertension, hypokalemia, leukopenia, thrombocytopenia, peptic ulcer disease, myocardial infarction," exact="congestive heart failure," post="anemia, syncope, cardiogenic shock with PEA and VT arrest,"/>
   <result pre="opacity with small bilateral pleural effusion, and repeated CxR showed" exact="pulmonary edema." post="Clinical Course: Patient continued to be hypotensive despite fluid"/>
   <result pre="a HCF that could provide hemodialysis when he went into" exact="cardiac arrest" post="and expired. Autopsy Findings: Petechial hemorrhages of the heart,"/>
   <result pre="naloxone infusion was continued. That evening, she went into acute" exact="respiratory failure" post="and suffered a cerebral herniation. Emergency craniotomy was performed"/>
   <result pre="norepinephrine, and vasopressin were used for pressure support. She developed" exact="diabetes insipidus." post="Continuous EEG showed no activity. She was determined to"/>
   <result pre="ED for an unknown reason. Past Medical History: COPD, hypertension," exact="diabetes mellitus," post="seizure disorder, and s/p pacemaker placement. Laboratory Data: K"/>
   <result pre="during transport to the ED. Past Medical History: Hypertension, COPD," exact="migraine" post="headache, major depressive disorder, GERD, dementia, seizure disorder. S/p"/>
   <result pre="to the ED. Past Medical History: Hypertension, COPD, migraine headache," exact="major depressive disorder," post="GERD, dementia, seizure disorder. S/p bilateral knee surgery, lower"/>
   <result pre="seizure disorder. S/p bilateral knee surgery, lower back surgery for" exact="degenerative disc disease," post="left hip fracture surgery (1 month prior). Medications: rantitidine,"/>
   <result pre="his gums, epistaxis, and hemoptysis. Past Medical History: Alzheimer's dementia," exact="alcoholic cardiomyopathy," post="cirrhosis, and anemia of chronic disease. Physical Exam: Alert"/>
   <result pre="hemoptysis. Past Medical History: Alzheimer's dementia, alcoholic cardiomyopathy, cirrhosis, and" exact="anemia" post="of chronic disease. Physical Exam: Alert and oriented, BP"/>
   <result pre="on Day 3. Autopsy Findings: Acute bilateral pneumonia, acute hemorrhagic" exact="pancreatitis" post="with retroperitoneal soft tissue hemorrhage, mild CAD, and moderate"/>
   <result pre="of lorazepam IV for agitation. Renal failure and anion gap" exact="metabolic acidosis" post="developed. She was intubated for airway protection. NS was"/>
   <result pre="10-sec tonic-clonic seizures, was intubated, and developed severe bradycardia and" exact="cardiac arrest." post="A temporary transcutaneous pacemaker was inserted. She became severely"/>
   <result pre="microscopic findings suggestive of extra lobar sequestration. He had acute" exact="bronchopneumonia" post="consistent with a period of obtunded survival and mild–moderate"/>
   <result pre="intubated her, and started CPR. Past Medical History: Diabetes mellitus," exact="breast cancer," post="CAD, chronic renal disease, hyperlipidemia, COPD, hypertension, allergies, anemia,"/>
   <result pre="body viewing was performed. Cause of death was undetermined with" exact="cocaine abuse" post="as a contributing factor and some consideration to &quot;drug"/>
   <result pre="methotrexate dosing was stopped. Past Medical History: Arthritis, diabetes, hypertension," exact="colon cancer," post="and chronic kidney infections. Laboratory Data: WBC 0.5, Hgb"/>
   <result pre="multiple vasopressors. Past Medical History: Congestive heart failure, severe dilated" exact="cardiomyopathy" post="of unknown cause, methamphetamine abuse. Physical Exam: Lethargic, but"/>
   <result pre="BP 93 systolic. At Hour 52 the patient suffered a" exact="cardiac arrest," post="was resuscitated and had multiple episodes of bradycardia and"/>
   <result pre="On arrival to the ED, he was intubated for impending" exact="respiratory failure." post="BP 40's, HR 30's. He had a brief period"/>
   <result pre="BP 40's, HR 30's. He had a brief period of" exact="cardiac arrest" post="which responded to CPR and epinephrine. Dopamine infusion was"/>
   <result pre="Past Medical History: Depression, anxiety, previous suicide attempts, diabetes, hypertension," exact="liver cancer," post="COPD, diabetic neuropathy, degenerative joint disease, hyperlipidemia, multiple falls,"/>
   <result pre="Depression, anxiety, previous suicide attempts, diabetes, hypertension, liver cancer, COPD," exact="diabetic neuropathy," post="degenerative joint disease, hyperlipidemia, multiple falls, myofascial pain dysfunction"/>
   <result pre="degenerative joint disease, hyperlipidemia, multiple falls, myofascial pain dysfunction syndrome," exact="radiculopathy" post="to bilateral lower extremities after laminectomy, shoulder pain, transient"/>
   <result pre="but it was initiated at the time that a bradysystolic" exact="cardiac arrest" post="occurred. Hour 5.5. CPR with epinephrine, atropine was unsuccessful."/>
   <result pre="talking to a friend. She was found to be in" exact="cardiac arrest," post="and transported to the ED. Past Medical History: Non-insulin"/>
   <result pre="and transported to the ED. Past Medical History: Non-insulin dependent" exact="diabetes mellitus," post="systemic lupus erythematosus, hypertension, bipolar disorder, fibromyalgia, and depression."/>
   <result pre="to the ED. Past Medical History: Non-insulin dependent diabetes mellitus," exact="systemic lupus erythematosus," post="hypertension, bipolar disorder, fibromyalgia, and depression. Laboratory Data: K"/>
   <result pre="the ED. Past Medical History: Non-insulin dependent diabetes mellitus, systemic" exact="lupus erythematosus," post="hypertension, bipolar disorder, fibromyalgia, and depression. Laboratory Data: K"/>
   <result pre="Medical History: Non-insulin dependent diabetes mellitus, systemic lupus erythematosus, hypertension," exact="bipolar disorder," post="fibromyalgia, and depression. Laboratory Data: K 2.9, Mg 1.5,"/>
   <result pre="leads. Systolic BP 160, HR 120, and she had a" exact="metabolic acidosis." post="She was transferred to a tertiary care hospital and"/>
   <result pre="She received potassium replacement for hypokalemia, was placed on post" exact="cardiac arrest" post="cooling protocol and started on propofol with BP 97/72,"/>
   <result pre="expired on Day 3 Autopsy Findings: Ischemic brain injury, bronchocentric" exact="pneumonia" post="and pulmonary edema. Urine from hospital admission positive for"/>
   <result pre="Day 3 Autopsy Findings: Ischemic brain injury, bronchocentric pneumonia and" exact="pulmonary edema." post="Urine from hospital admission positive for amitriptyline, diphenhydramine, nicotine,"/>
   <result pre="fluids and multiple vasopressors without measurable effect. She had a" exact="cardiac arrest" post="and died on Day 3. Autopsy Findings: Postmortem toxicological"/>
   <result pre="party by law enforcement Clinical Course: The patient had a" exact="cardiac arrest" post="upon arrival to the ED. His pupils remained dilated"/>
   <result pre="1. Autopsy Findings: Evidence of DIC, diffuse organ failure, massive" exact="pulmonary edema," post="bilateral pleural effusions, small subdural hematoma, and anoxic brain"/>
   <result pre="Blood products and N-acetylcysteine were administered. The patient suffered a" exact="cardiac arrest" post="and expired 17 h after admission to the hospital."/>
   <result pre="on Day 1 secondary to DIC and subsequently experienced a" exact="cardiac arrest" post="from which he could not be resuscitated. Autopsy Findings:"/>
   <result pre="and methylone with hyperthermia, cardiac hypertrophy with left ventricular hypertrophy," exact="aortic atherosclerosis," post="slight, obesity. Cause of death: Acute intoxication by the"/>
   <result pre="instituted and he expired on Day 1. Autopsy Findings: Bilateral" exact="pulmonary edema;" post="upper GI bleeding with 700 cc of coffee ground"/>
   <result pre="weeks for jaundice and elevated liver function tests with negative" exact="viral hepatitis" post="panel and undetectable acetaminophen level. Physical Exam: Obese, jaundiced,"/>
   <result pre="for jaundice and elevated liver function tests with negative viral" exact="hepatitis" post="panel and undetectable acetaminophen level. Physical Exam: Obese, jaundiced,"/>
   <result pre="PTT 48, serum acetaminophen 15 mcg/mL, serum salicylate not detected," exact="hepatitis" post="A negative, hepatitis C negative, previous hepatitis B infection,"/>
   <result pre="acetaminophen 15 mcg/mL, serum salicylate not detected, hepatitis A negative," exact="hepatitis" post="C negative, previous hepatitis B infection, anti-mitochondrial antibody and"/>
   <result pre="salicylate not detected, hepatitis A negative, hepatitis C negative, previous" exact="hepatitis" post="B infection, anti-mitochondrial antibody and ANA negative, HIV negative,"/>
   <result pre="baggies cocaine during the arrest and shortly thereafter suffered a" exact="cardiac arrest" post="in the field. The patient was reported to have"/>
   <result pre="vehicle prior to EMS arrival. EMS found the patient in" exact="cardiac arrest," post="intubated, began CPR, and transported him to the ED"/>
   <result pre="support, protocol for the provision of cardiac resuscitation ADHD =" exact="attention deficit hyperactivity disorder" post="AF = atrial fibrillation AICD = automatic implanted cardio"/>
   <result pre="cardiac resuscitation ADHD = attention deficit hyperactivity disorder AF =" exact="atrial fibrillation" post="AICD = automatic implanted cardio defibrillator Alk phos ="/>
   <result pre="support, protocol for the provision of cardiac resuscitation ARDS =" exact="acute respiratory distress syndrome" post="AST = Aspartate aminotransferase [12–38] U/L = (SGOT) AVblock"/>
   <result pre="AST = Aspartate aminotransferase [12–38] U/L = (SGOT) AVblock =" exact="atrioventricular block" post="BAL —British anti-Lewisite BE = base excess, mmol/L Bicarbonate"/>
   <result pre="dioxide serum or plasma [22–26]mmol/L COHb = carboxyhemoglobin COPD =" exact="chronic obstructive pulmonary disease" post="CPR = cardiopulmonary resuscitation Cr = creatinine [0.5–0.9] mg/dL"/>
   <result pre="= hospital day, that is, days since admission DIC =" exact="disseminated intravascular coagulation" post="Dx = diagnosis ECG = electrocardiogram (EKG), leads ="/>
   <result pre="[&amp;lt; 430] msec, adult female [&amp;lt; 450] msec RBBB =" exact="right bundle branch block" post="on ECG RBC = red blood cell(s) RR ="/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC4864730/results/search/disease/results.xml">
   <result pre="(PMR), biofeedback, and cognitive-behavioral therapy (CBT)) are Level A Evidence-Based" exact="migraine" post="treatments [ 2] that are essentially free of side"/>
   <result pre="N = 35 (ages 7–12) Pediatric clinics &amp;amp; children’s hospitals 4 weeks" exact="migraine" post="with or without aura min 1/week HA duration; HA"/>
   <result pre="newsletter announcements, neurology clinics, + social networking/community sites 4 weeks" exact="migraine" post="with or without aura min 2/month Pain catastrophizing; Self-efficacy;"/>
   <result pre="at least 2 times monthly Medication • Decrease in total" exact="migraine" post="drug intake at the end of the MBT program"/>
   <result pre="doses/subject/56 days) compared to controls, no significant difference in total" exact="migraine" post="medication drug intake in the control group (8.3 vs."/>
   <result pre="of patients receiving MBT+ hand massage had 50 % + reduction in" exact="migraine" post="frequency when compared to control group. 8.4 % Overall"/>
   <result pre="3.6 % in control group) • Hand massage NS on" exact="migraine" post="frequency compared to MBT alone. • NS in depression"/>
   <result pre="Self-efficacy; QoL; Disability; LoC • A 20–25 % decrease in" exact="migraine" post="frequency was found for both the tx + control groups, NS"/>
   <result pre="(especially the &quot;Ask an Expert&quot; feature) when they felt a" exact="migraine" post="coming on or had a migraine. • Caregivers reported"/>
   <result pre="(ages 10–17.5) Pediatric neurology clinic 6 months- 60 months Chronic" exact="migraine" post="or Chronic Tension-type HA QoL; Activity limitation; Other •"/>
   <result pre="was a positive outcome in headache frequency, severity, intensity and/or" exact="migraine" post="medications taken in 4/9 (44 %) studies. Of the"/>
   <result pre="these lines, given the high prevalence of psychiatric comorbidity and" exact="migraine" post="[ 34], future studies can be done to explore"/>
   <result pre="Sorbi MJ and Swaen SJ. Protocollaire behandeling van patienten met" exact="migraine" post="en spanningshoofdpijn:Ontspannings training en cognitieve training (Training according to"/>
   <result pre="spanningshoofdpijn:Ontspannings training en cognitieve training (Training according to protocol in" exact="migraine" post="and tension-type headache: Relaxation training and cognitive training). In:"/>
   <result pre="10.1111/j.1526-4610.2005.05105.x 15953270 2. Silberstein SD Practice parameter: Evidence-based guidelines for" exact="migraine" post="headache (an evidence-based review): Report of the quality standards"/>
   <result pre="3. Campbell J Penzien D Wall E Evidence-based guidelines for" exact="migraine" post="headache: Behavioral and physical treatments 1999 4. Andrasik F"/>
   <result pre="means of collecting quality-of-life and outcome data from patients with" exact="rheumatoid arthritis" post="Rheumatology (Oxford) 2006 45 1 66 71 10.1093/rheumatology/kei100 16263782"/>
   <result pre="of collecting quality-of-life and outcome data from patients with rheumatoid" exact="arthritis" post="Rheumatology (Oxford) 2006 45 1 66 71 10.1093/rheumatology/kei100 16263782"/>
   <result pre="EJ A randomized trial of a web-based intervention to improve" exact="migraine" post="self-management and coping Headache 2012 52 244 261 10.1111/j.1526-4610.2011.02031.x"/>
   <result pre="JA, Nicholson RA, Lipton RB (2015) Improving medication adherence in" exact="migraine" post="treatment. Curr Pain Headache Rep 19(6):24-015-0498-8. doi:10.1007/s11916-015-0498-8 37. Gillbody"/>
   <result pre="Doornen L Mobile web-based monitoring and coaching: Feasibility in chronic" exact="migraine" post="J Med Internet Res 2007 9 5 e38 10.2196/jmir.9.5.e38"/>
   <result pre="Connelly M Bickel JL et al. Headstrong intervention for pediatric" exact="migraine" post="headache: A randomized clinical trial J Headache Pain 2014"/>
   <result pre="Passchier J (2015) Medium-term effectiveness of online behavioral training in" exact="migraine" post="self-management: A randomized trial controlled over 10 months. Cephalalgia"/>
   <result pre="influence of multimodal behavioral treatment on the consumption of acute" exact="migraine" post="drugs: A randomized, controlled study Cephalalgia 2012 32 297"/>
   <result pre="Passchier J Short-term effectiveness of an online behavioral training in" exact="migraine" post="self-management: A randomized controlled trial Behav Res Ther 2014"/>
   <result pre="Vaart R User acceptance of an internet training aid for" exact="migraine" post="self-management J Telemed Telecare 2010 16 20 24 10.1258/jtt.2009.001007"/>
   <result pre="of online digital assistance (ODA) for behavioral attack prevention in" exact="migraine" post="Telemed J E Health 2009 15 682 690 10.1089/tmj.2009.0014"/>
   <result pre="controlled study of minimal-contact thermal biofeedback treatment in children with" exact="migraine" post="J Pediatr Psychol 2002 27 2 109 19 10.1093/jpepsy/27.2.109"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC4928724/results/search/disease/results.xml">
   <result pre="the efficacy and applications for clinical hypnosis for children with" exact="asthma" post="[ 33, 34], children with cancer [ 14, 22,"/>
   <result pre="hypnosis for children with asthma [ 33, 34], children with" exact="cancer" post="[ 14, 22, 23, 24, 25] and tic and"/>
   <result pre="of hypnosis training to medication in the treatment of juvenile" exact="migraine" post="[ 49]. In appropriate search of physiologic correlates of"/>
   <result pre="hypnosis [ 52, 53], pulmonary function changes in children with" exact="asthma" post="learning hypnosis [ 34, 54]. The value of hypnosis"/>
   <result pre="in modulating the negative effects of chemotherapy for children with" exact="cancer" post="(such as nausea and vomiting) has been demonstrated in"/>
   <result pre="the value of hypnosis (and biofeedback) with young people with" exact="autism" post="[ 59]. In recent years the increase in use"/>
   <result pre="of being on an elevator, so if he had a" exact="migraine" post="that was a ’10’, he’d push the button to"/>
   <result pre="years ago, I worked with a 17-year-old young woman, with" exact="migraine" post="problems, who rode horses. To control her migraines she’d"/>
   <result pre="less use of medication for &quot;severe&quot; HA, and decrease of" exact="migraine" post="prevention and anxiolytic medications. By the middle of the"/>
   <result pre="an important ingredient in an overall management plan (e.g., with" exact="asthma" post="or other chronic illnesses where learning self-hypnosis may not"/>
   <result pre="and anxiety during painful procedures in children and adolescents with" exact="cancer" post="J. Pediatr. 1982 101 1032 1035 10.1016/S0022-3476(82)80040-1 7143158 13."/>
   <result pre="Kohen D.P. Wynne E. Applying hypnosis in a preschool family" exact="asthma" post="education program: Uses of storytelling, imagery and relaxation Am."/>
   <result pre="of self-hypnosis and propranolol in the treatment of juvenile classic" exact="migraine" post="Pediatrics 1987 79 593 597 3822681 50. Dikel W."/>
   <result pre="327 10.1097/00004703-199610000-00006 8897220 54. Anbar R.D. Self-hypnosis for patients with" exact="cystic fibrosis" post="Pediatr. Pulm. 2000 30 461 465 10.1002/1099-0496(200012)30:6&amp;lt;461::AID-PPUL4&amp;gt;3.0.CO;2-4 55. Olness"/>
   <result pre="Symptoms as solutions: Hypnosis and biofeedback for autonomic regulation in" exact="autism" post="spectrum disorders Am. J. Clin. Hypn. 2013 56 152"/>
   <result pre="2013 56 152 173 24665817 60. Kohen D.P. Management of" exact="trichotillomania" post="with relaxation/mental imagery (self-hypnosis): Experience with five children J."/>
   <result pre="Evans K. A randomized trial of yoga for adolescents with" exact="irritable bowel syndrome" post="Pain Res. Manag. 2006 11 217 223 17149454 78."/>
   <result pre="Zeltzer L.K. Complementary and alternative medicine use in children with" exact="cancer" post="Psychosocial Aspects of Pediatric Oncology Kreitler S. Arush M.B."/>
   <result pre="study of behavioral intervention for chemotherapy distress in children with" exact="cancer" post="Pediatrics 1991 88 34 42 2057271 85. Anbar R.D."/>
   <result pre="Schlarb A.A. Brief hypnotherapeutic-behavioral intervention for functional abdominal pain and" exact="irritable bowel syndrome" post="in childhood: A randomized controlled trial Eur. J. Pediatr."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC5014910/results/search/disease/results.xml">
   <result pre="it was found that only around 30% of patients with" exact="epilepsy" post="and 50% of children with chronic health conditions who"/>
   <result pre="CAM in children with neurologic diseases such as epilepsy, migraine," exact="cerebral palsy," post="and congenital malformations in order to improve management through"/>
   <result pre="2008 study in Korea, 65 of 378 children (17%) with" exact="epilepsy" post="were found to be taking herbal medicines 4). In"/>
   <result pre="In our study in 2014, 19% (n=398) of children with" exact="epilepsy" post="used traditional Korean medicine (TKM) (acupuncture, moxibustion, herbal medicine)"/>
   <result pre="TKM to treat epilepsy. In addition, 60% of children with" exact="epilepsy" post="were receiving other types of CAM 10). According to"/>
   <result pre="cognitive function than motor functions, and parents of children with" exact="epilepsy" post="may believe that TKM has an effect on the"/>
   <result pre="evidence proving the effects of acupuncture and herbal medicine for" exact="epilepsy" post="patients 14 15). According to the study by Lee"/>
   <result pre="patients did not feel that CAM was superior to general" exact="epilepsy" post="treatments, although 32% of them continued using CAM 16)."/>
   <result pre="conditions (migraines, regular headaches, strokes, back pain with sciatica, seizures," exact="dementia" post="or memory loss) than in those without such conditions"/>
   <result pre="the following findings regarding CAM use: 60%–70% of patients with" exact="stroke" post="used CAM, 53% of those with cancer used it"/>
   <result pre="of patients with stroke used CAM, 53% of those with" exact="cancer" post="used it and 53% of patients with asthma and"/>
   <result pre="those with cancer used it and 53% of patients with" exact="asthma" post="and 48% of patients with psychiatric disorders used herbal"/>
   <result pre="a systematic review on the use of CAM in pediatric" exact="cancer" post="patients, the prevalence of use of CAM (since the"/>
   <result pre="highly prevalent. The proportions were 2% in insomnia, 3% in" exact="attention deficit hyperactivity disorder" post="(ADHD), 5% in other musculoskeletal diseases, 5% in stress"/>
   <result pre="with chronic diseases, such as asthma, autism, ADHD, cancer, and" exact="sickle cell anemia." post="Medical symptoms such as nausea and abdominal pain rather"/>
   <result pre="et al. 29), the researchers interviewed parents of children with" exact="epilepsy" post="(n=122), asthma (n=78), or sickle cell anemia (n=118). Three"/>
   <result pre="29), the researchers interviewed parents of children with epilepsy (n=122)," exact="asthma" post="(n=78), or sickle cell anemia (n=118). Three hundred three"/>
   <result pre="interviewed parents of children with epilepsy (n=122), asthma (n=78), or" exact="sickle cell anemia" post="(n=118). Three hundred three types of CAM were used"/>
   <result pre="of children with epilepsy (n=122), asthma (n=78), or sickle cell" exact="anemia" post="(n=118). Three hundred three types of CAM were used"/>
   <result pre="of CAM were used by 99 patients (31%) (epilepsy, 38%;" exact="sickle cell anemia," post="36%; asthma, 25%). The most commonly used CAMs were"/>
   <result pre="autistic spectrum disorder (ASD). About 50%–75% (n=50–112) of children with" exact="autism" post="were found to use CAM 31). Patients with comorbid"/>
   <result pre="Moore JL Reeves AL Alternative medicine use by patients with" exact="epilepsy" post="Epilepsy Behav 2000 1 74 77 12609128 6 Galicia-Connolly"/>
   <result pre="conventional medicine with traditional Korean medicine to treat children with" exact="epilepsy" post="J Altern Complement Med 2014 20 461 465 24773114"/>
   <result pre="the use of complementary and alternative medicine by people with" exact="epilepsy" post="Epilepsy Behav 2006 8 620 624 16530015 14 Li"/>
   <result pre="Chen X He L Zhou D Traditional Chinese medicine for" exact="epilepsy" post="Cochrane Database Syst Rev 2009 3 CD006454 19588391 15"/>
   <result pre="3 CD006454 19588391 15 Cheuk DK Wong V Acupuncture for" exact="epilepsy" post="Cochrane Database Syst Rev 2008 4 CD005062 18843676 16"/>
   <result pre="SY Chen C et al. Treatment-seeking behavior of people with" exact="epilepsy" post="in Taiwan: a preliminary study Epilepsy Behav 2011 22"/>
   <result pre="RS Bortz JJ Shulman DL Macleish M Complementary/alternative medicine for" exact="epilepsy" post="in Arizona Neurology 2003 61 576 577 12939447 19"/>
   <result pre="The use of complementary and alternative medicines by patients with" exact="peripheral neuropathy" post="J Neurol Sci 2004 218 59 66 14759634 22"/>
   <result pre="use of complementary and alternative medicines by patients with peripheral" exact="neuropathy" post="J Neurol Sci 2004 218 59 66 14759634 22"/>
   <result pre="of use of complementary and alternative medicine among patients with" exact="epilepsy" post="in the midwestern United States Epilepsy Behav 2007 10"/>
   <result pre="time and the aspect of using alternative medicine of acute" exact="stroke" post="patients J Korean Acad Adult Nurs 1999 11 389"/>
   <result pre="LI Lee YS Koo BH Utilization of alternative therapies in" exact="cancer" post="patients J Korean Cancer Assoc 1998 30 203 213"/>
   <result pre="Hyman SL Complementary and alternative medicine treatments for children with" exact="autism" post="spectrum disorders Child Adolesc Psychiatr Clin N Am 2008"/>
   <result pre="complementary and alternative medical therapy use in children diagnosed with" exact="autism" post="spectrum disorders J Autism Dev Disord 2006 36 901"/>
   <result pre="the use of complementary medicines and therapies in children with" exact="asthma" post="J Paediatr Child Health 2002 38 252 257 12047692"/>
   <result pre="Use of complementary and alternative medicine among children diagnosed with" exact="autism" post="spectrum disorder J Autism Dev Disord 2007 37 628"/>
   <result pre="Parental use of CAM Oshikoya et al. 29) Epilepsy, asthma," exact="sickle cell anemia" post="31 (99/318) (epilepsy, 38%; asthma, 36%; sickle cell anemia,"/>
   <result pre="of CAM Oshikoya et al. 29) Epilepsy, asthma, sickle cell" exact="anemia" post="31 (99/318) (epilepsy, 38%; asthma, 36%; sickle cell anemia,"/>
   <result pre="asthma, sickle cell anemia 31 (99/318) (epilepsy, 38%; asthma, 36%;" exact="sickle cell anemia," post="25%) Biological products (58%), alternative medical systems (27%), mind/body"/>
   <result pre="of conventional therapy 36) CAM, complementary and alternative medicine; ADHD," exact="attention deficit hyperactivity disorder;" post="ASD, Autistic spectrum disorder."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC5114030/results/search/disease/results.xml">
   <result pre="to perform a cost-utility analysis comparing OBS with SL for" exact="breast cancer" post="in the large breasted patient. METHODS: Cost-utility methodology involved"/>
   <result pre="perform a cost-utility analysis comparing OBS with SL for breast" exact="cancer" post="in the large breasted patient. METHODS: Cost-utility methodology involved"/>
   <result pre="compiling outcomes and their probabilities for the treatment of unilateral" exact="breast cancer" post="using either oncoplastic resection/reconstruction with contralateral symmetry operations or"/>
   <result pre="outcomes and their probabilities for the treatment of unilateral breast" exact="cancer" post="using either oncoplastic resection/reconstruction with contralateral symmetry operations or"/>
   <result pre="in LECs had no effect on the pathological changes of" exact="lymphedema" post="but did increase lymphangiogenesis. Systemic or topical application of"/>
   <result pre="that T cells are the primary source of TGF-β1 in" exact="lymphedema" post="and that inhibition with a novel anti-TGF-β1 compound potently"/>
   <result pre="to use this model to understand how lymphatic defects modulate" exact="metabolic syndrome" post="in obesity. METHODS: To activate VEGFR-3 signaling in LECs"/>
   <result pre="PTEN in obese mice significantly decreased the deleterious effects of" exact="obesity" post="on the lymphatic system compared with controls. Moreover, even"/>
   <result pre="when fed a high-fat diet, these mice were protected from" exact="metabolic syndrome" post="and hepatic steatosis suggesting that lymphatic function is a"/>
   <result pre="downstream signaling pathways of VEGFR-3 only in LECs significantly decreases" exact="metabolic syndrome" post="and hepatic steatosis. 4 Lymph Node Transfer Decreases Swelling"/>
   <result pre="to analyze lymphatic and immune function after LNT. METHODS: Hindlimb" exact="lymphedema" post="was induced in a transgenic mouse model by ablating"/>
   <result pre="a transgenic mouse model by ablating the lymphatic system using" exact="diphtheria" post="toxin. Two weeks later, experimental animals underwent popliteal LNT,"/>
   <result pre="METHODS: Forty subjects were prospectively enrolled and completed questionnaires on" exact="migraine" post="history, migraine headache index (MHI) [migraine headache (MHA) frequency"/>
   <result pre="subjects were prospectively enrolled and completed questionnaires on migraine history," exact="migraine" post="headache index (MHI) [migraine headache (MHA) frequency × duration"/>
   <result pre="(MHI) [migraine headache (MHA) frequency × duration × pain severity]," exact="migraine" post="disability, headache impact test (HIT6), and pain self-efficacy questionnaire."/>
   <result pre="frequency were not. Factors signifying MHA severity (MHI total score," exact="migraine" post="disability, HIT6, and pain self-efficacy questionnaire scores) were not"/>
   <result pre="When comparing patients with the best and worst outcomes after" exact="migraine" post="surgery, increasing age at MHA onset and longer MHA"/>
   <result pre="narrowing, representative of language specialization, in infants with nonsyndromic sagittal" exact="craniosynostosis" post="(NSC) preoperatively versus postoperatively using event-related potentials to measure"/>
   <result pre="function of hDPCs and hKCs and showed therapeutic potentials for" exact="androgenic alopecia" post="by modulating hair cycle such as anagen induction and"/>
   <result pre="of hDPCs and hKCs and showed therapeutic potentials for androgenic" exact="alopecia" post="by modulating hair cycle such as anagen induction and"/>
   <result pre="by involution. IHs are thought to originate from CD133 +" exact="hemangioma" post="stem cells (HemSCs). HemSCs are localized in perivascular regions"/>
   <result pre="axillary lymphadenectomy, axillary lymph node transplantation, and a mouse tail" exact="lymphedema" post="model. Embryonic stem cells (ESCs) from the reporter line"/>
   <result pre="reconstruction, but there are concerns regarding their oncological safety in" exact="cancer" post="patients. In this study, we investigate whether pretreatment of"/>
   <result pre="of human adipose-derived stem cells (ASCs) could induce apoptosis in" exact="breast cancer" post="cells and therefore confer oncological benefits in reconstruction. METHODS:"/>
   <result pre="human adipose-derived stem cells (ASCs) could induce apoptosis in breast" exact="cancer" post="cells and therefore confer oncological benefits in reconstruction. METHODS:"/>
   <result pre="exposure on TRAIL expression was determined. The mesenchymal triple negative" exact="breast cancer" post="cell line MDA-MB-231 was cocultured with IFN-γ-treated ASCs for"/>
   <result pre="on TRAIL expression was determined. The mesenchymal triple negative breast" exact="cancer" post="cell line MDA-MB-231 was cocultured with IFN-γ-treated ASCs for"/>
   <result pre="with the MDA-MB-231 cell line resulted in significant apoptosis of" exact="cancer" post="cells. Untreated ASCs did not significantly alter MDA-MB-231 proliferation"/>
   <result pre="rates. The presence of TRAIL death receptors (DR1/DR2) on MDA-MB-231" exact="breast cancer" post="cells was confirmed. Inhibition of TRAIL reversed the apoptotic"/>
   <result pre="The presence of TRAIL death receptors (DR1/DR2) on MDA-MB-231 breast" exact="cancer" post="cells was confirmed. Inhibition of TRAIL reversed the apoptotic"/>
   <result pre="expression resulting in apoptosis of the mesenchymal triple negative MDA-MB-231" exact="breast cancer" post="cell line. IFN-γ treatment of ASCs may confer oncological"/>
   <result pre="resulting in apoptosis of the mesenchymal triple negative MDA-MB-231 breast" exact="cancer" post="cell line. IFN-γ treatment of ASCs may confer oncological"/>
   <result pre="Memorial Sloan Kettering Cancer Center, New York, N.Y. PURPOSE: Diet-induced" exact="obesity" post="is a known risk factor for lymphedema. However, although"/>
   <result pre="risk factor for lymphedema. However, although it is clear that" exact="obesity" post="is associated with lymphatic dysfunction, it remains unclear whether"/>
   <result pre="was to evaluate the independent effects of high-fat diet or" exact="obesity" post="on lymphatic function in obesity-prone and obesity-resistant mice. METHODS:"/>
   <result pre="Memorial Sloan Kettering Cancer Center, New York, N.Y. PURPOSE: Scrotal" exact="lymphedema" post="is a challenging problem and affects nearly 30 million"/>
   <result pre="gap, we developed a novel transgenic animal model of scrotal" exact="lymphedema" post="by ablating the lymphatic system with diphtheria toxin. METHODS:"/>
   <result pre="model of scrotal lymphedema by ablating the lymphatic system with" exact="diphtheria" post="toxin. METHODS: We created Cre-lox mice that express the"/>
   <result pre="toxin. METHODS: We created Cre-lox mice that express the human" exact="diphtheria" post="toxin receptor selectively on lymphatic endothelial cells using a"/>
   <result pre="cells using a lymphatic specific promoter (FLT-4). This receptor binds" exact="diphtheria" post="toxin avidly and results in selective ablation of the"/>
   <result pre="in selective ablation of the target cells. We then injected" exact="diphtheria" post="toxin in the scrotum to selectively ablate the lymphatic"/>
   <result pre="vessels in this region and analyzed the development of scrotal" exact="lymphedema" post="as well as its pathological changes over time. RESULTS:"/>
   <result pre="of graft-versus-host disease was seen. An unexpected finding of persistent" exact="thrombocytopenia" post="resolved on loss of donor cell chimerism. CONCLUSIONS: This"/>
   <result pre="in the VCA. Current application of AMD3100 is limited by" exact="thrombocytopenia" post="but we are currently modifying the protocol to address"/>
   <result pre="with strong correlation with skeletal development. Osteogenic differentiation after siRNA-mediated" exact="suppression" post="of this lncRNA was determined. Subcellular location of the"/>
   <result pre="point tensile stress exceeds tissue strength. We propose a polypropylene" exact="hernia" post="mesh with seamlessly knit mesh extensions that are sewn"/>
   <result pre="Mass. PURPOSE: The relationship between radiation dose and acute radiation" exact="dermatitis" post="remains controversial. No objective methods exist to assess degree"/>
   <result pre="dermatitis, and HSI oxyHb. Because clinical stages of acute radiation" exact="dermatitis" post="are readily differentiated by oxyHb, HSI could be a"/>
   <result pre="treatment with 9-cis-retinoic acid (9cisRA) for 45 days prevents secondary" exact="lymphedema" post="in a mouse hindlimb model. To limit potential toxicity"/>
   <result pre="that 14 days of 9cisRA is effective in reducing postoperative" exact="lymphedema" post="in the mouse hindlimb model. Reduced toxicity and side"/>
   <result pre="Boston, Mass. PURPOSE: Several groups have shown positive responses to" exact="migraine" post="surgery in 68% to 95% of cases. However, most"/>
   <result pre="and asked to complete information on demographics, medical history, and" exact="migraine" post="history and to answer the following questionnaires: Migraine headache"/>
   <result pre="and to answer the following questionnaires: Migraine headache index [MHI;" exact="migraine" post="headache frequency (days) × duration (fraction of 24hours) ×"/>
   <result pre="our retrospective results, further supporting the safety and efficacy of" exact="migraine" post="surgery as a treatment option for migraine sufferers. No"/>
   <result pre="and efficacy of migraine surgery as a treatment option for" exact="migraine" post="sufferers. No significant difference in outcomes between 3 and"/>
   <result pre="to abnormal speech. In addition, patients with VPD often have" exact="obstructive sleep apnea" post="(OSA). This particular study sought to determine what variables"/>
   <result pre="abnormal speech. In addition, patients with VPD often have obstructive" exact="sleep apnea" post="(OSA). This particular study sought to determine what variables"/>
   <result pre="= 0.00 and P = 0.001, respectively), screen patients for" exact="sleep apnea" post="( P = 0.008), or change their management based"/>
   <result pre="in demographics and comorbidities among antibiotic groups. The rates of" exact="cellulitis" post="and deep space infection in both study groups was"/>
   <result pre="study groups was 10.7%. No significant difference was found in" exact="cellulitis" post="rates between the antibiotic groups ( P = 0.713),"/>
   <result pre="0.0386). Prolonged drain duration (&amp;gt;2 weeks) was associated with both" exact="cellulitis" post="and deep space infection rate ( P = 0.0015"/>
   <result pre="from diabetic foot ulcers. This retrospective study analyzed subjects with" exact="diabetes mellitus" post="and distal foot ulcers to determine the factors that"/>
   <result pre="was constructed from patient discharges containing diagnosis codes for both" exact="diabetes mellitus" post="and distal foot ulcer. Data were collected from the"/>
   <result pre="&amp;lt; 0.05). The most common diagnosis codes on readmission were" exact="diabetes mellitus" post="(19%) and infection (13%). In a multiple regression model,"/>
   <result pre="From the University of Michigan, Ann Arbor, Mich. PURPOSE: Metopic" exact="craniosynostosis" post="has traditionally been cited as the third most common"/>
   <result pre="with this change. METHODS: Patients who underwent operative correction of" exact="craniosynostosis" post="between 1989 and 2014 were retrospectively reviewed. The type"/>
   <result pre="between 1989 and 2014 were retrospectively reviewed. The type of" exact="craniosynostosis" post="as well as gender, family history, birth history, and"/>
   <result pre="was found to be the second most common type of" exact="craniosynostosis" post="between 2004 and 2014. Male gender and multiple gestations"/>
   <result pre="craniosynostosis. CONCLUSIONS: This study demonstrated an increasing incidence of metopic" exact="craniosynostosis" post="over time, which ascended to the second most common"/>
   <result pre="for treatment of genetic and traumatic causes of heterotopic ossification," exact="hereditary hemorrhagic telangiectasia," post="and fibrodysplasia ossificans progressive. Despite BMP signaling inhibitor’s utility,"/>
   <result pre="&amp;lt; 0.001), chronic hypertension ( P &amp;lt; 0.001), and chronic" exact="lung disease" post="( P &amp;lt; 0.05). However, controlling for patient characteristics/comorbidities,"/>
   <result pre="compression of the supraorbital and supratrochlear nerves and results in" exact="migraine" post="headaches. This study uses morphometric evaluation to determine whether"/>
   <result pre="whether anatomic differences exist at the corrugator trigger site between" exact="migraine" post="and control patients. METHODS: A retrospective investigation identified patients"/>
   <result pre="patients. METHODS: A retrospective investigation identified patients with and without" exact="migraine" post="headache. Each patient underwent a computed tomography scan for"/>
   <result pre="was performed in a randomized and blinded fashion on 90" exact="migraine" post="headache and 90 control patients. Measurements were also normalized"/>
   <result pre="conducted. Statistical comparisons were performed using t tests. RESULTS: Among" exact="migraine" post="patients, the mean corrugator volume was 0.97 ± 0.25"/>
   <result pre="in itself does not play a major role in triggering" exact="migraine" post="headaches. Instead, factors such as muscle hyperactivity or peripheral"/>
   <result pre="a viable treatment option for patients with previous bone flap" exact="osteomyelitis" post="and subsequent removal. As such, a reduced time interval"/>
   <result pre="Medicine, Philadelphia, Pa.; †Temple University Hospital, Philadelphia, Pa. PURPOSE: Nonsyndromic" exact="cleft palate" post="is the most common craniofacial birth defect. Despite its"/>
   <result pre="identified CTGF KO mice as a novel model to study" exact="cleft palate" post="development. METHODS: CTGF KO and WT palates were isolated"/>
   <result pre="cells. CONCLUSIONS: Defects in palatal mesenchyme growth contribute to the" exact="cleft palate" post="phenotype of CTGF KO mice. Multiple signaling pathways necessary"/>
   <result pre="is being used to elucidate the key mechanism(s) responsible for" exact="cleft palate" post="in CTGF KO mice. These studies will further our"/>
   <result pre="University of Michigan, Ann Arbor, Mich. PURPOSE: Radiation therapy for" exact="head and neck cancer" post="results in devastating morbidity for bone healing including the"/>
   <result pre="Ann Arbor, Mich. PURPOSE: Radiation therapy for head and neck" exact="cancer" post="results in devastating morbidity for bone healing including the"/>
   <result pre="Center, Timisoara, Romania. PURPOSE: The best surgical approach for limb" exact="lymphedema" post="is highly debated, with long-term histological evidence still lacking"/>
   <result pre="at the time of axillary lymph node dissection to reduce" exact="lymphedema" post="risk. We developed a novel application of fluorescein isothiocyanate"/>
   <result pre="this application. METHODS: We reviewed a prospectively collected database on" exact="breast cancer" post="patients who underwent LYMPHA from March to September 2015."/>
   <result pre="application. METHODS: We reviewed a prospectively collected database on breast" exact="cancer" post="patients who underwent LYMPHA from March to September 2015."/>
   <result pre="PURPOSE: Reverse lymphatic mapping (RLM) reduces the risk of donor-site" exact="lymphedema" post="during lymph node transplantation (LNT) but is limited as"/>
   <result pre="a high-fat diet for 10 to 12 weeks to induce" exact="obesity" post="and then were randomized to an aerobic exercise group"/>
   <result pre="suggests that implementation of aerobic exercise in the setting of" exact="obesity" post="can improve lymphatic function and may limit some of"/>
   <result pre="the efficacy of this treatment using a transgenic model of" exact="lymphedema" post="6 months after lymphedema was established. RESULTS: Our topical"/>
   <result pre="treatment using a transgenic model of lymphedema 6 months after" exact="lymphedema" post="was established. RESULTS: Our topical anti-TGF-β compound markedly decreased"/>
   <result pre="controls ( P &amp;lt; 0.001). Similarly, transgenic mice with established" exact="lymphedema" post="also had decreased fibrosis, adipose deposition, and perilymphatic inflammation"/>
   <result pre="chronic T-cell inflammation and improved lymphangiogenesis in various models of" exact="lymphedema" post="and lymphatic dysfunction. These results are exciting as they"/>
   <result pre="‡Chang Gung Memorial Hospital, Taoyuan, Taiwan. PURPOSE: Microsurgical treatment of" exact="lymphedema" post="with vascularized lymph node (LN) transfer can improve signs"/>
   <result pre="length of stay (LOS) for patients undergoing surgical treatment of" exact="breast cancer," post="including mastectomy with prosthetic reconstruction. However, evidence on the"/>
   <result pre="radiation, mastectomy type, flap type, unilateral versus bilateral surgery, or" exact="cancer" post="stage ( P &amp;gt; 0.05). PVB patients reported significantly"/>
   <result pre="PURPOSE: There is no universally accepted severity scale for unilateral" exact="cleft lip" post="that objectively quantifies the spectrum of disease, making it"/>
   <result pre="METHODS: Anthropometric measurements and photographs were prospectively collected from unilateral" exact="cleft lip" post="patients from Morocco, Bolivia, Vietnam, and Madagascar during medical"/>
   <result pre="lip height, and horizontal vermillion length. The number of primary" exact="cleft lip" post="repairs done in his/her lifetime was recorded for each"/>
   <result pre="Accurate measures of health-related quality of life among children with" exact="cleft lip" post="and palate (CLCP) are in high demand. The National"/>
   <result pre="Israel Deaconess Medical Center, Boston, Mass. PURPOSE: The incidence of" exact="breast cancer" post="(BC) cases has increased significantly over the past decades."/>
   <result pre="Deaconess Medical Center, Boston, Mass. PURPOSE: The incidence of breast" exact="cancer" post="(BC) cases has increased significantly over the past decades."/>
   <result pre="2; smoker, 35%; diabetes, 32%. Primary indication for TKA was" exact="arthritis" post="(64%). Primary indication for gastrocnemius flap was open wound"/>
   <result pre="P = 0.02) or if their indication for TKA was" exact="arthritis" post="( P = 0.01). Smokers were more likely to"/>
   <result pre="We investigate the in vitro and in vivo interaction of" exact="breast cancer" post="cells (BCCs) and adipose-derived stem cells (ASCs) in an"/>
   <result pre="investigate the in vitro and in vivo interaction of breast" exact="cancer" post="cells (BCCs) and adipose-derived stem cells (ASCs) in an"/>
   <result pre="migration of BCCs in cocultures and in vivo growth of" exact="breast cancer" post="xenografts. 135 Stem Cell Subpopulation Profiling as a Predictor"/>
   <result pre="of BCCs in cocultures and in vivo growth of breast" exact="cancer" post="xenografts. 135 Stem Cell Subpopulation Profiling as a Predictor"/>
   <result pre="follow-up of more than 500 days. RESULTS: Animal models of" exact="diabetes mellitus," post="obesity, and aging demonstrated depletion of ASC subpopulations important"/>
   <result pre="index (24–78 kg/m 2), and HBA1c (4.7%–14%) with diabetes and" exact="obesity" post="producing a significant 71-fold ( P &amp;lt; 0.0002) and"/>
   <result pre="is the primary risk factor for type 2 diabetes. Both" exact="obesity" post="and diabetes are now recognized as chronic proinflammatory diseases"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC5184808/results/search/disease/results.xml">
   <result pre="clinical team that is able to treat any type of" exact="pain disorder." post="The patient-centered treatment provided in these clinics is based"/>
   <result pre="methods. There are pain clinics that specialize in only one" exact="pain disorder" post="but fulfill all of the other criteria defined by"/>
   <result pre="period should be long enough to also account for pediatric" exact="migraine" post="patients, who sometimes experience attacks only once a month."/>
   <result pre="Fash K. Ferry K. Weiss P.F. The treatment of juvenile" exact="fibromyalgia" post="with an intensive physical and psychosocial program J. Pediatr."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC5203901/results/search/disease/results.xml">
   <result pre="2-year-old who took morphine (route of administration unclear) and suffered" exact="respiratory failure." post="Case  2 was an 18- year-old who took acetaminophen, alone,"/>
   <result pre="pain society recommendations for improving the quality of acute and" exact="cancer" post="pain management Archives of Internal Medicine 2005 165 14"/>
   <result pre="K. Muscle pain in the emergency department: a case of" exact="myositis" post="Journal of Pediatric Health Care 2012 26 3 204"/>
   <result pre="42 4 623 631 10.1016/j.jpainsymman.2011.01.008 21458223 41 Dixson M. Pediatric" exact="rash" post="and joint pain: a case review Journal of Emergency"/>
   <result pre="documentation and analgesia: a comparison of children and adults with" exact="appendicitis" post="EMA - Emergency Medicine Australasia 2008 20 6 482"/>
   <result pre="S. Rautakorpi U.-M. et al. Management of pain in acute" exact="otitis media" post="in Finnish primary care Scandinavian Journal of Infectious Diseases"/>
   <result pre="versus acetaminophen (paracetamol) and placebo for treatment of symptoms of" exact="tonsillitis" post="and pharyngitis in children The Journal of Pediatrics 1991"/>
   <result pre="(paracetamol) and placebo for treatment of symptoms of tonsillitis and" exact="pharyngitis" post="in children The Journal of Pediatrics 1991 119 5"/>
   <result pre="of ibuprofen versus acetaminophen and placebo for symptoms of acute" exact="otitis media" post="in children Fundamental and Clinical Pharmacology 1996 10 4"/>
   <result pre="al. Children's ibuprofen suspension for the acute treatment of pediatric" exact="migraine" post="Headache 2002 42 8 780 786 10.1046/j.1526-4610.2002.02180.x 12390641 62"/>
   <result pre="Laycock K. Millar K. et al. Treatment of children with" exact="migraine" post="in emergency departments: national practice variation study Pediatrics 2010"/>
   <result pre="S. Rahmann A. Kraemer C. et al. Treatment of childhood" exact="migraine" post="attacks with oral zolmitriptan and ibuprofen Neurology 2006 67"/>
   <result pre="Santavuori P. Ibuprofen or acetaminophen for the acute treatment of" exact="migraine" post="in children: a double-blind, randomized, placebo-controlled, crossover study Neurology"/>
   <result pre="L. Rosenfeld M. Redding G. J. The prevalence of ibuprofen-sensitive" exact="asthma" post="in children: a randomized controlled bronchoprovocation challenge study Journal"/>
   <result pre="1991, France, NR RCT ED mean 7.95 (SD 1.85) Acute" exact="tonsillitis" post="and pharyngitis (duration of sore throat ≤ 48 h) (i)"/>
   <result pre="NR RCT ED mean 7.95 (SD 1.85) Acute tonsillitis and" exact="pharyngitis" post="(duration of sore throat ≤ 48 h) (i) Ibuprofen (10 mg/kg),"/>
   <result pre="(iii) Placebo (10 mg/kg), n = 76 Nausea, abdominal pain, cutaneous" exact="rash" post="Ibuprofen, combined with antibiotic therapy, is effective and well-tolerated"/>
   <result pre="Outpatient clinic 1–6.75 (mean 2.98 ± 1.33) Otoscopically proven acute" exact="otitis media," post="either unilateral or bilateral (i) Ibuprofen (10 mg/kg), n ="/>
   <result pre="(iii) Placebo, n = 75 Nausea, vomiting, abdominal pain, cutaneous" exact="rash" post="11 children experienced mild unexpected events; treatment was never"/>
   <result pre="et al., 1997, Finland, NR RCT ED NR Migraine (≥2" exact="migraine" post="attacks/month lasting ≥2 h) (i) Acetaminophen (15 mg/kg), n = 88 "/>
   <result pre="600 mg), n = 112 Minor AEs such as nausea, sleepiness," exact="constipation" post="AEs were minimal; no significant difference between groups for"/>
   <result pre="tissue injury of ankle (no history of gastric ulcers or" exact="allergy" post="to acetaminophen or naproxen) (i) Naproxen (20 mg/kg), n ="/>
   <result pre="Migraine (headache at time of physician assessment and diagnosis of" exact="migraine" post="by emergency physician) (i) Ibuprofen (various doses)   (ii)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC5368427/results/search/disease/results.xml">
   <result pre="or emotional abuse; exposure to violence, mental illness, incarceration, or" exact="substance abuse" post="in the family; parental absence due to divorce or"/>
   <result pre="adulthood, and are further specifically associated with metabolic dysfunction and" exact="cardiovascular disease" post="in adulthood [ 10, 22, 23, 24]. Risky family"/>
   <result pre="relationship with the presence of mental health disorders, adult ischemic" exact="heart disease," post="cancer, chronic lung disease, skeletal fractures, and liver disease"/>
   <result pre="of mental health disorders, adult ischemic heart disease, cancer, chronic" exact="lung disease," post="skeletal fractures, and liver disease in a study of"/>
   <result pre="ischemic heart disease, cancer, chronic lung disease, skeletal fractures, and" exact="liver disease" post="in a study of 9508 Americans in 1998 ["/>
   <result pre="addition, ACEs have also been associated with alcoholism [ 26]," exact="chronic obstructive pulmonary disease" post="[ 27], autoimmune disease [ 28], quality of life"/>
   <result pre="with alcoholism [ 26], chronic obstructive pulmonary disease [ 27]," exact="autoimmune disease" post="[ 28], quality of life [ 29], drug use"/>
   <result pre="between childhood adversity and trauma and specific adult diagnoses including" exact="fibromyalgia" post="[ 35], migraine [ 36], irritable bowel syndrome ["/>
   <result pre="and trauma and specific adult diagnoses including fibromyalgia [ 35]," exact="migraine" post="[ 36], irritable bowel syndrome [ 37], insomnia and"/>
   <result pre="specific adult diagnoses including fibromyalgia [ 35], migraine [ 36]," exact="irritable bowel syndrome" post="[ 37], insomnia and insufficient sleep [ 38], cancer"/>
   <result pre="bowel syndrome [ 37], insomnia and insufficient sleep [ 38]," exact="cancer" post="[ 39], cognitive function in mental health disorders ["/>
   <result pre="[ 40], as well as learning and behavior problems and" exact="obesity" post="in youth [ 41] and adolescent pregnancy and fetal"/>
   <result pre="exposure to stress and trauma such as psychiatric, metabolic and" exact="cardiovascular disease" post="through the influence on lifestyle choices, underlying biochemistry and"/>
   <result pre="in specific conditions including quality of life in patients with" exact="multiple sclerosis" post="[ 72], depression and anxiety in patients with cancer"/>
   <result pre="multiple sclerosis [ 72], depression and anxiety in patients with" exact="cancer" post="[ 73], and specifically in trauma-exposed individuals with human"/>
   <result pre="[ 102]. In a cross-sectional study of 125 individuals with" exact="substance dependence" post="and a history of trauma, the characteristic of mindfulness"/>
   <result pre="age. For example, one study clustered female students with any" exact="eating disorder" post="history into a mindfulness program finding improved psychosocial outcomes"/>
   <result pre="Current concepts on the role of inflammation in COPD and" exact="lung cancer" post="Curr. Opin. Pharmacol. 2009 9 375 383 10.1016/j.coph.2009.06.009 19615942"/>
   <result pre="concepts on the role of inflammation in COPD and lung" exact="cancer" post="Curr. Opin. Pharmacol. 2009 9 375 383 10.1016/j.coph.2009.06.009 19615942"/>
   <result pre="influence of child abuse history on the cardinal symptoms of" exact="fibromyalgia" post="Clin. Exp. Rheumatol. 2016 34 S59 S66 26743156 36."/>
   <result pre="Herial N.A. Shah K. Adverse childhood experiences are associated with" exact="migraine" post="and vascular biomarkers Headache 2012 52 920 929 10.1111/j.1526-4610.2012.02165.x"/>
   <result pre="Mayer E.A. Chang L. Adverse childhood experiences are associated with" exact="irritable bowel syndrome" post="and gastrointestinal symptom severity Neurogastroenterol. Motil. 2016 28 1252"/>
   <result pre="Cohen S.A. Association between adverse childhood experiences and diagnosis of" exact="cancer" post="PLoS ONE 2013 8 e65524 10.1371/journal.pone.0065524 23776494 40. Poletti"/>
   <result pre="of mindfulness-based stress reduction on mood states of veterans with" exact="post-traumatic stress disorder" post="Arch. Trauma Res. 2013 1 151 154 10.5812/atr.8226 24396769"/>
   <result pre="Does it help adolescents and young adults who have completed" exact="cancer" post="treatment? J. Pediatr. Oncol. Nurs. 2015 32 189 194"/>
   <result pre="group intervention for depression and anxiety in a sample of" exact="cancer" post="patients Med. J. Aust. 2010 193 S79 S82 21542452"/>
   <result pre="26968457 103. Garland E.L. Roberts-Lewis A. Differential roles of thought" exact="suppression" post="and dispositional mindfulness in posttraumatic stress symptoms and craving"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC5406678/results/search/disease/results.xml">
   <result pre="effective for adolescents with medical conditions such as tension or" exact="migraine" post="headaches, enuresis, recurrent abdominal pain, constipation, sleep difficulties, acute"/>
   <result pre="adolescents, including anxiety, depression, conduct problems, cutting, disordered eating, and" exact="substance abuse" post="[ 18, 19, 20]. The prevalence of mental health"/>
   <result pre="history of physical, sexual, or emotional abuse and those with" exact="post-traumatic stress disorder" post="(PTSD), in which case coordination of care with a"/>
   <result pre="normal cognition and no apparent psychiatric disorder such as a" exact="conversion disorder," post="psychosis, or thought disorder. The initial session with her"/>
   <result pre="and screening lab tests. Past medical history was significant for" exact="attention deficit hyperactivity disorder," post="treated with methylphenidate. There was no history of other"/>
   <result pre="started a few months earlier. The patient reported symptoms of" exact="shortness" post="of breath, sharp chest pain, and hyperventilation. Extensive medical"/>
   <result pre="was referred by his primary care doctor for management of" exact="substance abuse," post="anxiety, and panic attacks. The patient experienced his first"/>
   <result pre="and no brakes: Developmental stress exposure and subsequent risk for" exact="substance abuse" post="Neurosci. Biobehav. Rev. 2009 33 516 524 10.1016/j.neubiorev.2008.09.009 18938197"/>
   <result pre="of mindfulness practice to a multicomponent behavioral sleep intervention following" exact="substance abuse" post="treatment in adolescents: A treatment-development study Subst. Abus. 2010"/>
   <result pre="vs. standard care in children with functional abdominal pain or" exact="irritable bowel syndrome" post="Am. J. Gastroenterol. 2012 107 627 631 10.1038/ajg.2011.487 22310221"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC5474682/results/search/disease/results.xml">
   <result pre="on the clinical observations and practices of the authors. myalgic" exact="encephalomyelitis" post="chronic fatigue syndrome pediatric adolescent diagnosis management postural tachycardia"/>
   <result pre="the clinical observations and practices of the authors. myalgic encephalomyelitis" exact="chronic fatigue syndrome" post="pediatric adolescent diagnosis management postural tachycardia syndrome joint hypermobility"/>
   <result pre="Initiative 10.13039/100009382 fig-count: table-count: equation-count: ref-count: page-count: word-count: Preface Myalgic" exact="encephalomyelitis" post="(ME), also known as chronic fatigue syndrome (CFS) or"/>
   <result pre="ref-count: page-count: word-count: Preface Myalgic encephalomyelitis (ME), also known as" exact="chronic fatigue syndrome" post="(CFS) or ME/CFS, affects children and adolescents as well"/>
   <result pre="shown to be the cause. Nomenclature Myalgic Encephalomyelitis (ME) and" exact="chronic fatigue syndrome" post="(CFS) were names given to two well-documented cluster outbreaks"/>
   <result pre="for the illness include chronic fatigue immune dysfunction syndrome, myalgic" exact="encephalopathy" post="and neuro-endocrine-immune dysfunction syndrome. In 2015 a new name,"/>
   <result pre="Symptoms of ME/CFS sometimes follow an acute illness, such as" exact="influenza" post="or infectious mononucleosis ( 4). If symptoms resolve within"/>
   <result pre="ME/CFS sometimes follow an acute illness, such as influenza or" exact="infectious mononucleosis" post="( 4). If symptoms resolve within 6 months, the term"/>
   <result pre="orthostatic symptoms. ME/CFS can follow a known illness such as" exact="infectious mononucleosis" post="( 4). A gradual onset is more common in"/>
   <result pre="lower than in other illnesses such as diabetes, epilepsy, and" exact="cystic fibrosis" post="( 17, 18). Symptoms often fluctuate significantly during the"/>
   <result pre="acute infection, including most prominently Epstein-Barr virus (EBV). After monospot-positive" exact="infectious mononucleosis," post="13%, 7%, and 4% of adolescents met criteria for"/>
   <result pre="associated with sub-orbital dark shadows. The pharynx can show non-exudative" exact="pharyngitis" post="and cervical and axillary lymph nodes might be palpable"/>
   <result pre="quantitative immunoglobulins, functional antibodies, response to pneumococcal vaccination Infectious diseases:" exact="infectious mononucleosis," post="lyme, and other tick-borne diseases ( Babesia microti, Anaplasma"/>
   <result pre="overtraining syndrome Bowel disorders: celiac disease, inflammatory bowel disease, and" exact="eosinophilic gastroenteritis" post="Chiari malformation or cervical spine stenosis Lyme disease and"/>
   <result pre="syndrome Bowel disorders: celiac disease, inflammatory bowel disease, and eosinophilic" exact="gastroenteritis" post="Chiari malformation or cervical spine stenosis Lyme disease and"/>
   <result pre="Endocrine/metabolic Insulin resistance Hypoglycemia Metabolic syndrome Polycystic ovary syndrome Severe" exact="obesity" post="Gastrointestinal Eosinophilic esophagitis Gastroesophageal reflux GI motility disturbances IgE-mediated"/>
   <result pre="obesity Gastrointestinal Eosinophilic esophagitis Gastroesophageal reflux GI motility disturbances IgE-mediated" exact="food allergy," post="non-IgE mediated milk protein or other food protein hypersensitivity"/>
   <result pre="food allergy, non-IgE mediated milk protein or other food protein" exact="hypersensitivity" post="Irritable bowel syndrome Lactose/fructose intolerance Gynecological Dysmenorrhea Endometriosis Pelvic"/>
   <result pre="Hypersensitivity to light, touch, sound, odors, and medicines Respiratory Allergic" exact="rhinitis" post="Asthma Chronic sinusitis Rheumatological Joint hypermobility syndrome Juvenile fibromyalgia"/>
   <result pre="touch, sound, odors, and medicines Respiratory Allergic rhinitis Asthma Chronic" exact="sinusitis" post="Rheumatological Joint hypermobility syndrome Juvenile fibromyalgia Myofascial pain syndrome"/>
   <result pre="and medicines Respiratory Allergic rhinitis Asthma Chronic sinusitis Rheumatological Joint" exact="hypermobility syndrome" post="Juvenile fibromyalgia Myofascial pain syndrome Ehlers-Danlos syndrome Temporomandibular joint"/>
   <result pre="Allergic rhinitis Asthma Chronic sinusitis Rheumatological Joint hypermobility syndrome Juvenile" exact="fibromyalgia" post="Myofascial pain syndrome Ehlers-Danlos syndrome Temporomandibular joint disease Sleep"/>
   <result pre="syndrome Ehlers-Danlos syndrome Temporomandibular joint disease Sleep disorders Periodic limb" exact="movement disorder" post="Restless leg syndrome Urinary Interstitial cystitis Cognitive Impairment Cognitive"/>
   <result pre="disorders Periodic limb movement disorder Restless leg syndrome Urinary Interstitial" exact="cystitis" post="Cognitive Impairment Cognitive deficits (sometimes called &quot;brain fog&quot;) are"/>
   <result pre="psychiatric illness such as Major Depressive Disorder (MDD) or an" exact="anxiety disorder" post="without co-existing ME/CFS. Emotional Responses to a Chronic Illness"/>
   <result pre="2% of children and 4–8% of adolescents have a diagnosable," exact="major depressive disorder" post="(MDD). Less severe episodes of depression can be seen"/>
   <result pre="with suicidal thinking is not present in ME/CFS without co-morbid" exact="major depressive disorder" post="Lack of interest in friendships/relationships Yes No Young patients"/>
   <result pre="traced back to a physical cause. Prior to diagnosing a" exact="somatoform disorder," post="it is necessary to rule out medical conditions with"/>
   <result pre="in young patients with ME/CFS who are misdiagnosed as having" exact="somatoform disorder" post="and given psychiatric treatment that includes rigidly enforced exercise."/>
   <result pre="nausea and gastrointestinal symptoms, ME/CFS must be distinguished from an" exact="eating disorder." post="ME/CFS may also need to be distinguished from substance"/>
   <result pre="eating disorder. ME/CFS may also need to be distinguished from" exact="substance abuse." post="Management/Treatment Myalgic encephalomyelitis/chronic fatigue syndrome impacts a young person’s"/>
   <result pre="be persuaded that their misapprehension that the young patient has" exact="factitious disorder" post="by proxy (Munchausen’s syndrome by proxy) or pervasive refusal"/>
   <result pre="but marked daytime sleepiness can result from conditions such as" exact="sleep apnea." post="Sleepiness can be measured using the Epworth sleepiness scale"/>
   <result pre="hydration and nourishment are inadequate, tube feeding is necessary. If" exact="hypersomnia" post="persists for months, the young person should be evaluated"/>
   <result pre="week-to-week, are common. If they are episodic, a diagnosis of" exact="migraine" post="should be considered. Possible triggers include inadequate sleep, stress,"/>
   <result pre="nightly (Up to 50 mg may be tolerated) Useful for co-morbid" exact="fibromyalgia" post="and abdominal hyperalgesia. Can cause lightheadedness and fatigue even"/>
   <result pre="take 4 weeks to become effective. Myalgia and pain from co-morbid" exact="fibromyalgia" post="can be found in from 10 to 30% of"/>
   <result pre="gradually off them, especially duloxetine. Duloxetine can be helpful for" exact="fibromyalgia" post="Anticonvulsants Topiramate (Topamax) 25–100 mg bid Helpful for widespread pain,"/>
   <result pre="been shown to be effective for fatigue in adults with" exact="multiple sclerosis." post="When tested in 14 adults with ME/CFS the treatment"/>
   <result pre="and it can be associated with serious adverse effects, e.g.," exact="aseptic meningitis" post="after infusion, and anaphylaxis in those with IgA deficiency"/>
   <result pre="it can be associated with serious adverse effects, e.g., aseptic" exact="meningitis" post="after infusion, and anaphylaxis in those with IgA deficiency"/>
   <result pre="or if taking antibiotics. Iron tablets for iron deficiency with/without" exact="anemia" post="(the cause of anemia should be determined), take with"/>
   <result pre="Iron tablets for iron deficiency with/without anemia (the cause of" exact="anemia" post="should be determined), take with citrus juice to aid"/>
   <result pre="of FODMAPs can have a beneficial effect for those with" exact="irritable bowel syndrome" post="and other functional gastrointestinal disorders. It might, therefore, be"/>
   <result pre="visual field, visual dimming, mental fog, headaches, nasuea, pain, or" exact="shortness" post="of breath. Upright posture consistently aggravates ME/CFS symptoms and"/>
   <result pre="try to use inhaled glucocorticoids, sodium chromoglycate, or montelukast for" exact="asthma" post="control. Medications that promote vasodilation, such as niacin, phenothiazine"/>
   <result pre="Add KCl 10 m Eq for every 0.1 mg fludrocortisone to prevent" exact="hypokalemia" post="Hormonal Contraceptives Medroxyprogesterone Most are fine. Conventional dosage or"/>
   <result pre="of the nose). Some with EDS develop early onset of" exact="varicose veins." post="In the classical form of EDS there can be"/>
   <result pre="symptoms are typically worse during the menstrual cycle. Adolescents with" exact="endometriosis" post="are more likely than their adult counterparts to report"/>
   <result pre="menorrhagia, the patient should be tested for the presence of" exact="iron deficiency anemia" post="and this should be treated if present. The menorrhagia"/>
   <result pre="patient should be tested for the presence of iron deficiency" exact="anemia" post="and this should be treated if present. The menorrhagia"/>
   <result pre="reflux, gastrointestinal motility disorders, celiac disease and non-celiac gluten sensitivity," exact="lactose intolerance," post="food allergies (e.g., nut, milk, eggs, and wheat), post-infectious"/>
   <result pre="food allergies (e.g., nut, milk, eggs, and wheat), post-infectious or" exact="irritable bowel syndrome" post="and constipation. These conditions should be considered in the"/>
   <result pre="after ingestion. Symptoms that indicate the possibility of a non-IgE-mediated" exact="allergy" post="or an intolerance of a food protein are: (a)"/>
   <result pre="fevers, headaches (including migraines), worsening lightheadedness, myalgias, sinusitis, and either" exact="constipation" post="or diarrhea. Skin testing in people with delayed gastrointestinal"/>
   <result pre="malformations, congenital cervical stenosis, cervical instability, tethered spinal cord, and" exact="thoracic outlet syndrome" post="( 146, 147). Taken together, these disorders represent a"/>
   <result pre="improve overall health. Commonly reported problems are xerostomia (dry mouth)," exact="dental caries," post="periodontal disease, bruxism, temporomandibular joint disorder (TMD) and impacted"/>
   <result pre="health. Commonly reported problems are xerostomia (dry mouth), dental caries," exact="periodontal disease," post="bruxism, temporomandibular joint disorder (TMD) and impacted third molar"/>
   <result pre="or from co-morbid medical conditions. It can lead to rampant" exact="dental caries," post="exacerbation of periodontal disease, or oral candidiasis. Standard treatment"/>
   <result pre="conditions. It can lead to rampant dental caries, exacerbation of" exact="periodontal disease," post="or oral candidiasis. Standard treatment includes increasing oral moistness"/>
   <result pre="lead to rampant dental caries, exacerbation of periodontal disease, or" exact="oral candidiasis." post="Standard treatment includes increasing oral moistness with regular fluid"/>
   <result pre="supplementation for home use, and professional dental prophylaxis. Treatment for" exact="dental caries" post="and periodontal disease follows standard dental practice. For those"/>
   <result pre="use, and professional dental prophylaxis. Treatment for dental caries and" exact="periodontal disease" post="follows standard dental practice. For those who might be"/>
   <result pre="should be administered with caution. Temporomandibular joint disorders (TMD) and" exact="bruxism" post="(tooth grinding) are more prevalent in ME/CFS patients than"/>
   <result pre="by families of children with other chronic illnesses such as" exact="leukemia" post="or juvenile rheumatoid arthritis, but with the additional challenges"/>
   <result pre="children with other chronic illnesses such as leukemia or juvenile" exact="rheumatoid arthritis," post="but with the additional challenges of widespread disbelief in"/>
   <result pre="ME/CFS tolerate standard immunizations. Immunization against human papilloma virus and" exact="hepatitis" post="B are important for long-term health. Yearly immunization against"/>
   <result pre="hepatitis B are important for long-term health. Yearly immunization against" exact="influenza" post="will prevent the serious relapse that can follow this"/>
   <result pre="such as school refusal, or the extremely rare condition of" exact="factitious disorder" post="by proxy (Munchausen’s syndrome by proxy). As a result,"/>
   <result pre="Mears CJ Binns HJ Taylor R Chronic fatigue syndrome following" exact="infectious mononucleosis" post="in adolescents. Pediatrics ( 2009) 124( 1): 189– 93."/>
   <result pre="DS Reese P Cooper L . Risk factors associated with" exact="chronic fatigue syndrome" post="in a cluster of pediatric cases. Rev Infect Dis"/>
   <result pre="T . Incidence, prognosis, and risk factors for fatigue and" exact="chronic fatigue syndrome" post="in adolescents: a prospective community study . Pediatrics ("/>
   <result pre="Emmons C Randall B et al. Prevalence and incidence of" exact="chronic fatigue syndrome" post="in Wichita, Kansas. Arch Intern Med ( 2003) 163:"/>
   <result pre="Plioplys AV Taylor RR et al. A community-based study of" exact="chronic fatigue syndrome." post="Arch Intern Med ( 1999) 159( 18): 2129– 37."/>
   <result pre="EM Emond AM Sterne JAC . Unidentified chronic fatigue syndrome/myalgic" exact="encephalomyelitis" post="(cfs/me) is a major cause of school absence: surveillance"/>
   <result pre="school absence and physical function in paediatric chronic fatigue syndrome/myalgic" exact="encephalopathy" post=". Arch Dis Child ( 2009) 94( 10): 752–"/>
   <result pre="disability, and illness attribution in adolescents with chronic fatigue or" exact="migraine" post=". Pediatrics ( 2003) 111: e376– 81. 10.1542/peds.111.4.e376 12671155"/>
   <result pre="JJF . Physical and functional impact of chronic fatigue syndrome/myalgic" exact="encephalomyelitis" post="in childhood . Pediatrics ( 2010) 125( 6): e1324–"/>
   <result pre="Rowe KS Moon J What is the natural history of" exact="chronic fatigue syndrome" post="in young people? Oral presentation IACFS/ME conference Ottawa ."/>
   <result pre="Robinson M . Thirteen-year follow-up of children and adolescents with" exact="chronic fatigue syndrome." post="Pediatrics ( 2001) 107( 5): 994– 8. 10.1542/peds.107.5.994 11331676"/>
   <result pre="Rowe KS Moon J What is the natural history of" exact="chronic fatigue syndrome" post="in young people? Paper Presented at IACFS/ME Biennial International"/>
   <result pre="Lapp C et al. A pediatric case definition for myalgic" exact="encephalomyelitis" post="and chronic fatigue syndrome. J Chronic Fatigue Syndr ("/>
   <result pre="et al. A pediatric case definition for myalgic encephalomyelitis and" exact="chronic fatigue syndrome." post="J Chronic Fatigue Syndr ( 2006) 13( 2–3): 1–"/>
   <result pre="10.1111/jpc.12425 24251657 29 Underhill R O’Gorman R The prevalence of" exact="chronic fatigue syndrome" post="and chronic fatigue among family members of CFS patients"/>
   <result pre="L Cannon-Albright LA . Evidence for a heritable predisposition to" exact="chronic fatigue syndrome." post="BMC Neurol ( 2011) 11: 62. 10.1186/1471-2377-11-62 21619629 31"/>
   <result pre="PC . Joint hypermobility is more common in children with" exact="chronic fatigue syndrome" post="than in healthy controls . J Pediatr ( 2002)"/>
   <result pre="Mears C Im Y Taylor RR . Predictors of post-infectious" exact="chronic fatigue syndrome" post="in adolescents. Health Psychol Behav Med ( 2014) 2("/>
   <result pre="and safety of valganciclovir in a subset of patients with" exact="chronic fatigue syndrome" post=". J Med Virol ( 2013) 85: 2101– 9."/>
   <result pre="A Lim W Larocque L Hyde BM Clinical improvement in" exact="chronic fatigue syndrome" post="is associated with enhanced natural killer cell-mediated cytotoxicity: the"/>
   <result pre="Ponzio NM Evidence for the presence of immune dysfunction in" exact="chronic fatigue syndrome." post="Clin Diagn Lab Immunol ( 2002) 9( 4): 747–"/>
   <result pre="of immune abnormalities in varying severities of chronic fatigue syndrome/myalgic" exact="encephalomyelitis" post="patients . J Transl Med ( 2015) 13: 299."/>
   <result pre="Salvato FR Morgan R Fletcher MA . Immunologic abnormalities in" exact="chronic fatigue syndrome." post="J Clin Microbiol ( 1990) 28( 6): 1403– 10."/>
   <result pre="Y Shigemori T Igarashi T Fukunaga Y . Fibromyalgia and" exact="chronic fatigue syndrome" post="in children. Pediatr Int ( 2012) 54( 2): 266–"/>
   <result pre="assess the efficacy of intravenous gammaglobulin for the management of" exact="chronic fatigue syndrome" post="in adolescents . J Psychiatr Res ( 1997) 31("/>
   <result pre="C Belch JJF . Biochemical and vascular aspects of pediatric" exact="chronic fatigue syndrome." post="Arch Pediatr Adolesc Med ( 2010) 164( 9): 817–"/>
   <result pre="L Sinnema G Heijnen CJ . Disturbed neuroendocrine-immune interactions in" exact="chronic fatigue syndrome." post="J Clin Endocrinol Metab ( 2000) 85( 2): 692–"/>
   <result pre="Ueland T Mollnes TE . Plasma cytokine expression in adolescent" exact="chronic fatigue syndrome." post="Brain Behav Immun ( 2015) 46: 80– 6. 10.1016/j.bbi.2014.12.025"/>
   <result pre="Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in" exact="chronic fatigue syndrome." post="A double-blind and placebo-controlled study . PLoS One ("/>
   <result pre="N Li K Munoz J . Orthostatic intolerance in adolescent" exact="chronic fatigue syndrome." post="Pediatrics ( 1999) 103( 1): 116– 21. 10.1542/peds.103.1.116 9917448"/>
   <result pre="neurocognitive and neuronal activated cerebral blood flow deficits in young" exact="chronic fatigue syndrome" post="patients with postural tachycardia syndrome . Am J Physiol"/>
   <result pre="J Calkins H Relationship between neurally mediated hypotension and the" exact="chronic fatigue syndrome." post="JAMA ( 1995) 274: 961– 7. 10.1001/jama.1995.03530120053041 7674527 52"/>
   <result pre="matched case control study of orthostatic intolerance in children/adolescents with" exact="chronic fatigue syndrome" post=". Pediatr Res ( 2008) 63( 2): 196– 202."/>
   <result pre="Orthostatic tolerance testing in a prospective cohort of adolescents with" exact="chronic fatigue syndrome" post="and recovered controls following infectious mononucleosis . Clin Pediatr"/>
   <result pre="of adolescents with chronic fatigue syndrome and recovered controls following" exact="infectious mononucleosis" post=". Clin Pediatr ( 2012) 51: 835– 9. 10.1177/0009922812455094"/>
   <result pre="Stewart JM . Increasing orthostatic stress impairs neurocognitive functioning in" exact="chronic fatigue syndrome" post="with postural tachycardia syndrome . Clin Sci ( 2012)"/>
   <result pre="21906029 59 Streeten DHP Bell DS Circulating blood volume in" exact="chronic fatigue syndrome." post="J Chronic Fatigue Syndr ( 1998) 4( 1): 3–"/>
   <result pre="tachycardia, and subnormal erythrocyte volume in the pathogenesis of the" exact="chronic fatigue syndrome" post=". Am J Med Sci ( 2000) 320( 1):"/>
   <result pre="van de Putte EM . The role of hypocortisolism in" exact="chronic fatigue syndrome." post="Psychoneuroendocrinology ( 2014) 42: 199– 206. 10.1016/j.psyneuen.2014.01.017 24636516 62"/>
   <result pre="PC Viner RM . Disturbed adrenal function in adolescents with" exact="chronic fatigue syndrome." post="J Pediatr Endocrinol Metab ( 2005) 18( 3): 295–"/>
   <result pre="al. Regional grey and white matter volumetric changes in myalgic" exact="encephalomyelitis" post="(chronic fatigue syndrome): a voxel-based morphometry 3 t mri"/>
   <result pre="68 Yoshiuchi K Farkas J Natelson BH . Patients with" exact="chronic fatigue syndrome" post="have reduced absolute cortical blood flow. Clin Physiol Funct"/>
   <result pre="Andrade G Nestadt P et al. Increased ventricular lactate in" exact="chronic fatigue syndrome" post="measured by 1h mrs imaging at 3.0 t. II:"/>
   <result pre="by 1h mrs imaging at 3.0 t. II: comparison with" exact="major depressive disorder" post=". NMR Biomed ( 2010) 23( 6): 643– 50."/>
   <result pre="Pillemer S Dyke JP et al. Increased ventricular lactate in" exact="chronic fatigue syndrome." post="III. Relationships to cortical glutathione and clinical symptoms implicate"/>
   <result pre="Functional neuroimaging correlates of mental fatigue induced by cognition among" exact="chronic fatigue syndrome" post="patients and controls . Neuroimage ( 2007) 36( 1):"/>
   <result pre="Less efficient and costly processes of frontal cortex in childhood" exact="chronic fatigue syndrome" post=". Neuroimage Clin ( 2015) 9: 355– 68. 10.1016/j.nicl.2015.09.001"/>
   <result pre="Single-photon emission computerized tomography and neurocognitive function in patients with" exact="chronic fatigue syndrome." post="[Erratum appears in psychosom med. 2003 Mar–Apr; 65(2):210] ."/>
   <result pre="cerebral blood flow during orthostasis: effect on N-back performance in" exact="chronic fatigue syndrome" post=". J Appl Physiol ( 2014) 117: 1157– 64."/>
   <result pre="validity of metabolic and workload measurements for identifying people with" exact="chronic fatigue syndrome" post=". Phys Ther ( 2013) 93( 11): 1484– 92."/>
   <result pre="Exercise tolerance testing in a prospective cohort of adolescents with" exact="chronic fatigue syndrome" post="and recovered controls following infectious mononucleosis . J Pediatr"/>
   <result pre="of adolescents with chronic fatigue syndrome and recovered controls following" exact="infectious mononucleosis" post=". J Pediatr ( 2010) 157( 3): 468– 472,472.e461."/>
   <result pre="exercise increases expression for sensory, adrenergic, and immune genes in" exact="chronic fatigue syndrome" post="patients but not in normal subjects . J Pain"/>
   <result pre="Vernon SD McGowan PO . DNA methylation modifications associated with" exact="chronic fatigue syndrome." post="PLoS One ( 2014) 9: e104757. 10.1371/journal.pone.0104757 25111603 85"/>
   <result pre="Crawley E . Memory and attention problems in children with" exact="chronic fatigue syndrome" post="or myalgic encephalopathy . Arch Dis Child ( 2009)"/>
   <result pre="attention problems in children with chronic fatigue syndrome or myalgic" exact="encephalopathy" post=". Arch Dis Child ( 2009) 94( 10): 757–"/>
   <result pre="98 Bell DS Bell KM Cheney PR . Primary juvenile" exact="fibromyalgia" post="syndrome and chronic fatigue syndrome in adolescents. Clin Infect"/>
   <result pre="Bell KM Cheney PR . Primary juvenile fibromyalgia syndrome and" exact="chronic fatigue syndrome" post="in adolescents. Clin Infect Dis ( 1994) 18( Suppl"/>
   <result pre="KS Rowe KJ Symptom patterns of children and adolescents with" exact="chronic fatigue syndrome." post="In: Nirbhay THO Singh N Ashvind NS , editors."/>
   <result pre="RM Visser FC Sluiter W Scholte HR . Patients with" exact="chronic fatigue syndrome" post="performed worse than controls in a controlled repeated exercise"/>
   <result pre="behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic" exact="encephalomyelitis" post="(ME)/chronic fatigue syndrome (CFS): CBT/GET is not only ineffective"/>
   <result pre="al. Impaired range of motion of limbs and spine in" exact="chronic fatigue syndrome." post="J Pediatr ( 2014) 165: 360– 6. 10.1016/j.jpeds.2014.04.051 24929332"/>
   <result pre="A pilot randomized controlled trial of dexamphetamine in patients with" exact="chronic fatigue syndrome" post=". Psychosomatics ( 2003) 44: 38– 43. 10.1176/appi.psy.44.1.38 12515836"/>
   <result pre="B Bobbaers H . Does methylphenidate reduce the symptoms of" exact="chronic fatigue syndrome?" post="Am J Med ( 2006) 119: 167.e23– 30. 10.1016/j.amjmed.2005.07.047"/>
   <result pre="treatment with modafanil may not be beneficial in patients with" exact="chronic fatigue syndrome" post=". J Psychopharmacol ( 2005) 19: 647– 60. 10.1177/0269881105056531"/>
   <result pre="al. Response to vitamin B12 and folic acid in myalgic" exact="encephalomyelitis" post="and fibromyalgia. PLoS One ( 2015) 10( 4): e0124648."/>
   <result pre="Rimes KA Wingrove J Mindfulness-based cognitive therapy for people with" exact="chronic fatigue syndrome" post="still experiencing excessive fatigue after cognitive behaviour therapy: a"/>
   <result pre="Mitchell E Tidy E Hunot V Cognitive behavioural therapy for" exact="chronic fatigue syndrome" post="in adults. Cochrane Database Syst Rev ( 2008) 3:"/>
   <result pre=". Effectiveness of internet-based cognitive behavioural treatment for adolescents with" exact="chronic fatigue syndrome" post="(FITNET): a randomised controlled trial . Lancet ( 2012)"/>
   <result pre="the treatment and management of myalgic encephalomyelitis/chronic fatigue syndrome and" exact="fibromyalgia" post=". J Altern Complement Med ( 2010) 16( 3):"/>
   <result pre="Maumenee IH Tong PY Geraghty MT . Orthostatic intolerance and" exact="chronic fatigue syndrome" post="associated with Ehlers-Danlos syndrome . J Pediatr ( 1999)"/>
   <result pre="Cow’s milk protein intolerance in adolescents and young adults with" exact="chronic fatigue syndrome" post=". Acta Paediatr ( 2016) 105( 9): e412– 8."/>
   <result pre="Clinical evidence for cervical myelopathy due to Chiari malformation and" exact="spinal stenosis" post="in a non-randomized group of patients with the diagnosis"/>
   <result pre="in a non-randomized group of patients with the diagnosis of" exact="fibromyalgia" post=". Eur Spine J ( 2004) 13: 516– 23."/>
   <result pre="Kimpen JL Hulshoff Pol HE et al. The impact of" exact="chronic fatigue syndrome" post="on cognitive functioning in adolescents. Eur J Pediatr ("/>
   <result pre="heart rate variability during head-up tilt testing in children with" exact="chronic fatigue syndrome" post=". Clin Auton Res ( 1998) 8: 221– 30."/>
   <result pre="cardiovascular control during orthostatic stress and isometric exercise in adolescent" exact="chronic fatigue syndrome" post=". Eur J Appl Physiol ( 2008) 102: 623–"/>
   <result pre="K Solhjell KK Bollerslev J . Hormonal alterations in adolescent" exact="chronic fatigue syndrome." post="Acta Paediatr ( 2010) 99: 770– 3. 10.1111/j.1651-2227.2010.01701.x 20199497"/>
   <result pre="et al. The capnography head-up tilt test for evaluation of" exact="chronic fatigue syndrome." post="Semin Arthritis Rheum ( 2000) 30: 79– 86. 10.1053/sarh.2000.9201"/>
   <result pre="al. Cerebral and systemic hemodynamics changes during upright tilt in" exact="chronic fatigue syndrome" post=". J Neuroimaging ( 2003) 13: 57– 67. 10.1111/j.1552-6569.2003.tb00158.x"/>
   <result pre="a biological marker for orthostatic intolerance in some patients with" exact="chronic fatigue syndrome" post=". Dyn Med ( 2007) 6: 2. 10.1186/1476-5918-6-2 17263876"/>
   <result pre="conditions with similar symptoms that require treatment. The diagnosis of" exact="chronic fatigue syndrome" post="cannot be made without such an evaluation. Appendix B"/>
   <result pre="conditions in the differential diagnosis of pediatric ME/CFS. Autoimmune/rheumatology Autoimmune" exact="hepatitis" post="Rheumatoid and other inflammatory arthritis Sjogren syndrome Systemic lupus"/>
   <result pre="of pediatric ME/CFS. Autoimmune/rheumatology Autoimmune hepatitis Rheumatoid and other inflammatory" exact="arthritis" post="Sjogren syndrome Systemic lupus erythematosus Wegener’s granulomatosis Cardiovascular/autonomic Aberrant"/>
   <result pre="Autoimmune hepatitis Rheumatoid and other inflammatory arthritis Sjogren syndrome Systemic" exact="lupus erythematosus" post="Wegener’s granulomatosis Cardiovascular/autonomic Aberrant coronary artery, coronary aneurysms Cardiomyopathy"/>
   <result pre="Metabolic syndrome Pituitary tumors or disorders Gastrointestinal/nutritional Celiac Disease Chronic" exact="liver disease" post="Eosinophilic gastroenteritis Inflammatory bowel disease Pancreatic insufficiency Vitamin D"/>
   <result pre="tumors or disorders Gastrointestinal/nutritional Celiac Disease Chronic liver disease Eosinophilic" exact="gastroenteritis" post="Inflammatory bowel disease Pancreatic insufficiency Vitamin D and B12"/>
   <result pre="syndrome Psychiatric Anorexia Nervosa Bipolar disorder Chronic psychosocial stress Generalized" exact="anxiety disorder" post="Major depressive disorder Personality disorder Post-traumatic stress disorder Respiratory"/>
   <result pre="disorder Personality disorder Post-traumatic stress disorder Respiratory Aspergillosis Asthma/allergies Chronic" exact="sinusitis" post="Cystic fibrosis Sarcoidosis Sleep disorders Central apnea Klein-Levin syndrome"/>
   <result pre="systems. ME/CFS occurs worldwide. In different countries, it is labeled" exact="chronic fatigue syndrome," post="myalgic encephalomyelitis or the acronym, ME/CFS. A new name,"/>
   <result pre="In different countries, it is labeled chronic fatigue syndrome, myalgic" exact="encephalomyelitis" post="or the acronym, ME/CFS. A new name, systemic exertion"/>
   <result pre="illness. Frequently the illness follows an acute infection such as" exact="infectious mononucleosis" post="and immune system changes found in ME/CFS are similar"/>
   <result pre="an outline of material taught. Use multi-sensory instruction, e.g., visual" exact="aids" post="like graphic organizers and non-linguistic representations to better suit"/>
   <result pre="ages among those with ME/CFS and in the related condition" exact="fibromyalgia" post="( 50, 188). In pediatric ME/CFS, rates of OI"/>
   <result pre="in symptoms on a 0–10 scale (lightheadedness, warmth, fatigue, headache," exact="shortness" post="of breath, mental fogginess, and pain). Not all individuals"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC5693816/results/search/disease/results.xml">
   <result pre="the increasing use of non-opioid and multimodal analgesic therapies, including" exact="migraine" post="therapies, regional anesthesia, subdissociative-dose ketamine, nitrous oxide, intravenous lidocaine"/>
   <result pre="the use of non-opioid analgesics and nonpharmacologic interventions. Results While" exact="migraine" post="therapies, regional anesthesia, nitrous oxide and subdissociative-dose ketamine are"/>
   <result pre="countries of the European Union report disparate rates of prescription" exact="opioid abuse" post="[ 14– 16]. The reasons for these cross-national consumption"/>
   <result pre="(noncardiac) 40 (5) Upper respiratory infection 30 (4) Abscess or" exact="cellulitis" post="25 (3) Toothache 19 (2) Urinary tract infection 16"/>
   <result pre="of Emergency Physicians published guidelines for the acute management of" exact="migraine" post="headaches [ 26], evidence reviews reveal that opioids remain"/>
   <result pre="harm in the USA provides additional stimulus to harmonize rational" exact="migraine" post="therapy across national boundaries. Emergency physician-administered regional anesthesia is"/>
   <result pre="specific conditions: acute low back pain, lumbar radiculopathy, renal colic," exact="migraine" post="and extremity fracture/dislocation. Condition-specific multimodal therapeutic protocols include a"/>
   <result pre="patients who may (or may not) be at risk for" exact="opioid abuse." post="The concept of empathy for those in pain involves"/>
   <result pre="Minen MT Tanev K Friedman BW Evaluation and treatment of" exact="migraine" post="in the emergency department: a review Headache 2014 54"/>
   <result pre="association of emergency physicians guidelines for the acute management of" exact="migraine" post="headache J Emerg Med 1999 17 137 144 10.1016/S0736-4679(98)00136-X"/>
   <result pre="Use of narcotic analgesics in the emergency department treatment of" exact="migraine" post="headaches Neurology 2004 62 1695 1700 10.1212/01.WNL.0000127304.91605.BA 15159464 31."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC5709272/results/search/disease/results.xml">
   <result pre="may in some cases be challenging. The clinical syndrome of" exact="idiopathic intracranial hypertension" post="results from an increase in intracranial pressure without an"/>
   <result pre="In addition to the headache patients commonly suffer from a" exact="papilledema" post="that leads to a progressive visual deficit which, if"/>
   <result pre="and preventive drugs in migraine. Development of therapies to treat" exact="migraine" post="has previously been hampered by a lack of biomarkers"/>
   <result pre="as a consequence of the increasing use of a human" exact="migraine" post="provocation model that demonstrates the importance of naturally occurring"/>
   <result pre="headache and focal neurologic signs includes primary etiologies, such as" exact="migraine" post="with aura, and secondary etiologies, such as trauma, infection,"/>
   <result pre="and understanding of its pathophysiology starts with the acknowledgment that" exact="migraine" post="is not simply a disease of intermittently occurring pain,"/>
   <result pre="If one wants to interpret the most recent findings in" exact="migraine" post="pathophysiology it is important to again discuss the clinical"/>
   <result pre="again discuss the clinical presentation of all phases of a" exact="migraine" post="attack. There are three clinical features of migraine which"/>
   <result pre="of a migraine attack. There are three clinical features of" exact="migraine" post="which point towards the limbic system and hypothalamus as"/>
   <result pre="functions, has only recently become a site of interest in" exact="migraine" post="research. Another neurotransmitter system involving the hypothalamus is the"/>
   <result pre="hypothalamus is the central dopaminergic system. Recent neuroimaging studies in" exact="migraine" post="patients undermine hypothalamic involvement in the premonitory and acute"/>
   <result pre="premonitory and acute pain phase of migraine. Most recently one" exact="migraine" post="patient went into the scanner daily over a whole"/>
   <result pre="in the prodromal phase (within the last 24 h before" exact="migraine" post="headache onset) as compared to the interictal state. More"/>
   <result pre="a crucial role in generating premonitory symptoms but also the" exact="migraine" post="attack itself. Moreover, using a recently developed protocol for"/>
   <result pre="These data corroborate a crucial role of the HT for" exact="migraine" post="chronification but also as for the sustainment of acute"/>
   <result pre="migraine chronification but also as for the sustainment of acute" exact="migraine" post="pain. References 1. Schulte LH, Sprenger C, May A."/>
   <result pre="high resolution fMRI. Neurology 2017 88:2011–2016 3. May A. Understanding" exact="migraine" post="as a cycling brain syndrome: reviewing the evidence from"/>
   <result pre="whether CGRP antagonists penetrate the blood brain barrier and abort" exact="migraine" post="headaches in part via central mechanisms. As migraine is"/>
   <result pre="and abort migraine headaches in part via central mechanisms. As" exact="migraine" post="is a CNS disorder a central abortive or preventative"/>
   <result pre="headache disorders such as migraine, tension-type headache, trigeminal autonomic cephalalgias," exact="trigeminal neuralgia" post="and persisting secondary headaches. S7 CGRP PNS models in"/>
   <result pre="sensory afferents that may be involved in the pathophysiology of" exact="migraine" post="as well as in the development of potential side"/>
   <result pre="which reflects the phenotype well. Understanding the non-pain phases of" exact="migraine" post="will lead to be a better formulation of the"/>
   <result pre="lead to be a better formulation of the pathophysiology of" exact="migraine" post="and eventually to better treatment. References 1. Disease GBD,"/>
   <result pre="4. Karsan N, Prabakhar P, Goadsby PJ. Premonitory symptoms of" exact="migraine" post="in childhood and adolescence. Current Pain and Headache Reports."/>
   <result pre="PJ. Brain activations in the premonitory phase of nitroglycerin triggered" exact="migraine" post="attacks. Brain. 2014;137:232-42. 6. Giffin NJ, Lipton RB, Silberstein"/>
   <result pre="NJ, Lipton RB, Silberstein SD, Olesen J, Goadsby PJ. The" exact="migraine" post="postdrome. An electronic diary study. Neurology (Minneap). 2016;87:1-5. 7."/>
   <result pre="of patients (90%) treated in primary care, the more complex" exact="migraine" post="and tension-type headache patients (7-8%) in secondary care with"/>
   <result pre="predictors are important for future planning. S11 GWAS studies in" exact="migraine" post="Arn M.J.M. van den Maagdenberg Departments of Human Genetics"/>
   <result pre="headache attacks with various associated neurological symptoms. About one-third of" exact="migraine" post="patients experience an aura preceding the headache phase: hence"/>
   <result pre="migraine patients experience an aura preceding the headache phase: hence" exact="migraine" post="with and without aura. Many migraine patients also suffer"/>
   <result pre="the headache phase: hence migraine with and without aura. Many" exact="migraine" post="patients also suffer from comorbid neurological disorders, such as"/>
   <result pre="of single nucleotide polymorphisms (SNPs) in tens of thousands of" exact="migraine" post="patients in genome-wide association studies (GWAS), made it feasible"/>
   <result pre="the common forms of migraine. Whereas GWAS performed in various" exact="migraine" post="subtypes yielded different top hits for the different subtypes,"/>
   <result pre="for diseases comorbid with migraine. Unlike gene mutations in monogenic" exact="migraine" post="subtypes, the effect size of gene variants in common"/>
   <result pre="migraine subtypes, the effect size of gene variants in common" exact="migraine" post="is small, thus complicating direct translation to diagnostic tests,"/>
   <result pre="epidermal nerve fibres in various peripheral nerve diseases, such as" exact="diabetic neuropathy," post="infectious and inflammatory neuropathies and neuropathies associated with systemic"/>
   <result pre="epidermal nerve fibre density was significantly lower in patients with" exact="neuropathy" post="than in controls. S13 Neuromodulation and Headache. Future perspectives"/>
   <result pre="placebo effect is a challange particularly for headache specialists.In chronic" exact="migraine" post="and chronic cluster headache patients occurrence of psychiatric comorbidities"/>
   <result pre="an addiction behavior - is frequently observed both in chronic" exact="migraine" post="and chronic cluster headache. The role of psychosocial factors"/>
   <result pre="is not there (3). Similarly other neurostimulation procedures tried in" exact="migraine" post="and cluster headache have shown poor, unsatisfactory ability to"/>
   <result pre="trust An underlying concept in the new ICHD-3 classification of" exact="trigeminal neuralgia" post="is the postulation that clinical presentations matter because they"/>
   <result pre="clinical symptoms and signs. Yet, the relatively strict criteria for" exact="trigeminal neuralgia" post="and its subgroups yield homogenous populations that allow advantage"/>
   <result pre="and Obstetrics, University of Szeged One third of women with" exact="epilepsy" post="(WWE) are in reproductive age, and nearly 50% of"/>
   <result pre="child; and/or c) changes in seizure activity. Nowadays, women with" exact="epilepsy" post="do not always get the right information; thus, it"/>
   <result pre="from trigeminal nerve endings. Animal studies investigating the mechanisms of" exact="migraine" post="and CSD are usually conducted under anesthesia, despite the"/>
   <result pre="Therefore CSD studies in awake animals are crucial for translational" exact="migraine" post="research. CSD in freely moving lissencephalic animals, led to"/>
   <result pre="of sensory stimulus and transient disruption of sensorial perception during" exact="migraine" post="headache attacks was reported (Boran et al, 2016). Disruption"/>
   <result pre="temporal discrimination of two consecutive sensorial stimuli seems specific to" exact="migraine" post="headache attacks (Vurallı et al, 2016, Vurallı et al,"/>
   <result pre="cortical event is important to explain several clinical features of" exact="migraine" post="such as 1) Dysfunction of the GABAergic neurons in"/>
   <result pre="sleep, 4) Thalamo-cortical gating could be a novel target in" exact="migraine" post="as valproate, triptans and CGRP antagonists MK-8825 suppressed CSD"/>
   <result pre="disorders that will ensure correct diagnosis. S19 The concept of" exact="trigeminal neuralgia" post="Giorgio Cruccu Trigeminal neuralgia (TN) is a neurological disease"/>
   <result pre="brain. SD is widely accepted as the pathophysiological event underlying" exact="migraine" post="aura, and may play a role in headache pathogenesis"/>
   <result pre="disorders in which invasive recordings are not possible. SD explains" exact="migraine" post="aura and progression of neurological deficits associated with other"/>
   <result pre="the chief complaint have a primary headache disorder, such as" exact="migraine" post="or tension-type headache, the diagnosis of which relies on"/>
   <result pre="artery dissection, cerebral venous thrombosis, reversible cerebral vasoconstriction syndrome and" exact="pituitary apoplexy" post="may present with isolated headache and normal physical examination,"/>
   <result pre="the ER should be based on the etiology. A severe" exact="migraine" post="attack can be treated by SC sumatriptan, intravenous non-steroidal"/>
   <result pre="the pain intensity. S23 Progestin-only contraception and beneficial effects on" exact="migraine" post="Gabriele S. Merki-Feld In women migraine prevalence peaks during"/>
   <result pre="and beneficial effects on migraine Gabriele S. Merki-Feld In women" exact="migraine" post="prevalence peaks during reproductive years. Menstruation is a significant"/>
   <result pre="during reproductive years. Menstruation is a significant risk factor for" exact="migraine" post="with attacks most likely to occur between 2 days"/>
   <result pre="contraception. Migraine with aura (MA) and to a lesser extent" exact="migraine" post="without aura (MO) increase the risk for cardiovascular events,"/>
   <result pre="shown that COC can initiate migraine, worsen the course of" exact="migraine" post="and induce a change from MO to MA. Several"/>
   <result pre="from MO to MA. Several clinical trials report improvements in" exact="migraine" post="frequency and intensity in users of the progestin-only pill"/>
   <result pre="into the IHS classification system. The current version defines the" exact="trigeminal neuralgia" post="and trigeminal neuropathy. Trigeminal neuralgia is subdivided into classical"/>
   <result pre="S26 Within person variation in headache days in persons with" exact="migraine" post="Richard Lipton Objective To determine persistence of and transitions"/>
   <result pre="Lipton Objective To determine persistence of and transitions between episodic" exact="migraine" post="(EM) and chronic migraine (CM) and to describe and"/>
   <result pre="persistence of and transitions between episodic migraine (EM) and chronic" exact="migraine" post="(CM) and to describe and model the natural variability"/>
   <result pre="of a year. These findings my influence case definitions of" exact="migraine" post="subtypes, the design and interpretation of epidemiologic studies and"/>
   <result pre="showing that cortical spreading depression (CSD), the neural correlate of" exact="migraine" post="aura, closes the paravascular space and impairs glymphatic flow."/>
   <result pre="glymphatic system in altered cortical and endothelial functioning of the" exact="migraine" post="brain, which can explain the increased risk of stroke"/>
   <result pre="the migraine brain, which can explain the increased risk of" exact="stroke" post="among migraine aura patients. S28 Photophobia and Hypothalamus Rami"/>
   <result pre="brain, which can explain the increased risk of stroke among" exact="migraine" post="aura patients. S28 Photophobia and Hypothalamus Rami Burstein, Rodrigo"/>
   <result pre="(a) hypothalamic-mediated autonomic responses such as chest tightness, throat tightness," exact="shortness" post="of breath, fast breathing, faster than usual heart rate,"/>
   <result pre="population) and of Cluster Headache 0.01% (n=0.74K of population). Chronic" exact="migraine" post="one-year prevalence was 1% (n=0.7K of population). Females tend"/>
   <result pre="in neurogenic inflammation, is now discussed throughout the communities of" exact="migraine" post="researchers, headache therapists and even migraine patients. The reason"/>
   <result pre="throughout the communities of migraine researchers, headache therapists and even" exact="migraine" post="patients. The reason for this surprising career of CGRP"/>
   <result pre="at elevated concentrations in the cranial outflow during attacks of" exact="migraine" post="and some trigemino-autonomic headaches; infusion of CGRP into patients"/>
   <result pre="is more-or-less stand-alone, in order to act as practical management" exact="aids" post="as well as educational resources. There is a set"/>
   <result pre="headache disorders and their management. LTB and EHF offer these" exact="aids" post="freely available for use without restriction. We hope for"/>
   <result pre="of L’Aquila, L’Aquila, Italy Several data indicate that migraine, especially" exact="migraine" post="with aura, is associated with an increased risk of"/>
   <result pre="with aura, is associated with an increased risk of ischemic" exact="stroke" post="and other vascular events. Of concern is whether the"/>
   <result pre="vascular events. Of concern is whether the risk of ischemic" exact="stroke" post="in migraineurs is magnified by the use of hormonal"/>
   <result pre="is magnified by the use of hormonal contraceptives (HCs). As" exact="migraine" post="prevalence is high in women of reproductive age, it"/>
   <result pre="reproductive age, it is common to face the issue of" exact="migraine" post="and HC use in clinical practice. To improve decision-making"/>
   <result pre="document pointed out that evidence addressing the risk of ischemic" exact="stroke" post="associated with the use of HCs is generally poor."/>
   <result pre="and in most cases results are not provided according to" exact="migraine" post="type. Despite those limitations, available data pointed toward an"/>
   <result pre="limitations, available data pointed toward an increased risk of ischemic" exact="stroke" post="associated with the use of HCs in women with"/>
   <result pre="and Reproductive Health (ESC). Hormonal contraceptives and risk of ischemic" exact="stroke" post="in women with migraine: a consensus statement from the"/>
   <result pre="used when the nervous system damage is due to a" exact="neurological disorder" post="such as stroke or peripheral diabetes neuropathy. In peripheral"/>
   <result pre="system damage is due to a neurological disorder such as" exact="stroke" post="or peripheral diabetes neuropathy. In peripheral neuropathic pain there"/>
   <result pre="of clinical neurophysiological and functional imaging studies have suggested that" exact="migraine" post="might be associated with cerebellar dysfunction. These studies all"/>
   <result pre="greater or lesser extent. Therefore, it is still uncertain whether" exact="migraine" post="is associated with cerebellar dysfunction, and, if so, to"/>
   <result pre="due to the increased prevalence of cerebellar ischemic lesions in" exact="migraine" post="patients or is there a more functional explanation similar"/>
   <result pre="there a more functional explanation similar to what’s seen in" exact="familial hemiplegic migraine" post="type 1 (FHM1)? Recent anatomical studies demonstrated that the"/>
   <result pre="more functional explanation similar to what’s seen in familial hemiplegic" exact="migraine" post="type 1 (FHM1)? Recent anatomical studies demonstrated that the"/>
   <result pre="revealed with almost all the sensory modalities of stimulation in" exact="migraine" post="between attacks, with its normalization during the attacks. Recently,"/>
   <result pre="on the point where the patient is recorded during the" exact="migraine" post="cycle. Thalamic/thalamocortical drives were found to be less active"/>
   <result pre="their site of release. Given the evidence for CGRP in" exact="migraine" post="and potential roles for other hypothalamic peptides, it seems"/>
   <result pre="integrates peripheral and central CGRP actions in photophobia. S38 Classical" exact="trigeminal neuralgia" post="– clinical and MRI findings Stine Maarbjerg Department of"/>
   <result pre="Maarbjerg Department of Neurology, Helse Fonna, Haugesund, Norway Background Classical" exact="trigeminal neuralgia" post="(TN) is a unique neuropathic facial pain disorder. As"/>
   <result pre="Background Classical trigeminal neuralgia (TN) is a unique neuropathic facial" exact="pain disorder." post="As there are no diagnostic tests to confirm the"/>
   <result pre="thorough history and exam. MRI is used to exclude symptomatic" exact="trigeminal neuralgia," post="not to confirm the diagnosis of TN. Knowing how"/>
   <result pre="both a clinical and a scientific perspective. S39 PACAP in" exact="migraine" post="László Vécsei 1,2, Délia Szok 1, János Tajti 1"/>
   <result pre="first evidence for potential role of PACAP in pathomechanism of" exact="migraine" post="was the intravenous administration of PACAP-38 caused headache and"/>
   <result pre="preclinical and clinical publications in the field of PACAP and" exact="migraine" post="in the database of MEDLINE/PubMed up to 31 May"/>
   <result pre="[5]. The recent functional imaging study pointed that intravenous PACAP-38-induced" exact="migraine" post="attacks was associated with alterations in brain network connectivity"/>
   <result pre="[6] Clinical investigation provided evidence of a clear association between" exact="migraine" post="phases (during a spontaneous migraine attack versus pain-free period)"/>
   <result pre="of a clear association between migraine phases (during a spontaneous" exact="migraine" post="attack versus pain-free period) and the alteration of plasma"/>
   <result pre="system by vasoactive neuropeptides might be crucial factors of the" exact="migraine" post="pathogenesis [8]. The recent preclinical and clinical studies suggest"/>
   <result pre="suggest the importance of PACAP as a future biomarker of" exact="migraine" post="headache. Acknowledgements This work was supported by the projects"/>
   <result pre="J., Ashina, M. PACAP38 induces migraine-like attacks in patients with" exact="migraine" post="without aura. Brain. 2009; 132:16-25. 3. Tuka, B., Helyes,"/>
   <result pre="Olesen, J., Ashina, M. Investigation of the pathophysiological mechanisms of" exact="migraine" post="attacks induced by pituitary adenylate cyclase-activating polypeptide-38. Brain 2014;"/>
   <result pre="T., Ashina, M. Change in brain network connectivity during PACAP38-induced" exact="migraine" post="attacks: A resting-state functional MRI study. Neurology 2016; 86:180-187."/>
   <result pre="immunoreactivity in the plasma during ictal and interictal periods of" exact="migraine" post="patients. Cephalalgia 2013; 33:1085-1095. 8. Vécsei L, Tuka B,"/>
   <result pre="Vécsei L, Tuka B, Tajti J. Role of PACAP in" exact="migraine" post="headaches. Brain 2014; 137:650-651. S40 Comorbidity Grounds Noemi Faedda"/>
   <result pre="The most frequently described comorbidities include anxiety, mood disorders [1]," exact="sleep disorder" post="[2] and attention hyperactive disorder [3]. The association between"/>
   <result pre="the consequence of a link between neurotransmitter systems involved in" exact="migraine" post="and psychiatric disorder, such as depression and anxiety [4]."/>
   <result pre="genotype, that seem to be associated with migraine, major depression," exact="generalized anxiety disorder," post="panic attacks and phobia [5]. It has been suggested"/>
   <result pre="that seem to be associated with migraine, major depression, generalized" exact="anxiety disorder," post="panic attacks and phobia [5]. It has been suggested"/>
   <result pre="vulnerability to anxiety disorders and affective disorders as well as" exact="migraine" post="might be attributed to the dysregulation of the serotonergic"/>
   <result pre="Twin studies have shown that the genetic liability related to" exact="migraine" post="amounts to 40-60%, while the contribution of non-shared environmental"/>
   <result pre="5. Peroutka SJ, Price SC, Wilhoit TL, Jones KW. Comorbid" exact="migraine" post="with aura, anxiety, and depression is associated with dopamine"/>
   <result pre="Roccella M, Carotenuto M. Attachment styles in children affected by" exact="migraine" post="without aura. Neuropsychiatr Dis Treat. 2013;9:1513-9. 11. Barone L,"/>
   <result pre="INVITED SPEAKERS S41 Application of &quot;very low-calorie ketogenic diet&quot; in" exact="migraine" post="treatment Cherubino Di Lorenzo 1, Roberta Ienca 2, Simona"/>
   <result pre="weight-loss was suggested as a useful strategy to improve both" exact="migraine" post="and metabolic syndrome. Among different approaches to achieve a"/>
   <result pre="suggested as a useful strategy to improve both migraine and" exact="metabolic syndrome." post="Among different approaches to achieve a rapid weight loss,"/>
   <result pre="headache in migraineurs. To assess if the favorable outcome on" exact="migraine" post="was due to the caloric restriction, instead of KBs,"/>
   <result pre="trigeminal and the cervical systems as a trait symptom in" exact="migraine" post="[6, 7]. The ICHD-III also does recommend the use"/>
   <result pre="RB, Hajiyeva N, Jensen R. Prevalence of neck pain in" exact="migraine" post="and tension-type headache: a population study. Cephalalgia. 2015;35(3):211-9. doi:10.1177/0333102414535110."/>
   <result pre="7. Luedtke K, Starke W, May A. Musculoskeletal dysfunction in" exact="migraine" post="patients. Cephalalgia. 2017; Jan 1:333102417716934. doi: 10.1177/0333102417716934. 8. Headache"/>
   <result pre="common neurological symptom in pediatric age. Among the primary headaches," exact="migraine" post="is far more prevalent than tension-type headache and cluster"/>
   <result pre="the possibility to classify some patients, such as children with" exact="migraine" post="with aura [2], they turned out to be unsuitable"/>
   <result pre="30 minutes, thus they could not be classified either in" exact="migraine" post="or in tension-type headache [3]. Several studies have shown"/>
   <result pre="role played by psychological factors in determining the severity of" exact="migraine" post="in children [4]. Therefore, a psychological examination is often"/>
   <result pre="B, Vigevano F, Valeriani M. Features of aura in paediatric" exact="migraine" post="diagnosed using the and ICHD 3III beta criteria. Cephalalgia,"/>
   <result pre="scrutiny but several reasons are called in cause: an appetite" exact="suppression" post="induced by proteins and (maybe) by ketone bodies (KBs),"/>
   <result pre="to be a promising approach in the early management of" exact="obesity" post="and in the preparation phase for patients that must"/>
   <result pre="by headache. A stronger association exists between TMD and chronic" exact="migraine" post="in comparison with other types of headache. Myofascial TMD"/>
   <result pre="nucleus by the TMD symptoms can favor the triggering of" exact="migraine" post="episode. Beside the epidemiological studies and the neurophysiologic hypothesis,"/>
   <result pre="TMD symptoms parallels an increase of frequency and intensity of" exact="migraine" post="and the simultaneous treatment of both conditions results in"/>
   <result pre="to be associated with the degree of widespread pressure pain" exact="hypersensitivity" post="in TTH patients, supporting the role of TrPs on"/>
   <result pre="Ther Assoc 2014; 17(1):31-38. S48 The use of nutraceuticals in" exact="migraine" post="Cherubino Di Lorenzo (cherub@inwind.it) Don Carlo Gnocchi Onlus Foundation,"/>
   <result pre="obtain some health benefits. Several nutraceutical products are proposed for" exact="migraine" post="and sold around the world, but researchers adequately study"/>
   <result pre="find researches that support the use of nutraceutical molecules in" exact="migraine" post="management. Results Available good quality data support the use"/>
   <result pre="of a combination of coenzyme Q10, feverfew and magnesium for" exact="migraine" post="prophylaxis: a prospective observational study. A double blind versus"/>
   <result pre="combination of riboflavin, coenzyme Q10, feverfew, andrographis and magnesium for" exact="migraine" post="prophylaxis is currently in progress. Conclusions Usually patients appreciate"/>
   <result pre="neurological patients .Usually, neuroimaging is unnecessary in patients with episodic" exact="migraine" post="or tension type headache with typical headache features and"/>
   <result pre="same study, after 5 years, a patient with a new" exact="migraine" post="has a 40% chance of receiving a neuroimaging examination[1]."/>
   <result pre="history of HIV or active infections, and prior history of" exact="stroke" post="or intracranial bleeding [2, 3]. A recent consensus recommends"/>
   <result pre="A recent consensus recommends brain MRI for the case of" exact="migraine" post="with aura that persists on one side or in"/>
   <result pre="headachedisorders. J Headache Pain. 2015;17:5. S51 Risk factors for chronic" exact="migraine" post="Cristina Tassorelli 1,2, Grazia Sances 1, Sara Bottiroli 1,"/>
   <result pre="Correspondence: Cristina Tassorelli (cristina.tassorelli@unipv.it) Migraine frequency fluctuates over time. Chronic" exact="migraine" post="is defined by the occurrence of headache on more"/>
   <result pre="more than 15 days/month for at least 3 months. Chronic" exact="migraine" post="affects 1–2% of the general population, and about 8%"/>
   <result pre="the literature, the most important recognized factors associated to chronic" exact="migraine" post="are overuse of acute migraine medication, ineffective acute treatment,"/>
   <result pre="recognized factors associated to chronic migraine are overuse of acute" exact="migraine" post="medication, ineffective acute treatment, obesity, depression, presence of allodynia"/>
   <result pre="of additional noncephalic pain site is a risk factor for" exact="migraine" post="chronification. For many of these factors the relationship with"/>
   <result pre="migraine chronification. For many of these factors the relationship with" exact="migraine" post="chronification may however be bi-directional. For instance, in the"/>
   <result pre="is possible that depression may negatively affect the response of" exact="migraine" post="to acute and prophylactic treatments, but it is also"/>
   <result pre="alterations. In the case of obesity, the association with chronic" exact="migraine" post="may simply be ascribed to the effect of fat"/>
   <result pre="of evidence suggest that the progression from episodic to chronic" exact="migraine" post="is associated to a progressive increase and stabilization of"/>
   <result pre="frame, it appears obvious that an additional cause for chronic" exact="migraine" post="is quite likely represented by the low rate of"/>
   <result pre="the American Migraine Prevalence and Prevention Study, nearly 40% of" exact="migraine" post="sufferers should be considered for preventive migraine therapy, while"/>
   <result pre="nearly 40% of migraine sufferers should be considered for preventive" exact="migraine" post="therapy, while only 13% of all patients with migraine"/>
   <result pre="preventive migraine therapy, while only 13% of all patients with" exact="migraine" post="currently use preventive therapy to control their attacks. The"/>
   <result pre="AM, Franznick DA, Adams AM, Lipton RB. Comorbid pain and" exact="migraine" post="chronicity: The Chronic Migraine Epidemiology and Outcomes Study. Neurology."/>
   <result pre="Silberstein SD, Diamond S, Loder E, et al. Prevalence of" exact="migraine" post="sufferers who are candidates for preventive therapy: results from"/>
   <result pre="who are candidates for preventive therapy: results from the American" exact="migraine" post="study (AMPP) study. Headache 2005; 45: 770– 771. Tassorelli"/>
   <result pre="headaches and their comorbidities are focused on migraine. Comorbidities of" exact="migraine" post="may include neurological and psychiatric conditions, as mood disorders"/>
   <result pre="conditions, as mood disorders (depression, mania, anxiety, panic attacks), epilepsy," exact="essential tremor," post="stroke, and the presence of white matter abnormalities [2]."/>
   <result pre="matter abnormalities [2]. Particularly, a complex and bidirectional relation between" exact="migraine" post="and stroke has been described, including migraine as a"/>
   <result pre="[2]. Particularly, a complex and bidirectional relation between migraine and" exact="stroke" post="has been described, including migraine as a risk factor"/>
   <result pre="bidirectional relation between migraine and stroke has been described, including" exact="migraine" post="as a risk factor for cerebral ischemia, migraine caused"/>
   <result pre="described, including migraine as a risk factor for cerebral ischemia," exact="migraine" post="caused by cerebral ischemia, migraine mimicking cerebral ischemia, migraine"/>
   <result pre="risk factor for cerebral ischemia, migraine caused by cerebral ischemia," exact="migraine" post="mimicking cerebral ischemia, migraine and cerebral ischemia sharing a"/>
   <result pre="ischemia, migraine caused by cerebral ischemia, migraine mimicking cerebral ischemia," exact="migraine" post="and cerebral ischemia sharing a common cause, and migraine"/>
   <result pre="ischemia, migraine and cerebral ischemia sharing a common cause, and" exact="migraine" post="associated with subclinical vascular brain lesions [2]. A recent"/>
   <result pre="vascular brain lesions [2]. A recent meta-analysis pointed out that" exact="migraine" post="is associated with increased ischemic stroke risk [3], and"/>
   <result pre="meta-analysis pointed out that migraine is associated with increased ischemic" exact="stroke" post="risk [3], and according to a systematic review and"/>
   <result pre="a systematic review and meta-analysis [4] the risk of hemorrhagic" exact="stroke" post="in migraineurs is increased with respect to non-migraineurs. Besides,"/>
   <result pre="in migraineurs compared to non-migraineurs [6]. Concerning the association between" exact="migraine" post="and vascular risk factors (arterial hypertension, diabetes mellitus, dyslipidemia,"/>
   <result pre="the association between migraine and vascular risk factors (arterial hypertension," exact="diabetes mellitus," post="dyslipidemia, obesity, alcohol consumption, family history of cardiovascular disease),"/>
   <result pre="vascular risk factors in migraineurs, with the only exceptions of" exact="dyslipidemia" post="and cigarette smoking, while a systematic review and meta-analysis"/>
   <result pre="and cigarette smoking, while a systematic review and meta-analysis regarding" exact="migraine" post="and body mass index categories [8] found an increased"/>
   <result pre="mass index categories [8] found an increased risk of having" exact="migraine" post="in underweight subjects and in obese women as compared"/>
   <result pre="(TTH) is highly prevalent, and may be as debilitating as" exact="migraine" post="[9]. It is noteworthy that, according to a review,"/>
   <result pre="been described the comorbidity of TTH with psychiatric disorders and" exact="fibromyalgia" post="[10]. References 1. Headache Classification Committee of the International"/>
   <result pre="Jayakumar M, Dalal D, Nazarian S. Migraine headache and ischemic" exact="stroke" post="risk: an updated meta-analysis. Am J Med. 2010; 123:612-624."/>
   <result pre="5. Sacco S, Kurth T. Migraine and the risk for" exact="stroke" post="and cardiovascular disease. Curr Cardiol Rep. 2014;16:524. 6. Sacco"/>
   <result pre="S, Kurth T. Migraine and the risk for stroke and" exact="cardiovascular disease." post="Curr Cardiol Rep. 2014;16:524. 6. Sacco S, Ornello R,"/>
   <result pre="Conventional vascular risk factors: Their role in the association between" exact="migraine" post="and cardiovascular diseases. Cephalalgia. 2015; 35:146-164. 8. Ornello R,"/>
   <result pre="RB, Hajiyeva N, Jensen R. Prevalence of neck pain in" exact="migraine" post="and tension-type headache: a population study. Cephalalgia. 2015;35(3):211-9. doi:10.1177/0333102414535110."/>
   <result pre="of pain. Pain. 2013;154 Suppl 1:S44-53. doi:10.1016/j.pain.2013.07.021. S55 OnabotulinumtoxinA for" exact="migraine" post="treatment Andrea Negro 1,2 (andrea.negro@uniroma1.it) 1Regional Referral Headache Centre,"/>
   <result pre="Italy Since 2010 the armamentarium of preventative drugs for chronic" exact="migraine" post="(CM) has become wider with the introduction of OnabotulinumtoxinA"/>
   <result pre="was more effective than 155 U in reducing headache days," exact="migraine" post="days, pain medication intake days and Headache Impact Test"/>
   <result pre="patients close to developing MOH, patients with high frequency episodic" exact="migraine" post="(HFEM), and those already abusing of drugs require special"/>
   <result pre="approval shown that it is ineffective in patients with episodic" exact="migraine" post="[4]. Those studies had important limitations as range doses"/>
   <result pre="represented in the majority by patients with low frequency episodic" exact="migraine" post="(an average of 6-7 attacks per month). Interestingly post"/>
   <result pre="6-7 attacks per month). Interestingly post hoc analyses including episodic" exact="migraine" post="patients with a greater mean frequency of headache days"/>
   <result pre="of botulinum toxin type A for the prophylaxis of episodic" exact="migraine" post="headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials. Pharmacotherapy"/>
   <result pre="symptom (conjunctival injection, lacrimation, nasal congestion, rhinorrhea, facial sweating, miosis," exact="ptosis" post="and eyelid edema). Trigger factors can include alcohol, volatile"/>
   <result pre="high economic burden (1). The most common forms include chronic" exact="migraine" post="(CM) and medication overuse headache (MOH), which are frequently"/>
   <result pre="In the primary headache group the most common disorders were" exact="migraine" post="without aura (26.0%), chronic tension-type headache (23.0%) and chronic"/>
   <result pre="migraine without aura (26.0%), chronic tension-type headache (23.0%) and chronic" exact="migraine" post="(20.3%). As for patients with migraine and chronic tension-type"/>
   <result pre="headache (23.0%) and chronic migraine (20.3%). As for patients with" exact="migraine" post="and chronic tension-type headache, the onset of headache occurred"/>
   <result pre="occurred in most cases before 45, in particular in chronic" exact="migraine" post="(89.2%), while in migraine with aura patients the headache"/>
   <result pre="before 45, in particular in chronic migraine (89.2%), while in" exact="migraine" post="with aura patients the headache started over 45 in"/>
   <result pre="cervicogenic headache, frequently associated with tension-type headache. Among cranial neuropathies," exact="trigeminal neuralgia" post="was by far the most commonly diagnosed headache. Conclusions"/>
   <result pre="diagnosed headache. Conclusions In our population of elderly headache patients," exact="migraine" post="without aura, chronic tension-type headache and chronic migraine accounted"/>
   <result pre="headache patients, migraine without aura, chronic tension-type headache and chronic" exact="migraine" post="accounted for 61.3% of the total cases. There was"/>
   <result pre="headaches, a medication overuse was found more frequently in chronic" exact="migraine" post="(71.6%), than in chronic tension-type headache (33.3%). The choice"/>
   <result pre="Brussels, Belgium Correspondence: Fenne Vandervorst Treatment of patients with chronic" exact="migraine" post="remains challenging in daily clinical practice due to several"/>
   <result pre="studies with anti-CGRP monoclonal antibodies for the treatment of chronic" exact="migraine" post="were conducted and some are still ongoing. Here, we"/>
   <result pre="next to the efficacy results of established prophylactics for chronic" exact="migraine" post="the ‘change in monthly migraine days compared to placebo’"/>
   <result pre="of established prophylactics for chronic migraine the ‘change in monthly" exact="migraine" post="days compared to placebo’ of each agent will be"/>
   <result pre="patients treated with Topiramate. The overall mean reduction of monthly" exact="migraine" post="days (compared to placebo) for the anti-CGRP monoclonal antibodies"/>
   <result pre="results of anti-CGRP monoclonal antibodies in the treatment of chronic" exact="migraine" post="are promising and at least comparable with the effect"/>
   <result pre="effect on biomarkers of inflammation and clinical indexes in chronic" exact="migraine" post="with medication overuse: results at 12 months after withdrawal."/>
   <result pre="Neurol Sci 2017;38(Suppl 1):173-175. P3 Outcome of microvascular decompression in" exact="trigeminal neuralgia" post="is highly dependent on sex and degree of neurovascular"/>
   <result pre="(MVD) is first choice neurosurgical treatment option in medically refractory" exact="trigeminal neuralgia" post="patients with an MRI verified neurovascular contact (NVC). There"/>
   <result pre="characteristics and outcome data were systematically recorded prospectively from consecutive" exact="trigeminal neuralgia" post="patients, using standardized semi-structured interviews and schemes. A pre-surgical"/>
   <result pre="need to develop new consensus criteria that define refractory chronic" exact="migraine" post="(rCM) and refractory chronic cluster headache (rCCH). These new"/>
   <result pre="BL, Siegel SE, Markley HG, Lipton RB (2008) Defining refractory" exact="migraine" post="and refractory chronic migraine: proposed criteria. Headache 48:778–782 3."/>
   <result pre="ganglion block using Tx360 device. First results in refractory chronic" exact="migraine" post="in Spain Jose M Sanchez, Maria Rico, Elena Ameijide,"/>
   <result pre="Serrano D, Reed ML, Turkel CC, Lipton RB. (2012) Chronic" exact="migraine" post="prevalence, disability, and sociodemographic factors: results from the American"/>
   <result pre="Headache. 2015;55:529-42. P6 Efficacy of erenumab (AMG 334) in chronic" exact="migraine" post="patients with prior prophylactic treatment failure: Subgroup analysis of"/>
   <result pre="erenumab (70 mg and 140 mg) in patients with chronic" exact="migraine" post="(CM), with a safety profile comparable to placebo. We"/>
   <result pre="(N=667; aged ≥18–65 years) with CM (≥15 headache days/month; ≥8" exact="migraine" post="days) were randomised (2:2:3) to once-monthly subcutaneous erenumab 70"/>
   <result pre="140 mg or placebo. Efficacy endpoints were change in monthly" exact="migraine" post="days (MMD), achievement of ≥50% reduction in MMD, change"/>
   <result pre="cognitive performance in subjects affected by different headache types including:" exact="migraine" post="without aura (MWA), chronic migraine (CM), tension type headache"/>
   <result pre="by different headache types including: migraine without aura (MWA), chronic" exact="migraine" post="(CM), tension type headache (TTH) and chronic tension type"/>
   <result pre="R, Oliveira AG, Martins IP. Assessment of cognitive dysfunction during" exact="migraine" post="attacks: a systematic review. J Neurol. 2015 Mar;262(3):654-65. P9"/>
   <result pre="tolerability of onabotulinumtoxinA and topiramate for preventive treatment of chronic" exact="migraine" post="(CM) in adults. Materials and Methods The FORWARD Study"/>
   <result pre="topiramate patients; serious AEs by 1.4% and 4.2%, respectively. Only" exact="sinusitis" post="was reported in ≥5% of 220 patients receiving onabotulinumtoxinA"/>
   <result pre="0 Funding Allergan plc Trial Registration ClinicalTrials.gov, NCT02191579 P10 Chronic" exact="migraine" post="treatment with erenumab: Responder rates Hans-Christoph Diener 1, Jan"/>
   <result pre="(CGRP) receptor antibody being evaluated as preventive treatment for chronic" exact="migraine" post="(CM). When assessing efficacy of CM treatments by responder"/>
   <result pre="with CM (≥15 headache days/month over 3 months with ≥8" exact="migraine" post="days), patients (N=667) were randomised to erenumab (70 mg"/>
   <result pre="of patients with ≥50%, ≥75%, or 100% reduction in monthly" exact="migraine" post="days (MMD) from baseline to last 4 weeks of"/>
   <result pre="Systematic Cochrane review of botulinum toxins for the prevention of" exact="migraine" post="in adults Alexandra Sinclair 1, Clare P Herd 2,"/>
   <result pre="treatment or different dose for prevention of episodic or chronic" exact="migraine" post="in adults. Background Many migraine patients suffer prolonged and"/>
   <result pre="prevention of episodic or chronic migraine in adults. Background Many" exact="migraine" post="patients suffer prolonged and frequent migraine attacks despite optimised"/>
   <result pre="in adults. Background Many migraine patients suffer prolonged and frequent" exact="migraine" post="attacks despite optimised acute and prophylactic treatments. Botulinum toxin"/>
   <result pre="toxin type A has been licensed for use in chronic" exact="migraine" post="in some countries, based largely on two commercially sponsored"/>
   <result pre="toxin in chronic migraineurs showed a reduced frequency of -3.1" exact="migraine" post="days/month (95% confidence interval (CI) -4.73 to -1.41) compared"/>
   <result pre="with placebo. Addition of one trial (418 participants) in episodic" exact="migraine" post="lowered this pooled estimate of effect to -2.39 days/month"/>
   <result pre="toxin. Secondary efficacy measures were inconsistent. Data for number of" exact="migraine" post="attacks from six trials including chronic and episodic migraineurs"/>
   <result pre="showed no significant between group difference (P=0.30), but severity of" exact="migraine" post="(10 cm visual analogue scale), was improved by -3.30"/>
   <result pre="In chronic migraine, botulinum toxin type A reduces frequency of" exact="migraine" post="by three days/month, reduces migraine severity by 30% and"/>
   <result pre="type A reduces frequency of migraine by three days/month, reduces" exact="migraine" post="severity by 30% and has a favourable safety profile"/>
   <result pre="support or refute the efficacy of botulinum toxin in episodic" exact="migraine" post="was not identified. P12 Complete detoxification is the most"/>
   <result pre="primary outcome. Results: We included 72 MOH-patients with a primary" exact="migraine" post="and/or tension-type headache diagnosis. Fifty-nine completed detoxification, 58 (81%)"/>
   <result pre="million €. References 1) Steiner TJ, et al GBD 2015:" exact="migraine" post="is the third cause of disability in under 50s."/>
   <result pre="three month, as recommended in local guidelines. Monthly headache and" exact="migraine" post="days before and after OnabotA injections were recorded in"/>
   <result pre="first procedure was 41.8 ± 11.4 years (18-71). Latency between" exact="migraine" post="onset and inclusion was 24 ± 12.9 years (2-61),"/>
   <result pre="age at inclusion (40.5±11 vs 47±12, p:0.02) and latency between" exact="migraine" post="onset and OnabotA therapy (22.3±11.71 vs 20.4±15.4 years, p:0.021)"/>
   <result pre="factors associated with (a) occurrence and (b) severity of both" exact="migraine" post="vs non-migraine headaches. Because profiles of headache triggers /"/>
   <result pre="daily data on headache occurrence, severity (level of pain), ICHD-3beta" exact="migraine" post="symptom criteria, and exposure to 70 migraine risk factors."/>
   <result pre="of pain), ICHD-3beta migraine symptom criteria, and exposure to 70" exact="migraine" post="risk factors. Nearly 88% of participants were female, 41%"/>
   <result pre="severity, 50% of risk factors were statistically associated with both" exact="migraine" post="and non-migraine headaches whereas the other half were unique"/>
   <result pre="of migraines both overlap and differ from the factors of" exact="migraine" post="severity. Moreover, these two sets of associations differ between"/>
   <result pre="migraine severity. Moreover, these two sets of associations differ between" exact="migraine" post="and non-migraine headaches. These observations imply that etiological factors"/>
   <result pre="the pain (and thus impairment) that patients experience during a" exact="migraine" post="headache, a strategy that could be particularly important for"/>
   <result pre="This investigation compared two within-individual analytic approaches to understand daily" exact="migraine" post="occurrence and severity patterns in relation to a spectrum"/>
   <result pre="a spectrum of suspected risk factors . Cox regression modelled" exact="migraine" post="occurrence whereas headache severity was modelled using a form"/>
   <result pre="of which risk factors were identified as possible &quot;triggers&quot; of" exact="migraine" post="occurrence versus possibly contributing to severity of a migraine."/>
   <result pre="on headache occurrence and severity (level of pain), ICHD- 3beta" exact="migraine" post="criteria, and exposure to 70 migraine risk factors. Nearly"/>
   <result pre="of pain), ICHD- 3beta migraine criteria, and exposure to 70" exact="migraine" post="risk factors. Nearly 88% of participants were female, 41%"/>
   <result pre="use, and travel. Cox regression modelled the binomial occurrence of" exact="migraine" post="attacks per individual participant; hazard ratios quantified their strength"/>
   <result pre="association with suspected triggers. The continuous measure of severity of" exact="migraine" post="headache was modelled using mixed model trajectory analysis (MMTA),"/>
   <result pre="Numerous risk factors were associated with occurrence and severity of" exact="migraine" post="headaches. Cox regression detected potential triggers that were associated"/>
   <result pre="triggers that were associated only with occurrence (not severity) of" exact="migraine" post="attacks. Consistent with past evidence, the profile of risk"/>
   <result pre="which only consider sample-aggregate results do not generalize to many" exact="migraine" post="patients. Conclusions Cox regression and MMTA each provide unique"/>
   <result pre="each provide unique insights regarding within-person patterns and correlates of" exact="migraine" post="occurrence and severity, respectively. Cox regression’s detection of unique"/>
   <result pre="Cox regression’s detection of unique risk factors for occurrence of" exact="migraine" post="headaches suggests that different risk factors are associated with"/>
   <result pre="suggests that different risk factors are associated with occurrence of" exact="migraine" post="attacks versus severity of migraine pain. Moreover, treatment of"/>
   <result pre="are associated with occurrence of migraine attacks versus severity of" exact="migraine" post="pain. Moreover, treatment of migraine headaches could aim to"/>
   <result pre="migraine attacks versus severity of migraine pain. Moreover, treatment of" exact="migraine" post="headaches could aim to not only prevent occurrence of"/>
   <result pre="but also reduce pain level (and thus impairment) during a" exact="migraine" post="headache, which could be especially important for patients with"/>
   <result pre="cervicogenic headache and neck pain. The C-spine MRI revealed the" exact="osteoarthritis" post="at the facet joints of left C 3-4, 4-5"/>
   <result pre="one of the most frequent neurological diseases. Specific features of" exact="migraine" post="are moderate to severe pain associated with photophobia, phonophobia,"/>
   <result pre="months with at least 8 attacks having the features of" exact="migraine" post="headache) [2]. The pain intensity and the frequency may"/>
   <result pre="excessive intake of medication for acute or symptomatic treatment of" exact="migraine" post="(triptans, AINS drugs, analgesics) leading to Medication Overuse Headache"/>
   <result pre="drugs, analgesics) leading to Medication Overuse Headache (MOH) [1]. Chronic" exact="migraine" post="condition has a negative influence on many aspects of"/>
   <result pre="The American Migraine Prevalence and Prevention Study (AMPP) showed that" exact="migraine" post="has a role both on absenteeism and presenteeism (reduced"/>
   <result pre="Buse DC, Lipton RB. Employment and work impact of chronic" exact="migraine" post="and episodic migraine. Journal of occupational and environmental medicine."/>
   <result pre="A systematic literature review and meta-analysis of prevalence estimates in" exact="migraine" post="Akaterini Bilitou 1, Pamela Vo 2, Sandra Lopez-Leon 3,"/>
   <result pre="Los Angeles/USA Correspondence:Akaterini Bilitou (katerina.bilitou@novartis.com) Introduction Reported epidemiological estimates in" exact="migraine" post="vary widely across studies, mainly because of geographic variations,"/>
   <result pre="study aimed to identify and summarize population-based prevalence estimates of" exact="migraine" post="in the last decade, after the revised International Classification"/>
   <result pre="Methods A systematic literature review (SLR) of epidemiological studies in" exact="migraine" post="published from 2006 until October 2016 from MEDLINE and"/>
   <result pre="extraction (Fig. 1). In total 31 studies reported 1- year" exact="migraine" post="prevalence, while 7 studies reported lifetime prevalence. Significant variation"/>
   <result pre="publications did not report the diagnostic criteria used. The estimated" exact="migraine" post="prevalence by any definition was 14.2% (n=19, range 5.7%"/>
   <result pre="range 5.7% to 25.6%, 95% CI 13%-15.5%). The prevalence of" exact="migraine" post="was higher among studies based on ICHD-II or later"/>
   <result pre="later definitions (15.1%, 95% CI 13.6%-16.6%) than those using other" exact="migraine" post="definitions (11.4%, 95% CI 10.4%-12.5%). The prevalence of episodic"/>
   <result pre="(11.4%, 95% CI 10.4%-12.5%). The prevalence of episodic and chronic" exact="migraine" post="were 13.6% (95%CI 10.4%-16.7%) and 0.9% (95%CI 0.32%-1.39%), respectively."/>
   <result pre="summary and evidence synthesis of the available prevalence estimates in" exact="migraine" post="during the last decade. Fig. 1 (abstract P22.) PRISMA"/>
   <result pre="P22.) PRISMA diagram for the SLR of epidemiologic studies in" exact="migraine" post="Competing interest This study was funded by Novartis AG,"/>
   <result pre="Vo (pamela.vo@novartis.com) Background A key measure of successful therapy in" exact="migraine" post="is the ability to sustain efficacy. Numerous prophylactic medications"/>
   <result pre="novel CGRP receptor antagonist erenumab, relative to other approved prophylactic" exact="migraine" post="therapies. Materials and Methods Potential trials for inclusion were"/>
   <result pre="only) were retained as comparators as they are approved for" exact="migraine" post="prophylaxis and available in the majority of European countries."/>
   <result pre="magnitude of LHH consistently favored erenumab. Conclusions While all prophylactic" exact="migraine" post="treatments were more likely to help than harm (LHH"/>
   <result pre="profile of erenumab to patients across the entire spectrum of" exact="migraine" post="compared with other migraine prophylactic treatments available in Europe."/>
   <result pre="patients across the entire spectrum of migraine compared with other" exact="migraine" post="prophylactic treatments available in Europe. Table 1 (abstract P24)."/>
   <result pre="NNH and LHH for CM and EM prophylactic treatments Chronic" exact="migraine" post="(CM) Episodic migraine (EM) Erenumab 140 mg Topiramate 100"/>
   <result pre="for CM and EM prophylactic treatments Chronic migraine (CM) Episodic" exact="migraine" post="(EM) Erenumab 140 mg Topiramate 100 mg Onabotulinum-toxin A"/>
   <result pre="7-10th September 2017, Vancouver, Canada. P25 Healthcare resource utilization among" exact="migraine" post="sufferers in the EU5 from the patient perspective Pamela"/>
   <result pre="of this study was to understand the incremental burden of" exact="migraine" post="on healthcare resource utilization (HRU) in adults in Europe"/>
   <result pre="was performed. Adult (≥18 years old) respondents with a self-reported" exact="migraine" post="diagnosis who completed the migraine module and with migraine"/>
   <result pre="old) respondents with a self-reported migraine diagnosis who completed the" exact="migraine" post="module and with migraine experienced for ≥4 headache days"/>
   <result pre="self-reported migraine diagnosis who completed the migraine module and with" exact="migraine" post="experienced for ≥4 headache days in the past month"/>
   <result pre="matched by propensity scores using sociodemographic characteristics to respondents without" exact="migraine" post="(controls). HRU was evaluated via the number of healthcare"/>
   <result pre="to determine significant differences between groups. Results Among respondents with" exact="migraine" post="(≥4 headache days/month; n=218), 79.4% were female, the mean"/>
   <result pre="ED visits (0.46 vs. 0.21, p=0.011) were significantly higher for" exact="migraine" post="patients than those without migraine. The number of hospitalizations"/>
   <result pre="those without migraine. The number of hospitalizations was higher among" exact="migraine" post="patients (0.18 vs. 0.11, p=0.056) but marginally significant. Compared"/>
   <result pre="significant. Compared with matched controls, a significantly higher proportion of" exact="migraine" post="respondents had ≥1 visits to a general/family practitioner (77.1%"/>
   <result pre="of individuals with ≥1 ED visit was significantly higher for" exact="migraine" post="patients than those without migraine (20.6% vs. 12.4%, p=0.02)"/>
   <result pre="visit was significantly higher for migraine patients than those without" exact="migraine" post="(20.6% vs. 12.4%, p=0.02) whereas the proportion hospitalized (12.8%"/>
   <result pre="in terms of HCPs, neurologists, psychiatrists, and ED visits for" exact="migraine" post="patients compared with non-migraine controls. To help reduce the"/>
   <result pre="compared with non-migraine controls. To help reduce the burden of" exact="migraine" post="on the European healthcare system better treatment options for"/>
   <result pre="Headache Society, 7-10th September 2017, Vancouver, Canada. P26 Burden of" exact="migraine" post="in the 5EU from the patient perspective: A cross-sectional"/>
   <result pre="of this study was to characterize the incremental burden of" exact="migraine" post="on quality of life (QoL), productivity, and healthcare resource"/>
   <result pre="productivity, and healthcare resource utilization (HRU) by the frequency of" exact="migraine" post="in adults using European data from the National Health"/>
   <result pre="Spain, and UK (5EU). Adult NHWS respondents with a self-reported" exact="migraine" post="diagnosis who completed the migraine module were matched by"/>
   <result pre="NHWS respondents with a self-reported migraine diagnosis who completed the" exact="migraine" post="module were matched by propensity scores to those without"/>
   <result pre="were stratified by frequency of migraines (headache days/month): 4-7 episodic" exact="migraine" post="(EM), 8-14 EM, and chronic migraine (≥15; CM). Independent"/>
   <result pre="(headache days/month): 4-7 episodic migraine (EM), 8-14 EM, and chronic" exact="migraine" post="(≥15; CM). Independent sample t-tests were used to determine"/>
   <result pre="to determine significant differences between controls and the frequency of" exact="migraine" post="groups. Results Results from the propensity score matched analysis"/>
   <result pre="that there is a statistically significant incremental burden due to" exact="migraine" post="on QoL, HRU and work productivity amongst the migraineurs"/>
   <result pre="in comparison to matched controls. P27 Understanding the impact of" exact="migraine" post="on work productivity using self-reported migraine diary data using"/>
   <result pre="Understanding the impact of migraine on work productivity using self-reported" exact="migraine" post="diary data using the Migraine Buddy application in Europe"/>
   <result pre="purpose of the study was to evaluate the impact of" exact="migraine" post="on work productivity as perceived by individuals suffering from"/>
   <result pre="migraine on work productivity as perceived by individuals suffering from" exact="migraine" post="in the real world using a self-reported smartphone application"/>
   <result pre="during the study period June 2015-July 2016. Data from chronic" exact="migraine" post="(CM: ≥15 headache days/month, N=900), 4-7 episodic migraine (EM)"/>
   <result pre="from chronic migraine (CM: ≥15 headache days/month, N=900), 4-7 episodic" exact="migraine" post="(EM) (n=1500) and 8-14 EM (n=1500) individuals were randomly"/>
   <result pre="was performed. Results A total of 10,347, 11,301 and 6,504" exact="migraine" post="records were retrieved from CM, 8-14 EM and 4-7"/>
   <result pre="respectively corresponding to a total of 16,815, 14,398, and 7,693" exact="migraine" post="days. Among employed migraineurs (n=3,106) who declared ‘work’ either"/>
   <result pre="Among employed migraineurs (n=3,106) who declared ‘work’ either as their" exact="migraine" post="location or in ‘affected activities’ at least once, an"/>
   <result pre="symptoms impacting the work productivity of employed migraineurs irrespective of" exact="migraine" post="frequency. Table 1 (abstract P27). Symptoms reported by working"/>
   <result pre="Symptoms reported by working migraineurs at least once in absenteeism-related" exact="migraine" post="records. Number and proportion of users reporting each of"/>
   <result pre="with the user-level data analysis. CM chronic migraine, EM episodic" exact="migraine" post="Funding: This study was funded by Novartis AG, Switzerland."/>
   <result pre="24-27, 2017. P28 A descriptive analysis of the burden of" exact="migraine" post="based on self-reported migraine diary data using the Migraine"/>
   <result pre="descriptive analysis of the burden of migraine based on self-reported" exact="migraine" post="diary data using the Migraine Buddy application in Europe"/>
   <result pre="07936-1080, USA Correspondence: Aikaterini Bilitou (katerina.bilitou@novartis.com) Introduction Migraine is a" exact="neurological disorder" post="that can cause severe disabling pain. The purpose of"/>
   <result pre="purpose of the study was to describe the burden of" exact="migraine" post="on health-related quality of life (HRQOL) as perceived by"/>
   <result pre="quality of life (HRQOL) as perceived by individuals suffering from" exact="migraine" post="in the real world using a self-reported mobile application."/>
   <result pre="based on data completeness (fill rates &amp;gt;70%) and stratified by" exact="migraine" post="headache days/month: 4-7 episodic migraine (EM) (n=1500), 8-14EM (n=1500),"/>
   <result pre="rates &amp;gt;70%) and stratified by migraine headache days/month: 4-7 episodic" exact="migraine" post="(EM) (n=1500), 8-14EM (n=1500), and chronic migraine (≥15; CM)"/>
   <result pre="days/month: 4-7 episodic migraine (EM) (n=1500), 8-14EM (n=1500), and chronic" exact="migraine" post="(≥15; CM) (n=900). Descriptive analysis was performed. Results More"/>
   <result pre="Results More than 95% of 3900 self-reported migraineurs reported that" exact="migraine" post="negatively impacted their daily activities in at least one"/>
   <result pre="migraine negatively impacted their daily activities in at least one" exact="migraine" post="attack. Attacks were estimated to affect 50.5% (184.4 days/year),"/>
   <result pre="of 4-7EM sufferers respectively reported anxiety and/or depression symptoms during" exact="migraine" post="attacks. Social or home activities, productivity, or sleep were"/>
   <result pre="self-reported as the most common medicines used by migraineurs across" exact="migraine" post="records (n=28152). Conclusion This study highlights the high burden"/>
   <result pre="records (n=28152). Conclusion This study highlights the high burden of" exact="migraine" post="on HRQOL and overall well-being of individuals suffering from"/>
   <result pre="and overall well-being of individuals suffering from migraines irrespective of" exact="migraine" post="frequency. Funding: This study was funded by Novartis AG,"/>
   <result pre="by Novartis AG, Switzerland. Table 1 (abstract P28). Impact of" exact="migraine" post="on daily activities as reported by migraineurs in at"/>
   <result pre="as reported by migraineurs in at least one of their" exact="migraine" post="records. Number and proportion of users, by migraine frequency"/>
   <result pre="of their migraine records. Number and proportion of users, by" exact="migraine" post="frequency and overall, reporting type of activity affected is"/>
   <result pre="one activity affected in their records; pooled results across all" exact="migraine" post="records are presented for the most recent 28-day period"/>
   <result pre="are presented for the most recent 28-day period reported by" exact="migraine" post="patients during the study (June 2015-July 2016) CM Chronic"/>
   <result pre="P29 Evaluating clinically meaningful within-subject change in functioning associated with" exact="migraine" post="prevention using the Migraine Physical Function Impact Diary (MPFID)"/>
   <result pre="item. We report a clinically meaningful within-patient change (CMWPC) in" exact="migraine" post="impact scores and evaluation of CMWPCs in the STRIVE"/>
   <result pre="CMWPCs in the STRIVE study (NCT02456740) in subjects with episodic" exact="migraine" post="(EM). Methods CMWPCs for MPFID were developed using anchor-"/>
   <result pre="observational study of patients who recently initiated or changed their" exact="migraine" post="preventive regimen. Clinically relevant anchor variables (≥30% and ≥50%"/>
   <result pre="Clinically relevant anchor variables (≥30% and ≥50% reduction in monthly" exact="migraine" post="days [MMD] and ≥20% and ≥50% reduction in MPFID"/>
   <result pre="was related to clinically meaningful reductions in the impact of" exact="migraine" post="on physical functioning versus placebo, based on greater proportions"/>
   <result pre="This supports the utility of MPFID as a marker for" exact="migraine" post="clinical benefit and demonstrates the value of erenumab as"/>
   <result pre="‘avoidance’. Cephalalgia. 2010; 30:634-637. 3. Martin PR. Behavioral management of" exact="migraine" post="headache triggers: Learning to cope with triggers. Current Pain"/>
   <result pre="(MU) and sleep quality (SQ) to be significant predictors of" exact="migraine" post="frequency, F (2, 367) = 78.21, p &amp;lt; .001,"/>
   <result pre="Mediation analysis revealed MU had a significant direct effect on" exact="migraine" post="(Predictor coefficient = .417, p &amp;lt; .001), which was"/>
   <result pre="1. Sullivan DP, Martin PR: Sleep and headaches: Relationships between" exact="migraine" post="and non-migraine headaches and sleep duration, sleep quality, chronotype,"/>
   <result pre="3:33-36. P32 State and Trait anger and its expression in" exact="migraine" post="and cluster headache Marialuisa Rausa 1,3, Sabina Cevoli 2,"/>
   <result pre="experience of pain [1]. It is reported that individuals with" exact="migraine" post="and tension type headache are more likely to hold"/>
   <result pre="study evaluated anger in cluster headache (CH) and differences between" exact="migraine" post="(M) and CH patients. The objective is to evaluate"/>
   <result pre="CH during cluster period have higher state anger than chronic" exact="migraine" post="patients, while CH patients in headache free period did"/>
   <result pre="was effective and well-tolerated as a preventive treatment of episodic" exact="migraine" post="and chronic migraine in phase 2 and phase 3"/>
   <result pre="well-tolerated as a preventive treatment of episodic migraine and chronic" exact="migraine" post="in phase 2 and phase 3 trials. The present"/>
   <result pre="injection site reactions, abdominal pain, headache, upper respiratory tract infection," exact="constipation" post="and nasopharyngitis. Local tolerability of the SC fremanezumab injection"/>
   <result pre="consecutive headache free days for patients with high frequency episodic" exact="migraine" post="Robert Noble, Ernesto Aycardi, Marcelo Bigal, Mirna McDonald, Pippa"/>
   <result pre="to be effective and well-tolerated as a preventive treatment for" exact="migraine" post="in phase 2 and 3 studies. Previously reported data"/>
   <result pre="of consecutive headache free days in the high frequency episodic" exact="migraine" post="(HFEM) study. Methods This was a randomized 3-month phase"/>
   <result pre="patients who were 80% compliant in diary entry and had" exact="migraine" post="headaches at least 8 but less than 14 days"/>
   <result pre="endpoint of the HFEM study, change in the number of" exact="migraine" post="days at month 3 relative to baseline; herein we"/>
   <result pre="was effective and well-tolerated as a preventive treatment of episodic" exact="migraine" post="and chronic migraine in phase 2 and phase 3"/>
   <result pre="well-tolerated as a preventive treatment of episodic migraine and chronic" exact="migraine" post="in phase 2 and phase 3 trials. The present"/>
   <result pre="injection site reactions, abdominal pain, headache, upper respiratory tract infection," exact="constipation" post="and nasopharyngitis. Local tolerability of the SC fremanezumab injection"/>
   <result pre="site reactions across four placebo controlled trials of erenumab for" exact="migraine" post="prevention Julio Pascual 1, David Doležil 2, Brendan Davies"/>
   <result pre="inhibits the calcitonin gene-related peptide (CGRP) receptor under investigation for" exact="migraine" post="prevention. Erenumab is administered monthly by subcutaneous injection. Here"/>
   <result pre="and injection site reaction, injection site induration, and injection site" exact="urticaria" post="(one subject each, &amp;lt;0.1%). There were no ISR-AEs of"/>
   <result pre="in both dose levels P37 Ipoglycemia a trigger factor for" exact="migraine" post="chronification in migraineurs: diagnosis with glycemic load Claudio Mostardini"/>
   <result pre="Headache Center, Ospedale G.B. Grassi, ASL Roma 3 Chronification of" exact="migraine" post="has many known factors and many others under study,"/>
   <result pre="research. Careful observation of headache diaries shows sometimes that some" exact="migraine" post="attacks may be recurrent and methodically after 2-3h after"/>
   <result pre="fact that nutritional and metabolic factors can worse and chronify" exact="migraine" post="is well known, but body weight and body mass"/>
   <result pre="evaluate in these patients. We therefore identify patients with chronic" exact="migraine" post="diagnosis in which a diary with a methodically post-prandial"/>
   <result pre="next 3h. Based on the data obtained, we have diagnosed" exact="metabolic syndrome" post="in 6 patients, for the correlation between hyperinsulinaemia and"/>
   <result pre="between hyperinsulinaemia and high BMI, and insulin resistance related to" exact="polycystic ovary syndrome" post="in 22 patients with hypoglicemya and PCOS history. Both"/>
   <result pre="with hypoglicemya and PCOS history. Both group of patients with" exact="metabolic syndrome" post="and insulin resistance, were then subjected low charb diet."/>
   <result pre="reduction in body weight and the reduction/ansence of post meal" exact="migraine" post="attack with a mean reduction of more than 50%"/>
   <result pre="Sci. 2017 May;38(Suppl 1):111-115 P38 Peripheral Vagal Nerve Stimulation attenuates" exact="migraine" post="aura: a case report Grazia Sances 1, Vito Bitetto"/>
   <result pre="Background Noninvasive neuromodulation techniques promise efficacy in the treatment of" exact="migraine" post="[1]. Interestingly, Ayata et al. have recently reported that"/>
   <result pre="report The subject is a 38-year-old female patient with both" exact="migraine" post="with (MA) and without aura (MwA), diagnosed according to"/>
   <result pre="was 4-5 per year. Usual aura consisted in monolateral negative" exact="scotoma" post="with gradual onset, progressively evolving in homonymous hemianopia (either"/>
   <result pre="was 1-2 hours, being followed almost immediately by severe unilateral" exact="migraine" post="(either left or right) resistant to triptans. MRI and"/>
   <result pre="relevance. The patient was taking cinnarizine, 25 mg daily, for" exact="migraine" post="prevention. She was also on combined oral contraception since"/>
   <result pre="device during a clinical study for the acute treatment of" exact="migraine" post="attacks. She was trained to deliver one 120&quot; stimulation"/>
   <result pre="the study, the patient had the possibility to treat multiple" exact="migraine" post="attacks. During the 3 treated MA attacks, the patient"/>
   <result pre="in patients with encephalitis, but it's an uncommon finding in" exact="migraine" post="and status migrainosus with or without aura. We present"/>
   <result pre="of a 14-year old male patient, without known history of" exact="migraine" post="or neurologic issues, who came to our attention for"/>
   <result pre="long persistent (&amp;gt;72h) symptomatology characterized by headache, confusional state, dysarthria," exact="aphasia" post="and visual disturbances. Clinical evaluation, laboratory tests and instrumental"/>
   <result pre="María-José Sánchez, Emili Comes. Cortical laminar necrosis related to migrainous" exact="cerebral infarction." post="World Journal of Clinical Cases 2013 November 16; 1(8):"/>
   <result pre="Cephalalgia 2007; 27: 965-975 - Tietjen EG. Migraine and ischaemic" exact="heart disease" post="and stroke: potential mechanisms and treatment implications. Cephalalgia 2007;"/>
   <result pre="2007; 27: 981-987 - Bousser MG, Welch KM. Relation between" exact="migraine" post="and stroke. Lancet Neurol 2005; 4: 533-542 - Komiyama"/>
   <result pre="Obach, J Rumia. Cortical laminar necrosis related to prolonged focal" exact="status epilepticus." post="J Neurol Neurosurg Psychiatry 2006;77:104–106. - Alexander M. McKinney,"/>
   <result pre="has recently been described as a distinct event from persistent" exact="migraine" post="aura and classification criteria have been proposed [1]. The"/>
   <result pre="headache outpatient clinic with the diagnosis of cerebral ischaemia and" exact="migraine" post="aura. Nine months before he was admitted to the"/>
   <result pre="to the neurological ward with the diagnosis of possible protracted" exact="migraine" post="aura. He was discharged 6 days later, with the"/>
   <result pre="inferior cerebral artery. Few weeks after the discharge, a paroxysmal" exact="atrial fibrillation" post="was detected on 24-hours ECG and a treatment with"/>
   <result pre="referred no significant headache ever. After the occurrence of the" exact="stroke" post="the same symptoms became persistent and localised at his"/>
   <result pre="a diagnosis of persistent partial VN phenomenon secondary to occipital" exact="stroke" post="was done and Magnetic Resonance Imaging (MRI) prescribed together"/>
   <result pre="field affected by ischaemic occipital stroke, as typically happens in" exact="migraine" post="stroke. This fact may open a new scenario in"/>
   <result pre="be the result rather then the actual cause of the" exact="stroke" post="itself. Consent for publication: Written informed consent was obtained"/>
   <result pre="Goadsby P. ‘Visual snow’ – a disorder distinct from persistent" exact="migraine" post="aura. Brain 2017:137; 1419-1428 2. Olesen J. Headache classification"/>
   <result pre="2015;84 (Supplement) P1.291 P41 Treatment patterns and medication use among" exact="migraine" post="patients in Finland Timo Purmonen, Hanna Wahlman, Minna Korolainen"/>
   <result pre="population, it presents significant indirect costs to society, especially when" exact="migraine" post="attacks are frequent. The aim of this study was"/>
   <result pre="In addition, we aimed to define the current primary care" exact="migraine" post="treatment patterns in Finland. Materials and methods We conducted"/>
   <result pre="they had ≥ 1 prescription for an acute or prophylactic" exact="migraine" post="medication during 1.1.2012-30.9.2016. Patients of all ages were included"/>
   <result pre="to confirm the accuracy of migraine-related use. Results Altogether 61,077" exact="migraine" post="patients were identified. Among these patients 94% were receiving"/>
   <result pre="20% at least one prophylactic treatment (n=12,082). The prevalence of" exact="migraine" post="was 2,9% in the overall population, and 4,2%-5,3% among"/>
   <result pre="(n=3,832) of patients on prophylactic treatment. Conclusions Medical treatment of" exact="migraine" post="in Finnish primary care is based on combinations of"/>
   <result pre="impact of fremanezumab on headache-related disability in patients with chronic" exact="migraine" post="using the Headache Impact Test Paul K Winner 1,"/>
   <result pre="19355, USA Correspondence: Paul K Winner Background Patients with chronic" exact="migraine" post="(CM) experience substantially impaired daily functioning and reduced quality"/>
   <result pre="duration of headaches in patients with CM. The impact of" exact="migraine" post="cannot be fully understood only by assessment of headache"/>
   <result pre="approach, with baseline HIT-6 score and years since onset of" exact="migraine" post="used as covariates. P-values for treatment comparisons were based"/>
   <result pre="Aging Sciences, Second University of Naples, Naples, Italy Background Chronic" exact="migraine" post="is an underdiagnosed and undertreated condition. Tools to improve"/>
   <result pre="is an underdiagnosed and undertreated condition. Tools to improve chronic" exact="migraine" post="detection by health care professionals may promote proper referral"/>
   <result pre="Korean Hand Therapy (KHT) as a tool for diagnosis of" exact="migraine" post="and tension type headache. Subjects and methods This procedure"/>
   <result pre="presented as Gallbladder and Urinary Bladder Meridian of KHT. The" exact="migraine" post="belonged to Gallbladder and tension-type headache belonged to Urinary"/>
   <result pre="to various combined Gallbladder and Urinary Bladder Meridian. The pure" exact="migraine" post="groups are divided into three, pure tension type headache"/>
   <result pre="might improve the diagnostic accuracy of primary headache such as" exact="migraine" post="and tension-type headache. P45 Use of nutraceutical Clevia, in"/>
   <result pre="Roma 3 The use of nutraceuticals in the prevention of" exact="migraine" post="is increasingly spreading, both for a more holistic approach"/>
   <result pre="forms of migraine, that is pure menstrual migraine, consisting of" exact="migraine" post="attacks closely related to the menstrual cycle. We selected"/>
   <result pre="selected 7 women with age between 25 and 46 with" exact="migraine" post="attacks exclusively during the menstrual phase, with the possibility"/>
   <result pre="such as Clevia can be useful in the management of" exact="migraine" post="patients and in particular of once with pure menstrual"/>
   <result pre="Res Int. 2017;2017:3804356. 6. Thompson DF, Saluja HS. Prophylaxis of" exact="migraine" post="headaches with riboflavin: A systematic review. J Clin Pharm"/>
   <result pre="recent study, we found an association between ambivalent attachment style," exact="migraine" post="severity and psychological symptoms in children/adolescents. There is evidence"/>
   <result pre="role of maternal alexithymia and attachment style on their children’s" exact="migraine" post="severity (intensity and frequency) and psychological profile (anxiety, depression,"/>
   <result pre="Materials and methods. We enrolled 84 consecutive patients suffering from" exact="migraine" post="without aura (female: 45, male: 39; age range 8-18"/>
   <result pre="were divided into two groups according to frequency of the" exact="migraine" post="episodes (high or low). According to headache attack intensity,"/>
   <result pre="show any relationship between TAS-20 and ASQ questionnaires and children’s" exact="migraine" post="intensity and frequency. Conclusions. Maternal alexithymia and attachment style"/>
   <result pre="Maternal alexithymia and attachment style have no impact on children's" exact="migraine" post="frequency and intensity. However, our results suggest that, although"/>
   <result pre="maternal alexithymic traits don’t play a causative role on children’s" exact="migraine" post="severity, they show a relationship with patients’ attachment style"/>
   <result pre="style and psychological symptoms, which in turn may impact on" exact="migraine" post="severity. P47 Post accidental dural puncture headache: 3 years"/>
   <result pre="more frequently as first or almost second choice for treating" exact="migraine" post="attack in adolescents. [5] Methods: 20 children (age 5"/>
   <result pre="20 children (age 5 – 16 years) with ≥ three" exact="migraine" post="attacks per month are treated with Aurastop. The treatment"/>
   <result pre="at the end of the 3-month-treatment-phase for days with migraine," exact="migraine" post="pain, burden of disease (HIT-6) and subjective evaluation of"/>
   <result pre="testing the synergistic effect of AurastopR as symptomatic treatment of" exact="migraine" post="aura and related symptoms in childhood and prophylaxis of"/>
   <result pre="health-related quality of life and overall health status in chronic" exact="migraine" post="Richard B Lipton 1, Sanjay K Gandhi 2, Timothy"/>
   <result pre="Frazer, Pennsylvania, 19355, USA Correspondence: Richard B Lipton Background Chronic" exact="migraine" post="(CM) is characterized by frequent attacks, which adversely affect"/>
   <result pre="using a mixed-effects repeated-measures model (with years since onset of" exact="migraine" post="and baseline MSQoL domain score as covariates). EQ-5D-5L analyses"/>
   <result pre="an analysis of covariance approach (with years since onset of" exact="migraine" post="and baseline EQ-5D-5L score as covariates). Results The study"/>
   <result pre="Teva Pharmaceutical Industries. P50 Clinical presentation and diagnostic evaluation of" exact="idiopathic intracranial hypertension" post="in children and adolescents Barbara Battan, Laura Papetti, Irene"/>
   <result pre="chronic, incapaciting disorder, characterized by attacks of severe headache. Episodic" exact="migraine" post="can progress to chronic migraine, which is defined as"/>
   <result pre="Italy in 2013 for symptom relief in patients with chronic" exact="migraine" post="who have failed, or do not tolerate, oral prophylactic"/>
   <result pre="free days on headache-related disability and productivity among people with" exact="migraine" post="with ≥4 headache days in the past month Lulu"/>
   <result pre="a self-administered, sample of adults (≥18 years). Patients with a" exact="migraine" post="diagnosis and reported experiencing ≥4 headache days a month"/>
   <result pre="associated with a decrease in headache-related disability among those with" exact="migraine" post="who are at risk for disease progression. Migraine places"/>
   <result pre="intended to reduce the frequency, severity, and disability associated with" exact="migraine" post="attacks, and faster onset of action could increase benefit"/>
   <result pre="the 12-week randomization period in the monthly average number of" exact="migraine" post="days, and results at Weeks 1, 2, 3 and"/>
   <result pre="and quarterly subcutaneous injections. P54 Burden of illness among treated" exact="migraine" post="patients with ≥4 headache days in the past month"/>
   <result pre="To determine the burden of illness among patients treated for" exact="migraine" post="with ≥4 headache days in the past month. Methods:"/>
   <result pre="respondents meeting the above criteria were matched with people without" exact="migraine" post="on age, gender, comorbidities (Charlson Comorbidity Index), annual household"/>
   <result pre="in each cohort. A statistically significantly greater proportion of treated" exact="migraine" post="patients reported being diagnosed with depression than non-migraine controls"/>
   <result pre="long-term disability compared to non-migraine controls (13.7% vs. 5.6%,p&amp;lt;0.003). Treated" exact="migraine" post="patients reported greater losses in work productivity and increases"/>
   <result pre="the previous 6 months. Greater work productivity loss among treated" exact="migraine" post="patients resulted in higher estimated annual indirect costs ($14,770.57"/>
   <result pre="($14,770.57 vs. $5,764.93, p&amp;lt;0.001) compared to non-migraine patient controls. Treated" exact="migraine" post="patients utilized more healthcare services than non-migraine patients ($24,499.90"/>
   <result pre="($24,499.90 vs. $15,318.91, p=0.013). Conclusions: The overall burden associated with" exact="migraine" post="is substantial despite the availability of treatment options. Migraine"/>
   <result pre="to people without migraine. As a result, patients treated for" exact="migraine" post="incurred substantially greater direct and indirect costs compared to"/>
   <result pre="Korea Background: Nausea and vomiting are a frequent accompaniment of" exact="migraine" post="and prokinetic medications are frequently used in its management."/>
   <result pre="in its management. Most prokinetic medications that are used in" exact="migraine" post="are dopamine antagonists and therefore have the potential to"/>
   <result pre="and safety of motilitone, a recently developed prokinetic drug, in" exact="migraine" post="patients with gastrointestinal symptoms. Materials and Methods: From two"/>
   <result pre="Methods: From two outpatient neurological clinics, we prospectively included 100" exact="migraine" post="patients with nausea and vomiting and treated them with"/>
   <result pre="treatment. Conclusions: Our study shows that medication including motiltione for" exact="migraine" post="patients with gastrointestinal symptoms is effective and there is"/>
   <result pre="setting topiramate may have additional advantages in IIH due to" exact="migraine" post="prevention and weight loss effects, though the potential for"/>
   <result pre="of key stakeholders. P58 Alcohol as a risk factor for" exact="migraine" post="attacks: an exploration Pablo Prieto 1, Gabriel Boucher 1,"/>
   <result pre="Pablo Prieto Background Alcohol has long been suspected as a" exact="migraine" post="trigger commonly resulting in avoidance and possible impact on"/>
   <result pre="intake of alcohol and occurrence of migraine. Methods Individuals with" exact="migraine" post="registered to use Curelator Headache (1) through a physician"/>
   <result pre="entering details about headaches and tracking factors that may affect" exact="migraine" post="occurrence. Alcohol consumption was recorded daily as ‘YES/NO’ and"/>
   <result pre="with attacks was determined [2]. Results Of 531 individuals with" exact="migraine" post="(Table 1), alcohol was suspected as a risk factor"/>
   <result pre="did suspect alcohol as a trigger showed no association with" exact="migraine" post="in the majority in both groups; alcohol as a"/>
   <result pre="Donoghue S, Torres F, Mian A, Wöber C. Towards improved" exact="migraine" post="management: Determining potential trigger factors in individual patients. Cephalalgia."/>
   <result pre="patterns in a cohort of US and UK individuals with" exact="migraine" post="using a digital platform Pablo Prieto 1, Gabriel Boucher"/>
   <result pre="Correspondence: Pablo Prieto Background Overuse of acute medications may worsen" exact="migraine" post="and lead to medication overuse headache (MOH) [1]. Here"/>
   <result pre="of overuse (MO) in users of a digital platform for" exact="migraine" post="(Curelator Headache TM). The objective is to compare medication"/>
   <result pre="patterns in individuals’ with both chronic (CM) and episodic (EM)" exact="migraine" post="from the US and the UK. Methods Individuals with"/>
   <result pre="migraine from the US and the UK. Methods Individuals with" exact="migraine" post="registered to use Curelator Headache (1) through a physician"/>
   <result pre="headache epidemiology study. Cephalalgia. 2010 Mar;30(3):321-8 P60 Individual self-prediction of" exact="migraine" post="attacks: longitudinal analysis of cohort of migraine patients using"/>
   <result pre="Individual self-prediction of migraine attacks: longitudinal analysis of cohort of" exact="migraine" post="patients using a digital platform Pablo Prieto 1, Gabriel"/>
   <result pre="Prediction of attacks might be expected to be difficult as" exact="migraine" post="premonitory symptoms, and the potential risk factors that trigger"/>
   <result pre="to self-predict attacks on an individual level. Methods: Individuals with" exact="migraine" post="registered to use a digital platform (Curelator Headache™) via"/>
   <result pre="about lifestyle factors, possible headaches, and medications as well as" exact="migraine" post="expectation for the next 24 hours (low/moderate/high). Patients with"/>
   <result pre="at least 10 low and 10 high expectations instances of" exact="migraine" post="were included in the analysis. Prediction was considered successful"/>
   <result pre="the analysis. Prediction was considered successful when 24hr expectation of" exact="migraine" post="was high and an attack occurred on the next"/>
   <result pre="24 hr expectation was low and was followed by a" exact="migraine" post="free day. Results: Of 497 episodic migraineurs examined in"/>
   <result pre="predictors were defined as those with ≤25% accuracy predicting a" exact="migraine" post="or a migraine-free day. In this study we found"/>
   <result pre="this study we found 9% ( n= 13) were good" exact="migraine" post="predictors and 27% ( n=40) were defined as bad"/>
   <result pre="migraine predictors and 27% ( n=40) were defined as bad" exact="migraine" post="predictors (Table 1), and both groups stood up as"/>
   <result pre="statistical significance ( p&amp;lt;0.001). Only 5% ( n=7) were good" exact="migraine" post="and migraine-free predictors. Conclusion: A substantial proportion (64%, n="/>
   <result pre="A substantial proportion (64%, n= 93) of users predict their" exact="migraine" post="with only moderate accuracy (&amp;gt;25% but &amp;lt;75%). A small"/>
   <result pre="and just 5% ( n=7) were able to accurately predict" exact="migraine" post="or migraine-free days. A next step would be to"/>
   <result pre="of their attacks. Table 1 (abstract P60). Ability to predict" exact="migraine" post="or a migraine-free day Good predictors (≥75% accuracy) Rest"/>
   <result pre="Donoghue S, Torres F, Mian A, Wöber C. Towards improved" exact="migraine" post="management: Determining potential trigger factors in individual patients. Cephalalgia."/>
   <result pre="P61 Withdrawn P62 A rapidly progressive cerebral hematoma secondary to" exact="cerebral venous sinus thrombosis" post="(CVST) - A Case Report Andrea Giorgetti (andrea.giorgetti@asst-ovestmi.it), Elena"/>
   <result pre="up then 15% of strokes. When hemorrhage is secondary to" exact="cerebral venous sinus thrombosis" post="(CVST) the diagnosis is sometimes difficult to establish. The"/>
   <result pre="involving left-side limbs. Recent past medical history was significant for" exact="ulcerative colitis" post="with ongoing steroid and anti-inflammatory therapy. Neurological evaluation revealed"/>
   <result pre="left-side limbs. Recent past medical history was significant for ulcerative" exact="colitis" post="with ongoing steroid and anti-inflammatory therapy. Neurological evaluation revealed"/>
   <result pre="upper limb weakness without Brudzinski and Kernig’s signs and no" exact="papilledema" post="on clinical examination. A cerebral computed tomography (CT) scan"/>
   <result pre="to develop CVST could be inflammatory bowel disease such as" exact="ulcerative colitis" post="and treatment like corticosteroids. The use of MRI is"/>
   <result pre="develop CVST could be inflammatory bowel disease such as ulcerative" exact="colitis" post="and treatment like corticosteroids. The use of MRI is"/>
   <result pre="To present the rare case of a 9-year-old girl with" exact="idiopathic intracranial hypertension" post="(IIH) secondary to hypoparathyroidism (HPTH) and our work-up, including"/>
   <result pre="a 9-year-old girl with idiopathic intracranial hypertension (IIH) secondary to" exact="hypoparathyroidism" post="(HPTH) and our work-up, including physical examination, blood tests,"/>
   <result pre="P66 Individual identification of factors associated with reduced risk of" exact="migraine" post="attacks: potential ‘protectors’ Stephen Donoghue 1, Francesc Peris 1,"/>
   <result pre="a digital platform that collects daily data about an individual’s" exact="migraine" post="attacks and up to 80 factors (mood, stress, diet,"/>
   <result pre="with episodic (EM) or chronic (CM) migraine. Methods Individuals with" exact="migraine" post="registered to use Curelator Headache via 1) a physician"/>
   <result pre="entering details about headaches and tracking factors that may affect" exact="migraine" post="attack occurrence, after which factor-attack associations were analyzed for"/>
   <result pre="days). Our data support what many clinicians and people with" exact="migraine" post="believe intuitively, i.e that moderate activity, staying relaxed, and"/>
   <result pre="17 (20.2%) References 1. Peris F et al. Towards improved" exact="migraine" post="management: determining potential trigger factors in individual patients. Cephalalgia"/>
   <result pre="Identification of ‘protectors’ - factors associated with reduced risk of" exact="migraine" post="attacks: some surprising observations and interpretations. Headache 2016; 56"/>
   <result pre="factors associated with attacks in individuals with episodic and chronic" exact="migraine" post="Stephen Donoghue 1, Gabriel Boucher 1, Francesc Peris 1,"/>
   <result pre="we compare in individuals with episodic (EM) or chronic (CM)" exact="migraine" post="their suspected, self-reported triggers versus risk factors identified statistically."/>
   <result pre="using a digital platform (Curelator Headache™) [3]. Methods Individuals with" exact="migraine" post="registered to use Curelator Headache via 1) a physician"/>
   <result pre="entering details about headaches and tracking factors that may affect" exact="migraine" post="attack occurrence. After 90 days factors were analyzed for"/>
   <result pre="were confirmed statistically or shown to have no association with" exact="migraine" post="attack risk. The CM group overall suspected more triggers"/>
   <result pre="per person but fewer of these were statistically associated with" exact="migraine" post="attacks ( p = 0.008). In the EM group"/>
   <result pre="Rep 2014; 18: 455-461. 2. Martin PR. Behavioural management of" exact="migraine" post="headache triggers: learning to cope with triggers. Curr Pain"/>
   <result pre="(Supp 1): 35. 4. Peris F et al. Towards improved" exact="migraine" post="management: determining potential trigger factors in individual patients. Cephalagia"/>
   <result pre="Trubetskaya st., Moscow 119991, Russia Correspondence: Tatiana Ivanova (itamail@mail.ru) Vestibular" exact="migraine" post="(VM) is the most common cause of episodic vertigo"/>
   <result pre="well as in children. (1).The exact neural mechanisms of vestibular" exact="migraine" post="are still unknown. Vestibular migraine often begins several years"/>
   <result pre="exact neural mechanisms of vestibular migraine are still unknown. Vestibular" exact="migraine" post="often begins several years after typical migraine and has"/>
   <result pre="still unknown. Vestibular migraine often begins several years after typical" exact="migraine" post="and has a variable clinical presentation. The neurological and"/>
   <result pre="presentation. The neurological and otoneurological examination of patients with vestibular" exact="migraine" post="is mostly normal and diagnosis are usually based on"/>
   <result pre="are usually based on clinical history. Treatment trials of vestibular" exact="migraine" post="are scarce and therapeutic recommendations are based on migraine"/>
   <result pre="vestibular migraine are scarce and therapeutic recommendations are based on" exact="migraine" post="guidelines. Objective: The aim of study is to determine"/>
   <result pre="is to determine the mechanisms of vertigo and dizziness in" exact="migraine" post="patients Methods: This study recruited 152 patients with migraine"/>
   <result pre="in migraine patients Methods: This study recruited 152 patients with" exact="migraine" post="with aura and migraine without aura as defined by"/>
   <result pre="This study recruited 152 patients with migraine with aura and" exact="migraine" post="without aura as defined by ICHD-3. VM was diagnosed"/>
   <result pre="by (ICHD-3) Diagnostic criteria.(2) We analyzed the medical history of" exact="migraine" post="patients with vertigo and dizziness, all patients had a"/>
   <result pre="Results: The main study group consisted of patients with vestibular" exact="migraine" post="(VM) – 13,8% (n=21), and controls were patients with"/>
   <result pre="HADS , HIT-6 in main and control group . Chronic" exact="migraine" post="and migraine without aura was more prevalent in patients"/>
   <result pre="HIT-6 in main and control group . Chronic migraine and" exact="migraine" post="without aura was more prevalent in patients with VM"/>
   <result pre="then in dizziness patients (15,43±5,9 vs 12,28±6,9,p&amp;lt;0,05) Vertigo manifest during" exact="migraine" post="attack and dizziness was permanent. VM patients have more"/>
   <result pre="attack and dizziness was permanent. VM patients have more often" exact="motion sickness" post=", subjective hearing loss, although otoneurologist found no current"/>
   <result pre="dizziness. Conclusion: VM is mostly observed in patients with chronic" exact="migraine" post="and migraine without aura. Our study suggests the role"/>
   <result pre="VM is mostly observed in patients with chronic migraine and" exact="migraine" post="without aura. Our study suggests the role of central"/>
   <result pre="part, of central sensitization in the genesis of vertigo in" exact="migraine" post="patients are warranted to pave the way to potential"/>
   <result pre="P69 Characterising the effect of lumbar puncture on headache in" exact="idiopathic intracranial hypertension" post="Andreas Yiangou 1,2, James Mitchell 1,3, Keira Annie Markey"/>
   <result pre="Yiangou (a.yiangou@bham.ac.uk) Introduction Headache is the most prevalent symptom in" exact="idiopathic intracranial hypertension" post="(IIH). This study aimed to evaluate the temporal change"/>
   <result pre="materials concerning headache ( more than 100 articles dedicated to" exact="migraine" post="aura, several books, many slide libraries on different headache"/>
   <result pre="5 - hydroxy tryptophan and magnesium (Aurastop©) efficacy in episodic" exact="migraine" post="prevention. A multicentric observational study Federico Mainardi 1, Paola"/>
   <result pre="to test the effectiveness of Aurastop© in the prophylaxis of" exact="migraine" post="without aura. Materials and methods: Sixty consecutive patients (F:"/>
   <result pre="mean age: 37.5±17.1) presenting with an ICHD-3 beta diagnosis of" exact="migraine" post="without aura (MO) were enrolled in the survey and"/>
   <result pre="Martelletti P. Altered kynurenine pathway metabolites in serum of chronic" exact="migraine" post="patients. J Headache Pain. 2015; 17: 47. Geppetti P,"/>
   <result pre="safety of 6,25 mg t.i.d feverfew CO2-extract ( MIG-99) in" exact="migraine" post="prevention – a randomized, double blind, multicenter, placebo controlled"/>
   <result pre="Tanacethum Parthenium, 5-Hydroxytryptophan and Magnesium (Aurastop®) in the treatment of" exact="migraine" post="aura: an observational study F. Antonaci 1-3, V.Rebecchi 4,"/>
   <result pre="mg) and Magnesium (185 mg) (Aurastop®) is now available for" exact="migraine" post="patients. The three components may tackle the main mechanisms"/>
   <result pre="may tackle the main mechanisms involved in the pathophysiology of" exact="migraine" post="with aura: Cortical Spreading Depression, sensitization of trigeminal vascular"/>
   <result pre="33.00 yrs ), 117 F and 83 M, suffering from" exact="migraine" post="with aura referred to 8 Lombardia Headache Centers. Patients"/>
   <result pre="and 5-HTP, (Aurastop®), could be an effective symptomatic treatment for" exact="migraine" post="aura. Randomised controlled trials are still required to confirm"/>
   <result pre="Martelletti P. Altered kynurenine pathway metabolites in serum of chronic" exact="migraine" post="patients. Journal of Headache pain 2015 Dec; 17(1):47. -"/>
   <result pre="Correspondence: Richard B. Lipton (Richard.Lipton@einstein.yu.edu) Background Many comorbidities associated with" exact="migraine" post="have a higher relative frequency in chronic migraine (CM)"/>
   <result pre="associated with migraine have a higher relative frequency in chronic" exact="migraine" post="(CM) than episodic migraine (EM). The objective of this"/>
   <result pre="a higher relative frequency in chronic migraine (CM) than episodic" exact="migraine" post="(EM). The objective of this study was to replicate"/>
   <result pre="Cardiovascular, and Gastrointestinal comorbidity categories. Results Available CaMEO respondents with" exact="migraine" post="(16,763) were sent the Comorbidities/Endophenotype module and 12,810 (76.4%)"/>
   <result pre="frequencies &amp;gt;10% higher in CM than EM included allergies/hay fever/allergic" exact="rhinitis" post="(EM, 37.4%; CM, 51.0%), sinusitis/sinus infection (EM, 47.3%; CM,"/>
   <result pre="Future analyses will address naturally occurring subgroups (taxa) defined by" exact="migraine" post="phenotypes and comorbidities and assess the relationships of these"/>
   <result pre="Development of a claims-based algorithm for use in patients with" exact="migraine" post="to identify potentially undiagnosed chronic migraine patients Jelena M."/>
   <result pre="use in patients with migraine to identify potentially undiagnosed chronic" exact="migraine" post="patients Jelena M. Pavlovic 1, Justin S. Yu 2,"/>
   <result pre="demonstrated that 75-80% of persons meeting the criteria for chronic" exact="migraine" post="(CM) do not report having received an accurate diagnosis"/>
   <result pre="to develop a claims-based algorithm for use in patients with" exact="migraine" post="to identify potentially undiagnosed CM patients. Materials and Methods"/>
   <result pre="States medical group. Eligible patients had continuous enrollment and a" exact="migraine" post="diagnosis (ICD-9/10 code of 346.xx/G43.xxx) in the 12-months prior"/>
   <result pre="were identified. Patients with ≥15 claims for acute treatment of" exact="migraine" post="(including opioids) were nearly six times as likely to"/>
   <result pre="CM (OR=9.17, 95% CI=1.26-66.51); patients with claims for ≥2 unique" exact="migraine" post="preventive classes were more than 4 times as likely"/>
   <result pre="2. Bigal M, Serrano D, Reed M, Lipton R. Chronic" exact="migraine" post="in the population. Neurology. 2008;71:559-566. P75 The relationship between"/>
   <result pre="various conditions, many with a greater relative frequency in chronic" exact="migraine" post="(CM) versus episodic migraine (EM). The objective of this"/>
   <result pre="a greater relative frequency in chronic migraine (CM) versus episodic" exact="migraine" post="(EM). The objective of this study was to replicate"/>
   <result pre="Psychiatric, and Endocrine/Neurological comorbidity categories. Results Available CaMEO respondents with" exact="migraine" post="(16,763) were sent the Comorbidities/Endophenotype module and 12,810 (76.4%:"/>
   <result pre="Preto-SP, Brazil Correspondence: Lidiane L. Florencio Background: Greater prevalence of" exact="migraine" post="in women and the fact that women seek out"/>
   <result pre="more often than men have lead to a presumption that" exact="migraine" post="is a female disorder. Possibly, this influenced to the"/>
   <result pre="female disorder. Possibly, this influenced to the actual under-diagnosis of" exact="migraine" post="and to the suboptimal headache management in men. Therefore,"/>
   <result pre="encouraged to enhance the knowledge among possible sex differences in" exact="migraine" post="clinical profile and comorbidities. Accordingly, the aim of the"/>
   <result pre="present study is to explore the self-related pain features, regarding" exact="migraine" post="and neck pain, among patients with migraine of both"/>
   <result pre="pain features, regarding migraine and neck pain, among patients with" exact="migraine" post="of both sexes. Materials and Methods: Patients with migraine,"/>
   <result pre="or head trauma. A structured questionnaire was applied to verify" exact="migraine" post="and neck pain characteristics. The outcomes of interest were"/>
   <result pre="conditions and its intensity. Severity of the disabilities related to" exact="migraine" post="and to neck pain were respectively assessed by the"/>
   <result pre="of significance of 0.05. Results: Groups did not differ regarding" exact="migraine" post="features and migraine related disability (p&amp;gt;0.05) (Table 1). Neck"/>
   <result pre="0.05. Results: Groups did not differ regarding migraine features and" exact="migraine" post="related disability (p&amp;gt;0.05) (Table 1). Neck pain was reported"/>
   <result pre="allodynia measured by the 12 item Allodynia Symptom Checklist (ASC-12);" exact="migraine" post="related disability assessed using the Migraine Disability Assessment (MIDAS)"/>
   <result pre="Sample characteristics considering self-report pain features and disability related to" exact="migraine" post="and neck pain Men with migraine (n=12) Women with"/>
   <result pre="and disability related to migraine and neck pain Men with" exact="migraine" post="(n=12) Women with migraine (n=12) Age (years) 34.2 (8.1)"/>
   <result pre="migraine and neck pain Men with migraine (n=12) Women with" exact="migraine" post="(n=12) Age (years) 34.2 (8.1) 34.3 (10.6) ASC-12 4.2"/>
   <result pre="capacity of cervical extensors and flexors muscles in individuals with" exact="migraine" post="and controls: a pilot study Iuri V De Oliveira"/>
   <result pre="Brazil Correspondence: Iuri V De Oliveira (iurivaloti@gmail.com) BACKGROUND Patients with" exact="migraine" post="often present neck pain. Additionally, migraine has been associated"/>
   <result pre="(iurivaloti@gmail.com) BACKGROUND Patients with migraine often present neck pain. Additionally," exact="migraine" post="has been associated to an altered neck muscle performance"/>
   <result pre="evaluate the endurance capacity of neck muscles in individuals with" exact="migraine" post="and controls. MATERIALS AND METHODS Fifteen subjects with migraine"/>
   <result pre="with migraine and controls. MATERIALS AND METHODS Fifteen subjects with" exact="migraine" post="were screened from a headache tertiary clinic and fifteen"/>
   <result pre="difference (Table 2). CONCLUSIONS Preliminary findings suggest that subjects with" exact="migraine" post="present worse performance of neck flexor endurance characterized by"/>
   <result pre="2008; (31):348-354 P78 Light-induced discomfort changes semi-static posture control of" exact="migraine" post="patients Carina F Pinheiro 1, Renato Moraes 2, Lais"/>
   <result pre="14049-900, Brazil Correspondence: Carina F Pinheiro (carinafp@hotmail.com) Background: Patients with" exact="migraine" post="have showed balance deficits with increased postural oscillation during"/>
   <result pre="in comparison to control subjects [1,2]. Light sensibility is a" exact="migraine" post="feature that happens mostly during headache attacks, but also"/>
   <result pre="present in lower intensity during the interictal period, contributing to" exact="migraine" post="disability [3]. However, it has not been established if"/>
   <result pre="to different light intensities modifies the semi-static posture control of" exact="migraine" post="patients in the interictal period. Our purpose was to"/>
   <result pre="period. Our purpose was to investigate bipedal postural control of" exact="migraine" post="women under different light intensities. Materials and Methods: Fourteen"/>
   <result pre="under different light intensities. Materials and Methods: Fourteen woman with" exact="migraine" post="[4] were selected from a headache tertiary clinic and"/>
   <result pre="Pinheiro CF, Gonçalves MC, Florencio LL, et al. Influence of" exact="migraine" post="and of migraine aura on balance and mobility -"/>
   <result pre="MC, Florencio LL, et al. Influence of migraine and of" exact="migraine" post="aura on balance and mobility - A controlled study."/>
   <result pre="knowledge of the association of poor sleep quality with probable" exact="migraine" post="(PM) in general population. In the present study, we"/>
   <result pre="proportional to population distribution in all Korean territories. Diagnoses of" exact="migraine" post="and PM were based on criteria A to D"/>
   <result pre="and PM were based on criteria A to D for" exact="migraine" post="without aura (code 1.1) in the International Classification of"/>
   <result pre="was lower among individuals with PM compared to those with" exact="migraine" post="(35.4% vs. 47.6%, p = 0.011) but higher than"/>
   <result pre="the total Korean population; and cases identified as migraine, probable" exact="migraine" post="and poor sleep quality Survey participants N (%) Total"/>
   <result pre="subcomponents score of PSQI of individual with non-headache, PM and" exact="migraine" post="Non-headache individuals N = 1,422 (52.8%) PM N ="/>
   <result pre="to individuals with non-headache bSignificantly different compared to individuals with" exact="migraine" post="References 1. Rains JC, Poceta JS, Penzien DB. Sleep"/>
   <result pre="fear of falling and disability among women and men with" exact="migraine" post="Gabriela Ferreira Carvalho 1; Lidiane L Florêncio 1, Carina"/>
   <result pre="balance such as kinesiophobia, fear of falling, dizziness handicap and" exact="migraine" post="disability are important for proper management among migraineurs. Objective:"/>
   <result pre="the presence of kinesiophobia, fear of falling, dizziness handicap and" exact="migraine" post="disability and its correlation among women and men with"/>
   <result pre="among women and men with migraine. Methods: Patients diagnosed with" exact="migraine" post="according with the ICHD-III were screened from a tertiary"/>
   <result pre="groups: women (n=38) and men (n=17). Subjects with systemic diseases," exact="vestibular disease" post="history, presence of other headache diagnosis or any musculoskeletal"/>
   <result pre="did differ in the following outcomes: age (p=0.12), BMI (p=0.13)," exact="migraine" post="frequency, intensity and headache onset (p&amp;gt;0.09). However, the level"/>
   <result pre="MIDAS (r=41) (Fig. 1). Conclusion: Few studies address men with" exact="migraine" post="and these results highlight the absence of significant differences"/>
   <result pre="questionnaires scores among men and women with migraine. Men with" exact="migraine" post="(n=17) Women with migraine (n=38) Age (years) 33.8 (7.3)"/>
   <result pre="and women with migraine. Men with migraine (n=17) Women with" exact="migraine" post="(n=38) Age (years) 33.8 (7.3) 34.2 (11.3) BMI 27.2"/>
   <result pre="it may mimic various serious, including life-threatening, diseases, such as" exact="stroke" post="and meningoencephalitis, which is why vigorous tests should be"/>
   <result pre="girl. Each patient presented with headache, altered conscious state and" exact="papilledema" post="associated with different neurological symptoms such as dysarthria, hemiplegia,"/>
   <result pre="meningeal irritation. They received Ceftriaxone, Aciclovir, and Dexamethasone for possible" exact="encephalitis" post="and/ or autoimmune disorders. Clinical manifestations were compatible with"/>
   <result pre="Correspondence: Tetiana Maikova (maykova@headache.com.ua) Background. The treatment and prevention of" exact="migraine" post="attacks has for long yielded insufficient results. A usual"/>
   <result pre="with the goal of increasing efficacy of the prevention of" exact="migraine" post="attacks using quetiapine as an additional (supplementary) medicine in"/>
   <result pre="high efficacy of quetiapine in resistant and chronic forms of" exact="migraine" post="(with and without aura). Referenses 1. Martelletti P., Katsarava"/>
   <result pre="6.8.2017). P84 Implementation of improved working practices in a chronic" exact="migraine" post="Botox® clinic has increased treatment capacity by up to"/>
   <result pre="NHS Trust, UK; 2ProcEx Solutions Ltd., Wales, UK Objective: Chronic" exact="migraine" post="is defined as headaches occurring on 15 or more"/>
   <result pre="more days each month, at least half of which have" exact="migraine" post="symptoms. Botox® (onabotulinum toxin A) is used extensively in"/>
   <result pre="are able to treat. P85 Zonisamide for headache prophylaxis in" exact="dementia" post="Yunju Choi 1, Seung H. Lee 2, Myeong K."/>
   <result pre="activity. Furthermore, recent studies have demonstrated additional therapeutic use in" exact="migraine" post="prophylaxis [1]. Zonisamide, a sulfonamide analog, is a drug"/>
   <result pre="Materials and Methods We enrolled 10 Alzheimer’s disease patients with" exact="migraine" post="headache, retrospectively. For headache, we investigated headache frequency with"/>
   <result pre="and visual analog scales (VAS). Mini-mental status examination (MMSE), clinical" exact="dementia" post="rating (CDR) was checked on visit and 3 months"/>
   <result pre="Rigshospitalet-Glostrup, Copenhagen, Denmark Correspondence: Vlasta Vukovic Cvetkovic (vlasta.vukovic@uclmail.net) Background: Retinal" exact="migraine" post="is a rare form of migraine. According to the"/>
   <result pre="has additional &quot;autonomic aura symptoms&quot;. A 69-year old man, with" exact="migraine" post="without aura and separately sudden attacks of complete visual"/>
   <result pre="aspirin had no effect on migraine. Conclusion: Although rare, retinal" exact="migraine" post="should not be misdiagnosed as amaurosis fugax, papilledema or"/>
   <result pre="rare, retinal migraine should not be misdiagnosed as amaurosis fugax," exact="papilledema" post="or optic disc disease, transient visual obscuration or Uhthoffs"/>
   <result pre="grey matter volume and functional connectivity in cluster headache versus" exact="migraine" post="Silvia Benemei 1, Antonio Giorgio 2, Jian Zhang 2,"/>
   <result pre="functional abnormalities in the brain of cluster headache (CH) and" exact="migraine" post="(M) patients. However, no between-group comparison of MRI measure"/>
   <result pre="key cognitive networks, with a possible maladaptive role. P89 Intercepting" exact="migraine" post="in its path towards chronicity Angela Koverech, Paolo Martelletti"/>
   <result pre="choice to treat with CGRP(r) mAbs the very low frequency" exact="migraine" post="subpopulation (4-6 migraine days per month). Unfortunately, the tight"/>
   <result pre="with CGRP(r) mAbs the very low frequency migraine subpopulation (4-6" exact="migraine" post="days per month). Unfortunately, the tight application of existing"/>
   <result pre="However, only 2% of the world's population suffers from chronic" exact="migraine" post="(with or without pharmacological abuse of acute drugs –"/>
   <result pre="burden, and who fluctuate in a pre-chronic phase with high-frequency" exact="migraine" post="crisis but who are not yet chronic. Only in"/>
   <result pre="this way will we reduce the huge number of chronic" exact="migraine" post="patients, who stray towards medication overuse headache (MOH) and"/>
   <result pre="priority, because we know that the rehabilitation procedures for chronic" exact="migraine" post="complicated by MOH present with relapse in 50% of"/>
   <result pre="migraine, as clinically defined by the European Headache Federation. Refractory" exact="migraine" post="is very hard to treat and has been the"/>
   <result pre="Reference Martelletti P. The application of CGRP(r) monoclonal antibodies in" exact="migraine" post="spectrum: needs and priorities. Biodrugs 2017 in press. P90"/>
   <result pre="Induction of migraine-like photophobia by PACAP-38: A potential target in" exact="migraine" post="treatment Adisa Kuburas 1, Bianca N. Mason 2, Maria-Christina"/>
   <result pre="Washington 98011 Correspondence: Andrew F. Russo Migraine is a disabling" exact="neurological disorder" post="and a significant public health problem. The pathophysiology of"/>
   <result pre="disorder and a significant public health problem. The pathophysiology of" exact="migraine" post="is not well understood, but studies have shown that"/>
   <result pre="Future work will attempt to understand more about PACAP38 in" exact="migraine" post="and to explore PACAP as a potential novel target"/>
   <result pre="and to explore PACAP as a potential novel target in" exact="migraine" post="therapy. P91 Burden and impact of migraine: a caregiver’s"/>
   <result pre="Migraine has far-reaching impacts on the family of individuals with" exact="migraine" post="but limited evidence is available to describe this reality."/>
   <result pre="of migraine, this study sought to describe the impact of" exact="migraine" post="from the caregiver’s perspective. Materials and Methods This cross-sectional"/>
   <result pre="Caregivers aged ≥25 years who were caring for an adult" exact="migraine" post="patient in their household were recruited to participate in"/>
   <result pre="where they were asked to respond to specific questions on" exact="migraine" post="and provide their perspectives on statements and other participants’"/>
   <result pre="reported that they were highly involved in the management of" exact="migraine" post="and that they spent an average of 15 hours/month"/>
   <result pre="being torn between commitment, self-sacrifice and resentment. All agreed that" exact="migraine" post="patients were thankful for their help and assistance. Conclusions"/>
   <result pre="a major impact on the lives of close relatives supporting" exact="migraine" post="patients. This study highlights how the burden of migraine"/>
   <result pre="supporting migraine patients. This study highlights how the burden of" exact="migraine" post="extends beyond the patients, with substantial functional and emotional"/>
   <result pre="experience and unmet needs in the current treatments available to" exact="migraine" post="patients. Funding This study was funded by Novartis AG,"/>
   <result pre="P93 Real-world patient perspective on the burden and impact of" exact="migraine" post="Elena Ruiz de la Torre 1, Paolo Martelletti 2,3,"/>
   <result pre="was undertaken to understand the full burden and impact of" exact="migraine" post="in everyday life from the patient’s point of view."/>
   <result pre="period of 4 consecutive days. Adults with chronic and episodic" exact="migraine" post="aged between 25 and 60 years old were recruited"/>
   <result pre="where they were asked to respond to specific questions on" exact="migraine" post="and to provide their perspective on statements and other"/>
   <result pre="by country and qualitatively analyzed. Results A total of 60" exact="migraine" post="patients participated in this pilot phase of a large"/>
   <result pre="1 st symptoms. Table 1 summarizes the 3 most common" exact="migraine" post="attack triggers, symptoms, and coping mechanisms reported by patients."/>
   <result pre="and frustration were most frequently reported as emotional consequences of" exact="migraine" post="in private/social life (92% and 72%) and work (97%"/>
   <result pre="88%). 87% of patients (n=52) had seen a physician for" exact="migraine" post="management but many (85%, n=51) did not consult regularly,"/>
   <result pre="Conclusions This study highlights the substantial functional and emotional burden" exact="migraine" post="exerts on individuals, as well as the significant unmet"/>
   <result pre="of Onabotulinumtoxin A and Physical Therapy combined treatment in chronic" exact="migraine" post="Antonio Granato 1; Antonella Monticco 2; Manuela Deodato 2;"/>
   <result pre="toxin A (BoNT-A) has proven to be effective in chronic" exact="migraine" post="(CM) prophylaxis. Currently no clinical studies about BoNT-A plus"/>
   <result pre="antimigraine action of butterbur. P96 Use of acute headache and" exact="migraine" post="medications in patients with episodic migrainein the STRIVE Phase"/>
   <result pre="episodic migrainein the STRIVE Phase 3 trial of erenumab for" exact="migraine" post="prevention Uwe Reuter 1, Jo Bonner 2, Gregor Broessner"/>
   <result pre="the STRIVE placebo-controlled Phase 3 trial in patients with episodic" exact="migraine" post="(EM; clinicaltrials.gov NCT02456740), erenumab 70 mg and 140 mg"/>
   <result pre="the primary endpoint of significantly reducing the number of monthly" exact="migraine" post="days versus placebo. Erenumab also achieved the secondary endpoint"/>
   <result pre="treatment, visit, treatment by visit interaction, stratification factors (region and" exact="migraine" post="prophylaxis medication status), and baseline value. Nominal p-values were"/>
   <result pre="Neurology, Evangelical Hospital Unna, Unna, Germany Background The evolution of" exact="migraine" post="(M) after the age of 50 has been insufficiently"/>
   <result pre="Results Compared to subjects with LLMAs in patients with CMR" exact="migraine" post="terminated a decade later (39±9 vs 49.7, p&amp;lt;0.05), in"/>
   <result pre="of both pain and aura. P98 Reducing the impact of" exact="migraine" post="on functioning: Results from the STRIVE trial, a phase"/>
   <result pre="randomised, double-blind, placebo-controlled study of erenumab in patients with episodic" exact="migraine" post="Dawn C Buse 1, Richard B Lipton 1, Daniel"/>
   <result pre="newly developed 31-item patient-reported outcome instrument assessing the impact of" exact="migraine" post="on functional outcomes over 7 days. The MFIQ includes"/>
   <result pre="erenumab, which is being developed as a preventive treatment for" exact="migraine" post="in adults, on functional outcomes using the MFIQ. Methods"/>
   <result pre="Methods In STRIVE, a total of 955 patients with episodic" exact="migraine" post="aged 18–65 years were randomised 1:1:1 to receive monthly"/>
   <result pre="greater reductions in the MFIQ scores, reflecting less impact of" exact="migraine" post="on their physical functioning, usual activity, and social and"/>
   <result pre="a phase 3, randomised, double-blind study of erenumab for episodic" exact="migraine" post="Asha Hareendran 1, Dawn C Buse 2, Richard B"/>
   <result pre="13-item patient-reported outcome (PRO) measure that assesses the impact of" exact="migraine" post="on Everyday Activities (EA) and Physical Impairment (PI) domains."/>
   <result pre="report the effect of erenumab, a preventive treatment for episodic" exact="migraine" post="(EM) in adults, on monthly days with impairment as"/>
   <result pre="standard efficacy measures. P100 Patient-reported outcomes in patients with chronic" exact="migraine" post="receiving placebo or erenumab (AMG 334) in a phase"/>
   <result pre="gene-related peptide (CGRP) receptor monoclonal antibody in clinical development for" exact="migraine" post="prevention. The objective of this study was to evaluate"/>
   <result pre="in a phase 2 clinical trial of erenumab for chronic" exact="migraine" post="(CM) (NCT02066415). Methods 667 adults with CM were randomised"/>
   <result pre="the calcitonin-gene related peptide (CGRP) ligand, a validated target for" exact="migraine" post="preventive therapy. Fremanezumab was found to be effective and"/>
   <result pre="to be effective and well-tolerated as a preventive treatment for" exact="migraine" post="in a high frequency episodic migraine (HFEM) phase 2"/>
   <result pre="a preventive treatment for migraine in a high frequency episodic" exact="migraine" post="(HFEM) phase 2 study. Study participants included patients classified"/>
   <result pre="2 study. Study participants included patients classified as having episodic" exact="migraine" post="(EM) per the ICHD III beta. Herein, we determined"/>
   <result pre="as having high frequency EM (HFEM) to moderate frequency episodic" exact="migraine" post="(MFEM) and low frequency episodic migraine (LFEM) during the"/>
   <result pre="to moderate frequency episodic migraine (MFEM) and low frequency episodic" exact="migraine" post="(LFEM) during the HFEM study. Methods Patients were randomized"/>
   <result pre="headache days (days of headaches lasting &amp;gt; 4 hours) and" exact="migraine" post="days (days with headaches classified as migraine, probable migraine"/>
   <result pre="and migraine days (days with headaches classified as migraine, probable" exact="migraine" post="or treated with triptan or ergot compounds) per month"/>
   <result pre="ergot compounds) per month were categorized into four types of" exact="migraine" post="classification: Chronic migraine (CM) as having ≥15 headache days"/>
   <result pre="month were categorized into four types of migraine classification: Chronic" exact="migraine" post="(CM) as having ≥15 headache days with 8 migraine"/>
   <result pre="Chronic migraine (CM) as having ≥15 headache days with 8" exact="migraine" post="days; HFEM 8 to 14 headache days with 8"/>
   <result pre="migraine days; HFEM 8 to 14 headache days with 8" exact="migraine" post="days; MFEM 4 to 7 headache days and 4-7"/>
   <result pre="migraine days; MFEM 4 to 7 headache days and 4-7" exact="migraine" post="days; LFEM 0 to 3 headache days and 0-3"/>
   <result pre="migraine days; LFEM 0 to 3 headache days and 0-3" exact="migraine" post="days. Analyses on the shifts for migraine classification from"/>
   <result pre="days and 0-3 migraine days. Analyses on the shifts for" exact="migraine" post="classification from baseline to month 3 were performed to"/>
   <result pre="HFEM. Results Overall, the fremanezumab arms showed significant improvement in" exact="migraine" post="classification compared to the placebo arm at month 3"/>
   <result pre="Table 1A). Chi square analyses indicated that the shift of" exact="migraine" post="classification during the study was not independent of treatment,"/>
   <result pre="patients on fremanezumab 225mg and 675mg showed a shift in" exact="migraine" post="category from HFEM to LFEM in 3 months compared"/>
   <result pre="study suggests that fremanezumab may potentially prevent the progression of" exact="migraine" post="to more chronic forms. Table 1 (abstract P101). Patient"/>
   <result pre="more chronic forms. Table 1 (abstract P101). Patient classification in" exact="migraine" post="categories during the HFEM study Table 1A. Overall shift"/>
   <result pre="categories during the HFEM study Table 1A. Overall shift in" exact="migraine" post="category a Placebo n = 104 Fremanezumab 225 mg"/>
   <result pre="(23%)  LFEM 20 (20%) 40 (45%) 47 (52%) aShift in" exact="migraine" post="category, worsen = HFEM to CM, stable = HFEM"/>
   <result pre="calcitonin gene-related peptide (CGRP) receptor and is under investigation for" exact="migraine" post="prevention. As the ligand CGRP is a vasodilator, inhibition"/>
   <result pre="mg had no relevant effect on BP in subjects with" exact="migraine" post="over 12 weeks versus placebo, and was not associated"/>
   <result pre="CGRP on the vasculature in a preclinical mouse model of" exact="migraine" post="Bianca Mason The neuropeptide calcitonin gene-related peptide (CGRP) is"/>
   <result pre="gene-related peptide (CGRP) is a key player in migraine. While" exact="migraine" post="can be induced by peripherally administered CGRP (intravenous) and"/>
   <result pre="levels of light and is experienced by approximately 90% of" exact="migraine" post="patients. We have previously shown that peripheral (intraperitoneal, IP)"/>
   <result pre="seen following central (intracerebroventricular, ICV) injection. Importantly, two clinically effective" exact="migraine" post="drugs, the 5-HT 1B/D agonist sumatriptan and a CGRP-blocking"/>
   <result pre="vagal nerve stimulation (nVNS) as a novel treatment approach for" exact="migraine" post="and cluster-headache patients [2-4]. However, nVNS seems to be"/>
   <result pre="RB, Grosberg B, Cady R, Dorlas S, et al. Chronic" exact="migraine" post="headache prevention with noninvasive vagus nerve stimulation The EVENT"/>
   <result pre="Neurobiol Dis. 2017;102:96-104. P106 Obesity is more prevalent in chronic" exact="migraine" post="than in episodic migraine Brad D Torphy 1, Nicole"/>
   <result pre="Obesity is more prevalent in chronic migraine than in episodic" exact="migraine" post="Brad D Torphy 1, Nicole Montes Buckley 2 1Diamond"/>
   <result pre="IL, 60602, USA Correspondence: Brad D Torphy BACKGROUND: Migraine and" exact="obesity" post="are two major public health problems in the USA"/>
   <result pre="around the world. In the USA 12% of individuals have" exact="migraine" post="and 37% of adults are obese 1. Evidence suggests"/>
   <result pre="adults are obese 1. Evidence suggests a possible link between" exact="migraine" post="and obesity, but research has been mixed. There are"/>
   <result pre="STUDY: The purpose of our study was to determine if" exact="obesity" post="is more prevalent in chronic migraine than in episodic"/>
   <result pre="was to determine if obesity is more prevalent in chronic" exact="migraine" post="than in episodic migraine. RESULTS: We analyzed the body"/>
   <result pre="a period of one year. The mean BMI of chronic" exact="migraine" post="(CM) patients was 28.8% versus 25.3% for episodic migraine"/>
   <result pre="chronic migraine (CM) patients was 28.8% versus 25.3% for episodic" exact="migraine" post="(EM) patients, both of which are defined as &quot;overweight.&quot;"/>
   <result pre="B Lipton Background As the seventh most disabling condition globally," exact="migraine" post="adversely affects the health-related quality of life (HRQoL) of"/>
   <result pre="the frequency of headaches and migraines in patients with episodic" exact="migraine" post="(EM). For a comprehensive understanding of the impact of"/>
   <result pre="confirmed EM (headache on 6–14 days and ≥4 days fulfilling" exact="migraine" post="criteria per month) were randomized 1:1:1 to receive subcutaneous"/>
   <result pre="mixed-effects model for repeated-measures, both with years since onset of" exact="migraine" post="and baseline MSQoL domain score as covariates. Results A"/>
   <result pre="Frazer, Pennsylvania, 19355, USA Correspondence: Paul K Winner Background Episodic" exact="migraine" post="(EM), characterized by attacks on ≤15 days per month,"/>
   <result pre="days per month, is a risk for transition to chronic" exact="migraine" post="and adversely affects daily functioning. In clinical trials, fremanezumab,"/>
   <result pre="frequency of headaches in patients with EM. The impact of" exact="migraine" post="can be more comprehensively understood through disability assessment. In"/>
   <result pre="analysis of covariance, with baseline disability score and years since" exact="migraine" post="onset as covariates. P-values for treatment comparisons were based"/>
   <result pre="on work productivity and activity impairment in patients with chronic" exact="migraine" post="Richard B Lipton 1; Sanjay K Gandhi 2; Timothy"/>
   <result pre="cost burden. In the EU, the total annual cost of" exact="migraine" post="among persons aged 18–65 years was estimated at €111"/>
   <result pre="with 93% of these costs attributed to indirect costs. Chronic" exact="migraine" post="(CM) creates an especially high burden. In clinical trials,"/>
   <result pre="study, eligible patients with CM (≥15 headache days and ≥8" exact="migraine" post="days per month), were randomized 1:1:1 to receive subcutaneous"/>
   <result pre="for publication. P111 Headache secondary to subarachnoid haemorrhage due to" exact="arteriovenous malformation" post="can be presented as migraine in its clinical phenotype"/>
   <result pre="subarachnoid haemorrhage due to arteriovenous malformation can be presented as" exact="migraine" post="in its clinical phenotype Srdjan Ljubisavljevic (srljub@gmail.com) Faculty of"/>
   <result pre="have been analyzed in reference to headache attributes according to" exact="arteriovenous malformation" post="(AVM) persistence. Results: The persistence of AVM was not"/>
   <result pre="AVM were significantly associated with previous history of headache with" exact="migraine" post="features, OR 1.74 [95%CI: 1.11-3.03], p=0.046. Also, the findings"/>
   <result pre="existence could be associated with previous history of headache with" exact="migraine" post="features. These facts could provide physicians to good evidence"/>
   <result pre="consider SAH in patients with previous history of headache with" exact="migraine" post="features newly presented with worst headache of their life,"/>
   <result pre="angiography in all SAH suggestive headaches which are accompanied with" exact="migraine" post="symptoms. Keywords: Migraine, Subarachnoid Hemorrhage P112 Decreased medial prefrontal"/>
   <result pre="Migraine, Subarachnoid Hemorrhage P112 Decreased medial prefrontal cortex volume in" exact="migraine" post="without aura: a multispectral MRI study Sourena Soheili-Nezhad 1,"/>
   <result pre="two-fold of its prevalence in the male population [1]. Although" exact="migraine" post="is classically considered an episodic disorder with no long-term"/>
   <result pre="in brain function. Similar to various neurodevelopmental and neurodegenerative disorders," exact="migraine" post="is predisposed by a strong genetic component (&amp;gt;50% [2])."/>
   <result pre="by a strong genetic component (&amp;gt;50% [2]). Quantitative neuroimaging of" exact="migraine" post="has recently revealed disrupted functional brain networks and abnormal"/>
   <result pre="changes in brain structure, and discovering such neuroimaging biomarkers of" exact="migraine" post="may enlighten disease mechanisms and guide future clinical trials."/>
   <result pre="future clinical trials. Materials and methods We enrolled 36 female" exact="migraine" post="without-aura patients (36.6 ± 8.8 years) and 33 age-matched"/>
   <result pre="[5] were explored in order to characterize MRI correlates of" exact="migraine" post="by using various statistical neuroimaging toolboxes including ANTS, FSL,"/>
   <result pre="of brain volume in right medial prefrontal cortex (mPFC) of" exact="migraine" post="patients (corrected p&amp;lt;0.05, Fig. 1) and suggestive loss of"/>
   <result pre="results demonstrate promise of quantitative neuroimaging in exploring pathophysiology of" exact="migraine" post="and identifying the dysfunctional pain network in patients. P113"/>
   <result pre="present report was to describe the features of chronic paroxysmal" exact="migraine" post="in four pediatric patients. Results. We detected 4 patients"/>
   <result pre="intended to reduce the frequency, severity, and disability associated with" exact="migraine" post="attacks, and faster onset of action could increase benefit"/>
   <result pre="regimens of fremanezumab and placebo (PBO) in adults with episodic" exact="migraine" post="(EM). Patients assigned randomly to 1:1:1 ratio to 1"/>
   <result pre="mean change from baseline in the monthly average number of" exact="migraine" post="days were assessed using a mixed-effect model for repeated"/>
   <result pre="Results: Statistically significant reduction in the monthly average number of" exact="migraine" post="days was experienced during the 12-week period after 1st"/>
   <result pre="dosing resulted in significant reduction in the weekly number of" exact="migraine" post="days: At Week 1, (-0.9 days; p&amp;lt;0.0001) versus placebo"/>
   <result pre="dosing resulted in significant reduction in the weekly number of" exact="migraine" post="days: At Week 1, (-0.8 days; p&amp;lt;0.0001) versus placebo"/>
   <result pre="(-0.6 days) Posthoc analysis indicated that more patients reported no" exact="migraine" post="days with fremanezumab monthly dosing (79.4%; p=0.0002) and fremanezumab"/>
   <result pre="dose regimens of fremanezumab in the preventive treatment of episodic" exact="migraine" post="(EM). Methods: 16-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study"/>
   <result pre="period) to 12-week randomization period in monthly average number of" exact="migraine" post="days was analyzed using an analysis of covariance method"/>
   <result pre="the Wilcoxon rank sum test. Results: The mean number of" exact="migraine" post="days was 9.1 days during the 28-day baseline period."/>
   <result pre="with fremanezumab had significant reductions in the number of monthly" exact="migraine" post="days during the 12-week period vs. placebo (-2.2 days"/>
   <result pre="days). A ≥50% reduction in the monthly average number of" exact="migraine" post="days was significantly improved with both dosing regimens [monthly"/>
   <result pre="dose regimens of fremanezumab in the preventive treatment of chronic" exact="migraine" post="(CM). Methods: 16-week, multicenter, randomized double-blind, placebo-controlled, parallel-group adult"/>
   <result pre="fremanezumab had statistically significant reductions in the number of monthly" exact="migraine" post="days during the 12-week period after the 1st dose,"/>
   <result pre="of six pharmacy-based surveys with 6.985 patients with headache or" exact="migraine" post="Marius Dörr, Uwe Gessner, Christoph Theurer Scientific Affairs Consumer"/>
   <result pre="from six pharmacy-based surveys in the self-treatment of headache or" exact="migraine" post="with Aspirin. Materials and methods The individual data of"/>
   <result pre="efficacy of Botox has been established in adults with chronic" exact="migraine" post="[1,2]. The injection procedure is superficial and does not"/>
   <result pre="chronic migraine. Neurology 2011;77:1465-72. P119 Impaired cholinergic transmission during the" exact="migraine" post="cycle: a short-latency afferent inhibition (SAI) study Davide Di"/>
   <result pre="(mostly GABAa) cortical networks. Materials and methods We recruited 30" exact="migraine" post="without aura patients (16 between [MO] and 14 during"/>
   <result pre="effectiveness and safety of real-life use of onabotulinumtoxinA for chronic" exact="migraine" post="(CM). Materials and Methods Adults prescribed onabotulinumtoxinA for CM"/>
   <result pre="to moderate severity, were reported by 18.3% of patients; eyelid" exact="ptosis" post="(5.4%), neck pain (3.0%), and musculoskeletal stiffness (2.7%) were"/>
   <result pre="Outcomes (CaMEO) Study assessed the relationship of sleep disturbances and" exact="sleep apnea" post="as comorbidities of episodic (EM) and chronic migraine (CM)."/>
   <result pre="and sleep apnea as comorbidities of episodic (EM) and chronic" exact="migraine" post="(CM). Materials and Methods CaMEO participants were recruited from"/>
   <result pre="over 1 year. The Comorbidities/Endophenotypes survey assessed the risk of" exact="sleep apnea" post="using the Berlin Scale for Sleep Apnea (&quot;yes&quot;=high risk;"/>
   <result pre="&quot;No&quot;=low risk) and a self-report of a physician diagnosis of" exact="sleep apnea." post="Sleep disturbances were measured using the Medical Outcomes Study"/>
   <result pre="on the Berlin Scale, 37.0% were &quot;at high risk&quot; for" exact="sleep apnea" post="(EM, 35.6%; CM, 51.8%; chi-square, 113.7; P&amp;lt;0.001). Sleep apnea"/>
   <result pre="10.2%, 14.4%, 29.8%, and 74.1% of respondents at risk for" exact="sleep apnea" post="when stratified by underweight (n=489), normal (n=4,813), overweight (n=3,534),"/>
   <result pre="overweight (n=3,534), and obese categories (n=3,974). 10.1% of respondents self-reported" exact="sleep apnea" post="(n=1,293: EM, 9.7%; CM, 14.1%; P&amp;lt;0.001) (Table 1). Among"/>
   <result pre="EM, 9.7%; CM, 14.1%; P&amp;lt;0.001) (Table 1). Among those reporting" exact="sleep apnea," post="75.7% also reported a physician diagnosis (EM, 74.7%; CM,"/>
   <result pre="reported general prevalence estimates ranging from 1.0% to 6.0% for" exact="sleep apnea," post="we found an increased risk and potential underdiagnosis of"/>
   <result pre="apnea, we found an increased risk and potential underdiagnosis of" exact="sleep apnea" post="and sleep disturbances among those with migraine, especially CM."/>
   <result pre="(100.0) 1,111 (100.0) 12,810 (100.0) Among those reporting ever having" exact="sleep apnea," post="&quot;Has this condition been diagnosed or confirmed by a"/>
   <result pre="in using Affective Neuroscience Personality Scales [4] in 48 chronic" exact="migraine" post="sufferers (21 males, mean age 37.1 ±3.5 SD) for"/>
   <result pre="started in December 2016. It has to include 400 chronic" exact="migraine" post="sufferers refractory to topiramate, known to antagonize glutamatergic receptor"/>
   <result pre="to antagonize glutamatergic receptor subgroups. Following data concern 102 chronic" exact="migraine" post="sufferers reporting topiramate – induced relief -14.2 ± 0.7"/>
   <result pre="-14.2 ± 0.7 hours with pain, -0.9 ±1 severity of" exact="migraine" post="attacks. Seventy-five out of them (43 females, 32 males"/>
   <result pre="in age, gender, ethnicity or medical history, including diagnosis of" exact="migraine" post="or TTH, between patients with occipital headaches and other"/>
   <result pre="were the most prevalent final diagnosis (97; 31%), followed by" exact="migraine" post="(37; 11.8%). Among the occipital group, viral infection was"/>
   <result pre="right forehead and the right hand in a cohort of" exact="migraine" post="patients. Materials and methods: Twenty-eight migraine patients were selected"/>
   <result pre="in a cohort of migraine patients. Materials and methods: Twenty-eight" exact="migraine" post="patients were selected and randomly assigned to active or"/>
   <result pre="are few data about adherence to preventive treatments in chronic" exact="migraine" post="[6], no one is aimed specifically to MOH patients."/>
   <result pre="hemodynamics in the anterior and posterior circulation in patients with" exact="migraine" post="with aura, stroke and controls Altamura Claudia 1, Paolucci"/>
   <result pre="anterior and posterior circulation in patients with migraine with aura," exact="stroke" post="and controls Altamura Claudia 1, Paolucci Matteo 2, Brunelli"/>
   <result pre="Department, Campus Bio-Medico University of Rome Background Patients affected by" exact="migraine" post="present a higher cerebrovascular risk and a more sever"/>
   <result pre="aimed at comparing VMR in patients with MA, patients with" exact="stroke" post="and controls. Materials and Methods We consecutively enrolled 32"/>
   <result pre="MA patients, 10 young (under 55 years) patients with cryptogenetic" exact="stroke" post="and 16 controls. To assess VMR, Breath Holding Index"/>
   <result pre="(MCA) and posterior (PCA) cerebral arteries in all subjects. In" exact="stroke" post="patients, VMR was assessed within 7 days from stroke"/>
   <result pre="In stroke patients, VMR was assessed within 7 days from" exact="stroke" post="onset. Results MA patients were more frequently female (F/M=5:1)"/>
   <result pre="patients were more frequently female (F/M=5:1) than controls (F/M=2:1) and" exact="stroke" post="patients (F/M=1:1). Stroke patients (49 ys) on average were"/>
   <result pre="patients displaying the highest VMR (MCA 1,72; PCA 1,73) and" exact="stroke" post="patients the poorest (MCA 1,34; PCA 1,38). Controls VMR"/>
   <result pre="resulted 1,47 in MCA and 1,45 PCA. Conclusions Differently from" exact="stroke" post="patients, migraneurs with aura present a higher VMR to"/>
   <result pre="P, Rossini PM, Silvestrini M. Increased cerebral vasomotor reactivity in" exact="migraine" post="with aura: an autoregulation disorder? A transcranial Doppler and"/>
   <result pre="Development of a claims-based algorithm for use in patients with" exact="migraine" post="to identify potentially undiagnosed chronic migraine patients Jelena M."/>
   <result pre="use in patients with migraine to identify potentially undiagnosed chronic" exact="migraine" post="patients Jelena M. Pavlovic 1, Justin S. Yu 2,"/>
   <result pre="demonstrated that 75-80% of persons meeting the criteria for chronic" exact="migraine" post="(CM) do not report having received an accurate diagnosis"/>
   <result pre="to develop a claims-based algorithm for use in patients with" exact="migraine" post="to identify potentially undiagnosed CM patients. Materials and Methods"/>
   <result pre="States medical group. Eligible patients had continuous enrollment and a" exact="migraine" post="diagnosis (ICD-9/10 code of 346.xx/G43.xxx) in the 12-months prior"/>
   <result pre="were identified. Patients with ≥15 claims for acute treatment of" exact="migraine" post="(including opioids) were nearly six times as likely to"/>
   <result pre="CM (OR=9.17, 95% CI=1.26-66.51); patients with claims for ≥2 unique" exact="migraine" post="preventive classes were more than 4 times as likely"/>
   <result pre="2. Bigal M, Serrano D, Reed M, Lipton R. Chronic" exact="migraine" post="in the population. Neurology. 2008;71:559-566. P135 Antibodies in patients"/>
   <result pre="maximal excursion and final excursion of the group control (CG)," exact="migraine" post="without aura (MoA), migraine with aura (MA) and chronic"/>
   <result pre="excursion of the group control (CG), migraine without aura (MoA)," exact="migraine" post="with aura (MA) and chronic migraine (CM) in the"/>
   <result pre="migraine without aura (MoA), migraine with aura (MA) and chronic" exact="migraine" post="(CM) in the eight test directions: forward (F), right"/>
   <result pre="changes of autoantibodies level against: Total number of patients Chronic" exact="migraine" post="Chronic tension type headache NF-200 11 (25%) 9 *"/>
   <result pre="Parthasarathy V. Reduction of CD4+CD25+ regulatory T-cells in migraine: Is" exact="migraine" post="an autoimmune disorder? Journal of Neuroimmunology. 2016, 290:54. 5."/>
   <result pre="only specific preventative treatment approved for adult patients with chronic" exact="migraine" post="(CM) [1-3]. Both experimental and real-life data show that"/>
   <result pre="P=0.010) (Table 2). We found a trend towards lower chronic" exact="migraine" post="duration and more depressive and anxiety symptoms in super-responders"/>
   <result pre="predictor of excellent responde to BoNT-A treatment as also shorter" exact="migraine" post="duration and lower burden in terms of psychiatric symptoms."/>
   <result pre="years, median (IQR) 44.5 (38-51) 27 (23-45) 0.144 - Chronic" exact="migraine" post="duration (months), median (IQR) 8.5 (5-12) 120 (24-120) 0.056"/>
   <result pre="years, median (IQR) 44.5 (38-51) 30 (23-45) 0.204 - Chronic" exact="migraine" post="duration (months), median (IQR) 8.5 (5-12) 60 (24-120) 0.061"/>
   <result pre="the symptomatology of existing comorbidities [1]. In real life setting," exact="migraine" post="patients can be affected by various different diseases not-related"/>
   <result pre="study we considered the available guidelines for therapy choices in" exact="migraine" post="(level of recommendation I &amp;amp; II) and we proposed"/>
   <result pre="each patient as a unique entity. Personalized Medicine applied to" exact="migraine" post="requires new models that consider the comorbidity with other"/>
   <result pre="G, Martelletti P. Choosing the safest acute therapy during chronic" exact="migraine" post="prophylactic treatment: pharmacokinetic and pharmacodynamic consideration. Exp Opin Drug"/>
   <result pre="advice of counselling avoidance of the triggers of headache and" exact="migraine" post="[1,2]. Problems with this approach include the danger of"/>
   <result pre="published [5]. Participants were included if they had suffered from" exact="migraine" post="or tension-type headache over a period of at least"/>
   <result pre="to investigate the prevalence of sleep disturbances in children with" exact="migraine" post="and TTH using a validated sleep screening instrument, and"/>
   <result pre="and a standardized questionnaire regarding headache characteristics. Results: Children with" exact="migraine" post="scored significantly higher than children with tension type headache"/>
   <result pre="meters (P = .02), and in those with noctur- nal" exact="hypoglycemia" post="vs those without (P = .023). The percentage of"/>
   <result pre="found in the other two age groups. Conclusions: Children with" exact="migraine" post="headaches have a high prevalence of sleep disturbances. This"/>
   <result pre="P143 Validity of the ICHD-IIIb criteria in the diagnosis of" exact="migraine" post="with aura in children and adolescents Martina Balestri, Alessandro"/>
   <result pre="Federico Vigevano, M. Valeriani Objective. Though common in pediatric age," exact="migraine" post="with aura (MA) has been scarcely studied in children."/>
   <result pre="the headache type was classified according to the ICHD-IIIb criteria," exact="migraine" post="was diagnosed only in 40.2% of patients and the"/>
   <result pre="duration was not considered, the headache could be classified as" exact="migraine" post="in 67% of patients and in no child the"/>
   <result pre="Danish group of healthy adults (RG). Materials and Methods Eighty" exact="migraine" post="patients without medication overuse and 80 MOH patients seen"/>
   <result pre="of men were identified in the MOH group 32.5% vs." exact="migraine" post="12.5% (p=0.002). There were no statistically significant differences between"/>
   <result pre="Neurological Institute in Pavia, Italy. All consecutive patients with chronic" exact="migraine" post="and medication overuse headache undergoing an inpatient detoxification program"/>
   <result pre="Cephalalgia. 2016; 36: 1356-1365. P148 Comorbidities in chronic and episodic" exact="migraine" post="Mansoureh Togha 1, Zahra Yari 1,2, Reza Rahmanzadeh 1,"/>
   <result pre="Correspondence:Mansoureh Togha Background: It has been known for years that" exact="migraine" post="is comorbid with a number of other diseases, which"/>
   <result pre="headache clinic, Tehran, Iran. A total of 370 (60%) episodic" exact="migraine" post="and 240 (40%) chronic migraine (with and without aura)"/>
   <result pre="total of 370 (60%) episodic migraine and 240 (40%) chronic" exact="migraine" post="(with and without aura) were diagnosed according to ICHD"/>
   <result pre="episodic, in terms of gastrointestinal diseases (including IBS, constipation, heartburn," exact="peptic ulcer" post="disease, dyspepsia and non-alcoholic fatty liver disease), thyroid disorders"/>
   <result pre="of gastrointestinal diseases (including IBS, constipation, heartburn, peptic ulcer disease," exact="dyspepsia" post="and non-alcoholic fatty liver disease), thyroid disorders (hypo- and"/>
   <result pre="is no significant difference between chronic and episodic type of" exact="migraine" post="regarding comorbidities but considering the number of headache days"/>
   <result pre="more digestive problems occur. These findings represent the importance of" exact="migraine" post="management and its effect on general health. Further studies"/>
   <result pre="the relationship between frequency and intensity of different subtypes of" exact="migraine" post="and its comorbidities. Keywords: Comorbidity, Migraine, Chronic, Episodic, Days"/>
   <result pre="2Neuropsychiatric, Insubria University, Varese, Italy Correspondence:Massimiliano Valeriani (m.valeriani@tiscali.it) Background: Chronic" exact="migraine" post="(CM), Chronic tension-type headache (CTTH) and new daily persistent"/>
   <result pre="percentage of patients. P150 Postural control impairment in patients with" exact="migraine" post="with and without aura and chronic migraine Gabriela Ferreira"/>
   <result pre="in patients with migraine with and without aura and chronic" exact="migraine" post="Gabriela Ferreira Carvalho 1; Lidiane L Florêncio 1, Carina"/>
   <result pre="To investigate the performance of patients with different subtypes of" exact="migraine" post="in two clinical balance tests. Methods: Women with migraine"/>
   <result pre="of migraine in two clinical balance tests. Methods: Women with" exact="migraine" post="were screened from a tertiary headache center and sorted"/>
   <result pre="was included migraineurs with aura (n=35), without aura (n=35), chronic" exact="migraine" post="(n=35) and headache-free controls (n=35). Subjects with systemic diseases,"/>
   <result pre="migraine (n=35) and headache-free controls (n=35). Subjects with systemic diseases," exact="vestibular disease" post="history, presence of other headache diagnosis, BMI over 30"/>
   <result pre="with a fixed significant level at 5%. Results: Patients with" exact="migraine" post="presented slower LOS reaction time for all directions, with"/>
   <result pre="time for all directions, with differences between all the three" exact="migraine" post="groups compared to controls for 5 of 8 directions,"/>
   <result pre="The LOS velocity was greater in controls compared to all" exact="migraine" post="groups for 6 of 8 directions (p&amp;lt;0.04). Furthermore, for"/>
   <result pre="for 5 of 8 directions in controls compared to all" exact="migraine" post="groups, p&amp;lt;0.02 (Fig. 1). At the condition firmOE of"/>
   <result pre="was not observed differences among groups. At the firmCE condition," exact="migraine" post="with aura and chronic migraine groups presented larger displacement"/>
   <result pre="groups. At the firmCE condition, migraine with aura and chronic" exact="migraine" post="groups presented larger displacement area than controls (p&amp;lt;0.02). For"/>
   <result pre="than controls (p&amp;lt;0.02). For the both foamOE and foamCE conditions," exact="migraine" post="with aura and chronic migraine groups also presented larger"/>
   <result pre="both foamOE and foamCE conditions, migraine with aura and chronic" exact="migraine" post="groups also presented larger displacement area than controls (p&amp;lt;0.005)"/>
   <result pre="of stability and static balance in migraineurs, mostly in chronic" exact="migraine" post="and migraine with aura, for almost all outcomes assessed."/>
   <result pre="and static balance in migraineurs, mostly in chronic migraine and" exact="migraine" post="with aura, for almost all outcomes assessed. The balance"/>
   <result pre="posturography displacement area (cm 2) in controls (CG), patients with" exact="migraine" post="without aura (MoA), with aura (MA) and chronic migraine"/>
   <result pre="with migraine without aura (MoA), with aura (MA) and chronic" exact="migraine" post="(CM) CG MoA MA CM FirmOE 1.20 (1.05 to"/>
   <result pre="needs to be unraveled in headache disorders. Acute attacks of" exact="migraine" post="and cluster headache are both associated with CGRP and"/>
   <result pre="levels are elevated in some studies during episodic and chronic" exact="migraine" post="compared to healthy human subjects. Pathophysiological alterations (e.g. functional"/>
   <result pre="and vascular function comes from recent genome-wide association studies investigating" exact="migraine" post="and cluster headache. Several underlying candidate headache genes (e.g."/>
   <result pre="spontaneous intracranial hypotension. Eur J Neurol 17:715–719. P154 Women with" exact="migraine" post="present hyperactivity of neck extensors muscles during maximal and"/>
   <result pre="Background: Despite of the confirmed association between neck pain and" exact="migraine" post="investigations of neck muscles controls in this population is"/>
   <result pre="compare activity of neck muscles in women with migraine, chronic" exact="migraine" post="and non-headache women during low load and maximal contractions."/>
   <result pre="without history of headache (age: 31 years old); 31 with" exact="migraine" post="(age: 33 years old) and 21 with chronic migraine"/>
   <result pre="with migraine (age: 33 years old) and 21 with chronic" exact="migraine" post="(age: 34 years old), diagnosed according to the third"/>
   <result pre="pregnancy, history of head or neck trauma, cervical spine diseases," exact="fibromyalgia" post="syndrome, medication overuse, or anesthetic blocks in the past"/>
   <result pre="level of 0.05. Results: In the low load task, chronic" exact="migraine" post="group demonstrated greater activity of upper trapezius in all"/>
   <result pre="control (p&amp;lt;0.001) (Fig. 1). No differences could be observed between" exact="migraine" post="and control groups not even among three groups regarding"/>
   <result pre="regarding superficial flexors activity (Fig. 1). Extensors activities of both" exact="migraine" post="groups were significant higher than controls during MIVC in"/>
   <result pre="hyperactivity of neck extensor can be observed only in chronic" exact="migraine" post="group. Fig. 2 (abstract P154). Normalized activity of the"/>
   <result pre="P157). Forest plots of the meta-analyses P155 The role of" exact="sexual dysfunction" post="and attachment style in migraine related quality of life"/>
   <result pre="P155 The role of sexual dysfunction and attachment style in" exact="migraine" post="related quality of life Maria Pia Prudenzano 1, Maria"/>
   <result pre="studies have focused on the occurrence and possible role of" exact="sexual dysfunction" post="in migraine patients quality of life [1,2]. Attachment behaviour"/>
   <result pre="on the occurrence and possible role of sexual dysfunction in" exact="migraine" post="patients quality of life [1,2]. Attachment behaviour is supposed"/>
   <result pre="Objectives: This study was conducted to investigate the association among" exact="sexual dysfunction," post="psychological factors, attachment style and quality of life, in"/>
   <result pre="attachment style and quality of life, in a sample of" exact="migraine" post="patients. Patients and Methods: 70 adult migraine outpatients (14"/>
   <result pre="a sample of migraine patients. Patients and Methods: 70 adult" exact="migraine" post="outpatients (14 males; 56 females, mean age 39,56±12,55) consecutively"/>
   <result pre="p=0,38), without difference according to age, marital status, job and" exact="migraine" post="type (with or without aura). Sexual Dysfunction was observed"/>
   <result pre="without aura). Sexual Dysfunction was observed more frequently in chronic" exact="migraine" post="patients than in episodic ones (73,07% vs 40,62%, p=0.02)."/>
   <result pre="in episodic ones (73,07% vs 40,62%, p=0.02). Migraine patients with" exact="sexual dysfunction" post="showed significantly lower scores in SF-36 Mental Component Summary"/>
   <result pre="dysfunction as an independent factor than anxiety and depression in" exact="migraine" post="related quality of life. Migraine patients with insecure attachment"/>
   <result pre="life. Migraine patients with insecure attachment both with and without" exact="sexual dysfunction" post="showed worse quality of life. Future longitudinal studies including"/>
   <result pre="P156 Migraine: a possible risk factor for the development of" exact="hypothyroidism" post="in women Carlo Lisotto 1, Federico Mainardi 2, Ferdinando"/>
   <result pre="Hospital of Venice, Venice, Italy Correspondence:Carlo Lisotto Background Migraine and" exact="hypothyroidism" post="(HT) are frequent disorders. Migraine occurs in about 15%"/>
   <result pre="headache sufferers. Results The population consisted of 2,640 patients with" exact="migraine" post="without aura (MO), 303 with migraine with aura (MA),"/>
   <result pre="of 2,640 patients with migraine without aura (MO), 303 with" exact="migraine" post="with aura (MA), 235 with MO + MA, 207"/>
   <result pre="TTH (2 males). The prevalence of HT was 5.4% in" exact="migraine" post="women, while it was 0.6% in men. The onset"/>
   <result pre="women, while it was 0.6% in men. The onset of" exact="migraine" post="occurred prior to HT in 97.5% of women, whereas"/>
   <result pre="headache in 78.2% of female patients. The mean age of" exact="migraine" post="onset was 23.9 ± 8.5 in women and 25.6"/>
   <result pre="women. Our results are consistent with past clinic-based studies demonstrating" exact="migraine" post="and HT to be comorbid conditions [2]. In migraineurs"/>
   <result pre="of cases. In a recent cohort study, patients with pre-existing" exact="migraine" post="showed a 41% increased risk of developing new onset"/>
   <result pre="41% increased risk of developing new onset HT, thus suggesting" exact="migraine" post="to be a possible risk factor for this endocrinopathy"/>
   <result pre="[3]. A plausible proposed mechanism to explain the association between" exact="migraine" post="and HT include alterations in the immune system, predisposing"/>
   <result pre="C, Mainardi F, Maggioni F, Zanchin G. The comorbidity between" exact="migraine" post="and hypothyroidism. J Headache Pain. 2013; 1:P138. 3. Martin"/>
   <result pre="P157 Contribution of hormonal contraceptives to the risk of ischemic" exact="stroke" post="in women with migraine: a meta-analysis of current data"/>
   <result pre="Correspondence: Simona Sacco (simona.sacco@univaq.it) Background According to current literature, both" exact="migraine" post="and hormonal contraceptive (HC) use are risk factors for"/>
   <result pre="and hormonal contraceptive (HC) use are risk factors for ischemic" exact="stroke" post="(IS). HC use and migraine likely interact in increasing"/>
   <result pre="are risk factors for ischemic stroke (IS). HC use and" exact="migraine" post="likely interact in increasing the risk of IS in"/>
   <result pre="was conducted to identify key papers addressing the association between" exact="migraine" post="and IS in women using HC. The reference lists"/>
   <result pre="binary outcome data [1-6]. When considering female patients with IS," exact="migraine" post="and HC use were not associated in cohort or"/>
   <result pre="[CI], 0.74-2.10; P=0.40 (Fig. 1). When considering women using HC," exact="migraine" post="and IS were not associated in case-control studies (OR"/>
   <result pre="1.82; 95% CI, 1.34-2.47; P&amp;lt;0.001) (Fig. 1). The combination of" exact="migraine" post="and HC use was strongly associated with IS in"/>
   <result pre="Our findings suggest that the combination between HC use and" exact="migraine" post="contributes to increase the risk of IS in women."/>
   <result pre="1) to formally assess the interaction between HC use and" exact="migraine" post="in the risk of IS in women; 2) to"/>
   <result pre="cardiovascular risk factors in the IS risk of women with" exact="migraine" post="using HC; 3) to clarify whether migraine with aura"/>
   <result pre="of women with migraine using HC; 3) to clarify whether" exact="migraine" post="with aura and migraine without aura carry the same"/>
   <result pre="using HC; 3) to clarify whether migraine with aura and" exact="migraine" post="without aura carry the same risk of IS in"/>
   <result pre="a condition References 1. Collaborative group for the study of" exact="stroke" post="in young women. Oral contraceptives and stroke in young"/>
   <result pre="the study of stroke in young women. Oral contraceptives and" exact="stroke" post="in young women. Associated risk factors. JAMA 1975; 231:718-722."/>
   <result pre="29:2277–2284. 3. Chang CL, Donaghy M, Poulter N. Migraine and" exact="stroke" post="in young women: case–control study. The World Health Organization"/>
   <result pre="Milhaud D, Bogousslavsky J, van Melle G, Liot P. Ischemic" exact="stroke" post="and active migraine. Neurology. 2001; 57:1805-1811. 5. Pezzini A,"/>
   <result pre="Italian Project on Stroke in Young Adults Investigators. Predictors of" exact="migraine" post="subtypes in young adults with ischemic stroke: the italian"/>
   <result pre="in young adults with ischemic stroke: the italian project on" exact="stroke" post="in young adults. Stroke. 2011; 42:17-21 6. Champaloux SW,"/>
   <result pre="USA Correspondence:Richard B. Lipton (Richard.Lipton@einstein.yu.edu) Background Many comorbidities associated with" exact="migraine" post="have a higher relative frequency in chronic migraine (CM)"/>
   <result pre="associated with migraine have a higher relative frequency in chronic" exact="migraine" post="(CM) than episodic migraine (EM). The objective of this"/>
   <result pre="a higher relative frequency in chronic migraine (CM) than episodic" exact="migraine" post="(EM). The objective of this study was to replicate"/>
   <result pre="Cardiovascular, and Gastrointestinal comorbidity categories. Results Available CaMEO respondents with" exact="migraine" post="(16,763) were sent the Comorbidities/Endophenotype module and 12,810 (76.4%)"/>
   <result pre="frequencies &amp;gt;10% higher in CM than EM included allergies/hay fever/allergic" exact="rhinitis" post="(EM, 37.4%; CM, 51.0%), sinusitis/sinus infection (EM, 47.3%; CM,"/>
   <result pre="Future analyses will address naturally occurring subgroups (taxa) defined by" exact="migraine" post="phenotypes and comorbidities and assess the relationships of these"/>
   <result pre="30-day headache diary was given to patients to report the" exact="migraine" post="characteristics including the intensity of headaches, the number of"/>
   <result pre="headache days per month (- 9.67±6.69, P value ≤0.000). The" exact="migraine" post="severity (VAS) and attacks duration also significantly reduced with"/>
   <result pre="probiotic on inflammatory markers in patients with CM. Keywords: chronic" exact="migraine" post="headache, probiotic, MIDAS, abortive drugs, frequency of headache days."/>
   <result pre="increased release at trigeminal nerve endings during both cluster and" exact="migraine" post="attacks [4]. Nonetheless, tachykinins’ release seems not pivotal in"/>
   <result pre="Observation -April 2016- March 2017. Entry criteria: Diagnosis of chronic" exact="migraine" post="(IHCD III b), exemption from other diseases. Drugs:100 μl"/>
   <result pre="consisted in test-retest acutely performed during headache attacks of chronic" exact="migraine" post="sufferers (n= 48, 20 males, mean age 31.8 ±"/>
   <result pre="peptide) andvasoactive intestinal polypeptide in human saliva: their pattern in" exact="migraine" post="and cluster headache. Cephalalgia 1990;10: 39-50. 5. Nicolodi M."/>
   <result pre="children. The most common primary headache syndromes in childhood are" exact="migraine" post="and TTH. However many times they seem to overlap."/>
   <result pre="children, 5-18 years of age, who met the criteria for" exact="migraine" post="were included. Results: Of 262 children (54% female) who"/>
   <result pre="Of 262 children (54% female) who had migraine, 26.2% had" exact="migraine" post="with aura. 59 children (22.5% of the full sample)"/>
   <result pre="aura, whereas gender was not significant (p&amp;gt;0.20). Children who had" exact="migraine" post="with aura were less likely to have mixed headaches"/>
   <result pre="mixed headaches were 2.7 times more likely to have a" exact="learning disability" post="than children with migraine alone. Conclusions: Episodic TTH and"/>
   <result pre="more likely to have a learning disability than children with" exact="migraine" post="alone. Conclusions: Episodic TTH and migraine without aura (mixed"/>
   <result pre="disability than children with migraine alone. Conclusions: Episodic TTH and" exact="migraine" post="without aura (mixed headaches) in children might be part"/>
   <result pre="explain the high incidence of their co-occurrence as opposed to" exact="migraine" post="with aura. Children with mixed headaches have a higher"/>
   <result pre="aura. Children with mixed headaches have a higher incidence of" exact="learning disability" post="compare to those with migraine alone. SISC POSTER PRESENTATIONS"/>
   <result pre="a higher incidence of learning disability compare to those with" exact="migraine" post="alone. SISC POSTER PRESENTATIONS P162 Clinical features of headache"/>
   <result pre="&amp;gt; 1 hour. In 50% headache features are similar to" exact="migraine" post="con nausea-vomiting, photophobia and phonophobia. In addition, patients may"/>
   <result pre="most common phenotypes represented by chronic tension type headache, chronic" exact="migraine" post="and chronic daily headache. A phenotypic classification is useful"/>
   <result pre="Exclusion criteria included other primary headaches, medication overuse headache, whiplash," exact="fibromyalgia" post="or any neurological disorder. A 1-month headache diary was"/>
   <result pre="other primary headaches, medication overuse headache, whiplash, fibromyalgia or any" exact="neurological disorder." post="A 1-month headache diary was used to collect clinical"/>
   <result pre="to lower widespread pressure pain sensitivity. P165 Recurrent painful ophthalmoplegic" exact="neuropathy" post="(RPON), can cerebrospinal fluid (CSF) analysis aid the diagnosis,"/>
   <result pre="Medicine, University of Pisa, Pisa, Italy Background Recurrent painful ophthalmoplegic" exact="neuropathy" post="(RPON) represents a condition, characterized by recurring headaches and"/>
   <result pre="pressure-like and holocranial with diplopia in all gaze directions and" exact="ptosis" post="of the left eye. The patient described a similar"/>
   <result pre="in 3 weeks, without therapy. He had no history of" exact="migraine" post="and never suffered of headache with similar characteristics. He"/>
   <result pre="a left third nerve palsy without pupil asymmetry, an incomplete" exact="ptosis" post="and inability to adduct or lower his left eye."/>
   <result pre="mg/dl). Blood routine tests and other investigations including autoimmune, sarcoidosis," exact="tuberculosis" post="and venereal disease screens, viral genome on CSF, antiganglioside"/>
   <result pre="Activation of meningeal nociceptors by cortical spreading depression: Implications to" exact="migraine" post="with aura. The Journal of neuroscience : the official"/>
   <result pre="symptoms ant it can be erroneously mistaken for an acute" exact="stroke" post="(AS) [1]. A complete diagnostic workup in Emergency Department"/>
   <result pre="after 70-120 minutes from symptoms onset. Two patients presented with" exact="aphasia" post="[5, 6], one patient with aphasia and right hemiparesis"/>
   <result pre="Two patients presented with aphasia [5, 6], one patient with" exact="aphasia" post="and right hemiparesis [7] and the last one with"/>
   <result pre="thrombolysis was given. Patient were discharged with final diagnosis of" exact="migraine" post="with aura. Cases report We report six cases accessed"/>
   <result pre="had mild headache (Table 1). All patients had history of" exact="migraine" post="in the past. Unenhanced CT, Angio-CT of intra and"/>
   <result pre="normal in all cases. Patients were discharged with diagnosis of" exact="migraine" post="with aura, probable sporadic hemiplegic migraine and probable first"/>
   <result pre="discharged with diagnosis of migraine with aura, probable sporadic hemiplegic" exact="migraine" post="and probable first attack of migraine with visual aura,"/>
   <result pre="aura, probable sporadic hemiplegic migraine and probable first attack of" exact="migraine" post="with visual aura, according with ICHD-3 beta criteria. Conclusions"/>
   <result pre="minutes no 2 hours 5 81 F yes (with aura)" exact="aphasia" post="no 4 60 minutes no 2 hours 6 91"/>
   <result pre="minutes no 2 hours 6 91 F yes (with aura)" exact="aphasia" post="no 3 90 minutes no 10 hours References 1."/>
   <result pre="A Koyfman A. Clinical mimics: an emergency medicine-focused review of" exact="stroke" post="mimics. The Journal of Emergency Medicine, 2017 Feb;52(2):176-183. 2."/>
   <result pre="2.71 years; 116 males and 126 females), 152 (62.81%) had" exact="migraine" post="(23 with aura), 24 (9.92%) had tension-type headache, 32"/>
   <result pre="patients with neuropsychiatric disorders, 120 (81.08%) had at least one" exact="sleep disorder," post="14 (9.46%) a neuropsychiatric disorder without any sleep disturbance"/>
   <result pre="disorder was significantly higher in the group of patients with" exact="migraine" post="with aura: this applies to both neuropsychiatric disorders considered"/>
   <result pre="found. Conclusions In this study we demonstrated that children with" exact="migraine" post="with aura significantly more probably have neuropsychiatric disorders in"/>
   <result pre="TanacethumPartenium, 5-Hydrossitriptophan (5-Http) and Magnesium (AURASTOP®) in children with episodic" exact="migraine" post="without aura: an observational study Antonia Versace, Barbara Lauria,"/>
   <result pre="now, the nutraceutical preparation have been given to adults with" exact="migraine" post="with aura as symptomatic treatment and as prophylactic treatment"/>
   <result pre="symptomatic treatment and as prophylactic treatment in those with episodic" exact="migraine" post="without aura, with several benefits. In this study we"/>
   <result pre="intensity, duration, frequency and analgesics use in children with episodic" exact="migraine" post="without aura. Materials and methods In this open prospective"/>
   <result pre="selected 21 children (age range: 6-16 years) suffering from episodic" exact="migraine" post="without aura for at least 6 months followed at"/>
   <result pre="the Regina Margherita Children’s Hospital of Turin, Italy.The diagnosis of" exact="migraine" post="without aura was done on HIS criteria (ICH-III b)"/>
   <result pre="a reduction in frequency and 4 (19.05%) in duration of" exact="migraine" post="episodes. A decrease in intensity was detected in 16"/>
   <result pre="represent an efficient prophylactic therapy also for children with episodic" exact="migraine" post="without aura. However, a large randomised control trial should"/>
   <result pre="beta version, ICHD-3 beta) are considered different disorders other than" exact="trigeminal neuralgia" post="(TN) 1. However clinical and terapheutic similarites let us"/>
   <result pre="on the symptoms. His medical history was remarkable for shoulders" exact="periarthritis" post="and renal colics. After the assessment in our Centre,"/>
   <result pre="and conclusion. Headache current 2017, 10.1111/head.13099. P170 Cerebral vasoreactivity in" exact="migraine" post="patients affected by Ehlers-Danlos syndromes Giada Giuliani 1, Massimiliano"/>
   <result pre="both headache frequency and its characteristics [1]. Altered autoregulation in" exact="migraine" post="with aura patients, possibly secondary to impaired cerebrovascular autonomic"/>
   <result pre="elasticity, we investigate by Transcranial Doppler if EDS patients with" exact="migraine" post="had the same vasoreactivity than controls. Materials and methods"/>
   <result pre="than controls. Materials and methods We recruited EDS patients with" exact="migraine" post="and sex and age matched healthy controls. Patients had"/>
   <result pre="patients (mean age 32±12 years, F/M:17/4) affected by EDS and" exact="migraine" post="(9 without and 12 with aura) and twenty healthy"/>
   <result pre="age 37±6 years, F/M:15/5) have been enrolled. At rest, EDS" exact="migraine" post="patients presented a significant higher mean flow velocities (p&amp;lt;0.01)"/>
   <result pre="controls (Table 1). After hypercapnia, vasomotor response (BHI) of EDS" exact="migraine" post="patients differ with respect to controls according to the"/>
   <result pre="without aura (p&amp;lt;0.001) whereas it was higher in EDS with" exact="migraine" post="with aura and lateralized pain (p&amp;lt;0.001) (Fig. 1). Conclusions"/>
   <result pre="disorder. After hypercapnia, TCD variations are more suggestive for the" exact="migraine" post="features. Increased BHI in patients affected by aura and"/>
   <result pre="predominance reflects alterations of intracranial vessel tone already observed in" exact="migraine" post="with aura [2]. In conclusion, in EDS migraine patients"/>
   <result pre="observed in migraine with aura [2]. In conclusion, in EDS" exact="migraine" post="patients TCD study showed two different responses, mainly reflecting"/>
   <result pre="responses, mainly reflecting the EDS disease at rest and the" exact="migraine" post="component during hypercapnia. Fig. 1 (abstract P171). Sustained Response"/>
   <result pre="B, Toscano M, Vicenzini E, et al. A study of" exact="migraine" post="characteristics in joint hypermobility syndrome a.k.a. Ehlers–Danlos syndrome, hypermobility"/>
   <result pre="E, et al. A study of migraine characteristics in joint" exact="hypermobility syndrome" post="a.k.a. Ehlers–Danlos syndrome, hypermobility type. Neurol. Sci. 2015 36(8):1417-1424."/>
   <result pre="P, Rossini PM, Silvestrini M. Increased cerebral vasomotor reactivity in" exact="migraine" post="with aura: an autoregulation disorder? A transcranial Doppler and"/>
   <result pre="- University of Insubria, Varese Background: BoNT-A effectiveness in chronic" exact="migraine" post="(CM) with or without medication overuse (MO) has been"/>
   <result pre="assessment in G1 vs G2 Fig. 1 (abstract P177). Ischemic" exact="stroke" post="of the right brachium pontis, corresponding to the trigeminal"/>
   <result pre="17:1-9 P172 Pharmacologically- controlled withdrawal from medication overuse in chronic" exact="migraine" post="does not improve the therapeutic response to long-term onabotulinumtoxin"/>
   <result pre="S, Guerriero R, Como G, Del Carro U, Refractrory chronic" exact="migraine" post=": is drug withdrawal necessary before starting a therapy"/>
   <result pre="major constituents of butterbur [ Petasites hybridus (L.) Gaertn.], in" exact="migraine" post="prevention has been obtained with a preparation that contains"/>
   <result pre="However, none of these actions seems to be relevant for" exact="migraine" post="pathophysiology. Petasin and its cross-conjugated isomer, isopetasin, contain electrophilic"/>
   <result pre="which mediate neurogenic inflammation. The possible role of TRPA1 in" exact="migraine" post="is supported by its co-expression in the same nociceptor"/>
   <result pre="nociceptor subpopulation with CGRP, the neuropeptide that markedly contributes to" exact="migraine" post="pain. Given the role of electrophilic compounds for the"/>
   <result pre="release CGRP and signal pain. Successful treatment and prevention of" exact="migraine" post="by targeting of TRPA1 ion channels and the ensuing"/>
   <result pre="at the root entry zone. There are anecdotal reports of" exact="herpes zoster," post="schwannoma or Lyme disease involving nervus intermedius [2]. Nervus"/>
   <result pre="root entry zone. There are anecdotal reports of herpes zoster," exact="schwannoma" post="or Lyme disease involving nervus intermedius [2]. Nervus intermedius"/>
   <result pre="cold air and chewing. The patient suffered also from episodic" exact="migraine" post="without aura, gastritis and he recently underwent dental implantation."/>
   <result pre="chewing. The patient suffered also from episodic migraine without aura," exact="gastritis" post="and he recently underwent dental implantation. Different clinical and"/>
   <result pre="J. 2017 Jun 8;4(3):75-78. P175 Impact of visceral pain on" exact="migraine" post="symptoms in comorbid patients Giannapia Affaitati 1, Raffaele Costantini"/>
   <result pre="very often coexists with visceral pain of various origin, e.g.," exact="irritable bowel syndrome" post="(IBS), primary dysmenorrhea (Dys) or pelvic pain from endometriosis"/>
   <result pre="bowel syndrome (IBS), primary dysmenorrhea (Dys) or pelvic pain from" exact="endometriosis" post="(Endo) [1,2]. The clinical observation suggests that visceral pain"/>
   <result pre="observation suggests that visceral pain episodes in comorbid patients trigger/exacerbate" exact="migraine" post="symptoms but systematic studies are still lacking with this"/>
   <result pre="the impact of visceral pain comorbidities and their treatment on" exact="migraine" post="symptoms and pain sensitivity in somatic tissues of extracranial"/>
   <result pre="and methods Female patients [18-43 years] with high frequency episodic" exact="migraine" post="were examined, who presented concurrent: IBS [n.37], Dys [n.35]"/>
   <result pre="conditions all comorbid patients vs M-only patients presented significantly higher" exact="migraine" post="pain and somatic tissue hypersensitivity (0.05 Conclusions Visceral pain"/>
   <result pre="M-only patients presented significantly higher migraine pain and somatic tissue" exact="hypersensitivity" post="(0.05 Conclusions Visceral pain significantly contributes to migraine pain,"/>
   <result pre="somatic tissue hypersensitivity (0.05 Conclusions Visceral pain significantly contributes to" exact="migraine" post="pain, probably through enhancement of the level of central"/>
   <result pre="empirical operation and set up rational therapeutic strategies. P177 A" exact="migraine" post="attack as onset of trigeminal root entry zone ischemic"/>
   <result pre="University of Padua, Padua, Italy Correspondence:VirginiaBozzoni (virginia.bozzoni@gmail.com) Background. Painful trigeminal" exact="neuropathy" post="and &quot;orofacial pain&quot; due to brain stem stroke have"/>
   <result pre="Painful trigeminal neuropathy and &quot;orofacial pain&quot; due to brain stem" exact="stroke" post="have already been described [1,2,3]. We report a case"/>
   <result pre="already been described [1,2,3]. We report a case of pontine" exact="stroke" post="presented as a migrainous attack with subsequent onset of"/>
   <result pre="(ICHD-III) [4] presented with sudden onset of a severe right" exact="migraine" post="attack with nausea, phono and photophobia stopped after NSAIDs"/>
   <result pre="pseudo-peripheral trigeminal symptoms and to determine a post-stroke painful trigeminal" exact="neuropathy" post="[3]. Here we described a trigeminal sensory deficit due"/>
   <result pre="selective trigeminal root entry zone ischemic lesion onset after a" exact="migraine" post="attack. Consent for publication: The authors declare that written"/>
   <result pre="importance of a multidisciplinary approach in the management of pediatric" exact="migraine" post="Marcuzzi E 1, Saretta F 1, Savi L 2"/>
   <result pre="are the goals of chosen therapies. The &quot;red flags&quot; for" exact="migraine" post="must be particularly highlighted and indications, on when and"/>
   <result pre="plays an irreplaceable role in the management of headache and" exact="migraine" post="in childhood on which physician should be properly educated."/>
   <result pre="AL, et al. Outcome of a multidisciplinary approach ti pediatric" exact="migraine" post="at 1,2 and 5 years. Headache 2005; 45:1298-303. P179"/>
   <result pre="of metacognitive executive dysfunctions in the pathogenic mechanism that underlies" exact="substance abuse" post="in MOH. Material &amp;amp; Methods: Fifty-two patients were selected"/>
   <result pre="coping behavior predisposes MOH patients to a relapse of chronic" exact="substance abuse." post="Additional studies are needed to confirm our data. References"/>
   <result pre="Headache Clinic - IRCCS Neuromed, Pozzilli (Isernia), Italy Prevalence of" exact="migraine" post="in women is almost three times greater than in"/>
   <result pre="This is true particularly in the childbearing age, whereas the" exact="migraine" post="prevalence tends to be similar in both genders during"/>
   <result pre="during the childhood and in the elderly patients. Although the" exact="migraine" post="disease is known to run in families, and it"/>
   <result pre="it is thus suggested to have a strong genetic predisposition," exact="migraine" post="attacks are usually started by external/internal triggers, among which"/>
   <result pre="among which the hormonal cycle plays a major role. Menstrual-related" exact="migraine" post="attacks are known to be longer and more severe"/>
   <result pre="during oral contraceptive treatments, and a significant amelioration of their" exact="migraine" post="frequency and severity during pregnancy and in menopause. This"/>
   <result pre="severity during pregnancy and in menopause. This strict correlation between" exact="migraine" post="and the hormonal cycle represents usually a therapeutic challenge"/>
   <result pre="and symptomatic strategies are unsuccessful when applied to control hormonal-related" exact="migraine" post="attacks. P181 Role of the transient receptor potential ankyrin"/>
   <result pre="of the transient receptor potential ankyrin type-1 (TRPA1) channel in" exact="migraine" post="pain: evaluation in an animal model Chiara Demartini 1,2,"/>
   <result pre="Florence, Italy Introduction - To date, the pharmacological treatment of" exact="migraine" post="remains somewhat unsatisfactory, partly because the pathophysiology of this"/>
   <result pre="of the transient receptor potential ankyrin type-1 (TRPA1) channels in" exact="migraine" post="pain. To further investigate the role of TRPA1 in"/>
   <result pre="further investigate the role of TRPA1 in the mechanisms of" exact="migraine" post="pain in an animal model of migraine using a"/>
   <result pre="the mechanisms of migraine pain in an animal model of" exact="migraine" post="using a novel TRPA1 antagonist (ADM_12) as a probe."/>
   <result pre="substance P (SP) in peripheral and central areas relevant for" exact="migraine" post="pain were analyzed. CGRP and SP protein immunoreactivity was"/>
   <result pre="in c-Fos and CGRP gene expression in areas involved in" exact="migraine" post="pain Rosaria Greco 1, Chiara Demartini 1,2, Anna Maria"/>
   <result pre="the trigeminovascular nociceptive system and it is likely implicated in" exact="migraine" post="chronicization. In the present study we investigated the role"/>
   <result pre="the present study we investigated the role of CGRP in" exact="migraine" post="chronicization in an animal model that mimics the condition"/>
   <result pre="underline the possibility and opportunity to pharmacologically intercept and prevent" exact="migraine" post="chronification. P183 Psychopathological profile of Medication Overuse Headache patients,"/>
   <result pre="M, Eusebi P, Sarchielli P, et al. Obsessive-compulsive disorder and" exact="migraine" post="with medication-overuse headache. Headache 2009, 49:1005–13. 3. Sarchielli P,"/>
   <result pre="J Neurol 2016, 23:85–91. P184 Education of the patient with" exact="migraine" post="Barbara Vitrani 1, Lidia Savi 2 1Master’s Degree in"/>
   <result pre="with M and 29% of F). The insomnia and the" exact="bruxism" post="are factors of chronification and aggravation of headache.We found"/>
   <result pre="Headache. 2008;48:1005-11. P187 Efficacy of KUZIK® in the prophylaxis of" exact="migraine" post="without aura: a retrospective observational study E.Pucci 1, F."/>
   <result pre="outpatient clinic, Verona; 7Gam Farma Srl. Milan Correspondence:E.Pucci Background A" exact="migraine" post="without aura is the most common type of migraine"/>
   <result pre="A migraine without aura is the most common type of" exact="migraine" post="headache ( about 60% to 80% of all migraines)."/>
   <result pre="and Methods Between January and April 2017, 30 patients with" exact="migraine" post="without aura were treated with Kuzik, once a day"/>
   <result pre="safety, and good tolerability of Kuzik in the prophylaxis of" exact="migraine" post="without aura and the use of this medication should"/>
   <result pre="serious clinical situation. References 1. Sanchez G et al.Course of" exact="migraine" post="in pregnancy and postpartum:a prospective study. Cephal 2003;23:197-205. 2."/>
   <result pre="Neurol Sci. May;2007;34:187-192. 4. Kvisik E et al Headache and" exact="migraine" post="during pregnancy and puerperium :the MIGRA-study.J Headache Pain 2011"/>
   <result pre="EV et al. Trends in pregnancy hospitalization that included a" exact="stroke" post="in USA from1994 to 2007 Stroke 2011;42: 2564-2570. P190"/>
   <result pre="Stroke 2011;42: 2564-2570. P190 Botulinum toxins for the prevention of" exact="migraine" post="in adults: the experience in headache Unit of Cassino"/>
   <result pre="Di Mauro, Fernando Ferrauti ASL Frosinone Correspondence:Ottavio Di Marco Background:" exact="migraine" post="is a severely debilitating desease, causing significant morbidity and"/>
   <result pre="toxin was shown to be effective in treatment of chronic" exact="migraine" post="(Kollowe, 2016) Materials and methods: 24 patients, suffering from"/>
   <result pre="(Kollowe, 2016) Materials and methods: 24 patients, suffering from chronic" exact="migraine" post="as defined by ICHD-3 ß criteria, subjected to at"/>
   <result pre="± 2,88). At T0 the sample had 13,6 days/month with" exact="migraine" post="and hight vaue of disability expecially in work and"/>
   <result pre="higher level of disability at DISS and average frequency of" exact="migraine" post="episodes of 15.87 (ds ± 4.2) days per month."/>
   <result pre="References Bigal ME, Serrano D, Reed M, Lipton RB. Chronic" exact="migraine" post="in the population - Burden, diagnosis, and satisfaction with"/>
   <result pre="D, Paracka L, Mohammadi B, KarstM. Long-term treatment of chronic" exact="migraine" post="with OnabotulinumtoxinA: efficacy, quality of life and tolerability in"/>
   <result pre="recent study, we found an association between ambivalent attachment style," exact="migraine" post="severity and psychological symptoms in children/adolescents. There is evidence"/>
   <result pre="role of maternal alexithymia and attachment style on their children’s" exact="migraine" post="severity (intensity and frequency) and psychological profile (anxiety, depression,"/>
   <result pre="Materials and methods. We enrolled 84 consecutive patients suffering from" exact="migraine" post="without aura (female: 45, male: 39; age range 8-18"/>
   <result pre="were divided into two groups according to frequency of the" exact="migraine" post="episodes (high or low). According to headache attack intensity,"/>
   <result pre="show any relationship between TAS-20 and ASQ questionnaires and children’s" exact="migraine" post="intensity and frequency. Conclusions. Maternal alexithymia and attachment style"/>
   <result pre="Maternal alexithymia and attachment style have no impact on children's" exact="migraine" post="frequency and intensity. However, our results suggest that, although"/>
   <result pre="maternal alexithymic traits don’t play a causative role on children’s" exact="migraine" post="severity, they show a relationship with patients’ attachment style"/>
   <result pre="style and psychological symptoms, which in turn may impact on" exact="migraine" post="severity. P192 Vitamin D as a possible new treatment"/>
   <result pre="severity. P192 Vitamin D as a possible new treatment for" exact="migraine" post="Baoran Yang 1,2, Giorgia Leodori 1,2, Emma De Maio"/>
   <result pre="Methods: 45 patients aged 18-50 years and suffering from primary" exact="migraine" post="were enrolled in the study. Patients were divided into"/>
   <result pre="into three main subgroup: Group 1: patients suffering from mild" exact="migraine" post="(no more than 4 days of disability per month"/>
   <result pre="with vitamin D administration only. Group 2: patients with moderate-severe" exact="migraine" post="(more than 4 days of disability per month or"/>
   <result pre="Pain Rating scale ranging from 0 to 10) of the" exact="migraine" post="attacks during the month. These two values were then"/>
   <result pre="1, treated with vitamin D administration only, a reduction in" exact="migraine" post="severity of 67% was observed at the end of"/>
   <result pre="combined treatment (group 3) resulted 1,24 more effective in reducing" exact="migraine" post="severity than traditional therapy alone (group 2) (Fig. 1)."/>
   <result pre="during the study was not statistically significative. Conclusion: Currently, mild" exact="migraine" post="is normally treated with once-a-need anti-inflammatory drugs. In our"/>
   <result pre="our study Vitamin D administration for the treatment of mild" exact="migraine" post="resulted effective, with a decrease in the number of"/>
   <result pre="tone. Combined treatment with vitamin D plus traditional therapy improved" exact="migraine" post="symptoms of 69%, and this result suggests that vitamin"/>
   <result pre="may improve the efficacy of traditional therapy alone for severe" exact="migraine" post="(Fig. 2). Fig. 2 (abstract P192). See text for"/>
   <result pre="Photobiol B 2010;101:142–149. P193 Clinical presentation and diagnostic evaluation of" exact="idiopathic intracranial hypertension" post="in children and adolescents Barbara Battan, Laura Papetti, Irene"/>
   <result pre="present report was to describe the features of chronic paroxysmal" exact="migraine" post="in four pediatric patients. Objectives. Chronic paroxysmal hemicrania (CPH)"/>
   <result pre="present report was to describe the features of chronic paroxysmal" exact="migraine" post="in four pediatric patients. Results. We detected 4 patients"/>
   <result pre="its possible correlation with cognitive impairment and driving performance in" exact="migraine" post="patients; pilot study Matteo Bellamio 1, Federico Mainardi 2,"/>
   <result pre="cases. Most prevalent primary forms are tension type headache and" exact="migraine" post="without aura and there are specific criteria and guidelines"/>
   <result pre="other trigeminal autonomic cephalalgias, as well (2). As far as" exact="migraine" post="pathophysiology is studied, it remains poorly defined and partially"/>
   <result pre="partially understood: although the areas involved in the development of" exact="migraine" post="attacks are mainly localized in the brainstem (3), other"/>
   <result pre="included the basal ganglia, seem to play a role during" exact="migraine" post="attacks (4). Because of this pathogenetic complexity, there are"/>
   <result pre="patients. Therefore the few observations we have about DBS in" exact="migraine" post="derived from case reports conducted on patients with different"/>
   <result pre="example, a recent case reported a significant improvement of chronic" exact="migraine" post="after anterior thalamic DBS, performed for drug-resistant idiopathic generalized"/>
   <result pre="particular in the movement impairment. The patient suffered from chronic" exact="migraine" post="too: prophylactic treatments with topiramate 50 mg x 2"/>
   <result pre="justified: results of a real-life monocentric prospective study in chronic" exact="migraine" post="Michele Romoli 1, Ilenia Corbelli 1, Laura Bernetti 1,"/>
   <result pre="Santa Lucia, Rome, Italy Correspondence: Michele Romoli (romoli.mic@gmail.com) Background Chronic" exact="migraine" post="(CM) is a highly disabling headache disorder (1). Onabotulinum"/>
   <result pre="to 9.2 ± 3.6; p&amp;lt;0.001). During 12 months (5 cycles)," exact="migraine" post="days per month progressively abated (from 18.5 to 8.7;"/>
   <result pre="2). Over 5 cycles, patients regressing from CM to episodic" exact="migraine" post="doubled (from 32% to 66%), with 78% of them"/>
   <result pre="to 66%), with 78% of them reaching less than 9" exact="migraine" post="days/month. Conclusions The positive effect of OnabotA treatment seems"/>
   <result pre="5-hydroxy tryptophan and magnesium (Aurastop®) in the prophylaxis of episodic" exact="migraine" post="without aura in a adult population Alessandra Mandelli, Natascia"/>
   <result pre="magnesium 185 mg (TP-5HT-M) Aurastop ® in the prophylaxis of" exact="migraine" post="without aura with an episodic pattern. Materials and methods"/>
   <result pre="age 32.9) presenting with a ICHD 3 βeta diagnosis of" exact="migraine" post="without aura with a frequency of less than 10"/>
   <result pre="were enrolled in the survey. Patients were suffering from episodic" exact="migraine" post="for at least 6 months and they were not"/>
   <result pre="at least 6 months and they were not assuming any" exact="migraine" post="preventive therapy. Patients were asked to report in the"/>
   <result pre="tablet bid for the following 3 months. The reduction of" exact="migraine" post="attacks per month was assessed as the primary end-point,"/>
   <result pre="5 was the maximum satisfaction. Results A significant reduction of" exact="migraine" post="attacks per month (mean 2.8 vs 6.6) and number"/>
   <result pre="mg) and Magnesium (185 mg) (Aurastop®) is now available for" exact="migraine" post="patients. The three components may tackle the main mechanisms"/>
   <result pre="may tackle the main mechanisms involved in the pathophysiology of" exact="migraine" post="with aura: Cortical Spreading Depression, sensitization of trigeminal vascular"/>
   <result pre="(mean age:33.00 yrs), 117 F and 83 M, suffering from" exact="migraine" post="with aura referred to 8 Lombardia Headache Centers. Patients"/>
   <result pre="and 5-HTP (Aurastop®) could be an effective symptomatic treatment for" exact="migraine" post="aura. Randomised controlled trials are still required to confirm"/>
   <result pre="Martelletti P. Altered kynurenine pathway metabolites in serum of chronic" exact="migraine" post="patients. Journal of Headache pain 2015 Dec; 17(1):47. -"/>
   <result pre="To present the rare case of a 9-year-old girl with" exact="idiopathic intracranial hypertension" post="(IIH) secondary to hypoparathyroidism (HPTH) and our work-up, including"/>
   <result pre="a 9-year-old girl with idiopathic intracranial hypertension (IIH) secondary to" exact="hypoparathyroidism" post="(HPTH) and our work-up, including physical examination, blood tests,"/>
   <result pre="J Neurol Neurosurg Psychiatry 1977; 40:1015-7. P202 Efficacy in episodic" exact="migraine" post="prevention of a combination of Tanacethum Parthenium, 5 -"/>
   <result pre="to test the effectiveness of Aurastop© in the prophylaxis of" exact="migraine" post="without aura. Materials and methods: Sixty consecutive patients (F:"/>
   <result pre="mean age: 37.5±17.1) presenting with an ICHD-3 beta diagnosis of" exact="migraine" post="without aura (MO) were enrolled in the survey and"/>
   <result pre="Martelletti P. Altered kynurenine pathway metabolites in serum of chronic" exact="migraine" post="patients. J Headache Pain. 2015; 17: 47. Geppetti P,"/>
   <result pre="safety of 6,25 mg t.i.d feverfew CO2-extract ( MIG-99) in" exact="migraine" post="prevention – a randomized, double blind, multicenter, placebo controlled"/>
   <result pre="prophylactic treatment of cluster headache (CH) is to produce a" exact="suppression" post="of attacks and to maintain a remission until the"/>
   <result pre="on the four main mechanisms involved in the pathophysiology of" exact="migraine" post="with aura: Cortical Spreading Depression, sensitization of trigeminal vascular"/>
   <result pre="is well known to interact with the aura phenomena and" exact="migraine" post="itself.With this study we want to compare the efficacy"/>
   <result pre="31 years ), 27 women and 23 men, suffering from" exact="migraine" post="with aura, not assuming migraine preventive therapy. They have"/>
   <result pre="and 23 men, suffering from migraine with aura, not assuming" exact="migraine" post="preventive therapy. They have to refer of an aura"/>
   <result pre="Martelletti P. Altered kynurenine pathway metabolites in serum of chronic" exact="migraine" post="patients. Journal of Headache pain 2015 Dec; 17(1):47. Geppetti"/>
   <result pre="Tanacethum Parthenium, 5-hydroxy tryptophan and magnesium in the prophylaxis of" exact="migraine" post="without aura Federico Mainardi 1, Giorgio Zanchin 2, Carlo"/>
   <result pre="an extensive literature supporting their role in the prophylaxis of" exact="migraine" post="without aura. Aim of this study is to prove"/>
   <result pre="mg and magnesium 185 mg (TP-5HT-M) in the prophylaxis of" exact="migraine" post="without aura. Materials and methods: Twenty consecutive patients (F:"/>
   <result pre="M: n=3) presenting with a ICHD 3 beta diagnosis of" exact="migraine" post="without aura (MO) were enrolled in the survey. Age"/>
   <result pre="for a status migrainosus. She was previously followed for episodic" exact="migraine" post="without aura (ICHD-3). During the month preceding hospital-admission, the"/>
   <result pre="Yang CY. Reversible splenial lesion of the corpus callosum in" exact="migraine" post="with aura. Neurologist. 2011; 17:157-159. 4. Agarwal A, Kanupriya"/>
   <result pre="restricted diffusion in the splenium of the corpus callosum in" exact="migraine" post="with aura. Wien Klin Wochenschr. 2012; 124:146-147. 5. Samanta"/>
   <result pre="During pregnancy, headache is mostly due to primary disorders, including" exact="migraine" post="and tension-type headache. Pregnancy tends to ameliorate migraine that"/>
   <result pre="disorders, including migraine and tension-type headache. Pregnancy tends to ameliorate" exact="migraine" post="that however may also begin or worsen in this"/>
   <result pre="to the foetus, should be avoided during pregnancy. However, severe" exact="migraine" post="is often not controlled by nonpharmacologic strategies, and many"/>
   <result pre="women before pregnancy received a diagnosis by a physician of" exact="migraine" post="(n=15) or tension-type headache (n=3). The mean frequency of"/>
   <result pre="2. Nezvalová-Henriksen K, Spigset O, Nordeng H. Maternal characteristics and" exact="migraine" post="pharmacotherapy during pregnancy: cross-sectional analysis of data from a"/>
   <result pre="In the second, episodic forms of tension type headache or" exact="migraine" post="(with or without aura). We have tested the CDSS"/>
   <result pre="a diagnosis of episodic forms of tension type headache or" exact="migraine" post="with or without aura (Simplex category); 86 patients have"/>
   <result pre="1 (abstract P219). A representative report of a single chronic" exact="migraine" post="patient, female, 43 years old, showing the reduction of"/>
   <result pre="Not P212 Withdrawn P213 Non pharmacological preventive therapy to chronic" exact="migraine" post="in the real world: a Short-Term Psychodynamic Psychotherapy approach"/>
   <result pre="(IREP), 00187 - Rome, Italy Correspondence:Barbara Petolicchio (barbara.petolicchio@uniroma1.it) Background Chronic" exact="migraine" post="(CM) represents one of the leading causes of disability."/>
   <result pre="study. J Headache Pain 2013; 14 (S13-S41): 31 P214 Chronic" exact="migraine" post="preventive treatment by prefrontal-occipital transcranial direct current stimulation (TDCS):"/>
   <result pre="without medication overuse headache (MOH), represents a therapeutic challenge in" exact="migraine" post="management. These patients have frequently psychiatric comorbidities that may"/>
   <result pre="20 min, three times a week for four weeks). Clinical" exact="migraine" post="data were recorded at baseline (t-0), at the end"/>
   <result pre="without MOH were studied. We found 6 patients affected by" exact="bipolar disorder" post="(BD), and 5 other patients with bipolar spectrum. In"/>
   <result pre="CM is higher than expected in both general population and" exact="migraine" post="patients. BD patients showed a worse baseline headache burden"/>
   <result pre="current International Classification of Headaches Disorders (ICHD-3 beta, 2013) of" exact="migraine" post="without or with aura (&amp;gt; 4 attacks/month), chronic migraine,"/>
   <result pre="The last is the only drug licensed in Italy for" exact="migraine" post="prophylaxis in children. Outcomes: headache diary; PedMidas and CBCL"/>
   <result pre="Neurological Institute in Pavia, Italy. All consecutive patients with chronic" exact="migraine" post="and medication overuse headache undergoing an inpatient detoxification program"/>
   <result pre="with several conditions including cardiovascular diseases [1,2]. The association between" exact="migraine" post="and several thrombophilic alterations has been studied in migraineurs,"/>
   <result pre="of the present study was to assess the association between" exact="migraine" post="and some thrombophilic disorders. Methods We included consecutive migraine"/>
   <result pre="between migraine and some thrombophilic disorders. Methods We included consecutive" exact="migraine" post="patients referring to a tertiary headache center between September"/>
   <result pre="1 st 2008 and March 31 st 2010. For each" exact="migraine" post="patient a control subject without migraine, matched by age"/>
   <result pre="μmol/L). Results We included in the study 329 subjects with" exact="migraine" post="(37.7% with aura) and 329 controls. Mean age±SD was"/>
   <result pre="OR 2.6; 95% CI 1.5-4.7; P=0.001) were more common in" exact="migraine" post="patients than in control subjects whereas we found no"/>
   <result pre="cerebrovascular diseases (OR 4.8, 95% CI 1.6-16.9; P=0.004) and ischemic" exact="heart disease" post="(OR 22.7, 95% CI 2.3-223.4; P=0.008) than those not"/>
   <result pre="find any difference in the thrombophilic disorders between subjects with" exact="migraine" post="with and without aura. Discussion Migraine is comorbid with"/>
   <result pre="history as an analgesic medication in chronic pain, neuralgia and" exact="migraine" post="[1]. It contains more than 60 phytocannabinoids, all ligands"/>
   <result pre="increasing, because they have improved post-surgical pain, as well as" exact="migraine" post="symptoms, with a safety profile comparable to the most"/>
   <result pre="Background Onabotulintoxin A (BONTA) is a treatment recommended for chronic" exact="migraine" post="CM). Its efficacy in reducing migraine frequency and disability"/>
   <result pre="treatment recommended for chronic migraine CM). Its efficacy in reducing" exact="migraine" post="frequency and disability was fully demonstrated (1), though its"/>
   <result pre="paper pain diaries. Results. A significant and progressive reduction of" exact="migraine" post="episodes was observed from the paper and the electronic"/>
   <result pre="groups,R group was significantly older and with more years of" exact="migraine" post="in history than SF group.Moreover, in R group, the"/>
   <result pre="diagnosis (young age and/or few years of episodic and chronic" exact="migraine" post="in history) of MOH is needed to ensure a"/>
   <result pre="(SIH) complicated with convexity subaracnoid haemorragy (SAH) in patient with" exact="lung cancer" post="Francesca Marsili 1, Antonio Matera 1, Luca Onofrio Scappatura"/>
   <result pre="complicated with convexity subaracnoid haemorragy (SAH) in patient with lung" exact="cancer" post="Francesca Marsili 1, Antonio Matera 1, Luca Onofrio Scappatura"/>
   <result pre="of a cortical bridging vein. We describe one patient with" exact="lung cancer" post="who had orthostatic headache secondary to SIH complicated with"/>
   <result pre="a cortical bridging vein. We describe one patient with lung" exact="cancer" post="who had orthostatic headache secondary to SIH complicated with"/>
   <result pre="A 64 years old male undergone to left pneumectomy for" exact="lung cancer" post="one year before, presented with one month history of"/>
   <result pre="64 years old male undergone to left pneumectomy for lung" exact="cancer" post="one year before, presented with one month history of"/>
   <result pre="intracranial hypotension. Eur J Neurol 2010; 17:715-719 P223 Awareness of" exact="migraine" post="in Neo-Latin countries: a study in 12 headache centers"/>
   <result pre="Pavia, Italy Correspondence:Michele Viana Objectives To assess the awareness of" exact="migraine" post="(M) and previous diagnostic and therapeutic paths in naïf"/>
   <result pre="Italy), tension-type headache (3%, mostly in Mexico, Chile and Uruguay)," exact="sinusitis" post="(1%). After multivariate analysis factors associated with the awareness"/>
   <result pre="to radiation. 28% of patients had previously received a symptomatic" exact="migraine" post="specific medication and 29% had received at least one"/>
   <result pre="P223). Association between sociodemographical and clinical factors and awarness of" exact="migraine" post="Sign OR (95% CI) High educational level &amp;lt;0.001 1.97"/>
   <result pre="educational level &amp;lt;0.001 1.97 (1.43-2.78) Number of family members with" exact="migraine" post="0.005 1.17 (1.04-1.31) Duration of attacks (hours) 0.001 0.98"/>
   <result pre="afferent inhibition discloses abnormal fluctuations of cholinergic transmission during the" exact="migraine" post="cycle Davide Di Lenola 1, Gianluca Coppola 2, Francesca"/>
   <result pre="(mostly GABAa) cortical networks. Materials and methods We recruited 30" exact="migraine" post="without aura patients (16 between [MO] and 14 during"/>
   <result pre="attack. P227 The clinical efficacy of short-lasting ketogenic diet in" exact="migraine" post="is due to a general normalization of the interictal"/>
   <result pre="period of ketogenic diet (KD) regimen can help to prevent" exact="migraine" post="and can normalize its interictal abnormal cortical hyperresponsivity. Here,"/>
   <result pre="the right supraorbital division of the trigeminal nerve in 18" exact="migraine" post="without aura patients before and after 1-month of KD,"/>
   <result pre="that the clinical efficacy of a short-lasting KD regimen in" exact="migraine" post="can be primarily due to a general normalization of"/>
   <result pre="activation. P228 Cerebral grey matter density is reduced in chronic" exact="migraine" post="patients: correlations with clinical features Gianluca Coppola 1, Barbara"/>
   <result pre="studies have explored brain morphometry in patients affected by chronic" exact="migraine" post="(CM). Most of these studies were performed in patients"/>
   <result pre="ORAL PRESENTATIONS O1 Efficacy of erenumab in subjects with episodic" exact="migraine" post="with prior preventive treatment failure(s) Koen Paemeleire 1, Gregor"/>
   <result pre="Background There is a high unmet need for new preventive" exact="migraine" post="treatments, especially for patients who have failed existing migraine"/>
   <result pre="preventive migraine treatments, especially for patients who have failed existing" exact="migraine" post="therapies. Erenumab is a fully human monoclonal antibody that"/>
   <result pre="mg and 140 mg demonstrated efficacy in subjects with episodic" exact="migraine" post="and showed a safety profile similar to placebo. Here"/>
   <result pre="and/or intolerability. Analyses included change from baseline in mean monthly" exact="migraine" post="days (MMDs) and achievement of ≥50% reduction from baseline"/>
   <result pre="140 mg erenumab in subjects who had previously failed preventive" exact="migraine" post="treatments. For 140 mg, effects were numerically greater in"/>
   <result pre="for reducing raised intracranial pressure (ICP) in conditions such as" exact="idiopathic intracranial hypertension" post="have limited efficacy and tolerability. As such, there is"/>
   <result pre="novel therapeutic strategy for conditions of raised ICP such as" exact="idiopathic intracranial hypertension." post="Additionally, GLP-1R agonist therapy promotes weight loss, which would"/>
   <result pre="agonist therapy promotes weight loss, which would be advantageous in" exact="idiopathic intracranial hypertension." post="O3 Phase 3, randomised, double-blind, placebo-controlled study to evaluate"/>
   <result pre="evaluate the efficacy and safety of erenumab (AMG 334) in" exact="migraine" post="prevention: Primary results of the STRIVE trial Uwe Reuter"/>
   <result pre="a human anti-CGRP receptor monoclonal antibody, were evaluated in episodic" exact="migraine" post="(EM) subjects in a multinational, phase 3 trial (NCT02456740)."/>
   <result pre="The primary endpoint was change from baseline in mean monthly" exact="migraine" post="days (MMDs) over weeks 13-24. Secondary endpoints were ≥50%"/>
   <result pre="sinusitis. Conclusion Erenumab 70 mg and 140 mg significantly reduced" exact="migraine" post="frequency and use of migraine-specific medications, reducing migraine’s impact"/>
   <result pre="of distributed neural excitability: correlation with clinical features in single" exact="migraine" post="with aura patients Marina de Tommaso 1,2, Julia Maria"/>
   <result pre="(marina.detommaso@uniba.it) Background Cortical spreading depression (SD) is thought to underlie" exact="migraine" post="aura but mechanisms of triggering SD and propagation in"/>
   <result pre="triggering SD and propagation in the structurally normal cortex of" exact="migraine" post="patients is still unknown. Some studies showed that the"/>
   <result pre="still unknown. Some studies showed that the sensory predominance of" exact="migraine" post="aura is likely due to a greater susceptibility of"/>
   <result pre="their structural complexity [1]. We used MRI imaging registration in" exact="migraine" post="with aura patients to elaborate a CSD propagation logarithm"/>
   <result pre="1, 2, 3, 4, 44, 45, 17, 18) in five" exact="migraine" post="with aura patients. According to the map of the"/>
   <result pre="blockades. Botulinum toxin injections are also approved effective methods for" exact="migraine" post="all over the World. There is some other indications"/>
   <result pre="and methods Eligible patients 18-65 years of age with chronic" exact="migraine" post="(≥15 headache days per month, of which at least"/>
   <result pre="was the overall mean change-from-baseline in the number of monthly" exact="migraine" post="headache days (MHD) during the 3-month double-blind treatment period."/>
   <result pre="as well as the changes in monthly MHD with acute" exact="migraine" post="treatments, the Role Function-Restrictive domain score of the Migraine-Specific"/>
   <result pre="≥75% response (p&amp;lt;.001), greater reductions in monthly MHD with acute" exact="migraine" post="treatment (p&amp;lt;.001), and greater improvement in the MSQ-RFR (p&amp;lt;.001)"/>
   <result pre="of injection site reaction (p&amp;lt;.05), injection site erythema (p&amp;lt;.01), and" exact="sinusitis" post="(p&amp;lt;.05) all in the 240-mg dose-group relative to placebo."/>
   <result pre="as NCT02614261 at ClinicalTrials.gov. O7 Improving the differential diagnosis between" exact="migraine" post="with aura and transient ischemic attacks Elena R Lebedeva"/>
   <result pre="Denmark Correspondence:Elena R Lebedeva (cosmos@k66.ru) Background The differential diagnosis between" exact="migraine" post="with aura (MA) and transient ischemic attacks (TIA) is"/>
   <result pre="clinical characteristics. Eligible patients with TIA had focal brain or" exact="retinal ischemia" post="with resolution of symptoms without presence of new infarction"/>
   <result pre="for specificity against TIA patients and for sensitivity against the" exact="migraine" post="materials. We developed explicit diagnostic criteria for TIA and"/>
   <result pre="and specificity. We strongly recommend implementation of these criteria in" exact="migraine" post="and cerebrovascular clinics. References 1. Easton JD, Saver JL,"/>
   <result pre="been demonstrated in clinical practice and pilot studies of acute" exact="migraine" post="treatment [1,2]. The ease of use, flexibility, and favourable"/>
   <result pre="double-blind, randomised, controlled trial (RCT) included 248 patients with episodic" exact="migraine" post="with or without aura from 10 Italian tertiary headache"/>
   <result pre="and those of previous nVNS studies. Within 20 minutes from" exact="migraine" post="pain onset, patients self-administered bilateral 120-second stimulations to the"/>
   <result pre="before 120 minutes was considered treatment failure. Up to 5" exact="migraine" post="attacks were treated in the double-blind period. Results Acute"/>
   <result pre="higher pain-free rates than sham (n=123) for the first treated" exact="migraine" post="attack at 30 minutes (12.7% vs 4.2%; P=0.012) and"/>
   <result pre="well tolerated, and practical for the acute treatment of episodic" exact="migraine" post="with or without aura. Significant benefits of nVNS versus"/>
   <result pre="J Headache Pain. 2015;16:61-65. O10 Differences between episodic and chronic" exact="migraine" post="in white-matter tracts: a diffusion-tensor imaging study Claudia Marsecano"/>
   <result pre="L’Aquila, Italy Correspondence:Simona Sacco (simona.sacco@univaq.it) Background Several studies indicated that" exact="migraine" post="patients have tract-specific alterations in several white-matter tracts as"/>
   <result pre="controls [1-12]. We investigated differences in white-matter tracts between episodic" exact="migraine" post="(EM) patients and chronic migraine (CM) patients. Materials and"/>
   <result pre="in white-matter tracts between episodic migraine (EM) patients and chronic" exact="migraine" post="(CM) patients. Materials and methods We included consecutive eligible"/>
   <result pre="and 20 CM patients (mean age±SD 43.8±6.9). Years lived with" exact="migraine" post="were similar in EM (mean±SD 14.3±7.0) and CM (mean±SD"/>
   <result pre="patients showed a negative age-adjusted correlation between years lived with" exact="migraine" post="and FA in the uncinate fasciculus (r=-.501; P=.048). CM"/>
   <result pre="patients showed a positive age-adjusted correlation between years lived with" exact="migraine" post="and MD in the corpus callosum forceps major (r=.500;"/>
   <result pre="P=.050). We did not find any correlation between frequency of" exact="migraine" post="attacks and MD or FA nor in the EM"/>
   <result pre="results also indicate that the longer the years lived with" exact="migraine" post="the greater is the impairment in selected white-matter tracts."/>
   <result pre="in selected white-matter tracts. In summary, our data suggest that" exact="migraine" post="type and number of years with migraine affects white-matter"/>
   <result pre="data suggest that migraine type and number of years with" exact="migraine" post="affects white-matter tract status. References 1. Chong CD, Schwedt"/>
   <result pre="Bianco F, Pierelli F. Dynamic changes in thalamic microstructure of" exact="migraine" post="without aura patients: A diffusion tensor magnetic resonance imaging"/>
   <result pre="N. Anatomical alterations of the visual motion processing network in" exact="migraine" post="with and without aura. PLoS Med 2006;3:e402. 4. Kara"/>
   <result pre="Ulusoy L, Mutlu A, Sirvanci M. DTI findings during spontaneous" exact="migraine" post="attacks. Clin Neuroradiol 2013;23:31-36. 5. Liu J, Lan L,"/>
   <result pre="Tian J. White matter integrity affected by depressive symptoms in" exact="migraine" post="without aura: a tract-based spatial statistics study. NMR Biomed"/>
   <result pre="Deneen KM, Tian J. Axonal loss of white matter in" exact="migraine" post="without aura: A tract-based spatial statistics study. Cephalalgia 2013;"/>
   <result pre="of corpus callosum modulates inter-hemispheric resting state functional connectivity in" exact="migraine" post="patients without aura. PloS One 2012;7:e45476. O11 Headache following"/>
   <result pre="O12 Cerebral grey matter density is abnormally reduced in chronic" exact="migraine" post="patients: correlations with clinical features Gianluca Coppola 1, Barbara"/>
   <result pre="studies have explored brain morphometry in patients affected by chronic" exact="migraine" post="(CM). Most of these studies were performed in patients"/>
   <result pre="various conditions, many with a greater relative frequency in chronic" exact="migraine" post="(CM) versus episodic migraine (EM). The objective of this"/>
   <result pre="a greater relative frequency in chronic migraine (CM) versus episodic" exact="migraine" post="(EM). The objective of this study was to replicate"/>
   <result pre="Psychiatric, and Endocrine/Neurological comorbidity categories. Results Available CaMEO respondents with" exact="migraine" post="(16,763) were sent the Comorbidities/Endophenotype module and 12,810 (76.4%:"/>
   <result pre="gene-related peptide (CGRP) and sildenafil are vasoactive substances that induce" exact="migraine" post="attacks in patients. The intradural arteries are thought to"/>
   <result pre="never been examined in vivo. Furthermore, sildenafil is the only" exact="migraine" post="inducing compound, where cephalic dilation is not reported. Here,"/>
   <result pre="sildenafil dilate intradural arteries, supporting the notion that all pharmacological" exact="migraine" post="triggers, so far, do indeed dilate cephalic vessels. We"/>
   <result pre="University of L’Aquila, L’Aquila, Italy Correspondence:Francesca Pistoia (francesca.pistoia@univaq.it) Background Chronic" exact="migraine" post="(CM) may be associated to specific cortical and subcortical"/>
   <result pre="causal relationship between these changes and the clinical course of" exact="migraine" post="or whether they are rather an epiphenomenon. The objective"/>
   <result pre="Materials and methods We included consecutive eligible patients with episodic" exact="migraine" post="(EM) or CM referring to a tertiary headache center."/>
   <result pre="and 17 CM patients (mean age±SD 43.1±6.4). Years lived with" exact="migraine" post="were not significantly different in EM (mean±SD 18.2±10.6) as"/>
   <result pre="disease duration, a negative age-adjusted correlation between years lived with" exact="migraine" post="and volumetric reduction was found in right (p&amp;lt;0.001) and"/>
   <result pre="Regions showing a volumetric reduction might represent crucial hubs in" exact="migraine" post="activity and pathophysiology. A better understanding of their role"/>
   <result pre="provide a model to improve treatment options in patients with" exact="migraine" post="[8]. References 1. Bilgiç B, Kocaman G, Arslan AB,"/>
   <result pre="population) and of Cluster Headache 0.01% (n=0.74K of population). Chronic" exact="migraine" post="one-year prevalence was 1% (n=0.7K of population). Females tend"/>
   <result pre="EVOLVE-2) to determine superiority to placebo in the prevention of" exact="migraine" post="headache. Methods EVOLVE-1 and EVOLVE-2 were double-blind, 6-month studies"/>
   <result pre="and EVOLVE-2 were double-blind, 6-month studies in patients with episodic" exact="migraine" post="(4 to 14 monthly migraine headache days [MHD]) conducted"/>
   <result pre="studies in patients with episodic migraine (4 to 14 monthly" exact="migraine" post="headache days [MHD]) conducted in North America and globally,"/>
   <result pre="overall mean change from baseline in monthly MHD with acute" exact="migraine" post="treatments, and mean change from baseline over Months 4-6"/>
   <result pre="overall mean reduction of monthly number of MHD with acute" exact="migraine" post="treatment for both galcanezumab doses relative to placebo (both"/>
   <result pre="effectiveness and safety of real-life use of onabotulinumtoxinA for chronic" exact="migraine" post="(CM). Materials and Methods Adults prescribed onabotulinumtoxinA for CM"/>
   <result pre="to moderate severity, were reported by 18.3% of patients; eyelid" exact="ptosis" post="(5.4%), neck pain (3.0%), and musculoskeletal stiffness (2.7%) were"/>
   <result pre="(* P&amp;lt;0.001) O20 Abnormal peripheral and central visual processing in" exact="migraine" post="Filippo Brighina, Elisa Catalano, Viviana Firpo, Giuseppe Cosentino, Salvatore"/>
   <result pre="recent study with SIFI confirmed hyperexcitability of visual cortex in" exact="migraine" post="[2]; patients with migraine show abnormality of chromatic perception"/>
   <result pre="confirmed hyperexcitability of visual cortex in migraine [2]; patients with" exact="migraine" post="show abnormality of chromatic perception with a more relevant"/>
   <result pre="with migraine, with and without aura examined interictally. Subjects: 15" exact="migraine" post="patients with aura (MWA) and 15 without aura(MWoA) were"/>
   <result pre="Baschi R, Vallar G, Fierro B. Visual cortex hyperexcitability in" exact="migraine" post="in response to sound-induced flash illusions. Neurology. 2015 May"/>
   <result pre="firing rate and might be involved in the pathogenesis of" exact="migraine" post="[1]. We sought to determine the relationship between plasma"/>
   <result pre="the relationship between plasma levels of neurosteroids in patients with" exact="migraine" post="and cluster headache. Materials and Methods Patients with episodic"/>
   <result pre="migraine and cluster headache. Materials and Methods Patients with episodic" exact="migraine" post="(EM, n=19), chronic migraine and medication overuse headache (CM,"/>
   <result pre="Materials and Methods Patients with episodic migraine (EM, n=19), chronic" exact="migraine" post="and medication overuse headache (CM, n=51), and cluster headache"/>
   <result pre="respectively. This suggests an attempt to modulate neuronal hyperexcitability in" exact="migraine" post="patients. Changes of neurosteroids concentrations in CH patients were"/>
   <result pre="and 100 mg) compared to placebo for acute treatment of" exact="migraine" post="Bernice Kuca 1; Linda Wietecha 2; Paul H Berg"/>
   <result pre="or photophobia) at 2 hours post dose, time course of" exact="migraine" post="response, rescue, and safety following treatment with lasmiditan 200"/>
   <result pre="mg) or placebo within 4 hours of onset of a" exact="migraine" post="attack (moderate severity or worse and not improving). Subjects"/>
   <result pre="assigned lasmiditan dose or placebo for rescue or recurrence of" exact="migraine" post="if needed (2 to 24 hours post initial dose);"/>
   <result pre="via logistic regression with terms for treatment group and background" exact="migraine" post="preventative use. Lasmiditan 100 mg and placebo were also"/>
   <result pre="which there are ample of evidence in human subjects suffering" exact="epilepsy" post="(and PIH), and thus, it bypass the bitter debate"/>
   <result pre="debate over the validity of studying the headache phase of" exact="migraine" post="using the controversial cortical spreading depression model – to"/>
   <result pre="actual occurrence in humans are scarce. O24 Association between subclinical" exact="hypothyroidism" post="and migraine Innocenzo Rainero 1,2*, Flora Govone 1, Francesca"/>
   <result pre="in humans are scarce. O24 Association between subclinical hypothyroidism and" exact="migraine" post="Innocenzo Rainero 1,2*, Flora Govone 1, Francesca Garino 3,"/>
   <result pre="increased attention has been devoted to the potential association between" exact="migraine" post="and thyroid function, with conflicting results. A few studies"/>
   <result pre="thyroid function, with conflicting results. A few studies found that" exact="migraine" post="may be associated with an increased risk for the"/>
   <result pre="increased risk for the development of both overt and subclinical" exact="hypothyroidism" post="(SH). On the contrary, the risk of developing migraine"/>
   <result pre="subclinical hypothyroidism (SH). On the contrary, the risk of developing" exact="migraine" post="in patients with hypothyroidism has been scarcely investigated. Therefore,"/>
   <result pre="the contrary, the risk of developing migraine in patients with" exact="hypothyroidism" post="has been scarcely investigated. Therefore, the main purpose of"/>
   <result pre="of our study was to investigate the association between subclinical" exact="hypothyroidism" post="and migraine in adults, using a case-control strategy. Materials"/>
   <result pre="study was to investigate the association between subclinical hypothyroidism and" exact="migraine" post="in adults, using a case-control strategy. Materials and methods"/>
   <result pre="9.19 years) were recruited for the study. In all subjects," exact="migraine" post="characteristics were collected through a direct face-to-face interview, using"/>
   <result pre="and anti-peroxidase antibodies) were compared between SH patients with comorbid" exact="migraine" post="and SH patients without migraine. Results The prevalence of"/>
   <result pre="and SH patients without migraine. Results The prevalence of lifetime" exact="migraine" post="was significantly higher in SH patients in comparison with"/>
   <result pre="vs 13%, p&amp;lt; 0.001; OR 5.80; 95% CI= 3.35-10.34). Both" exact="migraine" post="without aura and migraine with aura were significantly higher"/>
   <result pre="OR 5.80; 95% CI= 3.35-10.34). Both migraine without aura and" exact="migraine" post="with aura were significantly higher in SH patients than"/>
   <result pre="and antibodies levels were not different between SH patients with" exact="migraine" post="and those SH patients without migraine. Finally, a higher"/>
   <result pre="comorbidity for autoimmune diseases was found in SH patients with" exact="migraine" post="respect to SH patients without migraine. Conclusions Our data"/>
   <result pre="to SH patients without migraine. Conclusions Our data suggest that" exact="migraine" post="is significantly more frequent in patients with subclinical hypothyroidism"/>
   <result pre="that migraine is significantly more frequent in patients with subclinical" exact="hypothyroidism" post="respect to controls. Additional studies are needed in order"/>
   <result pre="that is involved in Cl - ions transport. Coexistence of" exact="cystic fibrosis" post="and sporadic hemiplegic migraine (SHM) has been reported in"/>
   <result pre="- ions transport. Coexistence of cystic fibrosis and sporadic hemiplegic" exact="migraine" post="(SHM) has been reported in only two cases in"/>
   <result pre="an unknown mutation on the other allele. He also had" exact="patent foramen ovale" post="that was surgically closed when he was 26-y.o. The"/>
   <result pre="was 26-y.o. The patient reported occasional cough bouts, triggering hemiplegic" exact="migraine" post="attacks In March 2017 a such cough bout, lasting"/>
   <result pre="the patient, suggests a migrainous infarction, since it followed the" exact="migraine" post="aura symtpoms and occurred in the brain regions implied"/>
   <result pre="from hypoxia due to cough bout and hemoptysis. In fact," exact="cerebral infarction," post="with prompt expansion of the core infarct, following mild"/>
   <result pre="Rao DS, Infeld MD, Stern RC, Chelimsky TC Cough-induced hemiplegic" exact="migraine" post="with impaired consciousness in cystic fibrosis. Pediatr Pulmonol. 2006"/>
   <result pre="RC, Chelimsky TC Cough-induced hemiplegic migraine with impaired consciousness in" exact="cystic fibrosis." post="Pediatr Pulmonol. 2006 Feb;41(2):171-6 2) Eikermann-Haerter K, Lee JH,"/>
   <result pre="K, Lee JH, Yuzawa I, et al. Migraine mutations increase" exact="stroke" post="vulnerability by facilitating ischemic depolarizations. Circulation 2012; 125(2): 335–345."/>
   <result pre="Gesù Children Hopsital, Rome, Italy Correspondence: Massimiliano Valeriani Objectives: Chronic" exact="migraine" post="(CM), Chronic tension-type headache (CTTH) and new daily persistent"/>
   <result pre="missing patients by improving patients’compliance and promoting the concept of" exact="migraine" post="as a disease that can cause relevant disability. Disclosure"/>
   <result pre="Medicine and Surgery, University of Parma, Parma, Italy Background Chronic" exact="migraine" post="(CM) is a disabling neurologic condition that affects 2-3%"/>
   <result pre="C was satisfied by having ≥8 days per month with" exact="migraine" post="without aura by the overwhelming majority of patients (95.5%),"/>
   <result pre="majority of patients (95.5%), while a not negligible percentage had" exact="migraine" post="with aura (9.1%) or headache relieved by a triptan"/>
   <result pre="allodynia (14.1%), life events (11.5%), excessive caffeine intake (10.4%), sleep" exact="bruxism" post="(9.1%), panic disorder (7.2%), and obesity (6.2%). Most represented"/>
   <result pre="life events (11.5%), excessive caffeine intake (10.4%), sleep bruxism (9.1%)," exact="panic disorder" post="(7.2%), and obesity (6.2%). Most represented comorbid disorders were:"/>
   <result pre="caffeine intake (10.4%), sleep bruxism (9.1%), panic disorder (7.2%), and" exact="obesity" post="(6.2%). Most represented comorbid disorders were: anxiety (32.3%), sleep"/>
   <result pre="disorders (32.2%), depression (25.4%), hypertension (20.5%), irritable bowel (8.4%), and" exact="fibromyalgia" post="(6.6%). CM was highly disabling in our population: mean"/>
   <result pre="number of symptomatic drugs was 28.8 (range 0-270). Refractory chronic" exact="migraine" post="(no MOH, unsuccessful use of at least 3 preventive"/>
   <result pre="Società Italiana per lo Studio delle Cefalee (SISC). O28 Prolonged" exact="migraine" post="aura: prevalence and comparison with &quot;normal&quot; auras Michele Viana"/>
   <result pre="diary-aided study. Methods: We recruited 224 consecutive patients affected by" exact="migraine" post="aura attending the Headache Centers of Pavia and Trondheim."/>
   <result pre="to report on an ad hoc diary, during three consecutive" exact="migraine" post="with aura attacks, quality of each aura symptom (AS),"/>
   <result pre="be. O29 Microvascular vasospasm of cerebral cortex in &quot;prolonged&quot; aura" exact="migraine" post="Stefano Viola 1*, Paolo Viola 2, Maria. P. Buongarzone"/>
   <result pre="authors have found a coronary microvascular endothelial dysfunction (CMED) in" exact="migraine" post="patients compared with control group suggesting that there would"/>
   <result pre="and 5 F, age range 21-41 years) during spontaneous &quot;prolonged&quot;" exact="migraine" post="aura in according to ICHD criteria and compared the"/>
   <result pre="compared with the headache-free periods. Conclusions: In conclusion during &quot;prolonged&quot;" exact="migraine" post="aura we find cortical areas of microvascular vasospasm corresponding"/>
   <result pre="Background: A wide range of medications is now available for" exact="migraine" post="prophylaxis but some patients don’t show a significant improvement"/>
   <result pre="date available in favour of and against their use in" exact="migraine" post="prophylaxis [1,2]. Objectives: To compare efficacy and tolerability of"/>
   <result pre="vs Amitriptyline 25 mg/die (AMI) for 3 months, as prophylactic" exact="migraine" post="therapy in a sample of adult outpatients. Patients and"/>
   <result pre="(52 females and 10 males), who received the diagnosis of" exact="migraine" post="with or without aura and were submitted to a"/>
   <result pre="Spitaleri D, Casucci G, Bussone G. Usefulness of nutraceuticals in" exact="migraine" post="prophylaxis. Neurol Sci. 2017 May;38(Suppl 1):117-120. O31 Comorbidity profiles"/>
   <result pre="prophylaxis. Neurol Sci. 2017 May;38(Suppl 1):117-120. O31 Comorbidity profiles of" exact="migraine" post="sufferers in headache center Alessandro Panconesi, Maria L Bartolozzi,"/>
   <result pre="prospectively the prevalence of some comorbidities in the first 1000" exact="migraine" post="patients (aged 15-65 years), afferent to Headache Center in"/>
   <result pre="district of Empoli Health Authority, classified with a diagnosis of" exact="migraine" post="without aura (MO), migraine with aura (MA), and chronic"/>
   <result pre="Authority, classified with a diagnosis of migraine without aura (MO)," exact="migraine" post="with aura (MA), and chronic migraine (CM) that also"/>
   <result pre="migraine without aura (MO), migraine with aura (MA), and chronic" exact="migraine" post="(CM) that also includes patients with medication overuse headache"/>
   <result pre="(mean age 38.2). This population included 866 patients with episodic" exact="migraine" post="(EM) (666 ♀ and 200 ♂, mean age 38.2)"/>
   <result pre="was: depression 5.6 %, hypertension, 9.3 %, diabetes 1.2 %," exact="asthma" post="3.3 %, hypothyroidism 6.4 %, hypercholesterolemia 0.5 %. Out"/>
   <result pre="%, hypertension, 9.3 %, diabetes 1.2 %, asthma 3.3 %," exact="hypothyroidism" post="6.4 %, hypercholesterolemia 0.5 %. Out of 56 patients"/>
   <result pre="carvedilol). Patients who assumed thyroid hormones were 64: they referred" exact="thyroiditis" post="(28), thyroidectomy (13), other (primitive, post-hyperthyroidism, etc) hypothyroidisms (16),"/>
   <result pre="post-hyperthyroidism, etc) hypothyroidisms (16), goitre in euthyroidism (7). Patients with" exact="asthma" post="were 65: 33 in current treatment and 32 in"/>
   <result pre="patients suffering of allergies were 198: 132 rhinitis, 42 drugs" exact="allergy" post="and 19 food allergy. Other somatic CC were: gallstones"/>
   <result pre="allergies were 198: 132 rhinitis, 42 drugs allergy and 19" exact="food allergy." post="Other somatic CC were: gallstones (5.4%), kidney stones (5.7%),"/>
   <result pre="inflammatory bowel disease (0.5%) including Crohn disease (3 patients) and" exact="ulcerative colitis" post="(2 patients), celiac disease (0.5%, all females), endometriosis (1.0%),"/>
   <result pre="bowel disease (0.5%) including Crohn disease (3 patients) and ulcerative" exact="colitis" post="(2 patients), celiac disease (0.5%, all females), endometriosis (1.0%),"/>
   <result pre="and ulcerative colitis (2 patients), celiac disease (0.5%, all females)," exact="endometriosis" post="(1.0%), psoriasis (0.7%), cardiac diseases (1.0%), rheumatic/autoimmune diseases (0.7%)"/>
   <result pre="colitis (2 patients), celiac disease (0.5%, all females), endometriosis (1.0%)," exact="psoriasis" post="(0.7%), cardiac diseases (1.0%), rheumatic/autoimmune diseases (0.7%) including lupus"/>
   <result pre="diseases (0.7%) including lupus (0.2%), Behcet disease, mixed connective disease," exact="rheumatoid arthritis," post="scleroderma, and Sjogren syndrome (0.1%).Vitiligo (0.2%), endometrial/breast cancer (0.5%),"/>
   <result pre="disease, rheumatoid arthritis, scleroderma, and Sjogren syndrome (0.1%).Vitiligo (0.2%), endometrial/breast" exact="cancer" post="(0.5%), meningioma (0.2%), hyperthyroidism (0.3%), restless legs syndrome (0.3%),"/>
   <result pre="arthritis, scleroderma, and Sjogren syndrome (0.1%).Vitiligo (0.2%), endometrial/breast cancer (0.5%)," exact="meningioma" post="(0.2%), hyperthyroidism (0.3%), restless legs syndrome (0.3%), fibromyalgia (0.2%),"/>
   <result pre="and Sjogren syndrome (0.1%).Vitiligo (0.2%), endometrial/breast cancer (0.5%), meningioma (0.2%)," exact="hyperthyroidism" post="(0.3%), restless legs syndrome (0.3%), fibromyalgia (0.2%), were also"/>
   <result pre="syndrome (0.1%).Vitiligo (0.2%), endometrial/breast cancer (0.5%), meningioma (0.2%), hyperthyroidism (0.3%)," exact="restless legs syndrome" post="(0.3%), fibromyalgia (0.2%), were also detected. Other CC whit"/>
   <result pre="cancer (0.5%), meningioma (0.2%), hyperthyroidism (0.3%), restless legs syndrome (0.3%)," exact="fibromyalgia" post="(0.2%), were also detected. Other CC whit a prevalence"/>
   <result pre="patients (Table 1). Conclusions The percentages of treated CC in" exact="migraine" post="patients in our survey, in particular those involved in"/>
   <result pre="same district [1,2]. In this comparison, the higher prevalence of" exact="hypothyroidism" post="was not statistically significant when migraine patients were considered"/>
   <result pre="the higher prevalence of hypothyroidism was not statistically significant when" exact="migraine" post="patients were considered by gender (♀ p = 0.067,"/>
   <result pre="(abstract O31). Percentage of treated diseases and lifetime allergies in" exact="migraine" post="patients All subjects ♂ ♀ EM CM Depression 5.6"/>
   <result pre="Mennuti N, Bartolozzi ML, Benemei S, Guidi L. Evaluation of" exact="migraine" post="comorbidities through clinical and pharmaceutical data. J Headache Pain"/>
   <result pre="KML, Ratanayake PD, Fagan E, Antony J. High-dose riboflavin for" exact="migraine" post="prophylaxis in children: a double-blind, randomized, placebo-controlled trial. J"/>
   <result pre="A, Luchetti A, Paolino MC, Villa MP. Melatonin to prevent" exact="migraine" post="or tension-type headache in children. Neurol Sci. 2008;29:285–7. 13."/>
   <result pre="16. Usai S, Grazzi L, Bussone G. Gingkolide B as" exact="migraine" post="preventive treatment in young age: results at 1-year follow-up."/>
   <result pre="Carotenuto M. Ginkgolide B complex efficacy for brief prophylaxis of" exact="migraine" post="in school-aged children: An open-label study. Neurol Sci. 2011;32:79–81."/>
   <result pre="Ruberto M, Pascotto A, Carotenuto M. Nutraceutical preparations in childhood" exact="migraine" post="prophylaxis: Effects on headache outcomes including disability and behaviour."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC5784532/results/search/disease/results.xml">
   <result pre="of consciousness, syncope, near syncope, headache, dizziness, dehydration, chest pain," exact="shortness" post="of breath, injury, trauma, wound, abrasion, or laceration underwent"/>
   <result pre="the complaint of chest pain, one with pre-syncope, one with" exact="migraine" post="symptoms, two with agitation and three with injuries all"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC5820821/results/search/disease/results.xml">
   <result pre="JPGM-64-66 doi: 10.4103/jpgm.JPGM_306_17 : Letters Cinema-like sensory phenomena in a" exact="migraine" post="patient on topiramate Tandon R Verma SK [], rtlib161080@gmail.com"/>
   <result pre="under the identical terms. Topiramate is an antiepileptic used for" exact="migraine" post="prophylaxis. Several side effects may follow topiramate use such"/>
   <result pre="be a need for greater vigilance while prescribing topiramate for" exact="migraine" post="prophylaxis and monitoring patients, especially pediatric and adolescent patients,"/>
   <result pre="May A &quot;Alice in Wonderland syndrome&quot; associated with topiramate for" exact="migraine" post="prevention J Neurol Neurosurg Psychiatry 2011 82 228 9"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC5932093/results/search/disease/results.xml">
   <result pre="adulthood. TS is also associated with various neuropsychiatric comorbidities including" exact="attention deficit hyperactivity disorder," post="obsessive compulsive disorder, rage attacks, sleep issues, depression, and"/>
   <result pre="using CAM therapy, which included 39% (24 of 62) of" exact="epilepsy" post="patients, 58% (11 of 19) of patients with headache,"/>
   <result pre="group of patients were dietary modification (49 of 115, 42.6%)" exact="allergy" post="treatment (28 of 115, 24.3%), homeopathy (18 of 115,"/>
   <result pre="and toxicity. There have been reports of herbal induced self-limited" exact="hepatitis" post="to fulminant hepatic failure. Some of the Chinese herbs"/>
   <result pre="Some of the Chinese herbs have been reported to cause" exact="nephropathy" post="and end-stage renal diseases. Primrose oil and fish oil"/>
   <result pre="reports of mechanical injury from the needle leading to pneumothorax," exact="cardiac tamponade," post="injury to spinal cord and nerve roots, and infectious"/>
   <result pre="skin infection, and cross contamination with resultant hepatitis, HIV and" exact="infective endocarditis" post="associated with improper handling of needles [ 12]. Variants"/>
   <result pre="infection, and cross contamination with resultant hepatitis, HIV and infective" exact="endocarditis" post="associated with improper handling of needles [ 12]. Variants"/>
   <result pre="References 1. collab: Association AP Diagnostic and statistical manual of" exact="mental disorder" post="2013 5 Arlington American Psychiatric Publishing 2. Patel N"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC5966347/results/search/disease/results.xml">
   <result pre=": Research Article Evaluation of gray matter perfusion in episodic" exact="migraine" post="using voxel-wise comparison of 3D pseudo-continuous arterial spin labeling"/>
   <result pre="studies have demonstrated that structural and functional abnormalities in episodic" exact="migraine" post="(EM), less is known about altered brain perfusion in"/>
   <result pre="further pathophysiological and neuropsychological study in EM. Keywords Brain Episodic" exact="migraine" post="Gray matter Magnetic resonance imaging 3D pseudo-continuous arterial spin"/>
   <result pre="vomiting, photophobia, phonophobia, or allodynia [ 2]. The pathogenesis of" exact="migraine" post="is not completely understood. Cortical spreading depression (CSD) has"/>
   <result pre="Cortical spreading depression (CSD) has been considered to account for" exact="migraine" post="aura and to be a migraine trigger via trigeminal"/>
   <result pre="considered to account for migraine aura and to be a" exact="migraine" post="trigger via trigeminal sensory afferents activation [ 3]. Cerebral"/>
   <result pre="release of vasoactive substances may lead to headache generation in" exact="migraine" post="[ 4]. Advanced imaging studies have provided more insights"/>
   <result pre="[ 4]. Advanced imaging studies have provided more insights into" exact="migraine" post="pathophysiology and migraine-related dysfunctions. The brainstem has been considered"/>
   <result pre="play a pivotal role in the first phase of a" exact="migraine" post="attack. Limbic pathways and cognitive processing network have participated"/>
   <result pre="attack. Limbic pathways and cognitive processing network have participated in" exact="migraine" post="processing. Hyperexcitability of visual cortex and thalamus in migraine"/>
   <result pre="in migraine processing. Hyperexcitability of visual cortex and thalamus in" exact="migraine" post="may be associated with photophobia and allodynia respectively. Interictal"/>
   <result pre="white matter lesions, altered neural activity and functional connectivity in" exact="migraine" post="and their correlation with migraine duration/frequency suggested migraine may"/>
   <result pre="activity and functional connectivity in migraine and their correlation with" exact="migraine" post="duration/frequency suggested migraine may be a progressive brain disorder"/>
   <result pre="connectivity in migraine and their correlation with migraine duration/frequency suggested" exact="migraine" post="may be a progressive brain disorder [ 5, 6]."/>
   <result pre="structure and function is the cause or the result of" exact="migraine" post="attack is still a debate. Previous perfusion imaging studies"/>
   <result pre="perfusion, and perfusion-weighted MR imaging (PWI) have been conducted for" exact="migraine" post="research. The hypoperfusion during aura in hemisphere contralateral to"/>
   <result pre="vascular distribution, supporting a neurogenic rather than vascular explanation for" exact="migraine" post="aura [ 7– 10]. However, The perfusion status of"/>
   <result pre="aura [ 7– 10]. However, The perfusion status of interictal" exact="migraine" post="were inconsistent [ 11– 13]. The previous perfusion studies"/>
   <result pre="clinical application range of ASL. ASL has been adopted for" exact="migraine" post="aura and hypoperfusion was detected, consistent with former perfusion"/>
   <result pre="However, so far, very few studies used ASL for interictal" exact="migraine" post="research and the results differed [ 16– 18]. The"/>
   <result pre="pattern of altered cerebral perfusion at interictal stage of episodic" exact="migraine" post="(EM) without aura. We prospectively obtained high resolution structural"/>
   <result pre="should be fulfilled as follows: 1) EM is defined as" exact="migraine" post="attack days being less than 15 days per month."/>
   <result pre="being less than 15 days per month. The definition of" exact="migraine" post="refers to 1.1 Migraine without aura in ICHD 3beta"/>
   <result pre="Migraine without aura in ICHD 3beta [ 2]; 2) no" exact="migraine" post="preventive medication used in the past 3 months; 3)"/>
   <result pre="psychiatric diseases, etc.; 4) absence of alcohol, nicotine, or other" exact="substance abuse;" post="and 5) patient’s willingness to engage in the study."/>
   <result pre="were given with the Visual Analogue Scale (VAS) and the" exact="migraine" post="disability assessment scale (MIDAS), and all the subjects received"/>
   <result pre="in the interictal stage at least three days after a" exact="migraine" post="attack for EM patients. All the subjects were right-handed"/>
   <result pre="and underwent conventional MRI examination to exclude the subjects with" exact="cerebral infarction," post="malacia, or occupying lesions. Alcohol, nicotine, caffeine, and other"/>
   <result pre="per month, the mean interictal time 10.27 ± 4.73 days after last" exact="migraine" post="attack at scanning, VAS 8(6,10), sleep quality 1(0,3) and"/>
   <result pre="0.117 VAS visual analogue scale, DD disease duration (years), MIDAS" exact="migraine" post="disability assessment scale, HF headache frequency (per month), SQ"/>
   <result pre="the left BA38. Perfusion imaging studies have been conducted for" exact="migraine" post="research for decades. For migraine with aura (MA), hypoperfusion"/>
   <result pre="studies have been conducted for migraine research for decades. For" exact="migraine" post="with aura (MA), hypoperfusion during aura in hemisphere with"/>
   <result pre="using PWI method. The perfusion status during headache attack of" exact="migraine" post="without aura (MO) varied more [ 32, 33], which"/>
   <result pre="when the imaging is done and the course of the" exact="migraine" post="attack. The interictal perfusion studies varied too. One study"/>
   <result pre="and interictal phase. Compared to the earlier perfusion techniques for" exact="migraine" post="research using xenon 133 intra-arterial injection, SPECT, CT perfusion,"/>
   <result pre="spatial resolution. Therefore, ASL may be an ideal technique for" exact="migraine" post="research since repeated ASL can be acquired during each"/>
   <result pre="since repeated ASL can be acquired during each phase of" exact="migraine" post="attack without harm to patients. Areas with altered interictal"/>
   <result pre="of MO which did not fulfill vascular distribution, supporting that" exact="migraine" post="was a primary neurogenic disorder. In this study, we"/>
   <result pre="provided much evidence supporting an important role of TP in" exact="migraine" post="pathophysiology. Gray matter density within left TP significantly decreased"/>
   <result pre="[ 39], implicating a key role in cyclical recurrence of" exact="migraine" post="attacks. The TP was hyperexcitable with painful heat stimulation"/>
   <result pre="stimulation and showed increased resting-state connectivity with hypothalamic in interictal" exact="migraine" post="patients, indicating that TP may be involved in the"/>
   <result pre="patients, indicating that TP may be involved in the interictal" exact="hypersensitivity" post="to pain, smell and light [ 40, 41].In another"/>
   <result pre="controls in the left TP, suggesting a role in olfactory" exact="hypersensitivity" post="of migraine [ 43].A recent study found that enhancing"/>
   <result pre="the left TP, suggesting a role in olfactory hypersensitivity of" exact="migraine" post="[ 43].A recent study found that enhancing excitability of"/>
   <result pre="44], supporting TP as a possible therapeutic target to relieve" exact="hypersensitivity" post="of migraine. Our study further provides evidence of TP"/>
   <result pre="study further provides evidence of TP perfusion abnormality in interictal" exact="migraine" post="and this structure needs deeper investigation. TP and superior"/>
   <result pre="with HAMD may be associated with the genesis of multisensory" exact="hypersensitivity" post="and mood disorder of migraine. The interictal perfusion alteration"/>
   <result pre="may be associated with the genesis of multisensory hypersensitivity and" exact="mood disorder" post="of migraine. The interictal perfusion alteration in this study"/>
   <result pre="of migraine. The interictal perfusion alteration in this study supported" exact="migraine" post="as a central nervous dysfunction and may provide biomarkers"/>
   <result pre="as a central nervous dysfunction and may provide biomarkers for" exact="migraine" post="diagnosis and treatment. The mechanism of how the perfusion"/>
   <result pre="cortex, etc., indicating the involvement of multiple brain regions in" exact="migraine" post="processing network [ 5, 6]. However, we did not"/>
   <result pre="and the dynamic perfusion changes during different phase of a" exact="migraine" post="attack and post-attack were not presented. In the future,"/>
   <result pre="were not presented. In the future, we may repeatedly scan" exact="migraine" post="patients at more timing points. Thirdly, the sample size"/>
   <result pre="processing in migraine. The pattern of cerebral hyperperfusion at interictal" exact="migraine" post="may elucidate the neurogenic mechanism in the EM genesis."/>
   <result pre="maps with brain extraction CBF cerebral blood flow EM episodic" exact="migraine" post="GM-TPM gray matter tissue probability map HAMA Hamilton Anxiety"/>
   <result pre="map HAMA Hamilton Anxiety Scale HAMD Hamilton Depression Scale MA" exact="migraine" post="with aura MIDAS migraine disability assessment scale MO migraine"/>
   <result pre="Scale HAMD Hamilton Depression Scale MA migraine with aura MIDAS" exact="migraine" post="disability assessment scale MO migraine without aura NC normal"/>
   <result pre="MA migraine with aura MIDAS migraine disability assessment scale MO" exact="migraine" post="without aura NC normal controls nCBF normalized CBF maps"/>
   <result pre="23771276 3. Eikermann-Haerter K Ayata C Cortical spreading depression and" exact="migraine" post="Curr Neurol Neurosci Rep 2010 10 167 173 10.1007/s11910-010-0099-1"/>
   <result pre="Larsson HB et al. Evidence for a vascular factor in" exact="migraine" post="Ann Neurol 2011 69 635 645 10.1002/ana.22292 21416486 5."/>
   <result pre="Kang M Choi S A case report of sporadic hemiplegic" exact="migraine" post="associated cerebral hypoperfusion: comparison of arterial spin labeling and"/>
   <result pre="Vidriales I Ruiz M Guerrero AL Telleria JJ Familial hemiplegic" exact="migraine" post="with severe attacks: a new report with ATP1A2 mutation"/>
   <result pre="VC Cooper PW Changes in cerebral blood flow during a" exact="migraine" post="attack Br Med J 1975 3 676 677 10.1136/bmj.3.5985.676"/>
   <result pre="et al. Interictal abnormalities of regional cerebral blood flow in" exact="migraine" post="with and without aura Minerva Med 1995 86 257"/>
   <result pre="Abnormalities of interictal cerebral perfusion in classic but not common" exact="migraine" post="Stroke 1988 19 1108 1111 10.1161/01.STR.19.9.1108 3413808 14. Burns"/>
   <result pre="D Arterial spin-labeled MR imaging detecting biphasic neurovascular changes in" exact="migraine" post="with persistent Aura Headache 2017 57 1627 1628 10.1111/head.13119"/>
   <result pre="Corouge I, et al.(2017) Magnetic resonance imaging in children presenting" exact="migraine" post="with aura: association of hypoperfusion detected by arterial spin"/>
   <result pre="Hu S Detre JA Cucchiara B Interictal cortical hyperresponsiveness in" exact="migraine" post="is directly related to the presence of aura Cephalalgia"/>
   <result pre="R Detre JA Cucchiara B White matter lesion burden in" exact="migraine" post="with aura may be associated with reduced cerebral blood"/>
   <result pre="analyze abnormal changes in brain perfusion and gray areas in" exact="nasopharyngeal carcinoma" post="patients undergoing radiotherapy Biomed Res 2017 28 7879 7885"/>
   <result pre="Bonafe A Thouvenot E Perfusion-weighted MR imaging in persistent hemiplegic" exact="migraine" post="Neuroradiology 2012 54 255 260 10.1007/s00234-011-0946-z 21833737 31. Gutschalk"/>
   <result pre="imaging of prolonged neurological deficits in a patient suffering from" exact="familial hemiplegic migraine" post="Neurosci Lett 2002 332 115 118 10.1016/S0304-3940(02)00940-0 12384224 32."/>
   <result pre="prolonged neurological deficits in a patient suffering from familial hemiplegic" exact="migraine" post="Neurosci Lett 2002 332 115 118 10.1016/S0304-3940(02)00940-0 12384224 32."/>
   <result pre="Martins IP An arterial spin labeling MRI perfusion study of" exact="migraine" post="without Aura attacks Front Neurol 2017 8 280 10.3389/fneur.2017.00280"/>
   <result pre="H Ito Y Suzuki C Arterial spin-labeled MRI study of" exact="migraine" post="attacks treated with rizatriptan J Headache Pain 2010 11"/>
   <result pre="D Cognitive disturbances and regional cerebral blood flow abnormalities in" exact="migraine" post="patients: their relationship with the clinical manifestations of the"/>
   <result pre="with technetium-99m hexamethyl propylenamino oxime in the pain-free interval of" exact="migraine" post="and cluster headache Eur Neurol 1990 30 153 156"/>
   <result pre="perfusion study group and the European consortium for ASL in" exact="dementia" post="Magn Reson Med 2015 73 102 116 10.1002/mrm.25197 24715426"/>
   <result pre="C et al. Evidence for brain morphometric changes during the" exact="migraine" post="cycle: a magnetic resonance-based morphometry study Cephalalgia 2015 35"/>
   <result pre="functional connectivity with autonomic circuits and the locus coeruleus in" exact="migraine" post="PLoS One 2014 9 e95508 10.1371/journal.pone.0095508 24743801 41. Moulton"/>
   <result pre="reveals hyperexcitability of the temporal pole in interictal and ictal" exact="migraine" post="states. Cerebral cortex (New York NY : 1991) (21):435–448"/>
   <result pre="Alterations in regional homogeneity assessed by fMRI in patients with" exact="migraine" post="without aura stratified by disease duration J Headache Pain."/>
   <result pre="43. Demarquay G Royet JP Mick G Ryvlin P Olfactory" exact="hypersensitivity" post="in migraineurs: a H(2)(15)O-PET study Cephalalgia 2008 28 1069"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC6045462/results/search/disease/results.xml">
   <result pre="MEG examinations remain few, mainly restricted to the diagnostics of" exact="epilepsy" post="and to preoperative functional evaluation of neurosurgical patients. We"/>
   <result pre="current dipole ECoG, electrocorticography fMRI, functional magnetic resonance imaging HE," exact="hepatic encephalopathy" post="IAP, intracarotid amobarbital procedure ICA, independent component analysis IES,"/>
   <result pre="dipole ECoG, electrocorticography fMRI, functional magnetic resonance imaging HE, hepatic" exact="encephalopathy" post="IAP, intracarotid amobarbital procedure ICA, independent component analysis IES,"/>
   <result pre="Preoperative evaluation Stroke Pain Traumatic brain injury Parkinson’s disease Hepatic" exact="encephalopathy" post="Alzheimer’s disease and dementia Neuropsychiatric disorders Brain maturation and"/>
   <result pre="Traumatic brain injury Parkinson’s disease Hepatic encephalopathy Alzheimer’s disease and" exact="dementia" post="Neuropsychiatric disorders Brain maturation and development Dyslexia Guidelines See"/>
   <result pre="the functional state of the primary motor cortex. Specifically, 20-Hz" exact="suppression" post="begins 0.5–2 s prior to a voluntary movement, with a"/>
   <result pre="about 0.5 s after the movement ends. This type of mu" exact="suppression" post="can also occur during action viewing and motor imagery"/>
   <result pre="illustrates how tSSS cleans spontaneous MEG data recorded from an" exact="epilepsy" post="patient in whom magnetic particles in the skull produced"/>
   <result pre="framework has been developed that allows optimization of the sensor-noise" exact="suppression" post="by fully exploiting both the spatial and temporal properties"/>
   <result pre="2008, Larson and Taulu, 2017b) Below we recommend some artifact" exact="suppression" post="methods, suitable for dampening different types of nuisance signals."/>
   <result pre="seizures but also occur in healthy infants. Here the recommended" exact="suppression" post="methods are SSS and tSSS. Minimum-norm-based methods (see below)"/>
   <result pre="be used as well, but a separate algorithm for the" exact="suppression" post="of movement-induced artifacts would need to be applied. Continuous"/>
   <result pre="al., 2002), and abnormal EEG–EMG coherence in acute and chronic" exact="stroke" post="patients ( von Carlowitz-Ghori et al., 2014). In general,"/>
   <result pre="manifestations, such as physiological tremor ( Raethjen et al., 2002)," exact="essential tremor" post="( Schnitzler et al., 2009), Parkinsonian tremor ( Timmermann"/>
   <result pre="reason not to always record EEG with MEG, especially in" exact="epilepsy" post="patients ( Lopes da Silva, 2008, Stefan and Trinka,"/>
   <result pre="MEG has become part of the standard of care at" exact="epilepsy" post="centers, utilized frequently to guide the implantation of intracranial"/>
   <result pre="only for localization of epileptic sources, but for diagnosis of" exact="epilepsy" post="( Colon et al., 2009, Duez et al., 2016,"/>
   <result pre="and Knowlton, 2015). MEG can confirm a patient’s suitability for" exact="epilepsy" post="surgery. The spatial resolution of MEG and the ability"/>
   <result pre="seizures. MEG has proven helpful for selecting good candidates for" exact="epilepsy" post="surgery when structural brain MRI is negative ( Jung"/>
   <result pre="Accordingly, MEG has been found more effective than EEG in" exact="epilepsy" post="screening ( Ossenblok et al., 2007). Identification of &quot;MEG-unique&quot;"/>
   <result pre="resected region. In the workup of patients under consideration for" exact="epilepsy" post="surgery, MEG provides complementary information. The MEG findings can"/>
   <result pre="acutely in the operating room, or chronically in a long-term" exact="epilepsy" post="monitoring unit (or neurosurgical intensive-care unit). Language-sensitive cortex is"/>
   <result pre="studies. 4 Clinical applications on the horizon 4.1 Stroke A" exact="stroke" post="in the territory of the middle cerebral artery typically"/>
   <result pre="to altered brain connectivity, some of the symptoms after a" exact="stroke" post="can arise from brain areas remote from the damaged"/>
   <result pre="skills. MEG is well suited for investigating neurophysiological changes after" exact="stroke" post="because it, unlike MRI, is independent of hemodynamic alterations;"/>
   <result pre="the patient, they are well suited for studies of acute" exact="stroke" post="patients ( Forss et al., 1999, Wikström et al.,"/>
   <result pre="Parkkonen et al., 2017). MEG recordings in severely ill acute" exact="stroke" post="patients are demanding as the co-operation may be poor"/>
   <result pre="in phantom pain ( Flor et al., 1995) and in" exact="complex regional pain syndrome" post="( Juottonen et al., 2002; Maihöfner et al., 2003)."/>
   <result pre="in patients suffering from various types of chronic pain including" exact="migraine" post="( Li et al., 2016, Xiang et al., 2016),"/>
   <result pre="al., 2016), menstrual pain ( Kuo et al., 2017), and" exact="fibromyalgia" post="( Lim et al., 2016, Hsiao et al., 2017)."/>
   <result pre="explored enough to be useful for clinical applications. 4.5 Hepatic" exact="encephalopathy" post="Hepatic encephalopathy (HE) is a complex neuropsychiatric disorder resulting"/>
   <result pre="to be useful for clinical applications. 4.5 Hepatic encephalopathy Hepatic" exact="encephalopathy" post="(HE) is a complex neuropsychiatric disorder resulting from acute"/>
   <result pre="is a complex neuropsychiatric disorder resulting from acute or chronic" exact="liver disease." post="Depending on the disease stage, the clinical symptoms range"/>
   <result pre="and monitor individual patients with HE. 4.6 Neuropsychiatric disorders and" exact="dementia" post="MEG has been used to investigate alterations in brain"/>
   <result pre="Monaural stimulation is preferred because during binaural stimulation significant central" exact="suppression" post="takes place so that the cortical responses to binaural"/>
   <result pre="their electrical counterparts—somatosensory evoked potentials—combined with high-resolution anatomical MRI. In" exact="stroke" post="patients, SEFs can provide information about disruptions of the"/>
   <result pre="in noninvasive presurgical evaluation of patients with medically intractable localization-related" exact="epilepsy" post="J Clin Neurophysiol 26 2009 290 293 19602984 Bagic"/>
   <result pre="M. Towards source volume estimation of interictal spikes in focal" exact="epilepsy" post="using magnetoencephalography Neuroimage 59 2012 3955 3966 22036998 Bouet"/>
   <result pre="D. Schnitzler A. The slowed brain: cortical oscillatory activity in" exact="hepatic encephalopathy" post="Arch Biochem Biophys 536 2013 197 203 23603113 Canolty"/>
   <result pre="Schnitzler A. The slowed brain: cortical oscillatory activity in hepatic" exact="encephalopathy" post="Arch Biochem Biophys 536 2013 197 203 23603113 Canolty"/>
   <result pre="J.A. MEG-based detection and localization of perilesional dysfunction in chronic" exact="stroke" post="Neuroimage Clin 8 2015 157 169 26106540 Cimatti Z."/>
   <result pre="Use of routine MEG in the primary diagnostic process of" exact="epilepsy" post="J Clin Neurophysiol 26 2009 326 332 19752741 Colon"/>
   <result pre="P. Evaluation of MEG vs EEG after sleep deprivation in" exact="epilepsy" post="Acta Neurol Scand 135 2017 247 251 26957488 Conway"/>
   <result pre="R.M. Spatial MEG laterality maps for language: clinical applications in" exact="epilepsy" post="Hum Brain Mapp 34 2013 1749 1760 22419535 Dabek"/>
   <result pre="J.S. Ebersole S.M. Combining MEG and EEG source modeling in" exact="epilepsy" post="evaluations J Clin Neurophysiol 27 2010 360 371 21076318"/>
   <result pre="Modified activation of somatosensory cortical network in patients with right-hemisphere" exact="stroke" post="Brain 122 1999 1889 1899 10506091 Forss N. Raij"/>
   <result pre="Salonen O. Activation in parietal operculum parallels motor recovery in" exact="stroke" post="Hum Brain Mapp 33 2012 534 541 21425393 Fries"/>
   <result pre="MEG and EEG sensitivity in a case of medial occipital" exact="epilepsy" post="Brain Topogr 27 2014 192 196 24005334 Giraud A.L."/>
   <result pre="of biomarkers and MEG-based imaging markers in the diagnosis of" exact="post-traumatic stress disorder" post="and blast-induced mild traumatic brain injury Psychoneuroendocrinology 63 2016"/>
   <result pre="magnetoencephalography for seizure-onset zone localization in magnetic resonance imaging-negative partial" exact="epilepsy" post="Brain 136 2013 3176 3186 24014520 Juottonen K.M.G. Silén"/>
   <result pre="R. Forss N. Altered central sensorimotor processing in patients with" exact="complex regional pain syndrome" post="Pain 98 2002 315 323 12127033 Kakigi R. Hoshiyama"/>
   <result pre="Kharkar S. Knowlton R. Magnetoencephalography in the presurgical evaluation of" exact="epilepsy" post="Epilepsy Behav 46 2015 19 26 25555504 Kiebel S.J."/>
   <result pre="Limdi N. Elgavish R.A. Killen J. Blount J. Effect of" exact="epilepsy" post="magnetic source imaging on intracranial electrode placement Ann Neurol"/>
   <result pre="L. Effect of afferent input on motor cortex excitability during" exact="stroke" post="recovery Clin Neurophysiol 123 2012 2429 2436 22721651 Laaksonen"/>
   <result pre="Mäkelä J.P. Mustanoja S. Alterations in spontaneous brain oscillations during" exact="stroke" post="recovery PLoS One 8 2013 e61146 23593414 Lankinen K."/>
   <result pre="Zhu D. Shi J. Abnormal resting-state brain activity in headache-free" exact="migraine" post="patients: a magnetoencephalography study Clin Neurophysiol 127 2016 2855"/>
   <result pre="low- and high-frequency oscillatory activity in the prefrontal cortex of" exact="fibromyalgia" post="patients Front Hum Neurosci 10 2016 111 27014041 Lin"/>
   <result pre="Wong T.T. Yeh T.C. Magnetoencephalographic yield of interictal spikes in" exact="temporal lobe epilepsy." post="Comparison with scalp EEG recordings Neuroimage 19 2003 1115"/>
   <result pre="signal processing and modeling in the diagnostic and management of" exact="epilepsy" post="IEEE Rev Biomed Eng 1 2008 143 156 22274902"/>
   <result pre="H.O. Neundorfer B. Birklein F. Patterns of cortical reorganization in" exact="complex regional pain syndrome" post="Neurol 61 2003 1707 1715 Mäkelä J. Kirveskari E."/>
   <result pre="Kaste M. Cortical excitability measured with nTMS and MEG during" exact="stroke" post="recovery Neural Plast 2015 2015 309546 26491569 Manshanden I."/>
   <result pre="R.A. Kakisaka Y. Correlating magnetoencephalography to stereo-electroencephalography in patients undergoing" exact="epilepsy" post="surgery Brain 39 2016 2935 2947 Muthukumaraswamy S.D. High-frequency"/>
   <result pre="Magnetoencephalography is more successful for screening and localizing frontal lobe" exact="epilepsy" post="than electroencephalography Epilepsia 48 2007 2139 2149 17662061 Oswal"/>
   <result pre="Forss N. Strength of ∼20-Hz rebound and motor recovery after" exact="stroke" post="Neurorehabil Neural Repair 31 2017 475 486 28164736 Parkkonen"/>
   <result pre="O. Tatlisumak T. Reorganization of the primary somatosensory cortex during" exact="stroke" post="recovery Clin Neurophysiol 122 2011 339 345 20673646 Romani"/>
   <result pre="M. Timmermann L. Gross J. Synchronized brain network associated with" exact="essential tremor" post="as revealed by magnetoencephalography Mov Disord 24 2009 1629"/>
   <result pre="Takano K. Okajima M. Knake S. Application of magnetoencephalography in" exact="epilepsy" post="patients with widespread spike or slow-wave activity Epilepsia 46"/>
   <result pre="of the ∼20-Hz motor-cortex rhythm in Univerricht-Lundborg type progresssive myoclonus" exact="epilepsy" post="Neuroimage 12 2000 707 717 11112402 Smeds E. Piitulainen"/>
   <result pre="Influence of magnetic source imaging for planning intracranial EEG in" exact="epilepsy" post="Neurol 71 2008 990 996 Takemi M. Masakado Y."/>
   <result pre="Stam C.J. Disruption of structural and functional networks in long-standing" exact="multiple sclerosis" post="Hum Brain Mapp 35 2014 5946 5961 25053254 The"/>
   <result pre="Uhlhaas P.J. Singer W. Abnormal neural oscillations and synchrony in" exact="schizophrenia" post="Nat Rev Neurosci 11 2010 100 113 20087360 Uhlhaas"/>
   <result pre="J.C. Verbunt J.P. Spike cluster analysis in neocortical localization related" exact="epilepsy" post="yields clinically significant equivalent source localization results in magnetoencephalogram"/>
   <result pre="techniques for improved functional localization for a selected group of" exact="epilepsy" post="surgery candidates Neuroimage 45 2009 342 348 19159694 von"/>
   <result pre="Curio G. Nikulin V.V. Corticomuscular coherence in acute and chronic" exact="stroke" post="Clin Neurophysiol 125 2014 1182 1191 24315544 Wada J."/>
   <result pre="magnetic fields from the primary somatosensory cortex (SI) in acute" exact="stroke" post="Clin Neurophysiol 110 1999 916 923 10400206 Wipf D."/>
   <result pre="Powers S.W. Hershey A.D. Spatial heterogeneity of cortical excitability in" exact="migraine" post="revealed by multifrequency neuromagnetic signals J Pain 17 2016"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC6111600/results/search/disease/results.xml">
   <result pre="pediatric learning problems [ 11, 12, 13], anesthesia [ 14]," exact="asthma" post="[ 15], drug abuse [ 16], burns [ 17],"/>
   <result pre="16], burns [ 17], enuresis [ 18, 19, 20], functional" exact="megacolon" post="[ 21], warts [ 22], sleep disorders [ 23,"/>
   <result pre="22], sleep disorders [ 23, 24], habit disorders [ 1]," exact="autism" post="[ 25], pelvic exams [ 26], cancer [ 2],"/>
   <result pre="disorders [ 1], autism [ 25], pelvic exams [ 26]," exact="cancer" post="[ 2], pain and procedure-related anxiety [ 27], psychoneuroimmunology"/>
   <result pre="[ 27], psychoneuroimmunology [ 28, 29], healing [ 30], refractory" exact="irritable bowel syndrome" post="[ 31], hemophilia [ 32], chronic illness [ 33],"/>
   <result pre="chronic illness [ 33], hospitalization [ 34], emergencies [ 35]," exact="aphasia" post="[ 36], Tourette’s syndrome [ 37, 38, 39], migraine"/>
   <result pre="35], aphasia [ 36], Tourette’s syndrome [ 37, 38, 39]," exact="migraine" post="[ 40, 41], sickle cell disease [ 42], chemotherapy-related"/>
   <result pre="and physical concerns and contexts include anxiety [ 49, 50]," exact="asthma" post="[ 51], cystic fibrosis [ 52], dental issues ["/>
   <result pre="and contexts include anxiety [ 49, 50], asthma [ 51]," exact="cystic fibrosis" post="[ 52], dental issues [ 53], enuresis [ 54],"/>
   <result pre="patients (ages 8–18) with diagnoses of functional abdominal pain or" exact="irritable bowel syndrome" post="compared to standard medical therapy (SMT), with continued efficacy"/>
   <result pre="the potential for negatives such as risk, threat, or danger;" exact="generalized anxiety disorder;" post="major depression; and/or sleep-onset or sleep-maintenance insomnia. This modality"/>
   <result pre="potential for negatives such as risk, threat, or danger; generalized" exact="anxiety disorder;" post="major depression; and/or sleep-onset or sleep-maintenance insomnia. This modality"/>
   <result pre="previously diagnosed M. with attention-deficit/hyperactivity disorder, inattentive type, co-occurring with" exact="generalized anxiety disorder," post="each treated with appropriate medications that had somewhat improved"/>
   <result pre="diagnosed M. with attention-deficit/hyperactivity disorder, inattentive type, co-occurring with generalized" exact="anxiety disorder," post="each treated with appropriate medications that had somewhat improved"/>
   <result pre="www.heartmath.com ); or EMG (electromyography) and peripheral skin temperature for" exact="migraine" post="headaches [ 112, 113]. It has been our experience"/>
   <result pre="applying hypnosis and pulmonary function biofeedback in a preschool family" exact="asthma" post="education program [ 15]. Writing in the first textbook"/>
   <result pre="function of underlying separation anxiety and not insomnia or other" exact="sleep disorder." post="He spoke of being afraid of the dark, not"/>
   <result pre="body aches, difficulty with sleep onset, and a history of" exact="generalized anxiety disorder." post="S.’s anxiety problems began at eight years of age"/>
   <result pre="aches, difficulty with sleep onset, and a history of generalized" exact="anxiety disorder." post="S.’s anxiety problems began at eight years of age"/>
   <result pre="began at eight years of age with separation anxiety and" exact="specific phobia" post="symptoms. On the first day of ninth grade, she"/>
   <result pre="Kohen D.P. Wynne E. Applying hypnosis in a preschool family" exact="asthma" post="education program: Uses of storytelling, imagery, and relaxation Am."/>
   <result pre="537 539 10.1001/archpedi.152.6.537 9641705 21. Olness K. Autohypnosis in functional" exact="megacolon" post="in children Am. J. Clin. Hypn. 1976 19 28"/>
   <result pre="potential for the use of hypnosis in the treatment of" exact="cancer" post="Am. J. Clin. Hypn. 1975 17 160 169 10.1080/00029157.1975.10403735"/>
   <result pre="and anxiety during painful procedures in children and adolescents with" exact="cancer" post="J. Pediatr. 1982 101 1032 1035 7143158 28. Hall"/>
   <result pre="Hypnosis and the immune system: A review with implications for" exact="cancer" post="and the psychology of healing Am. J. Clin. Hypn."/>
   <result pre="Effects of hypnosis and imagery training on naming behavior in" exact="aphasia" post="Brain Lang. 1986 28 141 153 10.1016/0093-934X(86)90097-0 3719294 37."/>
   <result pre="of self-hypnosis and propranolol in the treatment of juvenile classic" exact="migraine" post="Pediatrics 1987 79 593 597 3822681 41. McGrath P.J."/>
   <result pre="vs. standard care in children with functional abdominal pain or" exact="irritable bowel syndrome" post="Am. J. Gastroenterol. 2012 107 627 631 10.1038/ajg.2011.487 22310221"/>
   <result pre="M.G. Merkus M.P. et al. Gut-directed hypnotherapy in children with" exact="irritable bowel syndrome" post="or functional abdominal pain (syndrome): a randomized controlled trial"/>
   <result pre="vs individual hypnotherapy with a therapist for treatment of pediatric" exact="irritable bowel syndrome," post="functional abdominal pain, or functional abdominal pain syndrome JAMA"/>
   <result pre="E. A systematic review of guided imagery as an adjuvant" exact="cancer" post="therapy Psychooncology. 2005 14 607 617 10.1002/pon.889 15651053 72."/>
   <result pre="A.M. Benninga M.A. Gut-directed hypnotherapy for functional abdominal pain or" exact="irritable bowel syndrome" post="in children: A systematic review Arch. Dis. Child. 2013"/>
   <result pre="Tsao J.C.I. Iyengar yoga for adolescents and young adults with" exact="irritable bowel syndrome" post="J. Pediatr. Gastroenterol. Nutr. 2014 59 244 253 10.1097/MPG.0000000000000366"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC6213542/results/search/disease/results.xml">
   <result pre="facial dysmorphisms, dental abnormalities, hearing loss, ophthalmogical manifestations, joint and" exact="bone disease," post="cardiorespiratory problems, gastro-intestinal disorders, neurogical problems, and cognitive impairment"/>
   <result pre="we present a systematic review of the current knowledge regarding" exact="mucopolysaccharidosis" post="in children, with the purpose to discuss etiopathogenesis and"/>
   <result pre="are efficacious. Neuropathic pain is a common symptom associated with" exact="peripheral neuropathy" post="and carpal tunnel syndrome can be a possible cause"/>
   <result pre="efficacious. Neuropathic pain is a common symptom associated with peripheral" exact="neuropathy" post="and carpal tunnel syndrome can be a possible cause"/>
   <result pre="pain is a common symptom associated with peripheral neuropathy and" exact="carpal tunnel syndrome" post="can be a possible cause of neuropathic pain in"/>
   <result pre="MPS patients. Carpal tunnel syndrome is defined as an entrapment" exact="neuropathy" post="of the median nerve at the wrist [ 46]"/>
   <result pre="referred to their service for hip pain, frequently associated with" exact="osteonecrosis" post="of the femoral head (ONFH) [ 60]. De Ruijter"/>
   <result pre="the course of the disease (i.e., Hurler-Scheie or Scheie). Progressive" exact="arthropathy" post="(86%), in particular located at the interphalangeal joints, with"/>
   <result pre="gibbus (21%), kyphosis, scoliosis, and/or lordosis (24%) were also detected;" exact="carpal tunnel syndrome" post="was present in more than half of patients (66%);"/>
   <result pre="principal symptoms referred by children [ 65]. Cervical myelopathy and" exact="paraplegia" post="must be always considered as possible painful conditions in"/>
   <result pre="as compared to the placebo group. In addition, laronidasi improved" exact="sleep apnea" post="and shoulder mobility [ 78]. Gasulfase (recombinant human-acetylgalactosamine-4-sulftase) is"/>
   <result pre="used to treat moderate pain, particularly osteoarticular pain, headache, and" exact="migraine" post="attacks. Finally, Ibuprofen and Ketoprofen are NSAIDs with less"/>
   <result pre="different types of pain, such as refractory chemotherapy-related nausea and" exact="neuropathy" post="[ 86], neuropathic pain, spasticity in multiple sclerosis ["/>
   <result pre="chemotherapy-related nausea and neuropathy [ 86], neuropathic pain, spasticity in" exact="multiple sclerosis" post="[ 87], and AIDS-related neuropathy [ 88]. Few good"/>
   <result pre="neuropathic pain, spasticity in multiple sclerosis [ 87], and AIDS-related" exact="neuropathy" post="[ 88]. Few good quality randomized trials indicate that"/>
   <result pre="of different conditions in children, such as migraines, abdominal pain," exact="fibromyalgia" post="and complex pain regional syndrome has been reported in"/>
   <result pre="[ 117], trigger fingers, odontoid dysplasia or hypoplasia, and severe" exact="scoliosis" post="[ 118, 119]. Furthermore HSTC does not arrest the"/>
   <result pre="Pediatric Pain Service for irritability of unknown origin. On examination" exact="tetraplegia" post="with arms hypertonia and face grimaces, irregular breath, and"/>
   <result pre="van Diggelen O.P. Fietz M. Giugliani R. et al. Diagnosing" exact="mucopolysaccharidosis" post="IVA J. Inherit. Metab. Dis. 2013 36 293 307"/>
   <result pre="galsulfase enzyme replacement therapy on the growth of patients with" exact="mucopolysaccharidosis" post="VI (Maroteaux-Lamy syndrome) Mol. Genet. Metab. 2017 122 107"/>
   <result pre="Hopwood J.J. Walkley S.U. et al. A mouse model for" exact="mucopolysaccharidosis" post="type III A (Sanfilippo syndrome) Glycobiology 1999 9 1389"/>
   <result pre="D. Hopwood J.J. Skutelsky E. Ianelli C. et al. Human" exact="mucopolysaccharidosis" post="IIID: Clinical, biochemical, morphological and immunohistochemical characteristics J. Neuropathol."/>
   <result pre="lipids and lysosomal enzymes in patients with four types of" exact="mucopolysaccharidosis" post="and in normal controls J. Neurochem. 1978 30 965"/>
   <result pre="Dial S. Seim H. Abnormal neuronal metabolism and storage in" exact="mucopolysaccharidosis" post="type VI (Maroteaux-Lamy) disease Neuropathol. Appl. Neurobiol. 2005 31"/>
   <result pre="hallmark of pathogenesis in mouse models of GM1 and GM2" exact="gangliosidosis" post="Brain 2003 126 Pt 4 974 987 10.1093/brain/awg089 12615653"/>
   <result pre="presentation and follow-up of patients with the attenuated phenotype of" exact="mucopolysaccharidosis" post="type I Acta Paediatr. 2005 94 872 877 10.1080/08035250510031584"/>
   <result pre="Woodward A. Nurmikko T.J. Bundred P.E. Benbow S.J. Chronic painful" exact="peripheral neuropathy" post="in an urban community: A controlled comparison of people"/>
   <result pre="A. Nurmikko T.J. Bundred P.E. Benbow S.J. Chronic painful peripheral" exact="neuropathy" post="in an urban community: A controlled comparison of people"/>
   <result pre="Mawatari M. Clinical characteristics of neuropathic pain in patients with" exact="carpal tunnel syndrome" post="Hand Surg. 2014 19 43 48 10.1142/S0218810414500087 24641740 46."/>
   <result pre="Tylki-Szymańska A. Enzyme replacement therapy in an attenuated case of" exact="mucopolysaccharidosis" post="type I (Scheie syndrome): A 6.5-year detailed follow-up Pediatr."/>
   <result pre="Shapiro E.G. Long-term outcomes of adaptive functions for children with" exact="mucopolysaccharidosis" post="I (Hurler syndrome) treated with hematopoietic stem cell transplantation"/>
   <result pre="(laronidase) on restricted range of motion of upper extremities in" exact="mucopolysaccharidosis" post="type I patients J. Inherit. Metab. Dis. 2010 33"/>
   <result pre="Swiedler S.J. Kakkis E.D. et al. Enzyme replacement therapy for" exact="mucopolysaccharidosis" post="I: A randomized, double-blinded, placebo-controlled, multinational study of recombinant"/>
   <result pre="Elevated TNF-α is associated with pain and physical disability in" exact="mucopolysaccharidosis" post="types I, II, and VI Mol. Genet. Metab. 2016"/>
   <result pre="Bifulco M. Cannabinoids in the management of spasticity associated with" exact="multiple sclerosis" post="Neuropsychiatr. Dis. Treat. 2008 4 847 853 19183777 88."/>
   <result pre="decreases pain and improves cognitive function in middle-aged women with" exact="fibromyalgia" post="Clin. Exp. Rheumatol. 2007 25 823 830 18173915 110."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC6300897/results/search/disease/results.xml">
   <result pre="infant's communication as a guide. Neonatal Netw. 2013;32:404-8. A2 Retrocecal" exact="appendicitis" post="Ivan P Aloi, Arianna Bertocchini, Alessandro Inserra Department of"/>
   <result pre="condition of the abdomen. Despite technological advances, the diagnosis of" exact="appendicitis" post="is still based primarily on the patient's history and"/>
   <result pre="in the retrocecal position, the signs and symptoms of acute" exact="appendicitis" post="may be atypical and mimic pathology in the right"/>
   <result pre="hypochondrium, such as acute cholecystitis, diverticulitis, acute gastroenteritis, ureter colic," exact="acute pyelonephritis," post="and irritable bowel syndrome. Prompt diagnosis and surgical referral"/>
   <result pre="acute cholecystitis, diverticulitis, acute gastroenteritis, ureter colic, acute pyelonephritis, and" exact="irritable bowel syndrome." post="Prompt diagnosis and surgical referral may reduce the risk"/>
   <result pre="risk of perforation and prevent complications. The mortality in non-perforated" exact="appendicitis" post="is a rare event, but it may be more"/>
   <result pre="AIT course) on AR and its potential preventive effect on" exact="asthma" post="development [1]. AIT might be a strategy to prevent"/>
   <result pre="a promising treatment option in children with persistent IgE- mediated" exact="food allergy" post="[2,5]. The efficacy of AIT is under investigation also"/>
   <result pre="promising treatment option in children with persistent IgE- mediated food" exact="allergy" post="[2,5]. The efficacy of AIT is under investigation also"/>
   <result pre="of AIT is under investigation also in patients with extrinsic" exact="atopic dermatitis," post="currently with controversial results. Overall, the interest and the"/>
   <result pre="RG, Sheikh A, Muraro AEAACI Guidelines on allergen immunotherapy: IgE-mediated" exact="food allergy." post="Allergy. 2018;73:799-815. Halken S, Larenas-Linnemann D, Roberts G, Calderón"/>
   <result pre="central nervous system with consequent cognitive and behavioral impairment, to" exact="obesity" post="and type 2 diabetes mellitus. Scientific evidence also indicate"/>
   <result pre="consequent cognitive and behavioral impairment, to obesity and type 2" exact="diabetes mellitus." post="Scientific evidence also indicate endocrine disruptors as substances that"/>
   <result pre="range of causes, in children, leading to acute or chronic" exact="respiratory failure" post="due either to progressive lung disease, or to respiratory"/>
   <result pre="to acute or chronic respiratory failure due either to progressive" exact="lung disease," post="or to respiratory pump function deficit that can be"/>
   <result pre="for many reasons including inspiratory muscles weakness and ineffective cough;" exact="scoliosis" post="due to decreased muscle support; decreased spontaneous movement, which"/>
   <result pre="reductions in respiratory muscle strength and, consequently, cause symptoms like" exact="shortness" post="of breath, reduction in vital capacity, and acute hypercapnia."/>
   <result pre="place in every progressive NMD and patient with progressive chronic" exact="respiratory failure," post="with active involvement of the patient and family [6,7]."/>
   <result pre="make a difference in the life of the patient with" exact="respiratory failure" post="and his/her family. Child with respiratory failure, especially if"/>
   <result pre="the patient with respiratory failure and his/her family. Child with" exact="respiratory failure," post="especially if ventilated, calls into question the very bases"/>
   <result pre="the child [8]. In paediatric clinical practice the treatment of" exact="respiratory failure" post="raises ethical questions about the utility and limitations of"/>
   <result pre="dependent on technology; home caregivers’ burden and, because children with" exact="respiratory failure" post="often are not or cannot be involved in healthcare,"/>
   <result pre="Sharara RS, Singh AC, Balaan M. Pathophysiology and classification of" exact="respiratory failure." post="Crit Care Nurs Q. 2016; 39:85-93. Eber E, Midulla"/>
   <result pre="Longitudinal course of lung function and respiratory muscle strength in" exact="spinal muscular atrophy" post="type 2 and 3. Eur J Paediatr Neurol. 2013;"/>
   <result pre="Anestesiol. 2013; 79:419-33. Panitch HB. Diurnal hypercapnia in patients with" exact="neuromuscular disease." post="Paediatr Respir Rev. 2010; 11:3-8. Bach JR, Gonçalves MR,"/>
   <result pre="children correlate to sight difficulties, such as acute acquired comitant" exact="exotropia" post="[7] listening. A prolonged exposition of eardrums to intense"/>
   <result pre="7. Lee HS, Park SW, Heo H. Acute acquired comitant" exact="esotropia" post="related to excessive smartphone use. BMC Ophthalmology 2016; 16:37."/>
   <result pre="rate: Proportionate: Height SDS-MPH SDS&amp;gt;2 SDS  Sotos   YES: Simple" exact="obesity" post=" Weaver   Aromatase deficiency,  Fragile X   Oestrogen resistance  Smpson Golabi-Behmel"/>
   <result pre="Società Italiana di Pediatria, Italy Correspondence: Danilo Buonsenso (danilobuonsenso@gmail.com) Child" exact="tuberculosis" post="(TB) is a silent epidemic involving about one million"/>
   <result pre="with conditions that interfere with normal binocular vision, such as" exact="strabismus" post="(ocular misalignment), anisometropia (a difference in refractive power between"/>
   <result pre="interfere with normal binocular vision, such as strabismus (ocular misalignment)," exact="anisometropia" post="(a difference in refractive power between the two eyes),"/>
   <result pre="(a difference in refractive power between the two eyes), bilateral" exact="refractive error," post="and media opacity (such as cataracts) or other blockage"/>
   <result pre="cataracts) or other blockage of the visual pathway (such as" exact="ptosis" post="or eyelid drooping). We present main pre-scholar screening tests"/>
   <result pre="and to verify their role ibn the development of cryptogenic" exact="cirrhosis" post="and HCC [4] that carry a high incidence in"/>
   <result pre="Koulil S, van der Vleuten CJ. Propranolol treatment for infantile" exact="hemangioma" post="(IH) is not associated with the developmental risk or"/>
   <result pre="caused by a disease. When diseases like inflammatory bowel diseases," exact="coeliac disease," post="cystic fibrosis, thyroid or adrenal diseases are excluded, then"/>
   <result pre="a disease. When diseases like inflammatory bowel diseases, coeliac disease," exact="cystic fibrosis," post="thyroid or adrenal diseases are excluded, then the most"/>
   <result pre="to that of term infants, as in the case of" exact="hepatitis" post="B vaccine in infants with birth weight &amp;lt;2000 g."/>
   <result pre="AL, Weckx LY, Dos Santos AMN. Humoral immune response to" exact="measles" post="and varicella vaccination in former very low birth weight"/>
   <result pre="S, Mori K, Maeyama K, Nakayama T. Effect of early" exact="measles" post="vaccination (AIK-C strain) for preterm infants. Pediatr Int. 2013;55:163-8."/>
   <result pre="use of ABPM in children with high-risk conditions: secondary HYT," exact="chronic kidney disease" post="(CKD), diabetes, solid-organ transplant, obesity, obstructive sleep apnea syndrome"/>
   <result pre="secondary HYT, chronic kidney disease (CKD), diabetes, solid-organ transplant, obesity," exact="obstructive sleep apnea" post="syndrome and in some genetic syndrome (neurofibromatosis, Williams). As"/>
   <result pre="HYT, chronic kidney disease (CKD), diabetes, solid-organ transplant, obesity, obstructive" exact="sleep apnea" post="syndrome and in some genetic syndrome (neurofibromatosis, Williams). As"/>
   <result pre="Group, Cosenza, Italy Correspondence: Vita Cupertino (vitacupertino@gmail.com) Treatment of pediatric/adolescent" exact="obesity" post="is of interest for the entire community in terms"/>
   <result pre="primary care pediatrician represents the main reference for child/adolescent with" exact="obesity" post="and his family. Besides prevention and identification of children"/>
   <result pre="in most Italian regions, are the persistence of prejudice on" exact="obesity" post="as an exclusive personal responsibility, the failure to recognize"/>
   <result pre="obesity as an exclusive personal responsibility, the failure to recognize" exact="obesity" post="as a chronic disease and the lack of coordination"/>
   <result pre="on body weight, energy intake, and physical activity in childhood" exact="obesity" post="treatment: a randomized clinical trial. JAMA Pediatr. 2017;171:622-8. Consensus"/>
   <result pre="How good are BMI charts for monitoring children's attempts at" exact="obesity" post="reduction? Arch Dis Child. 2012;97:418-22. Gruppo di lavoro regionale"/>
   <result pre="2011; 77: 1629-1635. Srivastava AK, Schwartz CE. Intellectual disability and" exact="autism" post="spectrum disorders: causal genes and molecular mechanisms. Neurosci Biobehav"/>
   <result pre="undernutrition (stunting, wasting, vitamin and mineral deficiency) along with overweight," exact="obesity" post="or diet-related NCDs. To define the nutritional problem of"/>
   <result pre="development of two regional guidelines for common paediatric infections: acute" exact="otitis media" post="and sore throat. Guidelines were firstly published in 2007"/>
   <result pre="Main recommendations for sore throat treatment were: diagnosis of streptococcal" exact="pharyngitis" post="using an algorithm based on Mc Isaac score and"/>
   <result pre="tachyarrhythmias). They can be idiopathic or expression of a structural" exact="heart disease," post="a cardiomyopathy, a myocarditis, cardiac tumours, electrolytes disorders, channelopaties."/>
   <result pre="degree AVB can be isolated, usually congenital, or associated to" exact="congenital heart disease." post="In 70-80% of congenital isolated AV block, maternal autoantibodies"/>
   <result pre="AVB can be isolated, usually congenital, or associated to congenital" exact="heart disease." post="In 70-80% of congenital isolated AV block, maternal autoantibodies"/>
   <result pre="children with fetal, neonatal or childhood diagnosis of isolated congenital" exact="atrioventricular block." post="A single institution experience of 30 years. J Am"/>
   <result pre="Deng X, Chen Y, Liu S, Story M. Association between" exact="obesity" post="and puberty timing: a systematic review and meta-analysis. Int"/>
   <result pre="A, Ong KK, Perry JR. Puberty timing associated with diabetes," exact="cardiovascular disease" post="and also diverse health outcomes in men and women:"/>
   <result pre="for all vaccines that compose the hexavalent (diphtheria, tetanus, pertussis," exact="hepatitis" post="B, poliomyelitis and Haemophilus influenzae type b) vaccine; 88/112"/>
   <result pre="vaccines that compose the hexavalent (diphtheria, tetanus, pertussis, hepatitis B," exact="poliomyelitis" post="and Haemophilus influenzae type b) vaccine; 88/112 (78.6%) have"/>
   <result pre="for all vaccines that compose the hexavalent (diphtheria, tetanus, pertussis," exact="hepatitis" post="B, poliomyelitis and Haemophilus influenzae type b) vaccine; were"/>
   <result pre="vaccines that compose the hexavalent (diphtheria, tetanus, pertussis, hepatitis B," exact="poliomyelitis" post="and Haemophilus influenzae type b) vaccine; were vaccinated with"/>
   <result pre="in foster care. Iran J Public Health. 2013;42:368-373. A42 Farmacoresistent" exact="epilepsy" post="(DRE-ILAE) Alberto Fois (ftnp@libero.it) Siena, Italy AKA: Epilepsy not"/>
   <result pre="glycoprotein (Dgp), the resistance to multigrug associated protein (MRP), the" exact="breast cancer" post="resistance protein (BCRP). These proteins are important obstacles for"/>
   <result pre="(Dgp), the resistance to multigrug associated protein (MRP), the breast" exact="cancer" post="resistance protein (BCRP). These proteins are important obstacles for"/>
   <result pre="Animals models: It is yet non know how and why" exact="epilepsy" post="in some patients is intractable while in others with"/>
   <result pre="perspective two models look particularly interesting epileptic dogs with spontaneous" exact="epilepsy" post="and rats with amigdala epilepsy obtained with kindling. Some"/>
   <result pre="interesting epileptic dogs with spontaneous epilepsy and rats with amigdala" exact="epilepsy" post="obtained with kindling. Some hypotheses can at least in"/>
   <result pre="demonstrated in both monocytes and macrophages derived from patients with" exact="diabetes mellitus" post="2 and in monocytic cell lines exposed to hyperglycaemia."/>
   <result pre="referring to the pediatric age. A44 Is transition care in" exact="congenital heart disease" post="underestimated? Maria G Gagliardi, Micol Rebonato DMCCP, Ospedale Bambino"/>
   <result pre="to the pediatric age. A44 Is transition care in congenital" exact="heart disease" post="underestimated? Maria G Gagliardi, Micol Rebonato DMCCP, Ospedale Bambino"/>
   <result pre="transitioning process are paramount. The outlook for children born with" exact="congenital heart disease" post="continues to improve as a result of advances in"/>
   <result pre="process are paramount. The outlook for children born with congenital" exact="heart disease" post="continues to improve as a result of advances in"/>
   <result pre="to a significant increase in the population of adults with" exact="congenital heart disease." post="These young people need to be supported as they"/>
   <result pre="a significant increase in the population of adults with congenital" exact="heart disease." post="These young people need to be supported as they"/>
   <result pre="Child. 2007;92:927–930. 2. Mackie AS. Transition intervention for adolescents with" exact="congenital heart disease." post="JACC 2018;71:16. 3. Gibbs J, Gibbs S, Thorne S,"/>
   <result pre="2007;92:927–930. 2. Mackie AS. Transition intervention for adolescents with congenital" exact="heart disease." post="JACC 2018;71:16. 3. Gibbs J, Gibbs S, Thorne S,"/>
   <result pre="(about 30% of the malformations)[1]and severe (the main cause of" exact="chronic kidney disease" post="(CKD) in the pediatric age) and a predisposing factor"/>
   <result pre="the pediatric age) and a predisposing factor for hypertension and" exact="cardiovascular disease" post="[2].The acronym CAKUT includes a heterogeneous spectrum of pathologies:"/>
   <result pre="details of bladder, its only indication remains the diagnosis of" exact="vesicoureteral reflux" post="(VUR). Cystosonography or cystoscintigraphy[7-8] are always valid alternatives to"/>
   <result pre="L, Turck D, Gower-Rousseau C. Dramatic Increase in incidence of" exact="ulcerative colitis" post="and Crohn’s disease (1988-2011): a population-based study of French"/>
   <result pre="Turck D, Gower-Rousseau C. Dramatic Increase in incidence of ulcerative" exact="colitis" post="and Crohn’s disease (1988-2011): a population-based study of French"/>
   <result pre="the preconceptional period and environmental factors (infections, maternal metabolic diseases," exact="diabetes mellitus," post="drugs, alcohol) and the pregnancy [4]. Analysis of the"/>
   <result pre="G, La Placa S, Corsello G. Predictive factors of abdominal" exact="compartment syndrome" post="in neonatal age. Am J Perinatol. 2014; 31: 49-54."/>
   <result pre="cancers. Each year in Europe approximately 487.986 new cases of" exact="cancer" post="in females and 422.027 new cases in males are"/>
   <result pre="direct benefit to males, including prevention of genital warts and" exact="anal cancer." post="In addition, immunization of males is expected to provide"/>
   <result pre="C, Martin-Hirsch PP. Prophylactic vaccination against human papillomaviruses to prevent" exact="cervical cancer" post="and its precursors. Cochrane Database Syst Rev. 2018 May"/>
   <result pre="Martin-Hirsch PP. Prophylactic vaccination against human papillomaviruses to prevent cervical" exact="cancer" post="and its precursors. Cochrane Database Syst Rev. 2018 May"/>
   <result pre="Hepatitis C virus (HCV) is a leading cause of chronic" exact="viral hepatitis" post="in children. Before 1992, when the universal screening of"/>
   <result pre="C virus (HCV) is a leading cause of chronic viral" exact="hepatitis" post="in children. Before 1992, when the universal screening of"/>
   <result pre="Before 1992, when the universal screening of blood products began," exact="hepatitis" post="C was spread commonly through transfusions and organ transplants"/>
   <result pre="Nowadays, worldwide, children can acquire the infection from mothers with" exact="hepatitis" post="C or through the use of blood-contaminated objects (syringes"/>
   <result pre="spontaneous clearance of the infection while the remaining develop chronic" exact="hepatitis" post="and, if untreated, will become HCV infected adults [3]."/>
   <result pre="for treatment of children older than 12 years with chronic" exact="hepatitis" post="C virus genotype 1, 4, 5 or 6 and"/>
   <result pre="or without ribavirin for children older than 12 years with" exact="hepatitis" post="C virus genotype 1 or 4 infection, and for"/>
   <result pre="for the combination of sofosbuvir with daclatasvir for children with" exact="hepatitis" post="C virus genotype 4 infection [5]. All the results"/>
   <result pre="the new drugs, indications to treatment of children with chronic" exact="hepatitis" post="C virus have changed. Nowadays, direct-acting antiviral therapy is"/>
   <result pre="antiviral therapy is recommended for all the adolescents with chronic" exact="hepatitis" post="C virus infection independent of treatment history and disease"/>
   <result pre="direct-acting antivirals will be approved for younger age cohorts, all" exact="hepatitis" post="C virus-infected children older than three years will benefit"/>
   <result pre="54:852-857. Indolfi G, Azzari C, Resti M: Perinatal transmission of" exact="hepatitis" post="C virus. J Ped 2013;163:1549-1552. Resti M, Jara P,"/>
   <result pre="S, Bortolotti F. Clinical features and progression of perinatally acquired" exact="hepatitis" post="C virus infection. J Med Virol 2003; 70:373-377. Indolfi"/>
   <result pre="response to pegylated interferon and ribavirin in children with chronic" exact="hepatitis" post="C predicts the effect of treatment. Ped Infect Dis"/>
   <result pre="Serranti D, Resti M. Direct-acting antivirals for adolescents with chronic" exact="hepatitis" post="C. Lancet Child &amp;amp; Adol Health. 2018; 2:298- 304"/>
   <result pre="of mites, (2) or in the differential diagnosis of overlapping" exact="rhinitis" post="(allergic and Nares) (3) and in the diagnosis of"/>
   <result pre="Immunogenicity and nutritional value of protein-hydrolysed formulas for cow’s milk" exact="allergy" post="Amelia Licari, Gian Luigi Marseglia University of Pavia, Fondazione"/>
   <result pre="San Matteo, Pavia, Italy Correspondence: Amelia Licari (a.licari@smatteo.pv.it) Cow’s milk" exact="allergy" post="(CMA) is the most common food allergy in childhood,"/>
   <result pre="Licari (a.licari@smatteo.pv.it) Cow’s milk allergy (CMA) is the most common" exact="food allergy" post="in childhood, affecting 2–7 % of children [1]. The"/>
   <result pre="(a.licari@smatteo.pv.it) Cow’s milk allergy (CMA) is the most common food" exact="allergy" post="in childhood, affecting 2–7 % of children [1]. The"/>
   <result pre="J. 2010;3:57-161. Vandenplas Y. Prevention and management of cow's milk" exact="allergy" post="in non-exclusively breastfed infants. Nutrients. 2017;9: E731. Kiewiet MBG,"/>
   <result pre="most children pathological causes need to be excluded. Overweight and" exact="obesity" post="are a major health problem also in children, due"/>
   <result pre="identification of overweight children is of primary importance to prevent" exact="obesity" post="and its complications. A56 Complementary medicine in the treatment"/>
   <result pre="a study published in 2014 revealed that 37.5 % of" exact="breast cancer" post="patients had used CAM, especially young patients with a"/>
   <result pre="study published in 2014 revealed that 37.5 % of breast" exact="cancer" post="patients had used CAM, especially young patients with a"/>
   <result pre="of side effects in 74.8% of cases [1]. In paediatric" exact="cancer" post="patients, such treatments can lead to an effective improvement"/>
   <result pre="doctor relationship, as documented in a article investigating 98 paediatric" exact="cancer" post="patients treated with anthroposophy [2]. It has also been"/>
   <result pre="found that homeopathic remedies can have an apoptotic effect on" exact="cancer" post="cells [3]. References Saghatchian M, Bihan C, Chenailler C,"/>
   <result pre="use of complementary and alternative medicine among patients with early-stage" exact="breast cancer." post="Breast. 2014;23:279-85. Läengler A, Spix C, Edelhäuser F, Martin"/>
   <result pre="Khuda-Bukhsh AR. Psorinum 6 x trigger apoptosis signals in human" exact="lung cancer" post="cells. J Integr Med. 2016;14:143-53. A57 Respiratory infections: an"/>
   <result pre="AR. Psorinum 6 x trigger apoptosis signals in human lung" exact="cancer" post="cells. J Integr Med. 2016;14:143-53. A57 Respiratory infections: an"/>
   <result pre="abilities of foods, and, recently, the field of nutrition and" exact="respiratory disease" post="has continued to expand [5-7]. The immunomodulating effects of"/>
   <result pre="Engl J Med 1967;276:357-68. 2. Baraldi E. Filippone M. Chronic" exact="lung disease" post="after premature birth. N.Engl J Med 2007; 357: 1946-1955."/>
   <result pre="T, Lands LC. Sant'Anna G. Pathophysiology, screening and diagnosis of" exact="pulmonary hypertension" post="in infants with bronchopulmonary dysplasia - A review of"/>
   <result pre="Mourani PM, Abman SH. Pulmonary vascular disease in bronchopulmonary dysplasia:" exact="pulmonary hypertension" post="and beyond. Curr Opin Pediatr. 2013;25:329-37. 8. Alvira CM."/>
   <result pre="2016; 3:21. 9. Voynow JA. &quot;New&quot; bronchopulmonary dysplasia and chronic" exact="lung disease." post="Paediatric Respiratory Reviews, 2017;24:17-18. 10. Aschner JL, Bancalari EH,"/>
   <result pre="infections. Finally, specific measures are warranted to prevent ventilator associated" exact="pneumonia" post="(VAP), and among them, early weaning from mechanical ventilation"/>
   <result pre="Pediatrics, ISMETT, Palermo, 90100, Italy Cardiovascular diseases (CVD) including coronary" exact="heart disease," post="myocardial infarction, congestive heart failure, stroke, peripheral artery disease"/>
   <result pre="Italy Cardiovascular diseases (CVD) including coronary heart disease, myocardial infarction," exact="congestive heart failure," post="stroke, peripheral artery disease represent the main cause of"/>
   <result pre="including coronary heart disease, myocardial infarction, congestive heart failure, stroke," exact="peripheral artery disease" post="represent the main cause of mortality in developed Countries"/>
   <result pre="of CVD, age, gender, perinatal factors, overweight, tobacco exposure, hypertension," exact="dyslipidemia" post="represent risk factors for development of CVD [2]. Vascular"/>
   <result pre="risk factors [3]. Diabetes mellitus, hypertension, dyslipidemia, chronic renal failure," exact="obesity" post="in adults are clearly associated with CVD [4] and"/>
   <result pre="artery malformations); Metabolic diseases ( hyperomocisteinemia, glycogenosis); Neoplastic diseases (acute" exact="lymphoblastic leukemia," post="lymphoma); Autoinflammatory diseases (SLE, rheumatoid arthritis); Organ Transplantations; Migrane;"/>
   <result pre="E, Zaucha-Prażmo A, Brodzisz A, Kowalczyk J, Beń-Skowronek I. Premature" exact="atherosclerosis" post="after treatment for acute lymphoblastic leukemia in childhood. Ann"/>
   <result pre="A, Kowalczyk J, Beń-Skowronek I. Premature atherosclerosis after treatment for" exact="acute lymphoblastic leukemia" post="in childhood. Ann Agric Environ Med. 2018;25:71-76. Major RW,"/>
   <result pre="Kowalczyk J, Beń-Skowronek I. Premature atherosclerosis after treatment for acute" exact="lymphoblastic leukemia" post="in childhood. Ann Agric Environ Med. 2018;25:71-76. Major RW,"/>
   <result pre="J, Beń-Skowronek I. Premature atherosclerosis after treatment for acute lymphoblastic" exact="leukemia" post="in childhood. Ann Agric Environ Med. 2018;25:71-76. Major RW,"/>
   <result pre="Fujii T, Nitta K, Ohta A. Prevalence and mortality of" exact="chronic kidney disease" post="in lymphoma patients: A large retrospective cohort study. Medicine"/>
   <result pre="Ohta A. Prevalence and mortality of chronic kidney disease in" exact="lymphoma" post="patients: A large retrospective cohort study. Medicine (Baltimore). 2018;97:e9615."/>
   <result pre="FP, Triolo G, Afeltra A, Giacomelli R, Valentini G. Subclinical" exact="atherosclerosis" post="and history of cardiovascular events in Italian patients with"/>
   <result pre="pediatric population and generally occurring as a complication of acute" exact="otitis media" post="and mastoiditis [1]. Hypothesized pathophysiological mechanisms include cytokine release"/>
   <result pre="generally occurring as a complication of acute otitis media and" exact="mastoiditis" post="[1]. Hypothesized pathophysiological mechanisms include cytokine release by the"/>
   <result pre="mastoid mandatory. Case Report Seven year-old girl affected by bilateral" exact="coloboma" post="of the iris, congenital horizontal nystagmus and a history"/>
   <result pre="39o C), associated with nausea and vomiting. Otoscopy revealed bilateral" exact="otitis media" post="with effusion, whereas no signs of acute mastoiditis were"/>
   <result pre="bilateral otitis media with effusion, whereas no signs of acute" exact="mastoiditis" post="were present. On the following day, she returned to"/>
   <result pre="frank acute mastoiditis, but only aspecific otoscopic findings such as" exact="otitis media" post="with effusion. When clinical suspicion is raised, patients should"/>
   <result pre="the pediatrician should immediately consult the hematologist to screen for" exact="thrombophilia" post="and start anticoagulant therapy, and the otolaryngologist for an"/>
   <result pre="D, Goldfarb J, Sabella C. Lateral sinus thrombosis associated with" exact="mastoiditis" post="and otitis media in children: a retrospective chart review"/>
   <result pre="J, Sabella C. Lateral sinus thrombosis associated with mastoiditis and" exact="otitis media" post="in children: a retrospective chart review and review of"/>
   <result pre="critically ill newborn infant. Ital J Pediatr. 2017;43:100. A66 VRS" exact="bronchiolitis" post="in the 2017-2018 season Michele Miraglia del Giudice, Maria"/>
   <result pre="Vanvitelli&quot;, Napoli, Italy Correspondence: Michele Miraglia del Giudice (michele.miraglia@unicampania.it) Viral" exact="bronchiolitis" post="is a common clinical syndrome affecting infants and children"/>
   <result pre="last 3 season several Italian pediatric center enrolled infants with" exact="bronchiolitis" post="(&amp;lt;12 months) in order to study the clinical trend"/>
   <result pre="in order to study the clinical trend of patients with" exact="bronchiolitis" post="in different epidemic seasons based on the etiology and"/>
   <result pre="the etiology and available therapies. In Campania children hospitalized for" exact="bronchiolitis" post="were collected during 2014-2017. The patients were divided into"/>
   <result pre="a Lazio pediatric hospital were enrolled infants admitted for VRS" exact="bronchiolitis" post="during the last 3 seasons. In 2015/2016, 152 patients"/>
   <result pre="A69 Clinical results after 15 years of home telemonitoring in" exact="cystic fibrosis" post="Fabrizio Murgia (telemedicina@opbg.net) Department of Specialist Pediatrics- Integrated Home"/>
   <result pre="the Caucasian population. Classically, the CF is known as a" exact="respiratory disease," post="where it causes repeated infections and progressive bronchiectasis formations"/>
   <result pre="a respiratory disease, where it causes repeated infections and progressive" exact="bronchiectasis" post="formations until the development of respiratory failure. Respiratory exacerbations"/>
   <result pre="repeated infections and progressive bronchiectasis formations until the development of" exact="respiratory failure." post="Respiratory exacerbations are a critical event for the CF"/>
   <result pre="positive-pressure ventilation and conventional mechanical ventilation in patients with acute" exact="respiratory failure." post="N Engl J Med 1998; 339: 429–435. 4. Piastra"/>
   <result pre="a marked increase in the incidence of respiratory diseases, especially" exact="allergic rhinitis" post="among pediatric subjects. This is probably due to multiple"/>
   <result pre="marked increase in the incidence of respiratory diseases, especially allergic" exact="rhinitis" post="among pediatric subjects. This is probably due to multiple"/>
   <result pre="of allergens, with the consequent sensitization of their airways. Allergic" exact="rhinitis" post="(AR) is a public health problem that affects adults,"/>
   <result pre="mL/kg/day (6 L/day). Routinely, we tend to ascribe it to" exact="diabetes mellitus" post="(DM), but there are many causes to be considered"/>
   <result pre="kidney to reabsorb water in distal convoluted tubule as in" exact="diabetes insipidus" post=", nephrogenic diabtes insipidus, drugs and chronic renal failure."/>
   <result pre="diabetes may be unclear include: absence of symptoms, for example," exact="hyperglycemia" post="detected incidentally or in children participatingin screening studies; presence"/>
   <result pre="children participatingin screening studies; presence of mild/atypical symptoms of diabetes;" exact="hyperglycemia" post="detected under conditions of acute infective, traumatic, circulatory, or"/>
   <result pre="a factor of 120) for autoimmune cytopenia (anemia and thrombocytopenia)," exact="gastrointestinal disease," post="or arthritis. These data suggest that patients with autoimmune"/>
   <result pre="(carmelo.rizzari@gmail.com) Despite accounting for only 1% of all cancers, childhood" exact="cancer" post="is the leading disease-related cause of death in children."/>
   <result pre="tissues. [4] Results are particularly encouraging in the field of" exact="acute lymphoblastic leukemia" post="wherein fast-track approvals have been already granted by competent"/>
   <result pre="[4] Results are particularly encouraging in the field of acute" exact="lymphoblastic leukemia" post="wherein fast-track approvals have been already granted by competent"/>
   <result pre="Results are particularly encouraging in the field of acute lymphoblastic" exact="leukemia" post="wherein fast-track approvals have been already granted by competent"/>
   <result pre="Several additional trials are attempting to get similar results in" exact="acute myeloid leukemia," post="in chronic leukemias and solid tumors. As often happens"/>
   <result pre="additional trials are attempting to get similar results in acute" exact="myeloid leukemia," post="in chronic leukemias and solid tumors. As often happens"/>
   <result pre="deficiencies have been described as either cause or effect of" exact="short bowel syndrome" post="(SBS), which is the predominant underlying cause of intestinal"/>
   <result pre="full enteral nutrition [4,5]. Maternal/neonatal hypovitaminosis D can be associated" exact="necrotizing enterocolitis" post="(NEC) risk in premature infants supporting evidence that vitamin"/>
   <result pre="in patients with Crohn’s disease (CD), but not those with" exact="ulcerative colitis" post="(UC) [8]. Children with chronic diarrhea may present with"/>
   <result pre="patients with Crohn’s disease (CD), but not those with ulcerative" exact="colitis" post="(UC) [8]. Children with chronic diarrhea may present with"/>
   <result pre="not those with ulcerative colitis (UC) [8]. Children with chronic" exact="diarrhea" post="may present with deficiency of selected micronutrients such as"/>
   <result pre="G. Maternal/neonatal vitamin D deficiency: a new risk factor for" exact="necrotizing enterocolitis" post="in preterm infants? J Perinatol. 2017;37:673–678. 7. Pappa HM,"/>
   <result pre="and easily exported locally. A81 Atypical infantile presentation of hypertrophic" exact="cardiomyopathy" post="(HCM) detected incidentally by point of care ultrasound (POCUS)"/>
   <result pre="LV wall thickness was present on initial cardiac sonogram. Hypertrophic" exact="cardiomyopathy" post="(HCM) is a genetically heterogeneous disorder with a large"/>
   <result pre="One of the mainly roles of lactose is to prevent" exact="rickets" post="increasing the absorption of calcium and the galactose is"/>
   <result pre="5]. HMOs may play a role in the prevention of" exact="necrotizing enterocolitis," post="especially through a HMO, the disialyllacto-Ntetraose (DSLNT) [6]. In"/>
   <result pre="composition at six months, but it could also impact the" exact="obesity" post="development in later childhood[8]. Conclusions This review highlights the"/>
   <result pre="widespread chronic diseases in the world and is a multifactorial" exact="infectious disease." post="The World Health Organization (WHO) therefore urges the implementation"/>
   <result pre="reduction of the levels of lactic acid. A85 Treating children" exact="obesity" post="as a chronic disease: let us adopt the principles"/>
   <result pre="Study Group, Cosenza, Italy Correspondence: Rita Tanas (tanas.rita@tin.it) Prevalence of" exact="obesity" post="and consequences on physical and psychological health are more"/>
   <result pre="B, Juvet LK. Multicomponent lifestyle interventions for treating overweight and" exact="obesity" post="in children and adolescents: a systematic review and meta-analyses."/>
   <result pre="M, Usman Ali M, Raina P. Prevention of overweight and" exact="obesity" post="in children and youth: a systematic review and meta-analysis."/>
   <result pre="M, Gallagher C, Dietz WH. Current attitudes and practices of" exact="obesity" post="counselling by health care providers. Obes Res Clin Pract."/>
   <result pre="Ther. 20171:1. A86 Learning how to communicate the diagnosis of" exact="obesity" post="in childhood with the collaborative negotiation interview Rita Tanas"/>
   <result pre="has become an official tool for prevention and treatment of" exact="obesity" post="in childhood in many countries, although lacking in strong"/>
   <result pre="these approaches to childhood; push primary care pediatricians to treat" exact="obesity" post="with more confidence and determination; form them to a"/>
   <result pre="M, Gallagher C, Dietz WH. Current attitudes and practices of" exact="obesity" post="counselling by health care providers. Obes Res Clin Pract."/>
   <result pre="J, Wang Z, Koball A, Murad MH. Brief primary care" exact="obesity" post="interventions: a meta-analysis. Pediatrics. 2016;138:e2016014. Table 1 (abstract A86)."/>
   <result pre="(overuse injuries), infections (osteomyelitis and septic arthritis), inflammation (from transient" exact="synovitis" post="to rheumatic diseases), neoplasms (benign and malignant), and many"/>
   <result pre="barley. Spectrum of gluten-induced pathologies includes celiac disease, IgE-mediated wheat" exact="allergy" post="and non-celiac gluten sensitivity [1]. The first two conditions"/>
   <result pre="has been invoked, e.g. neurological diseases, autistic spectrum disorders, psoriasis," exact="fibromyalgia" post="and schizophrenia, but in many of these cases the"/>
   <result pre="Ullmann (nicola.ullmann@opbg.net) Acute lower respiratory tract infections (LRTI), such as" exact="pneumonia" post="and bronchiolitis, are the major causes of morbidity and"/>
   <result pre="Edition. 2014. [https://www.dors.it/alleg/0200/ragazzoni_quaderno.pdf] Accessed on 16 July 2018. A94 Bordetella" exact="pertussis" post="Piero Valentini (piero.valentini@unicatt.it) Department of Woman and Child Health,"/>
   <result pre="lasts 2-3 weeks, but any other respiratory infection can exacerbate" exact="pertussis" post="symptoms. Infants hospitalized for pertussis show apnea (50%), pneumonia"/>
   <result pre="other respiratory infection can exacerbate pertussis symptoms. Infants hospitalized for" exact="pertussis" post="show apnea (50%), pneumonia (20%), seizure (1%) and death"/>
   <result pre="exacerbate pertussis symptoms. Infants hospitalized for pertussis show apnea (50%)," exact="pneumonia" post="(20%), seizure (1%) and death (1%) as main complications"/>
   <result pre="its immunogenicity are increasing owing to a progressive rising of" exact="pertussis" post="incidence in many countries, maybe for reduced ability of"/>
   <result pre="fundamental in reducing the duration of nasopharyngeal carriage of B." exact="pertussis" post="and limit person-to-person transmission, although recent data shows that"/>
   <result pre="pertussis and limit person-to-person transmission, although recent data shows that" exact="pertussis" post="resurgence is not universal and the geographical variation in"/>
   <result pre="single explanation, such as the transition from whole-cell to acellular" exact="pertussis" post="vaccines [3-5]. References Kline JM, Lewis WD, Smith EA,"/>
   <result pre="and validation of laboratory methods for the diagnosis of Bordetella" exact="pertussis" post="infection: Culture, polymerase chain reaction (PCR) and anti-pertussis toxin"/>
   <result pre="toxin IgG serology (IgG-PT). PLoS ONE. 2018;13:e0195979. Plotkin SA. The" exact="pertussis" post="problem. Clin Infect Dis. 2014;58:830–3. Gill C, Rhoani P,"/>
   <result pre="de Cellès M, Magpantay FM, King AA, Rohani P. The" exact="pertussis" post="enigma: reconciling epidemiology, immunology and evolution. Proc Biol Sci."/>
   <result pre="- which include according to the DSM-5: attention deficit hyperactivity," exact="autism" post="spectrum, communication, intellectual developmental, motor and specific learning disorders"/>
   <result pre="Hall-Lande J, Van Naarden Braun K, Dowling NF. Prevalence of" exact="autism" post="spectrum disorder among children aged 8 years—autism and developmental"/>
   <result pre="Nelson BB, Karp EA, Kuo AA. The diagnostic odyssey of" exact="autism" post="spectrum disorder. Pediatrics. 2018;141:S272-S279. Vissers LELM, Gilissen C, Veltman"/>
   <result pre="status during pediatric age. Skeletal actions of vitamin D: nutritional" exact="rickets" post="represents the iceberg of vitamin D deficiency. The clinical"/>
   <result pre="the iceberg of vitamin D deficiency. The clinical presentation of" exact="rickets" post="is variable but is more likely to be seen"/>
   <result pre="during pediatric age may affect bone health, possibly predisposing to" exact="osteoporosis" post="later in life. Extraskeletal actions of vitamin D: besides"/>
   <result pre="respiratory tract infection [4], and significantly reduced the rate of" exact="asthma" post="exacerbations requiring treatment with systemic corticosteroids [5]. At present,"/>
   <result pre="I, Urashima M, Martineau AR. Vitamin D supplementation to prevent" exact="asthma" post="exacerbations: a systematic review and meta-analysis of individual participant"/>
   <result pre="San Raffaele Hospital, Milan, Italy Correspondence: Giovanna Weber (weber.giovanna@hsr.it) Subclinical" exact="hypothyroidism" post="(SH) is defined by the presence of TSH levels"/>
   <result pre="Autoimmune SH presents a higher risk of evolution toward overt" exact="hypothyroidism" post="compared to non-autoimmune SH (39,1% versus 13,6% after a"/>
   <result pre="elevated TSH serum levels in children and adolescents with Hashimoto’s" exact="thyroiditis" post="and isolated hyperthyrotropinemia: a 3‑year follow‑up. Clin Endocrinol. 2012;"/>
   <result pre="F.. Prospective evaluation of the natural course of idiopathic subclinical" exact="hypothyroidism" post="in childhood and adolescence. Eur J Endocrinol. 2009; 160,"/>
   <result pre="Endocrine disorders in childhood and adolescence. Natural history of subclinical" exact="hypothyroidism" post="in children and adolescents and potential effects of replacement"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC6406753/results/search/disease/results.xml">
   <result pre="support for their efficacy in improving pain-related outcomes such as" exact="fibromyalgia" post="symptoms, functional disability, cortisol levels, pain acceptance, and emotional"/>
   <result pre="for pain reduction have been noted in youth undergoing surgery," exact="cancer" post="patients, and young people diagnosed with irritable bowel syndrome"/>
   <result pre="youth undergoing surgery, cancer patients, and young people diagnosed with" exact="irritable bowel syndrome" post="(IBS) [ 102, 103, 104, 105]. In one noteworthy"/>
   <result pre="of hypnosis for abdominal pain, cancer, headaches, and juvenile classic" exact="migraine" post="[ 106, 107, 108, 109]. National training for pediatric"/>
   <result pre="efficacious in the treatment of chronic back pain, headaches, and" exact="osteoarthritis" post="among adults [ 117, 118, 119]. Pediatric applications have"/>
   <result pre="type of acupuncture, with 43 children who suffered from either" exact="migraine" post="or tension type headache. The mean number of headaches"/>
   <result pre="with sham acupuncture, 14 adolescents with pelvic pain due to" exact="endometriosis" post="experienced a 4.8 (SD 2.4) point reduction in pain"/>
   <result pre="non-pharmacological therapy in the management of acute postoperative pain and" exact="neonatal abstinence syndrome," post="and there is some preliminary evidence for chronic pediatric"/>
   <result pre="Mindfulness Decreased functional disability (33% improvement, p = 0.026); improved" exact="fibromyalgia" post="symptoms (26% improvement, p = 0.03), and improved mindfulness"/>
   <result pre="Raith et al. [ 123] RCT (2) 28 newborns with" exact="neonatal abstinence syndrome" post="Duration of morphine treatment; Length of stay Shorter duration"/>
   <result pre="for Children; LOS, length of stay; d, effect sizes; CRPS," exact="complex regional pain syndrome." post="References References 1. collab: Pain terms: A list with"/>
   <result pre="increases pain-evoked activation of the prefrontal cortex in patients with" exact="fibromyalgia" post="Pain 2012 153 1495 1503 10.1016/j.pain.2012.04.010 22617632 59. Williams"/>
   <result pre="hypnosis versus cognitive behavioral training for pain management with pediatric" exact="cancer" post="patients undergoing bone marrow aspirations Int. J. Clin. Exp."/>
   <result pre="vs. standard care in children with functional abdominal pain or" exact="irritable bowel syndrome" post="Am. J. Gastroenterol. 2012 107 627 631 10.1038/ajg.2011.487 22310221"/>
   <result pre="of self-hypnosis and propranolol in the treatment of juvenile classic" exact="migraine" post="Pediatrics 1987 79 593 597 3822681 110. Lin Y.C."/>
   <result pre="Wu X. et al. The long-term effect of acupuncture for" exact="migraine" post="prophylaxis: A randomized clinical trial JAMA Intern. Med. 2017"/>
   <result pre="A.M. Hochberg M.C. Effectiveness of acupuncture as adjunctive therapy in" exact="osteoarthritis" post="of the knee: A randomized, controlled trial Ann. Intern."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC6632133/results/search/disease/results.xml">
   <result pre="are more likely than white patients to be suspected of" exact="opioid abuse," post="subjected to more frequent urine screening, and referred to"/>
   <result pre="abuse, subjected to more frequent urine screening, and referred to" exact="substance abuse" post="services. 7 In the United States, SCD predominantly affects"/>
   <result pre="marijuana provides relief without the opioid adverse effects of severe" exact="constipation" post="and grogginess and may allow them to reduce or"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC6690403/results/search/disease/results.xml">
   <result pre="et al., 2015), including mental and behavioral health conditions (e.g.," exact="autism" post="or depression), medical conditions (e.g., sickle cell disease), and"/>
   <result pre="(e.g., sickle cell disease), and physical or intellectual disabilities (e.g.," exact="cerebral palsy" post="or Down syndrome). An estimated 19.8% of U.S. children"/>
   <result pre="pooled estimate of 13.4% of children and adolescents with any" exact="mental disorder" post="( Polanczyk et al., 2015). According to a systematic"/>
   <result pre="who had a child with a chronic illness (asthma, cancer," exact="cystic fibrosis," post="diabetes, epilepsy, juvenile rheumatoid arthritis and sickle cell disease)"/>
   <result pre="a chronic illness (asthma, cancer, cystic fibrosis, diabetes, epilepsy, juvenile" exact="rheumatoid arthritis" post="and sickle cell disease) reported significantly greater parenting stress,"/>
   <result pre="chronic illness (asthma, cancer, cystic fibrosis, diabetes, epilepsy, juvenile rheumatoid" exact="arthritis" post="and sickle cell disease) reported significantly greater parenting stress,"/>
   <result pre="child health symptoms or quality of life for children with" exact="asthma" post="( Martinez et al., 2009; Verkleij et al., 2015),"/>
   <result pre="2015), type 1 diabetes ( Carcone et al., 2012) and" exact="cerebral palsy" post="( Turkoglu et al., 2016). Although directionality of the"/>
   <result pre="witnessing other families experiencing similar challenges. Parents of children with" exact="autism" post="who have greater self-compassion reported greater life satisfaction and"/>
   <result pre="positive outcomes among parents of children with autism, developmental delay," exact="attention deficit hyperactivity disorder" post="(ADHD), mental health diagnoses, chronic pain, inflammatory bowel disease,"/>
   <result pre="that can have both a physical and intellectual impact like" exact="cerebral palsy," post="parents may need to provide assistance with feeding, help"/>
   <result pre="to ease feelings of guilt, shame, or disappointment that may" exact="plague" post="parents who are struggling to make meaning of the"/>
   <result pre="S. M. ( 2015). MYmind: mindfulness training for youngsters with" exact="autism" post="spectrum disorders and their parents . Autism 19, 906–"/>
   <result pre="N. ( 2014). Reducing distress in mothers of children with" exact="autism" post="and other disabilities: a randomized trial . Pediatrics 134,"/>
   <result pre="I. Arnaud C. Fauconnier J. ( 2017). Family adaptation to" exact="cerebral palsy" post="in adolescents: a European multicenter study. Res. Dev. Disabil."/>
   <result pre="C. ( 2009). The role of caregivers’ depressive symptoms and" exact="asthma" post="beliefs on asthma outcomes among low-income Puerto Rican children"/>
   <result pre="The role of caregivers’ depressive symptoms and asthma beliefs on" exact="asthma" post="outcomes among low-income Puerto Rican children . J. Asthma"/>
   <result pre="parents’ own words on how having a child in the" exact="autism" post="spectrum has affected their lives and their families’ lives"/>
   <result pre="2005). The health and well-being of caregivers of children with" exact="cerebral palsy." post="Pediatrics 115, e626– e636. 10.1542/peds.2004-1689 15930188 Raina P. O’Donnell"/>
   <result pre="Bogels S. M. ( 2018). Mindfulness-based program for children with" exact="autism" post="spectrum disorder and their parents: direct and long-term improvements"/>
   <result pre="E. ( 2012). Cancer-related sources of stress for children with" exact="cancer" post="and their parents. J. Pediatr. Psychol. 37, 185– 197."/>
   <result pre="of psychological adjustment and cognitive adaptational processes in children with" exact="cystic fibrosis" post="and sickle cell disease . J. Clin. Psychol. 54,"/>
   <result pre="anxiety and depression on quality of life of children with" exact="cerebral palsy" post=". Noro Psikiyatr. Ars. 53, 49– 54. 10.5152/npa.2015.10132 ,"/>
   <result pre="behavioral problems and disease severity in children with problematic severe" exact="asthma" post=". J. Clin. Psychol. Med. Settings 22, 179– 193."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC6787535/results/search/disease/results.xml">
   <result pre="sufficiently efficacious drugs, such as in Alzheimer disease (AD), or" exact="autism" post="spectrum disorder (ASD). Second, these molecules have been used"/>
   <result pre="stress, and mitochondrial dysfunction in disorders such as depression, schizophrenia," exact="bipolar disorder," post="and AD. 1 Acetylsalicylic acid and other nonsteroidal anti-inflammatory"/>
   <result pre="could also reduce traumatic memories and nightmares in patients with" exact="post-traumatic stress disorder" post="(PTSD). A systematic review found slight but positive evidence"/>
   <result pre="antiapoptotic, and neuroprotective effects. 24 Minocycline might be useful in" exact="major depressive disorder" post="(MDD) and in bipolar depression. 25 - 27 A"/>
   <result pre="clinical effects of adjunctive minocycline on the negative symptoms of" exact="schizophrenia" post="are controversial, 28 , 29 although a recent meta-analysis"/>
   <result pre="has efficacy in schizophrenia, but not in mood disorders or" exact="major depressive disorder." post="40 Further high-quality RCTs are warranted to determine the"/>
   <result pre="and D3 receptor agonist indicated in Parkinson disease (PD) and" exact="restless legs syndrome." post="Pramipexole is effective in unipolar and bipolar depression in"/>
   <result pre="propranolol. 47 , 48 Aside from cardiovascular indications, migraine, and" exact="essential tremor," post="propranolol might be useful in panic attacks. 49 Also,"/>
   <result pre="authors checked the files of 142 691 patients diagnosed with" exact="bipolar disorder," post="schizophrenia, or nonaffective psychosis, and found a reduction in"/>
   <result pre="data. The example of lithium as a first choice in" exact="bipolar disorder" post="is illustrative since this undisputed reference drug for bipolar"/>
   <result pre="bipolar disorder is illustrative since this undisputed reference drug for" exact="bipolar disorder" post="only has level 2 evidence in bipolar depression. Tamoxifen"/>
   <result pre="Examples are that the early detection of hypertension may reduce" exact="dementia" post="prevalence. 69 - 71 Cardiovascular prevention based on known"/>
   <result pre="Amino acid None Depression Amantadine NMDA receptor  antagonist Parkinsonian symptoms," exact="influenza" post="treatment and prophylaxis Alzheimer disease Bumetanide Loop diuretic Swelling"/>
   <result pre="prophylaxis Alzheimer disease Bumetanide Loop diuretic Swelling Autism spectrum disorders," exact="schizophrenia" post="Clonidine Central  a-2 agonist High blood pressure, cancer pain,"/>
   <result pre="spectrum disorders, schizophrenia Clonidine Central  a-2 agonist High blood pressure," exact="cancer" post="pain, ADHD in pediatric population ADHD Smoking cessation Recommended in"/>
   <result pre="pain Anxiety disorder,  bipolar disorder Yes as third-line treatment in" exact="panic disorder," post="second-line in social anxiety disorder, and third-line adjunctive therapy"/>
   <result pre="Yes as third-line treatment in panic disorder, second-line in social" exact="anxiety disorder," post="and third-line adjunctive therapy in PTSD62  As first-line treatment"/>
   <result pre="disorders Acetylsalicylic acid Cardiovascular  prophylaxis Schizophrenia Depression Pramipexole Antiparkinsonian Parkinsonian symptoms," exact="restless legs syndrome" post="Unipolar and bipolar depression As third-line adjunctive treatment in"/>
   <result pre="in bipolar depression45 Propranolol β-blockers High blood pressure, angina pectoris," exact="atrial fibrillation," post="migraine, essential tremor Anxiety disorders, PTSD prevention Not recommended"/>
   <result pre="Propranolol β-blockers High blood pressure, angina pectoris, atrial fibrillation, migraine," exact="essential tremor" post="Anxiety disorders, PTSD prevention Not recommended in GAD, SAD,"/>
   <result pre="Depression Statins Hypolipidemic drugs Hypercholesterolemia, hypertriglyceridemia Schizophrenia Tamoxifen Chemotherapy Breast" exact="cancer" post="Acute mania As third-line treatment in acute mania45 T3"/>
   <result pre="Kahn RS, Burger H. Adjuvant aspirin therapy reduces symptoms of" exact="schizophrenia" post="spectrum disorders: results from a randomized, double-blind, placebo-controlled trial."/>
   <result pre="of bumetanide on neurobehavioral function in children and adolescents with" exact="autism" post="spectrum disorders. Transl Psychiatry. 2017 7 3 e1056 10.1038/tp.2017.10."/>
   <result pre="10.1038/tp.2017.10. 28291262 11 Lemonnier E, Lazartigues A, Ben-Ari Y. Treating" exact="schizophrenia" post="with the diuretic bumetanide: a case report. Clin Neuropharmacol."/>
   <result pre="20 Guaiana G, Barbui C, Cipriani A. Hydroxyzine for generalised" exact="anxiety disorder." post="Cochrane Database Syst Rev. 2010 12 CD006815 10.1002/14651858.CD006815.pub2 21"/>
   <result pre="et al. The benefit of minocycline on negative symptoms of" exact="schizophrenia" post="in patients with recent-onset psychosis (BeneMin): a randomized, double-blind,"/>
   <result pre="Disorders (ISBD) 2018 guidelines for the management of patients with" exact="bipolar disorder." post="Bipolar Disord. 2018 20 2 97 170 29536616 46"/>
   <result pre="propranolol on psychophysiologic responding during subsequent script-driver traumatic imagery in" exact="post-traumatic stress disorder." post="J Psychiatr Res. 2008 42 6 503 506 17588604"/>
   <result pre="R, Yan R, et al. Adjunctive therapy with statins in" exact="schizophrenia" post="patients : a meta-analysis and implications. Psychiatry Res. 2018"/>
   <result pre="80 20808547 66 Qi W, Gevonden M, Shaly A. Preventionof" exact="post-traumatic stress disorder" post="after trauma : current evidence and future directions. Curr"/>
   <result pre="A, Bisson JI, Barbui C, Cuijpers P. Pharmacological prevention of" exact="post-traumatic stress disorder" post="and acute stress disorder: a systematic review and meta-analysis."/>
   <result pre="Nutt DJ, et al. Evidence-based pharmacological treatment of anxiety disorders," exact="post-traumatic stress disorder" post="and obsessive-compulsive disorder: a revision of the 2005 guidelines"/>
   <result pre="C. Can the treatment of hypertension in the middle-aged prevent" exact="dementia" post="in the elderly? High Blood Press Cardiovasc Prev. 2016"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC6827519/results/search/disease/results.xml">
   <result pre="a well-organized review of POTS and its &quot;overlapping pathophysiological mechanisms&quot;:" exact="chronic fatigue syndrome," post="Ehler-Danlos Syndrome and other hypermobile joint syndromes, vasovagal syncope,"/>
   <result pre="education or motivational-interviewing-based coaching compared to usual care to improve" exact="cancer" post="pain management . Oncol Nurs Forum . 2012; 39("/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC6918555/results/search/disease/results.xml">
   <result pre="University of Messina, Messina, Italy Correspondence: Stefania Arasi (stefania.arasi@opbg.net) IgE-mediated" exact="food allergy" post="(FA) has been emerging as a significant health issue"/>
   <result pre="of Messina, Messina, Italy Correspondence: Stefania Arasi (stefania.arasi@opbg.net) IgE-mediated food" exact="allergy" post="(FA) has been emerging as a significant health issue"/>
   <result pre="their family members. It represents a major cause of life-threatening" exact="hypersensitivity" post="reactions whose prevalence is increasing significantly. The diagnostic work-up"/>
   <result pre="of reaction in children with persistent cow’s milk, egg or" exact="peanut allergy" post="[3]. However, there are still several gaps to be"/>
   <result pre="reaction in children with persistent cow’s milk, egg or peanut" exact="allergy" post="[3]. However, there are still several gaps to be"/>
   <result pre="Alvaro-Lozano M, et al. EAACI Guidelines on allergen immunotherapy: IgE-mediated" exact="food allergy." post="Allergy. 2018; 73(4):799-815. 3. Nurmatov U, Dhami S, Arasi"/>
   <result pre="Pecora V, Fierro V, et al. Impact of omalizumab on" exact="food allergy" post="in patients treated for asthma: a real-life study. J"/>
   <result pre="V, Fierro V, et al. Impact of omalizumab on food" exact="allergy" post="in patients treated for asthma: a real-life study. J"/>
   <result pre="cycle of patients. A7 Lung ultrasound in infants with acute" exact="bronchiolitis" post="Carlotta Biagi, Anna Mingozzi, Luca Pierantoni, Marcello Lanari Pediatric"/>
   <result pre="Correspondence: Carlotta Biagi (carlottabiagi@yahoo.it) Background: The variable course of acute" exact="bronchiolitis" post="(AB) and the lack of current scoring systems that"/>
   <result pre="accuracy and reliability of LUS for the diagnosis of concomitant" exact="pneumonia" post="in infants with AB and to evaluate the correlation"/>
   <result pre="radiologist and pediatrician) who independently performed LUS. The diagnosis of" exact="pneumonia" post="was established by an expert clinician on the basis"/>
   <result pre="infants with AB were enrolled. A final diagnosis of concomitant" exact="pneumonia" post="was made in 27 patients. Sensitivity and specificity of"/>
   <result pre="patients. Sensitivity and specificity of LUS for the diagnosis of" exact="pneumonia" post="were 96.3% and 85.5% respectively, while CXR showed a"/>
   <result pre="This study shows the good accuracy of LUS in diagnosing" exact="pneumonia" post="in infants with AB. Added benefit of LUS included"/>
   <result pre="to predict the need of supplemental oxygen in infants with" exact="bronchiolitis" post="and to help clinician in the management of this"/>
   <result pre="Most frequently RSV may cause bronchiolitis, which could precipitate acute" exact="respiratory failure" post="requiring intensive care and ventilatory support. According to a"/>
   <result pre="a pediatric intensive care unit (PICU).[2] Co-morbidities, such as prematurity," exact="congenital heart disease," post="genetic abnormalities, chronic lung disease, sepsis or neuromuscular diseases,"/>
   <result pre="pediatric intensive care unit (PICU).[2] Co-morbidities, such as prematurity, congenital" exact="heart disease," post="genetic abnormalities, chronic lung disease, sepsis or neuromuscular diseases,"/>
   <result pre="Co-morbidities, such as prematurity, congenital heart disease, genetic abnormalities, chronic" exact="lung disease," post="sepsis or neuromuscular diseases, were important contributors for worse"/>
   <result pre="(CPAP) is changing the admission patterns and ventilation requirements for" exact="bronchiolitis" post="[4,5]. Non-invasive ventilation (NIV) seems to be the first"/>
   <result pre="electrical diaphragmatic activity [7]. In 11 children with severe RSV" exact="bronchiolitis" post="failing CPAP, non-invasive intermittent positive-pressure ventilation was provided using"/>
   <result pre="Schell DN, Egan JR. Humidified high-flow nasal cannula oxygen in" exact="bronchiolitis" post="reduces need for invasive ventilation but not intensive care"/>
   <result pre="V, et al. Improved clinical and economic outcomes in severe" exact="bronchiolitis" post="with pre-emptive nCPAP ventilatory strategy. Intensive Care Med. 2014;40:84–91."/>
   <result pre="sigh. The increased use of smartphones may result in dry" exact="eye disease," post="eye irritation and fatigue, burning sensation, conjunctival injection, decreased"/>
   <result pre="injection, decreased visual acuity, strain, and fatigue acute acquired comitant" exact="esotropia" post="[7,8]; addiction. Many adolescents use compulsively their smartphones to"/>
   <result pre="Children Hospital, Rome, Italy Correspondence: Elena Bozzola (elena.bozzola@opbg.net) Background Pediatric" exact="bacterial meningitis" post="is a real neurologic emergency. An early diagnosis and"/>
   <result pre="Hospital, Rome, Italy Correspondence: Elena Bozzola (elena.bozzola@opbg.net) Background Pediatric bacterial" exact="meningitis" post="is a real neurologic emergency. An early diagnosis and"/>
   <result pre="years literature to find out the possible way to prevent" exact="bacterial meningitis." post="Results In literature a number of risk factors of"/>
   <result pre="meningitis. Results In literature a number of risk factors of" exact="meningitis" post="are reported, including socioeconomic factors, age, genetic variation of"/>
   <result pre="has led to a significant decline in the frequency of" exact="bacterial meningitis" post="over the past years [4]. Anyway, prevention still remains"/>
   <result pre="led to a significant decline in the frequency of bacterial" exact="meningitis" post="over the past years [4]. Anyway, prevention still remains"/>
   <result pre="provide direct and indirect protection and reduce the incidence of" exact="bacterial meningitis." post="For example, in England, within three years, the vaccination"/>
   <result pre="is actually the only effective way to prevent some of" exact="bacterial meningitis." post="References 1. Posadas E, Fisher J. Pediatric bacterial meningitis:"/>
   <result pre="2:B3-9. 3. Lundbo LF, Benfield T. Risk factors for community-acquired" exact="bacterial meningitis." post="Infect Dis (Lond). 2017;49:433-444. 4. McIntyre PB, O'Brien KL,"/>
   <result pre="Greenwood B, van de Beek D. Effect of vaccines on" exact="bacterial meningitis" post="worldwide. Lancet. 2012;380:1703-1711. 5. Ramsay ME, Andrews NJ, Trotter"/>
   <result pre="B, van de Beek D. Effect of vaccines on bacterial" exact="meningitis" post="worldwide. Lancet. 2012;380:1703-1711. 5. Ramsay ME, Andrews NJ, Trotter"/>
   <result pre="Correspondence: Mauro Bozzola (mauro.bozzola@unipv.it) Celiac disease (CD) is an immune-mediated" exact="enteropathy" post="triggered by dietary gluten-containing cereals in genetically susceptible individuals"/>
   <result pre="disease. The pathogenesis of growth failure is probably due to" exact="malabsorption" post="or abnormality in the endocrine growth axis. A lack"/>
   <result pre="a potentially fatal complication of rheumatic diseases, particularly of systemic" exact="juvenile idiopathic arthritis" post="(sJIA). MAS is caused by excessive activation and proliferation"/>
   <result pre="fatal complication of rheumatic diseases, particularly of systemic juvenile idiopathic" exact="arthritis" post="(sJIA). MAS is caused by excessive activation and proliferation"/>
   <result pre="antibody, in patients with macrophage activation syndrome (MAS) complicating systemic" exact="juvenile idiopathic arthritis" post="(sJIA). Ann Rheum Dis. 2019; 78 (S2):178. A15 Congenital"/>
   <result pre="patients with macrophage activation syndrome (MAS) complicating systemic juvenile idiopathic" exact="arthritis" post="(sJIA). Ann Rheum Dis. 2019; 78 (S2):178. A15 Congenital"/>
   <result pre="follow-up after surgery. We recorded 7 cases of post-operative significant" exact="pericardial effusion;" post="6 of them had a diagnosis of anomalous origin"/>
   <result pre="such as (Shiga toxin-producing Escherichia coli) STEC-HUS or atypical post-infectious" exact="glomerulonephritis" post="(PIGN) [2]. Materials and methods 201 PIGN patients (121"/>
   <result pre="not statistically significant. No differences observed in age of onset," exact="proteinuria" post="and serum C4 levels (Table1). Conclusions The role of"/>
   <result pre="other kidney diseases such as PIGN, a common form of" exact="glomerulonephritis" post="in paediatric age. Prognosis is usually good; however, a"/>
   <result pre="with atypical features, such as persistent low C3 and/or persistent" exact="proteinuria" post="and/or decline in renal function. In our experience, these"/>
   <result pre="Riedl M, Thorner P, Licht C. C3 Glomerulopathy and post-infectious" exact="glomerulonephritis" post="define a disease spectrum. Pediatr Nephrol. 2016;31:2079-86. Fig. 1"/>
   <result pre="patients. EIB affects from 40 to 90% of individuals with" exact="asthma" post="[1] and approximately from 8 to 10% of children"/>
   <result pre="children without asthma. Children with EIB typically experience chest tightness," exact="shortness" post="of breath, cough, wheeze, due to bronchoconstriction which generally"/>
   <result pre="10-15 minutes and resolves by 60 minutes. Patients with atopic" exact="asthma" post="may present EIB more likely when exercise includes exposure"/>
   <result pre="when exercise includes exposure to the relevant allergen or when" exact="asthma" post="is not optimally controlled. The diagnosis of EIB is"/>
   <result pre="chronic pediatric onset disease, particularly in patients with Type 1" exact="diabetes mellitus." post="It is necessary to start a structured care pathway"/>
   <result pre="CBCL. Eur Child Adolesc Psychiatr. 2015;24(suppl.1):S22 A25 Management of chronic" exact="lung disease" post="in children Salvatore Cazzato, Federica Zallocco, Alessia Omenetti Pediatrics"/>
   <result pre="Correspondence: Salvatore Cazzato (salvatore.cazzato@ospedaliriuniti.marche.it) Among chronic lung diseases, non-cystic fibrosis" exact="bronchiectasis" post="(NCFB) has recently received growing attention, mainly due to"/>
   <result pre="and the current poor outcomes. An inappropriate medical approach to" exact="bronchiectasis" post="may actually be associated with rapid decline in lung"/>
   <result pre="strategies have been extrapolated from those used for children with" exact="cystic fibrosis" post="or adults with NCFB. The proposed methods used to"/>
   <result pre="effectiveness or inhalation of other mucoactive agents in children with" exact="bronchiectasis" post="is lacking [11]. Finally, nutritional aspects is another concern"/>
   <result pre="et al. Changes in the incidence, prevalence and mortality of" exact="bronchiectasis" post="in the UK from 2004 to 2013: a population-based"/>
   <result pre="4) McCallum GB, Binks MJ. The epidemiology of chronic suppurative" exact="lung disease" post="and bronchiectasis in children and adolescents. Front pediatr. 2017;20:5-27."/>
   <result pre="Binks MJ. The epidemiology of chronic suppurative lung disease and" exact="bronchiectasis" post="in children and adolescents. Front pediatr. 2017;20:5-27. 5) Kapur"/>
   <result pre="Main E, Grillo L, Rand S. Airway clearance strategies in" exact="cystic fibrosis" post="and non-cystic fibrosis bronchiectasis. Sem Respir Crit Care Med."/>
   <result pre="2015;11:CD008351. 10) Lee E, Hong SJ. Pharmacotherapeutic strategies for treating" exact="bronchiectasis" post="in pediatric patients. Expert Opin Pharmacother. 2019;22:1-2. 11) Elkins"/>
   <result pre="controlled trial of long-term inhaled hypertonic saline in patients with" exact="cystic fibrosis." post="N Engl J Med. 2006;354:229-40. 12) Bastardo CM, Sonnappa"/>
   <result pre="Navarro A, Lopez PM, Jaffe A, et al. Non-cystic fibrosis" exact="bronchiectasis" post="in childhood: longitudinal growth and lung function. Thorax. 2009;64:246-51."/>
   <result pre="settlements of shelter and marine colonies for children suffering from" exact="rickets" post="and scrofula spread. At the beginning of the twentieth"/>
   <result pre="shelter and marine colonies for children suffering from rickets and" exact="scrofula" post="spread. At the beginning of the twentieth century the"/>
   <result pre="Pediatrics.Good adherence to recommendations in literature for the treatment of" exact="allergic rhinitis" post="was found: oral antihistamines are used by 607 (61%)"/>
   <result pre="adherence to recommendations in literature for the treatment of allergic" exact="rhinitis" post="was found: oral antihistamines are used by 607 (61%)"/>
   <result pre="by 607 (61%) of the interviewed in case of secretory" exact="allergic rhinitis" post="while 649 (65%) use spray nasal corticoids for the"/>
   <result pre="607 (61%) of the interviewed in case of secretory allergic" exact="rhinitis" post="while 649 (65%) use spray nasal corticoids for the"/>
   <result pre="nasal corticoids for the obstructive type.For the treatment of the" exact="asthma" post="attack ICS are not used by 54% of the"/>
   <result pre="of need (49%) or as a maintenance therapy. Both for" exact="asthma" post="and wheezing ,treatment time before control appeared affected by"/>
   <result pre="survey. A good management of the child affected by recurrent" exact="asthma" post="or wheezing is shown as well as the choice"/>
   <result pre="needs. An excessive use of corticosteroids for the treatment of" exact="asthma" post="was found, expecially for the acute asthma attack as"/>
   <result pre="the treatment of asthma was found, expecially for the acute" exact="asthma" post="attack as well as for the dosages used in"/>
   <result pre="the organization of specific training courses. A30 Controversies in the" exact="tuberculosis" post="screening in internationally adopted children Elena Chiappini, Barba Bortone,"/>
   <result pre="infection (LTBI) is about 15%. The published screening protocols for" exact="tuberculosis" post="in IAC are discordant and the use of tuberculin"/>
   <result pre="age. In Italy, the national guidelines for the diagnosis of" exact="tuberculosis" post="in immigrants, published in 2018, suggest the possible use"/>
   <result pre="care (with an emphasis on age-specific needs), national centralisation of" exact="sarcoma" post="care, international consortia. As a matter of fact, different"/>
   <result pre="efforts from international collaborations between pediatric and adult oncologists of" exact="sarcoma" post="groups have optioned in converging towards a common therapeutic"/>
   <result pre="details. First, the outcome of adolescents and young adults with" exact="rhabdomyosarcoma" post="is decidedly worse than that generally seen in childhood."/>
   <result pre="than that generally seen in childhood. It is supposed that" exact="rhabdomyosarcoma" post="patients, regardless of their age, would receive better treatment"/>
   <result pre="pediatric population has not paralleled the progress seen in adult" exact="sarcoma" post="patients. Increased international collaboration between pediatric and adult sarcoma"/>
   <result pre="adult sarcoma patients. Increased international collaboration between pediatric and adult" exact="sarcoma" post="groups is of critical importance to facilitate the transfer"/>
   <result pre="Streptococcus pneumoniae (52.25%), Haemophilus influenzae B (7.36%), RSV (6.29%) and" exact="influenza" post="virus (1.28%) [1, 2, 3]. The Italian Society of"/>
   <result pre="Theodoratou E, Bhutta ZA, et al. Global burden of childhood" exact="pneumonia" post="and diarrhoea. Lancet. 2013;381:1405-1416. 3) GBD 2016 Lower Respiratory"/>
   <result pre="Accessed 8 August 2019. 4. World Health organization. Management of" exact="substance abuse" post="unit. Global status report on alcohol and health, 2014."/>
   <result pre="manifestations in paediatric subjects too. Some oral complications, such as" exact="periodontal disease," post="may be a possible risk factor for poor metabolic"/>
   <result pre="authors reviewed the literature to classify oral conditions related to" exact="diabetes mellitus" post="in paediatric age. Studies that had low or no"/>
   <result pre="paediatric age. Studies that had low or no association between" exact="diabetes mellitus" post="and oral manifestations were included too. Results In paediatric"/>
   <result pre="and oral manifestations were included too. Results In paediatric subjects," exact="diabetes mellitus" post="is associated with different frequency to the following oral"/>
   <result pre="associated with different frequency to the following oral clinical manifestations:" exact="periodontal disease" post="(increase of Plaque Index, Gingival Index, Bleeding on Probing),"/>
   <result pre="disease (increase of Plaque Index, Gingival Index, Bleeding on Probing)," exact="dental caries" post="(increase of dmft /DMFT), salivary changes (decreased of salivary"/>
   <result pre="to the time of diagnosis and the glycaemic control of" exact="diabetes mellitus." post="Particular attention was paid to salivary changes in the"/>
   <result pre="changes in the diabetic subject and the two-way relationship between" exact="diabetes mellitus" post="/periodontal disease and diabetes mellitus /periapical pathology, in particular"/>
   <result pre="and the two-way relationship between diabetes mellitus /periodontal disease and" exact="diabetes mellitus" post="/periapical pathology, in particular for preventive and interceptive purposes."/>
   <result pre="purposes. Some studies present conflicting results on the association between" exact="diabetes mellitus" post="and dental caries. Conclusions The prevention and interception of"/>
   <result pre="present conflicting results on the association between diabetes mellitus and" exact="dental caries." post="Conclusions The prevention and interception of some oral complications"/>
   <result pre="Conclusions The prevention and interception of some oral complications of" exact="diabetes mellitus" post="are fundamental both for oral health, but also for"/>
   <result pre="2008;122:1119-1126. A41 Outcomes of conservative treatment in children with acute" exact="appendicitis" post="Carolina D’Anna 1, Letizia Zenzeri 1, Maria Concetta Lonardo"/>
   <result pre="&quot;Federico II,&quot; Naples, Italy Correspondence: Carolina D’Anna (dannacarol@alice.it) Introduction Acute" exact="appendicitis" post="(AA) is still the most common indication as surgical"/>
   <result pre="clinical and laboratory examination improve diagnostic accuracy of acute uncomplicated" exact="appendicitis" post="(AUA). As second aim we evaluated the efficacy of"/>
   <result pre="at twelve months of follow-up underwent surgical treatment for complicated" exact="appendicitis" post="and 3(50%) during the long-term follow-up didn’t received any"/>
   <result pre="diagnosis of AA and especially in order to distinguish if" exact="appendicitis" post="is complicated or not. We observed in our study"/>
   <result pre="not. We observed in our study that the severity of" exact="appendicitis" post="correlates with decreased submucosal integrity rather than with appendiceal"/>
   <result pre="SW, Holcomb GW, Ostile DJ. An evidence-based definition for perforated" exact="appendicitis" post="derived from a prospective randomized trial. J Pediatr Surg."/>
   <result pre="Ansaloni L. Early appendectomy vs. conservative management in complicated acute" exact="appendicitis" post="in children: A meta-analysis. J Pediatr Surg. 2019; pii:"/>
   <result pre="2019; pii: S0022-3468(19)30125-3. A42 A problem at the Emergency Department:" exact="hyperglycemia" post="in diabetic child Giuseppe d’Annunzio, Nicola Minuto, Mohamad Maghnie"/>
   <result pre="Giuseppe d’Annunzio (giuseppedannunzio@gaslini.org) Despite increasing knowledge about the disease pathogenesis," exact="diabetic ketoacidosis" post="(DKA) is frequently observed in newly-diagnosed Type 1 Diabetes"/>
   <result pre="adverse event requiring hospitalization, with a prevalence of 2.4%. Insulin" exact="allergy" post="could elicit immediate reactions, usually induced by an IgE-mediated"/>
   <result pre="behaviour, mostly in females, for weight loss as expression of" exact="eating disorder" post="including &quot;diabulimia&quot;, or other severe psychological disturbances. Other acute"/>
   <result pre="complications leading to hospitalization in long-standing patients include acute appendicitis," exact="pancreatitis" post="and kidney injuries. As regards neurological involvement acute chorea"/>
   <result pre="appendicitis, pancreatitis and kidney injuries. As regards neurological involvement acute" exact="chorea" post="and central venous thrombosis have been described. Patients with"/>
   <result pre="of cases. The infections include bacteria (49%), viruses (49%), and" exact="tuberculosis" post="(2%). DKA with tuberculous meningitis, herpes simplex type 2"/>
   <result pre="(49%), viruses (49%), and tuberculosis (2%). DKA with tuberculous meningitis," exact="herpes simplex" post="type 2 encephalitis and group B streptococcal meningitis have"/>
   <result pre="tuberculosis (2%). DKA with tuberculous meningitis, herpes simplex type 2" exact="encephalitis" post="and group B streptococcal meningitis have also been reported."/>
   <result pre="tuberculous meningitis, herpes simplex type 2 encephalitis and group B" exact="streptococcal meningitis" post="have also been reported. Ileo psoas abscesses, rhinocerebral mucormycosis"/>
   <result pre="meningitis, herpes simplex type 2 encephalitis and group B streptococcal" exact="meningitis" post="have also been reported. Ileo psoas abscesses, rhinocerebral mucormycosis"/>
   <result pre="gene therapy. For several diseases target of prenatal diagnosis, including" exact="cystic fibrosis," post="spinal muscular atrophy, thalassemia and others, promising precision medicine"/>
   <result pre="For several diseases target of prenatal diagnosis, including cystic fibrosis," exact="spinal muscular atrophy," post="thalassemia and others, promising precision medicine protocols are becoming"/>
   <result pre="target of prenatal diagnosis, including cystic fibrosis, spinal muscular atrophy," exact="thalassemia" post="and others, promising precision medicine protocols are becoming available,"/>
   <result pre="with about 60% of affected males reaching diagnostic criteria for" exact="autism" post="spectrum disorder [2]. Anyway fragile-X children maintain an adequate"/>
   <result pre="them shows neuropsychiatric disorders [3]. Female carriers can have a" exact="premature ovarian failure," post="while a late-onset ataxic syndrome with tremor has been"/>
   <result pre="&quot;normal&quot; bowel function and long term artificial feeding requirement (encephalopathy," exact="cerebral palsy," post="repeated aspiration pneumonia, etc). Percutaneous endoscopic gastrostomy (PEG) is"/>
   <result pre="and long term artificial feeding requirement (encephalopathy, cerebral palsy, repeated" exact="aspiration pneumonia," post="etc). Percutaneous endoscopic gastrostomy (PEG) is easily and safety"/>
   <result pre="Respiratory physiotherapy is a fondamental tool for the cure of" exact="cystic fibrosis." post="Viscous mucus secretions obstruct airways, leading to recurrent and"/>
   <result pre="likelihood of avascular necrosis of the femoral head and early" exact="osteoarthritis" post="of the hip and leads to better results [7,8]."/>
   <result pre="parents on reasons for antibiotic prescription. Guidelines development on acute" exact="otitis media" post="and sore throat followed in 2007, a monitoring system"/>
   <result pre="child, that can take place only after the process of" exact="infertility" post="grief. The child of the new conception scenarios is"/>
   <result pre="progressive bronchial wall damage and dilatation, known as bronchiectasis. In" exact="bronchiectasis" post="mucus is even more stuck, which make infections and"/>
   <result pre="onset of sputum production and eventually bronchorrea. As a consequence," exact="bronchiectasis" post="severity correlates with worse pulmonary function [2]. Bronchiectasis is"/>
   <result pre="middle lobe, the lingula and the inferior lobes, while, unlike" exact="cystic fibrosis," post="upper lobes involvement can be found in most severe"/>
   <result pre="most severe cases and later disease stage. [4]. In children," exact="bronchiectasis" post="involves firstly the middle lobe, since the middle lobe"/>
   <result pre="Chest Tomography is still the gold standard test to diagnose" exact="bronchiectasis" post="and assess its extent and severity. Recently, some studies"/>
   <result pre="Resonance Imaging is an accurate and reliable method to evaluate" exact="bronchiectasis" post="in PCD patients [5]. Treatment of bronchiectasis is mainly"/>
   <result pre="method to evaluate bronchiectasis in PCD patients [5]. Treatment of" exact="bronchiectasis" post="is mainly based on respiratory physiotherapy and airway clearance"/>
   <result pre="al. Evaluation of pulmonary disease using static lung volumes in" exact="primary ciliary dyskinesia." post="Thorax. 2012;67:993-9. 3. Hosie PH, Fitzgerald DA, Jaffe A,"/>
   <result pre="Jaffe A, Birman CS, Rutland J, Morgan LC. Presentation of" exact="primary ciliary dyskinesia" post="in children: 30 years’ experience. J Paediatr Child Health."/>
   <result pre="SL, Knowles MR, et al. High-resolution CT of patients with" exact="primary ciliary dyskinesia." post="Am J Roentgenol. 2007;188:1232-8. 5. Montella S, Santamaria F,"/>
   <result pre="Ciliary Dyskinesia Paediatr Respir Rev. 2016;18:39-45. A53 Lung microbiome and" exact="asthma" post="in children Maria E Di Cicco 1,2, Mauro Pistello"/>
   <result pre="also known to be linked to a higher risk of" exact="asthma" post="at 5 years in children born to asthmatic mothers."/>
   <result pre="mothers. Moreover, the phylum Proteobacteria is linked to severity of" exact="asthma" post="and bronchial hyperreactivity. The lung microbiome may also interact"/>
   <result pre="panleukopenia, the recurrence of pulmonary infections may evolve to chronic" exact="lung disease" post="by early adulthood, and the specific susceptibility to chronic"/>
   <result pre="heart system development, other than hematopoiesis, the syndrome may feature" exact="congenital heart disease" post="and neurological abnormalities [6-7]. Conventional treatments include Granulocyte-Colony Stimulating"/>
   <result pre="system development, other than hematopoiesis, the syndrome may feature congenital" exact="heart disease" post="and neurological abnormalities [6-7]. Conventional treatments include Granulocyte-Colony Stimulating"/>
   <result pre="investigated patients had abnormal cerebellar morphology. All patients had severe" exact="neutropenia" post="at onset (150±105 cells/mmc), monocytopenia was reported in 13/21"/>
   <result pre="phenotypes, and it should always be suspected in cases of" exact="severe congenital neutropenia." post="The diagnosis is confirmed by molecular testing, but functional"/>
   <result pre="suggested since early childhood to prevent the development of chronic" exact="lung disease." post="References Hernandez PA, Gorlin RJ, Lukens JN, Taniuchi S,"/>
   <result pre="outcome of WHIM syndrome in 18 patients: high risk of" exact="lung disease" post="and HPV-related malignancies. J Allergy Clin Immunol Pract. 2019;7:1568-1577."/>
   <result pre="following criteria: patient’s age and type of pathology, presence of" exact="food allergy" post="or intolerance and mode or route of administration (through"/>
   <result pre="criteria: patient’s age and type of pathology, presence of food" exact="allergy" post="or intolerance and mode or route of administration (through"/>
   <result pre="been associated with a later increased risk of overweight and" exact="obesity" post="[3]. Intake of simple sugars, above all those from"/>
   <result pre="Group. Lower protein content in infant formula reduces BMI and" exact="obesity" post="risk at school age: follow-up of a randomized trial."/>
   <result pre="Daniela Fava (galanti.fava@gmail.com) Case report A 3-month-old male with progressive" exact="obesity" post="was referred for investigations. On admission, he presented apparent"/>
   <result pre="hypothermia were reported; RBCs and albumin were transfused due to" exact="anemia" post="and hypoalbuminemia. Since his Status Epilepticus he presented dysphagia"/>
   <result pre="perform a gastrostomy for enteral feeding in order to prevent" exact="aspiration pneumonia," post="dehydration and malnutrition and to make it easier to"/>
   <result pre="JE, Novak I, Cheong JLY. early diagnosis and treatment of" exact="cerebral palsy" post="in children with a history of preterm birth. Clin"/>
   <result pre="of the epileptogenic zone in children who are eligible for" exact="epilepsy" post="surgery Thomas Foiadelli 1, Katrien Jansen 2, Lieven Lagae"/>
   <result pre="Thomas Foiadelli (t.foiadelli@smatteo.pv.it) Background One out of three children with" exact="epilepsy" post="is drug-resistant. Children with drug-resistant epilepsy must undergo timely"/>
   <result pre="of three children with epilepsy is drug-resistant. Children with drug-resistant" exact="epilepsy" post="must undergo timely and thorough investigations to assess eligibility"/>
   <result pre="must undergo timely and thorough investigations to assess eligibility for" exact="epilepsy" post="surgery. Subtraction ictal-SPECT co-registered to MRI (SISCOM) is a"/>
   <result pre="feasibility and efficacy in children who are candidate for resective" exact="epilepsy" post="surgery. Methods We retrospectively analysed all pediatric patients (≤16"/>
   <result pre="retrospectively analysed all pediatric patients (≤16 years old) with drug-resistant" exact="epilepsy" post="that had entered the screening protocol for epilepsy surgery"/>
   <result pre="with drug-resistant epilepsy that had entered the screening protocol for" exact="epilepsy" post="surgery in the University Hospital of Leuven (Belgium), from"/>
   <result pre="quality of information available to the decision-maker. A65 Non diabetic" exact="hyperglycemia" post="in pediatric age Adriana Franzese (franzese@unina.it) Department of Translational"/>
   <result pre="the treatment of granuloma, and exclude other diagnoses such as" exact="herpes simplex" post="virus infection and Langerhans cell histiocytosis. Conclusion. As a"/>
   <result pre="Maria Giuseppina Gregorio (mariagiuseppina.gregorio@atssardegna.it) The World Health Organization (WHO) defines" exact="obesity" post="as ‘globesity’: a chronic disease so widespread to be"/>
   <result pre="34% of them have bariatric complications. However, the identification of" exact="obesity" post="as disease is recent: in medieval Europe, fat was"/>
   <result pre="would define &quot;fat&quot;. The Greeks were the first to recognize" exact="obesity" post="as a health disorder. Hippocrates wrote &quot;corpulence is not"/>
   <result pre="secondary pathologies were already known. The Indian surgeon Susruta linked" exact="obesity" post="to the onset of cardiac diseases and diabetes, suggesting"/>
   <result pre="to the Intensive Care Unit during the period determined with" exact="bronchiolitis" post="or pneumonia diagnosis. For the statistical analysis, frequencies were"/>
   <result pre="Intensive Care Unit during the period determined with bronchiolitis or" exact="pneumonia" post="diagnosis. For the statistical analysis, frequencies were calculated with"/>
   <result pre="adults Roberto Ieraci (roberto.ieraci@aslroma1.it) Asl Roma 1, Rome, Italy Cervical" exact="cancer" post="is the fourth most common malignancy worldwide. HPV infection"/>
   <result pre="countries where HPV vaccination programmes have been introduced, decrease in" exact="cancer" post="rates is speculated. In Australia, the first country to"/>
   <result pre="patient centered health promotion care that will decrease risks of" exact="cancer" post="in the future [4]. Increasing vaccination rates for HPV"/>
   <result pre="Bambino Gesù, Rome, Italy Correspondence: Andrzej Krzysztofiak (andrzej.krzysztofiak@opbg.net) Background Trauma-related" exact="osteomyelitis" post="are uncommon in children, but potentially devastating. The diagnosis"/>
   <result pre="using standard culture techniques [1]. Among bacterial pathogens responsible of" exact="osteomyelitis" post="following trauma and/or surgical fixation, the most frequent is"/>
   <result pre="clinical and microbiological characteristics of our pediatric cases with post-traumatic" exact="osteomyelitis" post="of extremity fractures. Material and Methods We retrospectively analyzed"/>
   <result pre="analyzed the cases of 14 children [Table 1] who developed" exact="osteomyelitis" post="after surgical treatment of a fracture. The median age"/>
   <result pre="Glaudemans AW. Accuracy of diagnostic imaging modalities for peripheral post-traumatic" exact="osteomyelitis" post="- a systematic review of the recent literature. Eur"/>
   <result pre="Y. Epidemiological, clinical and microbiological characteristics of patients with post-traumatic" exact="osteomyelitis" post="of limb fractures in southwest China: A Hospital-based study."/>
   <result pre="Infect Dis J. 2018;37:1204-1210. 5. Peltola H, Pääkkönen, M. Acute" exact="osteomyelitis" post="in children. N Engl J Med. 2014;370:352–360. Table 1"/>
   <result pre="1 (abstract A76). Clinical and Microbiological characteristics of patients with" exact="osteomyelitis" post="after fracture N pat Age years Sex Days from"/>
   <result pre="described as a comorbid for psychiatric depression, attention deficit/hyperactivity disorder," exact="social phobia," post="anxiety and impulse control disorders, and personality disorders. In"/>
   <result pre="Psichiatr. 2019; 54: 24-30. A79 &quot;Life changing&quot; treatments in pediatric" exact="allergy" post="Amelia Licari (amelia.licari@unipv.it) Department of Pediatrics, Fondazione IRCCS Policlinico"/>
   <result pre="IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy Severe" exact="asthma" post="in childhood is a major public health problem and"/>
   <result pre="the fact that conventional treatment options for children with severe" exact="asthma" post="are extremely limited, there are now some &quot;revolutionary, and"/>
   <result pre="asthma. As our understanding of the underlying pathophysiology of the" exact="asthma" post="spectrum expands, a number of pathways have drawn attention"/>
   <result pre="has been applied to many different therapeutic areas, whose severe" exact="asthma" post="is one that had its greatest development in the"/>
   <result pre="is now recommended as add-on treatment for children with severe" exact="allergic asthma." post="Binding to free IgE, omalizumab reduces cell-bound IgE, down-regulates"/>
   <result pre="[3]. Overall, omalizumab was effective in reducing the rate of" exact="asthma" post="exacerbations, the number of hospitalizations for acute asthma attacks"/>
   <result pre="rate of asthma exacerbations, the number of hospitalizations for acute" exact="asthma" post="attacks and the related need of oral corticosteroids in"/>
   <result pre="corticosteroids in severe asthmatic children; these effects resulted in better" exact="asthma" post="control and improvement of quality of life of children"/>
   <result pre="targeted age group [4]. The approved biologics for pediatric severe" exact="asthma" post="have emerged as important and effective treatments to improve"/>
   <result pre="asthma have emerged as important and effective treatments to improve" exact="asthma" post="outcomes; they are expensive therapies and require careful selection"/>
   <result pre="Obesity is also associated with and increased mortality. Rarely, severe" exact="obesity" post="in children can be the result of a monogenic"/>
   <result pre="leptin or with MC4R agonist drugs. Other forms od severe" exact="obesity" post="are part of complex developmental syndromes caused by monogenic"/>
   <result pre="syndrome and others. However, the large majority of forms of" exact="obesity" post="are the result of a complex interaction between predisposing"/>
   <result pre="development of anti-obesity drugs. Finally, recent research have shown that" exact="obesity" post="and its complications are associated with epigenetic alterations. The"/>
   <result pre="genes seem to play a role in the development of" exact="obesity" post="by controlling processes such as adipogenesis, inflammation, appetite and"/>
   <result pre="Obesity is also associated with and increased mortality. Rarely, severe" exact="obesity" post="in children can be the result of a monogenic"/>
   <result pre="leptin or with MC4R agonist drugs. Other forms od severe" exact="obesity" post="are part of complex developmental syndromes caused by monogenic"/>
   <result pre="syndrome and others. However, the large majority of forms of" exact="obesity" post="are the result of a complex interaction between predisposing"/>
   <result pre="development of anti-obesity drugs. Finally, recent research have shown that" exact="obesity" post="and its complications are associated with epigenetic alterations. The"/>
   <result pre="genes seem to play a role in the development of" exact="obesity" post="by controlling processes such as adipogenesis, inflammation, appetite and"/>
   <result pre="including autonomous signs or automatisms. The main etiology is hypoxic-ischemic" exact="encephalopathy" post="(about 45%) with early crises and variable semiology, including"/>
   <result pre="favorable prognosis (neonatal benign familial epilepsy) or unfavorable (early infantile" exact="encephalopathy" post="with epilepsy, early myoclonic encephalopathy and partial migration in"/>
   <result pre="epilepsy) or unfavorable (early infantile encephalopathy with epilepsy, early myoclonic" exact="encephalopathy" post="and partial migration in childhood) [3]. Knowledge of neonatal"/>
   <result pre="the upper airways, due for example to the presence of" exact="allergic rhinitis," post="but also from the postural changes of the intraoral"/>
   <result pre="extra and intraoral aspect of the mouth breathing child. Therefore," exact="allergic rhinitis" post="is one of the main causes of malocclusions in"/>
   <result pre="and intraoral aspect of the mouth breathing child. Therefore, allergic" exact="rhinitis" post="is one of the main causes of malocclusions in"/>
   <result pre="risk. It is estimated that in Italy the prevalence of" exact="allergic rhinitis" post="for subjects in the age range from 6 to"/>
   <result pre="It is estimated that in Italy the prevalence of allergic" exact="rhinitis" post="for subjects in the age range from 6 to"/>
   <result pre="preventive dental examination. A83 Biologic therapy in pediatric chronic non-infectious" exact="uveitis" post="Ilaria Maccora, Gabriele Simonini SODc di Reumatologia, AOU ANNA"/>
   <result pre="21% are associated to Juvenile Idiopathic Arthritis (JIA). Chronic pediatric" exact="uveitis" post="can be a complex therapeutic challenge, that if not"/>
   <result pre="us recommendation for the diagnosis, screening, treatment and management of" exact="uveitis" post="associated to JIA. There is agreement for the first-line"/>
   <result pre="anti-TNFα both result in efficacy. In children with anti-TNFα resistant" exact="uveitis" post="Abatacept, Tocilizumab and Rituximab are other possible options. Abatacept"/>
   <result pre="versus second-line. Tocilizumab is anti-IL6 is an emerging treatment for" exact="uveitis" post="and cystoid macular oedema. Rituximab and canakinumab are progressively"/>
   <result pre="Jacobs J, Springer DA, Crothers D. Homeopatic treatment of acute" exact="otitis media" post="in children: a preliminary randomized placebo- control trial. Pediatr"/>
   <result pre="immune response. IVIG are effective in the resolution of fever," exact="hepatitis" post="and/or cholestasis also if triggered by infections [3]. Anti-TNF-α"/>
   <result pre="IVIG are effective in the resolution of fever, hepatitis and/or" exact="cholestasis" post="also if triggered by infections [3]. Anti-TNF-α drugs are"/>
   <result pre="Maggio MC, Ragusa SS, Corsello G. Early treatment of systemic" exact="juvenile idiopathic arthritis" post="with canakinumab and complete remission after 2 years of"/>
   <result pre="Ragusa SS, Corsello G. Early treatment of systemic juvenile idiopathic" exact="arthritis" post="with canakinumab and complete remission after 2 years of"/>
   <result pre="Alessandra Marchesi (alessandra.marchesi@opbg.net) Kawasaki disease (KD) is an acute, systemic" exact="vasculitis" post="[1,2]. According to the &quot;Revised International Chapel Hill Consensus"/>
   <result pre="disease: a statement for health professionals from the committee on" exact="rheumatic fever," post="endocarditis and Kawasaki disease, council on cardiovascular disease in"/>
   <result pre="statement for health professionals from the committee on rheumatic fever," exact="endocarditis" post="and Kawasaki disease, council on cardiovascular disease in the"/>
   <result pre="committee on rheumatic fever, endocarditis and Kawasaki disease, council on" exact="cardiovascular disease" post="in the young, American Heart Association. Pediatrics. 2004;114:1708-33. 2."/>
   <result pre="2012 Revised international chapel hill consensus conference nomenclature of vasculitides." exact="arthritis" post="rheum. 2013;65:1-11. 4. Marchesi A, Tarissi de Jacobis I,"/>
   <result pre="clinical manifestation of nephropathy, and an independent risk factor for" exact="retinopathy" post="and cardiovascular disease. My work with cohorts of childhood-onset"/>
   <result pre="of nephropathy, and an independent risk factor for retinopathy and" exact="cardiovascular disease." post="My work with cohorts of childhood-onset T1D (Oxford Regional"/>
   <result pre="(AIT) is a proven therapeutic option for the treatment of" exact="allergic rhinitis" post="and/or asthma. AIT is the only therapy that can"/>
   <result pre="is a proven therapeutic option for the treatment of allergic" exact="rhinitis" post="and/or asthma. AIT is the only therapy that can"/>
   <result pre="Padova, 35128, Italy Correspondence: Davide Massano (davide.massano@aopd.veneto.it) Background The word" exact="lymphadenopathy" post="(LAP) identifies a condition in which lymph nodes are"/>
   <result pre="al. Development of an algorithm for the management of cervical" exact="lymphadenopathy" post="in children: consensus of the Italian Society of Preventive"/>
   <result pre="gene therapy and stem-cell technologies to treat patients affected by" exact="junctional epidermolysis bullosa" post="(JEB). They developed a method to extract stem cells"/>
   <result pre="therapy and stem-cell technologies to treat patients affected by junctional" exact="epidermolysis bullosa" post="(JEB). They developed a method to extract stem cells"/>
   <result pre="chimeric antigen receptors), which recently leads to further improvement of" exact="leukemia" post="immunotherapy. Despite only 7 years have passed since CRISPR-cas9"/>
   <result pre="and Kymriah® for the treatment of children with refractory B-cell" exact="acute lymphoblastic leukemia." post="However, they are personalized therapies and thus too expensive"/>
   <result pre="Kymriah® for the treatment of children with refractory B-cell acute" exact="lymphoblastic leukemia." post="However, they are personalized therapies and thus too expensive"/>
   <result pre="F, Di Iorio E, Recchia A, et al. Correction of" exact="junctional epidermolysis bullosa" post="by transplantation of genetically modified epidermal stem cells. Nat"/>
   <result pre="Di Iorio E, Recchia A, et al. Correction of junctional" exact="epidermolysis bullosa" post="by transplantation of genetically modified epidermal stem cells. Nat"/>
   <result pre="317 and 57 were defined as having non-severe and severe" exact="viral disease," post="respectively. TRAIL levels were markedly increased in all viral"/>
   <result pre="(MAS). In childhood, this condition occurs most commonly in systemic" exact="juvenile idiopathic arthritis" post="(sJIA). Primary HLH and MAS share many similarities in"/>
   <result pre="childhood, this condition occurs most commonly in systemic juvenile idiopathic" exact="arthritis" post="(sJIA). Primary HLH and MAS share many similarities in"/>
   <result pre="and the availability of the novel biologic medications. Focusing on" exact="juvenile idiopathic arthritis" post="(JIA), the most common rheumatic disease in childhood and"/>
   <result pre="availability of the novel biologic medications. Focusing on juvenile idiopathic" exact="arthritis" post="(JIA), the most common rheumatic disease in childhood and"/>
   <result pre="in polyarticular JIA and anti interleukin-1 and interleukin-6 in systemic" exact="juvenile idiopathic arthritis." post="Intrarticular corticosteroid injections (IACI) revolutionized not only the treatment"/>
   <result pre="It can be used in the management of children with" exact="bronchiolitis" post="[5] [6] It has also demonstrated 100% accuracy in"/>
   <result pre="accuracy. [9] It is useful even during pulse checks during" exact="cardiac arrest" post="resuscitation [10] and for categorization of shock state and"/>
   <result pre="with thoracic or abdominal trauma. It allows to check hemothorax," exact="pericardial effusion" post="and tamponade, and to identify an intra-abdominal source of"/>
   <result pre="Ellington LE, et al. Lung ultrasound for the diagnosis of" exact="pneumonia" post="in children: a meta-analysis. Pediatrics 2015;135:714–722. 5. Supino MC,"/>
   <result pre="Bock C, Chiaretti A. Point-of-care lung ultrasound in infants with" exact="bronchiolitis" post="in the pediatric emergency department: a prospective study. Eur"/>
   <result pre="Crashing Infant (LUCI) Protocol Study Group. Lung ultrasound for diagnosing" exact="pneumothorax" post="in the critically ill neonate. J Pediatr 2016;175:74–78. 8."/>
   <result pre="Sodano A, Capasso L, Raimondi F. Lung ultrasound- guided emergency" exact="pneumothorax" post="needle aspiration in a very preterm infant. BMJ Case"/>
   <result pre="et al. Emergency department point-of-care ultrasound in out-of-hospital and in-ED" exact="cardiac arrest." post="Resuscitation 2016;109:33-39. 11. Whitson MR, Mayo PH. Ultrasonography in"/>
   <result pre="(WHO 2015). Iron-Deficiency Anemia represents the most common cause of" exact="anemia" post="in immigrant children, but hemoglobinopathies are also frequent. Thalassemias"/>
   <result pre="However, in carriers of both the hemoglobin E gene and" exact="beta-thalassemia" post="severe anemia may result. HbC disease is frequent in"/>
   <result pre="carriers of both the hemoglobin E gene and beta-thalassemia severe" exact="anemia" post="may result. HbC disease is frequent in people originary"/>
   <result pre="is frequent in people originary from West Atlantic Africa. The" exact="anemia" post="is mycrocitic, usually mild or moderate, with a slight"/>
   <result pre="collaboration. A101 The workflow in a home telemonitoring project for" exact="cystic fibrosis" post="patients: the role of the nurse Clarissa Paglia, Bella"/>
   <result pre="the Caucasian population. Classically, the CF is known as a" exact="respiratory disease," post="where it causes repeated infections and progressive bronchiectasis formations"/>
   <result pre="a respiratory disease, where it causes repeated infections and progressive" exact="bronchiectasis" post="formations until the development of respiratory failure. Respiratory exacerbations"/>
   <result pre="repeated infections and progressive bronchiectasis formations until the development of" exact="respiratory failure." post="Respiratory exacerbations are a critical event for the CF"/>
   <result pre="AIT vaccines in adults and in children both for respiratory" exact="allergy" post="and for venom hypersensitivity and recent data look promising"/>
   <result pre="and in children both for respiratory allergy and for venom" exact="hypersensitivity" post="and recent data look promising also for IgE-mediated food"/>
   <result pre="venom hypersensitivity and recent data look promising also for IgE-mediated" exact="food allergy." post="However AIT for many reason remains underused. The European"/>
   <result pre="it is important to begin AIT in childhood when bronchial" exact="asthma" post="and other allergic comorbidities (i.e rhinitis) are often less"/>
   <result pre="efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass" exact="allergy" post="immunotherapy tablet. J Allergy Clin Immunol. 2010;125:131-8.e1-7. 4. Pajno"/>
   <result pre="Alvaro-Lozano M et al. EAACI Guidelines on allergen immunotherapy: IgE-mediated" exact="food allergy." post="Allergy. 2018;73:799-815. 9. Bonertz A, Roberts GC, Hoefnagel M,"/>
   <result pre="IMMUNOTHERAPY Immunotherapy is effective only in IgE-mediated diseases such as" exact="allergic rhinitis," post="allergic asthma and stinging insect anaphylaxis. Successful therapy require"/>
   <result pre="is effective only in IgE-mediated diseases such as allergic rhinitis," exact="allergic asthma" post="and stinging insect anaphylaxis. Successful therapy require years to"/>
   <result pre="effective only in IgE-mediated diseases such as allergic rhinitis, allergic" exact="asthma" post="and stinging insect anaphylaxis. Successful therapy require years to"/>
   <result pre="factors for systemic reaction such as of uncontrolled or severe" exact="asthma" post="or high allergen exposure need to be considered. A103"/>
   <result pre="than one-third of the costs (32%). A105 Endocrine consequences in" exact="cancer" post="survivors Stefania Pedicelli (stefania.pedicelli@gmail.com) Endocrinology Unit, &quot;Bambino Gesù&quot; Children’s"/>
   <result pre="Italy The continuous improvement in treatment and care of childhood" exact="cancer" post="has led to increased long-term survival rates. This has"/>
   <result pre="density. Recent data show that 40% to 50% of childhood" exact="cancer" post="survivors will develop at least one endocrine disorder over"/>
   <result pre="second neoplasia are still debated, whereas the risk of primary" exact="cancer" post="relapse seems to be not increased. Particular attention has"/>
   <result pre="strategies to preserve fertility. In conclusion, the follow-up of childhood" exact="cancer" post="survivors requires a multidisciplinary approach, and, considering that endocrine"/>
   <result pre="in good health and to prevent the problem of overweight," exact="obesity" post="and numerous diseases of young and adult age. As"/>
   <result pre="of PM 10 and PM 2.5 and increased incidence of" exact="asthma" post="and exertion asthma symptoms. In this context the pediatrician"/>
   <result pre="and PM 2.5 and increased incidence of asthma and exertion" exact="asthma" post="symptoms. In this context the pediatrician plays a role"/>
   <result pre="Migliaccio C, Borriello A, Cucciolla V, et al. Von Hippel-Lindau-dependent" exact="polycythemia" post="is endemic on the island of Ischia: identification of"/>
   <result pre="and Wales were the ones with the highest rates of" exact="heart disease." post="Why would this be, he wondered, when heart disease"/>
   <result pre="of heart disease. Why would this be, he wondered, when" exact="heart disease" post="was supposed to be a condition of affluence of"/>
   <result pre="(1921-25)— often an indication of poor prenatal nutrition — and" exact="heart disease" post="in middle age (1968-78) [1]. Faced with an inadequate"/>
   <result pre="a proposal of ten good practices to help to prevent" exact="obesity" post="in the unique window of opportunity, the first 1000"/>
   <result pre="health efforts are needed to achieve the healthy objectives for" exact="obesity" post="and nutrition and to fight the childhood obesity epidemic"/>
   <result pre="objectives for obesity and nutrition and to fight the childhood" exact="obesity" post="epidemic [6]. References 1. Barker DJ, Osmond C. Infant"/>
   <result pre="Barker DJ, Osmond C. Infant mortality, childhood nutrition, and ischaemic" exact="heart disease" post="in England and Wales. Lancet. 1986;1:1077-81. 2. Barker DJ,"/>
   <result pre="B, Simmonds SJ. Weight in infancy and death from ischaemic" exact="heart disease." post="Lancet. 1989;2:577-80. 3. Barker DJ, Gluckman PD, Godfrey KM,"/>
   <result pre="KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and" exact="cardiovascular disease" post="in adult life. Lancet. 1993;341:938-41. 4. Pietrobelli A, Agosti"/>
   <result pre="for prematurity), is generally considered an ominous sign predictive of" exact="cerebral palsy" post="(CP)[4]. The integration of perinatal history, clinical evaluation, cerebral"/>
   <result pre="A recent study showed in term infants with hypoxic ischemic" exact="encephalopathy" post="a strict correlation between GMs and the site and"/>
   <result pre="points and correlation with long term neuropsychiatric disorders such as" exact="autism" post="and ADHD [6-10]. Moreover, the opportunity for the clinician"/>
   <result pre="months of life: General movements in infants later diagnosed with" exact="autism" post="spectrum disorder or Rett Syndrome. Res Autism Spectr Disord."/>
   <result pre="The most common type of Primary headaches among children are" exact="migraine" post="and tension type headache (TTH), however their differential diagnosis"/>
   <result pre="manage the pain in the likely primary headache in particular" exact="migraine" post="and TTH among patients admitted in Pediatric emergency department"/>
   <result pre="primary headache in children. Ibuprofen maybe more effective in the" exact="migraine" post="and TTH than paracetamol administered orally, but it needs"/>
   <result pre="2012. pp 26-41. A112 Clinical features of the newborn with" exact="neuromuscular disease" post="Carmelo Rachele (carmelo.rachele@virgilio.it) Pediatra di Famiglia FIMP (Federazione Italiana"/>
   <result pre="isolate the genes and to identify the encoded proteins. Duchenne" exact="muscular dystrophy," post="characterized by progressive atrophy and weakness of skeletal and"/>
   <result pre="suspicion, a diagnostic process to confirm the existence of a" exact="neuromuscular disease." post="A113 Acute Ataxia Umberto Raucci (umberto.raucci@opbg.net) Pediatric Emergency Department,"/>
   <result pre="is a relatively uncommon neurological emergency in childhood. Acute post-infectious" exact="cerebellar ataxia" post="is the first cause of acute ataxia in children,"/>
   <result pre="ataxia, and altered levels of consciousness up to coma. Autoimmune" exact="encephalitis" post="(AE) is a severe condition in which the immune"/>
   <result pre="LGI1, CASPR2, VGKC-complex antibodies, AMPA, and GABA. In some patients," exact="encephalopathy" post="can be part of a paraneoplastic phenomenon, although in"/>
   <result pre="who are antibody negative in which etiology remains unknown. Steroid-responsive" exact="encephalopathy" post="associated with autoimmune thyroiditis (Hashimoto encephalopathy) in children or"/>
   <result pre="negative in which etiology remains unknown. Steroid-responsive encephalopathy associated with" exact="autoimmune thyroiditis" post="(Hashimoto encephalopathy) in children or adolescents can begin abruptly"/>
   <result pre="in which etiology remains unknown. Steroid-responsive encephalopathy associated with autoimmune" exact="thyroiditis" post="(Hashimoto encephalopathy) in children or adolescents can begin abruptly"/>
   <result pre="headaches, or acute focal neurological dysfunction. Conclusions. Infectious and non-infectious" exact="encephalitis" post="share similar clinical signs and symptoms. However, neuro-psychiatric symptoms"/>
   <result pre="indeed due to collateral effects (type A reactions), others are" exact="hypersensitivity" post="reactions (type B), while only a few are true"/>
   <result pre="mediated signs and symptoms (urticaria, angioedema, anaphylaxis). Other type of" exact="hypersensitivity" post="reactions have been described (Type II-IV) and require specific"/>
   <result pre="S, Saretta F, Mori F, Blanca-Lopez N, et al. Drug" exact="hypersensitivity" post="in children: report from the pediatric task force of"/>
   <result pre="G. Language and motor skills in siblings of children with" exact="autism" post="spectrum disorder: A meta‐analytic review. Autism Res. 2017;10:1737-1750. 5."/>
   <result pre="It doesn't occur exclusively during the course of anorexia or" exact="bulimia nervosa," post="from which differ for the absence of concern about"/>
   <result pre="isn't better explained by another mental disease. When co-exist a" exact="mental disorder," post="the severity exceeds that routinely associated with the basal"/>
   <result pre="17.4% across eating disorders. [6] Psychiatric comorbidities, including anxiety disorders," exact="autism" post="spectrum disorder and attention deficit hyperactivity disorder (ADHD) are"/>
   <result pre="[6] Psychiatric comorbidities, including anxiety disorders, autism spectrum disorder and" exact="attention deficit hyperactivity disorder" post="(ADHD) are common among individuals with ARFID [7]. ARFID"/>
   <result pre="studies show risk for amenorrhea, bradycardia, prolonged QT interval and" exact="hypokalemia" post="till to neurological degeneration because of folate deficiency. It"/>
   <result pre="N. Severe avoidant/restrictive food intake disorder and coexisting stimulant treated" exact="attention deficit hyperactivity disorder." post="Int J Eat Disord. 2016; 49(11):1036-1039. 8. Toufexis MD,"/>
   <result pre="in pediatric patients. A120 Andrological pathologies in pediatric age: preventing" exact="infertility" post="Matteo Sulpasso (sulpasso.matteo@libero.it) Pederzoli Hospital, Peschiera del Garda (Verona),"/>
   <result pre="may cause serious repercussions on normal fertility and, sometimes, ease" exact="cancer" post="outbreak. Materials and methods Andrological screening should be inserted"/>
   <result pre="sexual health: precocious puberty, delayed puberty, sexually transmitted diseases, varicocele," exact="cryptorchidism" post="and testicular cancer are often preventable and more often"/>
   <result pre="precocious puberty, delayed puberty, sexually transmitted diseases, varicocele, cryptorchidism and" exact="testicular cancer" post="are often preventable and more often curable. Already at"/>
   <result pre="puberty, delayed puberty, sexually transmitted diseases, varicocele, cryptorchidism and testicular" exact="cancer" post="are often preventable and more often curable. Already at"/>
   <result pre="male genital diseases such as varicocele, cryptorchidism, increased incidence of" exact="testicular cancer," post="reduction in semen quality and increase of hypospadias are"/>
   <result pre="of testicular cancer, reduction in semen quality and increase of" exact="hypospadias" post="are the expression of one single phenomenon: testicular dysgenesis"/>
   <result pre="3 adolescents has an andrological disease. The first cause of" exact="male infertility" post="is varicocele. Varicocele occurs in the development age (paediatric-adolescent"/>
   <result pre="adolescents has an andrological disease. The first cause of male" exact="infertility" post="is varicocele. Varicocele occurs in the development age (paediatric-adolescent"/>
   <result pre="with testicular hypotrophy. Cryptorchidism is the second leading cause of" exact="male infertility." post="The risk of developing testicular cancer is 3 to"/>
   <result pre="second leading cause of male infertility. The risk of developing" exact="testicular cancer" post="is 3 to 4 times higher in a criptorchide"/>
   <result pre="leading cause of male infertility. The risk of developing testicular" exact="cancer" post="is 3 to 4 times higher in a criptorchide"/>
   <result pre="4 times higher in a criptorchide patient. Early treatment of" exact="cryptorchidism" post="reduces the risk not only of infertility but also"/>
   <result pre="Early treatment of cryptorchidism reduces the risk not only of" exact="infertility" post="but also of testicular cancer. Conclusions These studies and"/>
   <result pre="reduces the risk not only of infertility but also of" exact="testicular cancer." post="Conclusions These studies and physicians daily experience confirm the"/>
   <result pre="motor function and health-related quality of life in children with" exact="cerebral palsy" post="as reported by their physiotherapists. BMC Pediatr. 2014;14:192. 4."/>
   <result pre="Italy Correspondence: Rita Tanas (tanas.rita@gmail.com) Is there any development in" exact="obesity" post="treatment? Obesity prevalence keeps rising among poorest countries and"/>
   <result pre="out jointly by politics, industry, media, and schools, starting with" exact="obesity" post="stigma. Stigma – which nowadays is spreading and increasing"/>
   <result pre="among professionals too. Failure to achieve the expected results in" exact="obesity" post="treatment leads to disappointment and guilt in pediatricians, who"/>
   <result pre="al. An integrated framework for the prevention and treatment of" exact="obesity" post="and its related chronic diseases. Health Aff (Millwood). 2015;34:1456-63."/>
   <result pre="body image dissatisfaction , eating disorders 3. Increase of weight," exact="obesity" post="comorbidities and death rate among the population 4. Decreased"/>
   <result pre="with families and support good qualities and intentions 2. Accept" exact="obesity" post="as a disease, indeed a chronic disease, and actually"/>
   <result pre="task, including social and incurable ones. 3. Accept that once" exact="obesity" post="has been established, weight loss results can be small."/>
   <result pre="are harmful to the body such as smoking, drugs and" exact="alcohol abuse." post="Physical activity improves the learning abilities and adaptability of"/>
   <result pre="an important form of prevention of respiratory and cardiovascular diseases," exact="obesity" post="and metabolic disease. Regular physical activity with an adequate"/>
   <result pre="physical activity with an adequate workload reduces minute ventilation and" exact="lactic acidosis," post="improves maximum oxygen consumption (VO2max), strengthens the muscle groups"/>
   <result pre="flow outcomes. Acad Emerg Med. 2008;15:832–7. A127 The impact of" exact="rheumatic fever" post="in a Province of Central-North Italy Elena Tronconi 1,"/>
   <result pre="of Bologna, Bologna, Italy Correspondence: Elena Tronconi (elena.tronconi@studio.unibo.it) Background Acute" exact="rheumatic fever" post="(ARF) is a multisystem complication of group A streptococcal"/>
   <result pre="Carditis was present in 27 patients (79.4% of cases) while" exact="chorea" post="in 10 children (29.4%). In 4 patients the diagnosis"/>
   <result pre="It is important to consider the new HR criteria for" exact="arthritis" post="in order not to miss diagnosis. A careful clinical"/>
   <result pre="mandatory. References 1. Carapetis J, McDonald M, Wilson N. Acute" exact="rheumatic fever." post="Lancet. 2005;366:155-168. 2. Gewitz H, Baltimore R, Lloyd T,"/>
   <result pre="Revision of the Jones Criteria for the diagnosis of acute" exact="rheumatic fever" post="in the era of Doppler echocardiography: a scientific statement"/>
   <result pre="Altobelli E. Population-based study of incidence and clinical characteristics of" exact="rheumatic fever" post="in Abruzzo, central Italy, 2000-2009. J Pediatr. 2012;160:832-836.e1. 4."/>
   <result pre="University of Chieti-Pescara, Chieti, Italy Correspondence: Stefano Tumini (stefano.tumini@gmail.com) The" exact="diabetic ketoacidosis" post="is one of the most frequent endocrine diseases in"/>
   <result pre="among the T1DM onset cases [1]. The DKA is a" exact="metabolic disorder" post="caused by the total or partial insulin deficiency and"/>
   <result pre="Sharp SJ, Walter FM. Factors associated with the presence of" exact="diabetic ketoacidosis" post="at diagnosis of diabetes in children and young adults:"/>
   <result pre="vs. 0.48%). Important causes for increased mortality in DS are" exact="congenital heart disease," post="leukemia, testicular cancer and sepsis. In addition, respiratory tract"/>
   <result pre="0.48%). Important causes for increased mortality in DS are congenital" exact="heart disease," post="leukemia, testicular cancer and sepsis. In addition, respiratory tract"/>
   <result pre="for increased mortality in DS are congenital heart disease, leukemia," exact="testicular cancer" post="and sepsis. In addition, respiratory tract infection represents the"/>
   <result pre="increased mortality in DS are congenital heart disease, leukemia, testicular" exact="cancer" post="and sepsis. In addition, respiratory tract infection represents the"/>
   <result pre="rhinoviruses, parainfluenza viruses type 1, 2, 3 and 4 and" exact="influenza" post="viruses type A and B. The remaining 20% of"/>
   <result pre="8. Kaur R, Morris M, Pichichero ME. Epidemiology of acute" exact="otitis media" post="in the postpneumococcal conjugate vaccine era. Pediatrics. 2017;140: pii:"/>
   <result pre="one lives, especially in later generations, with increased incidence of" exact="obesity" post="and its serious consequences up to DM2 and metabolic"/>
   <result pre="of obesity and its serious consequences up to DM2 and" exact="metabolic syndrome." post="All this may depend on various endogenous and exogenous"/>
   <result pre="many children, who come from areas with iodine deficiency, where" exact="congenital hypothyroidism" post="also appears to be more frequent, once they take"/>
   <result pre="children, who come from areas with iodine deficiency, where congenital" exact="hypothyroidism" post="also appears to be more frequent, once they take"/>
   <result pre="take normal iodine amounts they run the risk of developing" exact="autoimmune thyroiditis." post="Moreover, the frequent finding of elevated TSH at arrival"/>
   <result pre="is an endemic, underdiagnosed, bacterial respiratory infection caused by Bordetella" exact="pertussis" post=". Despite a widespread vaccination program, pertussis continues to"/>
   <result pre="caused by Bordetella pertussis . Despite a widespread vaccination program," exact="pertussis" post="continues to be a common worldwide infection in paediatric"/>
   <result pre="US, Canada and Australia too. Infants are known to acquire" exact="pertussis" post="from adolescents’ and adults’ contacts that return susceptible to"/>
   <result pre="on age: in previously immunised or infected adolescents and adults" exact="pertussis" post="can be atypical and often asymptomatic, with the main"/>
   <result pre="rates [2]. The cause of deaths in infants is irreversible" exact="pulmonary hypertension" post="associated with aggregates of white blood cells in pulmonary"/>
   <result pre="medications provide symptomatic relief from pertussis-associated cough. Antibiotics eliminate Bordetella" exact="pertussis" post="from nasopharynx and reduce the risk of transmission; they"/>
   <result pre="with WHO, demonstrate that the best cost-effective intervention in newborns" exact="pertussis" post="prevention is the vaccination with dTap vaccine in the"/>
   <result pre="Infect Dis. 2016;16:414. 2) Cherry JD. The prevention of severe" exact="pertussis" post="and pertussis deaths in young infant. Expert Rev Vaccines."/>
   <result pre="2016;16:414. 2) Cherry JD. The prevention of severe pertussis and" exact="pertussis" post="deaths in young infant. Expert Rev Vaccines. 2019;18:205-208. 3)"/>
   <result pre="Sin J, NG ESW, Wang K. Efficacy and safety of" exact="pertussis" post="vaccination for pregnant women - a systematic review of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="pediatricmusic/PMC6939407/results/search/disease/results.xml">
   <result pre="a solid evidence base for nonpharmacological interventions. Keywords tension﻿-type headache" exact="migraine" post="pain sleep quality of life coping fig-count: table-count: ref-count:"/>
   <result pre="headache more frequently after puberty. 3 Tension-type headache (TTH) and" exact="migraine" post="are considered different disorders with separate pathomechanisms that often"/>
   <result pre="varying relative importance over time, from predominant TTH to predominant" exact="migraine" post="and vice versa. 6, 8 In chronic forms in"/>
   <result pre="sensitization of the central nervous system in both TTH and" exact="migraine" post="9– 11 and further reinforced by lifestyle factors. Sensitization"/>
   <result pre="than other chronic or longer standing childhood illnesses, such as" exact="juvenile idiopathic arthritis" post="and cancer. 29 A child suffering from primary headache"/>
   <result pre="chronic or longer standing childhood illnesses, such as juvenile idiopathic" exact="arthritis" post="and cancer. 29 A child suffering from primary headache"/>
   <result pre="Participants were diagnosed with primary headache, tension-type headache (TTH) or" exact="migraine" post="Interventions Nonpharmacological interventions as standalone approaches or in combination"/>
   <result pre="and coping. Studies of mental illness, disability, and acute conditions," exact="anxiety disorder," post="attention deficit hyperactivity disorder and other psychiatric diagnoses, pharmacology,"/>
   <result pre="Studies of mental illness, disability, and acute conditions, anxiety disorder," exact="attention deficit hyperactivity disorder" post="and other psychiatric diagnoses, pharmacology, melatonin and solely or"/>
   <result pre="2 arms To examine the feasibility of telephone administered behavioural" exact="migraine" post="management vs drug therapy Migraine 2–6/M by ICHD-II. N=34,"/>
   <result pre="weekly learning tasks for 8 weeks T2: Triptan treatment at" exact="migraine" post="headache for 8 M. T1 demonstrated partial mastery of"/>
   <result pre="8 M. T1 demonstrated partial mastery of skills, clinically meaningful" exact="migraine" post="reduction and improvement of QOL. Sample sizes too small"/>
   <result pre="the clinical efficacy of the MIPAS-Family behavioral training program on" exact="migraine" post="iCNV habituation Migraine without aura by ICHD-II Right-handed. N=26,"/>
   <result pre="time. Group training and involvement of parents recommended. Significantly reduced" exact="migraine" post="frequency and intensity for both groups without between-group difference."/>
   <result pre="strengths and difficulties and satisfaction Frequent or chronic TTH and" exact="migraine" post="by ICHD-II N=78, 12–17 years and parents T: 40"/>
   <result pre="headache education plus amitriptyline on pain, disability and credibility Chronic" exact="migraine" post="by ICHD-II PedMIDAS ≥ 20 points N=135, 10–17 years"/>
   <result pre="participants in a previous trial needed less preventive medication Chronic" exact="migraine" post="by ICHD-II PedMIDAS ≥ 20 N=135, 10–17 years T1:"/>
   <result pre="46– 48, 51, 55 Medication Cottrell et al 53 used" exact="migraine" post="medication as an active control group and found an"/>
   <result pre="retrospective clinical study assessing the prevalence and occurrence of possible" exact="migraine" post="trigger factors in children and adolescents with migraine showed"/>
   <result pre="of possible migraine trigger factors in children and adolescents with" exact="migraine" post="showed that stress was the most frequently reported trigger"/>
   <result pre="control group, suggesting that better sleep quality led to altered" exact="migraine" post="patterns. Although this study did not directly measure the"/>
   <result pre="with stressful situations, adjust to aversive stimuli, and even prevent" exact="migraine" post="attacks. Gerber et al 54 found that parents were"/>
   <result pre="daily family routines. In terms of the feasibility of training" exact="migraine" post="management skills in a group setting for adolescents, Cottrell"/>
   <result pre="telephone-administered behavior treatment was associated with clinically significant improvements in" exact="migraine" post="that did not reach statistical significance due to small"/>
   <result pre="Sivaraman B , Graham C . Prevalence of headache and" exact="migraine" post="in children and adolescents: a systematic review of population-based"/>
   <result pre="et al. Symptoms of central sensitization and comorbidity for juvenile" exact="fibromyalgia" post="in childhood migraine: an observational study in a tertiary"/>
   <result pre="A , Squires A , Herrmann L . Meta-synthesis on" exact="migraine" post="management. Headache . 2018; 58( 1): 22– 44. doi:"/>
   <result pre="Child Health, Editorial Office. Clinical Answers: are nonpharmacological interventions for" exact="migraine" post="effective in children and adolescents? Evid-Based Child Health ."/>
   <result pre="behavioral therapy plus amitriptyline for children and adolescents with chronic" exact="migraine" post="reduces headache days to ≤4 per month . Headache"/>
   <result pre=", et al. Cognitive behavioral therapy plus amitriptyline for chronic" exact="migraine" post="in children and adolescents: a randomized clinical trial ."/>
   <result pre="F . Feasibility assessment of telephone-administered behavioral treatment for adolescent" exact="migraine" post=". Headache . 2007; 47( 9): 1293– 1302. doi:"/>
   <result pre=", Bickel JL , et al. Headstrong intervention for pediatric" exact="migraine" post="headache: a randomized clinical trial. J Headache Pain ."/>
   <result pre="contributes to normalization of contingent negative variation in children with" exact="migraine" post=". Cephalalgia . 2011; 31( 5): 562– 572. doi:"/>
   <result pre=", Galli F , Guidetti V . Sleep hygiene and" exact="migraine" post="in children and adolescents. Cephalalgia . 1999; 19: 57."/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
